10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 ______________________________________

Form 10-Q

(Mark One)

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2016

or

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM TO

Commission file number: 001-15787

 ________________________________________

MetLife, Inc.

(Exact name of registrant as specified in its charter)

Delaware	13-4075851
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
200 Park Avenue, New York, N.Y.	10166-0188
(Address of principal executive offices)	(Zip Code)

(212) 578-9500

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	þ		Accelerated filer	¨
Non-accelerated filer	¨	(Do not check if a smaller reporting company)	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨No þ

At October 31, 2016, 1,099,135,417 shares of the registrant’s common stock, $0.01 par value per share, were outstanding.

Table of Contents

		Page
Part I — Financial Information
Item 1.	Financial Statements (at September 30, 2016 (Unaudited) and December 31, 2015 and for the Three Months and Nine Months Ended September 30, 2016 and 2015 (Unaudited))	3
	Interim Condensed Consolidated Balance Sheets	3
	Interim Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)	4
	Interim Condensed Consolidated Statements of Equity	5
	Interim Condensed Consolidated Statements of Cash Flows	6
	Notes to the Interim Condensed Consolidated Financial Statements:
	Note 1 — Business, Basis of Presentation and Summary of Significant Accounting Policies	7
	Note 2 — Segment Information	9
	Note 3 — Disposition	18
	Note 4 — Insurance	18
	Note 5 — Deferred Policy Acquisition Costs and Value of Business Acquired	20
	Note 6 — Closed Block	20
	Note 7 — Investments	23
	Note 8 — Derivatives	37
	Note 9 — Fair Value	54
	Note 10 — Goodwill	76
	Note 11 — Equity	77
	Note 12 — Other Expenses	81
	Note 13 — Employee Benefit Plans	82
	Note 14 — Earnings Per Common Share	83
	Note 15 — Contingencies, Commitments and Guarantees	83
	Note 16 — Subsequent Event	91
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	92
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	181
Item 4.	Controls and Procedures	182
Part II — Other Information
Item 1.	Legal Proceedings	183
Item 1A.	Risk Factors	185
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	188
Item 6.	Exhibits	189
Signatures		190
Exhibit Index		E - 1

As used in this Form 10‑Q, “MetLife,” the “Company,” “we,” “our” and “us” refer to MetLife, Inc., a Delaware corporation incorporated in 1999, its subsidiaries and affiliates.

Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10‑Q, including Management’s Discussion and Analysis of Financial Condition and Results of Operations, may contain or incorporate by reference information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give expectations or forecasts of future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They use words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” and other words and terms of similar meaning, or are tied to future periods, in connection with a discussion of future operating or financial performance. In particular, these include statements relating to future actions, prospective services or products, future performance or results of current and anticipated services or products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, trends in operations and financial results.

Any or all forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining the actual future results of MetLife, Inc., its subsidiaries and affiliates. These statements are based on current expectations and the current economic environment. They involve a number of risks and uncertainties that are difficult to predict. These statements are not guarantees of future performance. Actual results could differ materially from those expressed or implied in the forward-looking statements. Risks, uncertainties, and other factors that might cause such differences include the risks, uncertainties and other factors identified in MetLife, Inc.’s filings with the U.S. Securities and Exchange Commission. These factors include: (1) difficult conditions in the global capital markets; (2) increased volatility and disruption of the global capital and credit markets, which may affect our ability to meet liquidity needs and access capital, including through our credit facilities, generate fee income and market-related revenue and finance statutory reserve requirements and may require us to pledge collateral or make payments related to declines in value of specified assets, including assets supporting risks ceded to certain of our captive reinsurers or hedging arrangements associated with those risks; (3) exposure to global financial and capital market risks, including as a result of the pending withdrawal of the United Kingdom from the European Union, other disruption in Europe and possible withdrawal of one or more countries from the Euro zone; (4) impact on us of comprehensive financial services regulation reform, including potential regulation of MetLife, Inc. as a non-bank systemically important financial institution, or otherwise; (5) numerous rulemaking initiatives required or permitted by the Dodd-Frank Wall Street Reform and Consumer Protection Act which may impact how we conduct our business, including those compelling the liquidation of certain financial institutions; (6) regulatory, legislative or tax changes relating to our insurance, international, or other operations that may affect the cost of, or demand for, our products or services, or increase the cost or administrative burdens of providing benefits to employees; (7) adverse results or other consequences from litigation, arbitration or regulatory investigations; (8) unanticipated developments that could delay, prevent or otherwise adversely affect the separation of Brighthouse Financial; (9) our ability to address difficulties, unforeseen liabilities, asset impairments, or rating agency actions arising from (a) business acquisitions and integrating and managing the growth of such acquired businesses, (b) dispositions of businesses via sale, initial public offering, spin-off or otherwise, including failure to achieve projected operational benefit from such transactions; (c) entry into joint ventures, or (d) legal entity reorganizations; (10) potential liquidity and other risks resulting from our participation in a securities lending program and other transactions; including any separated business’ incurrence of debt in connection with such a separation; (11) investment losses and defaults, and changes to investment valuations; (12) changes in assumptions related to investment valuations, deferred policy acquisition costs, deferred sales inducements, value of business acquired or goodwill; (13) impairments of goodwill and realized losses or market value impairments to illiquid assets; (14) defaults on our mortgage loans; (15) the defaults or deteriorating credit of other financial institutions that could adversely affect us; (16) economic, political, legal, currency and other risks relating to our international operations, including with respect to fluctuations of exchange rates; (17) downgrades in our claims paying ability, financial strength or credit ratings; (18) a deterioration in the experience of the closed block established in connection with the reorganization of Metropolitan Life Insurance Company; (19) availability and effectiveness of reinsurance, hedging or indemnification arrangements, as well as any default or failure of counterparties to perform; (20) differences between actual claims experience and underwriting and reserving assumptions; (21) ineffectiveness of risk management policies and procedures; (22) catastrophe losses; (23) increasing cost and limited market capacity for statutory life insurance reserve financings; (24) heightened competition, including with respect to pricing, entry of new competitors, consolidation of distributors, the development of new products by new and existing competitors, and for personnel; (25) exposure to losses related to variable annuity guarantee benefits, including from significant and sustained downturns or extreme volatility in equity markets, reduced interest rates, unanticipated policyholder behavior, mortality or longevity, and any adjustment for nonperformance risk; (26) legal, regulatory and other restrictions affecting MetLife, Inc.’s ability to pay dividends and repurchase common stock; (27) MetLife, Inc.’s and its subsidiary holding companies’ primary reliance, as holding companies, on dividends from its subsidiaries to meet its free cash flow targets and debt payment obligations and the applicable regulatory restrictions on the ability of the subsidiaries to pay such dividends; (28) the possibility that MetLife, Inc.’s Board of Directors may influence the outcome of stockholder votes through the voting provisions of the MetLife Policyholder Trust; (29) changes in accounting standards, practices and/or policies; (30) increased expenses relating to pension and postretirement benefit plans, as well as health care and other employee benefits; (31) inability to protect our intellectual property rights or claims of infringement of the intellectual property rights of others; (32) difficulties in marketing and distributing products through our distribution channels; (33) provisions of laws and our incorporation documents may delay, deter or prevent takeovers and corporate combinations involving MetLife; (34) the effects of business disruption or economic contraction due to disasters such as terrorist attacks, cyberattacks, other hostilities, or natural catastrophes, including any related impact on the value of our investment portfolio, our disaster recovery systems, cyber- or other information security systems and management continuity planning; (35) any failure to protect the confidentiality of client information; (36) the effectiveness of our programs and practices in avoiding giving our associates incentives to take excessive risks; (37) restrictions, liabilities, losses or indemnification obligations arising from any transitional services or tax arrangements related to the separation of any business, or from the failure of such a separation to qualify for any intended tax-free treatment; and (38) other risks and uncertainties described from time to time in MetLife, Inc.’s filings with the U.S. Securities and Exchange Commission.

MetLife, Inc. does not undertake any obligation to publicly correct or update any forward-looking statement if MetLife, Inc. later becomes aware that such statement is not likely to be achieved. Please consult any further disclosures MetLife, Inc. makes on related subjects in reports to the U.S. Securities and Exchange Commission.

Corporate Information

We announce financial and other information about MetLife to our investors through the MetLife Investor Relations web page at www.metlife.com, as well as U.S. Securities and Exchange Commission filings, news releases, public conference calls and webcasts. MetLife encourages investors to visit the Investor Relations web page from time to time, as information is updated and new information is posted. The information found on our website is not incorporated by reference into this Quarterly Report on Form 10-Q or in any other report or document we file with the U.S. Securities and Exchange Commission, and any references to our website are intended to be inactive textual references only.

Note Regarding Reliance on Statements in Our Contracts

See “Exhibit Index — Note Regarding Reliance on Statements in Our Contracts” for information regarding agreements included as exhibits to this Quarterly Report on Form 10-Q.

2

Part I — Financial Information

Item 1. Financial Statements

MetLife, Inc.

Interim Condensed Consolidated Balance Sheets

September 30, 2016 (Unaudited) and December 31, 2015

(In millions, except share and per share data)

	September 30, 2016			December 31, 2015
Assets
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $353,913 and $332,964, respectively; includes $3,533 and $4,277, respectively, relating to variable interest entities)	$	390,442		$	351,402
Equity securities available-for-sale, at estimated fair value (cost: $2,838 and $2,997, respectively)	3,289			3,321
Fair value option and trading securities, at estimated fair value (includes $0 and $404, respectively, of actively traded securities; and $9 and $13, respectively, relating to variable interest entities)	14,730			15,024
Mortgage loans (net of valuation allowances of $330 and $318, respectively; includes $143 and $172, respectively, at estimated fair value, relating to variable interest entities; includes $481 and $314, respectively, under the fair value option)	71,156			67,102
Policy loans (includes $0 and $4, respectively, relating to variable interest entities)	11,177			11,258
Real estate and real estate joint ventures (includes $33 and $47, respectively, of real estate held-for-sale)	9,186			8,433
Other limited partnership interests (includes $15 and $27, respectively, relating to variable interest entities)	6,878			7,096
Short-term investments, principally at estimated fair value (includes $0 and $26, respectively, relating to variable interest entities)	11,655			9,299
Other invested assets, principally at estimated fair value (includes $31 and $43, respectively, relating to variable interest entities)	30,278			22,524
Total investments	548,791			495,459
Cash and cash equivalents, principally at estimated fair value (includes $0 and $85, respectively, relating to variable interest entities)	15,883			12,752
Accrued investment income (includes $1 and $23, respectively, relating to variable interest entities)	4,197			3,988
Premiums, reinsurance and other receivables (includes $4 and $21, respectively, relating to variable interest entities)	26,178			22,702
Deferred policy acquisition costs and value of business acquired (includes $0 and $240, respectively, relating to variable interest entities)	24,748			24,130
Current income tax recoverable	—			161
Goodwill	9,592			9,477
Other assets (includes $3 and $148, respectively, relating to variable interest entities)	7,867			7,666
Separate account assets (includes $0 and $1,022, respectively, relating to variable interest entities)	315,648			301,598
Total assets	$	952,904		$	877,933
Liabilities and Equity
Liabilities
Future policy benefits (includes $0 and $716, respectively, relating to variable interest entities)	$	208,561		$	191,879
Policyholder account balances (includes $0 and $21, respectively, relating to variable interest entities)	216,192			202,722
Other policy-related balances (includes $0 and $238, respectively, relating to variable interest entities)	14,857			14,255
Policyholder dividends payable	763			720
Policyholder dividend obligation	3,352			1,783
Payables for collateral under securities loaned and other transactions	44,422			36,871
Short-term debt	201			100
Long-term debt (includes $38 and $63, respectively, at estimated fair value, relating to variable interest entities)	16,553			18,023
Collateral financing arrangements	4,084			4,139
Junior subordinated debt securities	3,168			3,194
Current income tax payable	151			—
Deferred income tax liability	14,359			10,592
Other liabilities (includes $0 and $81, respectively, relating to variable interest entities)	32,127			23,561
Separate account liabilities (includes $0 and $1,022, respectively, relating to variable interest entities)	315,648			301,598
Total liabilities	874,438			809,437
Contingencies, Commitments and Guarantees (Note 15)
Redeemable noncontrolling interests in partially-owned consolidated subsidiaries	—			77
Equity
MetLife, Inc.’s stockholders’ equity:
Preferred stock, par value $0.01 per share; $2,100 aggregate liquidation preference	—			—
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,161,994,036 and 1,159,590,766 shares issued, respectively; 1,098,985,931 and 1,098,028,525 shares outstanding, respectively	12			12
Additional paid-in capital	30,797			30,749
Retained earnings	37,054			35,519
Treasury stock, at cost; 63,008,105 and 61,562,241 shares, respectively	(3,172		)	(3,102		)
Accumulated other comprehensive income (loss)	13,595			4,771
Total MetLife, Inc.’s stockholders’ equity	78,286			67,949
Noncontrolling interests	180			470
Total equity	78,466			68,419
Total liabilities and equity	$	952,904		$	877,933

See accompanying notes to the interim condensed consolidated financial statements.

3

MetLife, Inc.

Interim Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

For the Three Months and Nine Months Ended September 30, 2016 and 2015 (Unaudited)

(In millions, except per share data)

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
Revenues
Premiums	$	10,391		$	10,375		$	29,501		$	28,940
Universal life and investment-type product policy fees	2,296			2,346			6,926			7,174
Net investment income	5,464			3,959			14,910			14,367
Other revenues	366			484			1,340			1,497
Net investment gains (losses):
Other-than-temporary impairments on fixed maturity securities	(8		)	(43		)	(94		)	(51		)
Other-than-temporary impairments on fixed maturity securities transferred to other comprehensive income (loss)	(6		)	16			(12		)	4
Other net investment gains (losses)	271			409			644			582
Total net investment gains (losses)	257			382			538			535
Net derivative gains (losses)	(1,051		)	485			(1,815		)	394
Total revenues	17,723			18,031			51,400			52,907
Expenses
Policyholder benefits and claims	10,855			10,334			30,807			28,943
Interest credited to policyholder account balances	1,820			647			4,646			3,940
Policyholder dividends	312			354			951			1,024
Goodwill impairment	260			—			260			—
Other expenses	3,928			4,533			11,366			12,665
Total expenses	17,175			15,868			48,030			46,572
Income (loss) before provision for income tax	548			2,163			3,370			6,335
Provision for income tax expense (benefit)	(25		)	965			480			1,855
Net income (loss)	573			1,198			2,890			4,480
Less: Net income (loss) attributable to noncontrolling interests	(4		)	(5		)	2			4
Net income (loss) attributable to MetLife, Inc.	577			1,203			2,888			4,476
Less: Preferred stock dividends	6			6			58			67
Preferred stock repurchase premium	—			—			—			42
Net income (loss) available to MetLife, Inc.’s common shareholders	$	571		$	1,197		$	2,830		$	4,367
Comprehensive income (loss)	$	(463	)	$	1,653		$	11,809		$	760
Less: Comprehensive income (loss) attributable to noncontrolling interests, net of income tax	(3		)	2			97			42
Comprehensive income (loss) attributable to MetLife, Inc.	$	(460	)	$	1,651		$	11,712		$	718

Net income (loss) available to MetLife, Inc.’s common shareholders per common share:
Basic	$	0.52	$	1.07	$	2.57	$	3.90
Diluted	$	0.51	$	1.06	$	2.55	$	3.86
Cash dividends declared per common share	$	0.400	$	0.375	$	1.175	$	1.100

See accompanying notes to the interim condensed consolidated financial statements.

4

MetLife, Inc.

Interim Condensed Consolidated Statements of Equity

For the Nine Months Ended September 30, 2016 and 2015 (Unaudited)

(In millions)

	Preferred Stock		Common Stock		Additional Paid-in Capital		Retained Earnings			Treasury Stock at Cost			Accumulated Other Comprehensive Income (Loss)		Total MetLife, Inc.’s Stockholders’ Equity			Noncontrolling Interests (1)			Total Equity
Balance at December 31, 2015	$	—	$	12	$	30,749	$	35,519		$	(3,102	)	$	4,771	$	67,949		$	470		$	68,419
Treasury stock acquired in connection with share repurchases										(70		)			(70		)				(70		)
Stock-based compensation					48										48						48
Dividends on preferred stock							(58		)						(58		)				(58		)
Dividends on common stock							(1,295		)						(1,295		)				(1,295		)
Change in equity of noncontrolling interests															—			(387		)	(387		)
Net income (loss)							2,888								2,888			2			2,890
Other comprehensive income (loss), net of income tax													8,824		8,824			95			8,919
Balance at September 30, 2016	$	—	$	12	$	30,797	$	37,054		$	(3,172	)	$	13,595	$	78,286		$	180		$	78,466

	Preferred Stock			Common Stock		Additional Paid-in Capital			Retained Earnings			Treasury Stock at Cost			Accumulated Other Comprehensive Income (Loss)			Total MetLife, Inc.’s Stockholders’ Equity			Noncontrolling Interests (1)			Total Equity
Balance at December 31, 2014	$	1		$	12	$	30,543		$	32,020		$	(1,172	)	$	10,649		$	72,053		$	507		$	72,560
Repurchase of preferred stock	(1		)			(1,459		)										(1,460		)				(1,460		)
Preferred stock repurchase premium									(42		)							(42		)				(42		)
Preferred stock issuance						1,483												1,483						1,483
Treasury stock acquired in connection with share repurchases												(1,107		)				(1,107		)				(1,107		)
Stock-based compensation						159												159						159
Dividends on preferred stock									(67		)							(67		)				(67		)
Dividends on common stock									(1,234		)							(1,234		)				(1,234		)
Change in equity of noncontrolling interests																		—			(64		)	(64		)
Net income (loss)									4,476									4,476			4			4,480
Other comprehensive income (loss), net of income tax															(3,758		)	(3,758		)	38			(3,720		)
Balance at September 30, 2015	$	—		$	12	$	30,726		$	35,153		$	(2,279	)	$	6,891		$	70,503		$	485		$	70,988

__________________

(1) Net income (loss) attributable to noncontrolling interests did not exclude any gains of redeemable noncontrolling interests in partially-owned consolidated subsidiaries at September 30,2016. Net income (loss) attributable to noncontrolling interests excluded losses of redeemable noncontrolling interests in partially-owned consolidated subsidiaries of less than $1 million at September 30,2015.

See accompanying notes to the interim condensed consolidated financial statements.

5

MetLife, Inc.

Interim Condensed Consolidated Statements of Cash Flows

For the Nine Months Ended September 30, 2016 and 2015 (Unaudited)

(In millions)

	Nine Months   Ended   September 30,
	2016			2015
Net cash provided by (used in) operating activities	$	9,183		$	9,527
Cash flows from investing activities
Sales, maturities and repayments of:
Fixed maturity securities	101,614			109,308
Equity securities	1,019			478
Mortgage loans	10,518			9,775
Real estate and real estate joint ventures	323			1,644
Other limited partnership interests	1,025			859
Purchases of:
Fixed maturity securities	(108,418		)	(105,128		)
Equity securities	(802		)	(431		)
Mortgage loans	(14,686		)	(13,814		)
Real estate and real estate joint ventures	(958		)	(977		)
Other limited partnership interests	(806		)	(935		)
Cash received in connection with freestanding derivatives	3,258			2,376
Cash paid in connection with freestanding derivatives	(4,317		)	(2,887		)
Cash received under repurchase agreements (Note 7)	—			199
Cash paid under reverse repurchase agreements (Note 7)	—			(199		)
Sales of businesses, net of cash and cash equivalents disposed of $135 and $0, respectively	156			—
Purchases of investments in operating joint ventures	(39		)	—
Net change in policy loans	201			10
Net change in short-term investments	(2,232		)	(6,644		)
Net change in other invested assets	(58		)	(350		)
Other, net	(384		)	(191		)
Net cash provided by (used in) investing activities	(14,586		)	(6,907		)
Cash flows from financing activities
Policyholder account balances:
Deposits	65,225			69,383
Withdrawals	(61,145		)	(72,940		)
Net change in payables for collateral under securities loaned and other transactions	7,227			2,664
Net change in short-term debt	(3		)	—
Long-term debt issued	—			1,578
Long-term debt repaid	(1,273		)	(1,078		)
Collateral financing arrangements repaid	(55		)	(44		)
Treasury stock acquired in connection with share repurchases	(70		)	(1,107		)
Preferred stock issued, net of issuance costs	—			1,483
Repurchase of preferred stock	—			(1,460		)
Preferred stock repurchase premium	—			(42		)
Dividends on preferred stock	(58		)	(67		)
Dividends on common stock	(1,295		)	(1,234		)
Other, net	(325		)	12
Net cash provided by (used in) financing activities	8,228			(2,852		)
Effect of change in foreign currency exchange rates on cash and cash equivalents balances	306			(360		)
Change in cash and cash equivalents	3,131			(592		)
Cash and cash equivalents, beginning of period	12,752			10,808
Cash and cash equivalents, end of period	$	15,883		$	10,216
Supplemental disclosures of cash flow information
Net cash paid (received) for:
Interest	$	875		$	836
Income tax	$	464		$	904
Non-cash transactions:
Fixed maturity securities received in connection with pension risk transfer transactions	$	985		$	903
Reduction of fixed maturity securities in connection with a reinsurance transaction	$	224		$	—
Deconsolidation of operating joint venture (Note 7):
Reduction of fixed maturity securities	$	917		$	—
Reduction of noncontrolling interests	$	373		$	—

See accompanying notes to the interim condensed consolidated financial statements.

6

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies

Business

“MetLife” and the “Company” refer to MetLife, Inc., a Delaware corporation incorporated in 1999, its subsidiaries and affiliates. MetLife is a global provider of life insurance, annuities, employee benefits and asset management. In anticipation of the Company’s plan to separate a substantial portion of its former Retail segment, as well as certain portions of its former Corporate Benefit Funding segment and Corporate & Other (the “Separation”), in the third quarter of 2016, MetLife reorganized its businesses into six segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa (“EMEA”); MetLife Holdings; and Brighthouse Financial. See Note 2 for further information on the reorganization of the Company’s segments in the third quarter of 2016, which was applied retrospectively.

Basis of Presentation

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the interim condensed consolidated financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from estimates.

Consolidation

The accompanying interim condensed consolidated financial statements include the accounts of MetLife, Inc. and its subsidiaries, as well as partnerships and joint ventures in which the Company has control, and variable interest entities (“VIEs”) for which the Company is the primary beneficiary. Intercompany accounts and transactions have been eliminated.

Prior to January 1, 2016, certain international subsidiaries had a fiscal year cutoff of November 30th. Accordingly, the Company’s interim condensed consolidated financial statements reflect the assets and liabilities of such subsidiaries as of November 30, 2015 and the operating results of such subsidiaries for the three months and nine months ended August 31, 2015. Effective January 1, 2016, the Company converted its Japan operations to calendar year-end reporting. The elimination of a one-month reporting lag of a subsidiary is considered a change in accounting principle and requires retrospective application. While the Company believes that eliminating the lag in the reporting of its Japan operations was preferable in order to consistently reflect events, economic conditions and global trends in the financial statements, the Company determined that it was impracticable to apply the effects of the lag elimination to financial reporting periods prior to January 1, 2015. The effect of not retroactively applying this change in accounting, however, was not material to the 2015 or 2016 consolidated financial statements. Therefore, the Company reported the cumulative effect of the change in accounting principle in net income for the three months ended March 31, 2016 and the nine months ended September 30, 2016 and did not retrospectively apply the effects of this change to prior periods. See Note 2.

The Company uses the equity method of accounting for equity securities when it has significant influence or at least 20% interest and for real estate joint ventures and other limited partnership interests (“investees”) when it has more than a minor ownership interest or more than a minor influence over the investee’s operations, but does not have a controlling financial interest. The Company generally recognizes its share of the investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period. The Company uses the cost method of accounting for investments in which it has virtually no influence over the investee’s operations.

Reclassifications

Certain amounts in the prior year periods’ interim condensed consolidated financial statements and related footnotes thereto have been reclassified to conform with the 2016 presentation as discussed throughout the Notes to the Interim Condensed Consolidated Financial Statements.

7

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

The accompanying interim condensed consolidated financial statements are unaudited and reflect all adjustments (including normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in conformity with GAAP. Interim results are not necessarily indicative of full year performance. The December 31, 2015 consolidated balance sheet data was derived from audited consolidated financial statements included in MetLife, Inc.’s Annual Report on Form 10‑K for the year ended December 31, 2015 (the “2015 Annual Report”), which include all disclosures required by GAAP. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company included in the 2015 Annual Report.

Adoption of New Accounting Pronouncement

Effective January 1, 2016, the Company retrospectively adopted new guidance relating to the consolidation of certain entities. The objective of the new standard is to improve targeted areas of the consolidation guidance and to reduce the number of consolidation models. The new consolidation standard provides guidance on how a reporting entity (i) evaluates whether the entity should consolidate limited partnerships and similar entities, (ii) assesses whether the fees paid to a decisionmaker or service provider are variable interests in a VIE, and (iii) assesses the variable interests in a VIE held by related parties of the reporting entity. The new guidance also eliminates the VIE consolidation model based on majority exposure to variability that applied to certain investment companies and similar entities. The adoption of the new guidance did not impact which entities are consolidated by the Company. The consolidated VIE assets and liabilities and unconsolidated VIE carrying amounts and maximum exposure to loss as of September 30, 2016, disclosed in Note 7, reflect the application of the new guidance.

Future Adoption of New Accounting Pronouncements

In October 2016, the Financial Accounting Standards Board (“FASB”) issued new guidance on consolidation evaluation for entities under common control (Accounting Standards Update (“ASU”) 2016-17,Consolidation (Topic 810): Interests Held through Related Parties That Are under Common Control). The new guidance is effective for fiscal years beginning after December 15, 2016 and interim periods within those fiscal years, and should be applied on a retrospective basis. Early adoption is permitted. The new guidance does not change the characteristics of a primary beneficiary under current GAAP. It changes how a reporting entity evaluates whether it is the primary beneficiary of a VIE by changing how a reporting entity that is a single decisionmaker of a VIE handles indirect interests in the entity held through related parties that are under common control with the reporting entity. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In October 2016, the FASB issued new guidance on tax accounting for intra-entity transfers of assets (ASU 2016-16,Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory). The new guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, and should be applied on a modified retrospective basis. Early adoption is permitted in the first interim or annual reporting period. Current guidance prohibits the recognition of current and deferred income taxes for an intra-entity asset transfer until the asset has been sold to an outside party. The new guidance requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. Also, the guidance eliminates the exception for an intra-entity transfer of an asset other than inventory. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In August 2016, the FASB issued new guidance on cash flow statement presentation (ASU 2016-15,Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments). The new guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, and should be applied retrospectively to all periods presented. Early adoption is permitted in any interim or annual period. This ASU addresses diversity in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In June 2016, the FASB issued new guidance on measurement of credit losses on financial instruments (ASU 2016-13,Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments). The new guidance is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. This ASU replaces the incurred loss impairment methodology with one that reflects expected credit losses. The measurement of expected credit losses should be based on historical loss information, current conditions, and reasonable and supportable forecasts. The guidance also requires enhanced disclosures. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

8

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

In March 2016, the FASB issued new guidance on stock compensation (ASU 2016-09,Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-based Payment Accounting. The new guidance is effective for the fiscal years beginning after December 15, 2016, including interim periods within those fiscal years, and requires either a modified retrospective, a retrospective or a prospective transition approach depending upon the type of change. Early adoption is permitted in any interim or annual period. The new guidance changes several aspects of the accounting for share-based payment award transactions, including: (i) income tax consequences when awards vest or are settled; (ii) classification of awards as either equity or liabilities due to statutory tax withholding requirements; and (iii) classification on the statement of cash flows. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In February 2016, the FASB issued new guidance on leasing transactions (ASU 2016-02,Leases - Topic 842). The new guidance is effective for the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and requires a modified retrospective transition approach which includes a number of optional practical expedients. Early adoption is permitted. The new guidance requires a lessee to recognize assets and liabilities for leases with lease terms of more than 12 months. Consistent with current guidance, leases would be classified as finance or operating leases. However, unlike current guidance, the new guidance will require both types of leases to be recognized on the balance sheet. Lessor accounting will remain largely unchanged from current guidance except for certain targeted changes. The new guidance will also require new qualitative and quantitative disclosures. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In January 2016, the FASB issued new guidance (ASU 2016-01,Financial Instruments-Overall: Recognition and Measurement of Financial Assets and Financial Liabilities)on the recognition and measurement of financial instruments. The new guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted for the instrument-specific credit risk provision. The new guidance changes the current accounting guidance related to (i) the classification and measurement of certain equity investments, (ii) the presentation of changes in the fair value of financial liabilities measured under the fair value option (“FVO”) that are due to instrument-specific credit risk, and (iii) certain disclosures associated with the fair value of financial instruments. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In May 2015, the FASB issued new guidance on short-duration insurance contracts (ASU 2015-09,Financial Services - Insurance (Topic 944): Disclosures about Short-Duration Contracts). The amendments in this new guidance are effective for annual periods beginning after December 15, 2015, and interim periods within annual periods beginning after December 15, 2016. The new guidance should be applied retrospectively by providing comparative disclosures for each period presented, except for those requirements that apply only to the current period. The new guidance requires insurance entities to provide users of financial statements with more transparent information about initial claim estimates and subsequent adjustments to these estimates, including information on: (i) reconciling from the claim development table to the balance sheet liability, (ii) methodologies and judgments in estimating claims, and (iii) the timing, and frequency of claims. The adoption will not have an impact on the Company’s consolidated financial statements other than expanded disclosures inNote 4.

In May 2014, the FASB issued a comprehensive new revenue recognition standard (ASU 2014-09,Revenue from Contracts with Customers (Topic 606)), effective for fiscal years beginning after December 15, 2016 and interim periods within those years and should be applied retrospectively. In August 2015, the FASB amended the guidance to defer the effective date by one year, effective for the fiscal years beginning after December 15, 2017, including interim periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. The new guidance will supersede nearly all existing revenue recognition guidance under GAAP; however, it will not impact the accounting for insurance contracts, leases, financial instruments and guarantees. For those contracts that are impacted by the new guidance, the guidance will require an entity to recognize revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled, in exchange for those goods or services. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

2. Segment Information

In anticipation of the Separation, in the third quarter of 2016, MetLife reorganized its businesses intosixsegments: U.S.; Asia; Latin America; EMEA; MetLife Holdings; and Brighthouse Financial. In addition, the Company reports certain of its results of operations in Corporate & Other. These changes were applied retrospectively and did not have an impact on total consolidated net income (loss) or operating earnings in the prior periods.

9

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

2. Segment Information (continued)

On January 12, 2016, MetLife, Inc. announced its plan to pursue the Separation. Additionally, on July 21, 2016, MetLife, Inc. announced that following the Separation, the separated business will be rebranded as “Brighthouse Financial.” On October 5, 2016, Brighthouse Financial, Inc., a subsidiary of MetLife, Inc. (“Brighthouse”), filed a registration statement on Form 10 (the “Form 10”) with the U.S. Securities and Exchange Commission (“SEC”). The information statement filed as an exhibit to the Form 10, disclosed that the Company intends to include MetLife Insurance Company USA (“MetLife USA”), New England Life Insurance Company (“NELICO”), First MetLife Investors Insurance Company (“FMLI”), MetLife Advisers, LLC and certain captive reinsurance companies in the proposed separated business and distribute at least 80.1% of the shares of Brighthouse’s common stock on apro ratabasis to the holders of MetLife, Inc. common stock.

The ultimate form and timing of the Separation will be influenced by a number of factors, including regulatory considerations and economic conditions. MetLife continues to evaluate and pursue structural alternatives for the proposed Separation. The Separation remains subject to certain conditions, including among others, obtaining final approval from the MetLife, Inc. Board of Directors, receipt of a favorable ruling from the Internal Revenue Service and an opinion from MetLife’s tax advisor regarding certain U.S. federal income tax matters, and an SEC declaration of the effectiveness of the Form 10.

This re-segmentation resulted in a $296 million, net of income tax, charge to earnings in the current period, all in the Brighthouse Financial segment, driven by the segment’s variable and universal life products. This charge is the direct result of the Company, beginning in the third quarter, no longer being able to aggregate, for loss recognition testing, the variable and universal life products of Brighthouse Financial with the variable and universal life products remaining with MetLife Holdings. Of this amount, the Company recorded $254 million, net of income tax, as a one-time charge, which was mostly recognized as a write-off of deferred policy acquisition costs (“DAC”), with the remaining $42 million, net of income tax, recognized as an increase in insurance-related liabilities.

U.S.

The U.S. segment offers a broad range of protection products and services aimed at serving the financial needs of customers throughout their lives. These products are sold to corporations and their respective employees, other institutions and their respective members, as well as individuals. The U.S. segment is organized into three businesses: Group Benefits, Retirement & Income Solutions and Property & Casualty.

• The Group Benefits business offers insurance products and services which include life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, critical illness, vision and accident & health coverages, as well as prepaid legal plans. This business also sells administrative services-only arrangements to some employers.

• The Retirement & Income Solutions business offers a broad range of annuity and investment products, including guaranteed interest contracts and other stable value products, income annuities and separate account contracts for the investment management of defined benefit and defined contribution plan assets. This business also includes structured settlements and certain products to fund postretirement benefits and company-, bank- or trust-owned life insurance used to finance nonqualified benefit programs for executives.

• The Property & Casualty business offers personal and commercial lines property and casualty insurance, including private passenger automobile, homeowners’ and personal excess liability insurance. In addition, Property & Casualty offers small business owners property, liability and business interruption insurance.

Asia

The Asia segment offers a broad range of products to both individuals and corporations, as well as other institutions and their respective employees, which include whole life, term life, variable life, universal life, accident & health insurance, fixed and variable annuities, credit insurance and endowment products.

Latin America

The Latin America segment offers a broad range of products to both individuals and corporations, as well as other institutions and their respective employees, which include life insurance, accident & health insurance, group medical, dental, credit insurance, endowment and retirement & savings products.

10

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

2. Segment Information (continued)

EMEA

The EMEA segment offers a broad range of products to both individuals and corporations, as well as other institutions and their respective employees, which include life insurance, accident & health insurance, credit insurance, annuities, endowment and retirement & savings products.

MetLife Holdings

The MetLife Holdings segment consists of operations relating to products and businesses no longer actively marketed by the Company in the U.S. These products and businesses include variable life, universal life, term life, whole life, variable annuities, fixed annuities and index-linked annuities. The MetLife Holdings segment also includes the Company’s discontinued long-term care businesses and the assumed reinsurance of certain variable annuity products from the Company’s former operating joint venture in Japan.

Brighthouse Financial

The Brighthouse Financial segment offers a broad range of products and services which include variable annuities, fixed annuities, index-linked annuities, income annuities, term life, whole life, universal life and variable life, as well as certain run-off businesses. These products and services, which exclude the run-off businesses, are actively marketed through various third party retail distribution channels in the U.S.

Corporate & Other

Corporate & Other contains the excess capital, as well as certain charges and activities, not allocated to the segments, including external integration costs, internal resource costs for associates committed to acquisitions, enterprise-wide strategic initiative restructuring charges and various start-up businesses (including expatriate benefits insurance and the investment management business through which the Company offers fee-based investment management services to institutional clients, as well as the direct to consumer portion of the U.S. Direct business). Additionally, Corporate & Other includes interest expense related to the majority of the Company’s outstanding debt and expenses associated with certain legal proceedings and income tax audit issues. Corporate & Other also includes the elimination of intersegment amounts, which generally relate to affiliated reinsurance and intersegment loans, which bear interest rates commensurate with related borrowings.

Financial Measures and Segment Accounting Policies

Operating earnings is used by management to evaluate performance and allocate resources. Consistent with GAAP guidance for segment reporting, operating earnings is also the Company’s GAAP measure of segment performance and is reported below. Operating earnings should not be viewed as a substitute for net income (loss). The Company believes the presentation of operating earnings as the Company measures it for management purposes enhances the understanding of its performance by highlighting the results of operations and the underlying profitability drivers of the business. Operating earnings allows analysis of the Company’s performance relative to the Company’s business plan and facilitates comparisons to industry results.

Operating earnings is defined as operating revenues less operating expenses, both net of income tax.

The financial measures of operating revenues and operating expenses focus on the Company’s primary businesses principally by excluding the impact of market volatility, which could distort trends, and revenues and costs related to non-core products and divested businesses and certain entities required to be consolidated under GAAP. Also, these measures exclude results of discontinued operations and other businesses that have been or will be sold or exited by MetLife and are referred to as divested businesses. In addition, for the three months ended March 31, 2016 and the nine months ended September 30, 2016, operating revenues and operating expenses exclude the financial impact of converting the Company’s Japan operations to calendar year-end reporting without retrospective application of this change to prior periods and is referred to as lag elimination. Operating revenues also excludes net investment gains (losses) and net derivative gains (losses). Operating expenses also excludes goodwill impairments.

11

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

2. Segment Information (continued)

The following additional adjustments are made to revenues, in the line items indicated, in calculating operating revenues:

• Universal life and investment-type product policy fees excludes the amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses) and certain variable annuity guaranteed minimum income benefits (“GMIBs”) fees (“GMIB Fees”);

• Net investment income: (i) includes investment hedge adjustments which represent earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment, (ii) excludes post-tax operating earnings adjustments relating to insurance joint ventures accounted for under the equity method, (iii) excludes certain amounts related to contractholder-directed unit-linked investments and (iv) excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP; and

• Other revenues are adjusted for settlements of foreign currency earnings hedges.

The following additional adjustments are made to expenses, in the line items indicated, in calculating operating expenses:

• Policyholder benefits and claims and policyholder dividends excludes: (i) changes in the policyholder dividend obligation related to net investment gains (losses) and net derivative gains (losses), (ii) inflation-indexed benefit adjustments associated with contracts backed by inflation-indexed investments and amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and other pass through adjustments, (iii) benefits and hedging costs related to GMIBs (“GMIB Costs”) and (iv) market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”);

• Interest credited to policyholder account balances includes adjustments for earned income on derivatives and amortization of premium on derivatives that are hedges of policyholder account balances but do not qualify for hedge accounting treatment and excludes amounts related to net investment income earned on contractholder-directed unit-linked investments;

• Amortization of DAC and value of business acquired (“VOBA”) excludes amounts related to: (i) net investment gains (losses) and net derivative gains (losses), (ii) GMIB Fees and GMIB Costs and (iii) Market Value Adjustments;

• Amortization of negative VOBA excludes amounts related to Market Value Adjustments;

• Interest expense on debt excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP; and

• Other expenses excludes costs related to: (i) noncontrolling interests, (ii) implementation of new insurance regulatory requirements, and (iii) acquisition, integration and other costs.

Operating earnings also excludes the recognition of certain contingent assets and liabilities that could not be recognized at acquisition or adjusted for during the measurement period under GAAP business combination accounting guidance.

The tax impact of the adjustments mentioned above are calculated net of the U.S. or foreign statutory tax rate, which could differ from the Company’s effective tax rate. Additionally, the provision for income tax (expense) benefit also includes the impact related to the timing of certain tax credits, as well as certain tax reforms

Set forth in the tables below is certain financial information with respect to the Company’s segments, as well as Corporate & Other, for thethree monthsandnine months endedSeptember 30, 2016 and 2015. The segment accounting policies are the same as those used to prepare the Company’s consolidated financial statements, except for operating earnings adjustments as defined above. In addition, segment accounting policies include the method of capital allocation described below, with the exception of the Brighthouse Financial segment,for which equity is reflective of the historical equity of the legal entities which comprise Brighthouse and related companies, which will be eliminated upon Separation. The Brighthouse Financial segment equity is not indicative of Brighthouse and related companies’ equity on a combined standalone basis.

Economic capital is an internally developed risk capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. The economic capital model accounts for the unique and specific nature of the risks inherent in the Company’s business.

12

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

2. Segment Information (continued)

The Company’s economic capital model, coupled with considerations of local capital requirements, aligns segment allocated equity with emerging standards and consistent risk principles. The model applies statistics-based risk evaluation principles to the material risks to which the Company is exposed. These consistent risk principles include calibrating required economic capital shock factors to a specific confidence level and time horizon while applying an industry standard method for the inclusion of diversification benefits among risk types.The Company’s management is responsible for the ongoing production and enhancement of the economic capital model and reviews its approach periodically to ensure that it remains consistent with emerging industry practice standards.

Segment net investment income, with the exception of the Brighthouse Financial segment, is credited or charged based on the level of allocated equity; however, changes in allocated equity do not impact the Company’s consolidated net investment income, net income (loss) or operating earnings. As noted above, the Brighthouse Financial segment’s net investment income represents that of the legal entities which comprise Brighthouse and related companies on a historical basis, however, may not be indicative of that on a combined standalone basis.

Net investment income is based upon the actual results of each segment’s specifically identifiable investment portfolios adjusted for allocated equity. Other costs are allocated to each of the segments based upon: (i) a review of the nature of such costs; (ii) time studies analyzing the amount of employee compensation costs incurred by each segment; and (iii) cost estimates included in the Company’s product pricing.

13

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

2. Segment Information (continued)

	Operating Results
Three Months Ended September 30, 2016	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate & Other			Total			Adjustments			Total Consolidated
	(In millions)
Revenues
Premiums	$	5,936		$	1,822		$	653		$	500		$	1,093		$	347		$	40		$	10,391		$	—		$	10,391
Universal life and investment-type product policy fees	245			394			227			104			357			903			(31		)	2,199			97			2,296
Net investment income	1,590			707			311			81			1,537			941			(7		)	5,160			304			5,464
Other revenues	192			12			11			17			105			50			(28		)	359			7			366
Net investment gains (losses)	—			—			—			—			—			—			—			—			257			257
Net derivative gains (losses)	—			—			—			—			—			—			—			—			(1,051		)	(1,051		)
Total revenues	7,963			2,935			1,202			702			3,092			2,241			(26		)	18,109			(386		)	17,723
Expenses
Policyholder benefits and claims and policyholder dividends	5,894			1,363			681			257			1,853			814			10			10,872			295			11,167
Interest credited to policyholder account balances	322			331			85			28			261			288			—			1,315			505			1,820
Goodwill impairment	—			—			—			—			—			—			—			—			260			260
Capitalization of DAC	(124		)	(440		)	(83		)	(103		)	(44		)	(70		)	1			(863		)	—			(863		)
Amortization of DAC and VOBA	117			331			(2		)	106			219			509			2			1,282			(265		)	1,017
Amortization of negative VOBA	—			(46		)	(1		)	(3		)	—			—			—			(50		)	(5		)	(55		)
Interest expense on debt	2			—			1			—			15			32			241			291			1			292
Other expenses	912			930			335			332			401			560			(3		)	3,467			70			3,537
Total expenses	7,123			2,469			1,016			617			2,705			2,133			251			16,314			861			17,175
Provision for income tax expense (benefit)	288			142			53			11			121			40			(287		)	368			(393		)	(25		)
Operating earnings	$	552		$	324		$	133		$	74		$	266		$	68		$	10		1,427
Adjustments to:
Total revenues																						(386		)
Total expenses																						(861		)
Provision for income tax (expense) benefit																						393
Net income (loss)																						$	573					$	573

14

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

2. Segment Information (continued)

	Operating Results
Three Months Ended September 30, 2015	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate & Other			Total			Adjustments			Total Consolidated
	(In millions)
Revenues
Premiums	$	6,023		$	1,736		$	586		$	501		$	1,115		$	468		$	(53	)	$	10,376		$	(1	)	$	10,375
Universal life and investment-type product policy fees	233			382			261			106			370			921			(26		)	2,247			99			2,346
Net investment income	1,522			670			277			82			1,521			862			(85		)	4,849			(890		)	3,959
Other revenues	184			26			10			11			223			99			(58		)	495			(11		)	484
Net investment gains (losses)	—			—			—			—			—			—			—			—			382			382
Net derivative gains (losses)	—			—			—			—			—			—			—			—			485			485
Total revenues	7,962			2,814			1,134			700			3,229			2,350			(222		)	17,967			64			18,031
Expenses
Policyholder benefits and claims and policyholder dividends	5,976			1,331			581			233			1,885			846			(72		)	10,780			(92		)	10,688
Interest credited to policyholder account balances	304			327			88			27			266			313			6			1,331			(684		)	647
Goodwill impairment	—			—			—			—			—			—			—			—			—			—
Capitalization of DAC	(128		)	(435		)	(81		)	(107		)	(101		)	(102		)	(1		)	(955		)	—			(955		)
Amortization of DAC and VOBA	118			309			48			127			173			197			(1		)	971			160			1,131
Amortization of negative VOBA	—			(77		)	—			(5		)	—			—			—			(82		)	(8		)	(90		)
Interest expense on debt	1			—			—			—			13			32			248			294			8			302
Other expenses	908			896			348			352			647			614			361			4,126			19			4,145
Total expenses	7,179			2,351			984			627			2,883			1,900			541			16,465			(597		)	15,868
Provision for income tax expense (benefit)	272			125			(33		)	7			103			103			214			791			174			965
Operating earnings	$	511		$	338		$	183		$	66		$	243		$	347		$	(977	)	711
Adjustments to:
Total revenues																						64
Total expenses																						597
Provision for income tax (expense) benefit																						(174		)
Net income (loss)																						$	1,198					$	1,198

15

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

2. Segment Information (continued)

	Operating Results
Nine Months Ended September 30, 2016	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate & Other			Total			Adjustments			Total Consolidated
	(In millions)
Revenues
Premiums	$	16,127		$	5,161		$	1,885		$	1,519		$	3,312		$	1,020		$	51		$	29,075		$	426		$	29,501
Universal life and investment-type product policy fees	743			1,114			764			294			1,073			2,622			(87		)	6,523			403			6,926
Net investment income	4,615			2,003			809			244			4,489			2,624			(37		)	14,747			163			14,910
Other revenues	589			45			26			56			512			482			(380		)	1,330			10			1,340
Net investment gains (losses)	—			—			—			—			—			—			—			—			538			538
Net derivative gains (losses)	—			—			—			—			—			—			—			—			(1,815		)	(1,815		)
Total revenues	22,074			8,323			3,484			2,113			9,386			6,748			(453		)	51,675			(275		)	51,400
Expenses
Policyholder benefits and claims and policyholder dividends	16,210			3,923			1,814			801			5,603			2,525			(26		)	30,850			908			31,758
Interest credited to policyholder account balances	967			974			249			87			780			868			5			3,930			716			4,646
Goodwill impairment	—			—			—			—			—			—			—			—			260			260
Capitalization of DAC	(356		)	(1,251		)	(236		)	(310		)	(240		)	(255		)	(6		)	(2,654		)	(105		)	(2,759		)
Amortization of DAC and VOBA	353			921			127			311			636			823			7			3,178			(1,045		)	2,133
Amortization of negative VOBA	—			(167		)	(1		)	(10		)	—			—			—			(178		)	(43		)	(221		)
Interest expense on debt	7			—			1			—			43			96			759			906			4			910
Other expenses	2,772			2,658			968			1,001			1,861			1,739			(163		)	10,836			467			11,303
Total expenses	19,953			7,058			2,922			1,880			8,683			5,796			576			46,868			1,162			48,030
Provision for income tax expense (benefit)	720			377			141			32			203			260			(658		)	1,075			(595		)	480
Operating earnings	$	1,401		$	888		$	421		$	201		$	500		$	692		$	(371	)	3,732
Adjustments to:
Total revenues																						(275		)
Total expenses																						(1,162		)
Provision for income tax (expense) benefit																						595
Net income (loss)																						$	2,890					$	2,890

16

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

2. Segment Information (continued)

	Operating Results
Nine Months Ended September 30, 2015	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate & Other			Total			Adjustments			Total Consolidated
	(In millions)
Revenues
Premiums	$	15,712		$	5,297		$	1,925		$	1,534		$	3,345		$	1,159		$	(30	)	$	28,942		$	(2	)	$	28,940
Universal life and investment-type product policy fees	700			1,179			856			322			1,117			2,789			(87		)	6,876			298			7,174
Net investment income	4,723			2,033			774			249			4,690			2,536			11			15,016			(649		)	14,367
Other revenues	567			82			27			40			711			310			(212		)	1,525			(28		)	1,497
Net investment gains (losses)	—			—			—			—			—			—			—			—			535			535
Net derivative gains (losses)	—			—			—			—			—			—			—			—			394			394
Total revenues	21,702			8,591			3,582			2,145			9,863			6,794			(318		)	52,359			548			52,907
Expenses
Policyholder benefits and claims and policyholder dividends	15,675			4,046			1,793			737			5,479			2,103			(103		)	29,730			237			29,967
Interest credited to policyholder account balances	905			992			263			91			793			940			20			4,004			(64		)	3,940
Goodwill impairment	—			—			—			—			—			—			—			—			—			—
Capitalization of DAC	(365		)	(1,268		)	(246		)	(372		)	(292		)	(305		)	(2		)	(2,850		)	—			(2,850		)
Amortization of DAC and VOBA	352			971			195			388			423			595			1			2,925			128			3,053
Amortization of negative VOBA	—			(241		)	(1		)	(13		)	—			—			—			(255		)	(27		)	(282		)
Interest expense on debt	4			—			—			—			41			96			757			898			10			908
Other expenses	2,740			2,669			1,070			1,103			1,988			1,830			408			11,808			28			11,836
Total expenses	19,311			7,169			3,074			1,934			8,432			5,259			1,081			46,260			312			46,572
Provision for income tax expense (benefit)	819			332			40			25			454			410			(156		)	1,924			(69		)	1,855
Operating earnings	$	1,572		$	1,090		$	468		$	186		$	977		$	1,125		$	(1,243	)	4,175
Adjustments to:
Total revenues																						548
Total expenses																						(312		)
Provision for income tax (expense) benefit																						69
Net income (loss)																						$	4,480					$	4,480

17

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

2. Segment Information (continued)

The following table presents total assets with respect to the Company’s segments, as well as Corporate & Other, at:

	September 30, 2016		December 31, 2015
	(In millions)
U.S.	$	257,943	$	237,858
Asia	133,881		113,895
Latin America	70,421		64,808
EMEA	27,764		26,767
MetLife Holdings	195,267		187,677
Brighthouse Financial	240,696		226,792
Corporate & Other	26,932		20,136
Total	$	952,904	$	877,933

3. Disposition

In July 2016, MetLife, Inc. completed the sale to Massachusetts Mutual Life Insurance Company (“MassMutual”) of its U.S. retail advisor force and certain assets associated with the MetLife Premier Client Group, including all of the issued and outstanding shares of MetLife’s affiliated broker-dealer, MetLife Securities, Inc. (“MSI”), a wholly-owned subsidiary of MetLife, Inc. (collectively, the “U.S. Retail Advisor Force Divestiture”) for $291 million. MassMutual assumed all of the liabilities related to such assets that arise or occur after the closing of the sale. The Company recorded a gain of $103 million ($58 million, net of income tax), in net investment gains (losses) for the three months and nine months ended September 30, 2016. See Notes 9 and 13 for discussion of certain charges related to the sale.

4. Insurance

Insurance Liabilities

Insurance liabilities are comprised of future policy benefits, policyholder account balances and other policy-related balances. Information regarding insurance liabilities by segment, as well as Corporate & Other, was as follows at:

	September 30, 2016			December 31, 2015
	(In millions)
U.S.	$	129,448		$	123,060
Asia	96,648			83,510
Latin America	15,228			14,022
EMEA	19,206			19,009
MetLife Holdings	105,995			102,853
Brighthouse Financial	79,241			71,853
Corporate & Other	(6,156		)	(5,451		)
Total	$	439,610		$	408,856

Guarantees

As discussed in Notes 1 and 4 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report, the Company issues directly and assumes through reinsurance variable annuity products with guaranteed minimum benefits. Guaranteed minimum accumulation benefits (“GMABs”) and the portions of both non-life-contingent guaranteed minimum withdrawal benefits (“GMWBs”) and the GMIBs that do not require annuitization are accounted for as embedded derivatives in policyholder account balances and are further discussed in Note 8.

18

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

4. Insurance (continued)

The Company also issues other annuity contracts that apply a lower rate on funds deposited if the contractholder elects to surrender the contract for cash and a higher rate if the contractholder elects to annuitize. These guarantees include benefits that are payable in the event of death, maturity or at annuitization. Certain other annuity contracts contain guaranteed annuitization benefits that may be above what would be provided by the current account value of the contract. Additionally, the Company issues universal and variable life contracts where the Company contractually guarantees to the contractholder a secondary guarantee or a guaranteed paid-up benefit.

Information regarding the Company’s guarantee exposure, which includes direct and assumed business, but excludes offsets from hedging or ceded reinsurance, if any, was as follows at:

	September 30, 2016								December 31, 2015
	In the Event of Death				At Annuitization				In the Event of Death				At Annuitization
	(Dollars in millions)
Annuity Contracts (1):
Variable Annuity Guarantees:
Total account value (2), (3)	$	183,010			$	92,187			$	181,413			$	91,240
Separate account value	$	153,486			$	88,546			$	151,901			$	87,841
Net amount at risk (2)	$	8,157	(4	)	$	4,663	(5	)	$	10,339	(4	)	$	2,762	(5	)
Average attained age of contractholders	66 years				66 years				66 years				66 years
Other Annuity Guarantees:
Total account value (3)	N/A				$	1,600			N/A				$	1,560
Net amount at risk	N/A				$	576	(6	)	N/A				$	422	(6	)
Average attained age of contractholders	N/A				50 years				N/A				51 years

	September 30, 2016				December 31, 2015
	Secondary Guarantees		Paid-Up Guarantees		Secondary Guarantees		Paid-Up Guarantees
	(Dollars in millions)
Universal and Variable Life Contracts (1):
Total account value (3)	$	17,640	$	3,365	$	17,211	$	3,461
Net amount at risk (7)	$	176,066	$	18,068	$	175,958	$	19,047
Average attained age of policyholders	57 years		62 years		57 years		62 years

__________________

(1) The Company’s annuity and life contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive.

(2) Includes amounts, which are not reported on the consolidated balance sheets, from assumed reinsurance of certain variable annuity products from the Company’s former operating joint venture in Japan.

(3) Includes the contractholder’s investments in the general account and separate account, if applicable.

(4) Defined as the death benefit less the total account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death.

(5) Defined as the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company’s potential economic exposure to such guarantees in the event all contractholders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contractholders have achieved.

19

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

4. Insurance (continued)

(6) Defined as either the excess of the upper tier, adjusted for a profit margin, less the lower tier, as of the balance sheet date or the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. These amounts represent the Company’s potential economic exposure to such guarantees in the event all contractholders were to annuitize on the balance sheet date.

(7) Defined as the guarantee amount less the account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date.

5. Deferred Policy Acquisition Costs and Value of Business Acquired

Information regarding total DAC and VOBA by segment, as well as Corporate & Other, was as follows at:

	September 30, 2016		December 31, 2015
	(In millions)
U.S.	$	618	$	615
Asia	9,148		8,374
Latin America	1,846		1,753
EMEA	1,554		1,532
MetLife Holdings	4,962		5,436
Brighthouse Financial	6,589		6,390
Corporate & Other	31		30
Total	$	24,748	$	24,130

6. Closed Block

On April 7, 2000 (the “Demutualization Date”), Metropolitan Life Insurance Company (“MLIC”) converted from a mutual life insurance company to a stock life insurance company and became a wholly-owned subsidiary of MetLife, Inc. The conversion was pursuant to an order by the New York Superintendent of Insurance approving MLIC’s plan of reorganization, as amended (the “Plan of Reorganization”). On the Demutualization Date, MLIC established a closed block for the benefit of holders of certain individual life insurance policies of MLIC.

Experience within the closed block, in particular mortality and investment yields, as well as realized and unrealized gains and losses, directly impact the policyholder dividend obligation. Amortization of the closed block DAC, which resides outside of the closed block, is based upon cumulative actual and expected earnings within the closed block. Accordingly, the Company’s net income continues to be sensitive to the actual performance of the closed block.

Closed block assets, liabilities, revenues and expenses are combined on a line-by-line basis with the assets, liabilities, revenues and expenses outside the closed block based on the nature of the particular item.

20

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

6. Closed Block (continued)

Information regarding the closed block liabilities and assets designated to the closed block was as follows at:

	September 30, 2016			December 31, 2015
	(In millions)
Closed Block Liabilities
Future policy benefits	$	40,840		$	41,278
Other policy-related balances	256			249
Policyholder dividends payable	506			468
Policyholder dividend obligation	3,352			1,783
Current income tax payable	8			—
Other liabilities	601			380
Total closed block liabilities	45,563			44,158
Assets Designated to the Closed Block
Investments:
Fixed maturity securities available-for-sale, at estimated fair value	29,194			27,556
Equity securities available-for-sale, at estimated fair value	107			111
Mortgage loans	5,739			6,022
Policy loans	4,553			4,642
Real estate and real estate joint ventures	672			462
Other invested assets	1,233			1,066
Total investments	41,498			39,859
Cash and cash equivalents	72			236
Accrued investment income	482			474
Premiums, reinsurance and other receivables	65			56
Current income tax recoverable	—			11
Deferred income tax assets	195			234
Total assets designated to the closed block	42,312			40,870
Excess of closed block liabilities over assets designated to the closed block	3,251			3,288
Amounts included in accumulated other comprehensive income (loss) (“AOCI”)
Unrealized investment gains (losses), net of income tax	2,452			1,382
Unrealized gains (losses) on derivatives, net of income tax	88			76
Allocated to policyholder dividend obligation, net of income tax	(2,179		)	(1,159		)
Total amounts included in AOCI	361			299
Maximum future earnings to be recognized from closed block assets and liabilities	$	3,612		$	3,587

Information regarding the closed block policyholder dividend obligation was as follows:

	Nine Months   Ended   September 30, 2016		Year   Ended   December 31, 2015
	(In millions)
Balance, beginning of period	$	1,783	$	3,155
Change in unrealized investment and derivative gains (losses)	1,569		(1,372		)
Balance, end of period	$	3,352	$	1,783

21

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

6. Closed Block (continued)

Information regarding the closed block revenues and expenses was as follows:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Revenues
Premiums	$	436		$	447		$	1,297		$	1,334
Net investment income	486			487			1,435			1,500
Net investment gains (losses)	(3		)	(9		)	(19		)	(8		)
Net derivative gains (losses)	4			13			(3		)	25
Total revenues	923			938			2,710			2,851
Expenses
Policyholder benefits and claims	619			635			1,861			1,886
Policyholder dividends	232			273			723			757
Other expenses	33			36			100			109
Total expenses	884			944			2,684			2,752
Revenues, net of expenses before provision for income tax expense (benefit)	39			(6		)	26			99
Provision for income tax expense (benefit)	13			(1		)	8			36
Revenues, net of expenses and provision for income tax expense (benefit)	$	26		$	(5	)	$	18		$	63

MLIC charges the closed block with federal income taxes, state and local premium taxes and other state or local taxes, as well as investment management expenses relating to the closed block as provided in the Plan of Reorganization. MLIC also charges the closed block for expenses of maintaining the policies included in the closed block.

22

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

7. Investments

Fixed Maturity and Equity Securities Available-for-Sale

Fixed Maturity and Equity Securities Available-for-Sale by Sector

The following table presents the fixed maturity and equity securities available-for-sale (“AFS”) by sector. Redeemable preferred stock is reported within U.S. corporate and foreign corporate fixed maturity securities and non-redeemable preferred stock is reported within equity securities. Included within fixed maturity securities are structured securities including residential mortgage-backed securities (“RMBS”), asset-backed securities (“ABS”) and commercial mortgage-backed securities (“CMBS”) (collectively, “Structured Securities”).

	September 30, 2016											December 31, 2015
	Cost or Amortized Cost		Gross Unrealized							Estimated Fair Value		Cost or Amortized Cost		Gross Unrealized							Estimated Fair Value
			Gains		Temporary Losses		OTTI Losses							Gains		Temporary Losses		OTTI Losses
	(In millions)
Fixed maturity securities:
U.S. corporate	$	95,808	$	10,589	$	721	$	—		$	105,676	$	96,466	$	6,583	$	2,255	$	—		$	100,794
U.S. government and agency	60,340		9,491		46		—			69,785		56,499		5,373		226		—			61,646
Foreign corporate	57,423		4,264		1,268		—			60,419		56,003		3,019		1,822		2			57,198
Foreign government	54,425		9,479		139		—			63,765		45,451		5,269		221		—			50,499
RMBS	43,838		1,788		310		7			45,309		37,914		1,366		424		59			38,797
State and political subdivision	14,539		2,939		11		4			17,463		13,723		1,795		67		10			15,441
ABS	15,685		122		220		3			15,584		14,498		131		229		6			14,394
CMBS (1)	11,855		662		77		(1		)	12,441		12,410		347		125		(1		)	12,633
Total fixed maturity securities	$	353,913	$	39,334	$	2,792	$	13		$	390,442	$	332,964	$	23,883	$	5,369	$	76		$	351,402
Equity securities:
Common stock	$	2,000	$	449	$	14	$	—		$	2,435	$	1,962	$	397	$	107	$	—		$	2,252
Non-redeemable preferred stock	838		63		47		—			854		1,035		85		51		—			1,069
Total equity securities	$	2,838	$	512	$	61	$	—		$	3,289	$	2,997	$	482	$	158	$	—		$	3,321

__________________

(1) The noncredit loss component of other-than-temporary impairment (“OTTI”) losses for CMBS was in an unrealized gain position of $1 million at both September 30, 2016 and December 31, 2015 due to increases in estimated fair value subsequent to initial recognition of noncredit losses on such securities. See also “— Net Unrealized Investment Gains (Losses).”

The Company held non-income producing fixed maturity securities with an estimated fair value of $44 million and $54 million with unrealized gains (losses) of ($5) million and $12 million at September 30, 2016 and December 31, 2015, respectively.

Maturities of Fixed Maturity Securities

The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at September 30, 2016:

	Due in One Year or Less		Due After One Year Through Five Years		Due After Five Years Through Ten Years		Due After Ten Years		Structured Securities		Total Fixed Maturity Securities
	(In millions)
Amortized cost	$	15,378	$	77,046	$	72,056	$	118,055	$	71,378	$	353,913
Estimated fair value	$	15,464	$	81,187	$	76,987	$	143,470	$	73,334	$	390,442

23

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

7. Investments (continued)

Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. Structured Securities are shown separately, as they are not due at a single maturity.

Continuous Gross Unrealized Losses for Fixed Maturity and Equity Securities AFS by Sector

The following table presents the estimated fair value and gross unrealized losses of fixed maturity and equity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position at:

	September 30, 2016								December 31, 2015
	Less than 12 Months				Equal to or Greater than 12 Months				Less than 12 Months				Equal to or Greater than 12 Months
	Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses
	(Dollars in millions)
Fixed maturity securities:
U.S. corporate	$	5,559	$	274	$	4,612	$	447	$	27,526	$	1,629	$	3,762	$	626
U.S. government and agency	6,305		24		164		22		19,628		222		298		4
Foreign corporate	6,781		404		6,112		864		14,447		911		5,251		913
Foreign government	2,136		75		851		64		3,530		166		429		55
RMBS	5,692		127		3,259		190		13,467		287		2,431		196
State and political subdivision	321		5		79		10		1,618		55		168		22
ABS	2,084		105		3,476		118		7,329		124		2,823		111
CMBS	701		34		791		42		4,876		81		637		43
Total fixed maturity securities	$	29,579	$	1,048	$	19,344	$	1,757	$	92,421	$	3,475	$	15,799	$	1,970
Equity securities:
Common stock	$	102	$	14	$	5	$	—	$	203	$	105	$	20	$	2
Non-redeemable preferred stock	49		3		163		44		79		2		200		49
Total equity securities	$	151	$	17	$	168	$	44	$	282	$	107	$	220	$	51
Total number of securities in an unrealized loss position	2,579				1,871				6,366				1,489

Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities

As described more fully in Notes 1 and 8 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report, the Company performs a regular evaluation of all investment classes for impairment, including fixed maturity securities, equity securities and perpetual hybrid securities, in accordance with its impairment policy, in order to evaluate whether such investments are other-than-temporarily impaired.

Current Period Evaluation

Based on the Company’s current evaluation of its AFS securities in an unrealized loss position in accordance with its impairment policy, and the Company’s current intentions and assessments (as applicable to the type of security) about holding, selling and any requirements to sell these securities, the Company concluded that these securities were not other-than-temporarily impaired at September 30, 2016. Future OTTI will depend primarily on economic fundamentals, issuer performance (including changes in the present value of future cash flows expected to be collected), changes in credit ratings, collateral valuation, interest rates and credit spreads. If economic fundamentals deteriorate or if there are adverse changes in the above factors, OTTI may be incurred in upcoming periods.

Gross unrealized losses on fixed maturity securities decreased$2.6 billionduring thenine months endedSeptember 30, 2016to$2.8 billion. The decrease in gross unrealized losses for thenine months endedSeptember 30, 2016was primarily attributable to a decrease in interest rates and, to a lesser extent, narrowing credit spreads.

At September 30, 2016, $321 million of the total $2.8 billion of gross unrealized losses were from 74 fixed maturity securities with an unrealized loss position of 20% or more of amortized cost for six months or greater.

24

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

7. Investments (continued)

Investment Grade Fixed Maturity Securities

Of the $321 million of gross unrealized losses on fixed maturity securities with an unrealized loss of 20% or more of amortized cost for six months or greater, $199 million, or 62%, were related to gross unrealized losses on 35 investment grade fixed maturity securities. Unrealized losses on investment grade fixed maturity securities are principally related to widening credit spreads and, with respect to fixed-rate fixed maturity securities, rising interest rates since purchase.

Below Investment Grade Fixed Maturity Securities

Of the $321 million of gross unrealized losses on fixed maturity securities with an unrealized loss of 20% or more of amortized cost for six months or greater, $122 million, or 38%, were related to gross unrealized losses on 39 below investment grade fixed maturity securities. Unrealized losses on below investment grade fixed maturity securities are principally related to U.S. and foreign corporate securities (primarily industrial securities) and are the result of significantly wider credit spreads resulting from higher risk premiums since purchase, largely due to economic and market uncertainties including concerns over lower oil prices in the energy sector. Management evaluates U.S. and foreign corporate securities based on factors such as expected cash flows and the financial condition and near-term and long-term prospects of the issuers.

Equity Securities

Gross unrealized losses on equity securities decreased $97 million during the nine months endedSeptember 30, 2016 to $61 million. Of the $61 million, $38 million were from six securities with gross unrealized losses of 20% or more of cost for 12 months or greater. Of the $38 million, 61% were rated A or better, and all were from financial services industry investment grade non-redeemable preferred stock.

Mortgage Loans

Mortgage Loans by Portfolio Segment

Mortgage loans are summarized as follows at:

	September 30, 2016					December 31, 2015
	Carrying Value			% of Total		Carrying Value			% of Total
	(Dollars in millions)
Mortgage loans:
Commercial	$	45,801		64.4	%	$	44,012		65.6	%
Agricultural	14,141			19.9		13,188			19.6
Residential	10,920			15.3		9,734			14.5
Subtotal (1)	70,862			99.6		66,934			99.7
Valuation allowances	(330		)	(0.5	)	(318		)	(0.5	)
Subtotal mortgage loans, net	70,532			99.1		66,616			99.2
Residential — FVO	481			0.7		314			0.5
Commercial mortgage loans held by CSEs — FVO	143			0.2		172			0.3
Total mortgage loans, net	$	71,156		100.0	%	$	67,102		100.0	%

__________________

(1) Purchases of mortgage loans were$856 millionand$2.3 billionfor thethree monthsandnine months endedSeptember 30, 2016, respectively, and$1.0 billionand$3.2 billionfor thethree monthsandnine months endedSeptember 30, 2015, respectively.

See “— Variable Interest Entities” for discussion of consolidated securitization entities (“CSEs”).

Information on commercial, agricultural and residential mortgage loans is presented in the tables below. Information on residential — FVO and commercial mortgage loans held by CSEs — FVO is presented in Note 9. The Company elects the FVO for certain mortgage loans and related long-term debt that are managed on a total return basis.

25

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

7. Investments (continued)

Mortgage Loans, Valuation Allowance and Impaired Loans by Portfolio Segment

Mortgage loans by portfolio segment, by method of evaluation of credit loss, impaired mortgage loans including those modified in a troubled debt restructuring, and the related valuation allowances, were as follows at:

	Evaluated Individually for Credit Losses										Evaluated Collectively for Credit Losses				Impaired Loans
	Impaired Loans with a Valuation Allowance						Impaired Loans without a Valuation Allowance
	Unpaid Principal Balance		Recorded Investment		Valuation Allowances		Unpaid Principal Balance		Recorded Investment		Recorded Investment		Valuation Allowances		Carrying Value
	(In millions)
September 30, 2016
Commercial	$	—	$	—	$	—	$	12	$	12	$	45,789	$	227	$	12
Agricultural	16		13		1		39		38		14,090		42		50
Residential	—		—		—		236		215		10,705		60		215
Total	$	16	$	13	$	1	$	287	$	265	$	70,584	$	329	$	277
December 31, 2015
Commercial	$	—	$	—	$	—	$	57	$	57	$	43,955	$	217	$	57
Agricultural	49		47		3		22		21		13,120		39		65
Residential	—		—		—		141		131		9,603		59		131
Total	$	49	$	47	$	3	$	220	$	209	$	66,678	$	315	$	253

The average recorded investment for impaired commercial, agricultural and residential mortgage loans was $90 million, $52 million and $202 million, respectively, for the three months endedSeptember 30, 2016; and $109 million, $56 million and $174 million, respectively, for the nine months endedSeptember 30, 2016.

The average recorded investment for impaired commercial, agricultural and residential mortgage loans was $118 million, $62 million and $96 million, respectively, for the three months endedSeptember 30, 2015; and $144 million, $62 million and $72 million, respectively, for the nine months endedSeptember 30, 2015.

Valuation Allowance Rollforward by Portfolio Segment

The changes in the valuation allowance, by portfolio segment, were as follows:

	Nine Months   Ended   September 30,
	2016												2015
	Commercial			Agricultural			Residential			Total			Commercial			Agricultural		Residential			Total
	(In millions)
Balance, beginning of period	$	217		$	42		$	59		$	318		$	224		$	39	$	42		$	305
Provision (release) (1)	153			3			13			169			3			2		27			32
Charge-offs, net of recoveries (1)	(143		)	(2		)	(12		)	(157		)	(12		)	—		(14		)	(26		)
Balance, end of period	$	227		$	43		$	60		$	330		$	215		$	41	$	55		$	311

__________________

(1) In connection with an acquisition in 2010, certain impaired commercial mortgage loans were acquired and accordingly, were not originated by the Company. Such commercial mortgage loans have been accounted for as purchased credit impaired (“PCI”) commercial mortgage loans. As explained in Note 8 of the Notes to Consolidated Financial Statements included in the 2015 Annual Report, decreases in cash flows expected to be collected on PCI commercial mortgage loans can result in provisions for losses on mortgage loan. For the nine months endedSeptember 30, 2016, in connection with the maturity of an acquired PCI commercial mortgage loan, an increase to the commercial mortgage loan valuation allowance of$143 millionwas recorded and charged-off upon maturity. The Company will recover a substantial portion of the loss on the loan incurred through an indemnification agreement entered into in connection with the acquisition in 2010.

26

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

7. Investments (continued)

Credit Quality of Commercial Mortgage Loans

The credit quality of commercial mortgage loans was as follows at:

	Recorded Investment										Estimated Fair Value		% of Total
	Debt Service Coverage Ratios								% of Total
	> 1.20x		1.00x - 1.20x		< 1.00x		Total
	(Dollars in millions)
September 30, 2016
Loan-to-value ratios:
Less than 65%	$	41,391	$	879	$	675	$	42,945	93.8	%	$	44,770	93.9	%
65% to 75%	2,194		39		298		2,531		5.5		2,563		5.4
76% to 80%	42		—		—		42		0.1		40		0.1
Greater than 80%	143		53		87		283		0.6		299		0.6
Total	$	43,770	$	971	$	1,060	$	45,801	100	%	$	47,672	100	%
December 31, 2015
Loan-to-value ratios:
Less than 65%	$	38,163	$	1,063	$	544	$	39,770	90.4	%	$	40,921	90.7	%
65% to 75%	3,270		138		76		3,484		7.9		3,451		7.7
76% to 80%	—		—		—		—		—		—		—
Greater than 80%	381		140		237		758		1.7		732		1.6
Total	$	41,814	$	1,341	$	857	$	44,012	100.0	%	$	45,104	100.0	%

Credit Quality of Agricultural Mortgage Loans

The credit quality of agricultural mortgage loans was as follows at:

	September 30, 2016				December 31, 2015
	Recorded Investment		% of Total		Recorded Investment		% of Total
	(Dollars in millions)
Loan-to-value ratios:
Less than 65%	$	13,543	95.8	%	$	12,399	94.0	%
65% to 75%	532		3.8		710		5.4
76% to 80%	20		0.1		21		0.2
Greater than 80%	46		0.3		58		0.4
Total	$	14,141	100.0	%	$	13,188	100.0	%

The estimated fair value of agricultural mortgage loans was $14.6 billion and $13.5 billion at September 30, 2016 and December 31, 2015, respectively.

Credit Quality of Residential Mortgage Loans

The credit quality of residential mortgage loans was as follows at:

	September 30, 2016				December 31, 2015
	Recorded Investment		% of Total		Recorded Investment		% of Total
	(Dollars in millions)
Performance indicators:
Performing	$	10,587	97.0	%	$	9,408	96.7	%
Nonperforming	333		3.0		326		3.3
Total	$	10,920	100.0	%	$	9,734	100.0	%

27

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

7. Investments (continued)

The estimated fair value of residential mortgage loans was $11.4 billion and $9.9 billion at September 30, 2016 and December 31, 2015, respectively.

Past Due and Interest Accrual Status of Mortgage Loans

The Company has a high quality, well performing mortgage loan portfolio, with 99% of all mortgage loans classified as performing at both September 30, 2016 and December 31, 2015. The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial and residential mortgage loans — 60 days and agricultural mortgage loans — 90 days. The past due and accrual status of mortgage loans at recorded investment, prior to valuation allowances, by portfolio segment, were as follows at:

	Past Due				Nonaccrual Status
	September 30, 2016		December 31, 2015		September 30, 2016		December 31, 2015
	(In millions)
Commercial	$	—	$	2	$	—	$	—
Agricultural	144		103		39		46
Residential	333		326		322		318
Total	$	477	$	431	$	361	$	364

Mortgage Loans Modified in a Troubled Debt Restructuring

During both thethree monthsandnine months endedSeptember 30, 2016and2015, the Company did not have a significant amount of mortgage loans modified in a troubled debt restructuring.

Cash Equivalents

The carrying value of cash equivalents, which includes securities and other investments with an original or remaining maturity of three months or less at the time of purchase, was $7.3 billion and $7.5 billion at September 30, 2016 and December 31, 2015, respectively.

Net Unrealized Investment Gains (Losses)

Unrealized investment gains (losses) on fixed maturity and equity securities AFS and the effect on DAC, VOBA, deferred sales inducements (“DSI”), future policy benefits and the policyholder dividend obligation, that would result from the realization of the unrealized gains (losses), are included in net unrealized investment gains (losses) in AOCI.

The components of net unrealized investment gains (losses), included in AOCI, were as follows:

	September 30, 2016			December 31, 2015
	(In millions)
Fixed maturity securities	$	36,444		$	18,164
Fixed maturity securities with noncredit OTTI losses included in AOCI	(13		)	(76		)
Total fixed maturity securities	36,431			18,088
Equity securities	579			422
Derivatives	3,648			2,350
Other	397			287
Subtotal	41,055			21,147
Amounts allocated from:
Future policy benefits	(5,571		)	(163		)
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(2		)	—
DAC, VOBA and DSI	(2,390		)	(1,273		)
Policyholder dividend obligation	(3,352		)	(1,783		)
Subtotal	(11,315		)	(3,219		)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	7			27
Deferred income tax benefit (expense)	(10,078		)	(6,151		)
Net unrealized investment gains (losses)	19,669			11,804
Net unrealized investment gains (losses) attributable to noncontrolling interests	(12		)	(31		)
Net unrealized investment gains (losses) attributable to MetLife, Inc.	$	19,657		$	11,773

The changes in fixed maturity securities with noncredit OTTI losses included in AOCI were as follows:

	Nine Months   Ended   September 30, 2016			Year   Ended   December 31, 2015
	(In millions)
Balance, beginning of period	$	(76	)	$	(112	)
Noncredit OTTI losses and subsequent changes recognized	12			6
Securities sold with previous noncredit OTTI loss	34			125
Subsequent changes in estimated fair value	17			(95		)
Balance, end of period	$	(13	)	$	(76	)

28

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

7. Investments (continued)

The changes in net unrealized investment gains (losses) were as follows:

	Nine Months   Ended   September 30, 2016
	(In millions)
Balance, beginning of period	$	11,773
Fixed maturity securities on which noncredit OTTI losses have been recognized	63
Unrealized investment gains (losses) during the period	19,845
Unrealized investment gains (losses) relating to:
Future policy benefits	(5,408		)
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(2		)
DAC, VOBA and DSI	(1,117		)
Policyholder dividend obligation	(1,569		)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	(20		)
Deferred income tax benefit (expense)	(3,927		)
Net unrealized investment gains (losses)	19,638
Net unrealized investment gains (losses) attributable to noncontrolling interests	19
Balance, end of period	$	19,657
Change in net unrealized investment gains (losses)	$	7,865
Change in net unrealized investment gains (losses) attributable to noncontrolling interests	19
Change in net unrealized investment gains (losses) attributable to MetLife, Inc.	$	7,884

Concentrations of Credit Risk

Investments in any counterparty that were greater than 10% of the Company’s equity, other than the U.S. government and its agencies, were in fixed income securities of the Japanese government and its agencies with an estimated fair value of $29.4 billion and $20.9 billion at September 30, 2016 and December 31, 2015, respectively. The Company’s investment in fixed maturity and equity securities to counterparties that primarily conduct business in Japan, including Japan government and agency fixed maturity securities, was $33.8 billion and $25.4 billion at September 30, 2016 and December 31, 2015, respectively.

Securities Lending

Elements of the securities lending program are presented below at:

	September 30, 2016		December 31, 2015
	(In millions)
Securities on loan: (1)
Amortized cost	$	26,855	$	27,223
Estimated fair value	$	31,326	$	29,646
Cash collateral on deposit from counterparties (2)	$	32,119	$	30,197
Security collateral on deposit from counterparties (3)	$	134	$	50
Reinvestment portfolio — estimated fair value	$	32,454	$	30,258

__________________

(1) Included within fixed maturity securities, cash equivalents and short-term investments. At September 30, 2016, both amortized cost and estimated fair value also included $114 million, at estimated fair value, of securities which are not reflected on the consolidated financial statements.

(2) Included within payables for collateral under securities loaned and other transactions.

(3) Security collateral on deposit from counterparties may not be sold or re-pledged, unless the counterparty is in default, and is not reflected on the consolidated financial statements.

29

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

7. Investments (continued)

The cash collateral liability by loaned security type and remaining tenor of the agreements were as follows at:

	September 30, 2016								December 31, 2015
	Remaining Tenor of Securities Lending Agreements								Remaining Tenor of Securities Lending Agreements
	Open (1)		1 Month or Less		1 to 6 Months		Total		Open (1)		1 Month or Less		1 to 6 Months		Total
	(In millions)
Cash collateral liability by loaned security type:
U.S. government and agency	$	8,362	$	10,162	$	11,090	$	29,614	$	10,116	$	11,157	$	5,986	$	27,259
Agency RMBS	—		—		1,196		1,196		—		951		600		1,551
Foreign government	—		836		50		886		2		510		486		998
U.S. corporate	1		391		—		392		9		380		—		389
Foreign corporate	—		31		—		31		—		—		—		—
Total	$	8,363	$	11,420	$	12,336	$	32,119	$	10,127	$	12,998	$	7,072	$	30,197

__________________

(1) The related loaned security could be returned to the Company on the next business day which would require the Company to immediately return the cash collateral.

If the Company is required to return significant amounts of cash collateral on short notice and is forced to sell securities to meet the return obligation, it may have difficulty selling such collateral that is invested in securities in a timely manner, be forced to sell securities in a volatile or illiquid market for less than what otherwise would have been realized under normal market conditions, or both. The estimated fair value of the securities on loan related to the cash collateral on open at September 30, 2016 was $8.1 billion, over 99% of which were U.S. government and agency securities which, if put back to the Company, could be immediately sold to satisfy the cash requirement.

The reinvestment portfolio acquired with the cash collateral consisted principally of fixed maturity securities (including U.S. government and agency, agency RMBS, short-term investments, ABS and U.S. corporate securities) with 65% invested in U.S. government and agency securities, agency RMBS, short-term investments, or held in cash and cash equivalents. If the securities on loan or the reinvestment portfolio become less liquid, the Company has the liquidity resources of most of its general account available to meet any potential cash demands when securities on loan are put back to the Company.

Repurchase Agreement Transactions

The Company participates in contemporaneous short-term repurchase agreements and reverse repurchase agreements with unaffiliated financial institutions. Under these agreements, the Company lends fixed maturity securities and contemporaneously borrows other fixed maturity securities (e.g., repurchase and reverse repurchase, respectively). The Company obtains cash collateral in an amount greater than or equal to 95% of the estimated fair value of the securities loaned, and pledges cash collateral in an amount generally equal to 98% of the estimated fair value of the borrowed securities at the inception of the transaction. The Company monitors the estimated fair value of the securities loaned and borrowed with additional collateral obtained as necessary throughout the duration of the transaction.

The Company accounted for these transactions as collateralized borrowing and lending. The amount of fixed maturity securities lent and borrowed, at estimated fair value, was $316 million and $306 million, respectively, at September 30, 2016. There were no such transactions outstanding as of December 31, 2015. Securities loaned under such transactions may be sold or re-pledged by the transferee. Securities borrowed under such transactions may be re-pledged and are not reflected on the consolidated financial statements. The amount of borrowed securities which were re-pledged was $114 million, at estimated fair value, at September 30, 2016.

30

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

7. Investments (continued)

The Company has elected to offset amounts recognized as receivables and payables resulting from these transactions. The gross amounts of the receivables and payables related to these transactions at September 30, 2016 were both $300 million. After the effect of offsetting of $300 million, the net amount presented on the consolidated balance sheet at September 30, 2016 was a liability of less than $1 million. Amounts owed to and due from counterparties may be settled in cash or offset, in accordance with the agreements. Cash inflows and outflows for cash settlements are reported on the consolidated statements of cash flows. At September 30, 2016, all $300 million of payables from repurchase agreements had a remaining tenor of one to six months and were primarily loans of U.S. corporate securities.

See Note 8 for information regarding the estimated fair value of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral.

The Company also participates in other short-term repurchase agreements with unaffiliated financial institutions. Under these agreements, the Company lends fixed maturity securities and receives cash as collateral in an amount generally equal to 85% to 100% of the estimated fair value of the securities loaned at the inception of the transaction. The associated liability is recorded at the amount of cash received. The Company monitors the estimated fair value of the collateral and the securities loaned throughout the duration of the transaction and additional collateral is obtained as necessary. Securities loaned under such transactions may be sold or re-pledged by the transferee.

Elements of the other short-term repurchase agreements are presented below at:

	September 30, 2016		December 31, 2015
	(In millions)
Securities on loan included within fixed maturity securities:
Amortized cost	$	91	$	51
Estimated fair value	$	109	$	56
Cash collateral received included within other liabilities	$	101	$	50
Reinvestment portfolio — estimated fair value	$	99	$	50

The cash collateral liability by loaned security type and remaining tenor of the agreements were as follows at:

	September 30, 2016						December 31, 2015
	Remaining Tenor of Other Repurchase Agreements						Remaining Tenor of Other Repurchase Agreements
	1 Month or Less		1 to 6  Months		Total		1 Month or Less		1 to 6 Months		Total
	(In millions)
Cash collateral liability by loaned security type:
Foreign corporate	$	14	$	13	$	27	$	—	$	25	$	25
All other corporate and government	37		37		$	74	—		25		$	25
Total	$	51	$	50	$	101	$	—	$	50	$	50

Invested Assets on Deposit, Held in Trust and Pledged as Collateral

Invested assets on deposit, held in trust and pledged as collateral are presented below at estimated fair value for all asset classes, except mortgage loans, which are presented at carrying value at:

	September 30, 2016		December 31, 2015
	(In millions)
Invested assets on deposit (regulatory deposits)	$	10,425	$	9,089
Invested assets held in trust (collateral financing arrangements and reinsurance agreements)	11,902		10,443
Invested assets pledged as collateral (1)	29,296		23,145
Total invested assets on deposit, held in trust and pledged as collateral	$	51,623	$	42,677

__________________

31

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

7. Investments (continued)

(1) The Company has pledged invested assets in connection with various agreements and transactions, including funding agreements (see Notes 4 and 12 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report), collateral financing arrangements (see Note 13 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report) and derivative transactions (see Note 8).

See “— Securities Lending” and “— Repurchase Agreement Transactions” for information regarding securities on loan and Note 6 for information regarding investments designated to the closed block.

Variable Interest Entities

The Company is involved with certain legal entities that are VIEs. In certain instances, the Company holds both the power to direct the most significant activities of the entity, as well as an economic interest in the entity and, as such, is deemed to be the primary beneficiary or consolidator of the entity. The determination of the VIE’s primary beneficiary requires an evaluation of the contractual and implied rights and obligations associated with each party’s relationship with or involvement in the entity.

Consolidated VIEs

Creditors or beneficial interest holders of VIEs where the Company is the primary beneficiary have no recourse to the general credit of the Company, as the Company’s obligation to the VIEs is limited to the amount of its committed investment.

The following table presents the total assets and total liabilities relating to VIEs for which the Company has concluded that it is the primary beneficiary and which are consolidated at:

	September 30, 2016				December 31, 2015
	Total Assets		Total Liabilities		Total Assets		Total Liabilities
	(In millions)
MRSC (collateral financing arrangement (primarily securities)) (1)	$	3,533	$	—	$	3,374	$	—
Operating joint venture (2)	—		—		2,465		2,079
CSEs (assets (primarily loans) and liabilities (primarily debt)) (3)	156		38		186		62
Other investments (4)	50		—		76		—
Total	$	3,739	$	38	$	6,101	$	2,141

__________________

(1) See Note 13 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report for a description of the MetLife Reinsurance Company of South Carolina (“MRSC”) collateral financing arrangement.

(2) Following a change in the foreign investment law in India, the Company no longer consolidated its India operating joint venture, effective January 1, 2016. Assets of the operating joint venture are primarily fixed maturity securities and separate account assets. Liabilities of the operating joint venture are primarily future policy benefits, other policy-related balances and separate account liabilities.

(3) The Company consolidates entities that are structured as CMBS and as collateralized debt obligations. The assets of these entities can only be used to settle their respective liabilities, and under no circumstances is the Company liable for any principal or interest shortfalls should any arise. The Company’s exposure was limited to that of its remaining investment in these entities of $98 million and $105 million at estimated fair value at September 30, 2016 and December 31, 2015, respectively.

(4) Other investments is primarily comprised of other invested assets and other limited partnership interests.

32

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

7. Investments (continued)

Unconsolidated VIEs

The carrying amount and maximum exposure to loss relating to VIEs in which the Company holds a significant variable interest but is not the primary beneficiary and which have not been consolidated were as follows at:

	September 30, 2016				December 31, 2015
	Carrying Amount		Maximum Exposure to Loss (1)		Carrying Amount		Maximum Exposure to Loss (1)
	(In millions)
Fixed maturity securities AFS:
Structured Securities (2)	$	73,334	$	73,334	$	65,824	$	65,824
U.S. and foreign corporate	3,374		3,374		3,261		3,261
Other limited partnership interests	5,978		10,572		5,186		7,074
Other invested assets	2,184		2,771		1,604		2,161
FVO and trading securities	576		576		586		586
Real estate joint ventures	107		137		65		82
Other (3)	120		120		71		71
Total	$	85,673	$	90,884	$	76,597	$	79,059

__________________

(1) The maximum exposure to loss relating to fixed maturity securities AFS, FVO and trading securities and equity securities AFS is equal to their carrying amounts or the carrying amounts of retained interests. The maximum exposure to loss relating to other limited partnership interests, mortgage loans and real estate joint ventures is equal to the carrying amounts plus any unfunded commitments. For certain of its investments in other invested assets, the Company’s return is in the form of income tax credits which are guaranteed by creditworthy third parties. For such investments, the maximum exposure to loss is equal to the carrying amounts plus any unfunded commitments, reduced by income tax credits guaranteed by third parties of $151 million and $179 million at September 30, 2016 and December 31, 2015, respectively. Such a maximum loss would be expected to occur only upon bankruptcy of the issuer or investee.

(2) For these variable interests, the Company’s involvement is limited to that of a passive investor in mortgage-backed or asset-backed securities issued by trusts that do not have substantial equity.

(3) Other is comprised of mortgage loans, non-redeemable preferred stock and a loan receivable.

As described in Note 15, the Company makes commitments to fund partnership investments in the normal course of business. Excluding these commitments, the Company did not provide financial or other support to investees designated as VIEs during both the nine months endedSeptember 30, 2016 and 2015.

33

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

7. Investments (continued)

Net Investment Income

The components of net investment income were as follows:

	Three Months   Ended   September 30,					Nine Months   Ended   September 30,
	2016		2015			2016		2015
	(In millions)
Investment income:
Fixed maturity securities	$	3,583	$	3,525		$	10,801	$	10,738
Equity securities	35		36			105		102
FVO and trading securities — Actively traded and FVO general account securities (1)	25		(35		)	41		4
Mortgage loans	806		786			2,464		2,317
Policy loans	148		147			444		450
Real estate and real estate joint ventures	210		233			516		767
Other limited partnership interests	263		216			429		681
Cash, cash equivalents and short-term investments	43		29			126		101
Operating joint ventures	5		(1		)	28		15
Other	95		28			187		180
Subtotal	5,213		4,964			15,141		15,355
Less: Investment expenses	281		308			862		923
Subtotal, net	4,932		4,656			14,279		14,432
FVO and trading securities — FVO contractholder-directed unit-linked investments (1)	529		(701		)	623		(79		)
FVO CSEs — interest income:
Commercial mortgage loans	3		4			8		13
Securities	—		—			—		1
Subtotal	532		(697		)	631		(65		)
Net investment income	$	5,464	$	3,959		$	14,910	$	14,367

__________________

(1) Changes in estimated fair value subsequent to purchase for securities still held as of the end of the respective periods included in net investment income were principally from FVO contractholder-directed unit-linked investments and, to a much lesser extent, Actively traded and FVO general account securities, and were $407 million and $283 million for the three months and nine months ended September 30, 2016, respectively, and ($872) million and ($645) million for the three months and nine months ended September 30, 2015, respectively.

See “— Variable Interest Entities” for discussion of CSEs.

FVO and trading securities are primarily comprised of securities for which the FVO has been elected (“FVO securities”). FVO securities include certain fixed maturity and equity securities held-for-investment by the general account to support asset and liability management strategies for certain insurance products and investments in certain separate accounts. FVO securities are primarily comprised of contractholder-directed investments supporting unit-linked variable annuity type liabilities which do not qualify for presentation as separate account summary total assets and liabilities. The investment returns on these investments inure to the contractholders and are offset by a corresponding change in policyholder account balances through interest credited to policyholder account balances. FVO securities also include securities held by CSEs. The Company previously maintained a trading securities portfolio, principally invested in fixed maturity securities, to support investment strategies that involved the active and frequent purchase and sale of actively traded securities and the execution of short sale agreements. In June 2016, the Company commenced a reinvestment of this portfolio into other asset classes and, at September 30, 2016, the Company no longer held any actively traded securities.

34

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

7. Investments (continued)

Net Investment Gains (Losses)

Components of Net Investment Gains (Losses)

The components of net investment gains (losses) were as follows:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Total gains (losses) on fixed maturity securities:
Total OTTI losses recognized — by sector and industry:
U.S. and foreign corporate securities — by industry:
Consumer	$	—		$	(17	)	$	—		$	(20	)
Industrial	—			(3		)	(79		)	(5		)
Communications	—			—			(3		)	—
Total U.S. and foreign corporate securities	—			(20		)	(82		)	(25		)
RMBS	(14		)	(1		)	(22		)	(16		)
ABS	—			—			(2		)	—
State and political subdivision	—			(6		)	—			(6		)
OTTI losses on fixed maturity securities recognized in earnings	(14		)	(27		)	(106		)	(47		)
Fixed maturity securities — net gains (losses) on sales and disposals	176			115			439			383
Total gains (losses) on fixed maturity securities	162			88			333			336
Total gains (losses) on equity securities:
Total OTTI losses recognized — by sector:
Non-redeemable preferred stock	—			(1		)	—			(1		)
Common stock	(5		)	(6		)	(72		)	(15		)
OTTI losses on equity securities recognized in earnings	(5		)	(7		)	(72		)	(16		)
Equity securities — net gains (losses) on sales and disposals	13			14			32			39
Total gains (losses) on equity securities	8			7			(40		)	23
Mortgage loans	(31		)	(26		)	(193		)	(78		)
Real estate and real estate joint ventures	(14		)	263			33			257
Other limited partnership interests	(9		)	(59		)	(50		)	(52		)
Other	(19		)	18			(94		)	14
Subtotal	97			291			(11		)	500
FVO CSEs:
Commercial mortgage loans	(3		)	(4		)	(3		)	(6		)
Securities	1			—			2			—
Long-term debt — related to commercial mortgage loans	1			1			1			3
Non-investment portfolio gains (losses) (1)	161			94			549			38
Subtotal	160			91			549			35
Total net investment gains (losses)	$	257		$	382		$	538		$	535

__________________

(1) Includes a gain from the U.S. Retail Advisor Force Divestiture of $103 million during both the three months and nine months ended September 30, 2016. See Note 3.

See “— Variable Interest Entities” for discussion of CSEs.

35

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

7. Investments (continued)

Gains (losses) from foreign currency transactions included within net investment gains (losses) were$69 millionand$437 millionfor thethree monthsandnine months endedSeptember 30, 2016, respectively, and$53 millionand($29) millionfor thethree monthsandnine months endedSeptember 30, 2015, respectively.

Sales or Disposals and Impairments of Fixed Maturity and Equity Securities

Investment gains and losses on sales of securities are determined on a specific identification basis. Proceeds from sales or disposals of fixed maturity and equity securities and the components of fixed maturity and equity securities net investment gains (losses) were as shown in the table below.

	Three Months   Ended   September 30,
	2016			2015			2016			2015
	Fixed Maturity Securities						Equity Securities
	(In millions)
Proceeds	$	25,091		$	27,264		$	64		$	55
Gross investment gains	$	310		$	371		$	15		$	20
Gross investment losses	(134		)	(256		)	(2		)	(6		)
OTTI losses	(14		)	(27		)	(5		)	(7		)
Net investment gains (losses)	$	162		$	88		$	8		$	7

	Nine Months   Ended   September 30,
	2016			2015			2016			2015
	Fixed Maturity Securities						Equity Securities
	(In millions)
Proceeds	$	83,352		$	86,590		$	151		$	211
Gross investment gains	$	1,025		$	1,047		$	40		$	54
Gross investment losses	(586		)	(664		)	(8		)	(15		)
OTTI losses	(106		)	(47		)	(72		)	(16		)
Net investment gains (losses)	$	333		$	336		$	(40	)	$	23

36

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

7. Investments (continued)

Credit Loss Rollforward

The table below presents a rollforward of the cumulative credit loss component of OTTI loss recognized in earnings on fixed maturity securities still held for which a portion of the OTTI loss was recognized in other comprehensive income (loss) (“OCI”):

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Balance, beginning of period	$	258		$	280		$	277		$	357
Additions:
Initial impairments — credit loss OTTI on securities not previously impaired	1			—			1			2
Additional impairments — credit loss OTTI on securities previously impaired	10			1			18			14
Reductions:
Sales (maturities, pay downs or prepayments) of securities previously impaired as credit loss OTTI	(17		)	(22		)	(43		)	(113		)
Securities impaired to net present value of expected future cash flows	—			—			(1		)	—
Increase in cash flows — accretion of previous credit loss OTTI	—			(1		)	—			(2		)
Balance, end of period	$	252		$	258		$	252		$	258

8. Derivatives

Accounting for Derivatives

Freestanding Derivatives

Freestanding derivatives are carried on the Company’s balance sheet either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement.

Accruals on derivatives are generally recorded in accrued investment income or within other liabilities. However, accruals that are not scheduled to settle within one year are included with the derivatives carrying value in other invested assets or other liabilities.

If a derivative is not designated as an accounting hedge or its use in managing risk does not qualify for hedge accounting, changes in the estimated fair value of the derivative are reported in net derivative gains (losses) except as follows:

Statement of Operations Presentation:	Derivative:
Policyholder benefits and claims	•	Economic hedges of variable annuity guarantees included in future policy benefits
Net investment income	•	Economic hedges of equity method investments in joint ventures
	•	All derivatives held in relation to trading portfolios
	•	Derivatives held within contractholder-directed unit-linked investments

37

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

8. Derivatives (continued)

Hedge Accounting

To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. Hedge designation and financial statement presentation of changes in estimated fair value of the hedging derivatives are as follows:

• Fair value hedge (a hedge of the estimated fair value of a recognized asset or liability) - in net derivative gains (losses), consistent with the change in estimated fair value of the hedged item attributable to the designated risk being hedged.

• Cash flow hedge (a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability) - effectiveness in OCI (deferred gains or losses on the derivative are reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item); ineffectiveness in net derivative gains (losses).

• Net investment in a foreign operation hedge - effectiveness in OCI, consistent with the translation adjustment for the hedged net investment in the foreign operation; ineffectiveness in net derivative gains (losses).

The changes in estimated fair values of the hedging derivatives are exclusive of any accruals that are separately reported on the statement of operations within interest income or interest expense to match the location of the hedged item. Accruals on derivatives in net investment hedges are recognized in OCI.

In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness and the method that will be used to measure ineffectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship. Assessments of hedge effectiveness and measurements of ineffectiveness are also subject to interpretation and estimation and different interpretations or estimates may have a material effect on the amount reported in net income.

The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument.

When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item, the derivative continues to be carried on the balance sheet at its estimated fair value, with changes in estimated fair value recognized in net derivative gains (losses). The carrying value of the hedged recognized asset or liability under a fair value hedge is no longer adjusted for changes in its estimated fair value due to the hedged risk, and the cumulative adjustment to its carrying value is amortized into income over the remaining life of the hedged item. Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.

When hedge accounting is discontinued because it is no longer probable that the forecasted transactions will occur on the anticipated date or within two months of that date, the derivative continues to be carried on the balance sheet at its estimated fair value, with changes in estimated fair value recognized currently in net derivative gains (losses). Deferred gains and losses of a derivative recorded in OCI pursuant to the discontinued cash flow hedge of a forecasted transaction that is no longer probable are recognized immediately in net derivative gains (losses).

In all other situations in which hedge accounting is discontinued, the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses).

38

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

8. Derivatives (continued)

Embedded Derivatives

The Company sells variable annuities and issues certain insurance products and investment contracts and is a party to certain reinsurance agreements that have embedded derivatives. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated. The embedded derivative is bifurcated from the host contract and accounted for as a freestanding derivative if:

• the combined instrument is not accounted for in its entirety at estimated fair value with changes in estimated fair value recorded in earnings;

• the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract; and

• a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument.

Such embedded derivatives are carried on the balance sheet at estimated fair value with the host contract and changes in their estimated fair value are generally reported in net derivative gains (losses), except for those in policyholder benefits and claims related to ceded reinsurance of GMIB. If the Company is unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income. Additionally, the Company may elect to carry an entire contract on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income if that contract contains an embedded derivative that requires bifurcation. At inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent “excess” fees and are reported in universal life and investment-type product policy fees.

See Note 9 for information about the fair value hierarchy for derivatives.

Derivative Strategies

The Company is exposed to various risks relating to its ongoing business operations, including interest rate, foreign currency exchange rate, credit and equity market. The Company uses a variety of strategies to manage these risks, including the use of derivatives.

Derivatives are financial instruments with values derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (“OTC-cleared”), while others are bilateral contracts between two counterparties (“OTC-bilateral”). The types of derivatives the Company uses include swaps, forwards, futures and option contracts. To a lesser extent, the Company uses credit default swaps and structured interest rate swaps to synthetically replicate investment risks and returns which are not readily available in the cash market.

Interest Rate Derivatives

The Company uses a variety of interest rate derivatives to reduce its exposure to changes in interest rates, including interest rate swaps, interest rate total return swaps, caps, floors, swaptions, futures and forwards.

Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). In an interest rate swap, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest amounts as calculated by reference to an agreed notional amount. The Company utilizes interest rate swaps in fair value, cash flow and nonqualifying hedging relationships.

The Company uses structured interest rate swaps to synthetically create investments that are either more expensive to acquire or otherwise unavailable in the cash markets. These transactions are a combination of a derivative and a cash instrument such as a U.S. government and agency, or other fixed maturity security. Structured interest rate swaps are included in interest rate swaps and are not designated as hedging instruments.

39

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

8. Derivatives (continued)

Interest rate total return swaps are swaps whereby the Company agrees with another party to exchange, at specified intervals, the difference between the economic risk and reward of an asset or a market index and the London Interbank Offered Rate (“LIBOR”), calculated by reference to an agreed notional amount. No cash is exchanged at the outset of the contract. Cash is paid and received over the life of the contract based on the terms of the swap. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made by the counterparty at each due date. Interest rate total return swaps are used by the Company to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). The Company utilizes interest rate total return swaps in nonqualifying hedging relationships.

The Company purchases interest rate caps and floors primarily to protect its floating rate liabilities against rises in interest rates above a specified level, and against interest rate exposure arising from mismatches between assets and liabilities, as well as to protect its minimum rate guarantee liabilities against declines in interest rates below a specified level, respectively. In certain instances, the Company locks in the economic impact of existing purchased caps and floors by entering into offsetting written caps and floors. The Company utilizes interest rate caps and floors in nonqualifying hedging relationships.

In exchange-traded interest rate (Treasury and swap) futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of interest rate securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded interest rate (Treasury and swap) futures are used primarily to hedge mismatches between the duration of assets in a portfolio and the duration of liabilities supported by those assets, to hedge against changes in value of securities the Company owns or anticipates acquiring, to hedge against changes in interest rates on anticipated liability issuances by replicating Treasury or swap curve performance, and to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. The Company utilizes exchange-traded interest rate futures in nonqualifying hedging relationships.

Swaptions are used by the Company to hedge interest rate risk associated with the Company’s long-term liabilities and invested assets. A swaption is an option to enter into a swap with a forward starting effective date. In certain instances, the Company locks in the economic impact of existing purchased swaptions by entering into offsetting written swaptions. The Company pays a premium for purchased swaptions and receives a premium for written swaptions. The Company utilizes swaptions in nonqualifying hedging relationships. Swaptions are included in interest rate options.

The Company enters into interest rate forwards to buy and sell securities. The price is agreed upon at the time of the contract and payment for such a contract is made at a specified future date. The Company utilizes interest rate forwards in cash flow and nonqualifying hedging relationships.

Foreign Currency Exchange Rate Derivatives

The Company uses foreign currency exchange rate derivatives, including foreign currency swaps, foreign currency forwards, currency options and exchange-traded currency futures, to reduce the risk from fluctuations in foreign currency exchange rates associated with its assets and liabilities denominated in foreign currencies. The Company also uses foreign currency derivatives to hedge the foreign currency exchange rate risk associated with certain of its net investments in foreign operations.

In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company utilizes foreign currency swaps in fair value, cash flow and nonqualifying hedging relationships.

In a foreign currency forward transaction, the Company agrees with another party to deliver a specified amount of an identified currency at a specified future date. The price is agreed upon at the time of the contract and payment for such a contract is made at the specified future date. The Company utilizes foreign currency forwards in fair value, net investment in foreign operations and nonqualifying hedging relationships.

40

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

8. Derivatives (continued)

The Company enters into currency options that give it the right, but not the obligation, to sell the foreign currency amount in exchange for a functional currency amount within a limited time at a contracted price. The contracts may also be net settled in cash, based on differentials in the foreign currency exchange rate and the strike price. The Company uses currency options to hedge against the foreign currency exposure inherent in certain of its variable annuity products. The Company also uses currency options as an economic hedge of foreign currency exposure related to the Company’s international subsidiaries. The Company utilizes currency options in net investment in foreign operations and nonqualifying hedging relationships.

To a lesser extent, the Company uses exchange-traded currency futures to hedge currency mismatches between assets and liabilities, and to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. The Company utilizes exchange-traded currency futures in nonqualifying hedging relationships.

Credit Derivatives

The Company enters into purchased credit default swaps to hedge against credit-related changes in the value of its investments. In a credit default swap transaction, the Company agrees with another party to pay, at specified intervals, a premium to hedge credit risk. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the delivery of par quantities of the referenced investment equal to the specified swap notional amount in exchange for the payment of cash amounts by the counterparty equal to the par value of the investment surrendered. Credit events vary by type of issuer but typically include bankruptcy, failure to pay debt obligations, repudiation, moratorium, involuntary restructuring or governmental intervention. In each case, payout on a credit default swap is triggered only after the Credit Derivatives Determinations Committee of the International Swaps and Derivatives Association, Inc. (“ISDA”) deems that a credit event has occurred. The Company utilizes credit default swaps in nonqualifying hedging relationships.

The Company enters into written credit default swaps to synthetically create credit investments that are either more expensive to acquire or otherwise unavailable in the cash markets. These transactions are a combination of a derivative and one or more cash instruments, such as U.S. government and agency securities, or other fixed maturity securities. These credit default swaps are not designated as hedging instruments.

The Company also enters into certain purchased and written credit default swaps held in relation to trading portfolios for the purpose of generating profits on short-term differences in price. These credit default swaps are not designated as hedging instruments.

The Company enters into forwards to lock in the price to be paid for forward purchases of certain securities. The price is agreed upon at the time of the contract and payment for the contract is made at a specified future date. When the primary purpose of entering into these transactions is to hedge against the risk of changes in purchase price due to changes in credit spreads, the Company designates these transactions as credit forwards. The Company utilizes credit forwards in cash flow hedging relationships.

Equity Derivatives

The Company uses a variety of equity derivatives to reduce its exposure to equity market risk, including equity index options, equity variance swaps, exchange-traded equity futures and equity total return swaps.

Equity index options are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. To hedge against adverse changes in equity indices, the Company enters into contracts to sell the equity index within a limited time at a contracted price. The contracts will be net settled in cash based on differentials in the indices at the time of exercise and the strike price. Certain of these contracts may also contain settlement provisions linked to interest rates. In certain instances, the Company may enter into a combination of transactions to hedge adverse changes in equity indices within a pre-determined range through the purchase and sale of options. The Company utilizes equity index options in nonqualifying hedging relationships.

Equity variance swaps are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. In an equity variance swap, the Company agrees with another party to exchange amounts in the future, based on changes in equity volatility over a defined period. The Company utilizes equity variance swaps in nonqualifying hedging relationships.

41

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

8. Derivatives (continued)

In exchange-traded equity futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of equity securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded equity futures are used primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. The Company utilizes exchange-traded equity futures in nonqualifying hedging relationships.

In an equity total return swap, the Company agrees with another party to exchange, at specified intervals, the difference between the economic risk and reward of an asset or a market index and LIBOR, calculated by reference to an agreed notional amount. No cash is exchanged at the outset of the contract. Cash is paid and received over the life of the contract based on the terms of the swap. The Company uses equity total return swaps to hedge its equity market guarantees in certain of its insurance products. Equity total return swaps can be used as hedges or to synthetically create investments. The Company utilizes equity total return swaps in nonqualifying hedging relationships.

42

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

8. Derivatives (continued)

Primary Risks Managed by Derivatives

The following table presents the gross notional amount, estimated fair value and primary underlying risk exposure of the Company’s derivatives, excluding embedded derivatives, held at:

		September 30, 2016						December 31, 2015
	Primary Underlying Risk Exposure	Gross Notional Amount		Estimated Fair Value				Gross Notional Amount		Estimated Fair Value
				Assets		Liabilities				Assets		Liabilities
		(In millions)
Derivatives Designated as Hedging Instruments:
Fair value hedges:
Interest rate swaps	Interest rate	$	5,383	$	2,824	$	14	$	5,528	$	2,215	$	12
Foreign currency swaps	Foreign currency exchange rate	1,221		28		156		2,154		62		159
Foreign currency forwards	Foreign currency exchange rate	1,485		196		—		1,685		—		52
Subtotal		8,089		3,048		170		9,367		2,277		223
Cash flow hedges:
Interest rate swaps	Interest rate	2,251		672		—		2,190		487		—
Interest rate forwards	Interest rate	2,032		49		10		105		23		—
Foreign currency swaps	Foreign currency exchange rate	27,202		2,212		1,684		23,661		1,303		1,803
Subtotal		31,485		2,933		1,694		25,956		1,813		1,803
Foreign operations hedges:
Foreign currency forwards	Foreign currency exchange rate	1,087		6		53		3,916		63		12
Currency options	Foreign currency exchange rate	9,212		18		226		7,569		205		36
Subtotal		10,299		24		279		11,485		268		48
Total qualifying hedges		49,873		6,005		2,143		46,808		4,358		2,074
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate swaps	Interest rate	82,791		9,586		3,033		89,336		5,111		2,247
Interest rate floors	Interest rate	15,201		350		34		23,837		311		48
Interest rate caps	Interest rate	79,030		35		3		68,928		105		3
Interest rate futures	Interest rate	9,110		4		41		5,808		4		7
Interest rate options	Interest rate	21,383		1,790		1		30,234		1,177		30
Interest rate forwards	Interest rate	171		16		—		43		1		—
Interest rate total return swaps	Interest rate	5,925		106		36		—		—		—
Synthetic GICs	Interest rate	5,328		—		—		4,216		—		—
Foreign currency swaps	Foreign currency exchange rate	12,790		1,183		467		11,081		766		431
Foreign currency forwards	Foreign currency exchange rate	17,371		584		250		11,724		154		220
Currency futures	Foreign currency exchange rate	1,060		—		2		930		—		—
Currency options	Foreign currency exchange rate	4,780		204		11		9,590		466		189
Credit default swaps — purchased	Credit	2,038		10		44		1,870		28		34
Credit default swaps — written	Credit	11,664		150		10		10,311		78		13
Equity futures	Equity market	12,886		13		68		7,206		63		18
Equity index options	Equity market	53,911		1,519		1,362		55,682		1,542		1,041
Equity variance swaps	Equity market	23,658		228		745		23,437		195		636
Equity total return swaps	Equity market	5,070		5		102		3,803		47		58
Total non-designated or nonqualifying derivatives		364,167		15,783		6,209		358,036		10,048		4,975
Total		$	414,040	$	21,788	$	8,352	$	404,844	$	14,406	$	7,049

43

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

8. Derivatives (continued)

Based on gross notional amounts, a substantial portion of the Company’s derivatives was not designated or did not qualify as part of a hedging relationship at both September 30, 2016 and December 31, 2015. The Company’s use of derivatives includes (i) derivatives that serve as macro hedges of the Company’s exposure to various risks and that generally do not qualify for hedge accounting due to the criteria required under the portfolio hedging rules; (ii) derivatives that economically hedge insurance liabilities that contain mortality or morbidity risk and that generally do not qualify for hedge accounting because the lack of these risks in the derivatives cannot support an expectation of a highly effective hedging relationship; (iii) derivatives that economically hedge embedded derivatives that do not qualify for hedge accounting because the changes in estimated fair value of the embedded derivatives are already recorded in net income; and (iv) written credit default swaps that are used to synthetically create credit investments and that do not qualify for hedge accounting because they do not involve a hedging relationship. For these nonqualified derivatives, changes in market factors can lead to the recognition of fair value changes on the statement of operations without an offsetting gain or loss recognized in earnings for the item being hedged.

Net Derivative Gains (Losses)

The components of net derivative gains (losses) were as follows:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Freestanding derivatives and hedging gains (losses) (1)	$	(1,852	)	$	2,318		$	3,177		$	1,433
Embedded derivatives gains (losses)	801			(1,833		)	(4,992		)	(1,039		)
Total net derivative gains (losses)	$	(1,051	)	$	485		$	(1,815	)	$	394

__________________

(1) Includes foreign currency transaction gains (losses) on hedged items in cash flow and nonqualifying hedging relationships, which are not presented elsewhere in this note.

The following table presents earned income on derivatives:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Qualifying hedges:
Net investment income	$	76		$	55		$	206		$	158
Interest credited to policyholder account balances	—			6			7			21
Other expenses	(3		)	(2		)	(9		)	(4		)
Nonqualifying hedges:
Net investment income	—			(1		)	(1		)	(3		)
Net derivative gains (losses)	312			256			843			757
Policyholder benefits and claims	6			4			17			12
Total	$	391		$	318		$	1,063		$	941

44

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

8. Derivatives (continued)

Nonqualifying Derivatives and Derivatives for Purposes Other Than Hedging

The following table presents the amount and location of gains (losses) recognized in income for derivatives that were not designated or not qualifying as hedging instruments:

	Net Derivative Gains (Losses)			Net Investment Income (1)			Policyholder Benefits and Claims (2)
	(In millions)
Three Months Ended September 30, 2016
Interest rate derivatives	$	(1,082	)	$	—		$	19
Foreign currency exchange rate derivatives	146			—			(5		)
Credit derivatives — purchased	(21		)	—			—
Credit derivatives — written	60			—			—
Equity derivatives	(1,212		)	(5		)	(260		)
Total	$	(2,109	)	$	(5	)	$	(246	)
Three Months Ended September 30, 2015
Interest rate derivatives	$	1,157		$	—		$	17
Foreign currency exchange rate derivatives	364			—			—
Credit derivatives — purchased	16			3			—
Credit derivatives — written	(77		)	(1		)	—
Equity derivatives	747			(1		)	340
Total	$	2,207		$	1		$	357
Nine Months Ended September 30, 2016
Interest rate derivatives	$	2,547		$	—		$	116
Foreign currency exchange rate derivatives	1,865			—			(17		)
Credit derivatives — purchased	(48		)	—			—
Credit derivatives — written	57			—			—
Equity derivatives	(1,472		)	(19		)	(293		)
Total	$	2,949		$	(19	)	$	(194	)
Nine Months Ended September 30, 2015
Interest rate derivatives	$	250		$	—		$	10
Foreign currency exchange rate derivatives	443			—			—
Credit derivatives — purchased	9			3			—
Credit derivatives — written	(108		)	—			—
Equity derivatives	99			(8		)	214
Total	$	693		$	(5	)	$	224

__________________

(1) Changes in estimated fair value related to economic hedges of equity method investments in joint ventures, derivatives held in relation to trading portfolios and derivatives held within contractholder-directed unit-linked investments.

(2) Changes in estimated fair value related to economic hedges of variable annuity guarantees included in future policy benefits.

Fair Value Hedges

The Company designates and accounts for the following as fair value hedges when they have met the requirements of fair value hedging: (i) interest rate swaps to convert fixed rate assets and liabilities to floating rate assets and liabilities; (ii) foreign currency swaps to hedge the foreign currency fair value exposure of foreign currency denominated assets and liabilities; and (iii) foreign currency forwards to hedge the foreign currency fair value exposure of foreign currency denominated investments.

45

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

8. Derivatives (continued)

The Company recognizes gains and losses on derivatives and the related hedged items in fair value hedges within net derivative gains (losses). The following table presents the amount of such net derivative gains (losses):

Derivatives in Fair Value Hedging Relationships	Hedged Items in Fair Value Hedging Relationships	Net Derivative Gains (Losses) Recognized for Derivatives			Net Derivative Gains (Losses) Recognized for Hedged Items			Ineffectiveness Recognized in Net Derivative Gains (Losses)
		(In millions)
Three Months Ended September 30, 2016
Interest rate swaps:	Fixed maturity securities	$	6		$	(5	)	$	1
	Policyholder liabilities (1)	(45		)	41			(4		)
Foreign currency swaps:	Foreign-denominated fixed maturity securities	1			(1		)	—
	Foreign-denominated policyholder account balances (2)	(1		)	1			—
Foreign currency forwards:	Foreign-denominated fixed maturity securities	19			(18		)	1
Total		$	(20	)	$	18		$	(2	)
Three Months Ended September 30, 2015
Interest rate swaps:	Fixed maturity securities	$	(4	)	$	3		$	(1	)
	Policyholder liabilities (1)	289			(290		)	(1		)
Foreign currency swaps:	Foreign-denominated fixed maturity securities	6			(3		)	3
	Foreign-denominated policyholder account balances (2)	(47		)	46			(1		)
Foreign currency forwards:	Foreign-denominated fixed maturity securities	49			(45		)	4
Total		$	293		$	(289	)	$	4
Nine Months Ended September 30, 2016
Interest rate swaps:	Fixed maturity securities	$	(5	)	$	2		$	(3	)
	Policyholder liabilities (1)	498			(507		)	(9		)
Foreign currency swaps:	Foreign-denominated fixed maturity securities	7			(7		)	—
	Foreign-denominated policyholder account balances (2)	(27		)	24			(3		)
Foreign currency forwards:	Foreign-denominated fixed maturity securities	295			(272		)	23
Total		$	768		$	(760	)	$	8
Nine Months Ended September 30, 2015
Interest rate swaps:	Fixed maturity securities	$	(5	)	$	8		$	3
	Policyholder liabilities (1)	120			(126		)	(6		)
Foreign currency swaps:	Foreign-denominated fixed maturity securities	13			(6		)	7
	Foreign-denominated policyholder account balances (2)	(186		)	179			(7		)
Foreign currency forwards:	Foreign-denominated fixed maturity securities	(49		)	45			(4		)
Total		$	(107	)	$	100		$	(7	)

__________________

(1) Fixed rate liabilities reported in policyholder account balances or future policy benefits.

(2) Fixed rate or floating rate liabilities.

46

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

8. Derivatives (continued)

For the Company’s foreign currency forwards, the change in the estimated fair value of the derivative related to the changes in the difference between the spot price and the forward price is excluded from the assessment of hedge effectiveness. For all other derivatives, all components of each derivative’s gain or loss were included in the assessment of hedge effectiveness. For the three months and nine months endedSeptember 30, 2016, ($6) million and ($16) million, respectively, of the change in estimated fair value of derivatives was excluded from the assessment of hedge effectiveness. For the three months and nine months endedSeptember 30, 2015, ($4) million and ($9) million, respectively, of the change in estimated fair value of derivatives was excluded from the assessment of hedge effectiveness.

Cash Flow Hedges

The Company designates and accounts for the following as cash flow hedges when they have met the requirements of cash flow hedging: (i) interest rate swaps to convert floating rate assets and liabilities to fixed rate assets and liabilities; (ii) foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated assets and liabilities; (iii) interest rate forwards and credit forwards to lock in the price to be paid for forward purchases of investments; (iv) interest rate swaps and interest rate forwards to hedge the forecasted purchases of fixed-rate investments; and (v) interest rate swaps and interest rate forwards to hedge forecasted fixed-rate borrowings.

In certain instances, the Company discontinued cash flow hedge accounting because the forecasted transactions were no longer probable of occurring. Because certain of the forecasted transactions also were not probable of occurring within two months of the anticipated date, the Company reclassified amounts from AOCI into net derivative gains (losses). These amounts were $12 million and $7 million for the three months and nine months endedSeptember 30, 2016, respectively. These amounts were ($3) million for the three months ended September 30, 2015. For the nine months endedSeptember 30, 2015, the amounts reclassified from AOCI into net derivative gains (losses) were not significant.

At September 30, 2016 and December 31, 2015, the maximum length of time over which the Company was hedging its exposure to variability in future cash flows for forecasted transactions did not exceed six years and five years, respectively.

At September 30, 2016 and December 31, 2015, the balance in AOCI associated with cash flow hedges was $3.6 billion and $2.4 billion, respectively.

47

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

8. Derivatives (continued)

The following table presents the effects of derivatives in cash flow hedging relationships on the consolidated statements of operations and comprehensive income (loss) and the consolidated statements of equity:

Derivatives in Cash Flow Hedging Relationships	Amount of Gains (Losses) Deferred in AOCI on Derivatives			Amount and Location of Gains (Losses) Reclassified from AOCI into Income (Loss)								Amount and Location of Gains (Losses) Recognized in Income (Loss) on Derivatives
	(Effective Portion)			(Effective Portion)								(Ineffective Portion)
				Net Derivative Gains (Losses)			Net Investment Income			Other Expenses		Net Derivative Gains (Losses)
	(In millions)
Three Months Ended September 30, 2016
Interest rate swaps	$	23		$	28		$	4		$	—	$	—
Interest rate forwards	(5		)	1			1			—		—
Foreign currency swaps	(42		)	59			—			—		(3		)
Credit forwards	—			—			1			—		—
Total	$	(24	)	$	88		$	6		$	—	$	(3	)
Three Months Ended September 30, 2015
Interest rate swaps	$	211		$	40		$	3		$	—	$	1
Interest rate forwards	7			1			1			1		—
Foreign currency swaps	(116		)	(286		)	—			—		4
Credit forwards	—			1			—			—		—
Total	$	102		$	(244	)	$	4		$	1	$	5
Nine Months Ended September 30, 2016
Interest rate swaps	$	376		$	56		$	11		$	—	$	—
Interest rate forwards	42			2			4			1		—
Foreign currency swaps	1,054			96			(1		)	1		(1		)
Credit forwards	—			3			1			—		—
Total	$	1,472		$	157		$	15		$	2	$	(1	)
Nine Months Ended September 30, 2015
Interest rate swaps	$	116		$	52		$	9		$	—	$	3
Interest rate forwards	2			5			3			2		—
Foreign currency swaps	(224		)	(563		)	(1		)	1		6
Credit forwards	—			1			1			—		—
Total	$	(106	)	$	(505	)	$	12		$	3	$	9

All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness.

AtSeptember 30, 2016, the Company expects to reclassify ($64) millionof deferred net gains (losses) on derivatives in AOCI to earnings within the next 12 months.

Hedges of Net Investments in Foreign Operations

The Company uses foreign currency exchange rate derivatives, which may include foreign currency forwards and currency options, to hedge portions of its net investments in foreign operations against adverse movements in exchange rates. The Company measures ineffectiveness on these derivatives based upon the change in forward rates.

When net investments in foreign operations are sold or substantially liquidated, the amounts in AOCI are reclassified to the statement of operations.

48

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

8. Derivatives (continued)

The following table presents the effects of derivatives in net investment hedging relationships on the consolidated statements of operations and comprehensive income (loss) and the consolidated statements of equity:

Derivatives in Net Investment Hedging Relationships (1), (2)	Amount of Gains (Losses) Deferred in AOCI (Effective Portion)
	(In millions)
Three Months Ended September 30, 2016
Foreign currency forwards	$	(23	)
Currency options	(37		)
Total	$	(60	)
Three Months Ended September 30, 2015
Foreign currency forwards	$	88
Currency options	(18		)
Total	$	70
Nine Months Ended September 30, 2016
Foreign currency forwards	$	(358	)
Currency options	(351		)
Total	$	(709	)
Nine Months Ended September 30, 2015
Foreign currency forwards	$	244
Currency options	(61		)
Total	$	183

__________________

(1) During both thethree monthsandnine months endedSeptember 30, 2016and2015, there werenosales or substantial liquidations of net investments in foreign operations that would have required the reclassification of gains or losses from AOCI into earnings.

(2) There was no ineffectiveness recognized for the Company’s hedges of net investments in foreign operations. All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness.

At September 30, 2016 and December 31, 2015, the cumulative foreign currency translation gain (loss) recorded in AOCI related to hedges of net investments in foreign operations was $347 million and $1.1 billion, respectively.

Credit Derivatives

In connection with synthetically created credit investment transactions and credit default swaps held in relation to the trading portfolio, the Company writes credit default swaps for which it receives a premium to insure credit risk. Such credit derivatives are included within the nonqualifying derivatives and derivatives for purposes other than hedging table. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the Company paying the counterparty the specified swap notional amount in exchange for the delivery of par quantities of the referenced credit obligation. The Company’s maximum amount at risk, assuming the value of all referenced credit obligations is zero, was $11.7 billion and $10.3 billion at September 30, 2016 and December 31, 2015, respectively. The Company can terminate these contracts at any time through cash settlement with the counterparty at an amount equal to the then current estimated fair value of the credit default swaps. At September 30, 2016 and December 31, 2015, the Company would have received $140 million and $65 million, respectively, to terminate all of these contracts.

49

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

8. Derivatives (continued)

The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at:

	September 30, 2016						December 31, 2015
Rating Agency Designation of Referenced Credit Obligations (1)	Estimated Fair Value of Credit Default Swaps			Maximum Amount of Future Payments under Credit Default Swaps		Weighted Average Years to Maturity (2)	Estimated Fair Value of Credit Default Swaps			Maximum Amount of Future Payments under Credit Default Swaps		Weighted Average Years to Maturity (2)
	(Dollars in millions)
Aaa/Aa/A
Single name credit default swaps (corporate)	$	7		$	483	3.3	$	6		$	661	2.5
Credit default swaps referencing indices	21			1,937		3.5	6			1,635		3.4
Subtotal	28			2,420		3.5	12			2,296		3.2
Baa
Single name credit default swaps (corporate)	8			946		2.6	8			1,349		2.5
Credit default swaps referencing indices	97			7,917		5.1	37			5,863		4.8
Subtotal	105			8,863		4.8	45			7,212		4.4
Ba
Single name credit default swaps (corporate)	(5		)	155		4.3	(2		)	64		2.3
Credit default swaps referencing indices	—			—		—	(1		)	100		1.0
Subtotal	(5		)	155		4.3	(3		)	164		1.5
B
Single name credit default swaps (corporate)	1			70		2.1	—			—		—
Credit default swaps referencing indices	11			156		5.3	11			639		4.9
Subtotal	12			226		4.3	11			639		4.9
Total	$	140		$	11,664	4.5	$	65		$	10,311	4.1

__________________

(1) The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s Investors Service (“Moody’s”), Standard & Poor’s Ratings Services (“S&P”) and Fitch Ratings. If no rating is available from a rating agency, then an internally developed rating is used.

(2) The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts.

The Company has also entered into credit default swaps to purchase credit protection on certain of the referenced credit obligations in the table above. As a result, the maximum amounts of potential future recoveries available to offset the $11.7 billion and $10.3 billion from the table above were $30 million and $80 million at September 30, 2016 and December 31, 2015, respectively.

At September 30, 2016, there were no written credit default swaps held in relation to the trading portfolio. At December 31, 2015, written credit default swaps held in relation to the trading portfolio amounted to $20 million in gross notional amount and ($2) million in estimated fair value.

Credit Risk on Freestanding Derivatives

The Company may be exposed to credit-related losses in the event of nonperformance by its counterparties to derivatives. Generally, the current credit exposure of the Company’s derivatives is limited to the net positive estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements.

50

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

8. Derivatives (continued)

The Company manages its credit risk related to derivatives by entering into transactions with creditworthy counterparties and establishing and monitoring exposure limits. The Company’s OTC-bilateral derivative transactions are generally governed by ISDA Master Agreements which provide for legally enforceable set-off and close-out netting of exposures to specific counterparties in the event of early termination of a transaction, which includes, but is not limited to, events of default and bankruptcy. In the event of an early termination, the Company is permitted to set off receivables from the counterparty against payables to the same counterparty arising out of all included transactions. Substantially all of the Company’s ISDA Master Agreements also include Credit Support Annex provisions which require both the pledging and accepting of collateral in connection with its OTC-bilateral derivatives.

The Company’s OTC-cleared derivatives are effected through central clearing counterparties and its exchange-traded derivatives are effected through regulated exchanges. Such positions are marked to market and margined on a daily basis (both initial margin and variation margin), and the Company has minimal exposure to credit-related losses in the event of nonperformance by counterparties to such derivatives.

See Note 9for a description of the impact of credit risk on the valuation of derivatives.

The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:

	September 30, 2016						December 31, 2015
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement (1)	Assets			Liabilities			Assets			Liabilities
	(In millions)
Gross estimated fair value of derivatives:
OTC-bilateral (2)	$	18,154		$	6,603		$	13,017		$	5,848
OTC-cleared (2)	3,949			1,627			1,600			1,217
Exchange-traded	18			111			67			25
Total gross estimated fair value of derivatives (2)	22,121			8,341			14,684			7,090
Amounts offset on the consolidated balance sheets	—			—			—			—
Estimated fair value of derivatives presented on the consolidated balance sheets (2)	22,121			8,341			14,684			7,090
Gross amounts not offset on the consolidated balance sheets:
Gross estimated fair value of derivatives: (3)
OTC-bilateral	(4,984		)	(4,984		)	(4,368		)	(4,368		)
OTC-cleared	(1,609		)	(1,609		)	(1,200		)	(1,200		)
Exchange-traded	(5		)	(5		)	(1		)	(1		)
Cash collateral: (4), (5)
OTC-bilateral	(9,606		)	—			(6,140		)	(7		)
OTC-cleared	(2,101		)	—			(378		)	(10		)
Exchange-traded	—			(9		)	—			(20		)
Securities collateral: (6)
OTC-bilateral	(3,199		)	(1,577		)	(2,078		)	(1,395		)
OTC-cleared	—			—			—			—
Exchange-traded	—			(95		)	—			(3		)
Net amount after application of master netting agreements and collateral	$	617		$	62		$	519		$	86

__________________

(1) See Note 7 for information regarding the Company’s gross and net payables and receivables under repurchase agreement transactions.

(2) At September 30, 2016 and December 31, 2015, derivative assets included income or expense accruals reported in accrued investment income or in other liabilities of $333 million and $278 million, respectively, and derivative liabilities included income or expense accruals reported in accrued investment income or in other liabilities of ($11) million and $41 million, respectively.

51

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

8. Derivatives (continued)

(3) Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.

(4) Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives is included in cash and cash equivalents, short-term investments or in fixed maturity securities, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet.

(5) The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At September 30, 2016 and December 31, 2015, the Company received excess cash collateral of $554 million and $89 million, respectively, and provided excess cash collateral of $432 million and $204 million, respectively, which is not included in the table above due to the foregoing limitation.

(6) Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at September 30, 2016, none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At September 30, 2016 and December 31, 2015, the Company received excess securities collateral with an estimated fair value of $137 million and $100 million, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At September 30, 2016 and December 31, 2015, the Company provided excess securities collateral with an estimated fair value of $185 million and $150 million, respectively, for its OTC-bilateral derivatives, and $960 million and $315 million, respectively, for its OTC-cleared derivatives, and $462 million and $224 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.

The Company’s collateral arrangements for its OTC-bilateral derivatives generally require the party in a net liability position, after considering the effect of netting agreements, to pledge collateral when the estimated fair value of that party’s derivatives reaches a minimum transfer amount. A small number of these arrangements also include credit-contingent provisions that include a threshold above which collateral must be posted. Such agreements provide for a reduction of these thresholds (on a sliding scale that converges toward zero) in the event of downgrades in the credit ratings of MetLife, Inc. and/or the counterparty. In addition, substantially all of the Company’s netting agreements for derivatives contain provisions that require both the Company and the counterparty to maintain a specific investment grade credit rating from each of Moody’s and S&P. If a party’s credit or financial strength rating, as applicable, were to fall below that specific investment grade credit rating, that party would be in violation of these provisions, and the other party to the derivatives could terminate the transactions and demand immediate settlement and payment based on such party’s reasonable valuation of the derivatives.

The following table presents the estimated fair value of the Company’s OTC-bilateral derivatives that are in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged. The table also presents the incremental collateral that MetLife, Inc. would be required to provide if there was a one-notch downgrade in MetLife, Inc.’s senior unsecured debt rating at the reporting date or if the Company’s credit or financial strength rating, as applicable, sustained a downgrade to a level that triggered full overnight collateralization or termination of the derivative position at the reporting date. OTC-bilateral derivatives that are not subject to collateral agreements are excluded from this table.

52

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

8. Derivatives (continued)

	September 30, 2016						December 31, 2015
	Derivatives Subject to Credit- Contingent Provisions		Derivatives Not Subject to Credit- Contingent Provisions		Total		Derivatives Subject to Credit- Contingent Provisions		Derivatives Not Subject to Credit- Contingent Provisions		Total
	(In millions)
Estimated Fair Value of Derivatives in a Net Liability Position (1)	$	1,606	$	12	$	1,618	$	1,270	$	207	$	1,477
Estimated Fair Value of Collateral Provided:
Fixed maturity securities	$	1,737	$	20	$	1,757	$	1,365	$	174	$	1,539
Cash	$	—	$	—	$	—	$	4	$	4	$	8
Estimated Fair Value of Incremental Collateral Provided Upon:
One-notch downgrade in the Company’s credit or financial strength rating, as applicable	$	2	$	—	$	2	$	1	$	—	$	1
Downgrade in the Company’s credit or financial strength rating, as applicable, to a level that triggers full overnight collateralization or termination of the derivative position	$	2	$	—	$	2	$	1	$	—	$	1

__________________

(1) After taking into consideration the existence of netting agreements.

Embedded Derivatives

The Company issues certain products or purchases certain investments that contain embedded derivatives that are required to be separated from their host contracts and accounted for as freestanding derivatives. These host contracts principally include: variable annuities with guaranteed minimum benefits, including GMWBs, GMABs and certain GMIBs; ceded reinsurance of guaranteed minimum benefits related to certain GMIBs; assumed reinsurance of guaranteed minimum benefits related to GMWBs and GMABs; funding agreements with equity or bond indexed crediting rates; funds withheld on assumed and ceded reinsurance; fixed annuities with equity-indexed returns; and certain debt and equity securities.

The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:

	Balance Sheet Location	September 30, 2016			December 31, 2015
		(In millions)
Net embedded derivatives within asset host contracts:
Ceded guaranteed minimum benefits	Premiums, reinsurance and other receivables	$	514		$	356
Funds withheld on assumed reinsurance	Other invested assets	64			35
Options embedded in debt or equity securities	Investments	(240		)	(220		)
Net embedded derivatives within asset host contracts		$	338		$	171
Net embedded derivatives within liability host contracts:
Direct guaranteed minimum benefits	Policyholder account balances and Future policy benefits	$	5,000		$	(20	)
Assumed guaranteed minimum benefits	Policyholder account balances	1,706			965
Funds withheld on ceded reinsurance	Other liabilities	79			(14		)
Other	Policyholder account balances	98			4
Net embedded derivatives within liability host contracts		$	6,883		$	935

53

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

8. Derivatives (continued)

The following table presents changes in estimated fair value related to embedded derivatives:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Net derivative gains (losses) (1)	$	801		$	(1,833	)	$	(4,992	)	$	(1,039	)
Policyholder benefits and claims	$	(14	)	$	59		$	91		$	40

__________________

(1) The valuation of guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were($224) millionand$1.2 billionfor thethree monthsandnine months endedSeptember 30, 2016, respectively, and$253 millionand$222 millionfor thethree monthsandnine months endedSeptember 30, 2015, respectively.

9. Fair Value

Considerable judgment is often required in interpreting market data to develop estimates of fair value, and the use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts.

Recurring Fair Value Measurements

The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, including those items for which the Company has elected the FVO, are presented below at:

54

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

	September 30, 2016
	Fair Value Hierarchy
	Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	98,569	$	7,107	$	105,676
U.S. government and agency	40,780		28,688		317		69,785
Foreign corporate	—		53,667		6,752		60,419
Foreign government	—		63,443		322		63,765
RMBS	4,349		35,510		5,450		45,309
State and political subdivision	—		17,417		46		17,463
ABS	—		14,506		1,078		15,584
CMBS	—		11,909		532		12,441
Total fixed maturity securities	45,129		323,709		21,604		390,442
Equity securities	1,364		1,270		655		3,289
FVO and trading securities:
Actively traded securities	—		—		—		—
FVO general account securities	578		30		113		721
FVO contractholder-directed unit-linked investments	11,061		2,816		123		14,000
FVO securities held by CSEs	—		2		7		9
Total FVO and trading securities	11,639		2,848		243		14,730
Short-term investments (1)	5,561		4,310		673		10,544
Mortgage loans:
Residential mortgage loans — FVO	—		—		481		481
Commercial mortgage loans held by CSEs — FVO	—		143		—		143
Total mortgage loans	—		143		481		624
Other investments	92		63		—		155
Derivative assets: (2)
Interest rate	4		15,272		156		15,432
Foreign currency exchange rate	—		4,369		62		4,431
Credit	—		141		19		160
Equity market	14		1,417		334		1,765
Total derivative assets	18		21,199		571		21,788
Net embedded derivatives within asset host contracts (3)	—		—		578		578
Separate account assets (4)	87,035		227,343		1,270		315,648
Total assets	$	150,838	$	580,885	$	26,075	$	757,798
Liabilities
Derivative liabilities: (2)
Interest rate	$	41	$	3,084	$	47	$	3,172
Foreign currency exchange rate	2		2,795		52		2,849
Credit	—		54		—		54
Equity market	68		1,448		761		2,277
Total derivative liabilities	111		7,381		860		8,352
Net embedded derivatives within liability host contracts (3)	—		—		6,883		6,883
Long-term debt of CSEs — FVO	—		26		12		38
Trading liabilities (5)	—		—		—		—
Separate account liabilities (4)	1		75		6		82
Total liabilities	$	112	$	7,482	$	7,761	$	15,355

55

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

	December 31, 2015
	Fair Value Hierarchy
	Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	93,758	$	7,036	$	100,794
U.S. government and agency	37,660		23,986		—		61,646
Foreign corporate	—		51,438		5,760		57,198
Foreign government	—		49,643		856		50,499
RMBS	—		34,088		4,709		38,797
State and political subdivision	—		15,395		46		15,441
ABS	—		12,731		1,663		14,394
CMBS	—		11,889		744		12,633
Total fixed maturity securities	37,660		292,928		20,814		351,402
Equity securities	1,274		1,615		432		3,321
FVO and trading securities:
Actively traded securities	—		400		4		404
FVO general account securities	506		32		89		627
FVO contractholder-directed unit-linked investments	10,829		2,985		167		13,981
FVO securities held by CSEs	—		2		10		12
Total FVO and trading securities	11,335		3,419		270		15,024
Short-term investments (1)	2,543		5,985		291		8,819
Mortgage loans:
Residential mortgage loans — FVO	—		—		314		314
Commercial mortgage loans held by CSEs — FVO	—		172		—		172
Total mortgage loans	—		172		314		486
Other investments	109		53		—		162
Derivative assets: (2)
Interest rate	4		9,405		25		9,434
Foreign currency exchange rate	—		3,003		16		3,019
Credit	—		99		7		106
Equity market	63		1,435		349		1,847
Total derivative assets	67		13,942		397		14,406
Net embedded derivatives within asset host contracts (3)	—		—		391		391
Separate account assets (4)	77,080		222,814		1,704		301,598
Total assets	$	130,068	$	540,928	$	24,613	$	695,609
Liabilities
Derivative liabilities: (2)
Interest rate	$	7	$	2,340	$	—	$	2,347
Foreign currency exchange rate	—		2,754		148		2,902
Credit	—		45		2		47
Equity market	18		1,077		658		1,753
Total derivative liabilities	25		6,216		808		7,049
Net embedded derivatives within liability host contracts (3)	—		—		935		935
Long-term debt of CSEs — FVO	—		49		11		60
Trading liabilities (5)	103		50		—		153
Separate account liabilities (4)	—		—		—		—
Total liabilities	$	128	$	6,315	$	1,754	$	8,197

__________________

(1) Short-term investments as presented in the tables above differ from the amounts presented on the consolidated balance sheets because certain short-term investments are not measured at estimated fair value on a recurring basis.

56

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

(2) Derivative assets are presented within other invested assets on the consolidated balance sheets and derivative liabilities are presented within other liabilities on the consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the consolidated balance sheets, but are presented net for purposes of the rollforward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables.

(3) Net embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables and other invested assets on the consolidated balance sheets. Net embedded derivatives within liability host contracts are presented within policyholder account balances, future policy benefits and other liabilities on the consolidated balance sheets. At September 30, 2016 and December 31, 2015, debt and equity securities also included embedded derivatives of ($240) million and ($220) million, respectively.

(4) Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders whose liability is reflected within separate account liabilities. Separate account liabilities are set equal to the estimated fair value of separate account assets. Separate account liabilities presented in the tables above represent derivative liabilities.

(5) Trading liabilities are presented within other liabilities on the consolidated balance sheets.

The following describes the valuation methodologies used to measure assets and liabilities at fair value. The description includes the valuation techniques and key inputs for each category of assets or liabilities that are classified within Level 2 and Level 3 of the fair value hierarchy.

Investments

Valuation Controls and Procedures

On behalf of the Company’s Chief Investment Officer and Chief Financial Officer, a pricing and valuation committee that is independent of the trading and investing functions and comprised of senior management, provides oversight of control systems and valuation policies for securities, mortgage loans and derivatives. On a quarterly basis, this committee reviews and approves new transaction types and markets, ensures that observable market prices and market-based parameters are used for valuation, wherever possible, and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. This committee also provides oversight of the selection of independent third-party pricing providers and the controls and procedures to evaluate third-party pricing. Periodically, the Chief Accounting Officer reports to the Audit Committee of MetLife, Inc.’s Board of Directors regarding compliance with fair value accounting standards.

The Company reviews its valuation methodologies on an ongoing basis and revises those methodologies when necessary based on changing market conditions. Assurance is gained on the overall reasonableness and consistent application of input assumptions, valuation methodologies and compliance with fair value accounting standards through controls designed to ensure valuations represent an exit price. Several controls are utilized, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the fair value estimates, comparing fair value estimates to management’s knowledge of the current market, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. The Company ensures that prices received from independent brokers, also referred to herein as “consensus pricing,” represent a reasonable estimate of fair value by considering such pricing relative to the Company’s knowledge of the current market dynamics and current pricing for similar financial instruments. While independent non-binding broker quotations are utilized, they are not used for a significant portion of the portfolio. For example, fixed maturity securities priced using independent non-binding broker quotations represent less than 1% of the total estimated fair value of fixed maturity securities and 5% of the total estimated fair value of Level 3 fixed maturity securities at September 30, 2016.

57

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

The Company also applies a formal process to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained, or an internally developed valuation is prepared. Internally developed valuations of current estimated fair value, which reflect internal estimates of liquidity and nonperformance risks, compared with pricing received from the independent pricing services, did not produce material differences in the estimated fair values for the majority of the portfolio; accordingly, overrides were not material. This is, in part, because internal estimates of liquidity and nonperformance risks are generally based on available market evidence and estimates used by other market participants. In the absence of such market-based evidence, management’s best estimate is used.

Securities, Short-term Investments, Other Investments, Long-term Debt of CSEs — FVO and Trading Liabilities

When available, the estimated fair value of these financial instruments is based on quoted prices in active markets that are readily and regularly obtainable. Generally, these are the most liquid of the Company’s securities holdings and valuation of these securities does not involve management’s judgment.

When quoted prices in active markets are not available, the determination of estimated fair value is based on market standard valuation methodologies, giving priority to observable inputs. The significant inputs to the market standard valuation methodologies for certain types of securities with reasonable levels of price transparency are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. When observable inputs are not available, the market standard valuation methodologies rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs can be based in large part on management’s judgment or estimation and cannot be supported by reference to market activity. Even though these inputs are unobservable, management believes they are consistent with what other market participants would use when pricing such securities and are considered appropriate given the circumstances.

The estimated fair value of investments in certain separate accounts included in FVO contractholder-directed unit-linked investments, FVO securities held by CSEs, other investments, long-term debt of CSEs — FVO and trading liabilities is determined on a basis consistent with the methodologies described herein for securities.

The valuation of most instruments listed below is determined using independent pricing sources, matrix pricing, discounted cash flow methodologies or other similar techniques that use either observable market inputs or unobservable inputs.

58

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

Instrument	Level 2 Observable Inputs			Level 3 Unobservable Inputs
Fixed Maturity Securities
U.S. corporate and Foreign corporate securities
	Valuation Techniques: Principally the market and income approaches.			Valuation Techniques: Principally the market approach.
	Key Inputs:			Key Inputs:
	•	quoted prices in markets that are not active		•	illiquidity premium
	•	benchmark yields; spreads off benchmark yields; new issuances; issuer rating		•	delta spread adjustments to reflect specific credit-related issues
	•	trades of identical or comparable securities; duration		•	credit spreads
	•	Privately-placed securities are valued using the additional key inputs:		•	quoted prices in markets that are not active for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2
		•	market yield curve; call provisions
		•	observable prices and spreads for similar public or private securities that incorporate the credit quality and industry sector of the issuer	•	independent non-binding broker quotations
		•	delta spread adjustments to reflect specific credit-related issues
U.S. government and agency, Foreign government and State and political subdivision securities
	Valuation Techniques: Principally the market approach.			Valuation Techniques: Principally the market approach.
	Key Inputs:			Key Inputs:
	•	quoted prices in markets that are not active		•	independent non-binding broker quotations
	•	benchmark U.S. Treasury yield or other yields		•	quoted prices in markets that are not active for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2
	•	the spread off the U.S. Treasury yield curve for the identical security
	•	issuer ratings and issuer spreads; broker-dealer quotes		•	credit spreads
	•	comparable securities that are actively traded
Structured Securities
	Valuation Techniques: Principally the market and income approaches.			Valuation Techniques: Principally the market and income approaches.
	Key Inputs:			Key Inputs:
	•	quoted prices in markets that are not active		•	credit spreads
	•	spreads for actively traded securities; spreads off benchmark yields		•	quoted prices in markets that are not active for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2
	•	expected prepayment speeds and volumes
	•	current and forecasted loss severity; ratings; geographic region		•	independent non-binding broker quotations
	•	weighted average coupon and weighted average maturity
	•	average delinquency rates; debt-service coverage ratios
	•	issuance-specific information, including, but not limited to:
		•	collateral type; structure of the security; vintage of the loans
		•	payment terms of the underlying assets
		•	payment priority within the tranche; deal performance

59

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

Instrument	Level 2 Observable Inputs		Level 3 Unobservable Inputs
Equity Securities
	Valuation Techniques: Principally the market approach.		Valuation Techniques: Principally the market and income approaches.
	Key Input:		Key Inputs:
	•	quoted prices in markets that are not considered active	•	credit ratings; issuance structures
			•	quoted prices in markets that are not active for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2
			•	independent non-binding broker quotations
FVO and trading securities, Short-term investments, and Other investments
	•	Contractholder-directed unit-linked investments include mutual fund interests without readily determinable fair values given prices are not published publicly. Valuation of these mutual funds is based upon quoted prices or reported net asset value (“NAV”) provided by the fund managers, which were based on observable inputs.	•	FVO and trading securities and short-term investments are of a similar nature and class to the fixed maturity and equity securities described above; accordingly, the valuation techniques and unobservable inputs used in their valuation are also similar to those described above.
	•	All other investments are of a similar nature and class to the fixed maturity and equity securities described above; accordingly, the valuation techniques and observable inputs used in their valuation are also similar to those described above.
Mortgage Loans — FVO
Commercial mortgage loans held by CSEs — FVO
	Valuation Techniques: Principally the market approach.		•	N/A
	Key Input:
	•	quoted securitization market price determined principally by independent pricing services using observable inputs
Residential mortgage loans — FVO
	•	N/A	Valuation Techniques: Principally the market approach, including matrix pricing or other similar techniques.
			Key Inputs:
			•	Inputs that are unobservable or cannot be derived principally from, or corroborated by, observable market data
Separate Account Assets and Separate Account Liabilities (1)
Mutual funds and hedge funds without readily determinable fair values as prices are not published publicly
	Key Input:		•	N/A
	•	quoted prices or reported NAV provided by the fund managers
Other limited partnership interests
	•	N/A	Valuation Techniques: Valued giving consideration to the underlying holdings of the partnerships and by applying a premium or discount, if appropriate.
			Key Inputs:
			•	liquidity; bid/ask spreads; performance record of the fund manager
			•	other relevant variables that may impact the exit value of the particular partnership interest

__________________

(1) Estimated fair value equals carrying value, based on the value of the underlying assets, including: mutual fund interests, fixed maturity securities, equity securities, derivatives, hedge funds, other limited partnership interests, short-term investments and cash and cash equivalents. Fixed maturity securities, equity securities, derivatives, short-term investments and cash and cash equivalents are similar in nature to the instruments described under “— Securities, Short-term Investments, Other Investments, Long-term Debt of CSEs — FVO and Trading Liabilities” and “— Derivatives — Freestanding Derivatives.”

60

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

Derivatives

The estimated fair value of derivatives is determined through the use of quoted market prices for exchange-traded derivatives, or through the use of pricing models for OTC-bilateral and OTC-cleared derivatives. The determination of estimated fair value, when quoted market values are not available, is based on market standard valuation methodologies and inputs that management believes are consistent with what other market participants would use when pricing such instruments. Derivative valuations can be affected by changes in interest rates, foreign currency exchange rates, financial indices, credit spreads, default risk, nonperformance risk, volatility, liquidity and changes in estimates and assumptions used in the pricing models. The valuation controls and procedures for derivatives are described in “— Investments.”

The significant inputs to the pricing models for most OTC-bilateral and OTC-cleared derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Certain OTC-bilateral and OTC-cleared derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments.

Most inputs for OTC-bilateral and OTC-cleared derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company’s derivatives and could materially affect net income.

The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral and OTC-cleared derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral and OTC-cleared derivatives using standard swap curves which may include a spread to the risk-free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company’s ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period.

Freestanding Derivatives

Level 2 Valuation Techniques and Key Inputs:

This level includes all types of derivatives utilized by the Company with the exception of exchange-traded derivatives included within Level 1 and those derivatives with unobservable inputs as described in Level 3.

Level 3 Valuation Techniques and Key Inputs:

These valuation methodologies generally use the same inputs as described in the corresponding sections for Level 2 measurements of derivatives. However, these derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data.

61

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

Freestanding derivatives are principally valued using the income approach. Valuations of non-option-based derivatives utilize present value techniques, whereas valuations of option-based derivatives utilize option pricing models. Key inputs are as follows:

Instrument		Interest Rate		Foreign Currency Exchange Rate		Credit		Equity Market
Inputs common to Level 2 and Level 3 by instrument type	•	swap yield curves	•	swap yield curves	•	swap yield curves	•	swap yield curves
	•	basis curves	•	basis curves	•	credit curves	•	spot equity index levels
	•	interest rate volatility (1)	•	currency spot rates	•	recovery rates	•	dividend yield curves
			•	cross currency basis curves			•	equity volatility (1)
			•	currency volatility (1)
Level 3	•	swap yield curves (2)	•	swap yield curves (2)	•	swap yield curves (2)	•	dividend yield curves (2)
	•	basis curves (2)	•	basis curves (2)	•	credit curves (2)	•	equity volatility (1), (2)
	•	interest rate volatility (1), (2)	•	cross currency basis curves (2)	•	credit spreads	•	correlation between model inputs (1)
	•	repurchase rates	•	currency correlation	•	repurchase rates
			•	currency volatility (1)	•	independent non-binding broker quotations

__________________

(1) Option-based only.

(2) Extrapolation beyond the observable limits of the curve(s).

Embedded Derivatives

Embedded derivatives principally include certain direct, assumed and ceded variable annuity guarantees, equity or bond indexed crediting rates within certain funding agreements and annuity contracts, and those related to funds withheld on ceded reinsurance agreements. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income.

The Company issues certain variable annuity products with guaranteed minimum benefits. GMWBs, GMABs and certain GMIBs contain embedded derivatives, which are measured at estimated fair value separately from the host variable annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances and future policy benefits on the consolidated balance sheets.

The Company’s actuarial department calculates the fair value of these embedded derivatives, which are estimated as the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations concerning policyholder behavior. The calculation is based on in-force business, and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk-free rates.

Capital market assumptions, such as risk-free rates and implied volatilities, are based on market prices for publicly traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience.

The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for MetLife, Inc.’s debt, including related credit default swaps. These observable spreads are then adjusted, as necessary, to reflect the priority of these liabilities and the claims paying ability of the issuing insurance subsidiaries compared to MetLife, Inc.

62

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees. These guarantees may be more costly than expected in volatile or declining equity markets. Market conditions including, but not limited to, changes in interest rates, equity indices, market volatility and foreign currency exchange rates; changes in nonperformance risk; and variations in actuarial assumptions regarding policyholder behavior, mortality and risk margins related to non-capital market inputs, may result in significant fluctuations in the estimated fair value of the guarantees that could materially affect net income.

The Company ceded the risk associated with certain of the GMIBs previously described. These reinsurance agreements contain embedded derivatives which are included within premiums, reinsurance and other receivables on the consolidated balance sheets with changes in estimated fair value reported in net derivative gains (losses) or policyholder benefits and claims depending on the statement of operations classification of the direct risk. The value of the embedded derivatives on the ceded risk is determined using a methodology consistent with that described previously for the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer.

The estimated fair value of the embedded derivatives within funds withheld related to certain ceded reinsurance is determined based on the change in estimated fair value of the underlying assets held by the Company in a reference portfolio backing the funds withheld liability. The estimated fair value of the underlying assets is determined as previously described in “— Investments — Securities, Short-term Investments, Other Investments, Long-term Debt of CSEs — FVO and Trading Liabilities.” The estimated fair value of these embedded derivatives is included, along with their funds withheld hosts, in other liabilities on the consolidated balance sheets with changes in estimated fair value recorded in net derivative gains (losses). Changes in the credit spreads on the underlying assets, interest rates and market volatility may result in significant fluctuations in the estimated fair value of these embedded derivatives that could materially affect net income.

The estimated fair value of the embedded equity and bond indexed derivatives contained in certain funding agreements is determined using market standard swap valuation models and observable market inputs, including a nonperformance risk adjustment. The estimated fair value of these embedded derivatives are included, along with their funding agreements host, within policyholder account balances with changes in estimated fair value recorded in net derivative gains (losses). Changes in equity and bond indices, interest rates and the Company’s credit standing may result in significant fluctuations in the estimated fair value of these embedded derivatives that could materially affect net income.

The Company issues certain annuity contracts which allow the policyholder to participate in returns from equity indices. These equity indexed features are embedded derivatives which are measured at estimated fair value separately from the host fixed annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances on the consolidated balance sheets.

The estimated fair value of the embedded equity indexed derivatives, based on the present value of future equity returns to the policyholder using actuarial and present value assumptions including expectations concerning policyholder behavior, is calculated by the Company’s actuarial department. The calculation is based on in-force business and uses standard capital market techniques, such as Black-Scholes, to calculate the value of the portion of the embedded derivative for which the terms are set. The portion of the embedded derivative covering the period beyond where terms are set is calculated as the present value of amounts expected to be spent to provide equity indexed returns in those periods. The valuation of these embedded derivatives also includes the establishment of a risk margin, as well as changes in nonperformance risk.

63

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

Embedded Derivatives Within Asset and Liability Host Contracts

Level 3 Valuation Techniques and Key Inputs:

Direct and assumed guaranteed minimum benefits

These embedded derivatives are principally valued using the income approach. Valuations are based on option pricing techniques, which utilize significant inputs that may include swap yield curves, currency exchange rates and implied volatilities. These embedded derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. Significant unobservable inputs generally include: the extrapolation beyond observable limits of the swap yield curves and implied volatilities, actuarial assumptions for policyholder behavior and mortality and the potential variability in policyholder behavior and mortality, nonperformance risk and cost of capital for purposes of calculating the risk margin.

Reinsurance ceded on certain guaranteed minimum benefits

These embedded derivatives are principally valued using the income approach. The valuation techniques and significant market standard unobservable inputs used in their valuation are similar to those described above in “— Direct and assumed guaranteed minimum benefits” and also include counterparty credit spreads.

Transfers between Levels

Overall, transfers between levels occur when there are changes in the observability of inputs and market activity. Transfers into or out of any level are assumed to occur at the beginning of the period.

Transfers between Levels 1 and 2:

For assets and liabilities measured at estimated fair value and still held at September 30, 2016, transfers between Levels 1 and 2 were not significant. For assets and liabilities measured at estimated fair value and still held at December 31, 2015, transfers between Levels 1 and 2 were $203 million.

Transfers into or out of Level 3:

Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable.

64

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)

The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:

					September 30, 2016				December 31, 2015				Impact of Increase in Input on Estimated Fair Value (2)
	Valuation Techniques		Significant Unobservable Inputs		Range			Weighted Average (1)	Range			Weighted Average (1)
Fixed maturity securities (3)
U.S. corporate and foreign corporate	•	Matrix pricing	•	Delta spread adjustments (4)	(269)	-	603	(4)	(65)	-	240	39	Decrease
	•	Market pricing	•	Quoted prices (5)	6	-	788	123	—	-	780	156	Increase
	•	Consensus pricing	•	Offered quotes (5)	23	-	121	98	68	-	121	98	Increase
Foreign government	•	Market pricing	•	Quoted prices (5)	100	-	124	104	96	-	135	113	Increase
RMBS	•	Market pricing	•	Quoted prices (5)	7	-	131	90	19	-	292	92	Increase (6)
ABS	•	Market pricing	•	Quoted prices (5)	5	-	105	99	16	-	109	100	Increase (6)
	•	Consensus pricing	•	Offered quotes (5)	98	-	107	100	66	-	105	99	Increase (6)
Derivatives
Interest rate	•	Present value techniques	•	Swap yield (7)	200	-	300		307	-	317		Increase (8)
			•	Repurchase rates (9)	(6)	-	17						Decrease (8)
Foreign currency exchange rate	•	Present value techniques	•	Swap yield (7)	50	-	328		28	-	381		Increase (8)
Credit	•	Present value techniques	•	Credit spreads (10)	97	-	100		98	-	100		Decrease (8)
	•	Consensus pricing	•	Offered quotes (11)
Equity market	•	Present value techniques or option pricing models	•	Volatility (12)	13%	-	36%		15%	-	36%		Increase (8)
			•	Correlation (13)	40%	-	40%		70%	-	70%
Embedded derivatives
Direct, assumed and ceded guaranteed minimum benefits	•	Option pricing techniques	•	Mortality rates:
				Ages 0 - 40	0%	-	0.21%		0%	-	0.21%		Decrease (14)
				Ages 41 - 60	0.01%	-	0.78%		0.01%	-	0.78%		Decrease (14)
				Ages 61 - 115	0%	-	100%		0.04%	-	100%		Decrease (14)
			•	Lapse rates:
				Durations 1 - 10	0.25%	-	100%		0.25%	-	100%		Decrease (15)
				Durations 11 - 20	2%	-	100%		2%	-	100%		Decrease (15)
				Durations 21 - 116	1.25%	-	100%		1%	-	100%		Decrease (15)
			•	Utilization rates	0%	-	25%		0%	-	25%		Increase (16)
			•	Withdrawal rates	0%	-	20%		0%	-	20%		(17)
			•	Long-term equity volatilities	9.95%	-	33%		8.79%	-	33%		Increase (18)
			•	Nonperformance risk spread	0.05%	-	2.03%		(0.47)%	-	1.31%		Decrease (19)

__________________

(1) The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities.

(2) The impact of a decrease in input would have the opposite impact on estimated fair value. For embedded derivatives, changes to direct and assumed guaranteed minimum benefits are based on liability positions; changes to ceded guaranteed minimum benefits are based on asset positions.

(3) Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations.

(4) Range and weighted average are presented in basis points.

(5) Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par.

65

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

(6) Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates.

(7) Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curves are utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.

(8) Changes in estimated fair value are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions.

(9) Ranges represent different repurchase rates utilized as components within the valuation methodology and are presented in basis points.

(10) Represents the risk quoted in basis points of a credit default event on the underlying instrument. Credit derivatives with significant unobservable inputs are primarily comprised of written credit default swaps.

(11) At both September 30, 2016 and December 31, 2015, independent non-binding broker quotations were used in the determination of less than 1% of the total net derivative estimated fair value.

(12) Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.

(13) Ranges represent the different correlation factors utilized as components within the valuation methodology. Presenting a range of correlation factors is more representative of the unobservable input used in the valuation. Increases (decreases) in correlation in isolation will increase (decrease) the significance of the change in valuations.

(14) Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(15) Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(16) The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(17) The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.

(18) Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(19) Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.

66

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

The following is a summary of the valuation techniques and significant unobservable inputs used in the fair value measurement of assets and liabilities classified within Level 3 that are not included in the preceding table. Generally, all other classes of securities classified within Level 3, including those within separate account assets and embedded derivatives within funds withheld related to certain ceded and assumed reinsurance, use the same valuation techniques and significant unobservable inputs as previously described for Level 3 securities. This includes matrix pricing and discounted cash flow methodologies, inputs such as quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2, as well as independent non-binding broker quotations. The residential mortgage loans — FVO and long-term debt of CSEs — FVO are valued using independent non-binding broker quotations and internal models including matrix pricing and discounted cash flow methodologies using current interest rates. The sensitivity of the estimated fair value to changes in the significant unobservable inputs for these other assets and liabilities is similar in nature to that described in the preceding table. The valuation techniques and significant unobservable inputs used in the fair value measurement for the more significant assets measured at estimated fair value on a nonrecurring basis and determined using significant unobservable inputs (Level 3) are summarized in “— Nonrecurring Fair Value Measurements.”

The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities
	Corporate (1)			U.S. Government and Agency			Foreign Government			Structured Securities			State and Political Subdivision			Equity Securities			FVO and Trading Securities (2)
	(In millions)
Three Months Ended September 30, 2016
Balance, beginning of period	$	13,710		$	323		$	376		$	6,700		$	53		$	682		$	231
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	15			—			2			34			—			5			4
Total realized/unrealized gains (losses) included in AOCI	98			(1		)	1			39			3			(9		)	—
Purchases (5)	680			99			21			1,034			—			4			18
Sales (5)	(595		)	—			(7		)	(512		)	—			(20		)	(6		)
Issuances (5)	—			—			—			—			—			—			—
Settlements (5)	—			—			—			—			—			—			—
Transfers into Level 3 (6)	424			—			—			81			7			1			—
Transfers out of Level 3 (6)	(473		)	(104		)	(71		)	(316		)	(17		)	(8		)	(4		)
Balance, end of period	$	13,859		$	317		$	322		$	7,060		$	46		$	655		$	243
Three Months Ended September 30, 2015
Balance, beginning of period	$	13,520		$	55		$	1,336		$	7,018		$	55		$	489		$	475
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	25			—			4			29			—			6			(16		)
Total realized/unrealized gains (losses) included in AOCI	(296		)	—			(1		)	(46		)	1			(14		)	—
Purchases (5)	955			—			17			2,544			20			12			91
Sales (5)	(351		)	(1		)	(17		)	(418		)	—			(13		)	(41		)
Issuances (5)	—			—			—			—			—			—			—
Settlements (5)	—			—			—			—			—			—			—
Transfers into Level 3 (6)	699			18			11			361			—			—			80
Transfers out of Level 3 (6)	(1,850		)	(55		)	(659		)	(955		)	(30		)	(30		)	(191		)
Balance, end of period	$	12,702		$	17		$	691		$	8,533		$	46		$	450		$	398
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2016 (7)	$	1		$	—		$	2		$	33		$	—		$	(1	)	$	4
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2015 (7)	$	10		$	—		$	4		$	33		$	—		$	—		$	(16	)

67

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Short-term Investments			Residential Mortgage Loans — FVO			Net Derivatives (8)			Net Embedded Derivatives (9)			Separate Accounts (10)			Long-term Debt of CSEs — FVO			Trading Liabilities
	(In millions)
Three Months Ended September 30, 2016
Balance, beginning of period	$	175		$	449		$	(132	)	$	(6,804	)	$	1,627		$	(12	)	$	—
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	1			10			(116		)	765			(25		)	—			—
Total realized/unrealized gains (losses) included in AOCI	(1		)	—			(7		)	(27		)	—			—			—
Purchases (5)	664			42			—			—			4			—			—
Sales (5)	(55		)	(5		)	—			—			(155		)	—			—
Issuances (5)	—			—			(1		)	—			30			—			—
Settlements (5)	—			(15		)	(33		)	(239		)	(45		)	—			—
Transfers into Level 3 (6)	—			—			—			—			8			—			—
Transfers out of Level 3 (6)	(111		)	—			—			—			(180		)	—			—
Balance, end of period	$	673		$	481		$	(289	)	$	(6,305	)	$	1,264		$	(12	)	$	—
Three Months Ended September 30, 2015
Balance, beginning of period	$	1,809		$	345		$	(372	)	$	841		$	1,925		$	(12	)	$	(4	)
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	—			(2		)	(97		)	(1,753		)	24			—			—
Total realized/unrealized gains (losses) included in AOCI	—			—			7			(38		)	—			—			—
Purchases (5)	1,296			18			—			—			95			—			(2		)
Sales (5)	(11		)	(37		)	—			—			(93		)	—			—
Issuances (5)	—			—			(1		)	—			—			—			—
Settlements (5)	—			(9		)	24			(216		)	—			1			—
Transfers into Level 3 (6)	5			—			—			—			2			—			—
Transfers out of Level 3 (6)	(1,786		)	—			—			—			(271		)	—			4
Balance, end of period	$	1,313		$	315		$	(439	)	$	(1,166	)	$	1,682		$	(11	)	$	(2	)
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2016 (7)	$	1		$	10		$	(103	)	$	750		$	—		$	—		$	—
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2015 (7)	$	—		$	(2	)	$	(103	)	$	(1,743	)	$	—		$	—		$	—

68

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities
	Corporate (1)			U.S. Government and Agency			Foreign Government			Structured Securities			State and Political Subdivision			Equity Securities			FVO and Trading Securities (2)
	(In millions)
Nine Months Ended September 30, 2016
Balance, beginning of period	$	12,796		$	—		$	856		$	7,116		$	46		$	432		$	270
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	(4		)	—			9			101			1			(21		)	9
Total realized/unrealized gains (losses) included in AOCI	1,027			17			(2		)	28			2			43			—
Purchases (5)	1,893			111			58			2,291			—			20			43
Sales (5)	(1,034		)	—			(36		)	(1,357		)	—			(25		)	(29		)
Issuances (5)	—			—			—			—			—			—			—
Settlements (5)	—			—			—			—			—			—			—
Transfers into Level 3 (6)	711			200			41			43			7			455			18
Transfers out of Level 3 (6)	(1,530		)	(11		)	(604		)	(1,162		)	(10		)	(249		)	(68		)
Balance, end of period	$	13,859		$	317		$	322		$	7,060		$	46		$	655		$	243
Nine Months Ended September 30, 2015
Balance, beginning of period	$	13,432		$	—		$	1,311		$	7,392		$	—		$	345		$	567
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	62			—			10			88			—			7			(27		)
Total realized/unrealized gains (losses) included in AOCI	(759		)	(1		)	1			(68		)	—			(22		)	—
Purchases (5)	1,884			—			30			4,062			46			57			130
Sales (5)	(964		)	(1		)	(39		)	(1,304		)	—			(34		)	(130		)
Issuances (5)	—			—			—			—			—			—			—
Settlements (5)	—			—			—			—			—			—			—
Transfers into Level 3 (6)	844			19			7			355			—			107			82
Transfers out of Level 3 (6)	(1,797		)	—			(629		)	(1,992		)	—			(10		)	(224		)
Balance, end of period	$	12,702		$	17		$	691		$	8,533		$	46		$	450		$	398
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2016 (7)	$	2		$	—		$	9		$	96		$	1		$	(27	)	$	9
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2015 (7)	$	21		$	—		$	10		$	89		$	—		$	—		$	(25	)

69

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Short-term Investments			Residential Mortgage Loans — FVO			Net Derivatives (8)			Net Embedded Derivatives (9)			Separate Accounts (10)			Long-term Debt of CSEs — FVO			Trading Liabilities
	(In millions)
Nine Months Ended September 30, 2016
Balance, beginning of period	$	291		$	314		$	(411	)	$	(544	)	$	1,704		$	(11	)	$	—
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	1			22			110			(4,851		)	7			—			—
Total realized/unrealized gains (losses) included in AOCI	4			—			36			(237		)	—			—			—
Purchases (5)	673			187			12			—			108			—			—
Sales (5)	(294		)	(12		)	—			—			(233		)	—			—
Issuances (5)	—			—			(1		)	—			27			—			—
Settlements (5)	—			(30		)	(33		)	(673		)	(58		)	(1		)	—
Transfers into Level 3 (6)	1			—			—			—			9			—			—
Transfers out of Level 3 (6)	(3		)	—			(2		)	—			(300		)	—			—
Balance, end of period	$	673		$	481		$	(289	)	$	(6,305	)	$	1,264		$	(12	)	$	—
Nine Months Ended September 30, 2015
Balance, beginning of period	$	336		$	308		$	(300	)	$	430		$	1,922		$	(13	)	$	—
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	1			18			(163		)	(964		)	5			—			—
Total realized/unrealized gains (losses) included in AOCI	—			—			3			(19		)	—			—			—
Purchases (5)	1,313			114			4			—			297			—			(2		)
Sales (5)	(28		)	(100		)	—			—			(232		)	—			—
Issuances (5)	—			—			(1		)	—			—			—			—
Settlements (5)	—			(25		)	18			(613		)	(2		)	2			—
Transfers into Level 3 (6)	—			—			—			—			3			—			—
Transfers out of Level 3 (6)	(309		)	—			—			—			(311		)	—			—
Balance, end of period	$	1,313		$	315		$	(439	)	$	(1,166	)	$	1,682		$	(11	)	$	(2	)
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2016 (7)	$	1		$	22		$	90		$	(4,884	)	$	—		$	—		$	—
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2015 (7)	$	—		$	18		$	(141	)	$	(973	)	$	—		$	—		$	—

__________________

(1) Comprised of U.S. and foreign corporate securities.

(2) Comprised of actively traded securities, FVO general account securities, FVO contractholder-directed unit-linked investments and FVO securities held by CSEs.

(3) Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities are included in net investment gains (losses), while changes in estimated fair value of residential mortgage loans — FVO are included in net investment income. Lapses associated with net embedded derivatives are included in net derivative gains (losses). Substantially all realized/unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivatives gains (losses).

(4) Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward.

(5) Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.

70

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

(6) Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.

(7) Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods. Substantially all changes in unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivative gains (losses).

(8) Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.

(9) Embedded derivative assets and liabilities are presented net for purposes of the rollforward.

(10) Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income (loss). For the purpose of this disclosure, these changes are presented within net investment gains (losses). Separate account assets and liabilities are presented net for the purposes of the rollforward.

Fair Value Option

The following table presents information for certain assets and liabilities accounted for under the FVO. These assets and liabilities were initially measured at fair value.

	Residential Mortgage Loans — FVO						Certain Assets and Liabilities of CSEs — FVO (1)
	September 30, 2016			December 31, 2015			September 30, 2016			December 31, 2015
	(In millions)
Assets
Unpaid principal balance	$	641		$	436		$	95		$	121
Difference between estimated fair value and unpaid principal balance	(160		)	(122		)	48			51
Carrying value at estimated fair value	$	481		$	314		$	143		$	172
Loans in non-accrual status	$	186		$	122		$	—		$	—
Liabilities
Contractual principal balance							$	50		$	71
Difference between estimated fair value and contractual principal balance							(12		)	(11		)
Carrying value at estimated fair value							$	38		$	60

__________________

(1) These assets and liabilities are comprised of commercial mortgage loans and long-term debt. Changes in estimated fair value on these assets and liabilities and gains or losses on sales of these assets are recognized in net investment gains (losses). Interest income on commercial mortgage loans held by CSEs — FVO is recognized in net investment income. Interest expense from long-term debt of CSEs — FVO is recognized in other expenses.

71

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

Nonrecurring Fair Value Measurements

The following table presents information for assets measured at estimated fair value on a nonrecurring basis during the periods and still held at the reporting dates (for example, when there is evidence of impairment). The estimated fair values for these assets were determined using significant unobservable inputs (Level 3).

	At   September 30,				Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016		2015		2016			2015			2016			2015
	Carrying Value After Measurement				Gains (Losses)
	(In millions)
Mortgage loans (1)	$	12	$	44	$	—		$	—		$	—		$	(1	)
Other limited partnership interests (2)	$	78	$	53	$	(9	)	$	(8	)	$	(45	)	$	(27	)
Other assets (3)	$	—	$	—	$	—		$	—		$	(44	)	$	—
Goodwill (4)	$	—	$	—	$	(260	)	$	—		$	(260	)	$	—

__________________

(1) Estimated fair values for impaired mortgage loans are based on independent broker quotations or valuation models using unobservable inputs or, if the loans are in foreclosure or are otherwise determined to be collateral dependent, are based on the estimated fair value of the underlying collateral or the present value of the expected future cash flows.

(2) For these cost method investments, estimated fair value is determined from information provided on the financial statements of the underlying entities including NAV data. These investments include private equity and debt funds that typically invest primarily in various strategies including domestic and international leveraged buyout funds; power, energy, timber and infrastructure development funds; venture capital funds; and below investment grade debt and mezzanine debt funds. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next two to 10 years. Unfunded commitments for these investments at both September 30, 2016 and 2015 were not significant.

(3) During the nine months ended September 30, 2016, the Company recognized an impairment of computer software in connection with the U.S. Retail Advisor Force Divestiture. See Note 3.

(4) As discussed in Note 10, for both the three months and nine months ended September 30, 2016, the Company recorded an impairment of goodwill associated with the reporting units within the Brighthouse Financial segment.

Fair Value of Financial Instruments Carried at Other Than Fair Value

The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income, payables for collateral under securities loaned and other transactions, short-term debt and those short-term investments that are not securities, such as time deposits, and therefore are not included in the three level hierarchy table disclosed in the “— Recurring Fair Value Measurements” section. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the tables below are not considered financial instruments subject to this disclosure.

72

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:

	September 30, 2016
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Mortgage loans	$	70,532	$	—	$	—	$	73,585	$	73,585
Policy loans	$	11,177	$	—	$	1,107	$	12,594	$	13,701
Real estate joint ventures	$	25	$	—	$	—	$	87	$	87
Other limited partnership interests	$	414	$	—	$	—	$	461	$	461
Other invested assets	$	559	$	169	$	—	$	390	$	559
Premiums, reinsurance and other receivables	$	4,030	$	—	$	910	$	3,218	$	4,128
Other assets	$	243	$	—	$	205	$	76	$	281
Liabilities
Policyholder account balances	$	126,417	$	—	$	—	$	133,084	$	133,084
Long-term debt	$	16,505	$	—	$	18,526	$	—	$	18,526
Collateral financing arrangements	$	4,084	$	—	$	—	$	3,749	$	3,749
Junior subordinated debt securities	$	3,168	$	—	$	4,142	$	—	$	4,142
Other liabilities	$	6,919	$	—	$	6,429	$	492	$	6,921
Separate account liabilities	$	123,253	$	—	$	123,253	$	—	$	123,253

	December 31, 2015
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Mortgage loans	$	66,616	$	—	$	—	$	68,539	$	68,539
Policy loans	$	11,258	$	—	$	1,279	$	12,072	$	13,351
Real estate joint ventures	$	35	$	—	$	—	$	104	$	104
Other limited partnership interests	$	524	$	—	$	—	$	615	$	615
Other invested assets	$	537	$	155	$	2	$	380	$	537
Premiums, reinsurance and other receivables	$	2,822	$	—	$	484	$	2,421	$	2,905
Other assets	$	235	$	—	$	207	$	60	$	267
Liabilities
Policyholder account balances	$	125,040	$	—	$	—	$	130,125	$	130,125
Long-term debt	$	17,954	$	—	$	19,360	$	—	$	19,360
Collateral financing arrangements	$	4,139	$	—	$	—	$	3,899	$	3,899
Junior subordinated debt securities	$	3,194	$	—	$	4,029	$	—	$	4,029
Other liabilities	$	2,249	$	—	$	865	$	1,385	$	2,250
Separate account liabilities	$	112,119	$	—	$	112,119	$	—	$	112,119

73

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

The methods, assumptions and significant valuation techniques and inputs used to estimate the fair value of financial instruments are summarized as follows:

Mortgage Loans

The estimated fair value of mortgage loans is primarily determined by estimating expected future cash flows and discounting them using current interest rates for similar mortgage loans with similar credit risk, or is determined from pricing for similar loans.

Policy Loans

Policy loans with fixed interest rates are classified within Level 3. The estimated fair values for these loans are determined using a discounted cash flow model applied to groups of similar policy loans determined by the nature of the underlying insurance liabilities. Cash flow estimates are developed by applying a weighted-average interest rate to the outstanding principal balance of the respective group of policy loans and an estimated average maturity determined through experience studies of the past performance of policyholder repayment behavior for similar loans. These cash flows are discounted using current risk-free interest rates with no adjustment for borrower credit risk, as these loans are fully collateralized by the cash surrender value of the underlying insurance policy. Policy loans with variable interest rates are classified within Level 2 and the estimated fair value approximates carrying value due to the absence of borrower credit risk and the short time period between interest rate resets, which presents minimal risk of a material change in estimated fair value due to changes in market interest rates.

Real Estate Joint Ventures and Other Limited Partnership Interests

The estimated fair values of these cost method investments are generally based on the Company’s share of the NAV as provided on the financial statements of the investees. In certain circumstances, management may adjust the NAV by a premium or discount when it has sufficient evidence to support applying such adjustments.

Other Invested Assets

These other invested assets are principally comprised of various interest-bearing assets held in foreign subsidiaries and certain amounts due under contractual indemnifications. For the various interest-bearing assets held in foreign subsidiaries, the Company evaluates the specific facts and circumstances of each instrument to determine the appropriate estimated fair values. These estimated fair values were not materially different from the recognized carrying values.

Premiums, Reinsurance and Other Receivables

Premiums, reinsurance and other receivables are principally comprised of certain amounts recoverable under reinsurance agreements, amounts on deposit with financial institutions to facilitate daily settlements related to certain derivatives and amounts receivable for securities sold but not yet settled.

Amounts recoverable under ceded reinsurance agreements, which the Company has determined do not transfer significant risk such that they are accounted for using the deposit method of accounting, have been classified as Level 3. The valuation is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using interest rates determined to reflect the appropriate credit standing of the assuming counterparty.

The amounts on deposit for derivative settlements, classified within Level 2, essentially represent the equivalent of demand deposit balances and amounts due for securities sold are generally received over short periods such that the estimated fair value approximates carrying value.

Other Assets

These other assets are principally comprised of a receivable for cash paid to an unaffiliated financial institution under the MetLife Reinsurance Company of Charleston (“MRC”) collateral financing arrangement described in Note 13 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report. The estimated fair value of the receivable for the cash paid to the unaffiliated financial institution under the MRC collateral financing arrangement is determined by discounting the expected future cash flows using a discount rate that reflects the credit rating of the unaffiliated financial institution.

74

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

9. Fair Value (continued)

Policyholder Account Balances

These policyholder account balances include investment contracts which primarily include certain funding agreements, fixed deferred annuities, modified guaranteed annuities, fixed term payout annuities and total control accounts (“TCA”). The valuation of these investment contracts is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using current market risk-free interest rates adding a spread to reflect the nonperformance risk in the liability.

Long-term Debt, Collateral Financing Arrangements and Junior Subordinated Debt Securities

The estimated fair values of long-term debt, collateral financing arrangements and junior subordinated debt securities are principally determined using market standard valuation methodologies.

Valuations of instruments classified as Level 2 are based primarily on quoted prices in markets that are not active or using matrix pricing that use standard market observable inputs such as quoted prices in markets that are not active and observable yields and spreads in the market. Instruments valued using discounted cash flow methodologies use standard market observable inputs including market yield curve, duration, call provisions, observable prices and spreads for similar publicly traded or privately traded issues.

Valuations of instruments classified as Level 3 are based primarily on discounted cash flow methodologies that utilize unobservable discount rates that can vary significantly based upon the specific terms of each individual arrangement. The determination of estimated fair values of collateral financing arrangements incorporates valuations obtained from the counterparties to the arrangements, as part of the collateral management process.

Other Liabilities

Other liabilities consist primarily of interest payable, amounts due for securities purchased but not yet settled, and funds withheld amounts payable, which are contractually withheld by the Company in accordance with the terms of the reinsurance agreements. The Company evaluates the specific terms, facts and circumstances of each instrument to determine the appropriate estimated fair values, which are not materially different from the carrying values, with the exception of certain deposit type reinsurance payables. For such payables, the estimated fair value is determined as the present value of expected future cash flows, which are discounted using an interest rate determined to reflect the appropriate credit standing of the assuming counterparty.

Separate Account Liabilities

Separate account liabilities represent those balances due to policyholders under contracts that are classified as investment contracts.

Separate account liabilities classified as investment contracts primarily represent variable annuities with no significant mortality risk to the Company such that the death benefit is equal to the account balance, funding agreements related to group life contracts and certain contracts that provide for benefit funding.

Since separate account liabilities are fully funded by cash flows from the separate account assets which are recognized at estimated fair value as described in the section “— Recurring Fair Value Measurements,” the value of those assets approximates the estimated fair value of the related separate account liabilities. The valuation techniques and inputs for separate account liabilities are similar to those described for separate account assets.

75

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

10. Goodwill

The Company tests goodwill for impairment during the third quarter of each year at the reporting unit level based upon the best available data at June 30, of that year. A reporting unit is the operating segment or a business one level below the operating segment, if discrete financial information is prepared and regularly reviewed by management at that level. Step 1 of the goodwill impairment process requires a comparison of the fair value of a reporting unit to its carrying value. To determine the fair values of its reporting units, the Company generally applies a market multiple, discounted cash flow, and/or an actuarial based valuation approach. The market multiple valuation approach utilizes market multiples of companies with similar businesses and the projected operating earnings of the reporting unit. The discounted cash flow valuation approach requires judgments about revenues, operating earnings projections, capital market assumptions and discount rates. The actuarial based approaches such as embedded value or cash flow testing estimate the net worth of the reporting unit and the value of existing and new business. The actuarial based approaches require judgments and assumptions about level of economic capital required to support the mix of business, long-term growth rates, the account value of in-force business, projections of new and renewal business, as well as margins on such business, the level of interest rates, credit spreads, equity market levels, and the discount rate that the Company believes is appropriate for the respective reporting unit.

In anticipation of the Separation, in the third quarter of 2016, MetLife reorganized its businesses into six segments: U.S.; Asia; Latin America; EMEA; MetLife Holdings; and Brighthouse Financial. In connection with the reorganization, MetLife realigned certain businesses among its existing and new segments. As a result, the Company reallocated goodwill based on the relative fair values of the reporting units within such segments.

Based on a quantitative analysis performed for the Life and Run-off reporting units within the Brighthouse Financial segment, the Company concluded that the carrying values of these reporting units exceeded their estimated fair values, indicating a potential for goodwill impairment. Accordingly, the Company performed Step 2 of the goodwill impairment process for each of the reporting units, which compares the implied estimated fair value of the reporting unit’s goodwill with its carrying value. This analysis indicated that the goodwill associated with these reporting units was not recoverable. As a result, the Company recorded a non-cash charge in the aggregate of $260 million ($223 million, net of income tax) for the impairment of the entire goodwill balance, which is reported in goodwill impairment in the interim condensed consolidated statements of operations and comprehensive income for both the three months and nine months ended September 30, 2016.

In addition, the Company performed its annual goodwill impairment tests of all other reporting units during the third quarter of 2016 using a qualitative assessment and/or quantitative assessments under the market multiple, discounted cash flow and/or actuarial based valuation approaches based on best available data as of June 30, 2016 and concluded that the estimated fair values of all such reporting units were in excess of their carrying values and, therefore, goodwill was not impaired.

Management continues to evaluate current market conditions that may affect the estimated fair value of the reporting units to assess whether any goodwill impairment exists. Deteriorating or adverse market conditions for certain reporting units may have a significant impact on the estimated fair value of these reporting units and could result in future impairments of goodwill.

Information regarding goodwill by segment, as well as Corporate & Other, was as follows:

	U.S.		Asia		Latin America		EMEA		MetLife Holdings			Brighthouse Financial			Corporate & Other			Total
	(In millions)
Balance at January 1, 2016
Goodwill	$	1,451	$	4,508	$	1,186	$	1,143	$	2,579		$	260		$	218		$	11,345
Accumulated impairment (1)	—		—		—		—		(1,692		)	—			(176		)	(1,868		)
Total goodwill, net	1,451		4,508		1,186		1,143		887			260			42			9,477
Dispositions (2)	—		—		—		—		—			—			(42		)	(42		)
Impairment	—		—		—		—		—			(260		)	—			(260		)
Effect of foreign currency translation and other	—		352		64		1		—			—			—			417
Balance at September 30, 2016
Goodwill	1,451		4,860		1,250		1,144		2,579			260			176			11,720
Accumulated impairment	—		—		—		—		(1,692		)	(260		)	(176		)	(2,128		)
Total goodwill, net	$	1,451	$	4,860	$	1,250	$	1,144	$	887		$	—		$	—		$	9,592

__________________

76

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (Continued)

10. Goodwill (continued)

(1) The $1.9 billion accumulated impairment relates to the retail annuities business, which was impaired in 2012 and includes the allocated goodwill from Corporate & Other. Although the entire balance is reflected in the MetLife Holdings segment, it also relates to the retail annuities business within the Brighthouse Financial segment.

(2) In conjunction with the U.S. Retail Advisor Force Divestiture, the Company reduced goodwill in Corporate & Other by $42 million during the nine months ended September 30, 2016. See Note 3.

11. Equity

Preferred Stock

Preferred stock authorized, issued and outstanding was as follows at both September 30, 2016 and December 31, 2015:

Series	Shares Authorized	Shares Issued	Shares Outstanding
Floating Rate Non-Cumulative Preferred Stock, Series A	27,600,000	24,000,000	24,000,000
5.25% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series C	1,500,000	1,500,000	1,500,000
Series A Junior Participating Preferred Stock	10,000,000	—	—
Not designated	160,900,000	—	—
Total	200,000,000	25,500,000	25,500,000

Common Stock

Duringthenine months endedSeptember 30, 2016and2015, MetLife, Inc. repurchased1,445,864 and22,475,816shares through open market purchases for$70 millionand$1.1 billion, respectively.

At September 30, 2016, MetLife, Inc. had no remaining common stock repurchase authorizations. Common stock repurchases are dependent upon several factors, including the Company’s capital position, liquidity, financial strength and credit ratings, general market conditions, the market price of MetLife, Inc.’s common stock compared to management’s assessment of the stock’s underlying value and applicable regulatory approvals, as well as other legal and accounting factors.

Stock-Based Compensation Plans

Performance Shares and Performance Units

Awards under the MetLife, Inc. 2005 Stock and Incentive Compensation Plan and the MetLife, Inc. 2015 Stock and Incentive Compensation Plan (the “2015 Stock Plan”) were outstanding at September 30, 2016. All awards granted in 2015 or later were granted under the 2015 Stock Plan. There were no outstanding awards to MetLife, Inc. directors, for their service as directors, as of September 30, 2016.

For Performance Share and Performance Unit awards outstanding as of September 30, 2016, any vested Performance Shares and Performance Units will be multiplied by a performance factor of 0% to 175%. Assuming that MetLife, Inc. has met threshold performance goals related to its adjusted income or total shareholder return, the MetLife, Inc. Compensation Committee will determine the performance factor in its discretion. In doing so, the Compensation Committee may consider MetLife, Inc.’s total shareholder return relative to the performance of its competitors and MetLife, Inc.’s operating return on equity relative to its business plan. The estimated fair value of Performance Shares and Performance Units will be remeasured each quarter until they become payable.

Payout of 2013 – 2015 Performance Shares and Performance Units

Final Performance Shares are paid in shares of MetLife, Inc. common stock. Final Performance Units are payable in cash equal to the closing price of MetLife, Inc. common stock on a date following the last day of the three-year performance period. The performance factor for the January 1, 2013 – December 31, 2015 performance period was 86.2%. This factor has been applied to the 1,592,650 Performance Shares and 234,787 Performance Units associated with that performance period that vested on December 31, 2015. As a result, in the first quarter of 2016, MetLife, Inc. issued 1,372,864 shares of its common stock (less withholding for taxes and other items, as applicable), excluding shares that payees choose to defer, and MetLife, Inc. or its affiliates paid the cash value of 202,386 units (less withholding for taxes and other items, as applicable).

77

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

11. Equity (continued)

Accumulated Other Comprehensive Income (Loss)

Information regarding changes in the balances of each component of AOCI attributable to MetLife, Inc., was as follows:

	Three Months   Ended   September 30, 2016
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Foreign Currency Translation Adjustments			Defined Benefit Plans Adjustment			Total
	(In millions)
Balance, beginning of period	$	18,204		$	2,431		$	(4,020	)	$	(1,983	)	$	14,632
OCI before reclassifications	(1,066		)	(24		)	49			(259		)	(1,300		)
Deferred income tax benefit (expense)	281			8			30			85			404
AOCI before reclassifications, net of income tax	17,419			2,415			(3,941		)	(2,157		)	13,736
Amounts reclassified from AOCI	(173		)	(94		)	—			46			(221		)
Deferred income tax benefit (expense)	60			30			—			(10		)	80
Amounts reclassified from AOCI, net of income tax	(113		)	(64		)	—			36			(141		)
Balance, end of period	$	17,306		$	2,351		$	(3,941	)	$	(2,121	)	$	13,595
	Three Months   Ended   September 30, 2015
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Foreign Currency Translation Adjustments			Defined Benefit Plans Adjustment			Total
	(In millions)
Balance, beginning of period	$	11,761		$	1,102		$	(4,214	)	$	(2,206	)	$	6,443
OCI before reclassifications	962			102			(336		)	—			728
Deferred income tax benefit (expense)	(340		)	(47		)	(24		)	—			(411		)
AOCI before reclassifications, net of income tax	12,383			1,157			(4,574		)	(2,206		)	6,760
Amounts reclassified from AOCI	(102		)	239			—			57			194
Deferred income tax benefit (expense)	34			(77		)	—			(20		)	(63		)
Amounts reclassified from AOCI, net of income tax	(68		)	162			—			37			131
Balance, end of period	$	12,315		$	1,319		$	(4,574	)	$	(2,169	)	$	6,891

78

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

11. Equity (continued)

	Nine Months   Ended   September 30, 2016
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Foreign Currency Translation Adjustments			Defined Benefit Plans Adjustment			Total
	(In millions)
Balance, beginning of period	$	10,315		$	1,458		$	(4,950	)	$	(2,052	)	$	4,771
OCI before reclassifications	10,872			1,472			809			(248		)	12,905
Deferred income tax benefit (expense)	(3,656		)	(460		)	200			81			(3,835		)
AOCI before reclassifications, net of income tax	17,531			2,470			(3,941		)	(2,219		)	13,841
Amounts reclassified from AOCI	(339		)	(174		)	—			145			(368		)
Deferred income tax benefit (expense)	114			55			—			(47		)	122
Amounts reclassified from AOCI, net of income tax	(225		)	(119		)	—			98			(246		)
Balance, end of period	$	17,306		$	2,351		$	(3,941	)	$	(2,121	)	$	13,595
	Nine Months   Ended   September 30, 2015
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Foreign Currency Translation Adjustments			Defined Benefit Plans Adjustment			Total
	(In millions)
Balance, beginning of period	$	15,159		$	1,076		$	(3,303	)	$	(2,283	)	$	10,649
OCI before reclassifications	(3,923		)	(106		)	(1,243		)	3			(5,269		)
Deferred income tax benefit (expense)	1,337			37			(28		)	(1		)	1,345
AOCI before reclassifications, net of income tax	12,573			1,007			(4,574		)	(2,281		)	6,725
Amounts reclassified from AOCI	(392		)	490			—			171			269
Deferred income tax benefit (expense)	134			(178		)	—			(59		)	(103		)
Amounts reclassified from AOCI, net of income tax	(258		)	312			—			112			166
Balance, end of period	$	12,315		$	1,319		$	(4,574	)	$	(2,169	)	$	6,891

__________________

(1) See Note 7 for information on offsets to investments related to future policy benefits, DAC, VOBA and DSI, and the policyholder dividend obligation.

79

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

11. Equity (continued)

Information regarding amounts reclassified out of each component of AOCI was as follows:

AOCI Components	Amounts Reclassified from AOCI												Consolidated Statement of Operations and Comprehensive Income (Loss) Locations
	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Net unrealized investment gains (losses):
Net unrealized investment gains (losses)	$	163		$	104		$	288		$	353		Net investment gains (losses)
Net unrealized investment gains (losses)	4			3			23			60			Net investment income
Net unrealized investment gains (losses)	6			(5		)	28			(21		)	Net derivative gains (losses)
Net unrealized investment gains (losses), before income tax	173			102			339			392
Income tax (expense) benefit	(60		)	(34		)	(114		)	(134		)
Net unrealized investment gains (losses), net of income tax	113			68			225			258
Unrealized gains (losses) on derivatives - cash flow hedges:
Interest rate swaps	28			40			56			52			Net derivative gains (losses)
Interest rate swaps	4			3			11			9			Net investment income
Interest rate forwards	1			1			2			5			Net derivative gains (losses)
Interest rate forwards	1			1			4			3			Net investment income
Interest rate forwards	—			1			1			2			Other expenses
Foreign currency swaps	59			(286		)	96			(563		)	Net derivative gains (losses)
Foreign currency swaps	—			—			(1		)	(1		)	Net investment income
Foreign currency swaps	—			—			1			1			Other expenses
Credit forwards	—			1			3			1			Net derivative gains (losses)
Credit forwards	1			—			1			1			Net investment income
Gains (losses) on cash flow hedges, before income tax	94			(239		)	174			(490		)
Income tax (expense) benefit	(30		)	77			(55		)	178
Gains (losses) on cash flow hedges, net of income tax	64			(162		)	119			(312		)
Defined benefit plans adjustment: (1)
Amortization of net actuarial gains (losses)	(47		)	(58		)	(150		)	(174		)
Amortization of prior service (costs) credit	1			1			5			3
Amortization of defined benefit plan items, before income tax	(46		)	(57		)	(145		)	(171		)
Income tax (expense) benefit	10			20			47			59
Amortization of defined benefit plan items, net of income tax	(36		)	(37		)	(98		)	(112		)
Total reclassifications, net of income tax	$	141		$	(131	)	$	246		$	(166	)

__________________

(1) These AOCI components are included in the computation of net periodic benefit costs. See Note 13.

80

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

12. Other Expenses

Information on other expenses was as follows:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Compensation	$	1,101		$	1,157		$	3,600		$	3,706
Pension, postretirement and postemployment benefit costs	80			100			323			297
Commissions	1,049			1,103			3,277			3,382
Volume-related costs	214			264			694			761
Capitalization of DAC	(863		)	(955		)	(2,759		)	(2,850		)
Amortization of DAC and VOBA	1,017			1,131			2,133			3,053
Amortization of negative VOBA	(55		)	(90		)	(221		)	(282		)
Interest expense on debt	292			302			910			908
Premium taxes, licenses and fees	187			199			591			568
Professional services	373			366			1,101			1,079
Rent and related expenses, net of sublease income	90			78			285			245
Other (1)	443			878			1,432			1,798
Total other expenses	$	3,928		$	4,533		$	11,366		$	12,665

__________________

(1) The Company recorded a non-cash charge to net income of $792 million, net of income tax, during the third quarter of 2015. The charge was related to an uncertain tax position and was comprised of a $557 million charge included in provision for income tax expense (benefit) and a $362 million ($235 million, net of income tax) charge included in other expenses.

81

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

13. Employee Benefit Plans

Pension and Other Postretirement Benefit Plans

Certain subsidiaries of MetLife, Inc. sponsor and/or administer various defined benefit pension plans and other postretirement employee benefit plans covering employees and sales representatives who meet specified eligibility requirements. These subsidiaries also provide certain postemployment benefits and certain postretirement medical and life insurance benefits for retired employees.

The components of net periodic benefit costs were as follows:

	Three Months   Ended   September 30,
	2016						2015
	Pension Benefits			Other Postretirement Benefits			Pension Benefits			Other Postretirement Benefits
	(In millions)
Service costs	$	67		$	4		$	68		$	3
Interest costs	102			21			106			22
Curtailment costs (1)	(1		)	(1		)	—			—
Expected return on plan assets	(140		)	(19		)	(136		)	(19		)
Amortization of net actuarial (gains) losses	44			3			48			10
Amortization of prior service costs (credit)	—			(1		)	(1		)	—
Net periodic benefit costs (credit)	$	72		$	7		$	85		$	16
	Nine Months   Ended   September 30,
	2016						2015
	Pension Benefits			Other Postretirement Benefits			Pension Benefits			Other Postretirement Benefits
	(In millions)
Service costs	$	212		$	8		$	206		$	12
Interest costs	322			63			318			67
Curtailment costs (1)	(1		)	26			—			—
Expected return on plan assets	(394		)	(56		)	(408		)	(59		)
Amortization of net actuarial (gains) losses	143			7			143			31
Amortization of prior service costs (credit)	—			(5		)	(1		)	(2		)
Net periodic benefit costs (credit)	$	282		$	43		$	258		$	49

__________________

(1) The Company recognized curtailment charges on certain postretirement benefit plans in connection with the U.S Retail Advisor Force Divestiture. See Note 3.

82

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

14. Earnings Per Common Share

The following table presents the weighted average shares used in calculating basic earnings per common share and those used in calculating diluted earnings per common share for each income category presented below:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016		2015
	(In millions, except share and per share data)
Weighted Average Shares:
Weighted average common stock outstanding for basic earnings per common share	1,100,504,563			1,118,856,041			1,100,558,083		1,120,130,708
Incremental common shares from assumed:
Exercise or issuance of stock-based awards	8,749,753			11,085,040			8,445,077		10,575,611
Weighted average common stock outstanding for diluted earnings per common share	1,109,254,316			1,129,941,081			1,109,003,160		1,130,706,319
Net Income (Loss):
Net income (loss)	$	573		$	1,198		$	2,890	$	4,480
Less: Net income (loss) attributable to noncontrolling interests	(4		)	(5		)	2		4
Less: Preferred stock dividends	6			6			58		67
Preferred stock repurchase premium	—			—			—		42
Net income (loss) available to MetLife, Inc.’s common shareholders	$	571		$	1,197		$	2,830	$	4,367
Basic	$	0.52		$	1.07		$	2.57	$	3.90
Diluted	$	0.51		$	1.06		$	2.55	$	3.86

15. Contingencies, Commitments and Guarantees

Contingencies

Litigation

The Company is a defendant in a large number of litigation matters. In some of the matters, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages or other relief. Jurisdictions may permit claimants not to specify the monetary damages sought or may permit claimants to state only that the amount sought is sufficient to invoke the jurisdiction of the trial court. In addition, jurisdictions may permit plaintiffs to allege monetary damages in amounts well exceeding reasonably possible verdicts in the jurisdiction for similar matters. This variability in pleadings, together with the actual experience of the Company in litigating or resolving through settlement numerous claims over an extended period of time, demonstrates to management that the monetary relief which may be specified in a lawsuit or claim bears little relevance to its merits or disposition value.

Due to the vagaries of litigation, the outcome of a litigation matter and the amount or range of potential loss at particular points in time may normally be difficult to ascertain. Uncertainties can include how fact finders will evaluate documentary evidence and the credibility and effectiveness of witness testimony, and how trial and appellate courts will apply the law in the context of the pleadings or evidence presented, whether by motion practice, or at trial or on appeal. Disposition valuations are also subject to the uncertainty of how opposing parties and their counsel will themselves view the relevant evidence and applicable law.

The Company establishes liabilities for litigation and regulatory loss contingencies when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Liabilities have been established for a number of the matters noted below. It is possible that some of the matters could require the Company to pay damages or make other expenditures or establish accruals in amounts that could not be reasonably estimated at September 30, 2016. While the potential future charges could be material in the particular quarterly or annual periods in which they are recorded, based on information currently known to management, management does not believe any such charges are likely to have a material effect on the Company’s financial position.

83

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

15. Contingencies, Commitments and Guarantees (continued)

Matters as to Which an Estimate Can Be Made

For some of the matters disclosed below, the Company is able to estimate a reasonably possible range of loss. For such matters where a loss is believed to be reasonably possible, but not probable, no accrual has been made. As of September 30, 2016, the Company estimates the aggregate range of reasonably possible losses in excess of amounts accrued for these matters to be $0 to $400 million.

Matters as to Which an Estimate Cannot Be Made

For other matters disclosed below, the Company is not currently able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts, and the progress of settlement negotiations. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation contingencies and updates its accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews.

Asbestos-Related Claims

MLIC is and has been a defendant in a large number of asbestos-related suits filed primarily in state courts. These suits principally allege that the plaintiff or plaintiffs suffered personal injury resulting from exposure to asbestos and seek both actual and punitive damages. MLIC has never engaged in the business of manufacturing, producing, distributing or selling asbestos or asbestos-containing products nor has MLIC issued liability or workers’ compensation insurance to companies in the business of manufacturing, producing, distributing or selling asbestos or asbestos-containing products. The lawsuits principally have focused on allegations with respect to certain research, publication and other activities of one or more of MLIC’s employees during the period from the 1920’s through approximately the 1950’s and allege that MLIC learned or should have learned of certain health risks posed by asbestos and, among other things, improperly publicized or failed to disclose those health risks. MLIC believes that it should not have legal liability in these cases. The outcome of most asbestos litigation matters, however, is uncertain and can be impacted by numerous variables, including differences in legal rulings in various jurisdictions, the nature of the alleged injury and factors unrelated to the ultimate legal merit of the claims asserted against MLIC. MLIC employs a number of resolution strategies to manage its asbestos loss exposure, including seeking resolution of pending litigation by judicial rulings and settling individual or groups of claims or lawsuits under appropriate circumstances.

Claims asserted against MLIC have included negligence, intentional tort and conspiracy concerning the health risks associated with asbestos. MLIC’s defenses (beyond denial of certain factual allegations) include that: (i) MLIC owed no duty to the plaintiffs— it had no special relationship with the plaintiffs and did not manufacture, produce, distribute or sell the asbestos products that allegedly injured plaintiffs; (ii) plaintiffs did not rely on any actions of MLIC; (iii) MLIC’s conduct was not the cause of the plaintiffs’ injuries; (iv) plaintiffs’ exposure occurred after the dangers of asbestos were known; and (v) the applicable time with respect to filing suit has expired. During the course of the litigation, certain trial courts have granted motions dismissing claims against MLIC, while other trial courts have denied MLIC’s motions. There can be no assurance that MLIC will receive favorable decisions on motions in the future. While most cases brought to date have settled, MLIC intends to continue to defend aggressively against claims based on asbestos exposure, including defending claims at trials.

As reported in the 2015 Annual Report, MLIC received approximately 3,856 asbestos-related claims in 2015. During the nine months endedSeptember 30, 2016 and 2015, MLIC received approximately 3,267 and 2,971 new asbestos-related claims, respectively. See Note 21 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report for historical information concerning asbestos claims and MLIC’s increase in its recorded liability at December 31, 2014. The number of asbestos cases that may be brought, the aggregate amount of any liability that MLIC may incur, and the total amount paid in settlements in any given year are uncertain and may vary significantly from year to year.

84

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

15. Contingencies, Commitments and Guarantees (continued)

The ability of MLIC to estimate its ultimate asbestos exposure is subject to considerable uncertainty, and the conditions impacting its liability can be dynamic and subject to change. The availability of reliable data is limited and it is difficult to predict the numerous variables that can affect liability estimates, including the number of future claims, the cost to resolve claims, the disease mix and severity of disease in pending and future claims, the impact of the number of new claims filed in a particular jurisdiction and variations in the law in the jurisdictions in which claims are filed, the possible impact of tort reform efforts, the willingness of courts to allow plaintiffs to pursue claims against MLIC when exposure to asbestos took place after the dangers of asbestos exposure were well known, and the impact of any possible future adverse verdicts and their amounts.

The ability to make estimates regarding ultimate asbestos exposure declines significantly as the estimates relate to years further in the future. In the Company’s judgment, there is a future point after which losses cease to be probable and reasonably estimable. It is reasonably possible that the Company’s total exposure to asbestos claims may be materially greater than the asbestos liability currently accrued and that future charges to income may be necessary. While the potential future charges could be material in the particular quarterly or annual periods in which they are recorded, based on information currently known by management, management does not believe any such charges are likely to have a material effect on the Company’s financial position.

The Company believes adequate provision has been made in its consolidated financial statements for all probable and reasonably estimable losses for asbestos-related claims. MLIC’s recorded asbestos liability is based on its estimation of the following elements, as informed by the facts presently known to it, its understanding of current law and its past experiences: (i) the probable and reasonably estimable liability for asbestos claims already asserted against MLIC, including claims settled but not yet paid; (ii) the probable and reasonably estimable liability for asbestos claims not yet asserted against MLIC, but which MLIC believes are reasonably probable of assertion; and (iii) the legal defense costs associated with the foregoing claims. Significant assumptions underlying MLIC’s analysis of the adequacy of its recorded liability with respect to asbestos litigation include: (i) the number of future claims; (ii) the cost to resolve claims; and (iii) the cost to defend claims.

MLIC reevaluates on a quarterly and annual basis its exposure from asbestos litigation, including studying its claims experience, reviewing external literature regarding asbestos claims experience in the United States, assessing relevant trends impacting asbestos liability and considering numerous variables that can affect its asbestos liability exposure on an overall or per claim basis. These variables include bankruptcies of other companies involved in asbestos litigation, legislative and judicial developments, the number of pending claims involving serious disease, the number of new claims filed against it and other defendants and the jurisdictions in which claims are pending. Based upon its regular reevaluation of its exposure from asbestos litigation, MLIC has updated its liability analysis for asbestos-related claims through September 30, 2016.

Regulatory Matters

The Company receives and responds to subpoenas or other inquiries seeking a broad range of information from state regulators, including state insurance commissioners; state attorneys general or other state governmental authorities; federal regulators, including the SEC; federal governmental authorities, including congressional committees; and the Financial Industry Regulatory Authority (“FINRA”), as well as from local and national regulators and government authorities in countries outside the United States where MetLife conducts business. The issues involved in information requests and regulatory matters vary widely. The Company cooperates in these inquiries.

Law Enforcement Inquiry Regarding Mortgage Servicing

MetLife, through its affiliate MetLife Bank, National Association (“MetLife Bank”), was engaged in the origination, sale and servicing of forward and reverse residential mortgage loans from 2008 to 2013. In May 2013, MetLife Bank received a subpoena from the U.S. Department of Justice requiring production of documents relating to MetLife Bank’s payment of certain foreclosure-related expenses to law firms and business entities affiliated with law firms and relating to MetLife Bank’s supervision of such payments, including expenses submitted to the Federal National Mortgage Association, the Federal Home Loan Mortgage Corp. and the U.S. Department of Housing and Urban Development for reimbursement. In August 2013, MetLife Bank merged with MetLife Home Loans LLC (“MLHL”) with MLHL as the surviving non-bank entity. Management believes that the Company’s consolidated financial statements as a whole will not be materially affected by this matter.

85

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

15. Contingencies, Commitments and Guarantees (continued)

In the Matter of Chemform, Inc. Site, Pompano Beach, Broward County, Florida

In July 2010, the Environmental Protection Agency (“EPA”) advised MLIC that it believed payments were due under two settlement agreements, known as “Administrative Orders on Consent,” that New England Mutual Life Insurance Company signed in 1989 and 1992 with respect to the cleanup of a Superfund site in Florida (the “Chemform Site”). The EPA is requesting payment of an amount under $1 million from MLIC and a third party for past costs and an additional amount for future environmental testing costs at the Chemform Site. In September 2012, the EPA, MLIC and the third party executed an Administrative Order on Consent under which MLIC and the third party have agreed to be responsible for certain environmental testing at the Chemform Site. The Company estimates that its costs for the environmental testing will not exceed $100,000. The September 2012 Administrative Order on Consent does not resolve the EPA’s claim for past clean-up costs. The EPA may seek additional costs if the environmental testing identifies issues. The Company estimates that the aggregate cost to resolve this matter will not exceed $1 million.

Sales Practices Regulatory Matters

Regulatory authorities in a number of states and FINRA, and occasionally the SEC, have had investigations or inquiries relating to sales of individual life insurance policies or annuities or other products by MLIC, MetLife USA, NELICO, General American Life Insurance Company (“GALIC”), FMLI, and MSI. These investigations often focus on the conduct of particular financial services representatives and the sale of unregistered or unsuitable products or the misuse of client assets. Over the past several years, these and a number of investigations by other regulatory authorities were resolved for monetary payments and certain other relief, including restitution payments. The Company may continue to resolve investigations in a similar manner. The Company believes adequate provision has been made in its consolidated financial statements for all probable and reasonably estimable losses for these sales practices-related investigations or inquiries.

Sale and Replacement of Variable Annuities and FINRA Letter of Acceptance, Waiver and Consent

MSI has entered into a Letter of Acceptance, Waiver and Consent with FINRA (hereinafter, the “Letter”). In the Letter, FINRA stated that, from 2009 through 2014, MSI violated certain National Association of Securities Dealers and FINRA rules in connection with replacements of certain variable annuities and the sale of certain riders on such annuities. MSI was censured, paid a $20 million fine and an additional $5 million to impacted customers.

Unclaimed Property Litigation

West Virginia Lawsuits

On September 20, 2012, the West Virginia Treasurer filed an action against MLIC in West Virginia state court(West Virginia ex rel. John D. Perdue v. Metropolitan Life Insurance Company, Circuit Court of Putnam County, Civil Action No. 12-C-295)alleging that MLIC violated the West Virginia Uniform Unclaimed Property Act (the “Act”), seeking to compel compliance with the Act, and seeking payment of unclaimed property, interest, and penalties. On November 14, 2012, November 21, 2012, December 28, 2012, and January 9, 2013, the Treasurer filed substantially identical suits against MetLife Investors USA, NELICO, MetLife Insurance Company of Connecticut and GALIC, respectively. On August 17, 2016, these companies and the West Virginia Treasurer reached an agreement in principle to resolve these actions.

City of Westland Police and Fire Retirement System v. MetLife, Inc., et. al. (S.D.N.Y., filed January 12, 2012)

Seeking to represent a class of persons who purchased MetLife, Inc. common shares between February 2, 2010, and October 6, 2011, the plaintiff filed a third amended complaint alleging that MetLife, Inc. and several current and former directors and executive officers of MetLife, Inc. violated the Securities Act of 1933 (“Securities Act”), as well as the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by issuing, or causing MetLife, Inc. to issue, materially false and misleading statements concerning MetLife, Inc.’s potential liability for millions of dollars in insurance benefits that should have been paid to beneficiaries or escheated to the states. Plaintiff seeks unspecified compensatory damages and other relief. The defendants intend to defend this action vigorously.

86

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

15. Contingencies, Commitments and Guarantees (continued)

City of Birmingham Retirement and Relief System v. MetLife, Inc., et al. (Circuit Court of Jefferson County, Alabama, filed July 5, 2012)

Seeking to represent a class of persons who purchased MetLife, Inc. common equity units in or traceable to a public offering in March 2011, the plaintiff filed an action alleging that MetLife, Inc., certain current and former directors and executive officers of MetLife, Inc., and various underwriters violated several provisions of the Securities Act related to the filing of the registration statement by issuing, or causing MetLife, Inc. to issue, materially false and misleading statements and/or omissions concerning MetLife, Inc.’s potential liability for millions of dollars in insurance benefits that should have been paid to beneficiaries or escheated to the states. Plaintiff seeks unspecified compensatory damages and other relief. On October 14, 2015, the court denied the defendants’ motion to dismiss the complaint. On October 28, 2016, the parties signed a stipulation of settlement agreeing to resolve this action. Plaintiff is seeking court approval of this settlement.

Total Control Accounts Litigation

Owens v. Metropolitan Life Insurance Company (N.D. Ga., filed April 17, 2014)

Plaintiff filed this putative class action lawsuit on behalf of all persons for whom MLIC established a retained asset account, known as a TCA, to pay death benefits under an Employee Retirement Income Security Act of 1974 (“ERISA”) plan. The action alleges that MLIC’s use of the TCA as the settlement option for life insurance benefits under some group life insurance policies violates MLIC’s fiduciary duties under ERISA. As damages, plaintiff seeks disgorgement of profits that MLIC realized on accounts owned by members of the putative class. On September 27, 2016, the court denied MLIC’s summary judgment motion in full and granted plaintiff’s partial summary judgment motion. The Company intends to defend this action vigorously.

Reinsurance Litigation

Robainas, et al. v. Metropolitan Life Insurance Company (S.D.N.Y., December 16, 2014)

Plaintiffs filed this putative class action lawsuit on behalf of themselves and all persons and entities who, directly or indirectly, purchased, renewed or paid premiums on life insurance policies issued by MLIC from 2009 through 2014 (the “Policies”). Two similar actions were subsequently filed,Yale v. Metropolitan Life Ins. Co. (S.D.N.Y., January 12, 2015) and International Association of Machinists and Aerospace Workers District Lodge 15 v. Metropolitan Life Ins. Co. (E.D.N.Y., February 2, 2015). Both of these actions were consolidated with the Robainas action. The consolidated complaint alleges that MLIC inadequately disclosed in its statutory annual statements that certain reinsurance transactions with affiliated reinsurance companies were collateralized using “contractual parental guarantees,” and thereby allegedly misrepresented its financial condition and the adequacy of its reserves. The lawsuit sought recovery under Section 4226 of the New York Insurance Law of a statutory penalty in the amount of the premiums paid for the Policies. On October 9, 2015, the court granted MLIC’s motion to dismiss the consolidated complaint, finding that plaintiffs lacked Article III standing because they did not allege any concrete injury as a result of the alleged conduct. Plaintiffs appealed this decision to the Second Circuit Court of Appeals.

Intoccia v. Metropolitan Life Insurance Company (S.D.N.Y., April 20, 2015)

Plaintiffs filed this putative class action on behalf of themselves and all persons and entities who, directly or indirectly, purchased, renewed or paid premiums for Guaranteed Benefits Insurance Riders attached to variable annuity contracts with MLIC from 2009 through 2015 (the “Annuities”). The court consolidatedWeilert v. Metropolitan Life Ins. Co. (S.D.N.Y., April 30, 2015) with theIntocciacase, and the consolidated, amended complaint alleges that MLIC inadequately disclosed in its statutory annual statements that certain reinsurance transactions with affiliated reinsurance companies were collateralized using “contractual parental guarantees,” and thereby allegedly misrepresented its financial condition and the adequacy of its reserves. The lawsuits seek recovery under Section 4226 of the New York Insurance Law of a statutory penalty in the amount of the premiums paid for Guaranteed Benefits Insurance Riders attached to the Annuities. The Court granted MLIC’s motion to dismiss, adopting the reasoning of theRobainas decision. Plaintiffs appealed this decision to the Second Circuit Court of Appeals.

87

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

15. Contingencies, Commitments and Guarantees (continued)

Diversified Lending Group Litigations

Hartshorne v. MetLife Inc., et al. (Los Angeles County Superior Court, filed March 25, 2015)

Plaintiffs have named MetLife, Inc., MSI and NELICO in 12 related lawsuits in California state court alleging various causes of action including multiple negligence and statutory claims relating to a Ponzi scheme involving the Diversified Lending Group (“DLG”). In August 2016, a trial of claims by one of the plaintiffs, Christine Ramirez, resulted in a verdict against MetLife, Inc., MSI, and NELICO for approximately $200 thousand in compensatory damages and $15 million in punitive damages. The Company intends to appeal this verdict.

Other Litigation

McGuire v. Metropolitan Life Insurance Company (E.D. Mich., filed February 22, 2012)

The fiduciary for the Union Carbide Employees’ Pension Plan alleged that MLIC, which issued annuity contracts to fund some of the benefits the Plan provides, engaged in transactions that ERISA prohibits and violated duties under ERISA and federal common law by determining that no dividends were payable with respect to the contracts from and after 1999. The parties have resolved this matter, and the court has dismissed the action.

Sun Life Assurance Company of Canada Indemnity Claim

In 2006, Sun Life Assurance Company of Canada (“Sun Life”), as successor to the purchaser of MLIC’s Canadian operations, filed a lawsuit in Toronto, seeking a declaration that MLIC remains liable for “market conduct claims” related to certain individual life insurance policies sold by MLIC that were subsequently transferred to Sun Life. In January 2010, the court found that Sun Life had given timely notice of its claim for indemnification but, because it found that Sun Life had not yet incurred an indemnifiable loss, granted MLIC’s motion for summary judgment. Both parties agreed to consider the indemnity claim through arbitration. In September 2010, Sun Life notified MLIC that a purported class action lawsuit was filed against Sun Life in Toronto alleging sales practices claims regarding the policies sold by MLIC and transferred to Sun Life. On August 30, 2011, Sun Life notified MLIC that another purported class action lawsuit was filed against Sun Life in Vancouver, BC alleging sales practices claims regarding certain of the same policies sold by MLIC and transferred to Sun Life. Sun Life contends that MLIC is obligated to indemnify Sun Life for some or all of the claims in these lawsuits. These sales practices cases against Sun Life are ongoing, and the Company is unable to estimate the reasonably possible loss or range of loss arising from this litigation.

Fauley v. Metropolitan Life Insurance Company, et al. (Circuit Court of the 19th Judicial Circuit, Lake County, Ill., July 3, 2014)

Plaintiffs filed this lawsuit against defendants, including MLIC and a former MetLife financial services representative, alleging that the defendants sent unsolicited fax advertisements to plaintiff and others in violation of the Telephone Consumer Protection Act, as amended by the Junk Fax Prevention Act, 47 U.S.C. § 227. The court issued a final order certifying a nationwide settlement class and approving a settlement under which MLIC has agreed to pay up to $23 million to resolve claims as to fax advertisements sent between August 23, 2008 and August 7, 2014. On March 23, 2016, the intermediate appellate court affirmed the trial court’s order. On September 28, 2016, the Illinois Supreme Court denied an objector’s petition for leave to appeal.

MetLife, Inc. v. Financial Stability Oversight Council (D. D.C., January 13, 2015)

MetLife, Inc. filed this action in U.S. District Court for the District of Columbia (“D.C. District Court”) seeking to overturn the Financial Stability Oversight Council’s (“FSOC”) designation of MetLife, Inc. as a non-bank systemically important financial institution (“non-bank SIFI”). The suit is brought under the section of the Dodd-Frank Wall Street Reform and Consumer Protection Act providing that a company designated as a non-bank SIFI may petition the federal courts for review, and seeks an order requiring that the final determination be rescinded. The D.C. District Court issued a decision on March 30, 2016 granting, in part, MetLife, Inc.’s cross motion for summary judgment and rescinding the FSOC’s designation of MetLife, Inc. as a non-bank SIFI. On April 8, 2016, the FSOC appealed the D.C. District Court’s order to the United States Court of Appeals for the District of Columbia.

88

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

15. Contingencies, Commitments and Guarantees (continued)

Voshall v. Metropolitan Life Insurance Company (Superior Court of the State of California, County of Los Angeles, April 8, 2015)

Plaintiff filed this putative class action lawsuit on behalf of himself and all persons covered under a long-term group disability income insurance policy issued by MLIC to public entities in California between April 8, 2011 and April 8, 2015. Plaintiff alleges that MLIC improperly reduced benefits by including cost of living adjustments and employee paid contributions in the employer retirement benefits and other income that reduces the benefit payable under such policies. Plaintiff asserts causes of action for declaratory relief, violation of the California Business & Professions Code, breach of contract and breach of the implied covenant of good faith and fair dealing. The Company intends to defend this action vigorously.

Martin v. Metropolitan Life Insurance Company, (Superior Court of the State of California, County of Contra Costa, filed December 17, 2015)

Plaintiffs filed this putative class action lawsuit on behalf of themselves and all California persons who have been charged compound interest by MLIC in life insurance policy and/or premium loan balances within the last four years. Plaintiffs allege that MLIC has engaged in a pattern and practice of charging compound interest on life insurance policy and premium loans without the borrower authorizing such compounding, and that this constitutes an unlawful business practice under California law. Plaintiff asserts causes of action for declaratory relief, violation of California’s Unfair Competition Law and Usury Law, and unjust enrichment. Plaintiff seeks declaratory and injunctive relief, restitution of interest, and damages in an unspecified amount. On April 12, 2016, the court granted MLIC’s motion to dismiss. Plaintiffs have filed a notice appealing this ruling.

Lau v. Metropolitan Life Insurance Company (S.D.N.Y. filed, December 3, 2015)

This putative class action lawsuit was filed by a single defined contribution plan participant on behalf of all ERISA plans whose assets were invested in MetLife’s “Group Annuity Contract Stable Value Funds” within the past six years. The suit alleges breaches of fiduciary duty under ERISA and challenges the “spread” with respect to the stable value fund group annuity products sold to retirement plans. The allegations focus on the methodology MetLife uses to establish and reset the crediting rate, the terms under which plan participants are permitted to transfer funds from a stable value option to another investment option, the procedures followed if an employer terminates a contract, and the level of disclosure provided. Plaintiff seeks declaratory and injunctive relief, as well as damages in an unspecified amount. The Company intends to defend this action vigorously.

Newman v. Metropolitan Life Insurance Company (N.D. Ill., filed March 23, 2016)

Plaintiff filed this putative class action alleging causes of action for breach of contract, fraud, and violations of the Illinois Consumer Fraud and Deceptive Business Practices Act, based on MLIC’s class-wide increase in premiums charged for long-term care insurance policies. Plaintiff alleges a class consisting of herself and all persons over age 65 who selected a Reduced Pay at Age 65 payment feature and whose premium rates were increased after age 65. Plaintiff asserts that premiums could not be increased for these class members and/or that marketing material was misleading as to MLIC’s right to increase premiums. Plaintiff seeks unspecified compensatory, statutory and punitive damages as well as recessionary and injunctive relief. The Company intends to defend this action vigorously.

Thrivent Financial for Lutherans v. MetLife Insurance Company USA, (E.D. Wis., filed September 12, 2016)

Plaintiff filed a complaint against MetLife USA contending that MetLife’s use of the Brighthouse Financial trademark and logo will infringe on its trademarks. Alleging violations of federal and state law, plaintiff seeks preliminary and permanent injunctions, compensatory damages, and other relief. MetLife USA intends to defend this action vigorously.

Sales Practices Claims

Over the past several years, the Company has faced numerous claims, including class action lawsuits, alleging improper marketing or sales of individual life insurance policies, annuities, mutual funds, other products or the misuse of client assets. Some of the current cases seek substantial damages, including punitive and treble damages and attorneys’ fees. The Company continues to defend vigorously against the claims in these matters. The Company believes adequate provision has been made in its consolidated financial statements for all probable and reasonably estimable losses for sales practices matters.

89

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

15. Contingencies, Commitments and Guarantees (continued)

Summary

Putative or certified class action litigation and other litigation and claims and assessments against the Company, in addition to those discussed previously and those otherwise provided for in the Company’s consolidated financial statements, have arisen in the course of the Company’s business, including, but not limited to, in connection with its activities as an insurer, mortgage lending bank, employer, investor, investment advisor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company’s compliance with applicable insurance and other laws and regulations.

It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings. In some of the matters referred to previously, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Although in light of these considerations it is possible that an adverse outcome in certain cases could have a material effect upon the Company’s financial position, based on information currently known by the Company’s management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company’s consolidated net income or cash flows in particular quarterly or annual periods.

Commitments

Mortgage Loan Commitments

The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $4.0 billion and $4.4 billion at September 30, 2016 and December 31, 2015, respectively.

Commitments to Fund Partnership Investments, Bank Credit Facilities, Bridge Loans and Private Corporate Bond Investments

The Company commits to fund partnership investments and to lend funds under bank credit facilities, bridge loans and private corporate bond investments. The amounts of these unfunded commitments were $8.6 billion and $7.1 billion at September 30, 2016 and December 31, 2015, respectively.

Guarantees

In the normal course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties such that it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other specific liabilities and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemnifications to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third-party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation ranging from less than $1 million to $329 million, with a cumulative maximum of $1.2 billion, while in other cases such limitations are not specified or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future. Management believes that it is unlikely the Company will have to make any material payments under these indemnities, guarantees, or commitments.

In addition, the Company indemnifies its directors and officers as provided in its charters and by-laws. Also, the Company indemnifies its agents for liabilities incurred as a result of their representation of the Company’s interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these indemnities in the future.

The Company has also minimum fund yield requirements on certain international pension funds in accordance with local laws. Since these guarantees are not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future.

The Company’s recorded liabilities were $9 million and $8 million at September 30, 2016 and December 31, 2015, respectively, for indemnities, guarantees and commitments.

90

MetLife, Inc.

Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)

16. Subsequent Event

Common Stock Dividend

On October 25, 2016, the MetLife, Inc. Board of Directors declared a fourth quarter 2016 common stock dividend of$0.40 per share payable on December 13, 2016 to shareholders of record as of November 7, 2016. The Company estimates that the aggregate dividend payment will be$441 million.

91

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations

	Page
Forward-Looking Statements and Other Financial Information	93
Executive Summary	93
Industry Trends	99
Summary of Critical Accounting Estimates	105
Economic Capital	108
Acquisitions and Dispositions	108
Results of Operations	109
Investments	137
Derivatives	153
Off-Balance Sheet Arrangements	156
Policyholder Liabilities	157
Liquidity and Capital Resources	166
Adoption of New Accounting Pronouncements	178
Future Adoption of New Accounting Pronouncements	178
Non-GAAP and Other Financial Disclosures	178
Subsequent Events	180

92

Forward-Looking Statements and Other Financial Information

For purposes of this discussion, “MetLife,” the “Company,” “we,” “our” and “us” refer to MetLife, Inc., a Delaware corporation incorporated in 1999, its subsidiaries and affiliates. Following this summary is a discussion addressing the consolidated results of operations and financial condition of the Company for the periods indicated. This discussion should be read in conjunction with MetLife, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2015 (the “2015 Annual Report”), the cautionary language regarding forward-looking statements included below, the “Risk Factors” set forth in Part II, Item 1A, and the additional risk factors referred to therein, “Quantitative and Qualitative Disclosures About Market Risk” and the Company’s interim condensed consolidated financial statements included elsewhere herein.

This Management’s Discussion and Analysis of Financial Condition and Results of Operations may contain or incorporate by reference information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give expectations or forecasts of future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They use words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” and other words and terms of similar meaning, or are tied to future periods, in connection with a discussion of future operating or financial performance. In particular, these include statements relating to future actions, prospective services or products, future performance or results of current and anticipated services or products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, trends in operations and financial results. Any or all forward-looking statements may turn out to be wrong. Actual results could differ materially from those expressed or implied in the forward-looking statements. See “Note Regarding Forward-Looking Statements.”

This Management’s Discussion and Analysis of Financial Condition and Results of Operations includes references to our performance measures, operating earnings and operating earnings available to common shareholders, that are not based on accounting principles generally accepted in the United States of America (“GAAP”). These measures are used by management to evaluate performance and allocate resources. Consistent with GAAP guidance for segment reporting, operating earnings is also our GAAP measure of segment performance. Operating earnings and other financial measures based on operating earnings are also the measures by which senior management’s and many other employees’ performance is evaluated for the purposes of determining their compensation under applicable compensation plans. Operating earnings and other financial measures based on operating earnings allow analysis of our performance relative to our business plan and facilitate comparisons to industry results. Forward-looking guidance provided on a non-GAAP basis cannot be reconciled to the most directly comparable GAAP measures on a forward-looking basis because net income may fluctuate significantly if net investment gains and losses and net derivative gains and losses move outside of estimated ranges. See “— Non-GAAP and Other Financial Disclosures” for definitions and a discussion of these measures, and “— Results of Operations” for reconciliations of historical non-GAAP measures to the most directly comparable GAAP measures.

Executive Summary

Overview

MetLife is a global provider of life insurance, annuities, employee benefits and asset management. In anticipation of the Company’s plan to separate a substantial portion of its former Retail segment, as well as certain portions of its former Corporate Benefit Funding segment and Corporate & Other (the “Separation”), in the third quarter of 2016, MetLife reorganized its businesses into six segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa (“EMEA”); MetLife Holdings; and Brighthouse Financial. In addition, the Company reports certain of its results of operations in Corporate & Other. See “— Other Key Information — Segment Information” and Note 2 of the Notes to the Interim Condensed Consolidated Financial Statements for further information on the Company’s segments and Corporate & Other. See also “— Other Key Information — Significant Events” for information on the Separation. Management continues to evaluate the Company’s segment performance and allocated resources and may adjust related measurements in the future to better reflect segment profitability.

Current Period Highlights

During the three months ended September 30, 2016, overall sales growth increased as compared to the three months ended September 30, 2015 as we experienced sales growth across certain products within our segments. In addition, positive net flows drove an increase in our investment portfolio. Our results for the quarter reflect a write-off of deferred policy acquisition costs (“DAC”) and an increase in our insurance-related liabilities due to loss recognition testing upon re-segmentation, as well as charges related to a goodwill impairment.

93

The following represents the segments’ contributions to total net income (loss) and total operating earnings for the nine months ended September 30, 2016:

__________________

(1) Excludes Corporate & Other.

(2) Stacked column chart reflects the contribution to total net income (loss) for each of the segments for the nine months ended September 30, 2016, including the net loss reflected in the Brighthouse Financial segment.

(3) See “— Results of Operations — Consolidated Results” and “— Non-GAAP and Other Financial Disclosures” for reconciliations and definitions of non-GAAP financial measures.

94

Three Months EndedSeptember 30, 2016 Compared with the Three Months EndedSeptember 30, 2015

			Consolidated Results - Highlights
			Net income (loss) down $625 million:
			•	Unfavorable net derivative gains (losses) of$1.5 billion ($998 million, net of income tax) driven by changes in interest rates
			•	Goodwill impairment charge of $260 million ($223 million, net of income tax)
			•	Operating earnings available to common shareholders up $716 million
(1) See “— Results of Operations — Consolidated Results” and “— Non-GAAP and Other Financial Disclosures” for reconciliations and definitions of non-GAAP financial measures.
Consolidated Results - Operating Highlights
Operating earnings available to common shareholders up $716 million:
•	Results of operations were impacted by lower tax and related interest expenses and higher net investment income from portfolio growth, partially offset by refinements made to DAC and certain insurance-related liabilities, as well as unfavorable underwriting.
•	Our results for the three months ended September 30, 2016 included the following:
	•	a $296 million, net of income tax, charge from the re-segmentation of our business, driven by the Brighthouse Financial segment’s variable and universal life policies. Of this amount, the Company recorded $254 million, net of income tax, as a one-time charge, which was mostly recognized as a write-off of DAC, with the remaining $42 million, net of income tax, recognized as an increase in insurance-related liabilities.
•	Our results for the three months ended September 30, 2015 included the following:
	•	a $557 million one-time tax charge and a $362 million ($235 million, net of income tax) one-time charge for interest on uncertain tax positions that were recorded under accounting guidance for the recognition of tax uncertainties related to the U.S. tax treatment of taxes paid by a wholly-owned United Kingdom (“U.K.”) investment subsidiary of Metropolitan Life Insurance Company (“MLIC”)
	•	a $60 million one-time tax benefit related to the restructuring of our business in Chile

For a more in-depth discussion of our consolidated results, see “— Results of Operations — Consolidated Results” and “— Results of Operations — Consolidated Results — Operating.”

95

Nine Months Ended September 30, 2016 Compared with the Nine Months Ended September 30, 2015

			Consolidated Results – Highlights
			Net income (loss) down $1.6 billion:
			•	Unfavorable net derivative gains (losses) of$2.2 billion ($1.4 billion, net of income tax) driven by the impact of the second quarter 2016 annual actuarial assumption review on certain variable annuity products that contain embedded derivatives, partially offset by changes in interest rates, foreign currency exchange rates, and a favorable change on the nonperformance risk adjustment on embedded derivatives
			•	Operating earnings available to common shareholders down $434 million
			•	Goodwill impairment charge of $260 million ($223 million, net of income tax)
			•	Current period includes the financial impact of converting the Company’s Japan operations to calendar year-end reporting without retrospective application of this change to prior periods
(1) See “— Results of Operations — Consolidated Results” and “— Non-GAAP and Other Financial Disclosures” for reconciliations and definitions of non-GAAP financial measures.
Consolidated Results - Operating Highlights
Operating earnings available to common shareholders down $434 million:
•	Results of operations were impacted by lower investment yields, refinements made to DAC and certain insurance-related liabilities, unfavorable underwriting and the impact of our annual actuarial assumption review, partially offset by lower tax and related interest expenses and higher net investment income from portfolio growth.
•	Our results for the nine months ended September 30, 2016 included the following:
	•	a $296 million, net of income tax, charge from the re-segmentation of our business, driven by the Brighthouse Financial segment’s variable and universal life policies. Of this amount, the Company recorded $254 million, net of income tax, as a one-time charge, which was mostly recognized as a write-off of DAC, with the remaining $42 million, net of income tax, recognized as an increase in insurance-related liabilities.
	•	unfavorable reserve adjustments of $257 million, net of income tax, resulting from modeling improvements in the reserving process
	•	unfavorable DAC unlockings of $161 million, net of income tax, related to our second quarter 2016 annual actuarial assumption review of our U.S. variable annuity business
	•	one-time charge of $44 million, net of income tax, related to an adjustment to reinsurance receivables in Australia
	•	tax benefit in Japan of $25 million related to a change in tax rate, which includes a one-time benefit of $20 million that pertains to prior periods
	•	tax charge in Chile of $12 million as a result of tax reform legislation, which includes a one-time charge of $10 million that pertains to prior periods
•	Our results for the nine months ended September 30, 2015 included the following:
	•	the aforementioned $557 million one-time tax charge and the aforementioned $362 million ($235 million, net of income tax) one-time charge for interest on uncertain tax positions
	•	a $60 million one-time tax benefit related to the restructuring of our business in Chile
	•	a $61 million one-time tax benefit in Japan related to a change in tax rate

96

Consolidated Company Outlook

As part of an enterprise-wide strategic initiative, we announced that, by 2016, we expected to increase our operating return on common stockholders’ equity (“operating ROE”), excluding accumulated other comprehensive income (“AOCI”) other than foreign currency translation adjustments (“FCTA”), driven by higher operating earnings. In 2016, we expect our operating ROE, excluding AOCI other than FCTA, to be lower than 11% due to unfavorable market factors, our current year reserve adjustments from modeling improvements and the effect of our annual variable annuity actuarial assumption review, as well as the activities associated with the proposed Separation of our U.S. retail business.

We believe that many of MetLife’s financial and business characteristics following the Separation will shift favorably and may be reflected in several important metrics, including an improvement in our operating ROE after the costs of the Separation are eliminated.

When making projections, we must rely on the accuracy of our assumptions about future economic and business conditions, which can be affected by known and unknown risks and other uncertainties. Our assumptions have been and will continue to be impacted by (i) MetLife, Inc.’s plan to pursue the Separation, (ii) regulatory uncertainty regarding capital requirements that would have been applicable to us as a result of the Financial Stability Oversight Council’s (“FSOC”) former designation of MetLife, Inc. as a non-bank systemically important financial institution (“non-bank SIFI”), which, among other things, impacted the level of our share repurchases, (iii) lower investment margins (primarily in the U.S.) as a result of the sustained low interest rate environment, (iv) lower than anticipated merger and acquisition activity, and (v) the impact on our foreign operations of the strengthening of the U.S. dollar. See “— Other Key Information — Significant Events” for information regarding the Separation, the sale to Massachusetts Mutual Life Insurance Company (“MassMutual”) of MetLife’s U.S. retail advisor force and certain assets associated with the MetLife Premier Client Group, including all of the issued and outstanding shares of MetLife’s affiliated broker-dealer, MetLife Securities, Inc. (“MSI”), a wholly-owned subsidiary of MetLife, Inc. (the “U.S. Retail Advisor Force Divestiture”), and the determination by the U.S. District Court for the District of Columbia (“D.C. District Court”) on March 30, 2016 to rescind the FSOC’s designation of MetLife, Inc. as a non-bank SIFI.

We have engaged and expect to continue to engage in a number of Separation-related transactions that will impact our holding companies’ liquid assets. Further, we have increased and expect to continue to increase our holding companies’ liquid assets over time as a result of (i) $291 million in cash proceeds that we received from the U.S. Retail Advisor Force Divestiture; (ii) dividends in the range of $3.3 billion to $3.8 billion that we expect to receive from Brighthouse (which may be partially funded by the issuance of debt by Brighthouse) and a MetLife-affiliated reinsurance company prior to the Separation; and (iii) proceeds from the disposition of our retained shares of Brighthouse common stock that we expect to receive over time. We expect our holding companies’ liquid assets to decrease in the second half of 2016 as a result of Separation-related items of approximately $1.5 billion consisting of foregone dividends, foregone incremental debt, and expenses to be incurred to effectuate the Separation. In addition to these Separation-related items, we expect to have cash commitments of between $1.0 billion and $2.0 billion over the two-year period of 2017 and 2018 relating to liability management transactions, including the repayment of certain debt maturities. Following the Separation, we plan to maintain a liquidity buffer of $3.0 to $4.0 billion of liquid assets at the holding companies.

Excluding the impact of the above Separation-related items occurring in 2016, we anticipate that our ratio of free cash flow to operating earnings, adjusting for notable items, for the year ended December 31, 2016 will be at or above the high end of a range of 55% to 65%. We expect the average ratio of free cash flow to operating earnings over the two-year period of 2017 and 2018, excluding the impact of the Separation, to be 65% to 75%. This expectation reflects our unit cost improvement program announced earlier this year and the related initiative to invest $1 billion by 2020 to generate $800 million pre-tax run rate annual savings, net of stranded overhead. It also assumes interest rates follow the observable forward yield curves as of August 30, 2016. We expect Separation-related events to occur in both 2016 and 2017 and, accordingly, we may adjust free cash flow in both years for such notable items. We believe that free cash flow is the key determinant of dividends and share repurchases.

97

Other Key Information

Basis of Presentation

Prior to January 1, 2016, certain international subsidiaries had a fiscal year cutoff of November 30th. Accordingly, the Company’s interim condensed consolidated financial statements reflect the assets and liabilities of such subsidiaries as of November 30, 2015 and the operating results of such subsidiaries for the three months and nine months ended August 31, 2015. Effective January 1, 2016, the Company converted its Japan operations to calendar year-end reporting. The elimination of a one-month reporting lag of a subsidiary is considered a change in accounting principle and requires retrospective application. While the Company believes that eliminating the lag in the reporting of its Japan operations was preferable in order to consistently reflect events, economic conditions and global trends in the financial statements, the Company determined that it was impracticable to apply the effects of the lag elimination to financial reporting periods prior to January 1, 2015. The effect of not retroactively applying this change in accounting, however, was not material to the 2015 or 2016 consolidated financial statements. Therefore, the Company reported the cumulative effect of the change in accounting principle in net income for the three months ended March 31, 2016 and the nine months ended September 30, 2016 and did not retrospectively apply the effects of this change to prior periods. See Note 2 of the Notes to the Interim Condensed Consolidated Financial Statements.

Segment Information

Based on the proposed Separation, in the third quarter of 2016, the Company reorganized its businesses as follows:

• The businesses the Company plans to separate and include in Brighthouse Financial are reflected in a new segment, Brighthouse Financial.

• The businesses formerly in the Retail segment, but that the Company does not plan to include in the Brighthouse Financial segment, are reflected in a new segment, MetLife Holdings. This segment also includes the long-term care business, formerly reported as part of the Group, Voluntary & Worksite Benefit (“GVWB”) segment, and the reinsurance treaty relating to the former Japan joint venture, previously reported in Corporate & Other.

• The Property & Casualty business, the Retirement & Income Solutions business (which represents most of the segment formerly known as Corporate Benefit Funding), and the Group Benefits business (consisting of the remaining components of the GVWB business, including the individual disability insurance business previously reported in the former Retail segment), are reflected in a new segment, U.S.

• The U.S. Direct business, previously reported as part of the Latin America segment, has been disaggregated and reported in the new U.S. segment and in Corporate & Other.

• The Asia and EMEA segments remain unchanged.

These changes were applied retrospectively and did not have an impact on total consolidated net income or operating earnings in the prior periods. See Note 2 of the Notes to the Interim Condensed Consolidated Financial Statements for further information on the Company’s segments.

This re-segmentation resulted in a $296 million, net of income tax, charge to earnings in the current period, all in the Brighthouse Financial segment, driven by the segment’s variable and universal life products. This charge is the direct result of the Company, beginning in the third quarter, no longer being able to aggregate, for loss recognition testing, the variable and universal life products of Brighthouse Financial with the variable and universal life products remaining with MetLife Holdings. Of this amount, the Company recorded $254 million, net of income tax, as a one-time charge, which was mostly recognized as a write-off of DAC, with the remaining $42 million, net of income tax, recognized as an increase in insurance-related liabilities. The ongoing impact to Brighthouse Financial from the loss of aggregation benefit is expected to be approximately $40 million, net of income tax, per quarter, gradually declining over time.

Significant Events

In July 2016, MetLife, Inc. completed the U.S. Retail Advisor Force Divestiture for $291 million. MassMutual assumed all of the liabilities related to such assets that arise or occur at or after the closing of the sale. As part of the transactions, MetLife, Inc. and MassMutual entered into a product development agreement under which MetLife’s U.S. retail business will be the exclusive developer of certain annuity products to be issued by MassMutual. In the MassMutual purchase agreement, MetLife, Inc. agreed to indemnify MassMutual for certain claims, liabilities and breaches of representations and warranties up to limits described in the purchase agreement. See Note 3 of the Notes to the Interim Condensed Consolidated Financial Statements for further information.

98

On December 18, 2014, the FSOC designated MetLife, Inc. as a non-bank SIFI subject to regulation by the Board of Governors of the Federal Reserve System (the “Federal Reserve Board”) and the Federal Reserve Bank of New York (collectively with the Federal Reserve Board, the “Federal Reserve”) and the Federal Deposit Insurance Corporation (the “FDIC”), as well as to enhanced supervision and prudential standards. On March 30, 2016, the D.C. District Court ordered that the designation of MetLife, Inc. as a non-bank SIFI by the FSOC be rescinded. On April 8, 2016, the FSOC appealed the D.C. District Court’s order to the United States Court of Appeals for the District of Columbia. If the FSOC prevails on appeal or designates MetLife, Inc. as systemically important as part of its ongoing review of non-bank financial companies, MetLife, Inc. could once again be subject to regulation as a non-bank SIFI. See “Business — U.S. Regulation — Regulation as a Non-Bank SIFI” in the 2015 Annual Report, as amended or supplemented in our subsequently filed Quarterly Reports on Form 10-Q under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Industry Trends — Regulatory Developments” and similarly named sections under the caption “Risk Factors.”

On January 12, 2016, MetLife, Inc. announced its plan to pursue the Separation. Additionally, on July 21, 2016, MetLife, Inc. announced that, following the Separation, the separated business will be rebranded as “Brighthouse Financial.” On October 5, 2016, Brighthouse Financial, Inc., a subsidiary of MetLife, Inc. (“Brighthouse”), filed a registration statement on Form 10 (the “Form 10”) with the U.S. Securities and Exchange Commission (“SEC”). The information statement filed as an exhibit to the Form 10 disclosed that the Company intends to include MetLife Insurance Company USA (“MetLife USA”), New England Life Insurance Company (“NELICO”), First MetLife Investors Insurance Company, MetLife Advisers, LLC and certain captive reinsurance companies in the proposed separated business and distribute at least 80.1% of the shares of Brighthouse’s common stock on apro ratabasis to the holders of MetLife, Inc. common stock. The ultimate form and timing of the Separation will be influenced by a number of factors, including regulatory considerations and economic conditions. MetLife continues to evaluate and pursue structural alternatives for the proposed Separation. MetLife expects that the life insurance closed block and the life and annuity business sold through MLIC will not be a part of Brighthouse Financial. The Separation remains subject to certain conditions including, among others, obtaining final approval from the MetLife, Inc. Board of Directors, receipt of a favorable ruling from the Internal Revenue Service (“IRS”) and an opinion from MetLife’s tax advisor regarding certain U.S. federal income tax matters, and an SEC declaration of the effectiveness of the Form 10.

Industry Trends

The following information on industry trends should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Industry Trends” in Part II, Item 7, of the 2015 Annual Report.

We continue to be impacted by the unstable global financial and economic environment that has been affecting the industry.

Financial and Economic Environment

Our business and results of operations are materially affected by conditions in the global capital markets and the economy generally. Stressed conditions, volatility and disruptions in global capital markets, particular markets, or financial asset classes can have an adverse effect on us, in part because we have a large investment portfolio and our insurance liabilities are sensitive to changing market factors.

Weakness in the energy and metals and mining sectors and concerns about the political and/or economic stability in the U.K., Brazil, Turkey, Russia, Ukraine, China, Japan, the Middle East and Puerto Rico, as well as Portugal, Ireland, Italy, Greece and Spain (“Europe’s perimeter region”) and Cyprus have contributed to global market volatility. See “— Investments — Current Environment — Selected Country and Sector Investments.” Events following the U.K.’s referendum on June 23, 2016 and the uncertainties associated with its pending withdrawal from the European Union (“EU”) have also contributed to market volatility. The risk of market volatility may spread beyond the U.K. and the uncertainties associated with its pending withdrawal from the EU could be intensified by foreign exchange risks. These factors could contribute to weakening gross domestic product (“GDP”) growth, primarily in the U.K. and Europe. The magnitude and longevity of the potential negative economic impacts would depend on the detailed agreements reached by the U.K. and the EU as a result of the exit negotiations and negotiations regarding trade and other arrangements.

99

Concerns about global economic conditions, capital markets and the solvency of certain EU member states, including Europe’s perimeter region, their banking systems and the financial institutions that have significant direct or indirect exposure to debt issued by these countries or their respective banking systems, have also been a cause of elevated levels of market volatility. See “— Investments — Current Environment” for information regarding our exposure to obligations of European governments, European private obligors and Europe’s perimeter region. Contributing to such volatility are concerns that such countries could default on their obligations, have to restructure their outstanding debt, or that financial institutions with significant holdings of sovereign or private debt of such countries, including Europe’s perimeter region, could experience financial stress, any of which could have significant adverse effects on the European and global economies and on financial markets, generally. While economic conditions in certain of these countries, including Europe’s perimeter region, seem to be stabilizing or improving, there is still concern that any support measures, including those made by the European Central Bank (“ECB”) to lessen the risk of deflation, lower borrowing costs in the Euro zone and encourage corporations to issue more asset-backed securities, could affect the Euro exchange rate and have uncertain impacts on interest rates and risk markets. See “Risk Factors — Economic Environment and Capital Markets-Related Risks — We Are Exposed to Significant Global Financial and Capital Markets Risks Which May Adversely Affect Our Results of Operations, Financial Condition and Liquidity, and May Cause Our Net Investment Income to Vary from Period to Period,” and “Risk Factors — Economic Environment and Capital Markets-Related Risks — If Difficult Conditions in the Global Capital Markets and the Economy Generally Persist, They May Materially Adversely Affect Our Business and Results of Operations” in the 2015 Annual Report, as amended or supplemented in our subsequently filed Quarterly Reports on Form 10-Q in similarly named sections under the caption “Risk Factors.”

We face substantial exposure to the Japanese economy given our operations there. Structural weaknesses and debt sustainability have yet to be addressed effectively. Going forward, Japan’s structural and demographic challenges may continue to limit its potential growth unless reforms that boost productivity are put into place. Japan’s high public sector debt levels are mitigated by low refinancing risks and its nominal yields on government debt have remained at a lower level than that of any other developed country. However, frequent changes in government have prevented policy makers from implementing fiscal reform measures to put public finances on a sustainable path. To avert deflation and to achieve sustainable economic growth, the government and the Bank of Japan have implemented a coordinated strategy which includes the imposition of a negative rate on commercial bank deposits, continued government bond purchases and tax reform, including the lowering of the Japanese corporate tax rate and the delay until 2019 of an increase in the consumption tax to 10%. As a result of the decrease in the corporate tax rate, the Company recorded a one-time benefit of $174 million in the second quarter of 2015, which included an increase in Asia’s operating earnings of $61 million.

Impact of a Sustained Low Interest Rate Environment

As a global insurance company, we are affected by the monetary policy of central banks around the world, as well as the monetary policy of the Federal Reserve Board in the United States. The Federal Reserve Board has taken a number of actions in recent years to spur economic activity, including asset purchases and keeping interest rates low. However, in December 2015, the Federal Reserve Board’s Federal Open Market Committee (“FOMC”) increased the federal funds rate for the first time in 10 years and has held it steady since then. Further increases in the federal funds rate in the future may affect interest rates and risk markets in the U.S. and other developed and emerging economies. See “— Financial and Economic Environment” for information regarding accommodative and other policy measures pursued by the ECB and the Bank of Japan. However, we cannot predict with certainty the effect of these programs and policies on interest rates or the impact on the pricing levels of risk-bearing investments at this time. See “— Investments — Current Environment.”

During periods of declining interest rates, we may have to invest insurance cash flows and reinvest the cash flows we received as interest or return of principal on our investments in lower yielding instruments. Moreover, borrowers may prepay or redeem the fixed income securities, commercial, agricultural or residential mortgage loans and mortgage-backed securities in our investment portfolio with greater frequency in order to borrow at lower market rates. Therefore, some of our products expose us to the risk that a reduction in interest rates will reduce the difference between the amounts that we are required to credit on contracts in our general account and the rate of return we are able to earn on investments intended to support obligations under these contracts. This difference between interest earned and interest credited, or margin, is a key metric for the management of, and reporting for, many of our businesses.

Our expectations regarding future margins are an important component impacting the amortization of certain intangible assets such as DAC and value of business acquired (“VOBA”). Significantly lower margins may cause us to accelerate the amortization, thereby reducing net income in the affected reporting period. Additionally, lower margins may also impact the recoverability of intangible assets such as goodwill, require the establishment of additional liabilities or trigger loss recognition events on certain policyholder liabilities. We review this long-term margin assumption, along with other assumptions, as part of our annual assumption review.

100

Competitive Pressures

The life insurance industry remains highly competitive. The product development and product life cycles have shortened in many product segments, leading to more intense competition with respect to product features. Larger companies have the ability to invest in brand equity, product development, technology and risk management, which are among the fundamentals for sustained profitable growth in the life insurance industry. In addition, several of the industry’s products can be quite homogeneous and subject to intense price competition. Sufficient scale, financial strength and financial flexibility are becoming prerequisites for sustainable growth in the life insurance industry. Larger market participants tend to have the capacity to invest in additional distribution capability and the information technology needed to offer the superior customer service demanded by an increasingly sophisticated industry client base. We believe that the continued volatility of the financial markets, its impact on the capital position of many competitors, and subsequent actions by regulators and rating agencies have altered the competitive environment. In particular, we believe that these factors have highlighted financial strength as the most significant differentiator from the perspective of some customers and certain distributors. We believe the Company is well positioned to compete in this environment.

Regulatory Developments

In the U.S., our life insurance companies are regulated primarily at the state level, with some products and services also subject to federal regulation. In addition, MetLife, Inc. and its U.S. insurance subsidiaries are subject to regulation under the insurance holding company laws of various U.S. jurisdictions. Furthermore, some of MetLife’s operations, products and services are subject to consumer protection laws, securities, broker-dealer and investment adviser regulations, environmental and unclaimed property laws and regulations, and to the Employee Retirement Income Security Act of 1974 (“ERISA”). If MetLife, Inc. were re-designated as a non-bank SIFI, it could also be subject to regulation by the Federal Reserve and the FDIC. See “— U.S. Regulation” below, as well as “Business — Regulation — U.S. Regulation,” “Risk Factors — Regulatory and Legal Risks — Our Insurance and Brokerage Businesses Are Highly Regulated, and Changes in Regulation and in Supervisory and Enforcement Policies May Reduce Our Profitability and Limit Our Growth,” “Risk Factors — Risks Related to Our Business — Our Statutory Life Insurance Reserve Financings May Be Subject to Cost Increases and New Financings May Be Subject to Limited Market Capacity,” and “Risk Factors — Regulatory and Legal Risks — Changes in U.S. Federal, State Securities and State Insurance Laws and Regulations May Affect Our Operations and Our Profitability” included in the 2015 Annual Report, as amended or supplemented in our subsequently filed Quarterly Reports on Form 10-Q under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Industry Trends — Regulatory Developments” and similarly named sections under the caption “Risk Factors.”

Our international insurance operations are principally regulated by insurance regulatory authorities in the jurisdictions in which they are located or operate. In addition, our investment and pension companies outside of the U.S. are subject to oversight by the relevant securities, pension and other authorities of the countries in which the companies operate. Our non-U.S. insurance businesses are also subject to current and developing solvency regimes which impose various capital and other requirements. As a global systemically important insurer (“G-SII”), MetLife, Inc. may also become subject to additional capital requirements. See “— International Regulation” below, as well as “Business — Regulation — International Regulation” included in the 2015 Annual Report, as amended or supplemented in our subsequently filed Quarterly Reports on Form 10-Q under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Industry Trends — Regulatory Developments.”

101

U.S. Regulation

Insurance Regulation

Insurance Regulatory Examinations and Other Activities

The International Association of Insurance Supervisors (“IAIS”) has encouraged U.S. insurance supervisors, such as the New York State Department of Financial Services (“NYDFS”), to establish Supervisory Colleges for U.S.-based insurance groups with international operations, including MetLife, to facilitate cooperation and coordination among the insurance groups’ supervisors and to enhance the member regulators’ understanding of an insurance group’s risk profile. A September 2016 Supervisory College was chaired by the NYDFS and attended by MetLife’s key U.S. and international regulators. We have not received any reports or recommendations from the Supervisory College meeting, and we do not expect any outcome of the meeting to have a material adverse effect on our business.

New York’s Proposed Cybersecurity Regulation

Since late 2015, the NYDFS has been considering a potential cybersecurity regulation for those banking and insurance entities under its jurisdiction. On September 13, 2016, the NYDFS released a proposed regulation for a 45-day comment period. The proposed regulation would require any person operating under a license or similar authorization under the New York banking, insurance or financial services law to establish a cybersecurity program meeting certain core functions, adopt a cybersecurity policy, appoint a Chief Information Security Officer, and oversee the cybersecurity practices of third-party service providers, among other requirements.

ERISA Considerations

The Department of Labor (“DOL”) issued new regulations on April 6, 2016 with an effective date for most provisions of April 10, 2017. These regulations substantially expand the definition of “investment advice” and thereby broaden the circumstances under which MetLife or its representatives, in providing investment advice with respect to ERISA plans, plan participants or Individual Retirement Accounts or Annuities (“IRAs”), will be deemed a fiduciary under ERISA or the Internal Revenue Code of 1986, as amended (the “Code”). Pursuant to the final regulations, certain communications with plans, plan participants and IRA holders, including the marketing of products, and marketing of investment management or advisory services, could be deemed fiduciary investment advice, thus, causing increased exposure to fiduciary liability if the distributor does not recommend what is in the client’s best interests. The DOL also issued amendments to certain of its prohibited transaction exemptions, and issued a new exemption, that applies more onerous disclosure and contract requirements to, and increases fiduciary requirements and fiduciary liability exposure in respect of, transactions involving ERISA plans, plan participants and IRAs. On September 27, 2016, the DOL released Frequently Asked Questions on the new exemption and amendments to certain existing exemptions, which provide guidance concerning the application and implementation of the new and amended prohibited transaction exemptions.

We anticipate that we will need to undertake certain additional tasks in order to comply with certain of the exemptions provided in the DOL regulations, including additional compliance reviews of material shared with distributors, wholesaler and call center training and product reporting and analysis. See “Risk Factors — Regulatory and Legal Risks — Our Insurance and Brokerage Businesses Are Highly Regulated, and Changes in Regulation and In Supervisory and Enforcement Policies May Reduce Our Profitability and Limit Our Growth.”

On July 11, 2016, the DOL, the IRS and the Pension Benefit Guaranty Corporation proposed revisions to the Form 5500, the form used for ERISA annual reporting. The revisions affect employee pension and welfare benefit plans, including our ERISA plans, and require audits of information, self-directed brokerage account disclosure and additional extensive disclosure. We cannot predict the effect these proposals will have on our business, if enacted, or what other proposals may be made, what legislation may be introduced or enacted, or what impact any such legislation may have on our results of operations and financial condition.

International Regulation

Our international operations are exposed to increased political, legal, financial, operational and other risks. See “Risk Factors — Risks Related to Our Business — Our International Operations Face Political, Legal, Operational and Other Risks, Including Exposure to Local and Regional Economic Conditions, That Could Negatively Affect Those Operations or Our Profitability” and “Risk Factors — Regulatory and Legal Risks — Our Insurance and Brokerage Businesses Are Highly Regulated, and Changes in Regulation and in Supervisory and Enforcement Policies May Reduce Our Profitability and Limit Our Growth” included in the 2015 Annual Report, as amended or supplemented in our subsequently filed Quarterly Reports on Form 10-Q in similarly named sections under the caption “Risk Factors.”

102

On June 23, 2016, the U.K. held a referendum regarding its membership in the EU, resulting in a narrow vote in favor of leaving the EU. The U.K. subsequently indicated that it will initiate the withdrawal process by the end of March 2017. The member withdrawal provisions in the applicable EU treaty have not been used before so it is unclear how the provisions will work in practice. Assuming the U.K. initiates the withdrawal process by giving notice that it is withdrawing from the EU, the relevant treaty provides that the U.K. and the EU will negotiate a withdrawal agreement during a maximum two-year period (unless such period is extended by unanimous vote of the other EU member states). It is currently anticipated that the withdrawal agreement would deal with the details of the immediate exit but would not set out final trade arrangements or deal comprehensively with other potentially significant matters. Upon effectiveness of the withdrawal agreement, or, if no agreement is concluded in the two-year period, at the end of the period, the U.K. will no longer be a member of the EU. In the meantime, however, the U.K. remains a member of the EU with unchanged rights to access the single EU market in goods and services. Our U.K. business model utilizes certain rights to operate cross-border insurance and investment operations which may be modified or eliminated as a result of the U.K. exiting the EU. Operating expenses within our businesses could increase as a result of uncertainties during the negotiation period and in the event of an eventual U.K. withdrawal.

Other changes in the laws and regulations of jurisdictions that affect our customers and independent sales intermediaries or their operations also may affect our business relationships with them and their ability to purchase or distribute our products. Such actions may negatively affect our business in these jurisdictions. The Polish Ministry of Economic Development recently proposed the transfer of certain pension fund assets to the government, the creation of private individual retirement accounts using certain other pension fund assets, and the implementation of additional pension plan options intended to boost savings and long-term investment. It is premature to predict the impact that such measures, if implemented, would have on our business in Poland. In Chile, in September 2015, a Presidential Advisory Committee issued several recommendations to reform the pension system. On August 9, 2016, Chilean President Bachelet proposed further changes to the pension system, including the (i) creation of a state-owned pension fund which may have the benefit of certain exceptions unavailable to private pension funds, (ii) implementation of a competitive bidding process for existing customers, which could result in loss of such customers to funds with lower commissions, and (iii) obligation for pension funds to refund commissions in the event of negative returns, which could, in turn, cause fund managers to invest in instruments which have lower volatility, but lower returns. These proposals, if enacted, may have a significant adverse effect on our business in Chile. The committee issued a series of recommendations in September 2015, but the reform proposal has not been finalized and may still change further if a bill results from their recommendations. It is premature to predict the impact of such reforms on our pension business in Chile. On July 21, 2016, the Chilean Pension Funds Superintendency instituted a proceeding to consider the validity of the action taken by the Superintendency in 2015 approving the merger of Administradora de Fondos de Pensiones ProVida, S.A. into a subsidiary of MetLife, Inc., which was effective on September 1, 2015. It is premature to predict the outcome of the proceedings and its potential impact on our pension business in Chile. 

The European Insurance and Occupational Pensions Authority, along with European legislation, requires European regulators, such as the Central Bank of Ireland (“CBI”), to establish Supervisory Colleges for European Economic Area-based insurance groups with significant European operations, including MetLife, to facilitate cooperation and coordination among the insurance groups’ European supervisors and to enhance the member regulators’ understanding of an insurance group’s risk profile. An October 2016 Supervisory College was chaired by the CBI and was attended by MetLife’s key European regulators. We have not received any reports or recommendations from the Supervisory College meeting, and we do not expect the outcome of the meeting to have a material adverse effect on our business.

Solvency Regimes

Other Solvency Regimes

Mexico adopted a reform of its Insurance Law in February 2013. In accordance with this reform, a Solvency II-type regulatory framework became effective on January 1, 2016 which instituted changes to reserve and capital requirements and corporate governance and fostered greater transparency. In line with the requirements of the local Solvency II, insurance companies calculate and report their capital requirement using a standard formula designed by the local regulators (“CNSF”). In addition, as required, the Company completed and submitted its first Own Risk and Solvency Assessment to the CSNF on October 31, 2016, as previously approved by the Board of Directors.

103

In Chile, the law implementing Solvency II-like regulation continues in the studies stage. However, the Chilean insurance regulator has already issued two resolutions, one for governance, and the other for risk management and control framework requirements. MetLife Chile has already implemented governance changes and risk policies to comply with these resolutions. A fourth impact study was completed and submitted in July 2016. On March 31, 2016, the local regulator issued a final regulation which requires insurance companies to implement a risk appetite framework and produce an Own Risk and Solvency Assessment. The first such report must be submitted to the local regulator no later than September 30, 2017. Even though a formal implementation date has not yet been set, it is estimated that the new solvency and supervisory regime could be in force between 2018 and 2019.

Global Systemically Important Insurers

The IAIS, an association of insurance supervisors and regulators and a member of the Financial Stability Board (“FSB”), an international entity established to coordinate, develop and promote regulatory, supervisory and other financial sector policies in the interest of financial stability, is participating in the FSB’s initiative to identify and manage global systemically important financial institutions. To this end, the IAIS published a methodology to assess the systemic relevance of global insurers and a framework of policy measures to be applied to G-SIIs and, on this basis, the FSB again so designated MetLife, Inc. in 2015. The IAIS/FSB process is separate from the U.S. FSOC designation process and MetLife, Inc. remains a G-SII in spite of the rescission of its U.S. non-bank SIFI designation on March 30, 2016. The global designation process is an annual process. Every three years, the IAIS evaluates whether updates to its assessment methodology are necessary.

Current standards call for G-SIIs to be subject to higher loss absorbency requirements (“HLA”). Given the absence of a common global base on which to calculate HLA for insurers, the FSB directed the IAIS to develop basic capital requirements (“BCR”). The first version of the IAIS HLA framework was endorsed by the FSB and the G20 in September and November 2015, respectively, and the BCR and HLA requirements are expected to be refined based on data confidentially submitted by certain G-SIIs to their group-wide supervisors until they are fully adopted and implemented in 2019. The IAIS published a new assessment methodology on June 16, 2016 which was used this year to assess a pool of approximately 50 insurers, including MetLife, Inc. The new methodology reflects changes in the previous definitions of non-traditional and non-insurance activity, along with certain other changes in both quantitative and qualitative assessments. The assessments are complete and designations are pending. It is uncertain whether MetLife, Inc. will be designated a G-SII by the FSB under this new methodology.

Mortgage and Foreclosure-Related Exposures

MetLife no longer engages in the origination, sale and servicing of forward and reverse residential mortgage loans. See Note 21 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report for further information regarding our mortgage and foreclosure-related exposures.

Notwithstanding MetLife Bank, National Association’s (“MetLife Bank”) exit from the origination and servicing businesses, MetLife Home Loans LLC remains obligated to repurchase loans or compensate for losses upon demand due to alleged defects by MetLife Bank or its predecessor servicers in past servicing of the loans and material representations made in connection with MetLife Bank’s sale of the loans. Reserves for representation and warranty repurchases and indemnifications were $45 million and $72 million at September 30, 2016 and December 31, 2015, respectively. Reserves for estimated future losses due to alleged deficiencies on loans originated and sold, as well as servicing of the loans including servicing acquired, are estimated based on unresolved claims and projected losses under investor servicing contracts where MetLife Bank’s past actions or inactions are likely to result in missing certain stipulated investor timelines. Reserves for servicing defects were $11 million and $31 million at September 30, 2016 and December 31, 2015, respectively. Management is satisfied that adequate provision has been made in the Company’s interim condensed consolidated financial statements for those representation and warranty obligations that are currently probable and reasonably estimable.

104

Summary of Critical Accounting Estimates

The preparation of financial statements in conformity with GAAP requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the Interim Condensed Consolidated Financial Statements. The most critical estimates include those used in determining:

(i) liabilities for future policy benefits and the accounting for reinsurance;

(ii) capitalization and amortization of DAC and the establishment and amortization of VOBA;

(iii) estimated fair values of investments in the absence of quoted market values;

(iv) investment impairments;

(v) estimated fair values of freestanding derivatives and the recognition and estimated fair value of embedded derivatives requiring bifurcation;

(vi) measurement of goodwill and related impairment;

(vii) measurement of employee benefit plan liabilities;

(viii) measurement of income taxes and the valuation of deferred tax assets; and

(ix) liabilities for litigation and regulatory matters.

In addition, the application of acquisition accounting requires the use of estimation techniques in determining the estimated fair values of assets acquired and liabilities assumed — the most significant of which relate to aforementioned critical accounting estimates. In applying our accounting policies, we make subjective and complex judgments that frequently require estimates about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to our business and operations. Actual results could differ from these estimates.

The above critical accounting estimates are described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Summary of Critical Accounting Estimates” and Note 1 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report.

We accelerated the annual review of our actuarial assumptions for our U.S. variable annuities business from the third quarter to the second quarter of 2016 in connection with the proposed Separation. As a result of this review, we made changes to policyholder behavior and long-term economic assumptions, as well as risk margins. With respect to policyholder behavior, which was the significant update for the second quarter of 2016, we have recorded charges, and in some cases benefits, in prior years as a result of the availability of sufficient and credible data at the conclusion of each review. As an example in 2012, we recorded a charge to reflect better than expected persistency; and in 2014, we recorded a charge as we began to reflect lower utilization of the elective annuitization option in early generations of our guaranteed minimum income benefit (“GMIBs”). In addition, in the third quarter of 2016, we performed the annual review of our actuarial assumptions for all of our remaining annuity and life businesses. See “— Deferred Policy Acquisition Costs and Value of Business Acquired” and “— Derivatives” noted below and “— Results of Operations — Consolidated Results — Three Months Ended September 30, 2016 Compared with the Three Months Ended September 30, 2015 — Actuarial Assumption Review” and “— Results of Operations — Consolidated Results — Nine Months Ended September 30, 2016 Compared with the Nine Months Ended September 30, 2015 — Actuarial Assumption Review” for further information.

Goodwill

Goodwill is tested for impairment at least annually or more frequently if events or circumstances, such as adverse changes in the business climate, indicate that there may be justification for conducting an interim test.

For purposes of goodwill impairment testing, if the carrying value of a reporting unit exceeds its estimated fair value, the implied fair value of the reporting unit goodwill is compared to the carrying value of that goodwill to measure the amount of impairment loss, if any. In such instances, the implied fair value of the goodwill is determined in the same manner as the amount of goodwill that would be determined in a business acquisition. The key inputs, judgments and assumptions necessary in determining estimated fair value of the reporting units include projected operating earnings, current book value, the level of economic capital required to support the mix of business, long-term growth rates, comparative market multiples, the account value of in-force business, projections of new and renewed business, as well as margins on such business, the level of interest rates, credit spreads, equity market levels, and the discount rate that we believe is appropriate for the respective reporting unit.

105

In connection with the reorganization, the Company realigned certain businesses among its existing and new segments. As a result, the Company reallocated goodwill based on the relative fair values of the businesses that it realigned and the portion of the reporting unit that it retained. The Company performed an analysis to identify all reporting units under this revised structure.

In the third quarter of 2016, the Company performed its annual goodwill impairment test on its Brighthouse Financial Life reporting unit and Brighthouse Financial Run-off reporting unit based upon its best available data at June 30, 2016. The Company utilized either an actuarial based embedded value or the cash flow testing valuation approaches, which estimate the net worth of the reporting unit and the value of existing and new business, if applicable. Under these actuarial-based methodologies, the estimated fair value of these reporting units was less than the carrying value, indicating a potential for goodwill impairment. The Brighthouse Financial Life reporting unit’s fair value is negatively impacted by a concentration in universal life products including those with secondary guarantees without the benefit of having a significant book of traditional life insurance. The Brighthouse Financial Run-off reporting unit, as a closed block, resulted in utilization of a higher discount rate reflective of expected risk-adjusted returns associated with such business which negatively impacted the estimated fair value of this reporting unit. As a result, the Company performed Step 2 of the goodwill impairment process, which compares the implied fair value of the reporting unit’s goodwill with its carrying value. This analysis indicated that the allocated goodwill associated with this reporting unit was not recoverable. Therefore, the Company recorded a non-cash charge of $147 million ($126 million, net of income tax) and $113 million ($97 million, net of income tax) for the Brighthouse Financial Life and Brighthouse Financial Run-off reporting units, respectively, for the impairment of the entire goodwill balance which is reported in goodwill impairment in the interim condensed consolidated statements of operations and comprehensive income for both the three months and nine months ended September 30, 2016.

In addition, in the third quarter of 2016, the Company tested the MetLife Holdings Life reporting unit for impairment using the actuarial based embedded value fair valuation approach. The estimated fair value of the reporting unit exceeded the carrying value by approximately 13% and, therefore, the reporting unit was not impaired. If we had assumed that the discount rate was 100 basis points higher than the discount rate used, the estimated fair value of the MetLife Holdings Life reporting unit would have been less than the carrying value by approximately 7%. The MetLife Holdings Life reporting unit consists of operations relating to products and businesses no longer actively marketed by the Company. As of September 30, 2016, the amount of goodwill allocated to the MetLife Holdings Life reporting unit was $887 million.

The Company also performed its annual goodwill impairment tests of all other reporting units during the third quarter of 2016 using a qualitative assessment and/or quantitative assessments under the market multiple, discounted cash flow and/or actuarial-based valuation approaches based on best available data as of June 30, 2016 and concluded that the estimated fair values of all such reporting units were in excess of their carrying values and, therefore, goodwill was not impaired.

We apply significant judgment when determining the estimated fair value of our reporting units and when assessing the relationship of market capitalization to the aggregate estimated fair value of our reporting units. The valuation methodologies utilized are subject to key judgments and assumptions that are sensitive to change. Estimates of fair value are inherently uncertain and represent only management’s reasonable expectation regarding future developments. These estimates and the judgments and assumptions upon which the estimates are based will, in all likelihood, differ in some respects from actual future results. Declines in the estimated fair value of our reporting units could result in goodwill impairments in future periods which could materially adversely affect our results of operations or financial position. See Note 10 of the Notes to the Interim Condensed Consolidated Financial Statements for additional information on the Company’s goodwill.

Deferred Policy Acquisition Costs and Value of Business Acquired

We periodically review long-term assumptions underlying the projections of estimated gross margins and profits. These assumptions primarily relate to investment returns, policyholder dividend scales, interest crediting rates, mortality, persistency, and expenses to administer business. Assumptions used in the calculation of estimated gross margins and profits which may have significantly changed are updated annually. We expect these assumptions to be the ones most reasonably likely to cause significant changes in the future. Changes in these assumptions can be offsetting and we are unable to predict their movement or offsetting impact over time.

As previously discussed, during the second quarter of 2016, the Company made changes to policyholder behavior and long-term economic assumptions, as well as risk margins, resulting in changes to the actual and expected future gross profits. Other assumptions, such as expenses, in-force or persistency assumptions and policyholder dividends on participating traditional life contracts, variable and universal life contracts were reviewed in the third quarter of 2016 as part of the annual actuarial assumption review. See “— Results of Operations — Consolidated Results — Three Months Ended September 30, 2016 Compared with the Three Months Ended September 30, 2015 — Actuarial Assumption Review” and “— Results of Operations — Consolidated Results — Nine Months Ended September 30, 2016 Compared with the Nine Months Ended September 30, 2015 — Actuarial Assumption Review” for further information.

106

At September 30, 2016, DAC and VOBA for the Company was $24.7 billion. In addition to assumption updates, amortization of DAC and VOBA associated with the variable and universal life and annuity contracts was significantly impacted by movements in equity markets. The following illustrates the effect on DAC and VOBA of changing each of the respective assumptions, as well as updating estimated gross margins or profits with actual gross margins or profits during the nine months ended September 30, 2016. Increases (decreases) in DAC and VOBA balances, as presented below, resulted in a corresponding decrease (increase) in amortization.

	Nine Months Ended September 30, 2016
	(In millions)
General account investment return	$	9
Separate account investment return	(10		)
Net investment gains (losses)/Net derivative gains (losses)	1,290
Guaranteed minimum income benefits	(173		)
Expense	(11		)
In-force/Persistency	(4		)
Other	(532		)
Total	$	569

The following represent significant items contributing to the changes to DAC and VOBA amortization for the nine months ended September 30, 2016:

• Changes in net investment and net derivative gains (losses) resulted in the following changes in DAC and VOBA amortization:

– Actual gross profits decreased as a result of an increase in liabilities associated with guarantee obligations on variable annuities, resulting in a decrease of DAC and VOBA amortization of approximately $1.1 billion, excluding the impact from our nonperformance risk and risk margins, which are described below. The increase in the guarantee liability valuations on variable annuities was mostly attributable to the annual assumption review, which is described more fully in “— Results of Operations — Consolidated Results — Nine Months Ended September 30, 2016 Compared with the Nine Months Ended September 30, 2016 — Actuarial Assumption Review.” Mark-to-market changes on the freestanding derivatives hedging such guarantee obligations resulted in a decrease in DAC and VOBA amortization of approximately $100 million.

– The Company’s nonperformance risk adjustment decreased the valuation of guaranteed liabilities, increased actual gross profits and increased DAC and VOBA amortization by approximately $265 million. This is more than offset by higher risk margins, which increased the guarantee liability valuations, decreased actual gross profits and decreased DAC and VOBA amortization by approximately $400 million.

• The change in current and projected GMIB liabilities, mostly attributable to long-term investment rate of return and policyholder behavior related assumptions updates, as well as hedge gains, resulted in an increase to DAC and VOBA amortization of approximately $170 million.

• The change in other is primarily driven by:

– An acceleration of approximately $360 million of DAC amortization associated with universal life products resulting from the re-segmentation of MetLife businesses to establish a Brighthouse Financial segment.

– An increase of approximately $110 million of DAC amortization resulting from the annual assumption update of the closed block.

Derivatives

The table below illustrates the impact that a range of reasonably likely variances in credit spreads would have on our consolidated balance sheet, excluding the effect of income tax, related to the embedded derivative valuation on certain variable annuity products measured at estimated fair value. In determining the ranges, we have considered current market conditions, as well as the market level of spreads that can reasonably be anticipated over the near term. The ranges do not reflect extreme market conditions such as those experienced during the 2008-2009 financial crisis as we do not consider those to be reasonably likely events in the near future.

107

As previously discussed, during the second quarter of 2016, the Company made changes to the actuarial assumptions that resulted in an increase in the fair value of the embedded derivatives. The impact of the range of reasonably likely variances in credit spreads also increased significantly as compared to prior periods. However, these estimated effects do not take into account potential changes in other variables, such as equity price levels and market volatility, which can also contribute significantly to changes in carrying values. Therefore, the table does not necessarily reflect the ultimate impact on the consolidated financial statement under the credit spread variance scenarios presented below.

	Changes in Balance Sheet Carrying Value At September 30, 2016
	Policyholder Account Balances		DAC and VOBA
	(In millions)
100% increase in our credit spread	$	5,357	$	981
As reported	$	6,706	$	1,529
50% decrease in our credit spread	$	8,126	$	2,112

See “— Results of Operations — Consolidated Results — Nine Months Ended September 30, 2016 Compared with the Nine Months Ended September 30, 2015 — Actuarial Assumption Review” for a more detailed analysis.

Economic Capital

Economic capital is an internally developed risk capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. The economic capital model accounts for the unique and specific nature of the risks inherent in our business.

Our economic capital model, coupled with considerations of local capital requirements, aligns segment allocated equity with emerging standards and consistent risk principles. The model applies statistics-based risk evaluation principles to the material risks to which the Company is exposed. These consistent risk principles include calibrating required economic capital shock factors to a specific confidence level and time horizon while applying an industry standard method for the inclusion of diversification benefits among risk types. Economic capital-based risk estimation is an evolving science and industry best practices have emerged and continue to evolve. Areas of evolving industry best practices include stochastic liability valuation techniques, alternative methodologies for the calculation of diversification benefits, and the quantification of appropriate shock levels. MetLife’s management is responsible for the ongoing production and enhancement of the economic capital model and reviews its approach periodically to ensure that it remains consistent with emerging industry practice standards.

Segment net investment income, with the exception of the Brighthouse Financial segment, is credited or charged based on the level of allocated equity; however, changes in allocated equity do not impact our consolidated net investment income, operating earnings or net income (loss). The Brighthouse Financial segment’s net investment income represents that of the legal entities which comprise Brighthouse and its subsidiaries on a historical basis, however, may not be indicative of that on a combined standalone basis.

Net investment income is based upon the actual results of each segment’s specifically identifiable investment portfolios adjusted for allocated equity. Other costs are allocated to each of the segments based upon: (i) a review of the nature of such costs; (ii) time studies analyzing the amount of employee compensation costs incurred by each segment; and (iii) cost estimates included in the Company’s product pricing.

Acquisitions and Dispositions

See “— Executive Summary — Other Key Information — Significant Events” and Note 3 of the Notes to the Interim Condensed Consolidated Financial Statements for information on the U.S. Retail Advisor Force Divestiture and the proposed Separation.

108

Results of Operations

Consolidated Results

Business Overview. Overall sales improved from prior period levels as a result of increased sales of certain products within our segments for the three months ended September 30, 2016, as compared to the three months ended September 30, 2015. An overall increase in sales from our U.S. segment was primarily driven by the timing of our funding agreement issuances and an increase in structured settlement annuity sales due to price competition, partially offset by lower pension risk transfers and decreases in sales of income annuities and post-retirement benefit products. For our EMEA segment, improved sales in the Middle East and the U.K. were partially offset by strong prior period sales in Poland. In our MetLife Holdings and Brighthouse Financial segments, life and annuity sales declined as a result of the proposed Separation and the U.S. Retail Advisor Force Divestiture. In our Latin America segment, lower group life, medical and pension sales were partially offset by higher sales of property & casualty and accident & health products. Sales in our Asia segment declined primarily due to management actions taken to improve product value.

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Revenues
Premiums	$	10,391		$	10,375		$	29,501		$	28,940
Universal life and investment-type product policy fees	2,296			2,346			6,926			7,174
Net investment income	5,464			3,959			14,910			14,367
Other revenues	366			484			1,340			1,497
Net investment gains (losses)	257			382			538			535
Net derivative gains (losses)	(1,051		)	485			(1,815		)	394
Total revenues	17,723			18,031			51,400			52,907
Expenses
Policyholder benefits and claims and policyholder dividends	11,167			10,688			31,758			29,967
Interest credited to policyholder account balances	1,820			647			4,646			3,940
Goodwill impairment	260			—			260			—
Capitalization of DAC	(863		)	(955		)	(2,759		)	(2,850		)
Amortization of DAC and VOBA	1,017			1,131			2,133			3,053
Amortization of negative VOBA	(55		)	(90		)	(221		)	(282		)
Interest expense on debt	292			302			910			908
Other expenses	3,537			4,145			11,303			11,836
Total expenses	17,175			15,868			48,030			46,572
Income (loss) before provision for income tax	548			2,163			3,370			6,335
Provision for income tax expense (benefit)	(25		)	965			480			1,855
Net income (loss)	573			1,198			2,890			4,480
Less: Net income (loss) attributable to noncontrolling interests	(4		)	(5		)	2			4
Net income (loss) attributable to MetLife, Inc.	577			1,203			2,888			4,476
Less: Preferred stock dividends	6			6			58			67
Preferred stock repurchase premium	—			—			—			42
Net income (loss) available to MetLife, Inc.’s common shareholders	$	571		$	1,197		$	2,830		$	4,367

Three Months EndedSeptember 30, 2016 Compared with the Three Months EndedSeptember 30, 2015

During the three months ended September 30, 2016, income (loss) before provision for income tax decreased $1.6 billion ($625 million, net of income tax) from the prior period primarily driven by an unfavorable change in net derivatives gains (losses) and a current period goodwill impairment charge, partially offset by a favorable change in operating earnings.

109

Management of Investment Portfolio and Hedging Market Risks with Derivatives. We manage our investment portfolio using disciplined Asset/Liability Management (“ALM”) principles, focusing on cash flow and duration to support our current and future liabilities. Our intent is to match the timing and amount of liability cash outflows with invested assets that have cash inflows of comparable timing and amount, while optimizing risk-adjusted net investment income and risk-adjusted total return. Our investment portfolio is heavily weighted toward fixed income investments, with over 80% of our portfolio invested in fixed maturity securities and mortgage loans. These securities and loans have varying maturities and other characteristics which cause them to be generally well suited for matching the cash flow and duration of insurance liabilities. We also use derivatives as an integral part of our management of the investment portfolio to hedge certain risks, including changes in interest rates, foreign currency exchange rates, credit spreads and equity market levels. In addition, our general account investment portfolio includes, within fair value option (“FVO”) and trading securities, contractholder-directed unit-linked investments supporting unit-linked variable annuity type liabilities, which do not qualify as separate account assets. The returns on these contractholder-directed unit-linked investments, which can vary significantly from period to period, include changes in estimated fair value subsequent to purchase, inure to contractholders and are offset in earnings by a corresponding change in policyholder account balances through interest credited to policyholder account balances.

We purchase investments to support our insurance liabilities and not to generate net investment gains and losses. However, net investment gains and losses are incurred and can change significantly from period to period due to changes in external influences, including changes in market factors such as interest rates, foreign currency exchange rates, credit spreads and equity markets; counterparty specific factors such as financial performance, credit rating and collateral valuation; and internal factors such as portfolio rebalancing. Changes in these factors from period to period can significantly impact the levels of both impairments and realized gains and losses on investments sold.

We use freestanding interest rate, equity, credit and currency derivatives to hedge certain invested assets and insurance liabilities. Certain of these hedges are designated and qualify as accounting hedges, which reduce volatility in earnings. For those hedges not designated as accounting hedges, changes in market factors lead to the recognition of fair value changes in net derivative gains (losses) generally without an offsetting gain or loss recognized in earnings for the item being hedged, which creates volatility in earnings.

Certain variable annuity products with guaranteed minimum benefits contain embedded derivatives that are measured at estimated fair value separately from the host variable annuity contract, with changes in estimated fair value recorded in net derivative gains (losses). We use freestanding derivatives to hedge the market risks inherent in these variable annuity guarantees. The valuation of these embedded derivatives includes a nonperformance risk adjustment, which is unhedged, and can be a significant driver of net derivative gains (losses) and volatility in earnings, but does not have an economic impact on us.

110

Net Derivative Gains (Losses).The variable annuity embedded derivatives and associated freestanding derivative hedges are collectively referred to as “VA program derivatives” in the following table. All other derivatives that are economic hedges of certain invested assets and insurance liabilities are referred to as “non-VA program derivatives” in the following table. The table below presents the impact on net derivative gains (losses) from non-VA program derivatives and VA program derivatives:

	Three Months   Ended   September 30,
	2016			2015
	(In millions)
Non-VA program derivatives
Interest rate	$	(272	)	$	723
Foreign currency exchange rate	67			139
Credit	57			(39		)
Equity	5			14
Non-VA embedded derivatives	(71		)	82
Total non-VA program derivatives	(214		)	919
VA program derivatives
Market risks in embedded derivatives	1,352			(1,684		)
Nonperformance risk adjustment on embedded derivatives	(224		)	253
Other risks in embedded derivatives	(256		)	(484		)
Total embedded derivatives	872			(1,915		)
Freestanding derivatives hedging embedded derivatives	(1,709		)	1,481
Total VA program derivatives	(837		)	(434		)
Net derivative gains (losses)	$	(1,051	)	$	485

The unfavorable change in net derivative gains (losses) on non-VA program derivatives was $1.1 billion ($736 million, net of income tax). This was primarily due to long-term interest rates decreasing less in the current period than in the prior period, unfavorably impacting receive-fixed interest rate swaps and interest rate swaptions primarily hedging long duration liability portfolios. In addition, a change in the value of the assets underlying reinsurance-related funds withheld unfavorably impacted non-VA embedded derivatives. Non-VA embedded derivatives were also unfavorably impacted by certain equity-indexed fixed annuities due to key equity index levels increasing in the current period but decreasing in the prior period. Because certain of these hedging strategies are not designated or do not qualify as accounting hedges, the changes in the estimated fair value of these freestanding derivatives are recognized in net derivative gains (losses) without an offsetting gain or loss recognized in earnings for the item being hedged.

The unfavorable change in net derivative gains (losses) on VA program derivatives was $403 million ($262 million, net of income tax). This was due to an unfavorable change of $477 million ($310 million, net of income tax) related to the change in the nonperformance risk adjustment on embedded derivatives and by an unfavorable change of $154 million ($100 million, net of income tax) in market risks in embedded derivatives, net of the impact of freestanding derivatives hedging those risks, partially offset by a favorable change of $228 million ($148 million, net of income tax) in other risks in embedded derivatives. Other risks relate primarily to the impact of policyholder behavior and other non-market risks that generally cannot be hedged.

The aforementioned $477 million ($310 million, net of income tax) unfavorable change in the nonperformance risk adjustment on embedded derivatives was due to an unfavorable change of $266 million, before income tax, as a result of model changes and changes in capital market inputs, such as long-term interest rates and key equity index levels, on the variable annuity guarantees and an unfavorable change of $211 million, before income tax, related to changes in our own credit spread.

The foregoing $154 million ($100 million, net of income tax) unfavorable change was comprised of a $3.2 billion ($2.1 billion, net of income tax) unfavorable change in freestanding derivatives hedging market risks in embedded derivatives, which was offset by a $3.0 billion ($2.0 billion, net of income tax) favorable change in market risks in embedded derivatives.

111

The primary changes in market factors are summarized as follows:

• Long-term interest rates decreased less in the current period than in the prior period, contributing to an unfavorable change in our freestanding derivatives and a favorable change in our embedded derivatives. For example, the 30-year U.S. swap rate decreased by 3% in the current period and decreased by 14% in the prior period.

• Key equity index levels mainly increased in the current period and decreased in the prior period, contributing to an unfavorable change in our freestanding derivatives and a favorable change in our embedded derivatives. For example, the Standard & Poor’s Ratings Services (“S&P”) 500 Index increased by 3% in the current period and decreased by 7% in the prior period.

• Key equity volatility measures decreased in the current period and were mixed in the prior period, contributing to a favorable change in our embedded derivatives and an unfavorable change in our freestanding derivatives.

The aforementioned $228 million ($148 million, net of income tax) favorable change in other risks in embedded derivatives reflected:

• The cross effect of capital markets changes, which resulted in a favorable period over period change in the valuation of the embedded derivatives;

• A decrease in the risk margin adjustment, measuring policyholder behavior risks, which was also affected by market and interest rate changes; and

• In-force changes and the mismatch of fund performance between actual and modeled funds; partially offset by

• A combination of other factors, including reserve changes influenced by benefit features and actual policyholder behavior, as well as FCTA.

When equity index levels decrease in isolation, the variable annuity guarantees become more valuable to policyholders, which results in an increase in the undiscounted embedded derivative liability. Discounting this unfavorable change by the risk adjusted rate yields a smaller loss than by discounting at the risk-free rate, thus creating a gain from including an adjustment for nonperformance risk.

When the risk-free interest rate decreases in isolation, discounting the embedded derivative liability produces a higher valuation of the liability than if the risk-free interest rate had remained constant. Discounting this unfavorable change by the risk adjusted rate yields a smaller loss than by discounting at the risk-free interest rate, thus creating a gain from including an adjustment for nonperformance risk.

When our own credit spread increases in isolation, discounting the embedded derivative liability produces a lower valuation of the liability than if our own credit spread had remained constant. As a result, a gain is created from including an adjustment for nonperformance risk. For each of these primary market drivers, the opposite effect occurs when they move in the opposite direction.

Net Investment Gains (Losses). The unfavorable change in net investment gains (losses) of $125 million ($81 million, net of income tax) primarily reflects higher gains on sales of real estate in the prior year. This unfavorable change was partially offset by higher current period gains on sales of fixed maturity securities and lower current period losses on other limited partnership interests, as well as a gain from the U.S. Retail Advisor Force Divestiture in the current period.

Goodwill. The three months ended September 30, 2016 includes a $260 million ($223 million, net of income tax) non-cash charge for goodwill impairment associated with our Brighthouse Financial segment. See Note 10 of the Notes to the Interim Condensed Consolidated Financial Statements.

Actuarial Assumption Review. We annually review our long-term actuarial assumption for policyholder behavior, market returns and other actuarial items. With respect to policyholder behavior, we have recorded charges, and in some cases, benefits in prior years as a result of the availability of sufficient and credible data at the conclusion of each review. See “— Summary of Critical Accounting Estimates.” During the current period, we performed a review of assumptions related to reserves and DAC for our annuity and life businesses, with the exception of our U.S. variable annuity business, which was reviewed in the second quarter of 2016 in connection with the proposed Separation.

Results for the current period include an $94 million ($59 million, net of income tax) loss associated with our annual assumption review related to reserves and DAC, of which a $15 million gain ($10 million, net of income tax) was recognized in net derivative gains (losses). Of the $94 million loss, $109 million ($69 million, net of income tax) was associated with DAC and a benefit of $15 million ($10 million, net of income tax) was related to reserves. The $15 million gain recognized in net derivative gains (losses) associated with this review of assumptions was included within the other risks caption in the table above.

112

As a result of our current period annual actuarial assumption review, changes were made to economic, policyholder behavior, mortality and other assumptions. The most significant impacts were in the MetLife Holdings segment and are summarized as follows:

• Change in economic assumptions resulted in a release of DAC and increase of reserves, resulting in a net loss of $57 million ($37 million, net of income tax).

• Change in policyholder behavior and mortality assumptions resulted in an increase in DAC, resulting in a net gain of $49 million ($33 million, net of income tax).

• The remaining assumption updates resulted in a release of DAC, partially offset by a decrease in reserves resulting in a loss of $86 million ($55 million, net of income tax). The most notable assumption update was a net loss related to our projection of closed block results.

Results for the prior period include a $313 million ($203 million, net of income tax) charge associated with our annual assumption review related to reserves and DAC for all of our annuity and life businesses, of which a $3 million loss ($2 million, net of income tax) was recognized in net derivative gains (losses). Of the $313 million charge, $60 million ($39 million, net of income tax) was related to DAC and $253 million ($164 million, net of income tax) was associated with reserves.

Divested Businesses.Income (loss) before provision for income tax related to the divested businesses, excluding net investment gains (losses) and net derivative gains (losses), increased $25 million ($16 million, net of income tax) to income of $24 million ($14 million, net of income tax) in the current period from a loss of $1 million ($2 million, net of income tax) in the prior period. Included in this decline was a slight decrease in total revenues and a decrease in total expenses of $26 million, before income tax. The current period includesexpenses and charges associated with theU.S Retail Advisor Force Divestitureand the proposed Separation.

Taxes. Income tax benefit for the three months ended September 30, 2016 was $25 million, or (5)% of income (loss) before provision for income tax, compared with income tax expense of $965 million, or 45% of income (loss) before provision for income tax, for the three months ended September 30, 2015. The Company’s effective tax rates differ from the U.S. statutory rate of 35% typically due to non-taxable investment income, tax credits for low income housing, and foreign earnings taxed at lower rates than the U.S. statutory rate. Current period results include a one-time tax benefit of $36 million for tax audit settlements, partially offset by a charge of $22 million related to the filing of the Company’s U.S. federal tax return. Current period results also include the aforementioned $260 million ($223 million, net of income tax) non-cash charge for goodwill impairment. The tax benefit on this charge was limited to $37 million on the associated tax goodwill. Prior period results include a one-time tax charge of $557 million recorded under accounting guidance for the recognition of tax uncertainties. In addition, prior period results include one-time tax benefits of $61 million related to the restructuring of our business in Chile, $57 million related to the repatriation of earnings from Japan and $16 million related to the filing of the Company’s U.S. federal tax return.

Operating Earnings. As more fully described in “— Non-GAAP and Other Financial Disclosures,” we use operating earnings, which does not equate to net income (loss) as determined in accordance with GAAP, to analyze our performance, evaluate segment performance, and allocate resources. We believe that the presentation of operating earnings and operating earnings available to common shareholders, as we measure it for management purposes, enhances the understanding of our performance by highlighting the results of operations and the underlying profitability drivers of the business. Operating earnings and operating earnings available to common shareholders should not be viewed as substitutes for net income (loss) and net income (loss) available to MetLife, Inc.’s common shareholders, respectively. Operating earnings available to common shareholders increased $716 million, net of income tax, to $1.4 billion, net of income tax, for the three months ended September 30, 2016 from $705 million, net of income tax, for the three months ended September 30, 2015.

Nine Months Ended September 30, 2016 Compared with the Nine Months Ended September 30, 2015

During the nine months ended September 30, 2016, income (loss) before provision for income tax decreased $3.0 billion ($1.6 billion, net of income tax) from the prior period primarily driven by unfavorable changes in net derivative gains (losses) and operating earnings, as well as a current period goodwill impairment charge. In addition, in the current period, income (loss) before provision for income tax includes the financial impact of converting the Company’s Japan operations to calendar year-end reporting without retrospective application of this change to prior periods.

113

Net Derivative Gains (Losses).The variable annuity embedded derivatives and associated freestanding derivative hedges are collectively referred to as “VA program derivatives” in the following table. All other derivatives that are economic hedges of certain invested assets and insurance liabilities are referred to as “non-VA program derivatives” in the following table. The table below presents the impact on net derivative gains (losses) from non-VA program derivatives and VA program derivatives:

	Nine Months   Ended   September 30,
	2016			2015
	(In millions)
Non-VA program derivatives
Interest rate	$	1,581		$	506
Foreign currency exchange rate	851			296
Credit	73			(36		)
Equity	(45		)	(78		)
Non-VA embedded derivatives	(207		)	87
Total non-VA program derivatives	2,253			775
VA program derivatives
Market risks in embedded derivatives	(1,330		)	(658		)
Nonperformance risk adjustment on embedded derivatives	1,238			222
Other risks in embedded derivatives	(4,693		)	(690		)
Total embedded derivatives	(4,785		)	(1,126		)
Freestanding derivatives hedging embedded derivatives	717			745
Total VA program derivatives	(4,068		)	(381		)
Net derivative gains (losses)	$	(1,815	)	$	394

The favorable change in net derivative gains (losses) on non-VA program derivatives was $1.5 billion ($961 million, net of income tax). This was primarily due to long-term interest rates decreasing more in the current period than in the prior period, favorably impacting receive-fixed interest rate swaps and interest rate swaptions primarily hedging long duration liability portfolios. The strengthening of the Japanese yen relative to other key currencies favorably impacted foreign currency forwards and futures that primarily hedge foreign denominated bonds. Because certain of these hedging strategies are not designated or do not qualify as accounting hedges, the changes in the estimated fair value of these freestanding derivatives are recognized in net derivative gains (losses) without an offsetting gain or loss recognized in earnings for the item being hedged.

These favorable changes were partially offset by a change in the value of the assets underlying reinsurance-related funds withheld unfavorably impacting non-VA embedded derivatives. Non-VA embedded derivatives were also unfavorably impacted by certain equity-indexed fixed annuities due to key equity index levels increasing in the current period but decreasing in the prior period.

The unfavorable change in net derivative gains (losses) on VA program derivatives was $3.7 billion ($2.4 billion, net of income tax). This was due to an unfavorable change of $4.0 billion ($2.6 billion, net of income tax) in other risks in embedded derivatives and an unfavorable change of $700 million ($455 million, net of income tax) in market risks in embedded derivatives, net of the impact of freestanding derivatives hedging those risks, partially offset by a favorable change of $1.0 billion ($660 million, net of income tax) related to the change in the nonperformance risk adjustment on embedded derivatives. Other risks relate primarily to the impact of policyholder behavior and other non-market risks that generally cannot be hedged.

The foregoing $4.0 billion ($2.6 billion, net of income tax) unfavorable change in other risks in embedded derivatives reflected:

• Updates to actuarial policyholder behavior assumptions within the valuation model. For details, see “— Actuarial Assumption Review”; and

• An increase in the risk margin adjustment, measuring policyholder behavior risks, which was also affected by the second quarter 2016 actuarial assumption update, along with market and interest rate changes; partially offset by

• The cross effect of capital market changes, a combination of other factors, including reserve changes influenced by benefit features and actual policyholder behavior, as well as FCTA.

114

The foregoing $700 million ($455 million, net of income tax) unfavorable change reflects a $672 million ($437 million, net of income tax) unfavorable change in market risks in embedded derivatives and a $28 million ($18 million, net of income tax) unfavorable change in freestanding derivatives hedging market risks in embedded derivatives.

The primary changes in market factors are summarized as follows:

• Long-term interest rates decreased more in the current period than in the prior period, contributing to a favorable change in our freestanding derivatives and an unfavorable change in our embedded derivatives. For example, the 30-year U.S. swap rate decreased by 32% in the current period and decreased by 7% in the prior period.

• Key equity index levels were mixed in the current period and mostly decreased in the prior period, contributing to an unfavorable change in our freestanding derivatives and a favorable change in our embedded derivatives. For example, the S&P 500 Index increased by 6% in the current period and decreased by 7% in the prior period.

• Changes in foreign currency exchange rates contributed to a favorable change in our freestanding derivatives and an unfavorable change in our embedded derivatives related to the assumed reinsurance of certain variable annuity products from the Company’s former operating joint venture in Japan. For example, the Japanese yen strengthened against the U.S. dollar by 16% in the current period and remained unchanged in the prior period.

The aforementioned $1.0 billion ($660 million, net of income tax) favorable change in the nonperformance risk adjustment on embedded derivatives resulted from a favorable change of $1.1 billion, before income tax, as a result of model changes and changes in capital market inputs, such as long-term interest rates and key equity index levels, on the variable annuity guarantees, partially offset by an unfavorable change of $34 million, before income tax, related to changes in our own credit spread.

Goodwill. The nine months ended September 30, 2016 includes a $260 million ($223 million, net of income tax) non-cash charge for goodwill impairment associated with our Brighthouse Financial segment. See Note 10 of the Notes to the Interim Condensed Consolidated Financial Statements.

Actuarial Assumption Review. Results for the current period include a $3.2 billion ($2.1 billion, net of income tax) non-cash charge associated with the annual review of assumptions related to reserves and DAC, of which a $3.7 billion loss ($2.4 billion, net of income tax) was recognized in net derivative gains (losses) and a loss of $103 million ($67 million, net of income tax) was recognized in updates to the closed block projection. Of the $3.2 billion charge, $3.9 billion ($2.5 billion, net of income tax) was related to reserves and a benefit of $732 million ($478 million, net of income tax) was associated with DAC.

The $3.7 billion loss recognized in net derivative gains (losses) associated with this review of assumptions was included within the other risks in embedded derivatives caption in the table above.

The significant impacts of the annual actuarial assumption review were on the U.S. variable annuity block of business and are summarized as follows:

• Changes in policyholder behavior assumptions resulted in reserve increases, partially offset by favorable DAC amortization, resulting in a net charge of $2.3 billion ($1.5 billion, net of income tax). The policyholder behavior assumption changes included:

– Lower utilization of the elective annuitization option on the guarantee riders on the contracts;

– Lower election of the guaranteed principal option in certain of our GMIBs, which, if exercised, returns to the policyholder the original purchase payment amounts;

– Adjusting the rate at which policyholders withdrew funds through systematic withdrawals; and

– Higher policyholder persistency related to the portion of the business that will remain with the Company after the proposed Separation, dependent on the amount a contract is in-the-money.

• Changes in economic assumptions resulted in reserve increases and unfavorable DAC amortization resulting in a charge of $487 million ($316 million, net of income tax). These changes include reducing the long-term separate account return assumption from 7.25% to 7.00% (from 7.00% to 6.75% for GMIB’s invested in managed volatility funds), and reducing the projected ultimate 10-year treasury rate from 4.50% to 4.25%.

• The remaining updates resulted in reserve increases from changes in risk margins, partially offset by favorable DAC, resulting in a charge of $428 million ($277 million, net of income tax).

115

Results for the prior period include a $313 million ($203 million, net of income tax) charge associated with our annual assumption review related to reserves and DAC, of which a $3 million loss ($2 million, net of income tax) was recognized in net derivative gains (losses). Of the $313 million charge, $60 million ($39 million, net of income tax) was related to DAC and $253 million ($164 million, net of income tax) was associated with reserves.

Divested Businesses and Lag Elimination.Income (loss) before provision for income tax related to the divested businesses and lag elimination, excluding net investment gains (losses) and net derivative gains (losses), decreased $46 million ($36 million, net of income tax) to a loss of $49 million ($35 million, net of income tax) in the current period from a loss of $3 million (income of $1 million, net of income tax) in the prior period. Included in this decline was an increase in total revenues of $660 million, before income tax, and an increase in total expenses of $706 million, before income tax. The current period includes thefinancial impact of converting the Company’s Japan operations to calendar year-end reporting without retrospective application of this change to prior periods, as well as expenses and charges associated with theU.S Retail Advisor Force Divestitureand the proposed Separation.

Taxes. Income tax expense for the nine months ended September 30, 2016 was $480 million, or 14% of income (loss) before provision for income tax, compared with $1.9 billion, or 29% of income (loss) before provision for income tax, for the nine months ended September 30, 2015. The Company’s effective tax rates differ from the U.S. statutory rate of 35% typically due to non-taxable investment income, tax credits for low income housing, and foreign earnings taxed at lower rates than the U.S. statutory rate. Our current period results include one-time tax benefits of $110 million in Japan related to a change in tax rate and $36 million for tax audit settlements, offset by one-time tax charges of $26 million related to the repatriation of earnings from Japan, $22 million related to the filing of the Company’s U.S. federal tax return and $19 million in Chile related to a change in tax rate. Current period results also include the aforementioned $260 million ($223 million, net of income tax) non-cash charge for goodwill impairment. The tax benefit on this charge was limited to $37 million on the associated tax goodwill. Prior period results include a one-time tax charge of $557 million recorded under accounting guidance for the recognition of tax uncertainties. In addition, prior period results include one-time tax benefits of $174 million in Japan related to a change in tax rate, $61 million related to the restructuring of our business in Chile, $57 million related to the repatriation of earnings from Japan and $16 million related to the filing of the Company’s U.S. federal tax return.

Operating Earnings. Operating earnings available to common shareholders decreased $434 million, net of income tax, to $3.7 billion, net of income tax, for the nine months ended September 30, 2016 from $4.1 billion, net of income tax, for the nine months ended September 30, 2015.

116

Reconciliation of net income (loss) to operating earnings available to common shareholders

Three Months Ended September 30, 2016

	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate& Other			Total
	(In millions)
Net income (loss)	$	520		$	361		$	148		$	115		$	(60	)	$	(534	)	$	23		$	573
Less: Net investment gains (losses)	44			66			12			24			5			25			81			257
Less: Net derivative gains (losses)	(20		)	(68		)	(9		)	25			(469		)	(501		)	(9		)	(1,051		)
Less: Goodwill impairment	—			—			—			—			—			(260		)	—			(260		)
Less: Other adjustments to net income (1)	(73		)	10			17			26			(36		)	(111		)	(26		)	(193		)
Less: Provision for income tax (expense) benefit	17			29			(5		)	(34		)	174			245			(33		)	393
Operating earnings	$	552		$	324		$	133		$	74		$	266		$	68		10			1,427
Less: Preferred stock dividends																			6			6
Operating earnings available to common shareholders																			$	4		$	1,421

Three Months Ended September 30, 2015

	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate& Other			Total
	(In millions)
Net income (loss)	$	735		$	655		$	85		$	85		$	403		$	262		$	(1,027	)	$	1,198
Less: Net investment gains (losses)	142			325			9			14			57			(37		)	(128		)	382
Less: Net derivative gains (losses)	243			107			(108		)	7			227			(60		)	69			485
Less: Other adjustments to net income (1)	(42		)	(21		)	(32		)	(14		)	(38		)	(36		)	(23		)	(206		)
Less: Provision for income tax (expense) benefit	(119		)	(94		)	33			12			(86		)	48			32			(174		)
Operating earnings	$	511		$	338		$	183		$	66		$	243		$	347		(977		)	711
Less: Preferred stock dividends																			6			6
Operating earnings available to common shareholders																			$	(983	)	$	705

__________________

(1) See definitions of operating revenues and operating expenses under “— Non-GAAP and Other Financial Disclosures” for the components of such adjustments.

117

Nine Months Ended September 30, 2016

	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate& Other			Total
	(In millions)
Net income (loss)	$	1,615		$	1,995		$	377		$	285		$	587		$	(1,354	)	$	(615	)	$	2,890
Less: Net investment gains (losses)	13			429			8			48			142			(16		)	(86		)	538
Less: Net derivative gains (losses)	512			949			47			27			(32		)	(3,181		)	(137		)	(1,815		)
Less: Goodwill impairment	—			—			—			—			—			(260		)	—			(260		)
Less: Other adjustments to net income (1)	(204		)	47			(88		)	92			24			392			(163		)	100
Less: Provision for income tax (expense) benefit	(107		)	(318		)	(11		)	(83		)	(47		)	1,019			142			595
Operating earnings	$	1,401		$	888		$	421		$	201		$	500		$	692		(371		)	3,732
Less: Preferred stock dividends																			58			58
Operating earnings available to common shareholders																			$	(429	)	$	3,674

Nine Months Ended September 30, 2015

	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate& Other			Total
	(In millions)
Net income (loss)	$	1,805		$	1,568		$	326		$	215		$	1,087		$	921		$	(1,442	)	$	4,480
Less: Net investment gains (losses)	306			450			7			22			88			(3		)	(335		)	535
Less: Net derivative gains (losses)	160			134			(145		)	21			318			(166		)	72			394
Less: Other adjustments to net income (1)	(109		)	(113		)	(52		)	(7		)	(237		)	(146		)	(29		)	(693		)
Less: Provision for income tax (expense) benefit	(124		)	7			48			(7		)	(59		)	111			93			69
Operating earnings	$	1,572		$	1,090		$	468		$	186		$	977		$	1,125		(1,243		)	4,175
Less: Preferred stock dividends																			67			67
Operating earnings available to common shareholders																			$	(1,310	)	$	4,108

__________________

(1) See definitions of operating revenues and operating expenses under “— Non-GAAP and Other Financial Disclosures” for the components of such adjustments.

118

Reconciliation of revenues to operating revenues and expenses to operating expenses

Three Months Ended September 30, 2016

	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate& Other			Total
	(In millions)
Total revenues	$	7,914		$	3,000		$	1,222		$	1,192		$	2,583		$	1,763		$	49		$	17,723
Less: Net investment gains (losses)	44			66			12			24			5			25			81			257
Less: Net derivative gains (losses)	(20		)	(68		)	(9		)	25			(469		)	(501		)	(9		)	(1,051		)
Less: Adjustments related to net investment gains (losses) and net derivative gains (losses)	—			(4		)	—			(1		)	—			(1		)	—			(6		)
Less: Other adjustments to revenues (1)	(73		)	71			17			442			(45		)	(1		)	3			414
Total operating revenues	$	7,963		$	2,935		$	1,202		$	702		$	3,092		$	2,241		$	(26	)	$	18,109
Total expenses	$	7,123		$	2,526		$	1,016		$	1,032		$	2,696		$	2,502		$	280		$	17,175
Less: Adjustments related to net investment gains (losses) and net derivative gains (losses)	—			(10		)	—			—			(71		)	(128		)	—			(209		)
Less: Goodwill impairment	—			—			—			—			—			260			—			260
Less: Other adjustments to expenses (1)	—			67			—			415			62			237			29			810
Total operating expenses	$	7,123		$	2,469		$	1,016		$	617		$	2,705		$	2,133		$	251		$	16,314

Three Months Ended September 30, 2015

	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate& Other			Total
	(In millions)
Total revenues	$	8,308		$	3,043		$	1,024		$	206		$	3,455		$	2,278		$	(283	)	$	18,031
Less: Net investment gains (losses)	142			325			9			14			57			(37		)	(128		)	382
Less: Net derivative gains (losses)	243			107			(108		)	7			227			(60		)	69			485
Less: Adjustments related to net investment gains (losses) and net derivative gains (losses)	—			2			—			(2		)	—			1			—			1
Less: Other adjustments to revenues (1)	(39		)	(205		)	(11		)	(513		)	(58		)	24			(2		)	(804		)
Total operating revenues	$	7,962		$	2,814		$	1,134		$	700		$	3,229		$	2,350		$	(222	)	$	17,967
Total expenses	$	7,182		$	2,169		$	1,005		$	126		$	2,864		$	1,961		$	561		$	15,868
Less: Adjustments related to net investment gains (losses) and net derivative gains (losses)	—			2			—			(2		)	(7		)	48			—			41
Less: Other adjustments to expenses (1)	3			(184		)	21			(499		)	(12		)	13			20			(638		)
Total operating expenses	$	7,179		$	2,351		$	984		$	627		$	2,883		$	1,900		$	541		$	16,465

__________________

(1) See definitions of operating revenues and operating expenses under “— Non-GAAP and Other Financial Disclosures” for the components of such adjustments.

119

Nine Months Ended September 30, 2016

	U.S.			Asia		Latin America		EMEA		MetLife Holdings			Brighthouse Financial			Corporate& Other			Total
	(In millions)
Total revenues	$	22,407		$	10,123	$	3,576	$	3,024	$	9,357		$	3,569		$	(656	)	$	51,400
Less: Net investment gains (losses)	13			429		8		48		142			(16		)	(86		)	538
Less: Net derivative gains (losses)	512			949		47		27		(32		)	(3,181		)	(137		)	(1,815		)
Less: Adjustments related to net investment gains (losses) and net derivative gains (losses)	—			28		—		—		—			—			—			28
Less: Other adjustments to revenues (1)	(192		)	394		37		836		(139		)	18			20			974
Total operating revenues	$	22,074		$	8,323	$	3,484	$	2,113	$	9,386		$	6,748		$	(453	)	$	51,675
Total expenses	$	19,965		$	7,433	$	3,047	$	2,624	$	8,520		$	5,682		$	759		$	48,030
Less: Adjustments related to net investment gains (losses) and net derivative gains (losses)	—			42		—		1		(257		)	(1,076		)	—			(1,290		)
Less: Goodwill impairment	—			—		—		—		—			260			—			260
Less: Other adjustments to expenses (1)	12			333		125		743		94			702			183			2,192
Total operating expenses	$	19,953		$	7,058	$	2,922	$	1,880	$	8,683		$	5,796		$	576		$	46,868

Nine Months Ended September 30, 2015

	U.S.			Asia		Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate& Other			Total
	(In millions)
Total revenues	$	22,049		$	9,267	$	3,451		$	1,953		$	10,084		$	6,677		$	(574	)	$	52,907
Less: Net investment gains (losses)	306			450		7			22			88			(3		)	(335		)	535
Less: Net derivative gains (losses)	160			134		(145		)	21			318			(166		)	72			394
Less: Adjustments related to net investment gains (losses) and net derivative gains (losses)	—			12		—			(4		)	—			—			—			8
Less: Other adjustments to revenues (1)	(119		)	80		7			(231		)	(185		)	52			7			(389		)
Total operating revenues	$	21,702		$	8,591	$	3,582		$	2,145		$	9,863		$	6,794		$	(318	)	$	52,359
Total expenses	$	19,302		$	7,374	$	3,132		$	1,706		$	8,484		$	5,457		$	1,117		$	46,572
Less: Adjustments related to net investment gains (losses) and net derivative gains (losses)	—			9		—			(4		)	61			(24		)	—			42
Less: Other adjustments to expenses (1)	(9		)	196		58			(224		)	(9		)	222			36			270
Total operating expenses	$	19,311		$	7,169	$	3,074		$	1,934		$	8,432		$	5,259		$	1,081		$	46,260

__________________

(1) See definitions of operating revenues and operating expenses under “— Non-GAAP and Other Financial Disclosures” for the components of such adjustments.

120

Consolidated Results — Operating

Three Months EndedSeptember 30, 2016 Compared with the Three Months EndedSeptember 30, 2015

Unless otherwise stated, all amounts discussed below are net of income tax.

Overview. The primary drivers of the increase in operating earnings were prior period charges for taxes and related interest expenses, as well as higher net investment income from portfolio growth, partially offset by refinements made to DAC and certain insurance-related liabilities and unfavorable underwriting.

Foreign Currency. Changes in foreign currency exchange rates had a $13 million positive impact on operating earnings for the third quarter of 2016 compared to the prior period. Unless otherwise stated, all amounts discussed below are net of foreign currency fluctuations. Foreign currency fluctuations can result in significant variances in the financial statement line items.

Business Growth. A $212 million increase in operating earnings was attributable to business growth. We benefited from positive net flows from many of our products. As a result, growth in the investment portfolios of our Asia, Brighthouse Financial, U.S., and Latin America segments generated higher net investment income. However, this was partially offset by a corresponding increase in interest credited expense on certain insurance liabilities.

Market Factors. Market factors, including sustained low interest rates, volatile equity markets, and foreign currency fluctuations, continued to impact our investment yields; however, certain impacts were mitigated by derivatives used to hedge these risks. Excluding the impact of changes in foreign currency exchange rates on reported net investment income in our non-U.S. segments and inflation-indexed investments, investment yields decreased. Investment yields were negatively impacted by the adverse impact of the sustained low interest rate environment on fixed maturity securities and mortgage loans as proceeds from maturing investments and the growth in the investment portfolio described above were invested at lower yields. Additionally, lower earnings on our securities lending program resulted from lower margins due to the impact of a flatter yield curve, as margins correlate more to the slope of the yield curve rather than the absolute level of interest rates. These decreases were partially offset by higher income on other limited partnership interests, alternative investments, bond prepayment fees, as well as currency and interest rate derivatives. In addition, we experienced higher costs associated with our variable annuity guaranteed minimum death benefits (“GMDBs”) in our Brighthouse Financial segment. These negative impacts to operating earnings were partially offset by lower DAC amortization, primarily in our Brighthouse Financial segment. The changes in market factors discussed above resulted in a $25 million decrease in operating earnings.

Underwriting, Actuarial Assumption Review and Other Insurance Adjustments. Unfavorable underwriting resulted in a $96 million decrease in operating earnings and was primarily due to unfavorable mortality, primarily in our Brighthouse Financial, MetLife Holdings and U.S. segments, partially offset by favorable morbidity in our U.S. segment. The impact of the annual actuarial assumption review resulted in an $11 million increase in operating earnings. The annual assumption review in the current period included our annuity and life businesses with the exception of our U.S. variable annuity business, which was reviewed in the second quarter of 2016; whereas, the annual review in the prior period included all of our annuity and life businesses. Refinements to DAC and certain insurance-related liabilities, which were recorded in both periods, resulted in a $232 million decrease in operating earnings, primarily as a result of a current period one-time charge of $254 million in our Brighthouse Financial segment, which was mostly recognized as a write-off of DAC. Our Brighthouse Financial segment also includes a current period charge of $42 million which resulted in an increase in our insurance-related liabilities. Both of these charges were due to loss recognition testing upon re-segmentation.

Expenses and Taxes. In the prior period, other expenses include the aforementioned $235 million charge for interest on uncertain tax positions. In addition, other expenses declined $51 million, primarily due to lower costs associated with corporate initiatives and projects and the impact of the U.S. Retail Advisor Force Divestiture. The Company’s current and prior period effective tax rates differed from the U.S. statutory rate of 35%, primarily due to non-taxable investment income, tax credits for low income housing, and foreign earnings taxed at lower rates than the U.S. statutory rate. Current period results include a one-time tax benefit of $36 million for tax audit settlements, offset by a charge of $22 million related to the filing of the U.S. federal tax return. Prior period results include a one-time tax charge of $557 million recorded under accounting guidance for the recognition of tax uncertainties. In addition, prior period results include one-time tax benefits of $60 million related to the restructuring of our business in Chile, $31 million related to the repatriation of earnings from Japan and $16 million related to the filing of the Company’s U.S. federal tax return.

Nine Months Ended September 30, 2016 Compared with the Nine Months Ended September 30, 2015

Unless otherwise stated, all amounts discussed below are net of income tax.

121

Overview. The primary drivers of the decrease in operating earnings were lower investment yields, refinements made to DAC and certain insurance-related liabilities, unfavorable underwriting and the impact of our annual actuarial assumption review, partially offset by prior period charges for taxes and related interest expenses, as well as higher net investment income from portfolio growth.

Foreign Currency. Changes in foreign currency exchange rates had a $36 million negative impact on operating earnings for the first nine months of 2016 compared to the prior period. Unless otherwise stated, all amounts discussed below are net of foreign currency fluctuations. Foreign currency fluctuations can result in significant variances in the financial statement line items.

Business Growth. A $522 million increase in operating earnings was attributable to business growth. We benefited from positive net flows from many of our products. As a result, growth in the investment portfolios of our Asia, Brighthouse Financial, U.S., and Latin America segments generated higher net investment income. However, this was partially offset by a corresponding increase in interest credited expense on certain insurance-related liabilities.

Market Factors. Market factors, including sustained low interest rates, volatile equity markets, and foreign currency fluctuations, continued to impact our investment yields; however, certain impacts were mitigated by derivatives used to hedge these risks. Excluding the impact of changes in foreign currency exchange rates on reported net investment income in our non-U.S. segments and inflation-indexed investments, investment yields decreased. Investment yields were negatively impacted by the adverse impact of the sustained low interest rate environment on fixed maturity securities and mortgage loans, as proceeds from maturing investments and the growth in the investment portfolio described above were invested at lower yields, in addition to a decrease in other limited partnership interests. Additionally, lower investment earnings on our securities lending program resulted from lower margins due to the impact of a flatter yield curve. These decreases in net investment income were partially offset by higher income on currency and interest rate derivatives. In our Brighthouse Financial and MetLife Holdings segments, declines in our average separate account balances resulted in a decrease in asset-based fee income. The changes in market factors discussed above resulted in a $800 million decrease in operating earnings.

Underwriting, Actuarial Assumption Review and Other Insurance Adjustments. Unfavorable underwriting resulted in a $208 million decrease in operating earnings as a result of higher non-catastrophe claim costs, less favorable development of prior year non-catastrophe losses, a charge related to an adjustment to reinsurance receivables in our Asia segment, as well as unfavorable mortality and morbidity experience primarily in our MetLife Holdings segment. The impact of the annual actuarial assumption review, which occurred in both periods, resulted in a $154 million decrease in operating earnings. Refinements to DAC and certain insurance-related liabilities, which were recorded in both periods, resulted in a $524 million decrease in operating earnings, primarily as a result of a current period reserve adjustment of $257 million resulting from modeling improvements in the reserving process in our universal life businesses, as well as the aforementioned current period charges in our Brighthouse Financial segment totaling $296 million due to loss recognition testing upon re-segmentation.

Expenses and Taxes. In the prior period, other expenses include the aforementioned $235 million charge for interest on uncertain tax positions. In addition, other expenses declined $78 million, primarily due to lower costs associated with corporate initiatives and projects, a decrease in employee-related costs and the impact of the U.S. Retail Advisor Force Divestiture. The Company’s current and prior period effective tax rates differed from the U.S. statutory rate of 35% primarily due to non-taxable investment income, tax credits for low income housing, and foreign earnings taxed at lower rates than the U.S. statutory rate. The current period includes one-time tax charges of $26 million related to the repatriation of earnings from Japan, $22 million related to the filing of the U.S. federal tax return and $12 million in Chile related to change in tax rate, offset by one-time tax benefits of $36 million for tax audit settlements and $25 million in Japan, also related to a change in tax rate. The $25 million benefit includes a one-time benefit of $20 million that pertains to prior periods; the $12 million tax charge includes a one-time charge of $10 million that pertains to prior periods. Prior period results include a one-time tax charge of $557 million recorded under accounting guidance for the recognition of tax uncertainties. In addition, prior period results include one-time tax benefits of $61 million in Japan related to a change in tax rate, $60 million related to the restructuring of our business in Chile, $31 million related to the repatriation of earnings from Japan and $16 million related to the filing of the Company’s U.S. federal tax return.

122

Segment Results and Corporate & Other

U.S.

Business Overview.An increase in sales was primarily driven by the timing of our funding agreement issuances in our Retirement & Income Solutions business. Funding ratios for defined benefit pension plans of S&P 500 companies continued to fall in 2016, limiting their ability to engage in full pension plan buyouts. However, we expect that customers may choose to close out portions of pension plans over time, with the largest volume of business generally occurring near the end of any year. The impact of this decline in funding ratios for defined benefit pension plans of S&P 500 companies was lower pension risk transfers, which resulted in lower premiums. In addition, sales of income annuities and post-retirement benefit products were lower. These decreases were partially offset by the impact of a change in competitive pricing in the market, which drove an increase in structured settlement annuity sales. Changes in premiums for the Retirement & Income Solutions business were almost entirely offset by the related changes in policyholder benefits and claims. In our Property & Casualty business, sales of new policies were slightly lower for both the auto and homeowners lines of business. New policy sales were not sufficient to offset the impact of policies that were not renewed, resulting in a decrease in exposures. Sales improved across the Group Benefits business compared to the prior period.

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Operating revenues
Premiums	$	5,936		$	6,023		$	16,127		$	15,712
Universal life and investment-type product policy fees	245			233			743			700
Net investment income	1,590			1,522			4,615			4,723
Other revenues	192			184			589			567
Total operating revenues	7,963			7,962			22,074			21,702
Operating expenses
Policyholder benefits and claims and policyholder dividends	5,894			5,976			16,210			15,675
Interest credited to policyholder account balances	322			304			967			905
Capitalization of DAC	(124		)	(128		)	(356		)	(365		)
Amortization of DAC and VOBA	117			118			353			352
Interest expense on debt	2			1			7			4
Other operating expenses	912			908			2,772			2,740
Total operating expenses	7,123			7,179			19,953			19,311
Provision for income tax expense (benefit)	288			272			720			819
Operating earnings	$	552		$	511		$	1,401		$	1,572

Three Months Ended September 30, 2016 Compared with the Three Months Ended September 30, 2015

Unless otherwise stated, all amounts discussed below are net of income tax.

Business Growth. An increase in average premium per policy in both our auto and homeowners businesses improved operating earnings. In addition, higher deposits and funding agreement issuances in the current period resulted in higher invested assets, which drove an increase in net investment income. However, consistent with the growth in average invested assets from increased premiums, interest credited on long-duration contracts increased. In addition, an increase in other operating expenses, mainly the result of growth across the segment, was more than offset by the remaining increase in premiums, fees and other revenues. The combined impact of the items discussed above increased operating earnings by $46 million.

123

Market Factors. Market factors, including sustained low interest rates, volatile equity markets, and foreign currency fluctuations, continued to impact our investment yields; however, certain impacts were mitigated by derivatives used to hedge these risks. Investment yields increased driven by higher income on interest rate and currency derivatives, higher returns on real estate and real estate joint ventures, hedge funds and alternative investments. These increases were partially offset by the adverse impact of the sustained low interest rate environment on our fixed maturity securities, as proceeds from maturing investments and the growth in the investment portfolio described above, were invested at lower yields, as well as lower returns on private equities. In addition, lower interest crediting rates, consistent with the sustained low interest rate environment, contributed to the increase to operating earnings. The changes in market factors discussed above resulted in an $8 million increase in operating earnings.

Underwriting. Less favorable mortality in our term life business, mainly due to higher severity, was partially offset by favorable claims experience in our universal life business, which resulted in a decrease of $24 million in operating earnings. Favorable claims experience in our dental business combined with favorable morbidity in our individual disability business drove an increase in operating earnings of $18 million. Favorable mortality from our income annuity business was mostly offset by less favorable mortality in our specialized life insurance products. In our Property & Casualty business, non-catastrophe claim costs increased by $16 million, as a result of higher severities and frequencies in both our auto and homeowners businesses. In addition, our Property & Casualty business experienced less favorable development of prior year non-catastrophe losses of $8 million. These decreases were partially offset by a decrease in catastrophe losses of $10 million.

Nine Months Ended September 30, 2016 Compared with the Nine Months Ended September 30, 2015

Unless otherwise stated, all amounts discussed below are net of income tax.

Business Growth. An increase in average premium per policy in both our auto and homeowners businesses improved operating earnings. The impact of deposits, funding agreement issuances and increased premiums in the current period resulted in higher average invested assets, improving net investment income. However, consistent with the growth in average invested assets from increased premiums, interest credited on long-duration contracts increased. In addition, an increase in other operating expenses, mainly the result of growth across the segment, was more than offset by the remaining increase in premiums, fees and other revenues. The combined impact of the items discussed above increased operating earnings by $124 million.

Market Factors.Market factors, including sustained low interest rates, volatile equity markets, and foreign currency fluctuations, continued to impact our investment yields: however, certain impacts were mitigated by derivatives used to hedge these risks.Investment yields decreased as a result of the impact of the sustained low interest rate environment on fixed maturity securities, asproceeds from maturing investments and the growth in the investment portfolio described above were invested at lower yields, as well as lower returns on other limited partnership interests and alternative investments. Additionally, lower investment earnings on our securities lending program resulted primarily from lower margins due to the impact of a flatter yield curve. These unfavorable changes were partially offset by higher income on interest rate and currency derivatives and higher returns on real estate and real estate joint ventures. Certain of our funding agreements and guaranteed interest contract liabilities have interest credited rates that are contractually tied to current market rates, specifically the 3-month London Interbank Offered Rate(“LIBOR”) and, as a result, a higher average interest credited rate drove an increase in interest credited expense.The changes in market factors discussed above resulted in an $181 million decrease in operating earnings.

Underwriting and Other Insurance Adjustments. Unfavorable claims experience in our group disability and dental businesses were mostly offset by favorable claims experience in our individual disability and voluntary businesses and resulted in a $5 million decrease in operating earnings. Favorable mortality in the current period, mainly due to favorable claims experience in our life business, resulted in a $29 million increase in operating earnings. Less favorable mortality from our specialized life insurance products and pension risk transfer business resulted in a $16 million decrease in operating earnings. In our Property & Casualty business, non-catastrophe claim costs increased by $62 million, resulting from higher frequencies and severities in both our auto and homeowners businesses. In addition, less favorable development of prior year non-catastrophe losses reduced operating earnings by $36 million and an increase in catastrophe losses reduced operating earnings $8 million. Refinements to certain insurance and other liabilities, which were recorded in both periods, resulted in a $23 million decrease in operating earnings.

124

Asia

Business Overview. Sales decreased compared to the prior period primarily due to management actions taken to improve product value in the region. In Japan, we have seen a successful shift in sales to foreign currency life products from yen life products and a decrease in accident and health sales. Sales also decreased, in comparison, as a result of the sale of a large group contract in Australia in the prior period. Sales increased in China, Hong Kong and Bangladesh mainly due to business growth.

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Operating revenues
Premiums	$	1,822		$	1,736		$	5,161		$	5,297
Universal life and investment-type product policy fees	394			382			1,114			1,179
Net investment income	707			670			2,003			2,033
Other revenues	12			26			45			82
Total operating revenues	2,935			2,814			8,323			8,591
Operating expenses
Policyholder benefits and claims and policyholder dividends	1,363			1,331			3,923			4,046
Interest credited to policyholder account balances	331			327			974			992
Capitalization of DAC	(440		)	(435		)	(1,251		)	(1,268		)
Amortization of DAC and VOBA	331			309			921			971
Amortization of negative VOBA	(46		)	(77		)	(167		)	(241		)
Other operating expenses	930			896			2,658			2,669
Total operating expenses	2,469			2,351			7,058			7,169
Provision for income tax expense (benefit)	142			125			377			332
Operating earnings	$	324		$	338		$	888		$	1,090

Three Months Ended September 30, 2016 Compared with the Three Months Ended September 30, 2015

Unless otherwise stated, all amounts discussed below are net of income tax.

Following a change in the foreign investment law in India, the Company no longer consolidates its India operating joint venture, effective January 1, 2016. While this change in accounting does affect the comparability of the financial statement line items, it did not have a significant impact on operating earnings and, therefore, is not discussed below.

Foreign Currency. The impact of changes in foreign currency exchange rates increased operating earnings by $27 million for the third quarter of 2016 compared to the prior period as a result of the strengthening of the Japanese yen and the Korean won against the U.S. dollar. Unless otherwise stated, all amounts discussed below are net of foreign currency fluctuations. Foreign currency fluctuations can result in significant variances in the financial statement line items.

Business Growth. Positive net flows in Japan and Korea resulted in higher average invested assets and an increase in net investment income. Asia’s premiums and fees decreased from the prior period mainly driven by lower fixed annuity surrenders and the continued shift from premium-based to fee-based products in the current period, as well as the discontinuation of single premium products in our accident and health business in Japan in the third quarter of 2015. Changes in premiums for these businesses were partially offset by related changes in policyholder benefits. The combined impact of the items discussed above improved operating earnings by $76 million.

Market Factors. Investment returns were unfavorably impacted by lower interest rates on fixed maturity securities, as well as the impact of incremental income recognized in the prior period from recovery of a previously impaired mortgage loan in Japan. These decreases were partially offset by improved returns on other limited partnership interests and the favorable impact of increased foreign currency-denominated fixed annuities in Japan, which drove an increase in higher yielding foreign currency-denominated fixed maturity securities. Lower investment yields, combined with the impact of foreign currency hedges, decreased operating earnings by $111 million.

125

Actuarial Assumption Review and Other Insurance Adjustments. The impact of our annual actuarial assumption review, which occurred in both periods, resulted in a net decrease of $35 million in operating earnings. Refinements to certain insurance and other liabilities, which were recorded in the current period, resulted in a $29 million increase in operating earnings.

Expenses and Taxes. A $14 million decrease in expenses was primarily driven by declines in corporate overhead, project costs, information-technology and marketing expenses, as well as lower consumption tax. Current period results include a $7 million tax benefit due to a lower tax rate in Japan. Prior period results include one-time tax benefits of $15 million related to the U.S. taxation of dividends from Japan and $6 million for a tax refund in Korea related to unclaimed surrender value.

Nine Months Ended September 30, 2016 Compared with the Nine Months Ended September 30, 2015

Unless otherwise stated, all amounts discussed below are net of income tax.

Following a change in the foreign investment law in India, the Company no longer consolidates its India operating joint venture, effective January 1, 2016. While this change in accounting does affect the comparability of the financial statement line items, it did not have a significant impact on operating earnings and, therefore, is not discussed below.

Foreign Currency. The impact of changes in foreign currency exchange rates increased operating earnings by $34 million for the first nine months of 2016 compared to the prior period as a result of the strengthening of the Japanese yen and the Korean won against the U.S. dollar. Unless otherwise stated, all amounts discussed below are net of foreign currency fluctuations. Foreign currency fluctuations can result in significant variances in the financial statement line items.

Business Growth. Positive net flows in Japan and Korea resulted in higher average invested assets and an increase in net investment income. Asia’s premiums and fees decreased from the prior period mainly driven by lower fixed annuity surrenders and the shift from premium-based to fee-based products in the current period and the discontinuation of single premium products in our accident & health business in Japan in the third quarter of 2015. Changes in premiums for these businesses were partially offset by related changes in policyholder benefits. The combined impact of the items discussed above improved operating earnings by $123 million.

Market Factors. Investment returns were unfavorably impacted by lower interest rates on fixed maturity securities and lower returns on other limited partnership interests in Japan, as well as the impact of incremental income recognized in the prior period from recovery of a previously impaired mortgage loan in Japan. The decreases in investment returns were partially offset by the favorable impact of increased foreign currency-denominated fixed annuities in Japan, which drove an increase in higher yielding foreign currency-denominated fixed maturity securities. Lower investment yields, combined with the impact of foreign currency hedges, decreased operating earnings by $222 million.

Underwriting, Actuarial Assumption Review and Other Insurance Adjustments. Our results for the current period include a $44 million charge related to an adjustment to reinsurance receivables in Australia. Excluding this charge, favorable claims experience in Australia and Korea, which was partially offset by lower fixed annuity surrender gains and higher lapses in Japan, increased operating earnings by $7 million. The impact of our annual actuarial assumption review, which occurred in both periods, resulted in a net decrease of $35 million in operating earnings. Refinements to certain insurance and other liabilities, which were recorded in the current period, resulted in a $29 million increase in operating earnings.

Taxes. Current period results include a $25 million tax benefit related to a change in the corporate tax rate in Japan (which includes a one-time benefit of $20 million that pertains to prior periods) and a $26 million tax charge related to the U.S. taxation of dividends from Japan. Prior period results include one-time tax benefits of $61 million related to a change in tax rates, $12 million for the settlement of an audit and $15 million related to the U.S. taxation of dividends, each related to Japan. In addition, in the prior period, Korea received a tax refund of $6 million related to unclaimed surrender value.

126

Latin America

Business Overview. Total sales for Latin America were down. The region experienced lower group life, medical and pension sales, partially offset by higher sales of property & casualty and accident & health products.

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Operating revenues
Premiums	$	653		$	586		$	1,885		$	1,925
Universal life and investment-type product policy fees	227			261			764			856
Net investment income	311			277			809			774
Other revenues	11			10			26			27
Total operating revenues	1,202			1,134			3,484			3,582
Operating expenses
Policyholder benefits and claims and policyholder dividends	681			581			1,814			1,793
Interest credited to policyholder account balances	85			88			249			263
Capitalization of DAC	(83		)	(81		)	(236		)	(246		)
Amortization of DAC and VOBA	(2		)	48			127			195
Amortization of negative VOBA	(1		)	—			(1		)	(1		)
Interest expense on debt	1			—			1			—
Other operating expenses	335			348			968			1,070
Total operating expenses	1,016			984			2,922			3,074
Provision for income tax expense (benefit)	53			(33		)	141			40
Operating earnings	$	133		$	183		$	421		$	468

Three Months Ended September 30, 2016 Compared with the Three Months Ended September 30, 2015

Unless otherwise stated, all amounts discussed below are net of income tax.

Foreign Currency. The impact of changes in foreign currency exchange rates decreased operating earnings by $10 million for the third quarter of 2016 compared to the prior period mainly due to the weakening of the Mexican peso against the U.S. dollar. Unless otherwise stated, all amounts discussed below are net of foreign currency fluctuations. Foreign currency fluctuations can result in significant variances in the financial statement line items.

Business Growth. Latin America experienced business growth across several lines of business within Chile and Argentina. This business growth resulted in increased premiums, which was partially offset by the related changes in policyholder benefits. Positive net flows, primarily from Chile and Mexico, resulted in an increase in average invested assets and generated higher net investment income. This was partially offset by a corresponding increase in interest credited expense on certain insurance liabilities. Business growth also drove an increase in commissions, which were offset by increased DAC capitalization. The items discussed above resulted in a $16 million increase in operating earnings.

Market Factors. Changes in market factors resulted in a $24 million increase to operating earnings. An increase in investment yields was primarily driven by higher returns on alternative investments in Chile, as well as a change in the crediting rate on allocated equity in Mexico and Chile. These increases were partially offset by lower returns on fixed maturity securities in Chile.

Underwriting, Actuarial Assumption Review and Other Insurance Adjustments. Unfavorable underwriting resulted in a $9 million decrease to operating earnings, driven by higher claims experience in Mexico. The impact of the annual actuarial assumption review, which occurred in both periods, resulted in a net operating earnings increase of $16 million. Refinements to certain insurance liabilities and other adjustments in both the current and prior periods resulted in a $6 million decrease in operating earnings.

Taxes. Effective September 1, 2015, AFP ProVida was merged into MetLife Chile Acquisition Company resulting in a one-time income tax benefit of $60 million in 2015. In addition, other tax-related adjustments resulted in a net decrease in operating earnings of $17 million and were mainly driven by tax charges related to the filing of local tax returns in Mexico and Chile.

127

Nine Months Ended September 30, 2016 Compared with the Nine Months Ended September 30, 2015

Unless otherwise stated, all amounts discussed below are net of income tax.

Foreign Currency. The impact of changes in foreign currency exchange rates decreased operating earnings by $58 million for the first nine months of 2016 compared to the prior period mainly due to the weakening of the Mexican and Chilean pesos against the U.S. dollar. Unless otherwise stated, all amounts discussed below are net of foreign currency fluctuations. Foreign currency fluctuations can result in significant variances in the financial statement line items.

Business Growth. Latin America experienced business growth across several lines of business within Mexico, Chile and Argentina, as well as in the ProVida pension business. This business growth resulted in increased premiums and policy fee income which was partially offset by the related changes in policyholder benefits. Positive net flows, primarily from Chile and Mexico, resulted in an increase in average invested assets and generated higher net investment income. This was partially offset by a corresponding increase in interest credited expense on certain insurance liabilities. Business growth also drove an increase in operating expenses, commissions and DAC amortization, which were partially offset by higher DAC capitalization. The items discussed above resulted in a $56 million increase in operating earnings.

Market Factors. Changes in market factors resulted in a $22 million increase to operating earnings as higher investment yields were partially offset by higher interest credited expense. An increase in investment yields was primarily driven by current period change in the crediting rate on allocated equity in Mexico and Chile and higher yields from fixed maturity securities in Argentina, Brazil and Mexico. These increases were partially offset by lower returns on fixed maturity securities and mortgage loans in Chile.

Underwriting, Actuarial Assumption Review and Other Insurance Adjustments. Favorable underwriting resulted in a $6 million increase in operating earnings driven by lower claims experience in Mexico and Chile. The impact of the annual actuarial assumption review, which occurred in both periods, resulted in a net operating earnings increase of $16 million. Refinements to certain insurance liabilities and other adjustments in both the current and prior periods resulted in a $2 million decrease to operating earnings.

Taxes. Effective September 1, 2015, AFP ProVida was merged into MetLife Chile Acquisition Company resulting in a one-time income tax benefit of $60 million in 2015. In the first quarter of 2016, our Chilean businesses, including ProVida, incurred a tax charge of $12 million as a result of tax reform legislation in Chile (including a one-time charge of $10 million that pertains to prior periods). In addition, other tax-related adjustments resulted in a net decrease in operating earnings of $7 million and were mainly driven by tax charges related to the filing of local tax returns in Mexico and Chile, partially offset by a 2016 tax benefit related to the devaluation of the peso in Argentina.

128

EMEA

Business Overview. Sales have increased due to growth in the Middle East and the U.K., partially offset by strong prior period sales in Poland.

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Operating revenues
Premiums	$	500		$	501		$	1,519		$	1,534
Universal life and investment-type product policy fees	104			106			294			322
Net investment income	81			82			244			249
Other revenues	17			11			56			40
Total operating revenues	702			700			2,113			2,145
Operating expenses
Policyholder benefits and claims and policyholder dividends	257			233			801			737
Interest credited to policyholder account balances	28			27			87			91
Capitalization of DAC	(103		)	(107		)	(310		)	(372		)
Amortization of DAC and VOBA	106			127			311			388
Amortization of negative VOBA	(3		)	(5		)	(10		)	(13		)
Other operating expenses	332			352			1,001			1,103
Total operating expenses	617			627			1,880			1,934
Provision for income tax expense (benefit)	11			7			32			25
Operating earnings	$	74		$	66		$	201		$	186

Three Months Ended September 30, 2016 Compared with the Three Months Ended September 30, 2015

Unless otherwise stated, all amounts discussed below are net of income tax.

Foreign Currency. The impact of changes in foreign currency exchange rates reduced operating earnings by $4 million for the third quarter of 2016 compared to the prior period, primarily driven by the strengthening of the U.S. dollar against the British pound and Russian ruble. Unless otherwise stated, all amounts discussed below are net of foreign currency fluctuations. Foreign currency fluctuations can result in significant variances in the financial statement line items.

Business Growth. Operating earnings benefited from business growth in the Middle East and the U.K., increasing operating earnings by $11 million.

Underwriting, Actuarial Assumption Review and Other Insurance Adjustments. Favorable underwriting, primarily in our accident & health business in Greece, resulted in an operating earnings increase of $10 million. The impact of the annual actuarial assumption review, which occurred in both periods, resulted in a net operating earnings decrease of $22 million. Refinements to certain insurance liabilities and other adjustments in the current period resulted in a $3 million increase to operating earnings.

Expenses. Operating earnings increased by $12 million primarily due to expense discipline across the region and lower allocated corporate overhead expenses.

Taxes. The Company received tax benefits in both periods; however, since the prior period benefit exceeded the current period benefit, operating earnings decreased by $5 million.

Nine Months Ended September 30, 2016 Compared with the Nine Months Ended September 30, 2015

Unless otherwise stated, all amounts discussed below are net of income tax.

Foreign Currency. The impact of changes in foreign currency exchange rates reduced operating earnings by $12 million for the first nine months of 2016 compared to the prior period, primarily driven by the strengthening of the U.S. dollar against the Russian ruble, British pound, Turkish lira and Egyptian pound. Unless otherwise stated, all amounts discussed below are net of foreign currency fluctuations. Foreign currency fluctuations can result in significant variances in the financial statement line items.

129

Business Growth. Operating earnings benefited from business growth in the Middle East and the U.K., increasing operating earnings by $31 million.

Underwriting, Actuarial Assumption Review and Other Insurance Adjustments. Unfavorable underwriting, primarily in our employee benefits business, was largely offset by favorable underwriting, primarily in our accident & health business in Greece, and resulted in an operating earnings decrease of $2 million. The impact of the annual actuarial assumption review, which occurred in both periods, resulted in a net operating earnings decrease of $22 million. Refinements to certain insurance liabilities and other adjustments in the current period resulted in a $3 million increase to operating earnings.

Expenses. Operating earnings increased by $27 million primarily due to expense discipline across the region and lower allocated corporate overhead expenses.

Taxes and Other. The Company received tax benefits in both periods; however, since the prior period benefit exceeded the current period benefit, operating earnings decreased by $9 million. Prior period operating earnings also benefited by $7 million as a result of the conversion to calendar year reporting for certain of our subsidiaries. Our current period operating earnings included a $3 million benefit following the cancellation of a distribution agreement with one of our bancassurance partners.

MetLife Holdings

Business Overview. As a result of the proposed Separation and the U.S. Retail Advisor Force Divestiture, we have discontinued the marketing of life and annuity products in this segment, which has led to lower sales and will result in a declining DAC asset over time. A significant portion of our operating earnings is driven by separate account balances. Most directly, these balances determine asset-based fee income but they also impact DAC amortization and asset-based commissions. Separate account balances are driven by sales, movements in the market, surrenders, withdrawals, benefit payments, transfers and policy charges. Separate account balances have increased due to market performance, partially offset by the impact of negative net flows, as benefits, surrenders and withdrawals exceeded sales. While net flows are still negative, we are seeing stability in surrenders and withdrawals. Although we have discontinued selling our long-term care product, we continue to collect premiums and administer the existing block of business, which contributed to asset growth in the segment.

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Operating revenues
Premiums	$	1,093		$	1,115		$	3,312		$	3,345
Universal life and investment-type product policy fees	357			370			1,073			1,117
Net investment income	1,537			1,521			4,489			4,690
Other revenues	105			223			512			711
Total operating revenues	3,092			3,229			9,386			9,863
Operating expenses
Policyholder benefits and claims and policyholder dividends	1,853			1,885			5,603			5,479
Interest credited to policyholder account balances	261			266			780			793
Capitalization of DAC	(44		)	(101		)	(240		)	(292		)
Amortization of DAC and VOBA	219			173			636			423
Interest expense on debt	15			13			43			41
Other operating expenses	401			647			1,861			1,988
Total operating expenses	2,705			2,883			8,683			8,432
Provision for income tax expense (benefit)	121			103			203			454
Operating earnings	$	266		$	243		$	500		$	977

Three Months Ended September 30, 2016 Compared with the Three Months Ended September 30, 2015

Unless otherwise stated, all amounts discussed below are net of income tax.

130

Business Growth. A decrease in our invested asset base was primarily due to negative net flows in our life business and the recapture of an assumed fixed annuity agreement with an affiliate, which is reported in our Brighthouse Financial segment, in the second quarter of 2016. These declines were partially offset by the aforementioned impact of our long-term care business on asset growth, resulting in a modest decrease in net investment income. Consistent with the asset growth in the long-term care business, interest credited on insurance liabilities increased. These decreases in operating earnings were offset by the elimination of an operating loss from the broker-dealer operations in connection with the U.S. Retail Advisor Force Divestiture in the current period. The elimination of the operating loss from the broker-dealer operations resulted in declines in both revenues and expenses. In addition, the decreases in operating earnings were also offset by lower interest expense related to the aforementioned recapture of an assumed fixed annuity agreement. The net impact of the aforementioned items resulted in a $32 million increase in operating earnings.

Market Factors. Market factors, including sustained low interest rates, volatile equity markets, and foreign currency fluctuations, continued to impact our investment yields; however, certain impacts were mitigated by derivatives used to hedge these risks. Higher returns on other limited partnership interests and increased prepayment fees contributed to this increase in operating earnings. In addition, the impact of lower average crediting rates on certain insurance liabilities and a decrease in DAC amortization contributed to the increase in operating earnings. These increases were partially offset by the impact of the sustained low interest rate environment on net investment income, specifically from fixed maturity securities and mortgage loans as proceeds from maturing investments were reinvested at lower yields. In addition, we had lower income on interest rate derivatives. The changes in market factors discussed above resulted in a $21 million increase in operating earnings.

Underwriting, Actuarial Assumption Review and Other Insurance Adjustments. Unfavorable mortality in our universal life and traditional life, businesses was partially offset by favorable morbidity in our long-term care business and resulted in a decrease of $30 million in operating earnings. The results of our annual review of actuarial assumptions resulted in a decrease in operating earnings of $10 million. The annual review in the current period included our annuity and life businesses with the exception of our U.S. variable annuity business, which was reviewed in the second quarter of 2016; whereas, the annual review in the prior period included all of our annuity and life businesses. Refinements to DAC and certain insurance-related liabilities recorded in the current period resulted in an increase in operating earnings of $5 million. In addition, an increase in policyholder dividends in the closed block, which we instituted in the fourth quarter of 2015, decreased operating earnings by $10 million.

Expenses. Operating earnings increased due to a decline in expenses of $18 million, mainly the result of lower amortization of deferred reinsurance commissions related to certain variable annuity reinsurance agreements entered into with an affiliate, which is reported in our Brighthouse Financial segment.

Nine Months Ended September 30, 2016 Compared with the Nine Months Ended September 30, 2015

Unless otherwise stated, all amounts discussed below are net of income tax.

Business Growth. Our life, annuities and long-term care businesses experienced net asset growth, which resulted in higher net investment income; however, consistent with the aforementioned asset growth, interest credited on insurance liabilities also increased. Additionally, the elimination of an operating loss from the broker-dealer operations in connection with the U.S. Retail Advisor Force Divestiture in the current period increased operating earnings. The elimination of the operating loss from the broker-dealer operations resulted in declines in both revenues and expenses. The aforementioned recapture of an assumed fixed annuity reinsurance agreement resulted in lower interest expense and an offsetting increase in DAC amortization. These increases were partially offset by a lower invested asset base due to the aforementioned recapture of an assumed fixed annuity agreement, the impact of lower sales and lower surrender charges in the current period. The combined impact of the items discussed above resulted in a $43 million increase in operating earnings.

Market Factors. Market factors, including sustained low interest rates, volatile equity markets, and foreign currency fluctuations, continued to impact our investment yields; however, certain impacts were mitigated by derivatives used to hedge these risks. Investment yields decreased on our fixed maturity securities and mortgage loans as proceeds from maturing investments and the growth in the investment portfolio described above were invested at lower yields. In addition, we had lower income on interest rate derivatives and alternative investments, as well as lower returns on other limited partnership interests. These decreases in net investment income were partially offset by higher prepayment fees and higher income on currency derivatives. In the deferred annuity business, operating earnings declined due to lower asset-based fee income, as average separate account balances decreased and DAC amortization increased. The changes in market factors discussed above resulted in a $193 million decrease in operating earnings.

131

Underwriting, Actuarial Assumption Review and Other Insurance Adjustments. Unfavorable claims experience in our long-term care business, unfavorable mortality in our traditional life businesses and less favorable fund returns related to a significant reinsurance treaty resulted in a $45 million decrease in operating earnings. The impact of our annual actuarial assumption review, which occurred in both periods, resulted in a net operating earnings decrease of $34 million and was primarily related to unfavorable DAC unlockings. Refinements to DAC and certain insurance-related liabilities that were recorded in both periods resulted in a $77 million decrease in operating earnings, which includes a current period reserve adjustment resulting from modeling improvements in the reserving process in our universal life business. In addition, an increase in policyholder dividends in the closed block, which we instituted in the fourth quarter of 2015, decreased operating earnings by $19 million.

Expenses. A $149 million net increase in expenses was primarily the result of costs associated with the aforementioned recapture of an assumed fixed annuity agreement. This increase in expenses was partially offset by lower amortization of deferred reinsurance commissions related to certain variable annuity reinsurance agreements entered into with an affiliate, which is reported in our Brighthouse Financial segment, as well as lower technology and employee-related costs.

Brighthouse Financial

Business Overview. Sales from our life business decreased by 46%, primarily due to the U.S. Retail Advisor Force Divestiture at the beginning of the third quarter of 2016. Annuity sales decreased by 34%, primarily driven by a 50% decrease in variable annuity sales as a result of the proposed Separation and the suspension of sales through one distributor. In our annuities business, despite positive market performance in the current period, average separate account balances decreased primarily due to higher negative net flows and the impact of a significant market decline in the third quarter of 2015, which was not fully reflected in the prior period average asset balance.

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Operating revenues
Premiums	$	347		$	468		$	1,020		$	1,159
Universal life and investment-type product policy fees	903			921			2,622			2,789
Net investment income	941			862			2,624			2,536
Other revenues	50			99			482			310
Total operating revenues	2,241			2,350			6,748			6,794
Operating expenses
Policyholder benefits and claims and policyholder dividends	814			846			2,525			2,103
Interest credited to policyholder account balances	288			313			868			940
Capitalization of DAC	(70		)	(102		)	(255		)	(305		)
Amortization of DAC and VOBA	509			197			823			595
Interest expense on debt	32			32			96			96
Other operating expenses	560			614			1,739			1,830
Total operating expenses	2,133			1,900			5,796			5,259
Provision for income tax expense (benefit)	40			103			260			410
Operating earnings	$	68		$	347		$	692		$	1,125

Three Months Ended September 30, 2016 Compared with the Three Months Ended September 30, 2015

Unless otherwise stated, all amounts discussed below are net of income tax.

Business Growth. A $50 million increase in operating earnings was attributable to business growth. Net investment income increased as a result of a larger invested asset base due to the recapture of a ceded fixed annuity agreement with an affiliate, which is reported in our MetLife Holdings segment, in the second quarter of 2016. Invested assets also increased as a result of a capital contribution from MetLife, Inc. and positive net flows in our general account from our annuities and life businesses, partially offset by funding agreement repayments. In our annuities business, other revenues decreased due to the aforementioned recapture of a ceded fixed annuity agreement.

132

Market Factors. Market factors, including sustained low interest rates, volatile equity markets, and foreign currency fluctuations, continued to impact our investment yields; however, certain impacts were mitigated by derivatives used to hedge these risks. Investment yields decreased on fixed maturity securities and mortgage loans, as proceeds from maturing investments and the growth in the investment portfolio described above were invested at lower yields. Additionally, lower investment earnings on our securities lending program resulted from the impact of the sustained low interest rate environment and lower margins due to the impact of a flatter yield curve, as margins correlate more to the slope of the yield curve rather than the absolute level of interest rates. These unfavorable changes were partially offset by higher income on other limited partnership interests, interest rate and currency derivatives and real estate joint ventures. In our annuities business, lower equity returns in 2015 drove a decline in our average separate account balances which resulted in a decrease in asset-based fee income relative to the prior period. In addition, we experienced higher costs associated with our variable annuity GMDBs. These negative impacts to operating earnings were partially offset by lower DAC amortization and lower average interest credited rates for our annuities business. The changes in market factors discussed above resulted in a $21 million decrease in operating earnings.

Underwriting, Actuarial Assumption Review and Other Insurance Adjustments. Less favorable mortality experience in our universal life and run-off businesses, partially offset by favorable mortality in our traditional life and income annuity businesses resulted in a net decrease of $51 million to operating earnings. The impact of our annual actuarial assumption review resulted in a net increase in operating earnings of $62 million, primarily related to favorable unlockings in our annuities and life businesses. The annual review in the current period included our annuity and life businesses with the exception of our U.S. variable annuity business, which was reviewed in the second quarter of 2016; whereas, the annual review in the prior period included all of our annuity and life businesses. Refinements to DAC and certain insurance-related liabilities recorded in the current period resulted in a decrease in operating earnings of $275 million, primarily as a result of a $254 million one-time charge, mostly recognized as write-off of DAC, and a $42 million increase in our insurance-related liabilities, both due to loss recognition testing upon re-segmentation.

Expenses and Taxes. Operating earnings increased due to a $13 million decrease in expenses primarily driven by lower expenses as a result of the U.S. Retail Advisor Force Divestiture. In the current period, we realized lower tax benefits of $57 million, primarily related to the separate account dividends received deduction.

Nine Months Ended September 30, 2016 Compared with the Nine Months Ended September 30, 2015

Unless otherwise stated, all amounts discussed below are net of income tax.

Business Growth. A $386 million increase in operating earnings was attributable to business growth. In the annuities business, an increase in fee income and a decrease in DAC amortization favorably impacted operating earnings primarily due to the aforementioned recapture of a ceded fixed annuity agreement. Net investment income also increased as a result of a larger invested asset base due to such recapture, a capital contribution from MetLife, Inc., and positive net flows in our general account from our annuities and life businesses, partially offset by funding agreement repayments. This increase in net investment income was also partially offset by higher interest credited expense as the same positive net flows in our general account resulted in a larger liability base. Additionally, other revenues decreased due to the aforementioned recapture of a ceded fixed annuity agreement.

Market Factors. Market factors, including sustained low interest rates, volatile equity markets, and foreign currency fluctuations, continued to impact our investment yields; however, certain impacts were mitigated by derivatives used to hedge these risks. Investment yields decreased on fixed maturity securities and mortgage loans as a result of the sustained low interest rate environment, as proceeds from maturing investments and the growth in the investment portfolio described above were invested at lower yields. Lower returns on real estate joint ventures also contributed to a decrease in net investment income. Additionally, lower earnings on our securities lending program resulted from lower margins as a result of the impact of a flatter yield curve. These unfavorable changes were partially offset by higher income on interest rate derivatives. In our annuities business, lower equity returns in 2015 drove a decline in our average separate account balances which resulted in a decrease in asset-based fee income relative to the prior period. In addition, we experienced higher costs associated with our variable annuity GMDBs, partially offset by lower DAC amortization and lower average interest crediting rates for our annuities business. The changes in market factors discussed above resulted in a $214 million decrease in operating earnings.

133

Underwriting, Actuarial Assumption Review and Other Insurance Adjustments. Less favorable mortality experience in our universal life business, partially offset by favorable mortality in our traditional life business, resulted in a net decrease of $25 million to operating earnings. The impact of our annual actuarial assumption review, which occurred in both periods, resulted in a net operating earnings decrease of $79 million and was primarily related to unfavorable DAC unlockings in our variable annuity business. Refinements to DAC and certain insurance-related liabilities recorded in the current period resulted in a decrease in operating earnings of $454 million, primarily driven by a $254 million one-time charge, mostly recognized as a write-off of DAC, and a $42 million increase in our insurance-related liabilities, both due to loss recognition testing upon re-segmentation, as well as a reserve adjustment of $171 million resulting from modeling improvements in the reserving process in our universal life business.

Expenses and Taxes. Operating earnings increased due to a decrease in expenses of $8 million primarily driven by the U.S. Retail Advisor Force Divestiture. In the current period, we realized lower tax benefits of $54 million, primarily related to the separate account dividends received deduction.

Corporate & Other

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Operating revenues
Premiums	$	40		$	(53	)	$	51		$	(30	)
Universal life and investment-type product policy fees	(31		)	(26		)	(87		)	(87		)
Net investment income	(7		)	(85		)	(37		)	11
Other revenues	(28		)	(58		)	(380		)	(212		)
Total operating revenues	(26		)	(222		)	(453		)	(318		)
Operating expenses
Policyholder benefits and claims and policyholder dividends	10			(72		)	(26		)	(103		)
Interest credited to policyholder account balances	—			6			5			20
Capitalization of DAC	1			(1		)	(6		)	(2		)
Amortization of DAC and VOBA	2			(1		)	7			1
Interest expense on debt	241			248			759			757
Other operating expenses	(3		)	361			(163		)	408
Total operating expenses	251			541			576			1,081
Provision for income tax expense (benefit)	(287		)	214			(658		)	(156		)
Operating earnings	10			(977		)	(371		)	(1,243		)
Less: Preferred stock dividends	6			6			58			67
Operating earnings available to common shareholders	$	4		$	(983	)	$	(429	)	$	(1,310	)

134

The table below presents operating earnings available to common shareholders by source, net of income tax:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Other business activities	$	6		$	(10	)	$	(5	)	$	(32	)
Other net investment income	2			(47		)	(17		)	15
Interest expense on debt	(157		)	(161		)	(494		)	(492		)
Preferred stock dividends	(6		)	(6		)	(58		)	(67		)
Corporate initiatives and projects	(23		)	(38		)	(80		)	(124		)
Incremental tax benefit (expense)	190			(482		)	297			(334		)
Other	(8		)	(239		)	(72		)	(276		)
Operating earnings available to common shareholders	$	4		$	(983	)	$	(429	)	$	(1,310	)

Three Months Ended September 30, 2016 Compared with the Three Months Ended September 30, 2015

Unless otherwise stated, all amounts discussed below are net of income tax.

Other Business Activities. Operating earnings from other business activities increased $16 million. This was primarily related to improved results from our start-up operations.

Other Net Investment Income. A $49 million increase in other net investment income was driven by higher returns on alternative investments and prior period mark-to-market losses on our trading securities.

Corporate Initiatives and Projects. Expenses associated with corporate initiatives and projects decreased by $15 million, primarily due to decreased costs associated with enterprise-wide initiatives taken by the Company.

Incremental Tax Benefit. Corporate & Other benefits from the impact of certain permanent tax preferenced items, including non-taxable investment income and tax credits for investments in low income housing. As a result, our effective tax rate differs from the U.S. statutory rate of 35%. The current period includes a one-time tax benefit of $36 million for tax audit settlements. The prior period includes the aforementioned tax charge of $557 million, which was recorded under accounting guidance for the recognition of tax uncertainties. In addition, we had higher utilization of tax preferenced items, which increased our operating earnings by $79 million over the prior period.

Other. The prior period included the aforementioned $235 million charge for interest on uncertain tax positions. The prior period also included a $20 million impairment charge on a real estate property. The current period included a $15 million decrease in operating earnings primarily resulting from higher employee-related costs, as well as an increase in interest on uncertain tax positions.

Nine Months Ended September 30, 2016 Compared with the Nine Months Ended September 30, 2015

Unless otherwise stated, all amounts discussed below are net of income tax.

Other Business Activities. Operating earnings from other business activities increased $27 million. This was primarily related to improved results from our start-up operations.

Other Net Investment Income. A $32 million decrease in other net investment income was driven by lower returns on real estate and real estate joint ventures and private equities, partially offset by higher mark-to-market income on residential mortgage loans for which the Company has elected the FVO.

Preferred Stock Dividends. Preferred stock dividends decreased by $9 million. In June 2015, MetLife, Inc. repurchased its 6.50% Non-Cumulative Preferred Stock, Series B (the “Series B preferred stock”) for which dividends were paid quarterly. Also in June 2015, MetLife, Inc. issued 1,500,000 shares of 5.25% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series C (the “Series C preferred stock”) for which dividends are payable semi-annually commencing December 15, 2015 and ending on June 15, 2020, and are payable quarterly thereafter.

Corporate Initiatives and Projects. Expenses associated with corporate initiatives and projects decreased by $44 million, primarily due to decreased costs associated with enterprise-wide initiatives taken by the Company.

135

Incremental Tax Benefit. Corporate & Other benefits from the impact of certain permanent tax preferenced items, including non-taxable investment income and tax credits for investments in low income housing. As a result, our effective tax rate differs from the U.S. statutory rate of 35%. The current period includes a one-time tax benefit of $36 million for tax audit settlements. The prior period included the aforementioned tax charge of $557 million, which was recorded under accounting guidance for the recognition of tax uncertainties. In addition, we had higher utilization of tax preferenced investments, which increased our operating earnings by $39 million over the prior period.

Other. The prior period included the aforementioned $235 million charge for interest on uncertain tax positions. The prior period also included a $20 million impairment charge on a real estate property. The current period included a $23 million decrease in operating earnings primarily resulting from higher employee-related costs and an increase in interest on uncertain tax positions. In addition, operating earnings decreased $15 million as a result of net adjustments to certain reinsurance assets and liabilities.

136

Investments

Investment Risks

Our primary investment objective is to optimize, net of income tax, risk-adjusted investment income and risk-adjusted total return while ensuring that assets and liabilities are managed on a cash flow and duration basis. The Investments Department, led by the Chief Investment Officer, manages investment risks using a risk control framework comprised of policies, procedures and limits, as discussed further below. The Investments Risk Committee, chaired by the Global Risk Management Department, reviews and monitors investment risk limits and tolerances. We are exposed to the following primary sources of investment risks:

• credit risk, relating to the uncertainty associated with the continued ability of a given obligor to make timely payments of principal and interest;

• interest rate risk, relating to the market price and cash flow variability associated with changes in market interest rates. Changes in market interest rates will impact the net unrealized gain or loss position of our fixed income investment portfolio and the rates of return we receive on both new funds invested and reinvestment of existing funds;

• liquidity risk, relating to the diminished ability to sell certain investments, in times of strained market conditions;

• market valuation risk, relating to the variability in the estimated fair value of investments associated with changes in market factors such as credit spreads. A widening of credit spreads will adversely impact the net unrealized gain (loss) position of the fixed income investment portfolio, will increase losses associated with credit-based non-qualifying derivatives where we assume credit exposure, and, if credit spreads widen significantly or for an extended period of time, will likely result in higher other-than-temporary impairment (“OTTI”). Credit spread tightening will reduce net investment income associated with purchases of fixed maturity securities and will favorably impact the net unrealized gain (loss) position of the fixed income investment portfolio;

• currency risk, relating to the variability in currency exchange rates for foreign denominated investments. This risk relates to potential decreases in estimated fair value and net investment income resulting from changes in currency exchange rates versus the U.S. dollar. In general, the weakening of foreign currencies versus the U.S. dollar will adversely affect the estimated fair value of our foreign denominated investments; and

• real estate risk, relating to commercial, agricultural and residential real estate, and stemming from factors, which include, but are not limited to, market conditions, including the demand and supply of leasable commercial space, creditworthiness of commercial tenants and partners, capital markets volatility and the inherent interest rate movement.

We manage investment risk through in-house fundamental credit analysis of the underlying obligors, issuers, transaction structures and real estate properties. We also manage credit risk, market valuation risk and liquidity risk through industry and issuer diversification and asset allocation. Risk limits to promote diversification by asset sector, avoid concentrations in any single issuer and limit overall aggregate credit exposure as measured by our economic capital framework, are approved annually by a committee of directors that oversees our investment portfolio. For real estate assets, we manage credit risk and market valuation risk through geographic, property type and product type diversification and asset allocation. We manage interest rate risk as part of our ALM strategies. These strategies include maintaining an investment portfolio with diversified maturities that has a weighted average duration that is approximately equal to the duration of our estimated liability cash flow profile, and utilizing product design, such as the use of market value adjustment features and surrender charges, to manage interest rate risk. We also manage interest rate risk through proactive monitoring and management of certain non-guaranteed elements of our products, such as the resetting of credited interest and dividend rates for policies that permit such adjustments. In addition to hedging with foreign currency derivatives, we manage currency risk by matching much of our foreign currency liabilities in our foreign subsidiaries with their respective foreign currency assets, thereby reducing our risk to foreign currency exchange rate fluctuation. We also use certain derivatives in the management of credit, interest rate, and equity market risks.

We use purchased credit default swaps to mitigate credit risk in our investment portfolio. Generally, we purchase credit protection by entering into credit default swaps referencing the issuers of specific assets we own. In certain cases, basis risk exists between these credit default swaps and the specific assets we own. For example, we may purchase credit protection on a macro basis to reduce exposure to specific industries or other portfolio concentrations. In such instances, the referenced entities and obligations under the credit default swaps may not be identical to the individual obligors or securities in our investment portfolio. In addition, our purchased credit default swaps may have shorter tenors than the underlying investments they are hedging. However, we dynamically hedge this risk through the rebalancing and rollover of our credit default swaps at their most liquid tenors. We believe that our purchased credit default swaps serve as effective economic hedges of our credit exposure.

137

We generally enter into market standard purchased and written credit default swap contracts. Payout under such contracts is triggered by certain credit events experienced by the referenced entities. For credit default swaps covering North American corporate issuers, credit events typically include bankruptcy and failure to pay on borrowed money. For European corporate issuers, credit events typically also include involuntary restructuring. With respect to credit default contracts on Western European sovereign debt, credit events typically include failure to pay debt obligations, repudiation, moratorium, or involuntary restructuring. In each case, payout on a credit default swap is triggered only after the Credit Derivatives Determinations Committee of the International Swaps and Derivatives Association deems that a credit event has occurred.

Current Environment

The global economy and markets continue to be affected by stress and volatility, which has adversely affected the financial services sector, in particular, and global capital markets. Recently, weakness in the energy and metals and mining sectors and political and/or economic instability in the U.K., Brazil, Turkey, Russia, Ukraine, China, Japan, the Middle East and Puerto Rico, as well as Europe’s perimeter region and Cyprus, have contributed to global market volatility.

Events following the U.K.’s referendum on June 23, 2016 and the uncertainties associated with its pending withdrawal from the EU have contributed to market volatility. The risk of market volatility may spread beyond the U.K., and could be intensified by foreign exchange risks. These factors could contribute to weakening GDP growth, primarily in the U.K. and Europe. The magnitude and longevity of the potential negative economic impacts would depend on the detailed agreements reached by the U.K. and the EU as a result of the exit negotiations and negotiations regarding trade and other arrangements.

As a global insurance company, we are affected by the monetary policy of central banks around the world. The ECB has adopted stimulus measures which are intended to lessen the risk of a prolonged period of deflation and support economic recovery in the Euro zone. See “— Industry Trends — Financial and Economic Environment” for further information on such measures, as well as for information regarding actions taken by Japan’s central government and the Bank of Japan to boost inflation expectations and achieve sustainable economic growth in Japan. See also “— Industry Trends — Impact of a Sustained Low Interest Rate Environment” for information regarding the December 2015 action taken by the FOMC to raise the federal funds rate and its subsequent determinations to maintain it. The Federal Reserve may take further actions to influence interest rates in the future, which may have an impact on the pricing levels of risk-bearing investments and may adversely impact the level of product sales.

European Region Investments

We maintain general account investments in certain EU member states and other countries in the region that are not members of the EU (collectively, the “European Region”) to support our insurance operations and related policyholder liabilities in these countries and certain of our non-European Region operations invest in the region for diversification. In the European Region, we have proactively mitigated risk in both direct and indirect exposures by investing in a diversified portfolio of high quality investments with a focus on the higher-rated countries, including the U.K., Germany, France, the Netherlands, Poland, Norway and Sweden. The sovereign debt of these countries continues to maintain investment grade credit ratings from all major rating agencies. Our European Region fixed maturity and perpetual hybrid securities classified as non-redeemable preferred stock are invested in a diversified portfolio of primarily non-financial services securities. At September 30, 2016, our exposure to such securities in the European Region totaled $40.7 billion, at estimated fair value, of which $9.1 billion was in sovereign fixed maturity securities. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Investments — Current Environment — European Region Investments” included in the 2015 Annual Report for further information.

Selected Country and Sector Investments

Recent country specific volatility due to local economic and/or political concerns, as well as recent weakness in certain sectors, has affected the performance of certain of our investments.

138

We have exposure to such volatility, as we maintain general account investments in the U.K., Turkey, Brazil, Russia, Puerto Rico, Jordan, Lebanon and Ukraine, as well as Europe’s perimeter region and Cyprus, to support our insurance operations and related policyholder liabilities in these countries; and we also have exposure through our global portfolio diversification. Our exposure to sovereign fixed maturity securities and total fixed maturity securities of the U.K., Turkey, Brazil, Russia, Puerto Rico, Jordan, Lebanon and Ukraine totaled $1.5 billion and $14.0 billion, at estimated fair value, respectively, at September 30, 2016. Our exposure to Puerto Rico political subdivision fixed maturities is in the form of secured revenue securities and we have no general obligation securities. Our exposure to sovereign fixed maturity securities and total fixed maturity securities of Europe’s perimeter region and Cyprus totaled $241 million and $1.6 billion, at estimated fair value, respectively, at September 30, 2016. Our exposure to both sovereign fixed maturity securities and total fixed maturity securities of Greece was less than $1 million, at estimated fair value, at September 30, 2016. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Investments — Current Environment — Selected Country and Sector Investments” included in the 2015 Annual Report for further information by country. See “— Mortgage Loans” for information about U.K. mortgage loan investments.

There has been an increased focus on energy sector and metals and mining sector investments as a result of lower energy, oil and commodity prices. Our net exposure to energy sector fixed maturity securities was $10.1 billion (comprised of fixed maturity securities of $10.1 billion at estimated fair value and related net written credit default swaps of $35 million at notional value), of which 80% were investment grade, with unrealized gains of $601 million at September 30, 2016. Our net exposure to metals and mining sector fixed maturity securities was $2.2 billion (comprised of fixed maturity securities of $2.2 billion at estimated fair value and related net purchased credit default swaps of $15 million at notional value), of which 72% were investment grade, with unrealized gains of $147 million at September 30, 2016.

We manage direct and indirect investment exposure in the selected countries, the energy sector and the metals and mining sector through fundamental credit analysis and we continually monitor and adjust our level of investment exposure. We do not expect that our general account investments in these countries, the energy sector or the metals and mining sector will have a material adverse effect on our results of operations or financial condition.

Current Environment — Summary

All of these factors have had and could continue to have an adverse effect on the financial results of companies in the financial services industry, including MetLife. Such global economic conditions, as well as the global financial markets, continue to impact our net investment income, net investment gains (losses), net derivative gains (losses), level of unrealized gains (losses) within the various asset classes in our investment portfolio, and our level of investment in lower yielding cash equivalents, short-term investments and government securities. See “— Industry Trends,” as well as “Risk Factors — Economic Environment and Capital Markets-Related Risks — We Are Exposed to Significant Global Financial and Capital Markets Risks Which May Adversely Affect Our Results of Operations, Financial Condition and Liquidity, and May Cause Our Net Investment Income to Vary from Period to Period” included in the 2015 Annual Report.

139

Investment Portfolio Results

The following yield table presents the yield and investment income (loss) for our investment portfolio for the periods indicated.Yields are calculated using reported net investment income which is not adjusted for the impact of changes in foreign currency exchange rates. As described below, this table reflects certain differences from the presentation of net investment income presented in the GAAP consolidated statements of operations. This yield table presentation is consistent with how we measure our investment performance for management purposes, and we believe it enhances understanding of our investment portfolio results.

	At or For the Three Months Ended September 30,												At or For the Nine Months Ended September 30,
	2016						2015						2016						2015
	Yield % (1)			Amount			Yield % (1)			Amount			Yield % (1)			Amount			Yield % (1)			Amount
	(Dollars in millions)
Fixed maturity securities (2),(3)	4.38		%	$	3,573		4.55		%	$	3,467		4.40		%	$	10,740		4.66		%	$	10,701
Mortgage loans (3)	4.60		%	806			4.95		%	785			4.74		%	2,464			4.95		%	2,316
Real estate and real estate joint ventures	5.68		%	130			3.99		%	101			3.99		%	269			4.83		%	371
Policy loans	5.28		%	148			5.09		%	147			5.24		%	444			5.18		%	450
Equity securities	4.94		%	35			4.66		%	36			4.83		%	105			4.42		%	102
Other limited partnership interests	15.19		%	263			10.82		%	216			8.21		%	429			11.27		%	681
Cash and short-term investments	1.01		%	27			0.74		%	23			1.07		%	83			0.93		%	89
Other invested assets				327						225						845						775
Total before investment fees and expenses	4.78		%	5,309			4.76		%	5,000			4.65		%	15,379			4.91		%	15,485
Investment fees and expenses	(0.13	)		(149		)	(0.14	)		(151		)	(0.14	)		(466		)	(0.15	)		(469		)
Net investment income including divested businesses and lag elimination (4), (5)	4.65		%	5,160			4.62		%	4,849			4.51		%	14,913			4.76		%	15,016
Less: net investment income from divested businesses and lag elimination (4), (5)				—						—						(166		)				—
Net investment income (5)				$	5,160					$	4,849					$	14,747					$	15,016

__________________

(1) Yields are calculated as investment income as a percent of average quarterly asset carrying values. Investment income excludes recognized gains and losses and reflects GAAP adjustments presented in footnote (5) below. Asset carrying values exclude unrealized gains (losses), collateral received in connection with our securities lending program, freestanding derivative assets, collateral received from derivative counterparties, the effects of consolidating certain variable interest entities (“VIEs”) under GAAP that are treated as consolidated securitization entities (“CSEs”) and contractholder-directed unit-linked investments. A yield is not presented for other invested assets, as it is not considered a meaningful measure of performance for this asset class.

(2) Investment income (loss) includes amounts for FVO and trading securities of $25 million and $41 million for the three months and nine months endedSeptember 30, 2016, respectively, and ($35) million and $4 million for the three months and nine months endedSeptember 30, 2015, respectively.

(3) Investment income from fixed maturity securities and mortgage loans includes prepayment fees.

(4) Net investment income included in yield calculations include earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting (“investment hedge adjustments”).

140

(5) Net investment income presented in the yield table varies from the most directly comparable GAAP measure due to certain reclassifications and excludes the effects of consolidating certain VIEs under GAAP that are treated as CSEs and contractholder-directed unit-linked investments. Such reclassifications are presented in the table below.

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Net investment income — in the above yield table	$	5,160		$	4,849		$	14,747		$	15,016
Investment hedge adjustments	(226		)	(194		)	(635		)	(574		)
Operating joint venture adjustments	—			(3		)	5			(6		)
Divested businesses and lag elimination (1)	—			—			166			—
Contractholder-directed unit-linked investments	529			(701		)	623			(79		)
Incremental net investment income from CSEs	1			8			4			10
Net investment income — GAAP consolidated statements of operations	$	5,464		$	3,959		$	14,910		$	14,367

__________________

(1) The amount of $166 million for the nine months endedSeptember 30, 2016, relates to the impact of converting the Company’s Japan operations to calendar year-end reporting. See Note 2 of the Notes to the Interim Condensed Consolidated Financial Statements for further information.

See “— Results of Operations — Consolidated Results — Three Months Ended September 30, 2016 Compared with the Three Months Ended September 30, 2015” and “— Results of Operations — Consolidated Results — Nine Months Ended September 30, 2016 Compared with the Nine Months Ended September 30, 2015” for an analysis of the period over period changes in net investment income.

Fixed Maturity and Equity Securities AFS

The following table presents fixed maturity and equity securities available-for-sale (“AFS”) by type (public or private) and information about perpetual and redeemable securities held at:

	September 30, 2016					December 31, 2015
	Estimated Fair Value			% of Total		Estimated Fair Value			% of Total
	(Dollars in millions)
Fixed maturity securities
Publicly-traded	$	338,028		86.6	%	$	302,400		86.1	%
Privately-placed	52,414			13.4		49,002			13.9
Total fixed maturity securities	$	390,442		100.0	%	$	351,402		100.0	%
Percentage of cash and invested assets	69.1		%			69.1		%
Equity securities
Publicly-traded	$	2,103		63.9	%	$	2,184		65.8	%
Privately-held	1,186			36.1		1,137			34.2
Total equity securities	$	3,289		100.0	%	$	3,321		100.0	%
Percentage of cash and invested assets	0.6		%			0.7		%
Perpetual securities included within fixed maturity and equity securities AFS	$	640				$	819
Redeemable preferred stock with a stated maturity included within fixed maturity securities AFS	$	649				$	1,216

141

Perpetual securities are included within fixed maturity and equity securities. Upon acquisition, we classify perpetual securities that have attributes of both debt and equity as fixed maturity securities if the securities have an interest rate step-up feature which, when combined with other qualitative factors, indicates that the securities have more debt-like characteristics; while those with more equity-like characteristics are classified as equity securities. Many of such securities, commonly referred to as “perpetual hybrid securities,” have been issued by non-U.S. financial institutions that are accorded the highest two capital treatment categories by their respective regulatory bodies (i.e. core capital, or “Tier 1 capital” and perpetual deferrable securities, or “Upper Tier 2 capital”).

Redeemable preferred stock with a stated maturity is included within fixed maturity securities. These securities, which are commonly referred to as “capital securities,” primarily have cumulative interest deferral features and are primarily issued by U.S. financial institutions.

In connection with our investment management business, we manage privately-placed and infrastructure fixed maturity securities on behalf of institutional clients, which are unaffiliated investors. These privately-placed and infrastructure fixed maturity securities had an estimated fair value of $7.9 billion and $6.1 billion at September 30, 2016 and December 31, 2015, respectively. These assets are not included in our interim condensed consolidated financial statements.

During the second quarter of 2016, we commenced management of below investment grade fixed maturity securities on behalf of institutional clients, which are unaffiliated investors. These fixed maturity securities had an estimated fair value of $318 million at September 30, 2016. These assets are not included in our interim condensed consolidated financial statements.

Also in connection with our investment management business, we manage index investment portfolios that track the return of standard industry fixed income and equity market indices such as the Barclay’s U.S. Aggregate Bond Index and S&P 500^® Index. These assets had an estimated fair value of $27.3 billion and $26.0 billion at September 30, 2016 and December 31, 2015, respectively, and are included within separate account assets in our interim condensed consolidated financial statements.

See also “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Investments — Fixed Maturity and Equity Securities AFS — Valuation of Securities” included in the 2015 Annual Report for further information on the processes used to value securities and the related controls.

Fair Value of Fixed Maturity and Equity Securities – AFS

Fixed maturity and equity securities AFS measured at estimated fair value on a recurring basis and their corresponding fair value pricing sources are as follows at:

	September 30, 2016
	Fixed Maturity Securities				Equity Securities
	(Dollars in millions)
Level 1
Quoted prices in active markets for identical assets	$	45,129	11.5	%	$	1,364	41.5	%
Level 2
Independent pricing sources	286,607		73.4		1,171		35.6
Internal matrix pricing or discounted cash flow techniques	37,102		9.5		99		3.0
Significant other observable inputs	323,709		82.9		1,270		38.6
Level 3
Independent pricing sources	7,289		1.9		509		15.5
Internal matrix pricing or discounted cash flow techniques	13,266		3.4		136		4.1
Independent broker quotations	1,049		0.3		10		0.3
Significant unobservable inputs	21,604		5.6		655		19.9
Total estimated fair value	$	390,442	100.0	%	$	3,289	100.0	%

See Note 9 of the Notes to the Interim Condensed Consolidated Financial Statements for the fixed maturity securities and equity securities AFS fair value hierarchy.

142

Thecomposition of fair value pricing sources for and significant changes in Level 3 securities at September 30, 2016 are as follows:

• The majority of the Level 3 fixed maturity and equity securities AFS were concentrated in three sectors: U.S. and foreign corporate securities and residential mortgage-backed securities (“RMBS”).

• Level 3 fixed maturity securities are priced principally through market standard valuation methodologies, independent pricing services and, to a much lesser extent, independent non-binding broker quotations using inputs that are not market observable or cannot be derived principally from or corroborated by observable market data. Level 3 fixed maturity securities consist of less liquid securities with very limited trading activity or where less price transparency exists around the inputs to the valuation methodologies. Level 3 fixed maturity securities include: sub-prime RMBS; certain below investment grade private securities and less liquid investment grade corporate securities (included in U.S. and foreign corporate securities); less liquid collateralized obligation asset-backed securities (“ABS”); and foreign government securities.

• During the three months endedSeptember 30, 2016, Level 3 fixed maturity securities increased by $442 million, or 2%. The increase was driven by purchases in excess of sales and an increase in estimated fair value recognized in other comprehensive income (loss), partially offset by net transfers out of Level 3.

• During the nine months endedSeptember 30, 2016, Level 3 fixed maturity securities increased by $790 million, or 4%. The increase was driven by purchases in excess of sales and an increase in estimated fair value recognized in other comprehensive income (loss), partially offset by net transfers out of Level 3.

See Note 9 of the Notes to the Interim Condensed Consolidated Financial Statements for a rollforward of the fair value measurements for fixed maturity securities and equity securities AFS measured at estimated fair value on a recurring basis using significant unobservable (Level 3) inputs; transfers into and/or out of Level 3; and further information about the valuation techniques and inputs by level by major classes of invested assets that affect the amounts reported above. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Summary of Critical Accounting Estimates — Estimated Fair Value of Investments” included in the 2015 Annual Report for further information on the estimates and assumptions that affect the amounts reported above.

Fixed Maturity Securities AFS

See Note 7 of the Notes to the Interim Condensed Consolidated Financial Statements for information about fixed maturity securities AFS by sector, contractual maturities and continuous gross unrealized losses.

Fixed Maturity Securities Credit Quality — Ratings

See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Investments — Fixed Maturity and Equity Securities AFS — Fixed Maturity Securities Credit Quality — Ratings” included in the 2015 Annual Report for a discussion of the credit quality ratings assigned by Nationally Recognized Statistical Rating Organizations (“NRSRO”) and credit quality designations assigned by and methodologies used by the Securities Valuation Office of the National Association of Insurance Commissioners (“NAIC”) for fixed maturity securities.

The NAIC has adopted revised methodologies for certain structured securities comprised of non-agency RMBS, commercial mortgage-backed securities (“CMBS”) and ABS. The NAIC’s objective with the revised methodologies for these structured securities was to increase the accuracy in assessing expected losses, and to use the improved assessment to determine a more appropriate capital requirement for such structured securities. The revised methodologies reduce regulatory reliance on rating agencies and allow for greater regulatory input into the assumptions used to estimate expected losses from structured securities. We apply the revised NAIC methodologies to structured securities held by MetLife, Inc.’s insurance subsidiaries that maintain the NAIC statutory basis of accounting. The NAIC’s present methodology is to evaluate structured securities held by insurers using the revised NAIC methodologies on an annual basis. If MetLife, Inc.’s insurance subsidiaries acquire structured securities that have not been previously evaluated by the NAIC, but are expected to be evaluated by the NAIC in the upcoming annual review, an internally developed designation is used until a final designation becomes available. These revised NAIC designations may not correspond to NRSRO ratings.

143

The following table presents total fixed maturity securities by NRSRO rating and the applicable NAIC designation from the NAIC published comparison of NRSRO ratings to NAIC designations, except for certain structured securities, which are presented using the revised NAIC methodologies as described above, as well as the percentage, based on estimated fair value that each designation is comprised of at:

		September 30, 2016									December 31, 2015
NAIC Designation	NRSRO Rating	Amortized Cost		Unrealized Gain (Loss)			Estimated Fair Value		% of Total		Amortized Cost		Unrealized Gain (Loss)			Estimated Fair Value		% of Total
		(Dollars in millions)
1	Aaa/Aa/A	$	255,025	$	29,501		$	284,526	72.9	%	$	234,176	$	16,627		$	250,803	71.4	%
2	Baa	77,210		6,391			83,601		21.4		77,313		2,210			79,523		22.6
	Subtotal investment grade	332,235		35,892			368,127		94.3		311,489		18,837			330,326		94.0
3	Ba	14,411		629			15,040		3.9		15,314		(172		)	15,142		4.3
4	B	5,900		54			5,954		1.5		5,083		(244		)	4,839		1.4
5	Caa and lower	1,318		(41		)	1,277		0.3		1,036		5			1,041		0.3
6	In or near default	49		(5		)	44		—		42		12			54		—
	Subtotal below investment  grade	21,678		637			22,315		5.7		21,475		(399		)	21,076		6.0
	Total fixed maturity securities	$	353,913	$	36,529		$	390,442	100.0	%	$	332,964	$	18,438		$	351,402	100.0	%

The following tables present total fixed maturity securities, based on estimated fair value, by sector classification and by NRSRO rating and the applicable NAIC designation from the NAIC published comparison of NRSRO ratings to NAIC designations, except for certain structured securities, which are presented using the NAIC methodologies as described above at:

	Fixed Maturity Securities — by Sector & Credit Quality Rating
NAIC Designation	1			2			3			4			5			6			Total Estimated Fair Value
NRSRO Rating	Aaa/Aa/A			Baa			Ba			B			Caa and Lower			In or Near Default
	(Dollars in millions)
September 30, 2016
U.S. corporate	$	47,061		$	45,097		$	8,849		$	3,870		$	799		$	—		$	105,676
U.S. government and agency	69,268			517			—			—			—			—			69,785
Foreign corporate	25,341			30,680			3,526			810			62			—			60,419
Foreign government	55,442			5,070			2,224			968			61			—			63,765
RMBS	43,585			772			294			284			331			43			45,309
State and political subdivision	16,826			548			68			—			21			—			17,463
ABS	14,649			839			70			22			3			1			15,584
CMBS	12,354			78			9			—			—			—			12,441
Total fixed maturity securities	$	284,526		$	83,601		$	15,040		$	5,954		$	1,277		$	44		$	390,442
Percentage of total	72.9		%	21.4		%	3.9		%	1.5		%	0.3		%	—		%	100.0		%
December 31, 2015
U.S. corporate	$	43,448		$	44,158		$	9,163		$	3,532		$	493		$	—		$	100,794
U.S. government and agency	61,646			—			—			—			—			—			61,646
Foreign corporate	23,368			29,362			3,621			732			114			1			57,198
Foreign government	43,911			4,098			1,730			395			326			39			50,499
RMBS	37,394			560			579			177			78			9			38,797
State and political subdivision	14,818			599			10			—			14			—			15,441
ABS	13,646			702			24			3			14			5			14,394
CMBS	12,572			44			15			—			2			—			12,633
Total fixed maturity securities	$	250,803		$	79,523		$	15,142		$	4,839		$	1,041		$	54		$	351,402
Percentage of total	71.4		%	22.6		%	4.3		%	1.4		%	0.3		%	—		%	100.0		%

144

U.S. and Foreign Corporate Fixed Maturity Securities

We maintain a diversified portfolio of corporate fixed maturity securities across industries and issuers. This portfolio does not have any exposure to any single issuer in excess of 1% of total investments and the top ten holdings comprise 2% of total investments at both September 30, 2016 and December 31, 2015. The tables below present our U.S. and foreign corporate securities holdings by industry at:

	September 30, 2016				December 31, 2015
	Estimated Fair Value		% of Total		Estimated Fair Value		% of Total
	(Dollars in millions)
Industrial	$	49,555	29.8	%	$	44,710	28.3	%
Consumer	37,918		22.8		37,317		23.6
Finance	36,048		21.7		33,050		20.9
Utility	25,632		15.4		27,770		17.6
Communications	13,867		8.4		11,559		7.3
Other	3,075		1.9		3,586		2.3
Total	$	166,095	100.0	%	$	157,992	100.0	%

Structured Securities 

We held $73.3 billion and $65.8 billion of structured securities, at estimated fair value, at September 30, 2016 and December 31, 2015, respectively, as presented in the RMBS, ABS and CMBS sections below.

RMBS

The table below presents our RMBS holdings at:

	September 30, 2016						December 31, 2015
	Estimated Fair Value		% of Total		Net Unrealized Gains (Losses)		Estimated Fair Value		% of Total		Net Unrealized Gains (Losses)
	(Dollars in millions)
By security type:
Collateralized mortgage obligations	$	22,865	50.5	%	$	920	$	20,604	53.1	%	$	578
Pass-through securities	22,444		49.5		551		18,193		46.9		305
Total RMBS	$	45,309	100.0	%	$	1,471	$	38,797	100.0	%	$	883
By risk profile:
Agency	$	31,709	70.0	%	$	1,182	$	26,214	67.6	%	$	763
Prime	1,919		4.2		75		1,960		5.1		41
Alt-A	6,471		14.3		161		5,990		15.4		(18		)
Sub-prime	5,210		11.5		53		4,633		11.9		97
Total RMBS	$	45,309	100.0	%	$	1,471	$	38,797	100.0	%	$	883
Ratings profile:
Rated Aaa/AAA	$	32,213	71.1	%			$	26,809	69.1	%
Designated NAIC 1	$	43,585	96.2	%			$	37,394	96.4	%

See also “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Investments — Fixed Maturity and Equity Securities AFS — Structured Securities — RMBS” included in the 2015 Annual Report for further information about collateralized mortgage obligations and pass-through mortgage-backed securities, as well as agency, prime, alternative residential mortgage loan and sub-prime RMBS.

145

Historically, we have managed our exposure to sub-prime RMBS holdings by: acquiring older vintage year securities that benefit from better underwriting, improved credit enhancement and higher levels of residential property price appreciation; reducing our overall exposure; stress testing the portfolio with severe loss assumptions; and closely monitoring the performance of the portfolio. Since 2012, we have increased our exposure by purchasing sub-prime RMBS at significant discounts to the expected principal recovery value of these securities. The estimated fair value of our sub-prime RMBS holdings purchased since 2012 was $4.7 billion and $4.0 billion with unrealized gains (losses) of $38 million and $74 million at September 30, 2016 and December 31, 2015, respectively.

ABS

Our ABS are diversified both by collateral type and by issuer. The following table presents our ABS holdings at:

	September 30, 2016							December 31, 2015
	Estimated Fair Value		% of Total		Net Unrealized Gains (Losses)			Estimated Fair Value		% of Total		Net Unrealized Gains (Losses)
	(Dollars in millions)
By collateral type:
Collateralized obligations	$	7,928	50.9	%	$	(135	)	$	7,698	53.5	%	$	(144	)
Foreign residential loans	1,330		8.5		21			1,365		9.5		32
Student loans	1,209		7.8		(37		)	1,284		8.9		(30		)
Automobile loans	1,731		11.1		7			1,153		8.0		—
Credit card loans	1,358		8.7		18			831		5.8		27
Other loans	2,028		13.0		25			2,063		14.3		11
Total	$	15,584	100.0	%	$	(101	)	$	14,394	100.0	%	$	(104	)
Ratings profile:
Rated Aaa/AAA	$	8,561	54.9	%				$	7,510	52.2	%
Designated NAIC 1	$	14,649	94.0	%				$	13,646	94.8	%

146

CMBS

Our CMBS holdings are diversified by vintage year. The following tables present our CMBS holdings by NRSRO rating and by vintage year at:

	September 30, 2016
	Aaa					Aa					A					Baa					Below Investment Grade					Total
	Amortized Cost		Estimated Fair Value			Amortized Cost		Estimated Fair Value			Amortized Cost		Estimated Fair Value			Amortized Cost		Estimated Fair Value			Amortized Cost		Estimated Fair Value			Amortized Cost		Estimated Fair Value
	(Dollars in millions)
2003 - 2005	$	124	$	137		$	20	$	21		$	26	$	28		$	22	$	22		$	3	$	4		$	195	$	212
2006	45		50			16		16			21		21			9		8			—		—			91		95
2007	341		344			54		55			70		72			3		3			23		25			491		499
2008 - 2010	5		5			—		—			—		—			—		—			—		—			5		5
2011	462		494			23		24			62		65			—		—			—		—			547		583
2012	568		616			429		457			332		350			8		9			—		—			1,337		1,432
2013	1,049		1,117			827		884			525		532			11		9			—		—			2,412		2,542
2014	999		1,053			950		996			268		268			—		—			—		—			2,217		2,317
2015	2,649		2,789			467		478			259		261			10		10			—		—			3,385		3,538
2016	948		988			109		110			58		59			60		61			—		—			1,175		1,218
Total	$	7,190	$	7,593		$	2,895	$	3,041		$	1,621	$	1,656		$	123	$	122		$	26	$	29		$	11,855	$	12,441
Ratings Distribution			61.0		%			24.5		%			13.3		%			1.0		%			0.2		%			100.0		%
	December 31, 2015
	Aaa					Aa					A					Baa					Below Investment Grade					Total
	Amortized Cost		Estimated Fair Value			Amortized Cost		Estimated Fair Value			Amortized Cost		Estimated Fair Value			Amortized Cost		Estimated Fair Value			Amortized Cost		Estimated Fair Value			Amortized Cost		Estimated Fair Value
	(Dollars in millions)
2003 - 2005	$	187	$	198		$	95	$	101		$	33	$	35		$	47	$	48		$	10	$	10		$	372	$	392
2006	1,061		1,070			79		79			76		77			50		56			—		—			1,266		1,282
2007	477		486			144		145			84		87			—		—			123		125			828		843
2008 - 2010	5		5			—		—			13		13			—		—			—		—			18		18
2011	560		593			23		24			63		64			—		—			—		—			646		681
2012	506		534			368		376			500		513			8		9			1		1			1,383		1,433
2013	989		1,036			696		735			893		925			12		10			—		—			2,590		2,706
2014	854		859			939		937			453		459			1		1			—		—			2,247		2,256
2015	2,258		2,227			445		436			325		327			32		32			—		—			3,060		3,022
Total	$	6,897	$	7,008		$	2,789	$	2,833		$	2,440	$	2,500		$	150	$	156		$	134	$	136		$	12,410	$	12,633
Ratings Distribution			55.5		%			22.4		%			19.8		%			1.2		%			1.1		%			100.0		%

The tables above reflect NRSRO ratings including Moody’s Investors Service, S&P, Fitch Ratings and Morningstar, Inc. CMBS designated NAIC 1 were 99.3% and 99.5% of total CMBS at September 30, 2016 and December 31, 2015, respectively.

Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities

See Note 7 of the Notes to the Interim Condensed Consolidated Financial Statements for information about the evaluation of fixed maturity securities and equity securities AFS for OTTI and evaluation of temporarily impaired AFS securities.

OTTI Losses on Fixed Maturity and Equity Securities AFS Recognized in Earnings

See Note 7 of the Notes to the Interim Condensed Consolidated Financial Statements for information about OTTI losses and gross gains and gross losses on AFS securities sold.

147

Overview of Fixed Maturity and Equity Security OTTI Losses Recognized in Earnings

Impairments of fixed maturity and equity securities were $19 million and $178 million for the three months and nine months endedSeptember 30, 2016, respectively, and $34 million and $63 million for the three months and nine months endedSeptember 30, 2015, respectively. Impairments of fixed maturity securities were $14 million and $106 million for the three months and nine months endedSeptember 30, 2016, respectively, and $27 million and $47 million for the three months and nine months endedSeptember 30, 2015, respectively. Impairments of equity securities were $5 million and $72 million for the three months and nine months endedSeptember 30, 2016, respectively, and $7 million and $16 million for the three months and nine months endedSeptember 30, 2015.

Credit-related impairments of fixed maturity securities were $14 million and $95 million for the three months and nine months endedSeptember 30, 2016, respectively, and $27 million and $47 million for the three months and nine months endedSeptember 30, 2015, respectively.

Explanations of changes in fixed maturity and equity securities impairments are as follows:

Three Months EndedSeptember 30, 2016 Compared with the Three Months EndedSeptember 30, 2015

Overall OTTI losses recognized in earnings on fixed maturity and equity securities were $19 million for the three months endedSeptember 30, 2016, as compared to $34 million for the three months endedSeptember 30, 2015. The most significant decreases in OTTI losses were in U.S. and foreign corporate securities, which decreased $20 million in the current period, and the decrease in losses was concentrated in the consumer industry.

Nine Months EndedSeptember 30, 2016 Compared with the Nine Months EndedSeptember 30, 2015

Overall OTTI losses recognized in earnings on fixed maturity and equity securities were $178 million for the nine months endedSeptember 30, 2016 as compared to $63 million in the prior period. The most significant increases in OTTI losses were in U.S. and foreign corporate securities and common stock, which comprised $154 million for the nine months endedSeptember 30, 2016, as compared to $40 million for the nine months endedSeptember 30, 2015. An increase of $57 million in OTTI losses on U.S. and foreign corporate securities was concentrated in the industrial industry and reflected the impact of lower oil prices on the energy sector. The increase in OTTI losses on common stock was $57 million for the nine months endedSeptember 30, 2016, as compared to the nine months endedSeptember 30, 2015, and was also concentrated in the industrial industry and reflected the impact of lower oil prices on the energy sector.

Future Impairments

Future OTTI will depend primarily on economic fundamentals, issuer performance (including changes in the present value of future cash flows expected to be collected), and changes in credit ratings, collateral valuation, interest rates and credit spreads. If economic fundamentals deteriorate or if there are adverse changes in the above factors, OTTI may be incurred in upcoming periods.

FVO and Trading Securities

FVO and trading securities are primarily comprised of securities for which the FVO has been elected (“FVO securities”). FVO securities include certain fixed maturity and equity securities held-for-investment by the general account to support ALM strategies for certain insurance products and investments in certain separate accounts. FVO securities are primarily comprised of contractholder-directed investments supporting unit-linked variable annuity type liabilities which do not qualify for presentation as separate account summary total assets and liabilities. These investments are primarily mutual funds and, to a lesser extent, fixed maturity and equity securities, short-term investments and cash and cash equivalents. The investment returns on these investments inure to the contractholder and are offset by a corresponding change in policyholder account balances through interest credited to policyholder account balances. FVO securities also include securities held by CSEs. We previously maintained a trading securities portfolio, principally invested in fixed maturity securities, to support investment strategies that involved the active and frequent purchase and sale of actively traded securities and the execution of short sale agreements. In June 2016, we commenced a reinvestment of this portfolio into other asset classes. FVO and trading securities were $14.7 billion and $15.0 billion at estimated fair value, or 2.6% and 3.0% of total cash and invested assets, at September 30, 2016 and December 31, 2015, respectively. See Note 9 of the Notes to the Interim Condensed Consolidated Financial Statements for the FVO and trading securities fair value hierarchy and a rollforward of the fair value measurements for FVO and trading securities measured at estimated fair value on a recurring basis using significant unobservable (Level 3) inputs.

148

Securities Lending

We participate in a securities lending program whereby securities are loaned to third parties, primarily brokerage firms and commercial banks. We obtain collateral, usually cash, in an amount generally equal to 102% of the estimated fair value of the securities loaned, which is obtained at the inception of a loan and maintained at a level greater than or equal to 100% for the duration of the loan. We monitor the estimated fair value of the securities loaned on a daily basis with additional collateral obtained as necessary throughout the duration of the loan. Securities loaned under such transactions may be sold or re-pledged by the transferee. We are liable to return to our counterparties the cash collateral under our control. Security collateral on deposit from counterparties may not be sold or re-pledged, unless the counterparty is in default, and is not reflected in the consolidated financial statements. These transactions are treated as financing arrangements and the associated cash collateral liability is recorded at the amount of the cash received.

See “— Liquidity and Capital Resources — The Company — Liquidity and Capital Uses — Securities Lending” and Note 7 of the Notes to the Interim Condensed Consolidated Financial Statements for information regarding our securities lending program.

Repurchase Agreement Transactions

We participate in short-term repurchase and reverse repurchase agreement transactions whereby fixed maturity securities are loaned to, and contemporaneously other fixed maturity securities are borrowed from, unaffiliated financial institutions. We obtain cash collateral in an amount greater than or equal to 95% of the estimated fair value of the securities loaned, and pledge cash collateral in an amount generally equal to 98% of the estimated fair value of the borrowed securities at the inception of the transaction. We monitor the estimated fair value of the securities loaned and borrowed on a daily basis with additional collateral obtained as necessary throughout the duration of the transaction. Securities loaned under such transactions may be sold or re-pledged by the transferee. Securities borrowed under such transactions may be re-pledged, and are not reflected in the consolidated financial statements. These transactions are treated as collateralized borrowing and lending and the Company has elected to offset amounts recognized as receivables and payables resulting from these transactions.

The Company also participates in other short-term repurchase agreements with unaffiliated financial institutions. Under these agreements, the Company lends fixed maturity securities and receives cash as collateral in an amount generally equal to 85% to 100% of the estimated fair value of the securities loaned at the inception of the transaction. The associated liability is recorded at the amount of cash received. The Company monitors the estimated fair value of the collateral and the securities loaned throughout the duration of the transaction and additional collateral is obtained as necessary. Securities loaned under such transactions may be sold or re-pledged by the transferee.

See Note 7 of the Notes to the Interim Condensed Consolidated Financial Statements for additional information regarding our repurchase and reverse repurchase agreement transactions, as well as our other short-term repurchase agreement transactions.

Mortgage Loans

Our mortgage loans are principally collateralized by commercial, agricultural and residential properties. Mortgage loans and the related valuation allowances are summarized as follows at:

	September 30, 2016									December 31, 2015
		Recorded Investment		% of Total		Valuation Allowance		% of Recorded Investment		Recorded Investment		% of Total		Valuation Allowance		% of Recorded Investment
		(Dollars in millions)
Commercial		$	45,801	64.6	%	$	227	0.5	%	$	44,012	65.8	%	$	217	0.5	%
Agricultural		14,141		20.0		43		0.3	%	13,188		19.7		42		0.3	%
Residential		10,920		15.4		60		0.5	%	9,734		14.5		59		0.6	%
Total		$	70,862	100.0	%	$	330	0.5	%	$	66,934	100.0	%	$	318	0.5	%

The information presented in the tables herein exclude mortgage loans where we elected the FVO. Such amounts are presented in Note 7 of the Notes to the Interim Condensed Consolidated Financial Statements.

149

We diversify our mortgage loan portfolio by both geographic region and property type to reduce the risk of concentration. Of our commercial and agricultural mortgage loan portfolios, 85% are collateralized by properties located in the U.S., with the remaining 15% collateralized by properties located outside the U.S., which includes 6% of properties located in the U.K., at September 30, 2016. The carrying value of our commercial and agricultural mortgage loans located in California, New York and Texas were 18%, 12% and 8%, respectively, of commercial and agricultural mortgage loans at September 30, 2016. Additionally, we manage risk when originating commercial and agricultural mortgage loans by generally lending up to 75% of the estimated fair value of the underlying real estate collateral.

We manage our residential mortgage loan portfolio in a similar manner to reduce risk of concentration, with 91% collateralized by properties located in the U.S., and the remaining 9% collateralized by properties located outside the U.S., as of September 30, 2016. The carrying value of our residential mortgage loans located in California, Florida, and New York were 34%, 8%, and 6%, respectively, of residential mortgage loans at September 30, 2016.

In connection with our investment management business, we manage commercial mortgage loans on behalf of institutional clients, which are unaffiliated investors. These commercial mortgage loans had an estimated fair value of $2.9 billion and $2.0 billion at September 30, 2016 and December 31, 2015, respectively. These assets are not included in our interim condensed consolidated financial statements.

Commercial Mortgage Loans by Geographic Region and Property Type. As shown above, commercial mortgage loans are the largest component of the mortgage loan invested asset class. The tables below present the diversification across geographic regions and property types of commercial mortgage loans at:

	September 30, 2016				December 31, 2015
	Amount		% of Total		Amount		% of Total
	(Dollars in millions)
Region
Pacific	$	9,661	21.1	%	$	9,583	21.8	%
Middle Atlantic	8,435		18.4		8,154		18.5
International	8,169		17.8		7,889		17.9
South Atlantic	6,031		13.2		6,127		13.9
West South Central	4,303		9.4		4,311		9.8
East North Central	2,303		5.0		2,346		5.3
New England	1,417		3.1		1,367		3.1
Mountain	1,548		3.4		1,117		2.5
West North Central	506		1.1		520		1.2
East South Central	633		1.4		512		1.2
Multi-Region and Other	2,795		6.1		2,086		4.8
Total recorded investment	45,801		100.0	%	44,012		100.0	%
Less: valuation allowances	227				217
Carrying value, net of valuation allowances	$	45,574			$	43,795
Property Type
Office	$	22,552	49.2	%	$	21,525	48.9	%
Retail	10,424		22.8		10,466		23.8
Apartment	5,989		13.1		5,171		11.7
Hotel	4,197		9.1		4,396		10.0
Industrial	2,415		5.3		2,334		5.3
Other	224		0.5		120		0.3
Total recorded investment	45,801		100.0	%	44,012		100.0	%
Less: valuation allowances	227				217
Carrying value, net of valuation allowances	$	45,574			$	43,795

150

Mortgage Loan Credit Quality - Monitoring Process.We monitor our mortgage loan investments on an ongoing basis, including a review of loans that are current, past due, restructured and under foreclosure. See Note 7of the Notes to the Interim Condensed Consolidated Financial Statements for tables that present mortgage loans by credit quality indicator, past due and nonaccrual mortgage loans, as well as impaired mortgage loans. See “— Real Estate and Real Estate Joint Ventures” for real estate acquired through foreclosure.

We review our commercial mortgage loans on an ongoing basis. These reviews may include an analysis of the property financial statements and rent roll, lease rollover analysis, property inspections, market analysis, estimated valuations of the underlying collateral, loan-to-value ratios, debt service coverage ratios, and tenant creditworthiness. The monitoring process focuses on higher risk loans, which include those that are classified as restructured, delinquent or in foreclosure, as well as loans with higher loan-to-value ratios and lower debt service coverage ratios. The monitoring process for agricultural mortgage loans is generally similar, with a focus on higher risk loans, such as loans with higher loan-to-value ratios, including reviews on a geographic and sector basis. We also review our residential mortgage loans on an ongoing basis. See Note 8 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report for information on our evaluation of residential mortgage loans and related valuation allowance methodology.

Loan-to-value ratios and debt service coverage ratios are common measures in the assessment of the quality of commercial mortgage loans. Loan-to-value ratios are a common measure in the assessment of the quality of agricultural mortgage loans. Loan-to-value ratios compare the amount of the loan to the estimated fair value of the underlying collateral. A loan-to-value ratio greater than 100% indicates that the loan amount is greater than the collateral value. A loan-to-value ratio of less than 100% indicates an excess of collateral value over the loan amount. Generally, the higher the loan-to-value ratio, the higher the risk of experiencing a credit loss. The debt service coverage ratio compares a property’s net operating income to amounts needed to service the principal and interest due under the loan. Generally, the lower the debt service coverage ratio, the higher the risk of experiencing a credit loss. For our commercial mortgage loans, our average loan-to-value ratio was 52% at both September 30, 2016 and December 31, 2015 and our average debt service coverage ratio was 2.7x and 2.6x at September 30, 2016 and December 31, 2015, respectively. Our debt service coverage ratio and the values utilized in calculating the ratio are updated annually, on a rolling basis, with a portion of the portfolio updated each quarter. Our loan-to-value ratio is routinely updated for all but the lowest risk loans as part of our ongoing review of our commercial mortgage loan portfolio. For our agricultural mortgage loans, our average loan-to-value ratio was 42% and 43% at September 30, 2016 and December 31, 2015, respectively. The values utilized in calculating the agricultural mortgage loan loan-to-value ratio are developed in connection with the ongoing review of the agricultural loan portfolio and are routinely updated.

Mortgage Loan Valuation Allowances. Our valuation allowances are established both on a loan specific basis for those loans considered impaired where a property specific or market specific risk has been identified that could likely result in a future loss, as well as for pools of loans with similar risk characteristics where a property specific or market specific risk has not been identified, but for which we expect to incur a loss. Accordingly, a valuation allowance is provided to absorb these estimated probable credit losses.

The determination of the amount of valuation allowances is based upon our periodic evaluation and assessment of known and inherent risks associated with our loan portfolios. Such evaluations and assessments are based upon several factors, including our experience with losses on loans, defaults and loss severity, and loss expectations for loans with similar risk characteristics. These evaluations and assessments are revised as conditions change and new information becomes available, which can cause the valuation allowances to increase or decrease over time as such evaluations are revised. Negative credit migration, including an actual or expected increase in the level of problem loans, will result in an increase in the valuation allowance. Positive credit migration, including an actual or expected decrease in the level of problem loans, will result in a decrease in the valuation allowance.

See Notes 7 and 9 of the Notes to the Interim Condensed Consolidated Financial Statements for information about how valuation allowances are established and monitored, activity in and balances of the valuation allowance, and the estimated fair value of impaired mortgage loans and related impairments included within net investment gains (losses) as of and for the nine months endedSeptember 30, 2016 and 2015.

Real Estate and Real Estate Joint Ventures

We diversify our real estate investments by both geographic region and property type to reduce risk of concentration. Of our real estate investments, excluding funds, 73% were located in the U.S., with the remaining 27% located outside the U.S., at September 30, 2016. The carrying value of our real estate investments, excluding funds, located in Japan, California and District of Columbia were 24%, 17% and 9%, respectively, of total real estate investments, excluding funds, at September 30, 2016. Real estate funds, including those classified within Traditional, were 10% of our real estate investments, at September 30, 2016. The majority of these funds hold underlying real estate investments that are well diversified across the U.S.

151

Real estate investments by type consisted of the following at: 

	September 30, 2016				December 31, 2015
	Carrying Value		% of Total		Carrying Value		% of Total
	(Dollars in millions)
Traditional	$	8,829	96.1	%	$	7,859	93.2	%
Real estate joint ventures and funds	265		2.9		482		5.7
Foreclosed (commercial, agricultural and residential)	59		0.6		45		0.5
Real estate held-for-investment	9,153		99.6		8,386		99.4
Real estate held-for-sale	33		0.4		47		0.6
Total real estate and real estate joint ventures	$	9,186	100.0	%	$	8,433	100.0	%

See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Investments — Real Estate and Real Estate Joint Ventures” included in the 2015 Annual Report for a discussion of the types of investments reported within Traditional and Real estate joint ventures and funds. The estimated fair value of the Traditional, as well as the Held-for-sale real estate investment portfolios, was $13.8 billion and $12.4 billion at September 30, 2016 and December 31, 2015, respectively.

In connection with our investment management business, we manage real estate investments on behalf of institutional clients, which are unaffiliated investors. These real estate investments had an estimated fair value of $4.3 billion and $3.8 billion at September 30, 2016 and December 31, 2015, respectively. These assets are not included in our interim condensed consolidated financial statements.

Other Limited Partnership Interests

Other limited partnership interests are comprised of private equity funds and hedge funds. The carrying value of other limited partnership interests was $6.9 billion and $7.1 billion at September 30, 2016 and December 31, 2015, respectively, which included $1.4 billion and $1.9 billion of hedge funds, at September 30, 2016 and December 31, 2015, respectively.

Other Invested Assets

The following table presents the carrying value of our other invested assets by type at:

	September 30, 2016				December 31, 2015
	Carrying Value		% of Total		Carrying Value		% of Total
	(Dollars in millions)
Freestanding derivatives with positive estimated fair values	$	21,788	72.0	%	$	14,406	64.0	%
Tax credit and renewable energy partnerships	3,197		10.6		3,145		13.9
Leveraged leases, net of non-recourse debt	1,625		5.4		1,712		7.6
Direct financing leases	1,155		3.8		1,076		4.8
Funds withheld	855		2.8		771		3.4
Operating joint ventures	769		2.5		605		2.7
Other	889		2.9		809		3.6
Total	$	30,278	100.0	%	$	22,524	100.0	%

Short-term Investments and Cash Equivalents

The carrying value of short-term investments, which approximates estimated fair value, was $11.7 billion and $9.3 billion, or 2.1% and 1.8% of total cash and invested assets, at September 30, 2016 and December 31, 2015, respectively. The carrying value of cash equivalents, which approximates estimated fair value, was $7.3 billion and $7.5 billion, or 1.3% and 1.5% of total cash and invested assets, at September 30, 2016 and December 31, 2015, respectively.

152

Derivatives

Derivative Risks

We are exposed to various risks relating to our ongoing business operations, including interest rate, foreign currency exchange rate, credit and equity market. We use a variety of strategies to manage these risks, including the use of derivatives. See Note 8 of the Notes to the Interim Condensed Consolidated Financial Statements for: 

• A comprehensive description of the nature of our derivatives, including the strategies for which derivatives are used in managing various risks.

• Information about the gross notional amount, estimated fair value, and primary underlying risk exposure of our derivatives by type of hedge designation, excluding embedded derivatives held at September 30, 2016 and December 31, 2015.

• The statement of operations effects of derivatives in net investments in foreign operations, cash flow, fair value, or nonqualifying hedge relationships for the three months and nine months endedSeptember 30, 2016 and 2015.

See “Quantitative and Qualitative Disclosures About Market Risk — Management of Market Risk Exposures — Hedging Activities” included in the 2015 Annual Report for more information about our use of derivatives by major hedge program.

Fair Value Hierarchy

See Note 9 of the Notes to the Interim Condensed Consolidated Financial Statements for derivatives measured at estimated fair value on a recurring basis and their corresponding fair value hierarchy.

The valuation of Level 3 derivatives involves the use of significant unobservable inputs and generally requires a higher degree of management judgment or estimation than the valuations of Level 1 and Level 2 derivatives. Although Level 3 inputs are unobservable, management believes they are consistent with what other market participants would use when pricing such instruments and are considered appropriate given the circumstances. The use of different inputs or methodologies could have a material effect on the estimated fair value of Level 3 derivatives and could materially affect net income.

Derivatives categorized as Level 3 at September 30, 2016 include: interest rate forwards with maturities which extend beyond the observable portion of the yield curve; interest rate total return swaps with unobservable repurchase rates; foreign currency swaps and forwards with certain unobservable inputs, including the unobservable portion of the yield curve; credit default swaps priced using unobservable credit spreads, or that are priced through independent broker quotations; equity variance swaps with unobservable volatility inputs; and equity index options with unobservable correlation inputs. At September 30, 2016, less than 1% of the estimated fair value of our derivatives was priced through independent broker quotations.

See Note 9 of the Notes to the Interim Condensed Consolidated Financial Statements for a rollforward of the fair value measurements for derivatives measured at estimated fair value on a recurring basis using significant unobservable (Level 3) inputs.

The gain (loss) on Level 3 derivatives primarily relates to interest rate total return swaps with unobservable repurchase rates, certain purchased equity index options that are valued using models dependent on an unobservable market correlation input, equity variance swaps that are valued using observable equity volatility data plus an unobservable equity variance spread and foreign currency swaps and forwards that are valued using an unobservable portion of the swap yield curves. Other significant inputs, which are observable, include equity index levels, equity volatility and the swap yield curves. We validate the reasonableness of these inputs by valuing the positions using internal models and comparing the results to broker quotations.

153

The gain (loss) on Level 3 derivatives, percentage of gain (loss) attributable to observable and unobservable inputs, and the primary drivers of observable gain (loss) are summarized as follows:

	Three Months   Ended   September 30, 2016	Nine Months   Ended   September 30, 2016
Gain (loss) recognized in net income (loss)	$(116) million	$110 million
Percentage of gain (loss) attributable to observable inputs	117%	(41)%
Primary drivers of observable gain (loss)	Increases in interest rates on interest rate total return swaps; decreases in certain equity volatility levels; and increases in certain equity index levels.	Decreases in interest rates on interest rate total return swaps; weakening of the U.S. dollar versus foreign currencies on receive inflation-linked foreign currency, pay U.S. dollar forwards and swaps; partially offset by decreases in certain equity volatility levels; and increases in certain equity index levels.
Percentage of gain (loss) attributable to unobservable inputs	(17)%	141%

See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Summary of Critical Accounting Estimates — Derivatives” included in the 2015 Annual Report for further information on the estimates and assumptions that affect derivatives.

Credit Risk

See Note 8 of the Notes to the Interim Condensed Consolidated Financial Statements for information about how we manage credit risk related to derivatives and for the estimated fair value of our net derivative assets and net derivative liabilities after the application of master netting agreements and collateral.

Our policy is not to offset the fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement. This policy applies to the recognition of derivatives in the consolidated balance sheets, and does not affect our legal right of offset.

Credit Derivatives

The following table presents the gross notional amount and estimated fair value of credit default swaps at:

	September 30, 2016					December 31, 2015
Credit Default Swaps	Gross Notional Amount		Estimated Fair Value			Gross Notional Amount		Estimated Fair Value
	(In millions)
Purchased (1)	$	2,038	$	(34	)	$	1,870	$	(6	)
Written (2)	11,664		140			10,311		65
Total	$	13,702	$	106		$	12,181	$	59

__________________

(1) At September 30, 2016 there were no purchased credit default swaps held in relation to the trading portfolio. At December 31, 2015 purchased credit default swaps held in relation to the trading portfolio amounted to $175 million in gross notional amount and ($2) million in estimated fair value.

(2) At September 30, 2016, there were no written credit default swaps held in relation to the trading portfolio. At December 31, 2015, written credit default swaps held in relation to the trading portfolio amounted to $20 million in gross notional amount and ($2) million in estimated fair value.

154

The following table presents the gross gains, gross losses and net gain (losses) recognized in income for credit default swaps as follows:

	Three Months   Ended   September 30,																Nine Months   Ended   September 30,
	2016								2015								2016								2015
Credit Default Swaps	Gross Gains  (1)		Gross Losses  (1)			Net Gains (Losses)			Gross Gains  (1)		Gross Losses  (1)			Net Gains (Losses)			Gross Gains  (1)		Gross Losses  (1)			Net Gains (Losses)			Gross Gains  (1)		Gross Losses  (1)			Net Gains (Losses)
	(In millions)
Purchased (2), (4)	$	—	$	(21	)	$	(21	)	$	20	$	(1	)	$	19		$	6	$	(54	)	$	(48	)	$	32	$	(20	)	$	12
Written (3), (4)	60		—			60			—		(78		)	(78		)	81		(24		)	57			16		(124		)	(108		)
Total	$	60	$	(21	)	$	39		$	20	$	(79	)	$	(59	)	$	87	$	(78	)	$	9		$	48	$	(144	)	$	(96	)

__________________

(1) Gains (losses) are reported in net derivative gains (losses), except for gains (losses) on the trading portfolio, which are reported in net investment income.

(2) There were no gross gains and gross (losses) for purchased credit default swaps in the trading portfolio for the three months ended September 30, 2016. The gross gains and gross (losses) for purchased credit default swaps in the trading portfolio were $4 million and ($4) million, respectively, for the nine months endedSeptember 30, 2016. The gross gains and gross (losses) for purchased credit default swaps in the trading portfolio were $4 million and ($1) million, respectively, for the three months endedSeptember 30, 2015 and $7 million and ($4) million, respectively, for the nine months endedSeptember 30, 2015.

(3) There were no gross gains and gross (losses) for written credit default swaps in the trading portfolio for the three months ended September 30, 2016. The gross gains and gross (losses) for written credit default swaps in the trading portfolio were $3 million and ($3) million, respectively, for the nine months endedSeptember 30, 2016. The gross gains and gross (losses) for written credit default swaps in the trading portfolio were $2 million and ($3) million for the three months endedSeptember 30, 2015 and $3 million and ($3) million, respectively, for the nine months endedSeptember 30, 2015.

(4) Gains (losses) do not include earned income (expense) on credit default swaps.

The unfavorable change in net gains (losses) on purchased credit default swaps of $40 million for the three months ended September 30, 2016 compared to the three months ended September 30, 2015 was due to credit spreads narrowing in the current period compared to the prior period on credit default swaps hedging certain bonds. The favorable change in net gains (losses) on written credit default swaps of $138 million for the three months ended September 30, 2016 compared to the three months ended September 30, 2015 was due to credit spreads narrowing in the current period compared to the prior period on certain credit default swaps used as replications.

The unfavorable change in net gains (losses) on purchased credit default swaps of $60 million for the nine months ended September 30, 2016 compared to the nine months ended September 30, 2015 was due to credit spreads narrowing in the current period compared to the prior period on credit default swaps hedging certain bonds. The favorable change in net gains (losses) on written credit default swaps of $165 million for the nine months ended September 30, 2016 compared to the nine months ended September 30, 2015 was due to credit spreads narrowing in the current period compared to the prior period on certain credit default swaps used as replications.

The maximum amount at risk related to our written credit default swaps is equal to the corresponding gross notional amount. In a replication transaction, we pair an asset on our balance sheet with a written credit default swap to synthetically replicate a corporate bond, a core asset holding of life insurance companies. Replications are entered into in accordance with the guidelines approved by insurance regulators and are an important tool in managing the overall corporate credit risk within the Company. In order to match our long-dated insurance liabilities, we will seek to buy long-dated corporate bonds. In some instances, these may not be readily available in the market, or they may be issued by corporations to which we already have significant corporate credit exposure. For example, by purchasing Treasury bonds (or other high-quality assets) and associating them with written credit default swaps on the desired corporate credit name, we, at times, can replicate the desired bond exposures and meet our ALM needs. In addition, given the shorter tenor of the credit default swaps (generally five-year tenors) versus a long-dated corporate bond, we have more flexibility in managing our credit exposures.

155

Embedded Derivatives

See Note 9 of the Notes to the Interim Condensed Consolidated Financial Statements for information about embedded derivatives measured at estimated fair value on a recurring basis and their corresponding fair value hierarchy.

See Note 9 of the Notes to the Interim Condensed Consolidated Financial Statements for a rollforward of the fair value measurements for net embedded derivatives measured at estimated fair value on a recurring basis using significant unobservable (Level 3) inputs.

See Note 8 of the Notes to the Interim Condensed Consolidated Financial Statements for information about the nonperformance risk adjustment included in the valuation of guaranteed minimum benefits accounted for as embedded derivatives.

See “— Summary of Critical Accounting Estimates — Derivatives” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Summary of Critical Accounting Estimates — Derivatives” included in the 2015 Annual Report for further information on the estimates and assumptions that affect embedded derivatives.

Off-Balance Sheet Arrangements

Credit and Committed Facilities

We maintain an unsecured credit facility and certain committed facilities with various financial institutions. See “— Liquidity and Capital Resources — The Company — Liquidity and Capital Sources — Global Funding Sources — Credit and Committed Facilities” for further descriptions of such arrangements. For the classification of expenses on such credit and committed facilities and the nature of the associated liability for letters of credit issued and drawdowns on these credit and committed facilities, see Note 12 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report.

Collateral for Securities Lending, Repurchase Agreement Transactions, Third-Party Custodian Administered Repurchase Program and Derivatives

We participate in a securities lending program in the normal course of business for the purpose of enhancing the total return on our investment portfolio. Periodically, we receive non-cash collateral for securities lending from counterparties, which cannot be sold or re-pledged, and which has not been recorded on our consolidated balance sheets. The amount of this collateral was $134 million and $50 million at estimated fair value at September 30, 2016 and December 31, 2015, respectively. See Note 7 of the Notes to the Interim Condensed Consolidated Financial Statements and “— Investments — Securities Lending,” as well as “Summary of Significant Accounting Policies — Investments — Securities Lending Program” in Note 1 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report for discussion of our securities lending program, the classification of revenues and expenses, and the nature of the secured financing arrangement and associated liability.

We participate in repurchase and reverse repurchase agreement transactions. In connection with these transactions, we obtain fixed maturity securities as collateral from unaffiliated financial institutions, which can be re-pledged, and which have not been recorded on our consolidated balance sheets. The amount of these securities and the amount which were re-pledged was $306 million and $114 million, respectively, at estimated fair value at September 30, 2016. We had no such securities as of December 31, 2015. See “— Investments — Repurchase Agreement Transactions” and Note 7 of the Notes to the Interim Condensed Consolidated Financial Statements for discussion of our repurchase and reverse repurchase agreements, and the classification of the associated net receivable/payable and expense.

We also participate in third-party custodian administered repurchase programs for the purpose of enhancing the total return on our investment portfolio. We loan certain of our fixed maturity securities to financial institutions and, in exchange, non-cash collateral is put on deposit by the financial institutions on our behalf with third-party custodians. The estimated fair value of securities loaned in connection with these transactions was $347 million and $738 million at September 30, 2016 and December 31, 2015, respectively. Non-cash collateral on deposit with third-party custodians on our behalf was $359 million and $781 million at September 30, 2016 and December 31, 2015, respectively, which cannot be sold or re-pledged, and which has not been recorded on our consolidated balance sheets.

We enter into derivatives to manage various risks relating to our ongoing business operations. We have non-cash collateral from counterparties for derivatives, which can be sold or re-pledged subject to certain constraints, and which has not been recorded on our consolidated balance sheets. The amount of this non-cash collateral was $3.3 billion and $2.2 billion at September 30, 2016 and December 31, 2015, respectively. See “— Liquidity and Capital Resources — The Company — Liquidity and Capital Uses — Pledged Collateral” and Note 8 of the Notes to the Interim Condensed Consolidated Financial Statements for information regarding the earned income on and the gross notional amount, estimated fair value of assets and liabilities and primary underlying risk exposure of our derivatives.

156

Lease Commitments

As lessee, we have entered into various lease and sublease agreements for office space, information technology and other equipment. Our commitments under such lease agreements are included within the contractual obligations table. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources — The Company — Contractual Obligations” and Note 21 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report.

Guarantees

See “Guarantees” in Note 15 of the Notes to the Interim Condensed Consolidated Financial Statements.

Other

Additionally, we make mortgage loan commitments and commitments to fund partnerships, bank credit facilities, bridge loans and private corporate bond investments in the normal course of business for the purpose of enhancing the total return on our investment portfolio. Other than these investment-related commitments which are disclosed in Note 15 of the Notes to the Interim Condensed Consolidated Financial Statements, there are no other material obligations or liabilities arising from these investment- related commitments. For further information on these investment-related commitments see “— Liquidity and Capital Resources — The Company — Contractual Obligations.” See “Net Investment Income” and “Net Investment Gains (Losses)” in Note 7 of the Notes to the Interim Condensed Consolidated Financial Statements for information on the investment income, investment expense, gains and losses from such investments. See also “— Investments — Fixed Maturity and Equity Securities AFS,” “— Investments — Mortgage Loans,” “— Investments — Real Estate and Real Estate Joint Ventures” and “— Investments — Other Limited Partnership Interests” for information on our investments in fixed maturity and equity securities, mortgage loans and partnerships.

Policyholder Liabilities

We establish, and carry as liabilities, actuarially determined amounts that are calculated to meet policy obligations or to provide for future annuity payments. Amounts for actuarial liabilities are computed and reported in the interim condensed consolidated financial statements in conformity with GAAP. For more details on Policyholder Liabilities, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Summary of Critical Accounting Estimates” included in the 2015 Annual Report.

Due to the nature of the underlying risks and the uncertainty associated with the determination of actuarial liabilities, we cannot precisely determine the amounts that will ultimately be paid with respect to these actuarial liabilities, and the ultimate amounts may vary from the estimated amounts, particularly when payments may not occur until well into the future.

We periodically review our estimates of actuarial liabilities for future benefits and compare them with our actual experience. We revise estimates, to the extent permitted or required under GAAP, if we determine that future expected experience differs from assumptions used in the development of actuarial liabilities. We charge or credit changes in our liabilities to expenses in the period the liabilities are established or re-estimated. If the liabilities originally established for future benefit payments prove inadequate, we must increase them. Such an increase could adversely affect our earnings and have a material adverse effect on our business, results of operations and financial condition.

We have experienced, and will likely in the future experience, catastrophe losses and possibly acts of terrorism, as well as turbulent financial markets that may have an adverse impact on our business, results of operations, and financial condition. Due to their nature, we cannot predict the incidence, timing, severity or amount of losses from catastrophes and acts of terrorism, but we make broad use of catastrophic and non-catastrophic reinsurance to manage risk from these perils.

Insurance regulators in many of the non-U.S. countries in which we operate require certain MetLife entities to prepare a sufficiency analysis of the reserves presented in the locally required regulatory financial statements, and to submit that analysis to the regulatory authorities. See “Business — Regulation — U.S. Regulation — Insurance Regulation — Policy and Contract Reserve Adequacy Analysis” and “Business — Regulation — International Regulation” included in the 2015 Annual Report.

Future Policy Benefits

We establish liabilities for amounts payable under insurance policies. See Notes 1 and 4 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report for additional information. See also “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Industry Trends — Impact of a Sustained Low Interest Rate Environment — Low Interest Rate Scenario” included in the 2015 Annual Report and “— Variable Annuity Guarantees.” A discussion of future policy benefits by segment (as well as Corporate & Other) follows.

157

U.S.

Amounts payable under insurance policies for this segment are comprised of group insurance and annuities, as well as property & casualty policies. For group insurance, future policyholder benefits are comprised mainly of liabilities for disabled lives under disability waiver of premium policy provisions, liabilities for survivor income benefit insurance, active life policies and premium stabilization and other contingency liabilities held under life insurance contracts. For group annuity contracts, future policyholder benefits are primarily related to payout annuities, including pension risk transfers, structured settlement annuities and institutional income annuities. There is no interest rate crediting flexibility on these liabilities. As a result, a sustained low interest rate environment could negatively impact earnings; however, we mitigate our risks by applying various ALM strategies, including the use of various derivative positions, primarily interest rate floors and interest rate swaps. The components of future policy benefits our property & casualty policies are liabilities for unpaid claims, estimated based upon assumptions such as rates of claim frequencies, levels of severities, inflation, judicial trends, legislative changes or regulatory decisions. Assumptions are based upon our historical experience and analysis of historical development patterns of the relationship of loss adjustment expenses to losses for each line of business, and we consider the effects of current developments, anticipated trends and risk management programs, reduced for anticipated salvage and subrogation.

Asia

Future policy benefits for this segment are held primarily for traditional life, endowment, annuity and accident & health contracts. They are also held for total return pass-through provisions included in certain universal life and savings products. They include certain liabilities for variable annuity and variable life guarantees of minimum death benefits, and longevity guarantees. Factors impacting these liabilities include sustained periods of lower yields than rates established at policy issuance, lower than expected asset reinvestment rates, market volatility, actual lapses resulting in lower than expected income, and actual mortality or morbidity resulting in higher than expected benefit payments. We mitigate our risks by applying various ALM strategies.

Latin America

Future policy benefits for this segment are held primarily for immediate annuities in Chile, Argentina and Mexico and traditional life contracts mainly in Mexico, Brazil and Colombia. There are also liabilities held for total return pass-through provisions included in certain universal life and savings products in Mexico. Factors impacting these liabilities include sustained periods of lower yields than rates established at policy issuance, lower than expected asset reinvestment rates, and mortality and lapses different than expected. We mitigate our risks by applying various ALM strategies.

EMEA

Future policy benefits for this segment include unearned premium reserves for group life and credit insurance contracts. Future policy benefits are also held for traditional life, endowment and annuity contracts with significant mortality risk and accident & health contracts. Factors impacting these liabilities include lower than expected asset reinvestment rates, market volatility, actual lapses resulting in lower than expected income, and actual mortality or morbidity resulting in higher than expected benefit payments. We mitigate our risks by having premiums which are adjustable or cancellable in some cases, and by applying various ALM strategies.

MetLife Holdings

Future policy benefits for the life business are comprised mainly of liabilities for traditional life and for universal and variable life insurance contracts. In order to manage risk, we have often reinsured a portion of the mortality risk on life insurance policies. The reinsurance programs are routinely evaluated and this may result in increases or decreases to existing coverage. We have entered into various derivative positions, primarily interest rate swaps and swaptions, to mitigate the risk that investment of premiums received and reinvestment of maturing assets over the life of the policy will be at rates below those assumed in the original pricing of these contracts. For the annuities business, future policy benefits are comprised mainly of liabilities for life-contingent income annuities, and liabilities for the variable annuity guaranteed minimum benefits accounted for as insurance. Other future policyholder benefits are comprised mainly of liabilities for disabled lives under disability waiver of premium policy provisions, and active life policies. In addition, for our other products, future policyholder benefits related to the reinsurance of our former Japan joint venture are comprised of liabilities for the variable annuity guaranteed minimum benefits accounted for as insurance.

158

Brighthouse Financial

Future policy benefits for the life business are comprised mainly of liabilities for traditional life and for universal and variable life insurance contracts. In order to manage risk, we have often reinsured a portion of the mortality risk on life insurance policies. The reinsurance programs are routinely evaluated and this may result in increases or decreases to existing coverage. We have entered into various derivative positions, primarily interest rate swaps and swaptions, to mitigate the risk that investment of premiums received and reinvestment of maturing assets over the life of the policy will be at rates below those assumed in the original pricing of these contracts. For the annuities business, future policy benefits are comprised mainly of liabilities for life-contingent income annuities, and liabilities for the variable annuity guaranteed minimum benefits accounted for as insurance. For our other products, future policyholder benefits are comprised mainly of group annuity contracts, primarily related to payout annuities, including pension risk transfers, structured settlement annuities and institutional income annuities. There is no interest rate crediting flexibility on these liabilities. As a result, a sustained low interest rate environment could negatively impact earnings; however, we mitigate our risks by applying various ALM strategies, including the use of various derivative positions, primarily interest rate floors and interest rate swaps.

Corporate & Other

Future policy benefits primarily include liabilities for the global employee benefits reinsurance business. Additionally, future policy benefits include liabilities for the U.S direct business sold directly to consumers.

Policyholder Account Balances

Policyholder account balances are generally equal to the account value, which includes accrued interest credited, but excludes the impact of any applicable charge that may be incurred upon surrender. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Industry Trends — Impact of a Sustained Low Interest Rate Environment — Low Interest Rate Scenario” included in the 2015 Annual Report and “— Variable Annuity Guarantees.” See also Notes 1 and 4 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report for additional information. A discussion of policyholder account balances by segment (as well as Corporate & Other) follows.

U.S.

Policyholder account balances in this segment are comprised of funding agreements, retained asset accounts, universal life policies, the fixed account of variable life insurance policies and specialized life insurance products for benefit programs.

Group Benefits

Policyholder account balances in this business are held for retained asset accounts, universal life policies, the fixed account of variable life insurance policies and specialized life insurance products for benefit programs. Policyholder account balances are credited interest at a rate we determine, which is influenced by current market rates. A sustained low interest rate environment could negatively impact earnings as a result of the minimum credited rate guarantees present in most of these policyholder account balances. We have various derivative positions, primarily interest rate floors, to partially mitigate the risks associated with such a scenario.

The table below presents the breakdown of account value subject to minimum guaranteed crediting rates for Group Benefits:

	September 30, 2016
Guaranteed Minimum Crediting Rate	Account Value (1)		Account Value at Guarantee (1)
	(In millions)
Greater than 0% but less than 2%	$	5,018	$	4,890
Equal to 2% but less than 4%	$	1,913	$	1,913
Equal to or greater than 4%	$	701	$	675

__________________

(1)These amounts are not adjusted for policy loans.

Retirement & Income Solutions

159

Policyholder account balances in this business are comprised of funding agreements. Interest crediting rates vary by type of contract, and can be fixed or variable. Variable interest crediting rates are generally tied to an external index, most commonly (1-month or 3-month) LIBOR. We are exposed to interest rate risks, as well as foreign currency exchange rate risk, when guaranteeing payment of interest and return of principal at the contractual maturity date. We may invest in floating rate assets or enter into receive-floating interest rate swaps, also tied to external indices, as well as caps, to mitigate the impact of changes in market interest rates. We also mitigate our risks by applying various ALM strategies and seek to hedge all foreign currency exchange rate risk through the use of foreign currency hedges, including cross currency swaps.

Asia

Policyholder account balances in this segment are held largely for fixed income retirement and savings plans, fixed deferred annuities, interest sensitive whole life products, universal life and, to a lesser degree, liability amounts for unit-linked-type funds that do not meet the GAAP definition of separate accounts. Also included are certain liabilities for retirement and savings products sold in certain countries in Asia that generally are sold with minimum credited rate guarantees. Liabilities for guarantees on certain variable annuities in Asia are accounted for as embedded derivatives and recorded at estimated fair value and are also included within policyholder account balances. These liabilities are generally impacted by sustained periods of low interest rates, where there are interest rate guarantees. We mitigate our risks by applying various ALM strategies and with reinsurance. Liabilities for unit-linked-type funds are impacted by changes in the fair value of the associated underlying investments, as the return on assets is generally passed directly to the policyholder.

The table below presents the breakdown of account value subject to minimum guaranteed crediting rates for Asia:

	September 30, 2016
Guaranteed Minimum Crediting Rate (1)	Account Value (2)		Account Value at Guarantee (2)
	(In millions)
Annuities
Greater than 0% but less than 2%	$	20,784	$	3,125
Equal to 2% but less than 4%	$	1,153	$	441
Equal to or greater than 4%	$	2	$	2
Life & Other
Greater than 0% but less than 2%	$	8,634	$	8,258
Equal to 2% but less than 4%	$	20,194	$	9,280
Equal to or greater than 4%	$	272	$	272

__________________

(1) Excludes negative VOBA liabilities of $1.1 billion at September 30, 2016, primarily held in Japan. These liabilities were established in instances where the estimated fair value of contract obligations exceeded the book value of assumed insurance policy liabilities associated with the acquisition of American Life Insurance Company (“American Life”) and Delaware American Life Insurance Company (collectively, “ALICO”). These negative liabilities were established primarily for decreased market interest rates subsequent to the issuance of the policy contracts.

(2) These amounts are not adjusted for policy loans.

Latin America

Policyholder account balances in this segment are held largely for investment-type products and universal life products in Mexico and Chile, and deferred annuities in Brazil. Some of the deferred annuities in Brazil are unit-linked-type funds that do not meet the GAAP definition of separate accounts. The rest of the deferred annuities have minimum credited rate guarantees, and these liabilities and the universal life liabilities are generally impacted by sustained periods of low interest rates. Liabilities for unit-linked-type funds are impacted by changes in the fair value of the associated investments, as the return on assets is generally passed directly to the policyholder.

160

EMEA

Policyholder account balances in this segment are held mostly for universal life, deferred annuity, pension products, and unit-linked-type funds that do not meet the GAAP definition of separate accounts. They are also held for endowment products without significant mortality risk. Where there are interest rate guarantees, these liabilities are generally impacted by sustained periods of low interest rates. We mitigate our risks by applying various ALM strategies. Liabilities for unit-linked-type funds are impacted by changes in the fair value of the associated investments, as the return on assets is generally passed directly to the policyholder.

MetLife Holdings

Life policyholder account balances are held for retained asset accounts, universal life policies, the fixed account of variable life insurance policies, embedded derivatives related to the reinsurance of our former Japan joint venture, and funding agreements. For annuities, policyholder account balances are held for fixed deferred annuities, the fixed account portion of variable annuities, and non-life contingent income annuities. Interest is credited to the policyholder’s account at interest rates we determine which are influenced by current market rates, subject to specified minimums. A sustained low interest rate environment could negatively impact earnings as a result of the minimum credited rate guarantees present in most of these policyholder account balances. We have various derivative positions, primarily interest rate floors, to partially mitigate the risks associated with such a scenario. Additionally, for our other products policyholder account balances are held for variable annuity guaranteed minimum living benefits that are accounted for as embedded derivatives.

The table below presents the breakdown of account value subject to minimum guaranteed crediting rates for the MetLife Holdings segment:

	September 30, 2016
Guaranteed Minimum Crediting Rate	Account Value (1)		Account Value at Guarantee (1)
	(In millions)
Greater than 0% but less than 2%	$	1,988	$	1,882
Equal to 2% but less than 4%	$	20,352	$	17,215
Equal to or greater than 4%	$	9,430	$	6,410

__________________

(1) These amounts are not adjusted for policy loans.

As a result of acquisitions, we establish additional liabilities known as excess interest reserves for policies with credited rates in excess of market rates as of the applicable acquisition dates. At September 30, 2016, excess interest reserves were $2,266 million for the MetLife Holdings segment.

Brighthouse Financial

Life policyholder account balances are held for universal life policies and the fixed account of variable life insurance policies. For annuities, policyholder account balances are held for fixed deferred annuities, the fixed account portion of variable annuities, and non-life contingent income annuities. For our other products, policyholder account balances are comprised of funding agreements. Interest is credited to the policyholder’s account at interest rates we determine which are influenced by current market rates, subject to specified minimums Interest crediting rates vary by type of contract, and can be fixed or variable. Variable interest crediting rates are generally tied to an external index, most commonly (1-month or 3-month) LIBOR. We are exposed to interest rate risks, as well as foreign currency exchange rate risk, when guaranteeing payment of interest and return of principal at the contractual maturity date. We may invest in floating rate assets or enter into receive-floating interest rate swaps, also tied to external indices, as well as caps, to mitigate the impact of changes in market interest rates. We also mitigate our risks by applying various ALM strategies and seek to hedge all foreign currency exchange rate risk through the use of foreign currency hedges, including cross currency swaps. A sustained low interest rate environment could negatively impact earnings as a result of the minimum credited rate guarantees present in most of these policyholder account balances. We have various derivative positions, primarily interest rate floors, to partially mitigate the risks associated with such a scenario. Additionally, for our other products policyholder account balances are held for variable annuity guaranteed minimum living benefits that are accounted for as embedded derivatives.

161

The table below presents the breakdown of account value subject to minimum guaranteed crediting rates for the Brighthouse Financial segment:

	September 30, 2016
Guaranteed Minimum Crediting Rate	Account Value (1)		Account Value at Guarantee (1)
	(In millions)
Greater than 0% but less than 2%	$	1,759	$	1,276
Equal to 2% but less than 4%	$	22,475	$	14,942
Equal to or greater than 4%	$	3,750	$	2,849

(1) These amounts are not adjusted for policy loans.

As a result of acquisitions, we establish additional liabilities known as excess interest reserves for policies with credited rates in excess of market rates as of the applicable acquisition dates. At September 30, 2016, excess interest reserves were $424 million for the Brighthouse Financial segment.

Variable Annuity Guarantees

We issue, directly and through assumed business, certain variable annuity products with guaranteed minimum benefits that provide the policyholder a minimum return based on their initial deposit (i.e., the benefit base) less withdrawals. In some cases, the benefit base may be increased by additional deposits, bonus amounts, accruals or optional market value resets. See Notes 1 and 4 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report, as well as Note 4 of the Interim Condensed Consolidated Financial Statements, for additional information.

Certain guarantees, including portions thereof, have insurance liabilities established that are included in future policy benefits. Guarantees accounted for in this manner include GMDBs, the life-contingent portion of certain guaranteed minimum withdrawal benefit (“GMWBs”), and the non-life contingent portions of both GMWBs and GMIBs that require annuitization. These liabilities are accrued over the life of the contract in proportion to actual and future expected policy assessments based on the level of guaranteed minimum benefits generated using multiple scenarios of separate account returns. The scenarios are based on best estimate assumptions consistent with those used to amortize DAC. When current estimates of future benefits exceed those previously projected or when current estimates of future assessments are lower than those previously projected, liabilities will increase, resulting in a current period charge to net income. The opposite result occurs when the current estimates of future benefits are lower than those previously projected or when current estimates of future assessments exceed those previously projected. At each reporting period, we update the actual amount of business remaining in-force, which impacts expected future assessments and the projection of estimated future benefits resulting in a current period charge or increase to earnings.

Certain guarantees, including portions thereof, accounted for as embedded derivatives, are recorded at estimated fair value and included in policyholder account balances. Guarantees accounted for as embedded derivatives include guaranteed minimum accumulation benefits (“GMABs”), and the non-life contingent portions of both GMWBs and GMIBs that do not require annuitization. The estimated fair values of guarantees accounted for as embedded derivatives are determined based on the present value of projected future benefits minus the present value of projected future fees. The projections of future benefits and future fees require capital market and actuarial assumptions including expectations concerning policyholder behavior. A risk neutral valuation methodology is used to project the cash flows from the guarantees under multiple capital market scenarios to determine an economic liability. The reported estimated fair value is then determined by taking the present value of these risk-free generated cash flows using a discount rate that incorporates a spread over the risk-free rate to reflect our nonperformance risk and adding a risk margin. For more information on the determination of estimated fair value, see Note 9 of the Notes to the Interim Condensed Consolidated Financial Statements.

162

The table below contains the carrying value for guarantees at: 

	Future Policy Benefits				Policyholder Account Balances
	September 30, 2016		December 31, 2015		September 30, 2016			December 31, 2015
	(In millions)
Asia
GMDB	$	27	$	25	$	—		$	—
GMAB	—		—		55			37
GMWB	106		89		255			151
EMEA
GMDB	1		2		—			—
GMAB	—		—		23			16
GMWB	5		8		(10		)	(63		)
MetLife Holdings
GMDB	240		209		—			153
GMIB	462		406		430			(516		)
GMAB	—		—		39			23
GMWB	205		127		1,907			1,009
Brighthouse Financial
GMDB	953		741		—			—
GMIB	2,299		2,004		3,097			(153		)
GMAB	—		—		16			8
GMWB	133		104		894			280
Total	$	4,431	$	3,715	$	6,706		$	945

The carrying amounts for guarantees included in policyholder account balances above include nonperformance risk adjustments of $1,700 million and $462 million at September 30, 2016 and December 31, 2015, respectively. These nonperformance risk adjustments represent the impact of including a credit spread when discounting the underlying risk neutral cash flows to determine the estimated fair values. The nonperformance risk adjustment does not have an economic impact on us as it cannot be monetized given the nature of these policyholder liabilities. The change in valuation arising from the nonperformance risk adjustment is not hedged.

The carrying values of these guarantees can change significantly during periods of sizable and sustained shifts in equity market performance, equity volatility, interest rates or foreign currency exchange rates. Carrying values are also impacted by our assumptions around mortality, separate account returns and policyholder behavior, including lapse rates.

As discussed below, we use a combination of product design, hedging strategies, reinsurance, and other risk management actions to mitigate the risks related to these benefits. Within each type of guarantee, there is a range of product offerings reflecting the changing nature of these products over time. Changes in product features and terms are in part driven by customer demand but, more importantly, reflect our risk management practices of continuously evaluating the guaranteed benefits and their associated asset-liability matching. Recently, we have been diversifying the concentration of income benefits in the portfolio of the Company’s annuities business by focusing on withdrawal benefits, variable annuities without living benefits and index-linked annuities. To this end, the GMIBs were no longer available for new purchases after February 19, 2016.

The sections below provide further detail by total account value for certain of our most popular guarantees. Total account values include amounts not reported in the consolidated balance sheets from assumed business, contractholder-directed investments which do not qualify for presentation as separate account assets, and amounts included in our general account. The total account values and the net amounts at risk include direct and assumed business, but exclude offsets from hedging or ceded reinsurance, if any.

163

GMDBs

We offer a range of GMDBs to our contractholders. The table below presents GMDBs, by benefit type, at September 30, 2016:

	Total Account Value (1)
	Asia & EMEA		MetLife Holdings		Brighthouse Financial
	(In millions)
Return of premium or five to seven year step-up	$	9,072	$	56,043	$	56,844
Annual step-up	—		3,741		23,675
Roll-up and step-up combination	—		6,617		30,400
Total	$	9,072	$	66,401	$	110,919

__________________

(1) Total account value excludes $2.2 billion for contracts with no GMDBs. Further, many of our annuity contracts offer more than one type of guarantee such that GMDB amounts listed above are not mutually exclusive to the amounts in the living benefit guarantees table below.

Based on total account value, less than 39% of our GMDBs included enhanced death benefits such as the annual step-up or roll-up and step-up combination products. We expect the above GMDB risk profile to be relatively consistent for the foreseeable future.

Living Benefit Guarantees

The table below presents our living benefit guarantees based on total account values at September 30, 2016:

	Total Account Value (1)
	Asia & EMEA		MetLife Holdings		Brighthouse Financial
	(In millions)
GMIB	$	—	$	24,914	$	66,148
GMWB - non-life contingent (2)	2,610		3,934		3,466
GMWB - life-contingent	4,065		12,005		19,409
GMAB	1,347		947		716
	$	8,022	$	41,800	$	89,739

__________________

(1) Total account value excludes $48.0 billion for contracts with no living benefit guarantees. Further, many of our annuity contracts offer more than one type of guarantee such that living benefit guarantee amounts listed above are not mutually exclusive of the amounts in the GMDBs table above.

(2) The Asia and EMEA segments include the non-life contingent portion of the GMWB total account value of $1,125 million with a guarantee at annuitization.

In terms of total account value, GMIBs are our most significant living benefit guarantee. Our primary risk management strategy for our GMIB products is our derivatives hedging program as discussed below. Additionally, we have engaged in certain reinsurance agreements covering some of our GMIB business. As part of our overall risk management approach for living benefit guarantees, we continually monitor the reinsurance markets for the right opportunity to purchase additional coverage for our GMIB business.

164

The table below presents our GMIB associated total account values, by their guaranteed payout basis, at September 30, 2016:

	Total Account Value
	(In millions)
7-year setback, 2.5% interest rate	$	32,459
7-year setback, 1.5% interest rate	5,374
10-year setback, 1.5% interest rate	18,176
10-year mortality projection, 10-year setback, 1.0% interest rate	30,737
10-year mortality projection, 10-year setback, 0.5% interest rate	4,316
	$	91,062

The annuitization interest rates on GMIBs have been decreased from 2.5% to 0.5% over time, partially in response to the low interest rate environment, accompanied by an increase in the setback period from seven years to 10 years and the introduction of a 10-year mortality projection.

Additionally, 33% of the $91.1 billion of GMIB total account value has been invested in managed volatility funds as of September 30, 2016. These funds seek to manage volatility by adjusting the fund holdings within certain guidelines based on capital market movements. Such activity reduces the overall risk of the underlying funds while maintaining their growth opportunities. These risk mitigation techniques translate to a reduction or elimination of the need for us to manage the funds’ volatility through hedging or reinsurance.

Our GMIB products typically have a waiting period of 10 years to be eligible for annuitization. As of September 30, 2016, only 17% of our contracts with GMIBs were eligible for annuitization. The remaining contracts are not eligible for annuitization for an average of six years.

Once eligible for annuitization, contractholders would only be expected to annuitize if their contracts were in-the-money. We calculate in-the-moneyness with respect to GMIBs consistent with net amount at risk as discussed in Note 4 of the Notes to the Interim Condensed Consolidated Financial Statements, by comparing the contractholders’ income benefits based on total account values and current annuity rates versus the guaranteed income benefits. The net amount at risk was $4,663 million at September 30, 2016, of which $4,423 million was related to GMIB guarantees. For those contracts with GMIB, the table below presents details of contracts that are in-the-money and out-of-the-money at September 30, 2016:

	In-the- Moneyness	Total Account Value		% of Total
	(Dollars in millions)
In-the-money	30% +	$	4,532	5	%
	20% to 30%	3,263		4	%
	10% to 20%	5,383		6	%
	0% to 10%	10,099		11	%
		23,277
Out-of-the-money	-10% to 0%	12,125		13	%
	-20% to -10%	7,586		8	%
	-20% +	48,074		53	%
		67,785
Total GMIBs		$	91,062

Derivatives Hedging Variable Annuity Guarantees

Our risk mitigating hedging strategy uses various over-the-counter and exchange traded derivatives. The table below presents the gross notional amount, estimated fair value and primary underlying risk exposure of the derivatives hedging our variable annuity guarantees:

165

	Instrument Type	September 30, 2016						December 31, 2015
Primary Underlying Risk Exposure		Gross Notional Amount		Estimated Fair Value				Gross Notional Amount		Estimated Fair Value
				Assets		Liabilities				Assets		Liabilities
		(In millions)
Interest rate	Interest rate swaps	$	35,137	$	4,513	$	1,593	$	23,430	$	2,056	$	966
	Interest rate futures	6,851		3		39		3,915		4		5
	Interest rate options	18,943		1,473		—		24,923		994		7
Foreign currency exchange rate	Foreign currency forwards	2,995		101		20		2,305		29		7
	Foreign currency futures	127		—		1		135		—		—
Equity market	Equity futures	12,710		12		68		7,104		61		18
	Equity options	51,209		1,504		1,361		54,113		1,541		1,041
	Variance swaps	23,658		228		745		23,437		195		636
	Total rate of return swaps	5,070		5		102		3,803		47		58
	Total	$	156,700	$	7,839	$	3,929	$	143,165	$	4,927	$	2,738

The change in estimated fair values of our derivatives is recorded in policyholder benefits and claims if such derivatives are hedging guarantees included in future policy benefits, and in net derivative gains (losses) if such derivatives are hedging guarantees included in policyholder account balances.

Our hedging strategy involves the significant use of static longer-term derivative instruments to avoid the need to execute transactions during periods of market disruption or higher volatility. We continually monitor the capital markets for opportunities to adjust our liability coverage, as appropriate. Futures are also used to dynamically adjust the daily coverage levels as markets and liability exposures fluctuate.

We remain liable for the guaranteed benefits in the event that reinsurers or derivative counterparties are unable or unwilling to pay. Certain of our reinsurance agreements and most derivative positions are collateralized and derivatives positions are subject to master netting agreements, both of which significantly reduce the exposure to counterparty risk. In addition, we are subject to the risk that hedging and other risk management actions prove ineffective or that unanticipated policyholder behavior or mortality, combined with adverse market events, produces economic losses beyond the scope of the risk management techniques employed.

Liquidity and Capital Resources

Overview

Our business and results of operations are materially affected by conditions in the global capital markets and the economy generally. Stressed conditions, volatility and disruptions in global capital markets, particular markets, or financial asset classes can have an adverse effect on us, in part because we have a large investment portfolio and our insurance liabilities are sensitive to changing market factors. The global markets and economy continue to experience volatility that may affect our financing costs and market interest for our debt or equity securities. For further information regarding market factors that could affect our ability to meet liquidity and capital needs, see “— Industry Trends” and “— Investments — Current Environment.”

Liquidity Management

Based upon the strength of our franchise, diversification of our businesses, strong financial fundamentals and the substantial funding sources available to us as described herein, we continue to believe we have access to ample liquidity to meet business requirements under current market conditions and reasonably possible stress scenarios. We continuously monitor and adjust our liquidity and capital plans for MetLife, Inc. and its subsidiaries in light of market conditions, as well as changing needs and opportunities.

Short-term Liquidity

We maintain a substantial short-term liquidity position, which was $12.0 billion and $11.1 billion at September 30, 2016 and December 31, 2015, respectively. Short-term liquidity includes cash and cash equivalents and short-term investments, excluding assets that are pledged or otherwise committed, including those in connection with securities lending, repurchase agreements, derivatives, the closed block and secured borrowings.

166

Liquid Assets

An integral part of our liquidity management includes managing our level of liquid assets, which was $248.7 billion and $229.4 billion at September 30, 2016 and December 31, 2015, respectively. Liquid assets include cash and cash equivalents, short-term investments and publicly-traded securities, excluding assets that are pledged or otherwise committed. Assets pledged or otherwise committed include those in connection with securities lending, repurchase agreements, derivatives, the closed block, regulatory deposits and custodial accounts, collateral financing agreements, funding agreements and secured borrowings.

Capital Management

We have established several senior management committees as part of our capital management process. These committees, including the Capital Management Committee and the Enterprise Risk Committee (“ERC”), regularly review actual and projected capital levels (under a variety of scenarios including stress scenarios) and our annual capital plan in accordance with our capital policy. The Capital Management Committee is comprised of members of senior management, including MetLife, Inc.’s Chief Financial Officer, Treasurer and Chief Risk Officer (“CRO”). The ERC is also comprised of members of senior management, including MetLife, Inc.’s Chief Financial Officer, CRO and Chief Investment Officer.

Our Board and senior management are directly involved in the development and maintenance of our capital policy. The capital policy sets forth, among other things, minimum and target capital levels and the governance of the capital management process. All capital actions, including proposed changes to the annual capital plan, capital targets or capital policy, are reviewed by the Finance and Risk Committee of the Board prior to obtaining full Board approval. The Board approves the capital policy and the annual capital plan and authorizes capital actions, as required.

See “Risk Factors — Capital-Related Risks — Regulatory Restrictions and Uncertainty and Restrictions Under the Terms of Certain of Our Securities May Prevent Us from Repurchasing Our Stock and Paying Dividends at the Level We Wish” in the 2015 Annual Report, as amended or supplemented in our subsequently filed Quarterly Reports on Form 10-Q in similarly named sections under the caption “Risk Factors” and Note 16 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report for information regarding restrictions on payment of dividends and stock repurchases. See also “— The Company — Liquidity and Capital Uses — Common Stock Repurchases” for information regarding MetLife, Inc.’s common stock repurchase authorizations.

The Company

Liquidity

Liquidity refers to a company’s ability to generate adequate amounts of cash to meet its needs. In the event of significant cash requirements beyond anticipated liquidity needs, we have various alternatives available depending on market conditions and the amount and timing of the liquidity need. These available alternatives include cash flows from operations, sales of liquid assets, global funding sources and various credit facilities.

Capital

We manage our capital position to maintain our financial strength and credit ratings. Our capital position is supported by our ability to generate strong cash flows within our operating companies and borrow funds at competitive rates, as well as by our demonstrated ability to raise additional capital to meet operating and growth needs despite adverse market and economic conditions.

167

Summary of the Company’s Primary Sources and Uses of Liquidity and Capital

Our primary sources and uses of liquidity and capital are summarized as follows:

	Nine Months   Ended   September 30,
	2016		2015
	(In millions)
Sources:
Operating activities, net	$	9,183	$	9,527
Changes in policyholder account balances, net	4,080		—
Changes in payables for collateral under securities loaned and other transactions, net	7,227		2,664
Long-term debt issued	—		1,578
Preferred stock issued, net of issuance costs	—		1,483
Other, net	—		12
Effect of change in foreign currency exchange rates on cash and cash equivalents	306		—
Total sources	20,796		15,264
Uses:
Investing activities, net	14,586		6,907
Changes in policyholder account balances, net	—		3,557
Short-term debt repayments, net	3		—
Long-term debt repaid	1,273		1,078
Collateral financing arrangements repaid	55		44
Treasury stock acquired in connection with share repurchases	70		1,107
Repurchase of preferred stock	—		1,460
Preferred stock repurchase premium	—		42
Dividends on preferred stock	58		67
Dividends on common stock	1,295		1,234
Other, net	325		—
Effect of change in foreign currency exchange rates on cash and cash equivalents	—		360
Total uses	17,665		15,856
Net increase (decrease) in cash and cash equivalents	$	3,131	$	(592	)

Cash Flows from Operations

The principal cash inflows from our insurance activities come from insurance premiums, net investment income, annuity considerations and deposit funds. The principal cash outflows relate to various life insurance, property & casualty, annuity and pension products, operating expenses and income tax, as well as interest expense. A primary liquidity concern with respect to these cash flows is the risk of early contractholder and policyholder withdrawal.

Cash Flows from Investments

The principal cash inflows from our investment activities come from repayments of principal, proceeds from maturities and sales of investments and settlements of freestanding derivatives. The principal cash outflows relate to purchases of investments, issuances of policy loans and settlements of freestanding derivatives. Additional cash outflows relate to purchases of businesses. We typically have a net cash outflow from investing activities because cash inflows from insurance operations are reinvested in accordance with our ALM discipline to fund insurance liabilities. We closely monitor and manage these risks through our comprehensive investment risk management process. The primary liquidity concerns with respect to these cash flows are the risk of default by debtors and market disruption.

168

Cash Flows from Financing

The principal cash inflows from our financing activities come from issuances of debt and other securities, deposits of funds associated with policyholder account balances and lending of securities. The principal cash outflows come from repayments of debt, payments of dividends on and repurchases of MetLife, Inc.’s securities, withdrawals associated with policyholder account balances and the return of securities on loan. The primary liquidity concerns with respect to these cash flows are market disruption and the risk of early contractholder and policyholder withdrawal.

Liquidity and Capital Sources

In addition to the general description of liquidity and capital sources in “— Summary of the Company’s Primary Sources and Uses of Liquidity and Capital,” the following additional information is provided regarding our primary sources of liquidity and capital:

Global Funding Sources

Liquidity is provided by a variety of global funding sources, including funding agreements, credit facilities and commercial paper. Capital is provided by a variety of global funding sources, including short-term and long-term debt, collateral financing arrangements, junior subordinated debt securities, preferred securities, equity securities and equity-linked securities. The diversity of our global funding sources enhances our funding flexibility, limits dependence on any one market or source of funds and generally lowers the cost of funds. Our primary global funding sources include:

Common Stock

During the nine months endedSeptember 30, 2016 and 2015, MetLife, Inc. issued 2,403,270 and 5,312,287 new shares of its common stock for $94 million and $208 million, respectively, to satisfy various stock option exercises and other stock-based awards.

Commercial Paper, Reported in Short-term Debt

MetLife, Inc. and MetLife Funding, Inc. (“MetLife Funding”) each have a commercial paper program that is supported by the $4.0 billion general corporate credit facility (see “— Credit and Committed Facilities”). MetLife Funding raises cash from its commercial paper program and uses the proceeds to extend loans through MetLife Credit Corp., another subsidiary of MLIC, to affiliates in order to enhance the financial flexibility and liquidity of these companies.

Federal Home Loan Bank Funding Agreements, Reported in Policyholder Account Balances

Certain of our domestic insurance subsidiaries are members of a regional Federal Home Loan Bank (“FHLB”). During the nine months endedSeptember 30, 2016 and 2015, we issued $14.2 billion and $16.5 billion, respectively, and repaid $12.6 billion and $16.0 billion, respectively, under funding agreements with certain regional FHLBs. At September 30, 2016 and December 31, 2015, total obligations outstanding under these funding agreements were $17.1 billion and $15.5 billion, respectively. See Note 4 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report.

Special Purpose Entity Funding Agreements, Reported in Policyholder Account Balances

We issue fixed and floating rate funding agreements, which are denominated in either U.S. dollars or foreign currencies, to certain special purpose entities (“SPEs”) that have issued either debt securities or commercial paper for which payment of interest and principal is secured by such funding agreements. During the nine months endedSeptember 30, 2016 and 2015, we issued $30.8 billion and $35.5 billion, respectively, and repaid $33.5 billion and $38.2 billion, respectively, under such funding agreements. At September 30, 2016 and December 31, 2015, total obligations outstanding under these funding agreements were $29.5 billion and $31.6 billion, respectively. See Note 4 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report.

169

Federal Agricultural Mortgage Corporation Funding Agreements, Reported in Policyholder Account Balances

We have issued funding agreements to a subsidiary of the Federal Agricultural Mortgage Corporation (“Farmer Mac”), as well as to certain SPEs that have issued debt securities for which payment of interest and principal is secured by such funding agreements, and such debt securities are also guaranteed as to payment of interest and principal by Farmer Mac. The obligations under all such funding agreements are secured by a pledge of certain eligible agricultural real estate mortgage loans. During the nine months endedSeptember 30, 2016 and 2015, we issued $1.2 billion and $50 million, respectively, and repaid $1.0 billion and $250 million, respectively, under such funding agreements. At September 30, 2016 and December 31, 2015, total obligations outstanding under these funding agreements were $2.7 billion and $2.6 billion, respectively. See Note 4 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report.

Credit and Committed Facilities

 At September 30, 2016, we maintained a $4.0 billion unsecured credit facility and certain committed facilities aggregating $11.6 billion. When drawn upon, these facilities bear interest at varying rates in accordance with the respective agreements.

The unsecured credit facility is used for general corporate purposes, to support the borrowers’ commercial paper programs and for the issuance of letters of credit. At September 30, 2016, we had outstanding $711 million in letters of credit and no drawdowns against this facility. Remaining availability was $3.3 billion at September 30, 2016.

The committed facilities are used for collateral for certain of our affiliated reinsurance liabilities. At September 30, 2016, $6.2 billion in letters of credit and $2.8 billion in aggregate drawdowns under collateral financing arrangements were outstanding. Remaining availability was $2.6 billion at September 30, 2016.

See Note 12 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report for further information about these facilities.

We have no reason to believe that our lending counterparties will be unable to fulfill their respective contractual obligations under these facilities. As commitments associated with letters of credit and financing arrangements may expire unused, these amounts do not necessarily reflect our actual future cash funding requirements.

Outstanding Debt Under Global Funding Sources

The following table summarizes our outstanding debt at:

	September 30, 2016		December 31, 2015 (1)
	(In millions)
Short-term debt	$	201	$	100
Long-term debt (2), (3)	$	16,515	$	17,889
Collateral financing arrangements	$	4,084	$	4,139
Junior subordinated debt securities	$	3,168	$	3,168

__________________

(1) Net of $100 million of debt issuance costs, which were reported in other assets at December 31, 2015.

(2) Excludes $38 million and $60 million at September 30, 2016 and December 31, 2015, respectively, of long-term debt relating to CSEs — FVO (see Note 7 of the Notes to the Interim Condensed Consolidated Financial Statements). For more information regarding long-term debt, see Note 12 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report.

(3) Includes $403 million of non-recourse debt at both September 30, 2016 and December 31, 2015, for which creditors have no access, subject to customary exceptions, to the general assets of the Company other than recourse to certain investment subsidiaries.

Debt and Facility Covenants

Certain of our debt instruments and committed facilities, as well as our unsecured credit facility, contain various administrative, reporting, legal and financial covenants. We believe we were in compliance with all applicable covenants at September 30, 2016.

170

Dispositions

Cash proceeds from dispositions during the nine months endedSeptember 30, 2016 and 2015 were $291 million and $0, respectively. See “— Executive Summary — Consolidated Company Outlook,” “— Executive Summary — Other Key Information — Significant Events” and Note 3 of the Notes to the Interim Condensed Consolidated Financial Statements for further information.

Liquidity and Capital Uses

In addition to the general description of liquidity and capital uses in “— Summary of the Company’s Primary Sources and Uses of Liquidity and Capital,” the following additional information is provided regarding our primary uses of liquidity and capital:

Common Stock Repurchases

Utilizing authorizations from the MetLife, Inc. Board of Directors, MetLife, Inc. may purchase its common stock from the MetLife Policyholder Trust, in the open market (including pursuant to the terms of a pre-set trading plan meeting the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934 (“Exchange Act”)) and in privately negotiated transactions. See “Unregistered Sales of Equity Securities and Use of Proceeds — Issuer Purchases of Equity Securities.”

During the nine months endedSeptember 30, 2016 and 2015, MetLife, Inc. repurchased 1,445,864 shares and 22,475,816 shares of common stock in the open market purchases for $70 million and $1.1 billion, respectively.

At September 30, 2016, MetLife, Inc. had no remaining common stock repurchase authorizations. Common stock repurchases are dependent upon several factors, including our capital position, liquidity, financial strength and credit ratings, general market conditions, the market price of MetLife, Inc.’s common stock compared to management’s assessment of the stock’s underlying value and applicable regulatory approvals, as well as other legal and accounting factors. See “Business — Regulation — U.S. Regulation — Regulation as a Non-Bank SIFI” in the 2015 Annual Report, as amended or supplemented in our subsequently filed Quarterly Reports on Form 10-Q under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Industry Trends — Regulatory Developments” and similarly named sections under the caption “Risk Factors” and “— Industry Trends — Regulatory Developments — International Regulation — Global Systemically Important Insurers.” See also “Risk Factors — Capital-Related Risks — Regulatory Restrictions and Uncertainty and Restrictions Under the Terms of Certain of Our Securities May Prevent Us from Repurchasing Our Stock and Paying Dividends at the Level We Wish” in the 2015 Annual Report, as amended or supplemented in our subsequently filed Quarterly Reports on Form 10-Q in similarly named sections under the caption “Risk Factors” and Note 16 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report.

Preferred Stock Dividends

Information on the declaration, record and payment dates, as well as per share and aggregate dividend amounts, for MetLife, Inc.’s preferred stock was as follows for the nine months endedSeptember 30, 2016 and 2015:

Declaration Date	Record Date	Payment Date	Preferred Stock Dividend
			Series A Per  Share		Series A Aggregate		Series B Per Share		Series B Aggregate		Series C Per Share		Series C Aggregate
			(In millions, except per share data)
August 15, 2016	August 31, 2016	September 15, 2016	$	0.256	$	6	$	—	$	—	$	—	$	—
May 16, 2016	May 31, 2016	June 15, 2016	$	0.256	7		$	—	—		$	26.250	39
March 7, 2016	February 29, 2016	March 15, 2016	$	0.253	6		$	—	—		$	—	—
					$	19			$	—			$	39
August 17, 2015	August 31, 2015	September 15, 2015	$	0.256	$	6	$	—	$	—	$	—	$	—
May 15, 2015	May 31, 2015	June 15, 2015	$	0.256	7		$	0.406	24		$	—	—
March 5, 2015	February 28, 2015	March 16, 2015	$	0.250	6		$	0.406	24		$	—	—
					$	19			$	48			$	—

171

Preferred stock dividends are paid quarterly in accordance with the terms of MetLife, Inc.’s Floating Rate Non-Cumulative Preferred Stock, Series A. Dividends for the Series B preferred stock, which was redeemed in 2015, ended with the June 15, 2015 payment date. Dividends are paid semi-annually in accordance with the terms of MetLife, Inc.’s Series C preferred stock, commencing December 15, 2015 and ending on June 15, 2020 and, thereafter, will be paid quarterly.

Common Stock Dividends

Information on the declaration, record and payment dates, as well as per share and aggregate dividend amounts, for MetLife, Inc.’s common stock was as follows for the nine months endedSeptember 30, 2016 and 2015:

Declaration Date	Record Date	Payment Date	Common Stock Dividend
			Per Share		Aggregate
			(In millions, except per share data)
July 7, 2016	August 8, 2016	September 13, 2016	$	0.400	$	441
April 26, 2016	May 9, 2016	June 13, 2016	$	0.400	441
January 6, 2016	February 5, 2016	March 14, 2016	$	0.375	413
					$	1,295
July 7, 2015	August 7, 2015	September 11, 2015	$	0.375	$	420
April 28, 2015	May 11, 2015	June 12, 2015	$	0.375	420
January 6, 2015	February 6, 2015	March 13, 2015	$	0.350	394
					$	1,234

The declaration and payment of common stock dividends is subject to the discretion of our Board of Directors, and will depend on MetLife, Inc.’s financial condition, results of operations, cash requirements, future prospects, regulatory restrictions on the payment of dividends by MetLife, Inc.’s insurance subsidiaries and other factors deemed relevant by the Board. See Note 16 of the Notes to the Interim Condensed Consolidated Financial Statements for information regarding a common stock dividend declared subsequent to September 30, 2016.

Dividend Restrictions

If MetLife, Inc. were re-designated as a non-bank SIFI, the payment of dividends and other distributions by MetLife, Inc. to its security holders may be subject to regulation by the Federal Reserve. See “Business — Regulation —U.S. Regulation — Regulation as a Non-Bank SIFI.” in the 2015 Annual Report, as amended or supplemented in our subsequently filed Quarterly Reports on Form 10-Q under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Industry Trends — Regulatory Developments” and similarly named sections under the caption “Risk Factors.” In addition, if additional capital requirements are imposed on MetLife, Inc. as a G-SII, its ability to pay dividends could be reduced by any such additional capital requirements that might be imposed. See “— Industry Trends — Regulatory Developments — International Regulation — Global Systemically Important Insurers.” The payment of dividends is also subject to restrictions under the terms of our preferred stock and junior subordinated debentures in situations where we may be experiencing financial stress. See “Risk Factors — Capital-Related Risks — Regulatory Restrictions and Uncertainty and Restrictions Under the Terms of Certain of Our Securities May Prevent Us from Repurchasing Our Stock and Paying Dividends at the Level We Wish” in the 2015 Annual Report, as amended or supplemented in our subsequently filed Quarterly Reports on Form 10-Q in similarly named sections under the caption “Risk Factors” and Note 16 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report.

Debt Repayments

In June 2016, MetLife, Inc. repaid at maturity its $1.3 billion 6.750% senior notes.

In 2016, following regulatory approval, MetLife Reinsurance Company of Charleston, a wholly-owned subsidiary of MetLife, Inc., repurchased and canceled $55 million in aggregate principal amount of its surplus notes, which were reported in collateral financing arrangements on the consolidated balance sheet.

172

Debt Repurchases

We may from time to time seek to retire or purchase our outstanding debt through cash purchases and/or exchanges for other securities, in open market purchases, privately negotiated transactions or otherwise. Any such repurchases or exchanges will be dependent upon several factors, including our liquidity requirements, contractual restrictions, general market conditions, and applicable regulatory, legal and accounting factors. Whether or not to repurchase any debt and the size and timing of any such repurchases will be determined at our discretion.

Support Agreements

MetLife, Inc. and several of its subsidiaries (each, an “Obligor”) are parties to various capital support commitments and guarantees with subsidiaries. Under these arrangements, each Obligor, with respect to the applicable entity, has agreed to cause such entity to meet specified capital and surplus levels or has guaranteed certain contractual obligations. We anticipate that in the event that these arrangements place demands upon us, there will be sufficient liquidity and capital to enable us to meet anticipated demands. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources — MetLife, Inc. — Liquidity and Capital Uses — Support Agreements” included in the 2015 Annual Report.

Insurance Liabilities

Liabilities arising from our insurance activities primarily relate to benefit payments under various life insurance, property & casualty, annuity and group pension products, as well as payments for policy surrenders, withdrawals and loans. For annuity or deposit type products, surrender or lapse behavior differs somewhat by segment. In the MetLife Holdings and Brighthouse Financial segments, which include individual annuities, lapses and surrenders tend to occur in the normal course of business. During the nine months endedSeptember 30, 2016 and 2015, general account surrenders and withdrawals from annuity products were $2.4 billion and $2.6 billion, respectively. In the Retirement & Income Solutions business within the U.S. segment, which includes pension risk transfers, bank-owned life insurance and other fixed annuity contracts, as well as funding agreements and other capital market products, most of the products offered have fixed maturities or fairly predictable surrenders or withdrawals. With regard to the Retirement & Income Solutions business liabilities that provide customers with limited rights to accelerate payments, at September 30, 2016 there were no funding agreements or other capital market products that could be put back to the Company.

Pledged Collateral

We pledge collateral to, and have collateral pledged to us by, counterparties in connection with our derivatives. At September 30, 2016 and December 31, 2015, we had received cash collateral of $12.3 billion and $6.6 billion, respectively. At September 30, 2016 and December 31, 2015, we had pledged cash collateral of $441 million and $241 million, respectively. With respect to OTC-bilateral derivatives in a net liability position that have credit contingent provisions, a one-notch downgrade in the Company’s credit or financial strength rating, as applicable, would have required $2 million of additional collateral be provided to our counterparties as of September 30, 2016. See Note 8 of the Notes to the Interim Condensed Consolidated Financial Statements for additional information about collateral pledged to us, collateral we pledge and derivatives subject to credit contingent provisions.

We pledge collateral and have had collateral pledged to us, and may be required from time to time to pledge additional collateral or be entitled to have additional collateral pledged to us, in connection with collateral financing arrangements related to the reinsurance of closed block and universal life secondary guarantee liabilities.

We pledge collateral from time to time in connection with funding agreements. See Note 4 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report.

Securities Lending

We participate in a securities lending program whereby securities are loaned to third parties, primarily brokerage firms and commercial banks. We obtain collateral, usually cash, from the borrower, which must be returned to the borrower when the loaned securities are returned to us. Under our securities lending program, we were liable for cash collateral under our control of $32.1 billion and $30.2 billion at September 30, 2016 and December 31, 2015, respectively. Of these amounts, $8.4 billion and $10.1 billion at September 30, 2016 and December 31, 2015, respectively, were on open, meaning that the related loaned security could be returned to us on the next business day requiring the immediate return of cash collateral we hold. The estimated fair value of the securities on loan related to the cash collateral on open at September 30, 2016 was $8.1 billion, over 99% of which were U.S. government and agency securities which, if put to us, could be immediately sold to satisfy the cash requirements to immediately return the cash collateral. See Note 7 of the Notes to the Interim Condensed Consolidated Financial Statements.

173

Litigation

Putative or certified class action litigation and other litigation, and claims and assessments against us, in addition to those discussed elsewhere herein and those otherwise provided for in the consolidated financial statements, have arisen in the course of our business, including, but not limited to, in connection with our activities as an insurer, employer, investor, investment advisor, taxpayer and, formerly, a mortgage lending bank. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning our compliance with applicable insurance and other laws and regulations. See Note 15 of the Notes to the Interim Condensed Consolidated Financial Statements.

We establish liabilities for litigation and regulatory loss contingencies when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. For material matters where a loss is believed to be reasonably possible but not probable, no accrual is made but we disclose the nature of the contingency and an aggregate estimate of the reasonably possible range of loss in excess of amounts accrued, when such an estimate can be made. It is not possible to predict or determine the ultimate outcome of all pending investigations and legal proceedings. In some of the matters referred to herein, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Although in light of these considerations, it is possible that an adverse outcome in certain cases could have a material adverse effect upon our financial position, based on information currently known by us, in our opinion, the outcome of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material adverse effect on our consolidated net income or cash flows in particular quarterly or annual periods.

Acquisitions

There were no acquisitions during either of the nine months endedSeptember 30, 2016 or 2015.

Contractual Obligations

See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources — The Company — Contractual Obligations” included in the 2015 Annual Report for additional information regarding the Company’s contractual obligations.

MetLife, Inc.

Liquidity and Capital Management

Liquidity and capital are managed to preserve stable, reliable and cost-effective sources of cash to meet all current and future financial obligations and are provided by a variety of sources, including a portfolio of liquid assets, a diversified mix of short- and long-term funding sources from the wholesale financial markets and the ability to borrow through credit and committed facilities. Liquidity is monitored through the use of internal liquidity risk metrics, including the composition and level of the liquid asset portfolio, timing differences in short-term cash flow obligations, access to the financial markets for capital and debt transactions and exposure to contingent draws on MetLife, Inc.’s liquidity. MetLife, Inc. is an active participant in the global financial markets through which it obtains a significant amount of funding. These markets, which serve as cost-effective sources of funds, are critical components of MetLife, Inc.’s liquidity and capital management. Decisions to access these markets are based upon relative costs, prospective views of balance sheet growth and a targeted liquidity profile and capital structure. A disruption in the financial markets could limit MetLife, Inc.’s access to liquidity.

MetLife, Inc.’s ability to maintain regular access to competitively priced wholesale funds is fostered by its current credit ratings from the major credit rating agencies. We view our capital ratios, credit quality, stable and diverse earnings streams, diversity of liquidity sources and our liquidity monitoring procedures as critical to retaining such credit ratings.

See “— Executive Summary — Consolidated Company Outlook” for a discussion of expected impacts to liquidity and capital resources in connection with the Separation including incremental sources of liquidity and capital from subsidiary dividends that we expect to receive from Brighthouse Financial (expected to be partially funded from the issuance of debt by Brighthouse Financial) and a MetLife-affiliated reinsurance subsidiary, and proceeds over time from the disposition of our retained shares of Brighthouse common stock, as well as incremental uses of liquidity and capital from foregone subsidiary dividends and foregone incremental debt issuances and ongoing uses of liquidity and capital from the repayment of debt maturities.

Liquidity

For a summary of MetLife, Inc.’s liquidity, see “— The Company — Liquidity.”

174

Capital

For a summary of MetLife, Inc.’s capital, see “— The Company — Capital.” For further information regarding potential capital restrictions and limitations on MetLife, Inc. as a non-bank SIFI and G-SII, see “Business — Regulation — U.S. Regulation — Regulation as a Non-Bank SIFI” and “Business — Regulation — International Regulation — Global Systemically Important Insurers” included in the 2015 Annual Report, as amended or supplemented in our subsequently filed Quarterly Reports on Form 10-Q under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Industry Trends — Regulatory Developments” and similarly named sections under the caption “Risk Factors.” See also “— The Company — Liquidity and Capital Uses — Common Stock Repurchases” for information regarding MetLife, Inc.’s common stock repurchases.

Liquid Assets

At September 30, 2016 and December 31, 2015, MetLife, Inc. and other MetLife holding companies had $5.6 billion and $6.4 billion, respectively, in liquid assets. Of these amounts, $4.1 billion and $5.3 billion were held by MetLife, Inc. and $1.5 billion and $1.1 billion were held by other MetLife holding companies, at September 30, 2016 and December 31, 2015, respectively. Liquid assets include cash and cash equivalents, short-term investments and publicly-traded securities excluding assets that are pledged or otherwise committed. Assets pledged or otherwise committed include those in connection with derivatives and collateral financing arrangements.

Liquid assets held in non-U.S. holding companies are generated in part through dividends from non-U.S. insurance operations. Such dividends are subject to local insurance regulatory requirements, as discussed in “— Liquidity and Capital Sources — Dividends from Subsidiaries.” The cumulative earnings of certain active non-U.S. operations have been reinvested indefinitely in such non-U.S. operations, as described in Note 19 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report. Under current tax laws, should we repatriate such earnings, we may be subject to additional U.S. income taxes and foreign withholding taxes.

See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources — MetLife, Inc. — Liquid Assets” included in the 2015 Annual Report for additional information on the sources and uses of liquid assets for MetLife, Inc. and other MetLife holding companies. See also “— Executive Summary — Consolidated Company Outlook” for the targeted level of liquid assets at the holding companies following the Separation.

Liquidity and Capital Sources

In addition to the description of liquidity and capital sources in “— The Company — Summary of the Company’s Primary Sources and Uses of Liquidity and Capital” and “— The Company — Liquidity and Capital Sources,” the following additional information is provided regarding MetLife, Inc.’s primary sources of liquidity and capital:

Dividends from Subsidiaries

MetLife, Inc. relies, in part, on dividends from its subsidiaries to meet its cash requirements. MetLife, Inc.’s insurance subsidiaries are subject to regulatory restrictions on the payment of dividends imposed by the regulators of their respective domiciles. The dividend limitation for U.S. insurance subsidiaries is generally based on the surplus to policyholders at the end of the immediately preceding calendar year and statutory net gain from operations for the immediately preceding calendar year. Statutory accounting practices, as prescribed by insurance regulators of various states in which we conduct business, differ in certain respects from accounting principles used in financial statements prepared in conformity with GAAP. The significant differences relate to the treatment of DAC, certain deferred income tax, required investment liabilities, statutory reserve calculation assumptions, goodwill and surplus notes.

175

The table below sets forth the dividends permitted to be paid in 2016 by MetLife, Inc.’s primary insurance subsidiaries without insurance regulatory approval and the respective dividends paid during the nine months endedSeptember 30, 2016:

Company	Paid		Permitted w/o Approval (1)
	(In millions)
Metropolitan Life Insurance Company	$	3,600	$	3,753
American Life Insurance Company	$	—	$	—
MetLife Insurance Company USA	$	—	$	586
Metropolitan Property and Casualty Insurance Company	$	—	$	233	(2	)
Metropolitan Tower Life Insurance Company	$	—	$	70

__________________

(1) Reflects dividend amounts that may be paid during 2016 without prior regulatory approval. However, because dividend tests may be based on dividends previously paid over rolling 12-month periods, if paid before a specified date during 2016, some or all of such dividends may require regulatory approval.

(2) Reflects revised interpretation of statutory dividend limits from amount reported in the 2015 Annual Report.

In addition to the amounts presented in the table above, for the nine months endedSeptember 30, 2016, MetLife, Inc. received cash of $100 million from certain of its other subsidiaries, of which $20 million represented a dividend and $80 million represented a return of capital.

The dividend capacity of our non-U.S. operations is subject to similar restrictions established by the local regulators. The non-U.S. regulatory regimes also commonly limit the dividend payments to the parent to a portion of the prior year’s statutory income, as determined by the local accounting principles. The regulators of our non-U.S. operations, including Japan’s Financial Services Agency, may also limit or not permit profit repatriations or other transfers of funds to the U.S. if such transfers are deemed to be detrimental to the solvency or financial strength of the non-U.S. operations, or for other reasons. Most of the non-U.S. subsidiaries are second tier subsidiaries which are owned by various non-U.S. holding companies. The capital and rating considerations applicable to the first tier subsidiaries may also impact the dividend flow into MetLife, Inc.

We actively manage target and excess capital levels and dividend flows on a proactive basis and forecast local capital positions as part of the financial planning cycle. The dividend capacity of certain U.S. and non-U.S. subsidiaries is also subject to business targets in excess of the minimum capital necessary to maintain the desired rating or level of financial strength in the relevant market. We cannot provide assurance that MetLife, Inc.’s subsidiaries will have statutory earnings to support payment of dividends to MetLife, Inc. in an amount sufficient to fund its cash requirements and pay cash dividends and that the applicable regulators will not disapprove any dividends that such subsidiaries must submit for approval. See “Risk Factors — Capital-Related Risks — As a Holding Company, MetLife, Inc. Depends on the Ability of Its Subsidiaries to Pay Dividends, a Major Component of Holding Company Free Cash Flow” included in the 2015 Annual Report and Note 16 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report.

Short-term Debt

MetLife, Inc. maintains a commercial paper program, the proceeds of which can be used to finance the general liquidity needs of MetLife, Inc. and its subsidiaries. MetLife, Inc. had no short-term debt outstanding at either September 30, 2016 or December 31, 2015.

Maturity and Issuance of Affiliated Long-term Debt

In September 2016, a $250 million senior note issued to MLIC matured and, subsequently, in September 2016 MetLife, Inc. issued a new $250 million senior note to MLIC. The $250 million senior note matures in September 2020 and bears interest at a rate per annum of 3.03%, payable semi-annually.

Credit and Committed Facilities

In June 2016, MetLife, Inc. entered into a five-year agreement with an indirect wholly-owned subsidiary, MetLife Ireland Treasury Limited (“MITL”), to borrow up to $1.25 billion on a revolving basis, at interest rates based on the Internal Revenue Service safe harbor interest rate in effect at the time of the borrowing. MetLife, Inc. may borrow funds under the agreement at MITL’s discretion and subject to the availability of funds. There were no outstanding borrowings at September 30, 2016.

176

See “— The Company — Liquidity and Capital Sources — Global Funding Sources — Credit and Committed Facilities” for information about MetLife, Inc.’s unsecured credit facility.

MetLife, Inc. maintains a committed facility with a capacity of $425 million. At September 30, 2016, MetLife, Inc. had outstanding $425 million in letters of credit, no drawdowns outstanding and no remaining availability with this facility. In addition, MetLife, Inc. is a party and/or guarantor to committed facilities of certain of its subsidiaries, which aggregated $11.2 billion, for which there was $5.8 billion in letters of credit outstanding and $2.8 billion in aggregate drawdowns at September 30, 2016. The committed facilities are used as collateral for certain of the Company’s affiliated reinsurance liabilities.

See “— The Company — Liquidity and Capital Sources — Global Funding Sources — Credit and Committed Facilities” for further information regarding these facilities.

Long-term Debt Outstanding

The following table summarizes the outstanding long-term debt of MetLife, Inc. at:

	September 30, 2016		December 31, 2015 (1)
	(In millions)
Long-term debt — unaffiliated	$	15,551	$	16,927
Long-term debt — affiliated	$	3,100	$	3,314
Collateral financing arrangements	$	2,797	$	2,797
Junior subordinated debt securities	$	1,734	$	1,733

__________________

(1) Net of $82 million of debt issuance costs, which were reported in other assets at December 31, 2015.

Debt and Facility Covenants

Certain of MetLife, Inc.’s debt instruments and committed facilities, as well as its credit facility, contain various administrative, reporting, legal and financial covenants. MetLife, Inc. believes it was in compliance with all applicable covenants at September 30, 2016.

Dispositions

Cash proceeds from dispositions during the nine months endedSeptember 30, 2016 and 2015 were $291 million and $0, respectively.

Liquidity and Capital Uses

The primary uses of liquidity of MetLife, Inc. include debt service, cash dividends on common and preferred stock, capital contributions to subsidiaries, common and preferred stock repurchases, payment of general operating expenses and acquisitions. Based on our analysis and comparison of our current and future cash inflows from the dividends we receive from subsidiaries that are permitted to be paid without prior insurance regulatory approval, our investment portfolio and other cash flows and anticipated access to the capital markets, we believe there will be sufficient liquidity and capital to enable MetLife, Inc. to make payments on debt, pay cash dividends on its common and preferred stock, contribute capital to its subsidiaries, repurchase its common and preferred stock, pay all general operating expenses and meet its cash needs.

In addition to the description of liquidity and capital uses in “— The Company — Liquidity and Capital Uses,” the following additional information is provided regarding MetLife, Inc.’s primary uses of liquidity and capital:

Affiliated Capital and Debt Transactions

During the nine months endedSeptember 30, 2016 and 2015, MetLife, Inc. invested a net amount of $1.3 billion and $230 million, respectively, in various subsidiaries. The investment in the first quarter of 2016 included a cash capital contribution of $1.5 billion to MetLife USA.

MetLife, Inc. lends funds, as necessary, to its subsidiaries and affiliates, some of which are regulated, to meet their capital requirements. MetLife, Inc. had loans to subsidiaries outstanding of $1.2 billion at both September 30, 2016 and December 31, 2015.

In April 2016, American Life issued a $140 million short-term note to MetLife, Inc. which was repaid in June 2016. The short-term note bore interest at six-month LIBOR plus 1.00%.

177

In June and March 2016, MetLife, Inc. repaid $204 million and $10 million, respectively, of affiliated long-term debt to MetLife Exchange Trust I, at maturity, in exchange for returns of capital. The long-term notes bore interest at three-month LIBOR plus 0.70%.

Support Agreements

MetLife, Inc. is party to various capital support commitments and guarantees with certain of its subsidiaries. Under these arrangements, MetLife, Inc. has agreed to cause each such entity to meet specified capital and surplus levels or has guaranteed certain contractual obligations. See “— The Company — Liquidity and Capital Uses — Support Agreements.”

Acquisitions

There were no acquisitions by MetLife, Inc. during either of the nine months endedSeptember 30, 2016 or 2015.

Adoption of New Accounting Pronouncements

See Note 1 of the Notes to the Interim Condensed Consolidated Financial Statements.

Future Adoption of New Accounting Pronouncements

See Note 1 of the Notes to the Interim Condensed Consolidated Financial Statements.

Non-GAAP and Other Financial Disclosures

In this report, the Company presents certain measures of its performance that are not calculated in accordance with GAAP. We believe that these non-GAAP financial measures enhance the understanding of our performance by highlighting the results of operations and the underlying profitability drivers of our business.

The following non-GAAP financial measures should not be viewed as substitutes for the most directly comparable financial measures calculated in accordance with GAAP:

Non-GAAP financial measures:		Comparable GAAP financial measures:
(i)	operating revenues	(i)	revenues
(ii)	operating expenses	(ii)	expenses
(iii)	operating earnings	(iii)	net income (loss)
(iv)	operating earnings available to common shareholders	(iv)	net income (loss) available to MetLife, Inc.’s common shareholders

See “— Results of Operations” for reconciliations of these measures to the most directly comparable historical GAAP measures. A reconciliation of these non-GAAP measures to the most directly comparable GAAP measures is not accessible on a forward-looking basis because we believe it is not possible without unreasonable efforts to provide other than a range of net investment gains and losses and net derivative gains and losses, which can fluctuate significantly within or outside the range and from period to period and may have a material impact on net income.

Our definitions of the various non-GAAP and other financial measures discussed in this report may differ from those used by other companies:

Operating earnings and related measures:

• operating earnings; and

• operating earnings available to common shareholders.

These measures are used by management to evaluate performance and allocate resources. Consistent with GAAP guidance for segment reporting, operating earnings is also our GAAP measure of segment performance. Operating earnings and other financial measures based on operating earnings are also the measures by which senior management’s and many other employees’ performance is evaluated for the purposes of determining their compensation under applicable compensation plans. Operating earnings and other financial measures based on operating earnings allow analysis of our performance relative to our business plan and facilitate comparisons to industry results.

Operating earnings is defined as operating revenues less operating expenses, both net of income tax. Operating earnings available to common shareholders is defined as operating earnings less preferred stock dividends.

178

Operating revenues and operating expenses

These financial measures focus on our primary businesses principally by excluding the impact of market volatility, which could distort trends, and revenues and costs related to non-core products and divested businesses and certain entities required to be consolidated under GAAP. Also, these measures exclude results of discontinued operations and other businesses that have been or will be sold or exited by MetLife and are referred to as divested businesses. In addition, for the three months ended March 31, 2016 and the nine months ended September 30, 2016, operating revenues and operating expenses exclude the financial impact of converting the Company’s Japan operations to calendar year-end reporting without retrospective application of this change to prior periods and is referred to as lag elimination. Operating revenues also excludes net investment gains (losses) and net derivative gains (losses). Operating expenses also excludes goodwill impairments.

The following additional adjustments are made to revenues, in the line items indicated, in calculating operating revenues:

• Universal life and investment-type product policy fees excludes the amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses) and certain variable annuity GMIB fees (“GMIB Fees”);

• Net investment income: (i) includes investment hedge adjustments, (ii) excludes post-tax operating earnings adjustments relating to insurance joint ventures accounted for under the equity method, (iii) excludes certain amounts related to contractholder-directed unit-linked investments, and (iv) excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP; and

• Other revenues are adjusted for settlements of foreign currency earnings hedges.

The following additional adjustments are made to expenses, in the line items indicated, in calculating operating expenses:

• Policyholder benefits and claims and policyholder dividends excludes: (i) changes in the policyholder dividend obligation related to net investment gains (losses) and net derivative gains (losses), (ii) inflation-indexed benefit adjustments associated with contracts backed by inflation-indexed investments and amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and other pass through adjustments (also known as asymmetrical and non-economic accounting for insurance contracts), (iii) benefits and hedging costs related to GMIBs (“GMIB Costs”), and (iv) market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”);

• Interest credited to policyholder account balances includes adjustments for earned income on derivatives and amortization of premium on derivatives that are hedges of policyholder account balances but do not qualify for hedge accounting treatment and excludes amounts related to net investment income earned on contractholder-directed unit-linked investments;

• Amortization of DAC and VOBA excludes amounts related to: (i) net investment gains (losses) and net derivative gains (losses), (ii) GMIB Fees and GMIB Costs, and (iii) Market Value Adjustments;

• Amortization of negative VOBA excludes amounts related to Market Value Adjustments;

• Interest expense on debt excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP; and

• Other operating expenses excludes costs related to: (i) noncontrolling interests, (ii) implementation of new insurance regulatory requirements, and (iii) acquisition, integration and other costs.

Operating earnings also excludes the recognition of certain contingent assets and liabilities that could not be recognized at acquisition or adjusted for during the measurement period under GAAP business combination accounting guidance.

The tax impact of the adjustments mentioned are calculated net of the U.S. or foreign statutory tax rate, which could differ from the Company’s effective tax rate. Additionally, the provision for income tax (expense) benefit also includes the impact related to the timing of certain tax credits, as well as certain tax reforms.

Return on equity, allocated equity and related measures:

• Operating ROE is defined as operating earnings available to common shareholders, divided by average GAAP common stockholders’ equity.

• Operating ROE, excluding AOCI other than FCTA, is defined as operating earnings available to common shareholders divided by average GAAP common stockholders’ equity, excluding AOCI other than FCTA.

The above measures represent a level of equity consistent with the view that, in the ordinary course of business, we do not plan to sell most investments for the sole purpose of realizing gains or losses.

179

The following additional information is relevant to an understanding of our performance results:

• The impact of changes in our foreign currency exchange rates is calculated using the average foreign currency exchange rates for the current period and is applied to each of the comparable periods (“Constant Currency Basis”).

• We sometimes refer to sales activity for various products. These sales statistics do not correspond to revenues under GAAP, but are used as relevant measures of business activity. Further, sales statistics for our Latin America, Asia and EMEA segments are on a Constant Currency Basis.

• Allocated equity is the portion of MetLife, Inc.’s common stockholders’ equity that management allocates to each of its segments and sub-segments based on local capital requirements and economic capital. See “— Economic Capital.” Allocated equity excludes the impact of AOCI other than FCTA.

• The Company uses a measure of free cash flow to facilitate an understanding of its ability to generate cash for reinvestment into its businesses or use in discretionary capital actions. The Company defines free cash flow as the sum of cash available at MetLife’s holding companies from dividends from operating subsidiaries, expenses and other net flows of the holding companies, and net contributions from debt to be at or below target leverage ratios. This measure of free cash flow is prior to discretionary capital deployment, including common stock dividends and repurchases, debt reduction and mergers and acquisitions. Free cash flow should not be viewed as a substitute for net cash provided by (used in) operating activities calculated in accordance with GAAP. The free cash flow ratio is typically expressed as a percentage of annual operating earnings available to common shareholders.

Subsequent Events

See Note 16 of the Notes to the Interim Condensed Consolidated Financial Statements.

180

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We regularly analyze our exposure to interest rate, equity market price and foreign currency exchange rate risks. As a result of that analysis, we have determined that the estimated fair values of certain assets and liabilities are materially exposed to changes in interest rates, foreign currency exchange rates and changes in the equity markets. We have exposure to market risk through our insurance operations and investment activities. We use a variety of strategies to manage interest rate, foreign currency exchange rate and equity market risk, including the use of derivatives. A description of our market risk exposures may be found under “Quantitative and Qualitative Disclosures About Market Risk” in Part II, Item 7A, of the 2015 Annual Report. There have been no material changes to our market risk exposures from the market risk exposures previously disclosed in the 2015 Annual Report.

181

Item 4. Controls and Procedures

Management, with the participation of the Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as defined in Exchange Act Rule 13a-15(e) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures are effective.

There were no changes to the Company’s internal control over financial reporting as defined in Exchange Act Rule 13a-15(f) during the quarter ended September 30, 2016 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

182

Part II — Other Information

Item 1. Legal Proceedings

The following should be read in conjunction with (i) Part I, Item 3, of the 2015 Annual Report; (ii) Part II, Item 1, of MetLife, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2016 (the “First Quarter 2016 Report”) and MetLife, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2016 (the “Second Quarter 2016 Report”); and (iii) Note 15 of the Notes to the Interim Condensed Consolidated Financial Statements in Part I of this report.

Asbestos-Related Claims

MLIC is and has been a defendant in a large number of asbestos-related suits filed primarily in state courts. These suits principally allege that the plaintiff or plaintiffs suffered personal injury resulting from exposure to asbestos and seek both actual and punitive damages.

As reported in the 2015 Annual Report, MLIC received approximately 3,856 asbestos-related claims in 2015. During the nine months ended September 30, 2016 and 2015, MLIC received approximately 3,267 and 2,971 new asbestos-related claims, respectively. See Note 21 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report for historical information concerning asbestos claims and MLIC’s increase in its recorded liability at December 31, 2014. The number of asbestos cases that may be brought, the aggregate amount of any liability that MLIC may incur, and the total amount paid in settlements in any given year are uncertain and may vary significantly from year to year.

MLIC reevaluates on a quarterly and annual basis its exposure from asbestos litigation, including studying its claims experience, reviewing external literature regarding asbestos claims experience in the United States, assessing relevant trends impacting asbestos liability and considering numerous variables that can affect its asbestos liability exposure on an overall or per claim basis. These variables include bankruptcies of other companies involved in asbestos litigation, legislative and judicial developments, the number of pending claims involving serious disease, the number of new claims filed against it and other defendants and the jurisdictions in which claims are pending. Based upon its regular reevaluation of its exposure from asbestos litigation, MLIC has updated its liability analysis for asbestos-related claims through September 30, 2016.

Unclaimed Property Litigation

West Virginia Lawsuits

On September 20, 2012, the West Virginia Treasurer filed an action against MLIC in West Virginia state court(West Virginia ex rel. John D. Perdue v. Metropolitan Life Insurance Company, Circuit Court of Putnam County, Civil Action No. 12-C-295)alleging that MLIC violated the West Virginia Uniform Unclaimed Property Act (the “Act”), seeking to compel compliance with the Act, and seeking payment of unclaimed property, interest, and penalties. On November 14, 2012, November 21, 2012, December 28, 2012, and January 9, 2013, the Treasurer filed substantially identical suits against MetLife Investors USA, NELICO, MetLife Insurance Company of Connecticut and General American Life Insurance Company, respectively. On August 17, 2016, these companies and the West Virginia Treasurer reached an agreement in principle to resolve these actions.

City of Birmingham Retirement and Relief System v. MetLife, Inc., et al. (Circuit Court of Jefferson County, Alabama, filed July 5, 2012)

Seeking to represent a class of persons who purchased MetLife, Inc. common equity units in or traceable to a public offering in March 2011, the plaintiff filed an action alleging that MetLife, Inc., certain current and former directors and executive officers of MetLife, Inc., and various underwriters violated several provisions of the Securities Act of 1933 related to the filing of the registration statement by issuing, or causing MetLife, Inc. to issue, materially false and misleading statements and/or omissions concerning MetLife, Inc.’s potential liability for millions of dollars in insurance benefits that should have been paid to beneficiaries or escheated to the states. Plaintiff seeks unspecified compensatory damages and other relief. On October 14, 2015, the court denied the defendants’ motion to dismiss the complaint. On October 28, 2016, the parties signed a stipulation of settlement agreeing to resolve this action. Plaintiff is seeking court approval of this settlement.

183

Total Control Accounts Litigation

Owens v. Metropolitan Life Insurance Company (N.D. Ga., filed April 17, 2014)

Plaintiff filed this putative class action lawsuit on behalf of all persons for whom MLIC established a retained asset account, known as a total control account (“TCA”), to pay death benefits under an ERISA plan. The action alleges that MLIC’s use of the TCA as the settlement option for life insurance benefits under some group life insurance policies violates MLIC’s fiduciary duties under ERISA. As damages, plaintiff seeks disgorgement of profits that MLIC realized on accounts owned by members of the putative class. On September 27, 2016 the court denied MLIC’s summary judgmentmotion in full and granted plaintiff’s partial summary judgment motion. The Company intends to defend this action vigorously.

Diversified Lending Group Litigations

Hartshorne v. MetLife Inc., et al. (Los Angeles County Superior Court, filed March 25, 2015)

Plaintiffs have named MetLife, Inc., MSI and NELICO in 12 related lawsuits in California state court alleging various causes of action including multiple negligence and statutory claims relating to a Ponzi scheme involving the Diversified Lending Group (“DLG”). In August 2016, a trial of claims by one of the plaintiffs, Christine Ramirez, resulted in a verdict against MetLife, Inc., MSI, and NELICO for approximately $200 thousand in compensatory damages and $15 million in punitive damages. The Company intends to appeal this verdict.

Other Litigation

Fauley v. Metropolitan Life Insurance Company, et al. (Circuit Court of the 19th Judicial Circuit, Lake County, Ill., July 3, 2014)

Plaintiffs filed this lawsuit against defendants, including MLIC and a former MetLife financial services representative, alleging that the defendants sent unsolicited fax advertisements to plaintiff and others in violation of the Telephone Consumer Protection Act, as amended by the Junk Fax Prevention Act, 47 U.S.C. § 227. The court issued a final order certifying a nationwide settlement class and approving a settlement under which MLIC has agreed to pay up to $23 million to resolve claims as to fax advertisements sent between August 23, 2008 and August 7, 2014. On March 23, 2016, the intermediate appellate court affirmed the trial court’s order. On September 28, 2016, the Illinois Supreme Court denied an objector’s petition for leave to appeal.

Thrivent Financial for Lutherans v. MetLife Insurance Company USA, (E.D. Wis., filed September 12, 2016)

Plaintiff filed a complaint against MetLife USA contending that MetLife’s use of the Brighthouse Financial trademark and logo will infringe on its trademarks. Alleging violations of federal and state law, plaintiff seeks preliminary and permanent injunctions, compensatory damages, and other relief. MetLife USA intends to defend this action vigorously.

Summary

Putative or certified class action litigation and other litigation and claims and assessments against the Company, in addition to those discussed previously and those otherwise provided for in the Company’s consolidated financial statements, have arisen in the course of the Company’s business, including, but not limited to, in connection with its activities as an insurer, mortgage lending bank, employer, investor, investment advisor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company’s compliance with applicable insurance and other laws and regulations.

It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings. In some of the matters referred to previously, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Although in light of these considerations it is possible that an adverse outcome in certain cases could have a material effect upon the Company’s financial position, based on information currently known by the Company’s management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company’s consolidated net income or cash flows in particular quarterly or annual periods.

184

Item 1A. Risk Factors

The following should be read in conjunction with, and supplements and amends, the factors that may affect the Company’s business or operations described under “Risk Factors” in Part I, Item 1A, of the 2015 Annual Report, as amended or supplemented by the information under “Risk Factors” in Part II, Item 1A, of each of the First Quarter 2016 Report and the Second Quarter 2016 Report. Other than as described in this Item 1A, there have been no other material changes to our risk factors from the risk factors previously disclosed in the 2015 Annual Report, as amended or supplemented by such information in the First Quarter 2016 Report and the Second Quarter 2016 Report.

Regulatory and Legal Risks

The following updates and replaces the similarly named sections of the risk factor entitled “Our Insurance and Brokerage Businesses Are Highly Regulated, and Changes in Regulation and in Supervisory and Enforcement Policies May Reduce Our Profitability and Limit Our Growth” included in the 2015 Annual Report, as amended or supplemented by such information in the First Quarter 2016 Report and the Second Quarter 2016 Report. There have been no material changes to other sections of such risk factor, which include: “U.S. Regulation — Insurance Regulation,” “U.S. Regulation — U.S. Federal Regulation Affecting Insurance,” “U.S. Regulation — Potential Regulation of MetLife, Inc. as a Non-Bank SIFI,” “International Regulation” and “General.”

Our Insurance and Brokerage Businesses Are Highly Regulated, and Changes in Regulation and in Supervisory and Enforcement Policies May Reduce Our Profitability and Limit Our Growth

Our insurance operations and brokerage businesses are subject to a wide variety of insurance and other laws and regulations. See “Business — Regulation” included in the 2015 Annual Report, as amended or supplemented by discussions of regulatory developments elsewhere herein and in our subsequently filed Quarterly Reports on Form 10-Q under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Industry Trends — Regulatory Developments,” and as further amended or supplemented below.

U.S. Regulation

ERISA Considerations

We provide products and services to certain employee benefit plans that are subject to ERISA or the Code. As such, our activities are subject to the restrictions imposed by ERISA and the Code, including the requirement under ERISA that fiduciaries must perform their duties solely in the interests of ERISA plan participants and beneficiaries, and those fiduciaries may not cause a covered plan to engage in certain prohibited transactions. The prohibited transaction rules of ERISA and the Code generally restrict the provision of investment advice to ERISA plans and participants and IRAs if the investment recommendation results in fees paid to the individual advisor, the firm that employs the advisor or their affiliates that vary according to the investment recommendation chosen. Similarly, without an exemption, fiduciary advisors are prohibited from receiving compensation from third parties in connection with their advice. ERISA also affects certain of our in-force insurance policies and annuity contracts, as well as insurance policies and annuity contracts we may sell in the future.

The DOL issued new regulations on April 6, 2016 with an effective date for most provisions of April 10, 2017. These regulations substantially expand the definition of “investment advice” and thereby broaden the circumstances under which MetLife or its representatives, in providing investment advice with respect to ERISA plans, plan participants or IRAs, will be deemed a fiduciary under ERISA or the Code. Pursuant to the final regulations, certain communications with plans, plan participants and IRAs holders, including the marketing of products, and marketing of investment management or advisory services, could be deemed fiduciary investment advice, thus causing increased exposure to fiduciary liability if the distributor does not recommend what is in the client’s best interests. While the final regulations also provide that, to a limited extent, contracts sold and advice provided prior to April 10, 2017 do not have to be modified to comply with the new investment advice regulations, there is lack of clarity surrounding some of the conditions for qualifying for this limited exception. There can be no assurance that the DOL will agree with our interpretation of these provisions, in which case the DOL and IRS could assess significant penalties against a portion of products sold prior to April 10, 2017. The assessment of such penalties could also trigger substantial litigation risk. Any such penalties and related litigation could adversely affect our results of operations and financial condition.

The DOL also issued amendments to certain of its prohibited transaction exemptions, and issued a new exemption that applies more onerous disclosure and contract requirements to, and increases fiduciary requirements and fiduciary liability exposure in respect of, transactions involving ERISA plans, plan participants and IRAs.

185

While we continue to analyze the impact of the final regulations on our business, we believe they could have an adverse effect on sales of annuity products to ERISA qualified plans such as IRAs through our independent distribution partners. The new regulations deem advisors, including independent distributors, who sell fixed index-linked annuities to IRAs, IRA rollovers or 401(k) plans, fiduciaries and prohibit them from receiving compensation unless they comply with a prohibited transaction exemption. The exemption requires advisors to comply with impartial conduct standards and may require us to exercise additional oversight of the sales process. Compliance with the prohibited transaction exemption will likely result in increased regulatory burdens on us and our independent distribution partners, changes to our compensation practices and product offerings and increased litigation risk, which could adversely affect our results of operations and financial condition. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Industry Trends — Regulatory Developments — U.S. Regulation — ERISA Considerations,” as well as “Business — Regulation — U.S. Regulation — ERISA Considerations” included in the 2015 Annual Report.

We cannot predict what other proposals may be made, what legislation may be introduced or enacted, or what impact any such legislation may have on our business, results of operations and financial condition.

Risks Related to Acquisitions, Dispositions or Other Structural Changes

We May Not Complete the Separation of Brighthouse Financial on the Terms or Timeline Currently Contemplated, if at All

On October 5, 2016, our wholly-owned subsidiary, Brighthouse, filed a registration statement on Form 10 with the SEC in connection with the previously announced Separation of a substantial portion of our former Retail segment, as well as certain portions of our former Corporate Benefit Funding segment. The Form 10 reflects our current plan to initiate the Separation in the form of an initial spin-off of 80.1% of the outstanding common stock of Brighthouse. While we and Brighthouse are currently preparing for a spin-off transaction, the ultimate form and timing of a separation will be influenced by a number of factors, including regulatory considerations and economic conditions. We continue to evaluate and pursue structural alternatives for the proposed Separation. While we expect to complete the first part of the Separation in the first half of 2017, unanticipated developments could delay, prevent or otherwise adversely affect the currently proposed spin-off of Brighthouse Financial, including possible problems or delays in obtaining various insurance and other regulatory approvals, tax approvals and disruptions in the capital and financial markets. In addition, consummation of the currently proposed spin-off will require final approval from our Board of Directors. Therefore, we cannot assure that we will complete the Separation in the form, on the terms or on the timeline that we announced, if at all.

In order to position ourselves for the proposed Separation, we are actively pursuing strategic, structural and process realignment and restructuring actions within our former Retail segment (now, the Brighthouse Financial and MetLife Holdings segments). These actions could lead to disruption of our operations, loss of, or inability to recruit, key personnel needed to operate and grow our businesses and complete the proposed Separation, weakening of our internal standards, controls or procedures, and impairment of our relationship with key customers and counterparties. We have and will continue to incur significant expenses in connection with the proposed Separation. We also may not achieve certain of the benefits that we expect to achieve in connection with the Separation, including dividends from Brighthouse to MetLife, Inc., due to, among other things, the inability of Brighthouse to raise sufficient funds by the incurrence of debt or otherwise, or lower than expected dividends received by Brighthouse from its subsidiaries. In addition, completion of the proposed Separation will require significant amounts of our management’s time and effort which may divert management’s attention from operating and growing our remaining businesses and could adversely affect our business, results of operations and financial condition.

Risks Related to Our Business

The following updates and replaces the similar paragraphs in the risk factor entitled “Our International Operations Face Political, Legal, Operational and Other Risks, Including Exposure to Local and Regional Economic Conditions, That Could Negatively Affect Those Operations or Our Profitability” included in the 2015 Annual Report, as amended or supplemented by such information in the First Quarter 2016 Report and the Second Quarter 2016 Report.

186

Our International Operations Face Political, Legal, Operational and Other Risks, Including Exposure to Local and Regional Economic Conditions, That Could Negatively Affect Those Operations or Our Profitability

Our international operations face political, legal, financial, operational and other risks. These operations may be materially adversely affected by the actions and decisions of foreign authorities and regulators, such as through nationalization or expropriation of assets; the imposition of limits on foreign ownership of local companies which may increase our dependence on joint venture counterparties and/or impact how we account for our joint venture ownership interests; changes in laws (including tax laws and regulations), their application or interpretation; political instability (including any resulting economic or trade sanctions); dividend limitations; price controls; changes in applicable currency; currency exchange controls or other restrictions that prevent us from transferring funds from these operations out of the countries in which they operate or converting local currencies we hold into U.S. dollars or other currencies, as well as other adverse actions by foreign governmental authorities and regulators, such as the retroactive application of new requirements on our current and prior activities or operations and the imposition of regulations limiting our ability to distribute our products. Such actions may negatively affect our business in these jurisdictions and could indirectly affect our business in other jurisdictions as well. Some of our foreign insurance operations are, and are likely to continue to be, in emerging markets where these risks are heightened. For example, proposed reform of the Chilean pension system, if enacted, may have a significant adverse effect on our business in Chile. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Industry Trends — Regulatory Developments — International Regulation.”

On June 23, 2016, the U.K. held a referendum regarding its membership in the EU, resulting in a narrow vote in favor of leaving the EU. The U.K. subsequently indicated that it will initiate the withdrawal process by the end of March 2017. The member withdrawal provisions in the applicable EU treaty have not been used before so it is unclear how the provisions will work in practice. Assuming the U.K. initiates the withdrawal process by giving notice that it is withdrawing from the EU, the relevant treaty provides that the U.K. and the EU will negotiate a withdrawal agreement during a maximum two-year period (unless such period is extended by unanimous vote of the other EU member states). It is currently anticipated that the withdrawal agreement would deal with the details of the immediate exit but would not set out final trade arrangements or deal comprehensively with other potentially significant matters. Upon effectiveness of the withdrawal agreement, or, if no agreement is concluded in the two-year period, at the end of the period, the U.K. will no longer be a member of the EU. In the meantime, however, the U.K. remains a member of the EU with unchanged rights to access the single EU market in goods and services. Our U.K. business model utilizes certain rights to operate cross-border insurance and investment operations which may be modified or eliminated as a result of the U.K. exiting the EU. Operating expenses within our businesses could increase as a result of uncertainties during the negotiation period and in the event of an eventual U.K. withdrawal.

Operational Risks

Any Failure To Protect The Confidentiality Of Client Information Could Adversely Affect Our Reputation And Have A Material Adverse Effect On Our Business, Financial Condition And Results Of Operations

Pursuant to U.S. federal and state laws, and laws of other jurisdictions in which we operate, various government agencies have established rules protecting the privacy and security of personal information. In addition, most U.S. states and a number of jurisdictions outside the United States, have enacted laws, which vary significantly from jurisdiction to jurisdiction, to safeguard the privacy and security of personal information. Many of our employees have access to, and routinely process, personal information of clients through a variety of media, including information technology systems. We rely on various internal processes and controls to protect the confidentiality of client information that is accessible to, or in the possession of, our company and our employees. It is possible that an employee could, intentionally or unintentionally, disclose or misappropriate confidential client information or our data could be the subject of a cybersecurity attack. If we fail to maintain adequate internal controls or if our employees fail to comply with our policies and procedures, misappropriation or intentional or unintentional inappropriate disclosure or misuse of client information could occur. Such internal control inadequacies or non-compliance could materially damage our reputation or lead to civil or criminal penalties, which, in turn, could have a material adverse effect on our business, financial condition and results of operations. In addition, we analyze customer data to better manage our business. There has been increased scrutiny, including from U.S. state regulators, regarding the use of “big data” techniques such as price optimization. We cannot predict what, if any, actions may be taken with regard to “big data,” but any inquiries could cause reputational harm and any limitations could have a material impact on our business, financial condition and results of operations.

187

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

Purchases of common stock made by or on behalf of MetLife, Inc. or its affiliates during the quarter ended September 30, 2016 are set forth below:

Period	(a) Total Number of Shares Purchased (1)	(b) Average Price Paid per Share		(c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	(d) Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs (2)
July 1 — July 31, 2016	—	$	—	—	$	—
August 1 — August 31, 2016	—	$	—	—	$	—
September 1 — September 30, 2016	781	$	43.87	—	$	—

__________________

(1) During the periods July 1 through July 31, 2016, August 1 through August 31, 2016 and September 1 through September 30, 2016, separate account index funds purchased 0 shares, 0 shares and 781 shares, respectively, of common stock on the open market in nondiscretionary transactions. Except for the foregoing, there were no shares of common stock which were repurchased by MetLife, Inc.

(2) At September 30, 2016, MetLife, Inc. had no remaining authorizations approved by its Board of Directors to purchase shares of common stock. Common stock repurchases, if and when authorized by the Board of Directors, are dependent upon several factors, including our capital position, liquidity, financial strength and credit ratings, general market conditions, the market price of MetLife, Inc.’s common stock compared to management’s assessment of the stock’s underlying value and applicable regulatory approvals, as well as other legal and accounting factors. See “Risk Factors — Capital-Related Risks — Regulatory Restrictions and Uncertainty and Restrictions Under the Terms of Certain of Our Securities May Prevent Us from Repurchasing Our Stock and Paying Dividends at the Level We Wish” included in the 2015 Annual Report, as amended or supplemented in our subsequently filed Quarterly Reports on Form 10-Q in similarly named sections under the caption “Risk Factors,” as well as Note 16 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report.

188

Item 6. Exhibits

(Note Regarding Reliance on Statements in Our Contracts:In reviewing the agreements included as exhibits to this Quarterly Report on Form 10-Q, please remember that they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about MetLife, Inc., its subsidiaries or affiliates, or the other parties to the agreements. The agreements contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties have been made solely for the benefit of the other parties to the applicable agreement and (i) should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate; (ii) have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement; (iii) may apply standards of materiality in a way that is different from what may be viewed as material to investors; and (iv) were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments. Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time. Additional information about MetLife, Inc., its subsidiaries and affiliates may be found elsewhere in this Quarterly Report on Form 10-Q and MetLife, Inc.’s other public filings, which are available without charge through the U.S. Securities and Exchange Commission website at www.sec.gov.)

Exhibit No.	Description
3.1	Amended and Restated By-Laws of MetLife, Inc., effective September 27, 2016. (Incorporated by reference to Exhibit 3.2 to MetLife, Inc.'s Current Report on Form 8-K dated September 29, 2016).
10.1	Form of Agreement to Protect Corporate Property executed by Martin J. Lippert on July 6, 2016. (Incorporated by reference to Exhibit 10.1 to MetLife, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2016).*
31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document.
101.SCH	XBRL Taxonomy Extension Schema Document.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB	XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.

______________

*Indicates management contracts or compensatory plans or arrangements.

189

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

METLIFE, INC.
By:	/s/ Peter M. Carlson
	Name:  Peter M. Carlson Title:    Executive Vice President              and Chief Accounting Officer              (Authorized Signatory and Principal               Accounting Officer)

Date: November 3, 2016

190

Exhibit Index

(Note Regarding Reliance on Statements in Our Contracts: In reviewing the agreements included as exhibits to this Quarterly Report on Form 10-Q, please remember that they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about MetLife, Inc., its subsidiaries or affiliates, or the other parties to the agreements. The agreements contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties have been made solely for the benefit of the other parties to the applicable agreement and (i) should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate; (ii) have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement; (iii) may apply standards of materiality in a way that is different from what may be viewed as material to investors; and (iv) were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments. Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time. Additional information about MetLife, Inc., its subsidiaries and affiliates may be found elsewhere in this Quarterly Report on Form 10-Q and MetLife, Inc.’s other public filings, which are available without charge through the U.S. Securities and Exchange Commission website at www.sec.gov.)

Exhibit No.	Description
3.1	Amended and Restated By-Laws of MetLife, Inc., effective September 27, 2016. (Incorporated by reference to Exhibit 3.2 to MetLife, Inc.'s Current Report on Form 8-K dated September 29, 2016).
10.1	Form of Agreement to Protect Corporate Property executed by Martin J. Lippert on July 6, 2016. (Incorporated by reference to Exhibit 10.1 to MetLife, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2016).*
31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document.
101.SCH	XBRL Taxonomy Extension Schema Document.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB	XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.

______________

*Indicates management contracts or compensatory plans or arrangements.

E - 1

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Steven A. Kandarian, certify that:

1. I have reviewed this quarterly report on Form 10-Q of MetLife, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:     November 3, 2016

/s/ Steven A. Kandarian

Steven A. Kandarian

Chairman of the Board, President and

Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, John C. R. Hele, certify that:

1. I have reviewed this quarterly report on Form 10-Q of MetLife, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:     November 3, 2016

/s/ John C. R. Hele

John C. R. Hele

Executive Vice President and

Chief Financial Officer

EX-32.1

Exhibit 32.1

SECTION 906 CERTIFICATION

CERTIFICATION PURSUANT TO SECTION 1350 OF CHAPTER 63 OF TITLE 18 OF THE UNITED

STATES CODE

I, Steven A. Kandarian, certify that (i) MetLife, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2016 (the “Form 10-Q”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and (ii) the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of MetLife, Inc.

Date:     November 3, 2016

/s/ Steven A. Kandarian

Steven A. Kandarian

Chairman of the Board, President and

Chief Executive Officer

A signed original of this written statement required by Section 906 has been provided to MetLife, Inc. and will be retained by MetLife, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

SECTION 906 CERTIFICATION

CERTIFICATION PURSUANT TO SECTION 1350 OF CHAPTER 63 OF TITLE 18 OF THE UNITED

STATES CODE

I, John C. R. Hele, certify that (i) MetLife, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2016 (the “Form 10-Q”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and (ii) the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of MetLife, Inc.

Date:     November 3, 2016

/s/ John C. R. Hele

John C. R. Hele

Executive Vice President and

Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to MetLife, Inc. and will be retained by MetLife, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - USD ($) $ in Billions	9 Months Ended
	Sep. 30, 2016	Oct. 31, 2016	Sep. 30, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	METLIFE INC
Entity Central Index Key	0001099219
Document Type	10-Q
Document Period End Date	Sep. 30, 2016
Amendment Flag	false
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float			$ 62.6
Entity Common Stock, Shares Outstanding		1,099,135,417

XML

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $353,913 and $332,964, respectively; includes $3,533 and $4,277, respectively, relating to variable interest entities)	$ 390,442	$ 351,402
Equity securities available-for-sale, at estimated fair value (cost: $2,838 and $2,997, respectively)	3,289	3,321
Fair value option and trading securities, at estimated fair value (includes $0 and $404, respectively, of actively traded securities; and $9 and $13, respectively, relating to variable interest entities)	14,730	15,024
Mortgage loans (net of valuation allowances of $330 and $318, respectively; includes $143 and $172, respectively, at estimated fair value, relating to variable interest entities; includes $481 and $314, respectively, under the fair value option)	71,156	67,102
Policy loans (includes $0 and $4, respectively, relating to variable interest entities)	11,177	11,258
Real estate and real estate joint ventures (includes $33 and $47, respectively, of real estate held-for-sale)	9,186	8,433
Other limited partnership interests (includes $15 and $27, respectively, relating to variable interest entities)	6,878	7,096
Short-term investments, principally at estimated fair value (includes $0 and $26, respectively, relating to variable interest entities)	11,655	9,299
Other invested assets, principally at estimated fair value (includes $31 and $43, respectively, relating to variable interest entities)	30,278	22,524
Total investments	548,791	495,459
Cash and cash equivalents, principally at estimated fair value (includes $0 and $85, respectively, relating to variable interest entities)	15,883	12,752
Accrued investment income (includes $1 and $23, respectively, relating to variable interest entities)	4,197	3,988
Premiums, reinsurance and other receivables (includes $4 and $21, respectively, relating to variable interest entities)	26,178	22,702
Deferred policy acquisition costs and value of business acquired (includes $0 and $240, respectively, relating to variable interest entities)	24,748	24,130
Current income tax recoverable	0	161
Goodwill	9,592	9,477
Other assets (includes $3 and $148, respectively, relating to variable interest entities)	7,867	7,666
Separate account assets (includes $0 and $1,022, respectively, relating to variable interest entities)	315,648	301,598
Total assets	952,904	877,933
Liabilities
Future policy benefits (includes $0 and $716, respectively, relating to variable interest entities)	208,561	191,879
Policyholder account balances (includes $0 and $21, respectively, relating to variable interest entities)	216,192	202,722
Other policy-related balances (includes $0 and $238, respectively, relating to variable interest entities)	14,857	14,255
Policyholder dividends payable	763	720
Policyholder dividend obligation	3,352	1,783
Payables for collateral under securities loaned and other transactions	44,422	36,871
Short-term debt	201	100
Long-term debt (includes $38 and $63, respectively, at estimated fair value, relating to variable interest entities)	16,553	18,023
Collateral financing arrangements	4,084	4,139
Junior subordinated debt securities	3,168	3,194
Current income tax payable	151	0
Deferred income tax liability	14,359	10,592
Other liabilities (includes $0 and $81, respectively, relating to variable interest entities)	32,127	23,561
Separate account liabilities (includes $0 and $1,022, respectively, relating to variable interest entities)	315,648	301,598
Total liabilities	874,438	809,437
Contingencies, Commitments and Guarantees (Note 15)
Redeemable noncontrolling interests in partially-owned consolidated subsidiaries	0	77
MetLife, Inc.’s stockholders’ equity:
Preferred stock, par value $0.01 per share; $2,100 aggregate liquidation preference	0	0
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,161,994,036 and 1,159,590,766 shares issued, respectively; 1,098,985,931 and 1,098,028,525 shares outstanding, respectively	12	12
Additional paid-in capital	30,797	30,749
Retained earnings	37,054	35,519
Treasury stock, at cost; 63,008,105 and 61,562,241 shares, respectively	(3,172)	(3,102)
Accumulated other comprehensive income (loss)	13,595	4,771
Total MetLife, Inc.’s stockholders’ equity	78,286	67,949
Noncontrolling interests	180	470
Total equity	78,466	68,419
Total liabilities and equity	$ 952,904	$ 877,933

XML

Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Assets
Amortized cost of fixed maturity securities available-for-sale	$ 353,913	$ 332,964
Fixed maturity securities relating to variable interest entities	390,442	351,402
Cost of equity securities available-for-sale	2,838	2,997
Actively traded securities	0	404
Fair value option and trading securities relating to variable interest entities	14,730	15,024
Mortgage loans valuation allowances	330	318
Mortgage Loans on Real Estate	71,156	67,102
Policy loans	11,177	11,258
Real estate held-for-sale	33	47
Other limited partnership interests relating to variable interest entities	6,878	7,096
Short-term investments	11,655	9,299
Other invested assets relating to variable interest entities	30,278	22,524
Cash and cash equivalents relating to variable interest entities	15,883	12,752
Accrued investment income relating to variable interest entities	4,197	3,988
Premiums, reinsurance and other receivables relating to variable interest entities	26,178	22,702
Deferred policy acquisition costs and value of business acquired relating to variable interest entities	24,748	24,130
Other assets relating to variable interest entities	7,867	7,666
Separate account assets	315,648	301,598
Liabilities
Future policy benefits relating to variable interest entities	208,561	191,879
Policyholder account balances	216,192	202,722
Other policy-related balances relating to variable interest entities	14,857	14,255
Long-term debt, at estimated fair value, relating to variable interest entities	16,553	18,023
Other liabilities relating to variable interest entities	32,127	23,561
Separate account liabilities	$ 315,648	$ 301,598
MetLife, Inc.’s stockholders’ equity:
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, aggregate liquidation preference	2,100	2,100
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	3,000,000,000	3,000,000,000
Common stock, shares issued	1,161,994,036	1,159,590,766
Common stock, shares outstanding	1,098,985,931	1,098,028,525
Treasury stock, shares	63,008,105	61,562,241
Residential mortgage loans — FVO
Assets
Mortgage Loans on Real Estate	$ 481	$ 314
Variable interest entities
Assets
Fixed maturity securities relating to variable interest entities	3,533	4,277
Fair value option and trading securities relating to variable interest entities	9	13
Mortgage Loans on Real Estate	143	172
Policy loans	0	4
Other limited partnership interests relating to variable interest entities	15	27
Short-term investments	0	26
Other invested assets relating to variable interest entities	31	43
Cash and cash equivalents relating to variable interest entities	0	85
Accrued investment income relating to variable interest entities	1	23
Premiums, reinsurance and other receivables relating to variable interest entities	4	21
Deferred policy acquisition costs and value of business acquired relating to variable interest entities	0	240
Other assets relating to variable interest entities	3	148
Separate account assets	0	1,022
Liabilities
Future policy benefits relating to variable interest entities	0	716
Policyholder account balances	0	21
Other policy-related balances relating to variable interest entities	0	238
Long-term debt, at estimated fair value, relating to variable interest entities	38	63
Other liabilities relating to variable interest entities	0	81
Separate account liabilities	$ 0	$ 1,022

XML

Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Revenues
Premiums	$ 10,391	$ 10,375	$ 29,501	$ 28,940
Universal life and investment-type product policy fees	2,296	2,346	6,926	7,174
Net investment income	5,464	3,959	14,910	14,367
Other revenues	366	484	1,340	1,497
Net investment gains (losses):
Other-than-temporary impairments on fixed maturity securities	(8)	(43)	(94)	(51)
Other-than-temporary impairments on fixed maturity securities transferred to other comprehensive income (loss)	(6)	16	(12)	4
Other net investment gains (losses)	271	409	644	582
Total net investment gains (losses)	257	382	538	535
Net derivative gains (losses)	(1,051)	485	(1,815)	394
Total revenues	17,723	18,031	51,400	52,907
Expenses
Policyholder benefits and claims	10,855	10,334	30,807	28,943
Interest credited to policyholder account balances	1,820	647	4,646	3,940
Policyholder dividends	312	354	951	1,024
Goodwill impairment	260	0	260	0
Other expenses	3,928	4,533	11,366	12,665
Total expenses	17,175	15,868	48,030	46,572
Income (loss) before provision for income tax	548	2,163	3,370	6,335
Provision for income tax expense (benefit)	(25)	965	480	1,855
Net income (loss)	573	1,198	2,890	4,480
Less: Net income (loss) attributable to noncontrolling interests	(4)	(5)	2	4
Net income (loss) attributable to MetLife, Inc.	577	1,203	2,888	4,476
Less: Preferred stock dividends	6	6	58	67
Preferred stock repurchase premium	0	0	0	42
Net income (loss) available to MetLife, Inc.’s common shareholders	571	1,197	2,830	4,367
Comprehensive income (loss)	(463)	1,653	11,809	760
Less: Comprehensive income (loss) attributable to noncontrolling interests, net of income tax	(3)	2	97	42
Comprehensive income (loss) attributable to MetLife, Inc.	$ (460)	$ 1,651	$ 11,712	$ 718
Net income (loss) available to MetLife, Inc.’s common shareholders per common share:
Basic	$ 0.52	$ 1.07	$ 2.57	$ 3.90
Diluted	0.51	1.06	2.55	3.86
Cash dividends declared per common share	$ 0.400	$ 0.375	$ 1.175	$ 1.100

XML

Consolidated Statements of Equity (Unaudited) - USD ($) $ in Millions	Total	Maximum	Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings	Treasury Stock at Cost	Accumulated Other Comprehensive Income (Loss)	Total MetLife, Inc.’s Stockholders’ Equity	Noncontrolling Interests
Beginning Balance at Dec. 31, 2014	$ 72,560		$ 1	$ 12	$ 30,543	$ 32,020	$ (1,172)	$ 10,649	$ 72,053	$ 507
Repurchase of preferred stock	(1,460)		(1)		(1,459)				(1,460)
Preferred stock repurchase premium	(42)					(42)			(42)
Preferred stock issuance	1,483				1,483				1,483
Treasury stock acquired in connection with share repurchases	(1,107)						(1,107)		(1,107)
Stock-based compensation	159				159				159
Dividends on preferred stock	(67)					(67)			(67)
Dividends on common stock	(1,234)					(1,234)			(1,234)
Change in equity of noncontrolling interests	(64)								0	(64)
Net income (loss)	4,480					4,476			4,476	4	[1]
Other comprehensive income (loss), net of income tax	(3,720)							(3,758)	(3,758)	38
Ending Balance at Sep. 30, 2015	70,988		0	12	30,726	35,153	(2,279)	6,891	70,503	485
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest		$ (1)
Beginning Balance at Dec. 31, 2015	68,419		0	12	30,749	35,519	(3,102)	4,771	67,949	470
Preferred stock repurchase premium	0
Treasury stock acquired in connection with share repurchases	(70)						(70)		(70)
Stock-based compensation	48				48				48
Dividends on preferred stock	(58)					(58)			(58)
Dividends on common stock	(1,295)					(1,295)			(1,295)
Change in equity of noncontrolling interests	(387)								0	(387)
Net income (loss)	2,890					2,888			2,888	2	[1]
Other comprehensive income (loss), net of income tax	8,919							8,824	8,824	95
Ending Balance at Sep. 30, 2016	$ 78,466		$ 0	$ 12	$ 30,797	$ 37,054	$ (3,172)	$ 13,595	$ 78,286	$ 180

[1] (1)Net income (loss) attributable to noncontrolling interests did not exclude any gains of redeemable noncontrolling interests in partially-owned consolidated subsidiaries at September 30, 2016. Net income (loss) attributable to noncontrolling interests excluded losses of redeemable noncontrolling interests in partially-owned consolidated subsidiaries of less than $1 million at September 30, 2015.

XML

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Statement of Cash Flows [Abstract]
Net cash provided by (used in) operating activities	$ 9,183	$ 9,527
Cash flows from investing activities
Sales, maturities and repayments of fixed maturity securities	101,614	109,308
Sales, maturities and repayments of equity securities	1,019	478
Sales, maturities and repayments of mortgage loans	10,518	9,775
Sales, maturities and repayments of real estate and real estate joint ventures	323	1,644
Sales, maturities and repayments of other limited partnership interests	1,025	859
Purchases of fixed maturity securities	(108,418)	(105,128)
Purchases of equity securities	(802)	(431)
Purchases of mortgage loans	(14,686)	(13,814)
Purchases of real estate and real estate joint ventures	(958)	(977)
Purchases of other limited partnership interests	(806)	(935)
Cash received in connection with freestanding derivatives	3,258	2,376
Cash paid in connection with freestanding derivatives	(4,317)	(2,887)
Cash received under repurchase agreements (Note 7)	0	199
Cash paid under reverse repurchase agreements (Note 7)	0	(199)
Sales of businesses, net of cash and cash equivalents disposed of $135 and $0, respectively	156	0
Purchases of investments in operating joint ventures	(39)	0
Net change in policy loans	201	10
Net change in short-term investments	(2,232)	(6,644)
Net change in other invested assets	(58)	(350)
Other, net	(384)	(191)
Net cash provided by (used in) investing activities	(14,586)	(6,907)
Cash flows from financing activities
Policyholder account balances: Deposits	65,225	69,383
Policyholder account balances: Withdrawals	(61,145)	(72,940)
Net change in payables for collateral under securities loaned and other transactions	7,227	2,664
Net change in short-term debt	(3)	0
Long-term debt issued	0	1,578
Long-term debt repaid	(1,273)	(1,078)
Collateral financing arrangements repaid	(55)	(44)
Treasury stock acquired in connection with share repurchases	(70)	(1,107)
Preferred stock issued, net of issuance costs	0	1,483
Repurchase of preferred stock	0	(1,460)
Preferred stock repurchase premium	0	(42)
Dividends on preferred stock	(58)	(67)
Dividends on common stock	(1,295)	(1,234)
Other, net	(325)	12
Net cash provided by (used in) financing activities	8,228	(2,852)
Effect of change in foreign currency exchange rates on cash and cash equivalents balances	306	(360)
Change in cash and cash equivalents	3,131	(592)
Cash and cash equivalents, beginning of period	12,752	10,808
Cash and cash equivalents, end of period	15,883	10,216
Supplemental disclosures of cash flow information:
Net cash paid for Interest	875	836
Net cash paid (received) for Income tax	464	904
Non-cash transactions:
Fixed maturity securities received in connection with pension risk transfer transactions	985	903
Reduction of fixed maturity securities in connection with a reinsurance transaction	224	0
Deconsolidation of operating joint venture (Note 6):
Reduction of fixed maturity securities	917	0
Reduction of noncontrolling interests	$ 373	$ 0

XML

Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from investing activities
Cash disposed from sale of businesses	$ 135	$ 0

XML

Business, Basis of Presentation and Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Business, Basis of Presentation and Summary of Significant Accounting Policies

1. Business, Basis of Presentation and Summary of Significant Accounting Policies

Business

“MetLife” and the “Company” refer to MetLife, Inc., a Delaware corporation incorporated in 1999, its subsidiaries and affiliates. MetLife is a global provider of life insurance, annuities, employee benefits and asset management. In anticipation of the Company’s plan to separate a substantial portion of its former Retail segment, as well as certain portions of its former Corporate Benefit Funding segment and Corporate & Other (the “Separation”), in the third quarter of 2016, MetLife reorganized its businesses into six segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa (“EMEA”); MetLife Holdings; and Brighthouse Financial. See Note 2 for further information on the reorganization of the Company’s segments in the third quarter of 2016, which was applied retrospectively.

Basis of Presentation

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the interim condensed consolidated financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from estimates.

Consolidation

The accompanying interim condensed consolidated financial statements include the accounts of MetLife, Inc. and its subsidiaries, as well as partnerships and joint ventures in which the Company has control, and variable interest entities (“VIEs”) for which the Company is the primary beneficiary. Intercompany accounts and transactions have been eliminated.

Prior to January 1, 2016, certain international subsidiaries had a fiscal year cutoff of November 30th. Accordingly, the Company’s interim condensed consolidated financial statements reflect the assets and liabilities of such subsidiaries as of November 30, 2015 and the operating results of such subsidiaries for the three months and nine months ended August 31, 2015. Effective January 1, 2016, the Company converted its Japan operations to calendar year-end reporting. The elimination of a one-month reporting lag of a subsidiary is considered a change in accounting principle and requires retrospective application. While the Company believes that eliminating the lag in the reporting of its Japan operations was preferable in order to consistently reflect events, economic conditions and global trends in the financial statements, the Company determined that it was impracticable to apply the effects of the lag elimination to financial reporting periods prior to January 1, 2015. The effect of not retroactively applying this change in accounting, however, was not material to the 2015 or 2016 consolidated financial statements. Therefore, the Company reported the cumulative effect of the change in accounting principle in net income for the three months ended March 31, 2016 and the nine months ended September 30, 2016 and did not retrospectively apply the effects of this change to prior periods. See Note 2.

The Company uses the equity method of accounting for equity securities when it has significant influence or at least 20% interest and for real estate joint ventures and other limited partnership interests (“investees”) when it has more than a minor ownership interest or more than a minor influence over the investee’s operations, but does not have a controlling financial interest. The Company generally recognizes its share of the investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period. The Company uses the cost method of accounting for investments in which it has virtually no influence over the investee’s operations.

Reclassifications

Certain amounts in the prior year periods’ interim condensed consolidated financial statements and related footnotes thereto have been reclassified to conform with the 2016 presentation as discussed throughout the Notes to the Interim Condensed Consolidated Financial Statements.

The accompanying interim condensed consolidated financial statements are unaudited and reflect all adjustments (including normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in conformity with GAAP. Interim results are not necessarily indicative of full year performance. The December 31, 2015 consolidated balance sheet data was derived from audited consolidated financial statements included in MetLife, Inc.’s Annual Report on Form 10‑K for the year ended December 31, 2015 (the “2015 Annual Report”), which include all disclosures required by GAAP. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company included in the 2015 Annual Report.

Adoption of New Accounting Pronouncement

Effective January 1, 2016, the Company retrospectively adopted new guidance relating to the consolidation of certain entities. The objective of the new standard is to improve targeted areas of the consolidation guidance and to reduce the number of consolidation models. The new consolidation standard provides guidance on how a reporting entity (i) evaluates whether the entity should consolidate limited partnerships and similar entities, (ii) assesses whether the fees paid to a decisionmaker or service provider are variable interests in a VIE, and (iii) assesses the variable interests in a VIE held by related parties of the reporting entity. The new guidance also eliminates the VIE consolidation model based on majority exposure to variability that applied to certain investment companies and similar entities. The adoption of the new guidance did not impact which entities are consolidated by the Company. The consolidated VIE assets and liabilities and unconsolidated VIE carrying amounts and maximum exposure to loss as of September 30, 2016, disclosed in Note 7, reflect the application of the new guidance.

Future Adoption of New Accounting Pronouncements

In October 2016, the Financial Accounting Standards Board (“FASB”) issued new guidance on consolidation evaluation for entities under common control (Accounting Standards Update (“ASU”) 2016-17,Consolidation (Topic 810): Interests Held through Related Parties That Are under Common Control). The new guidance is effective for fiscal years beginning after December 15, 2016 and interim periods within those fiscal years, and should be applied on a retrospective basis. Early adoption is permitted. The new guidance does not change the characteristics of a primary beneficiary under current GAAP. It changes how a reporting entity evaluates whether it is the primary beneficiary of a VIE by changing how a reporting entity that is a single decisionmaker of a VIE handles indirect interests in the entity held through related parties that are under common control with the reporting entity. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In October 2016, the FASB issued new guidance on tax accounting for intra-entity transfers of assets (ASU 2016-16,Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory). The new guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, and should be applied on a modified retrospective basis. Early adoption is permitted in the first interim or annual reporting period. Current guidance prohibits the recognition of current and deferred income taxes for an intra-entity asset transfer until the asset has been sold to an outside party. The new guidance requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. Also, the guidance eliminates the exception for an intra-entity transfer of an asset other than inventory. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In August 2016, the FASB issued new guidance on cash flow statement presentation (ASU 2016-15,Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments). The new guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, and should be applied retrospectively to all periods presented. Early adoption is permitted in any interim or annual period. This ASU addresses diversity in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In June 2016, the FASB issued new guidance on measurement of credit losses on financial instruments (ASU 2016-13,Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments). The new guidance is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. This ASU replaces the incurred loss impairment methodology with one that reflects expected credit losses. The measurement of expected credit losses should be based on historical loss information, current conditions, and reasonable and supportable forecasts. The guidance also requires enhanced disclosures. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In March 2016, the FASB issued new guidance on stock compensation (ASU 2016-09,Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-based Payment Accounting. The new guidance is effective for the fiscal years beginning after December 15, 2016, including interim periods within those fiscal years, and requires either a modified retrospective, a retrospective or a prospective transition approach depending upon the type of change. Early adoption is permitted in any interim or annual period. The new guidance changes several aspects of the accounting for share-based payment award transactions, including: (i) income tax consequences when awards vest or are settled; (ii) classification of awards as either equity or liabilities due to statutory tax withholding requirements; and (iii) classification on the statement of cash flows. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In February 2016, the FASB issued new guidance on leasing transactions (ASU 2016-02,Leases - Topic 842). The new guidance is effective for the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and requires a modified retrospective transition approach which includes a number of optional practical expedients. Early adoption is permitted. The new guidance requires a lessee to recognize assets and liabilities for leases with lease terms of more than 12 months. Consistent with current guidance, leases would be classified as finance or operating leases. However, unlike current guidance, the new guidance will require both types of leases to be recognized on the balance sheet. Lessor accounting will remain largely unchanged from current guidance except for certain targeted changes. The new guidance will also require new qualitative and quantitative disclosures. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In January 2016, the FASB issued new guidance (ASU 2016-01,Financial Instruments-Overall: Recognition and Measurement of Financial Assets and Financial Liabilities)on the recognition and measurement of financial instruments. The new guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted for the instrument-specific credit risk provision. The new guidance changes the current accounting guidance related to (i) the classification and measurement of certain equity investments, (ii) the presentation of changes in the fair value of financial liabilities measured under the fair value option (“FVO”) that are due to instrument-specific credit risk, and (iii) certain disclosures associated with the fair value of financial instruments. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

In May 2015, the FASB issued new guidance on short-duration insurance contracts (ASU 2015-09,Financial Services - Insurance (Topic 944): Disclosures about Short-Duration Contracts). The amendments in this new guidance are effective for annual periods beginning after December 15, 2015, and interim periods within annual periods beginning after December 15, 2016. The new guidance should be applied retrospectively by providing comparative disclosures for each period presented, except for those requirements that apply only to the current period. The new guidance requires insurance entities to provide users of financial statements with more transparent information about initial claim estimates and subsequent adjustments to these estimates, including information on: (i) reconciling from the claim development table to the balance sheet liability, (ii) methodologies and judgments in estimating claims, and (iii) the timing, and frequency of claims. The adoption will not have an impact on the Company’s consolidated financial statements other than expanded disclosures inNote 4.

In May 2014, the FASB issued a comprehensive new revenue recognition standard (ASU 2014-09,Revenue from Contracts with Customers (Topic 606)), effective for fiscal years beginning after December 15, 2016 and interim periods within those years and should be applied retrospectively. In August 2015, the FASB amended the guidance to defer the effective date by one year, effective for the fiscal years beginning after December 15, 2017, including interim periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. The new guidance will supersede nearly all existing revenue recognition guidance under GAAP; however, it will not impact the accounting for insurance contracts, leases, financial instruments and guarantees. For those contracts that are impacted by the new guidance, the guidance will require an entity to recognize revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled, in exchange for those goods or services. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

XML

Segment Information

9 Months Ended

Sep. 30, 2016

Segment Reporting [Abstract]

Segment Information

2. Segment Information

In anticipation of the Separation, in the third quarter of 2016, MetLife reorganized its businesses intosixsegments: U.S.; Asia; Latin America; EMEA; MetLife Holdings; and Brighthouse Financial. In addition, the Company reports certain of its results of operations in Corporate & Other. These changes were applied retrospectively and did not have an impact on total consolidated net income (loss) or operating earnings in the prior periods.

On January 12, 2016, MetLife, Inc. announced its plan to pursue the Separation. Additionally, on July 21, 2016, MetLife, Inc. announced that following the Separation, the separated business will be rebranded as “Brighthouse Financial.” On October 5, 2016, Brighthouse Financial, Inc., a subsidiary of MetLife, Inc. (“Brighthouse”), filed a registration statement on Form 10 (the “Form 10”) with the U.S. Securities and Exchange Commission (“SEC”). The information statement filed as an exhibit to the Form 10, disclosed that the Company intends to include MetLife Insurance Company USA (“MetLife USA”), New England Life Insurance Company (“NELICO”), First MetLife Investors Insurance Company (“FMLI”), MetLife Advisers, LLC and certain captive reinsurance companies in the proposed separated business and distribute at least 80.1% of the shares of Brighthouse’s common stock on apro ratabasis to the holders of MetLife, Inc. common stock.

The ultimate form and timing of the Separation will be influenced by a number of factors, including regulatory considerations and economic conditions. MetLife continues to evaluate and pursue structural alternatives for the proposed Separation. The Separation remains subject to certain conditions, including among others, obtaining final approval from the MetLife, Inc. Board of Directors, receipt of a favorable ruling from the Internal Revenue Service and an opinion from MetLife’s tax advisor regarding certain U.S. federal income tax matters, and an SEC declaration of the effectiveness of the Form 10.

This re-segmentation resulted in a $296 million, net of income tax, charge to earnings in the current period, all in the Brighthouse Financial segment, driven by the segment’s variable and universal life products. This charge is the direct result of the Company, beginning in the third quarter, no longer being able to aggregate, for loss recognition testing, the variable and universal life products of Brighthouse Financial with the variable and universal life products remaining with MetLife Holdings. Of this amount, the Company recorded $254 million, net of income tax, as a one-time charge, which was mostly recognized as a write-off of deferred policy acquisition costs (“DAC”), with the remaining $42 million, net of income tax, recognized as an increase in insurance-related liabilities.

U.S.

The U.S. segment offers a broad range of protection products and services aimed at serving the financial needs of customers throughout their lives. These products are sold to corporations and their respective employees, other institutions and their respective members, as well as individuals. The U.S. segment is organized into three businesses: Group Benefits, Retirement & Income Solutions and Property & Casualty.

• The Group Benefits business offers insurance products and services which include life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, critical illness, vision and accident & health coverages, as well as prepaid legal plans. This business also sells administrative services-only arrangements to some employers.

• The Retirement & Income Solutions business offers a broad range of annuity and investment products, including guaranteed interest contracts and other stable value products, income annuities and separate account contracts for the investment management of defined benefit and defined contribution plan assets. This business also includes structured settlements and certain products to fund postretirement benefits and company-, bank- or trust-owned life insurance used to finance nonqualified benefit programs for executives.

• The Property & Casualty business offers personal and commercial lines property and casualty insurance, including private passenger automobile, homeowners’ and personal excess liability insurance. In addition, Property & Casualty offers small business owners property, liability and business interruption insurance.

Asia

The Asia segment offers a broad range of products to both individuals and corporations, as well as other institutions and their respective employees, which include whole life, term life, variable life, universal life, accident & health insurance, fixed and variable annuities, credit insurance and endowment products.

Latin America

The Latin America segment offers a broad range of products to both individuals and corporations, as well as other institutions and their respective employees, which include life insurance, accident & health insurance, group medical, dental, credit insurance, endowment and retirement & savings products.

EMEA

The EMEA segment offers a broad range of products to both individuals and corporations, as well as other institutions and their respective employees, which include life insurance, accident & health insurance, credit insurance, annuities, endowment and retirement & savings products.

MetLife Holdings

The MetLife Holdings segment consists of operations relating to products and businesses no longer actively marketed by the Company in the U.S. These products and businesses include variable life, universal life, term life, whole life, variable annuities, fixed annuities and index-linked annuities. The MetLife Holdings segment also includes the Company’s discontinued long-term care businesses and the assumed reinsurance of certain variable annuity products from the Company’s former operating joint venture in Japan.

Brighthouse Financial

The Brighthouse Financial segment offers a broad range of products and services which include variable annuities, fixed annuities, index-linked annuities, income annuities, term life, whole life, universal life and variable life, as well as certain run-off businesses. These products and services, which exclude the run-off businesses, are actively marketed through various third party retail distribution channels in the U.S.

Corporate & Other

Corporate & Other contains the excess capital, as well as certain charges and activities, not allocated to the segments, including external integration costs, internal resource costs for associates committed to acquisitions, enterprise-wide strategic initiative restructuring charges and various start-up businesses (including expatriate benefits insurance and the investment management business through which the Company offers fee-based investment management services to institutional clients, as well as the direct to consumer portion of the U.S. Direct business). Additionally, Corporate & Other includes interest expense related to the majority of the Company’s outstanding debt and expenses associated with certain legal proceedings and income tax audit issues. Corporate & Other also includes the elimination of intersegment amounts, which generally relate to affiliated reinsurance and intersegment loans, which bear interest rates commensurate with related borrowings.

Financial Measures and Segment Accounting Policies

Operating earnings is used by management to evaluate performance and allocate resources. Consistent with GAAP guidance for segment reporting, operating earnings is also the Company’s GAAP measure of segment performance and is reported below. Operating earnings should not be viewed as a substitute for net income (loss). The Company believes the presentation of operating earnings as the Company measures it for management purposes enhances the understanding of its performance by highlighting the results of operations and the underlying profitability drivers of the business. Operating earnings allows analysis of the Company’s performance relative to the Company’s business plan and facilitates comparisons to industry results.

Operating earnings is defined as operating revenues less operating expenses, both net of income tax.

The financial measures of operating revenues and operating expenses focus on the Company’s primary businesses principally by excluding the impact of market volatility, which could distort trends, and revenues and costs related to non-core products and divested businesses and certain entities required to be consolidated under GAAP. Also, these measures exclude results of discontinued operations and other businesses that have been or will be sold or exited by MetLife and are referred to as divested businesses. In addition, for the three months ended March 31, 2016 and the nine months ended September 30, 2016, operating revenues and operating expenses exclude the financial impact of converting the Company’s Japan operations to calendar year-end reporting without retrospective application of this change to prior periods and is referred to as lag elimination. Operating revenues also excludes net investment gains (losses) and net derivative gains (losses). Operating expenses also excludes goodwill impairments.

The following additional adjustments are made to revenues, in the line items indicated, in calculating operating revenues:

• Universal life and investment-type product policy fees excludes the amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses) and certain variable annuity guaranteed minimum income benefits (“GMIBs”) fees (“GMIB Fees”);

• Net investment income: (i) includes investment hedge adjustments which represent earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment, (ii) excludes post-tax operating earnings adjustments relating to insurance joint ventures accounted for under the equity method, (iii) excludes certain amounts related to contractholder-directed unit-linked investments and (iv) excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP; and

• Other revenues are adjusted for settlements of foreign currency earnings hedges.

The following additional adjustments are made to expenses, in the line items indicated, in calculating operating expenses:

• Policyholder benefits and claims and policyholder dividends excludes: (i) changes in the policyholder dividend obligation related to net investment gains (losses) and net derivative gains (losses), (ii) inflation-indexed benefit adjustments associated with contracts backed by inflation-indexed investments and amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and other pass through adjustments, (iii) benefits and hedging costs related to GMIBs (“GMIB Costs”) and (iv) market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”);

• Interest credited to policyholder account balances includes adjustments for earned income on derivatives and amortization of premium on derivatives that are hedges of policyholder account balances but do not qualify for hedge accounting treatment and excludes amounts related to net investment income earned on contractholder-directed unit-linked investments;

• Amortization of DAC and value of business acquired (“VOBA”) excludes amounts related to: (i) net investment gains (losses) and net derivative gains (losses), (ii) GMIB Fees and GMIB Costs and (iii) Market Value Adjustments;

• Amortization of negative VOBA excludes amounts related to Market Value Adjustments;

• Interest expense on debt excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP; and

• Other expenses excludes costs related to: (i) noncontrolling interests, (ii) implementation of new insurance regulatory requirements, and (iii) acquisition, integration and other costs.

Operating earnings also excludes the recognition of certain contingent assets and liabilities that could not be recognized at acquisition or adjusted for during the measurement period under GAAP business combination accounting guidance.

The tax impact of the adjustments mentioned above are calculated net of the U.S. or foreign statutory tax rate, which could differ from the Company’s effective tax rate. Additionally, the provision for income tax (expense) benefit also includes the impact related to the timing of certain tax credits, as well as certain tax reforms

Set forth in the tables below is certain financial information with respect to the Company’s segments, as well as Corporate & Other, for thethree monthsandnine months endedSeptember 30, 2016 and 2015. The segment accounting policies are the same as those used to prepare the Company’s consolidated financial statements, except for operating earnings adjustments as defined above. In addition, segment accounting policies include the method of capital allocation described below, with the exception of the Brighthouse Financial segment,for which equity is reflective of the historical equity of the legal entities which comprise Brighthouse and related companies, which will be eliminated upon Separation. The Brighthouse Financial segment equity is not indicative of Brighthouse and related companies’ equity on a combined standalone basis.

Economic capital is an internally developed risk capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. The economic capital model accounts for the unique and specific nature of the risks inherent in the Company’s business.

The Company’s economic capital model, coupled with considerations of local capital requirements, aligns segment allocated equity with emerging standards and consistent risk principles. The model applies statistics-based risk evaluation principles to the material risks to which the Company is exposed. These consistent risk principles include calibrating required economic capital shock factors to a specific confidence level and time horizon while applying an industry standard method for the inclusion of diversification benefits among risk types.The Company’s management is responsible for the ongoing production and enhancement of the economic capital model and reviews its approach periodically to ensure that it remains consistent with emerging industry practice standards.

Segment net investment income, with the exception of the Brighthouse Financial segment, is credited or charged based on the level of allocated equity; however, changes in allocated equity do not impact the Company’s consolidated net investment income, net income (loss) or operating earnings. As noted above, the Brighthouse Financial segment’s net investment income represents that of the legal entities which comprise Brighthouse and related companies on a historical basis, however, may not be indicative of that on a combined standalone basis.

Net investment income is based upon the actual results of each segment’s specifically identifiable investment portfolios adjusted for allocated equity. Other costs are allocated to each of the segments based upon: (i) a review of the nature of such costs; (ii) time studies analyzing the amount of employee compensation costs incurred by each segment; and (iii) cost estimates included in the Company’s product pricing.

	Operating Results
Three Months Ended September 30, 2016	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate & Other			Total			Adjustments			Total Consolidated
	(In millions)
Revenues
Premiums	$	5,936		$	1,822		$	653		$	500		$	1,093		$	347		$	40		$	10,391		$	—		$	10,391
Universal life and investment-type product policy fees	245			394			227			104			357			903			(31		)	2,199			97			2,296
Net investment income	1,590			707			311			81			1,537			941			(7		)	5,160			304			5,464
Other revenues	192			12			11			17			105			50			(28		)	359			7			366
Net investment gains (losses)	—			—			—			—			—			—			—			—			257			257
Net derivative gains (losses)	—			—			—			—			—			—			—			—			(1,051		)	(1,051		)
Total revenues	7,963			2,935			1,202			702			3,092			2,241			(26		)	18,109			(386		)	17,723
Expenses
Policyholder benefits and claims and policyholder dividends	5,894			1,363			681			257			1,853			814			10			10,872			295			11,167
Interest credited to policyholder account balances	322			331			85			28			261			288			—			1,315			505			1,820
Goodwill impairment	—			—			—			—			—			—			—			—			260			260
Capitalization of DAC	(124		)	(440		)	(83		)	(103		)	(44		)	(70		)	1			(863		)	—			(863		)
Amortization of DAC and VOBA	117			331			(2		)	106			219			509			2			1,282			(265		)	1,017
Amortization of negative VOBA	—			(46		)	(1		)	(3		)	—			—			—			(50		)	(5		)	(55		)
Interest expense on debt	2			—			1			—			15			32			241			291			1			292
Other expenses	912			930			335			332			401			560			(3		)	3,467			70			3,537
Total expenses	7,123			2,469			1,016			617			2,705			2,133			251			16,314			861			17,175
Provision for income tax expense (benefit)	288			142			53			11			121			40			(287		)	368			(393		)	(25		)
Operating earnings	$	552		$	324		$	133		$	74		$	266		$	68		$	10		1,427
Adjustments to:
Total revenues																						(386		)
Total expenses																						(861		)
Provision for income tax (expense) benefit																						393
Net income (loss)																						$	573					$	573

	Operating Results
Three Months Ended September 30, 2015	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate & Other			Total			Adjustments			Total Consolidated
	(In millions)
Revenues
Premiums	$	6,023		$	1,736		$	586		$	501		$	1,115		$	468		$	(53	)	$	10,376		$	(1	)	$	10,375
Universal life and investment-type product policy fees	233			382			261			106			370			921			(26		)	2,247			99			2,346
Net investment income	1,522			670			277			82			1,521			862			(85		)	4,849			(890		)	3,959
Other revenues	184			26			10			11			223			99			(58		)	495			(11		)	484
Net investment gains (losses)	—			—			—			—			—			—			—			—			382			382
Net derivative gains (losses)	—			—			—			—			—			—			—			—			485			485
Total revenues	7,962			2,814			1,134			700			3,229			2,350			(222		)	17,967			64			18,031
Expenses
Policyholder benefits and claims and policyholder dividends	5,976			1,331			581			233			1,885			846			(72		)	10,780			(92		)	10,688
Interest credited to policyholder account balances	304			327			88			27			266			313			6			1,331			(684		)	647
Goodwill impairment	—			—			—			—			—			—			—			—			—			—
Capitalization of DAC	(128		)	(435		)	(81		)	(107		)	(101		)	(102		)	(1		)	(955		)	—			(955		)
Amortization of DAC and VOBA	118			309			48			127			173			197			(1		)	971			160			1,131
Amortization of negative VOBA	—			(77		)	—			(5		)	—			—			—			(82		)	(8		)	(90		)
Interest expense on debt	1			—			—			—			13			32			248			294			8			302
Other expenses	908			896			348			352			647			614			361			4,126			19			4,145
Total expenses	7,179			2,351			984			627			2,883			1,900			541			16,465			(597		)	15,868
Provision for income tax expense (benefit)	272			125			(33		)	7			103			103			214			791			174			965
Operating earnings	$	511		$	338		$	183		$	66		$	243		$	347		$	(977	)	711
Adjustments to:
Total revenues																						64
Total expenses																						597
Provision for income tax (expense) benefit																						(174		)
Net income (loss)																						$	1,198					$	1,198

	Operating Results
Nine Months Ended September 30, 2016	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate & Other			Total			Adjustments			Total Consolidated
	(In millions)
Revenues
Premiums	$	16,127		$	5,161		$	1,885		$	1,519		$	3,312		$	1,020		$	51		$	29,075		$	426		$	29,501
Universal life and investment-type product policy fees	743			1,114			764			294			1,073			2,622			(87		)	6,523			403			6,926
Net investment income	4,615			2,003			809			244			4,489			2,624			(37		)	14,747			163			14,910
Other revenues	589			45			26			56			512			482			(380		)	1,330			10			1,340
Net investment gains (losses)	—			—			—			—			—			—			—			—			538			538
Net derivative gains (losses)	—			—			—			—			—			—			—			—			(1,815		)	(1,815		)
Total revenues	22,074			8,323			3,484			2,113			9,386			6,748			(453		)	51,675			(275		)	51,400
Expenses
Policyholder benefits and claims and policyholder dividends	16,210			3,923			1,814			801			5,603			2,525			(26		)	30,850			908			31,758
Interest credited to policyholder account balances	967			974			249			87			780			868			5			3,930			716			4,646
Goodwill impairment	—			—			—			—			—			—			—			—			260			260
Capitalization of DAC	(356		)	(1,251		)	(236		)	(310		)	(240		)	(255		)	(6		)	(2,654		)	(105		)	(2,759		)
Amortization of DAC and VOBA	353			921			127			311			636			823			7			3,178			(1,045		)	2,133
Amortization of negative VOBA	—			(167		)	(1		)	(10		)	—			—			—			(178		)	(43		)	(221		)
Interest expense on debt	7			—			1			—			43			96			759			906			4			910
Other expenses	2,772			2,658			968			1,001			1,861			1,739			(163		)	10,836			467			11,303
Total expenses	19,953			7,058			2,922			1,880			8,683			5,796			576			46,868			1,162			48,030
Provision for income tax expense (benefit)	720			377			141			32			203			260			(658		)	1,075			(595		)	480
Operating earnings	$	1,401		$	888		$	421		$	201		$	500		$	692		$	(371	)	3,732
Adjustments to:
Total revenues																						(275		)
Total expenses																						(1,162		)
Provision for income tax (expense) benefit																						595
Net income (loss)																						$	2,890					$	2,890

	Operating Results
Nine Months Ended September 30, 2015	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate & Other			Total			Adjustments			Total Consolidated
	(In millions)
Revenues
Premiums	$	15,712		$	5,297		$	1,925		$	1,534		$	3,345		$	1,159		$	(30	)	$	28,942		$	(2	)	$	28,940
Universal life and investment-type product policy fees	700			1,179			856			322			1,117			2,789			(87		)	6,876			298			7,174
Net investment income	4,723			2,033			774			249			4,690			2,536			11			15,016			(649		)	14,367
Other revenues	567			82			27			40			711			310			(212		)	1,525			(28		)	1,497
Net investment gains (losses)	—			—			—			—			—			—			—			—			535			535
Net derivative gains (losses)	—			—			—			—			—			—			—			—			394			394
Total revenues	21,702			8,591			3,582			2,145			9,863			6,794			(318		)	52,359			548			52,907
Expenses
Policyholder benefits and claims and policyholder dividends	15,675			4,046			1,793			737			5,479			2,103			(103		)	29,730			237			29,967
Interest credited to policyholder account balances	905			992			263			91			793			940			20			4,004			(64		)	3,940
Goodwill impairment	—			—			—			—			—			—			—			—			—			—
Capitalization of DAC	(365		)	(1,268		)	(246		)	(372		)	(292		)	(305		)	(2		)	(2,850		)	—			(2,850		)
Amortization of DAC and VOBA	352			971			195			388			423			595			1			2,925			128			3,053
Amortization of negative VOBA	—			(241		)	(1		)	(13		)	—			—			—			(255		)	(27		)	(282		)
Interest expense on debt	4			—			—			—			41			96			757			898			10			908
Other expenses	2,740			2,669			1,070			1,103			1,988			1,830			408			11,808			28			11,836
Total expenses	19,311			7,169			3,074			1,934			8,432			5,259			1,081			46,260			312			46,572
Provision for income tax expense (benefit)	819			332			40			25			454			410			(156		)	1,924			(69		)	1,855
Operating earnings	$	1,572		$	1,090		$	468		$	186		$	977		$	1,125		$	(1,243	)	4,175
Adjustments to:
Total revenues																						548
Total expenses																						(312		)
Provision for income tax (expense) benefit																						69
Net income (loss)																						$	4,480					$	4,480

The following table presents total assets with respect to the Company’s segments, as well as Corporate & Other, at:

	September 30, 2016		December 31, 2015
	(In millions)
U.S.	$	257,943	$	237,858
Asia	133,881		113,895
Latin America	70,421		64,808
EMEA	27,764		26,767
MetLife Holdings	195,267		187,677
Brighthouse Financial	240,696		226,792
Corporate & Other	26,932		20,136
Total	$	952,904	$	877,933

XML

Disposition

9 Months Ended

Sep. 30, 2016

Business Combinations [Abstract]

Acquisitions and Dispositions

3. Disposition

In July 2016, MetLife, Inc. completed the sale to Massachusetts Mutual Life Insurance Company (“MassMutual”) of its U.S. retail advisor force and certain assets associated with the MetLife Premier Client Group, including all of the issued and outstanding shares of MetLife’s affiliated broker-dealer, MetLife Securities, Inc. (“MSI”), a wholly-owned subsidiary of MetLife, Inc. (collectively, the “U.S. Retail Advisor Force Divestiture”) for $291 million. MassMutual assumed all of the liabilities related to such assets that arise or occur after the closing of the sale. The Company recorded a gain of $103 million ($58 million, net of income tax), in net investment gains (losses) for the three months and nine months ended September 30, 2016. See Notes 9 and 13 for discussion of certain charges related to the sale.

XML

Insurance

9 Months Ended

Sep. 30, 2016

Insurance [Abstract]

Insurance

4. Insurance

Insurance Liabilities

Insurance liabilities are comprised of future policy benefits, policyholder account balances and other policy-related balances. Information regarding insurance liabilities by segment, as well as Corporate & Other, was as follows at:

	September 30, 2016			December 31, 2015
	(In millions)
U.S.	$	129,448		$	123,060
Asia	96,648			83,510
Latin America	15,228			14,022
EMEA	19,206			19,009
MetLife Holdings	105,995			102,853
Brighthouse Financial	79,241			71,853
Corporate & Other	(6,156		)	(5,451		)
Total	$	439,610		$	408,856

Guarantees

As discussed in Notes 1 and 4 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report, the Company issues directly and assumes through reinsurance variable annuity products with guaranteed minimum benefits. Guaranteed minimum accumulation benefits (“GMABs”) and the portions of both non-life-contingent guaranteed minimum withdrawal benefits (“GMWBs”) and the GMIBs that do not require annuitization are accounted for as embedded derivatives in policyholder account balances and are further discussed in Note 8.

The Company also issues other annuity contracts that apply a lower rate on funds deposited if the contractholder elects to surrender the contract for cash and a higher rate if the contractholder elects to annuitize. These guarantees include benefits that are payable in the event of death, maturity or at annuitization. Certain other annuity contracts contain guaranteed annuitization benefits that may be above what would be provided by the current account value of the contract. Additionally, the Company issues universal and variable life contracts where the Company contractually guarantees to the contractholder a secondary guarantee or a guaranteed paid-up benefit.

Information regarding the Company’s guarantee exposure, which includes direct and assumed business, but excludes offsets from hedging or ceded reinsurance, if any, was as follows at:

	September 30, 2016								December 31, 2015
	In the Event of Death				At Annuitization				In the Event of Death				At Annuitization
	(Dollars in millions)
Annuity Contracts (1):
Variable Annuity Guarantees:
Total account value (2), (3)	$	183,010			$	92,187			$	181,413			$	91,240
Separate account value	$	153,486			$	88,546			$	151,901			$	87,841
Net amount at risk (2)	$	8,157	(4	)	$	4,663	(5	)	$	10,339	(4	)	$	2,762	(5	)
Average attained age of contractholders	66 years				66 years				66 years				66 years
Other Annuity Guarantees:
Total account value (3)	N/A				$	1,600			N/A				$	1,560
Net amount at risk	N/A				$	576	(6	)	N/A				$	422	(6	)
Average attained age of contractholders	N/A				50 years				N/A				51 years

	September 30, 2016				December 31, 2015
	Secondary Guarantees		Paid-Up Guarantees		Secondary Guarantees		Paid-Up Guarantees
	(Dollars in millions)
Universal and Variable Life Contracts (1):
Total account value (3)	$	17,640	$	3,365	$	17,211	$	3,461
Net amount at risk (7)	$	176,066	$	18,068	$	175,958	$	19,047
Average attained age of policyholders	57 years		62 years		57 years		62 years

__________________

(1) The Company’s annuity and life contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive.

(2) Includes amounts, which are not reported on the consolidated balance sheets, from assumed reinsurance of certain variable annuity products from the Company’s former operating joint venture in Japan.

(3) Includes the contractholder’s investments in the general account and separate account, if applicable.

(4) Defined as the death benefit less the total account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death.

(5) Defined as the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company’s potential economic exposure to such guarantees in the event all contractholders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contractholders have achieved.

(6) Defined as either the excess of the upper tier, adjusted for a profit margin, less the lower tier, as of the balance sheet date or the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. These amounts represent the Company’s potential economic exposure to such guarantees in the event all contractholders were to annuitize on the balance sheet date.

(7) Defined as the guarantee amount less the account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date.

XML

Deferred Policy Acquisition Costs and Value of Business Acquired

9 Months Ended

Sep. 30, 2016

Deferred Policy Acquisition Costs and Value of Business Acquired [Abstract]

Deferred Policy Acquisition Costs, Value of Business Acquired and Other Policy-Related Intangibles

5. Deferred Policy Acquisition Costs and Value of Business Acquired

Information regarding total DAC and VOBA by segment, as well as Corporate & Other, was as follows at:

	September 30, 2016		December 31, 2015
	(In millions)
U.S.	$	618	$	615
Asia	9,148		8,374
Latin America	1,846		1,753
EMEA	1,554		1,532
MetLife Holdings	4,962		5,436
Brighthouse Financial	6,589		6,390
Corporate & Other	31		30
Total	$	24,748	$	24,130

XML

Closed Block

9 Months Ended

Sep. 30, 2016

Closed Block Disclosure [Abstract]

Closed Block

6. Closed Block

On April 7, 2000 (the “Demutualization Date”), Metropolitan Life Insurance Company (“MLIC”) converted from a mutual life insurance company to a stock life insurance company and became a wholly-owned subsidiary of MetLife, Inc. The conversion was pursuant to an order by the New York Superintendent of Insurance approving MLIC’s plan of reorganization, as amended (the “Plan of Reorganization”). On the Demutualization Date, MLIC established a closed block for the benefit of holders of certain individual life insurance policies of MLIC.

Experience within the closed block, in particular mortality and investment yields, as well as realized and unrealized gains and losses, directly impact the policyholder dividend obligation. Amortization of the closed block DAC, which resides outside of the closed block, is based upon cumulative actual and expected earnings within the closed block. Accordingly, the Company’s net income continues to be sensitive to the actual performance of the closed block.

Closed block assets, liabilities, revenues and expenses are combined on a line-by-line basis with the assets, liabilities, revenues and expenses outside the closed block based on the nature of the particular item.

Information regarding the closed block liabilities and assets designated to the closed block was as follows at:

	September 30, 2016			December 31, 2015
	(In millions)
Closed Block Liabilities
Future policy benefits	$	40,840		$	41,278
Other policy-related balances	256			249
Policyholder dividends payable	506			468
Policyholder dividend obligation	3,352			1,783
Current income tax payable	8			—
Other liabilities	601			380
Total closed block liabilities	45,563			44,158
Assets Designated to the Closed Block
Investments:
Fixed maturity securities available-for-sale, at estimated fair value	29,194			27,556
Equity securities available-for-sale, at estimated fair value	107			111
Mortgage loans	5,739			6,022
Policy loans	4,553			4,642
Real estate and real estate joint ventures	672			462
Other invested assets	1,233			1,066
Total investments	41,498			39,859
Cash and cash equivalents	72			236
Accrued investment income	482			474
Premiums, reinsurance and other receivables	65			56
Current income tax recoverable	—			11
Deferred income tax assets	195			234
Total assets designated to the closed block	42,312			40,870
Excess of closed block liabilities over assets designated to the closed block	3,251			3,288
Amounts included in accumulated other comprehensive income (loss) (“AOCI”)
Unrealized investment gains (losses), net of income tax	2,452			1,382
Unrealized gains (losses) on derivatives, net of income tax	88			76
Allocated to policyholder dividend obligation, net of income tax	(2,179		)	(1,159		)
Total amounts included in AOCI	361			299
Maximum future earnings to be recognized from closed block assets and liabilities	$	3,612		$	3,587

Information regarding the closed block policyholder dividend obligation was as follows:

	Nine Months   Ended   September 30, 2016		Year   Ended   December 31, 2015
	(In millions)
Balance, beginning of period	$	1,783	$	3,155
Change in unrealized investment and derivative gains (losses)	1,569		(1,372		)
Balance, end of period	$	3,352	$	1,783

Information regarding the closed block revenues and expenses was as follows:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Revenues
Premiums	$	436		$	447		$	1,297		$	1,334
Net investment income	486			487			1,435			1,500
Net investment gains (losses)	(3		)	(9		)	(19		)	(8		)
Net derivative gains (losses)	4			13			(3		)	25
Total revenues	923			938			2,710			2,851
Expenses
Policyholder benefits and claims	619			635			1,861			1,886
Policyholder dividends	232			273			723			757
Other expenses	33			36			100			109
Total expenses	884			944			2,684			2,752
Revenues, net of expenses before provision for income tax expense (benefit)	39			(6		)	26			99
Provision for income tax expense (benefit)	13			(1		)	8			36
Revenues, net of expenses and provision for income tax expense (benefit)	$	26		$	(5	)	$	18		$	63

MLIC charges the closed block with federal income taxes, state and local premium taxes and other state or local taxes, as well as investment management expenses relating to the closed block as provided in the Plan of Reorganization. MLIC also charges the closed block for expenses of maintaining the policies included in the closed block.

XML

Investments

9 Months Ended

Sep. 30, 2016

Investments, Debt and Equity Securities [Abstract]

Investments

7. Investments

Fixed Maturity and Equity Securities Available-for-Sale

Fixed Maturity and Equity Securities Available-for-Sale by Sector

The following table presents the fixed maturity and equity securities available-for-sale (“AFS”) by sector. Redeemable preferred stock is reported within U.S. corporate and foreign corporate fixed maturity securities and non-redeemable preferred stock is reported within equity securities. Included within fixed maturity securities are structured securities including residential mortgage-backed securities (“RMBS”), asset-backed securities (“ABS”) and commercial mortgage-backed securities (“CMBS”) (collectively, “Structured Securities”).

	September 30, 2016											December 31, 2015
	Cost or Amortized Cost		Gross Unrealized							Estimated Fair Value		Cost or Amortized Cost		Gross Unrealized							Estimated Fair Value
			Gains		Temporary Losses		OTTI Losses							Gains		Temporary Losses		OTTI Losses
	(In millions)
Fixed maturity securities:
U.S. corporate	$	95,808	$	10,589	$	721	$	—		$	105,676	$	96,466	$	6,583	$	2,255	$	—		$	100,794
U.S. government and agency	60,340		9,491		46		—			69,785		56,499		5,373		226		—			61,646
Foreign corporate	57,423		4,264		1,268		—			60,419		56,003		3,019		1,822		2			57,198
Foreign government	54,425		9,479		139		—			63,765		45,451		5,269		221		—			50,499
RMBS	43,838		1,788		310		7			45,309		37,914		1,366		424		59			38,797
State and political subdivision	14,539		2,939		11		4			17,463		13,723		1,795		67		10			15,441
ABS	15,685		122		220		3			15,584		14,498		131		229		6			14,394
CMBS (1)	11,855		662		77		(1		)	12,441		12,410		347		125		(1		)	12,633
Total fixed maturity securities	$	353,913	$	39,334	$	2,792	$	13		$	390,442	$	332,964	$	23,883	$	5,369	$	76		$	351,402
Equity securities:
Common stock	$	2,000	$	449	$	14	$	—		$	2,435	$	1,962	$	397	$	107	$	—		$	2,252
Non-redeemable preferred stock	838		63		47		—			854		1,035		85		51		—			1,069
Total equity securities	$	2,838	$	512	$	61	$	—		$	3,289	$	2,997	$	482	$	158	$	—		$	3,321

__________________

(1) The noncredit loss component of other-than-temporary impairment (“OTTI”) losses for CMBS was in an unrealized gain position of $1 million at both September 30, 2016 and December 31, 2015 due to increases in estimated fair value subsequent to initial recognition of noncredit losses on such securities. See also “— Net Unrealized Investment Gains (Losses).”

The Company held non-income producing fixed maturity securities with an estimated fair value of $44 million and $54 million with unrealized gains (losses) of ($5) million and $12 million at September 30, 2016 and December 31, 2015, respectively.

Maturities of Fixed Maturity Securities

The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at September 30, 2016:

	Due in One Year or Less		Due After One Year Through Five Years		Due After Five Years Through Ten Years		Due After Ten Years		Structured Securities		Total Fixed Maturity Securities
	(In millions)
Amortized cost	$	15,378	$	77,046	$	72,056	$	118,055	$	71,378	$	353,913
Estimated fair value	$	15,464	$	81,187	$	76,987	$	143,470	$	73,334	$	390,442

Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. Structured Securities are shown separately, as they are not due at a single maturity.

Continuous Gross Unrealized Losses for Fixed Maturity and Equity Securities AFS by Sector

The following table presents the estimated fair value and gross unrealized losses of fixed maturity and equity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position at:

	September 30, 2016								December 31, 2015
	Less than 12 Months				Equal to or Greater than 12 Months				Less than 12 Months				Equal to or Greater than 12 Months
	Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses
	(Dollars in millions)
Fixed maturity securities:
U.S. corporate	$	5,559	$	274	$	4,612	$	447	$	27,526	$	1,629	$	3,762	$	626
U.S. government and agency	6,305		24		164		22		19,628		222		298		4
Foreign corporate	6,781		404		6,112		864		14,447		911		5,251		913
Foreign government	2,136		75		851		64		3,530		166		429		55
RMBS	5,692		127		3,259		190		13,467		287		2,431		196
State and political subdivision	321		5		79		10		1,618		55		168		22
ABS	2,084		105		3,476		118		7,329		124		2,823		111
CMBS	701		34		791		42		4,876		81		637		43
Total fixed maturity securities	$	29,579	$	1,048	$	19,344	$	1,757	$	92,421	$	3,475	$	15,799	$	1,970
Equity securities:
Common stock	$	102	$	14	$	5	$	—	$	203	$	105	$	20	$	2
Non-redeemable preferred stock	49		3		163		44		79		2		200		49
Total equity securities	$	151	$	17	$	168	$	44	$	282	$	107	$	220	$	51
Total number of securities in an unrealized loss position	2,579				1,871				6,366				1,489

Evaluation of AFS Securities for OTTI and Evaluating Temporarily Impaired AFS Securities

As described more fully in Notes 1 and 8 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report, the Company performs a regular evaluation of all investment classes for impairment, including fixed maturity securities, equity securities and perpetual hybrid securities, in accordance with its impairment policy, in order to evaluate whether such investments are other-than-temporarily impaired.

Current Period Evaluation

Based on the Company’s current evaluation of its AFS securities in an unrealized loss position in accordance with its impairment policy, and the Company’s current intentions and assessments (as applicable to the type of security) about holding, selling and any requirements to sell these securities, the Company concluded that these securities were not other-than-temporarily impaired at September 30, 2016. Future OTTI will depend primarily on economic fundamentals, issuer performance (including changes in the present value of future cash flows expected to be collected), changes in credit ratings, collateral valuation, interest rates and credit spreads. If economic fundamentals deteriorate or if there are adverse changes in the above factors, OTTI may be incurred in upcoming periods.

Gross unrealized losses on fixed maturity securities decreased$2.6 billionduring thenine months endedSeptember 30, 2016to$2.8 billion. The decrease in gross unrealized losses for thenine months endedSeptember 30, 2016was primarily attributable to a decrease in interest rates and, to a lesser extent, narrowing credit spreads.

At September 30, 2016, $321 million of the total $2.8 billion of gross unrealized losses were from 74 fixed maturity securities with an unrealized loss position of 20% or more of amortized cost for six months or greater.

Investment Grade Fixed Maturity Securities

Of the $321 million of gross unrealized losses on fixed maturity securities with an unrealized loss of 20% or more of amortized cost for six months or greater, $199 million, or 62%, were related to gross unrealized losses on 35 investment grade fixed maturity securities. Unrealized losses on investment grade fixed maturity securities are principally related to widening credit spreads and, with respect to fixed-rate fixed maturity securities, rising interest rates since purchase.

Below Investment Grade Fixed Maturity Securities

Of the $321 million of gross unrealized losses on fixed maturity securities with an unrealized loss of 20% or more of amortized cost for six months or greater, $122 million, or 38%, were related to gross unrealized losses on 39 below investment grade fixed maturity securities. Unrealized losses on below investment grade fixed maturity securities are principally related to U.S. and foreign corporate securities (primarily industrial securities) and are the result of significantly wider credit spreads resulting from higher risk premiums since purchase, largely due to economic and market uncertainties including concerns over lower oil prices in the energy sector. Management evaluates U.S. and foreign corporate securities based on factors such as expected cash flows and the financial condition and near-term and long-term prospects of the issuers.

Equity Securities

Gross unrealized losses on equity securities decreased $97 million during the nine months endedSeptember 30, 2016 to $61 million. Of the $61 million, $38 million were from six securities with gross unrealized losses of 20% or more of cost for 12 months or greater. Of the $38 million, 61% were rated A or better, and all were from financial services industry investment grade non-redeemable preferred stock.

Mortgage Loans

Mortgage Loans by Portfolio Segment

Mortgage loans are summarized as follows at:

	September 30, 2016					December 31, 2015
	Carrying Value			% of Total		Carrying Value			% of Total
	(Dollars in millions)
Mortgage loans:
Commercial	$	45,801		64.4	%	$	44,012		65.6	%
Agricultural	14,141			19.9		13,188			19.6
Residential	10,920			15.3		9,734			14.5
Subtotal (1)	70,862			99.6		66,934			99.7
Valuation allowances	(330		)	(0.5	)	(318		)	(0.5	)
Subtotal mortgage loans, net	70,532			99.1		66,616			99.2
Residential — FVO	481			0.7		314			0.5
Commercial mortgage loans held by CSEs — FVO	143			0.2		172			0.3
Total mortgage loans, net	$	71,156		100.0	%	$	67,102		100.0	%

__________________

(1) Purchases of mortgage loans were$856 millionand$2.3 billionfor thethree monthsandnine months endedSeptember 30, 2016, respectively, and$1.0 billionand$3.2 billionfor thethree monthsandnine months endedSeptember 30, 2015, respectively.

See “— Variable Interest Entities” for discussion of consolidated securitization entities (“CSEs”).

Information on commercial, agricultural and residential mortgage loans is presented in the tables below. Information on residential — FVO and commercial mortgage loans held by CSEs — FVO is presented in Note 9. The Company elects the FVO for certain mortgage loans and related long-term debt that are managed on a total return basis.

Mortgage Loans, Valuation Allowance and Impaired Loans by Portfolio Segment

Mortgage loans by portfolio segment, by method of evaluation of credit loss, impaired mortgage loans including those modified in a troubled debt restructuring, and the related valuation allowances, were as follows at:

	Evaluated Individually for Credit Losses										Evaluated Collectively for Credit Losses				Impaired Loans
	Impaired Loans with a Valuation Allowance						Impaired Loans without a Valuation Allowance
	Unpaid Principal Balance		Recorded Investment		Valuation Allowances		Unpaid Principal Balance		Recorded Investment		Recorded Investment		Valuation Allowances		Carrying Value
	(In millions)
September 30, 2016
Commercial	$	—	$	—	$	—	$	12	$	12	$	45,789	$	227	$	12
Agricultural	16		13		1		39		38		14,090		42		50
Residential	—		—		—		236		215		10,705		60		215
Total	$	16	$	13	$	1	$	287	$	265	$	70,584	$	329	$	277
December 31, 2015
Commercial	$	—	$	—	$	—	$	57	$	57	$	43,955	$	217	$	57
Agricultural	49		47		3		22		21		13,120		39		65
Residential	—		—		—		141		131		9,603		59		131
Total	$	49	$	47	$	3	$	220	$	209	$	66,678	$	315	$	253

The average recorded investment for impaired commercial, agricultural and residential mortgage loans was $90 million, $52 million and $202 million, respectively, for the three months endedSeptember 30, 2016; and $109 million, $56 million and $174 million, respectively, for the nine months endedSeptember 30, 2016.

The average recorded investment for impaired commercial, agricultural and residential mortgage loans was $118 million, $62 million and $96 million, respectively, for the three months endedSeptember 30, 2015; and $144 million, $62 million and $72 million, respectively, for the nine months endedSeptember 30, 2015.

Valuation Allowance Rollforward by Portfolio Segment

The changes in the valuation allowance, by portfolio segment, were as follows:

	Nine Months   Ended   September 30,
	2016												2015
	Commercial			Agricultural			Residential			Total			Commercial			Agricultural		Residential			Total
	(In millions)
Balance, beginning of period	$	217		$	42		$	59		$	318		$	224		$	39	$	42		$	305
Provision (release) (1)	153			3			13			169			3			2		27			32
Charge-offs, net of recoveries (1)	(143		)	(2		)	(12		)	(157		)	(12		)	—		(14		)	(26		)
Balance, end of period	$	227		$	43		$	60		$	330		$	215		$	41	$	55		$	311

__________________

(1) In connection with an acquisition in 2010, certain impaired commercial mortgage loans were acquired and accordingly, were not originated by the Company. Such commercial mortgage loans have been accounted for as purchased credit impaired (“PCI”) commercial mortgage loans. As explained in Note 8 of the Notes to Consolidated Financial Statements included in the 2015 Annual Report, decreases in cash flows expected to be collected on PCI commercial mortgage loans can result in provisions for losses on mortgage loan. For the nine months endedSeptember 30, 2016, in connection with the maturity of an acquired PCI commercial mortgage loan, an increase to the commercial mortgage loan valuation allowance of$143 millionwas recorded and charged-off upon maturity. The Company will recover a substantial portion of the loss on the loan incurred through an indemnification agreement entered into in connection with the acquisition in 2010.

Credit Quality of Commercial Mortgage Loans

The credit quality of commercial mortgage loans was as follows at:

	Recorded Investment										Estimated Fair Value		% of Total
	Debt Service Coverage Ratios								% of Total
	> 1.20x		1.00x - 1.20x		< 1.00x		Total
	(Dollars in millions)
September 30, 2016
Loan-to-value ratios:
Less than 65%	$	41,391	$	879	$	675	$	42,945	93.8	%	$	44,770	93.9	%
65% to 75%	2,194		39		298		2,531		5.5		2,563		5.4
76% to 80%	42		—		—		42		0.1		40		0.1
Greater than 80%	143		53		87		283		0.6		299		0.6
Total	$	43,770	$	971	$	1,060	$	45,801	100	%	$	47,672	100	%
December 31, 2015
Loan-to-value ratios:
Less than 65%	$	38,163	$	1,063	$	544	$	39,770	90.4	%	$	40,921	90.7	%
65% to 75%	3,270		138		76		3,484		7.9		3,451		7.7
76% to 80%	—		—		—		—		—		—		—
Greater than 80%	381		140		237		758		1.7		732		1.6
Total	$	41,814	$	1,341	$	857	$	44,012	100.0	%	$	45,104	100.0	%

Credit Quality of Agricultural Mortgage Loans

The credit quality of agricultural mortgage loans was as follows at:

	September 30, 2016				December 31, 2015
	Recorded Investment		% of Total		Recorded Investment		% of Total
	(Dollars in millions)
Loan-to-value ratios:
Less than 65%	$	13,543	95.8	%	$	12,399	94.0	%
65% to 75%	532		3.8		710		5.4
76% to 80%	20		0.1		21		0.2
Greater than 80%	46		0.3		58		0.4
Total	$	14,141	100.0	%	$	13,188	100.0	%

The estimated fair value of agricultural mortgage loans was $14.6 billion and $13.5 billion at September 30, 2016 and December 31, 2015, respectively.

Credit Quality of Residential Mortgage Loans

The credit quality of residential mortgage loans was as follows at:

	September 30, 2016				December 31, 2015
	Recorded Investment		% of Total		Recorded Investment		% of Total
	(Dollars in millions)
Performance indicators:
Performing	$	10,587	97.0	%	$	9,408	96.7	%
Nonperforming	333		3.0		326		3.3
Total	$	10,920	100.0	%	$	9,734	100.0	%

The estimated fair value of residential mortgage loans was $11.4 billion and $9.9 billion at September 30, 2016 and December 31, 2015, respectively.

Past Due and Interest Accrual Status of Mortgage Loans

The Company has a high quality, well performing mortgage loan portfolio, with 99% of all mortgage loans classified as performing at both September 30, 2016 and December 31, 2015. The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial and residential mortgage loans — 60 days and agricultural mortgage loans — 90 days. The past due and accrual status of mortgage loans at recorded investment, prior to valuation allowances, by portfolio segment, were as follows at:

	Past Due				Nonaccrual Status
	September 30, 2016		December 31, 2015		September 30, 2016		December 31, 2015
	(In millions)
Commercial	$	—	$	2	$	—	$	—
Agricultural	144		103		39		46
Residential	333		326		322		318
Total	$	477	$	431	$	361	$	364

Mortgage Loans Modified in a Troubled Debt Restructuring

During both thethree monthsandnine months endedSeptember 30, 2016and2015, the Company did not have a significant amount of mortgage loans modified in a troubled debt restructuring.

Cash Equivalents

The carrying value of cash equivalents, which includes securities and other investments with an original or remaining maturity of three months or less at the time of purchase, was $7.3 billion and $7.5 billion at September 30, 2016 and December 31, 2015, respectively.

Net Unrealized Investment Gains (Losses)

Unrealized investment gains (losses) on fixed maturity and equity securities AFS and the effect on DAC, VOBA, deferred sales inducements (“DSI”), future policy benefits and the policyholder dividend obligation, that would result from the realization of the unrealized gains (losses), are included in net unrealized investment gains (losses) in AOCI.

The components of net unrealized investment gains (losses), included in AOCI, were as follows:

	September 30, 2016			December 31, 2015
	(In millions)
Fixed maturity securities	$	36,444		$	18,164
Fixed maturity securities with noncredit OTTI losses included in AOCI	(13		)	(76		)
Total fixed maturity securities	36,431			18,088
Equity securities	579			422
Derivatives	3,648			2,350
Other	397			287
Subtotal	41,055			21,147
Amounts allocated from:
Future policy benefits	(5,571		)	(163		)
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(2		)	—
DAC, VOBA and DSI	(2,390		)	(1,273		)
Policyholder dividend obligation	(3,352		)	(1,783		)
Subtotal	(11,315		)	(3,219		)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	7			27
Deferred income tax benefit (expense)	(10,078		)	(6,151		)
Net unrealized investment gains (losses)	19,669			11,804
Net unrealized investment gains (losses) attributable to noncontrolling interests	(12		)	(31		)
Net unrealized investment gains (losses) attributable to MetLife, Inc.	$	19,657		$	11,773

The changes in fixed maturity securities with noncredit OTTI losses included in AOCI were as follows:

	Nine Months   Ended   September 30, 2016			Year   Ended   December 31, 2015
	(In millions)
Balance, beginning of period	$	(76	)	$	(112	)
Noncredit OTTI losses and subsequent changes recognized	12			6
Securities sold with previous noncredit OTTI loss	34			125
Subsequent changes in estimated fair value	17			(95		)
Balance, end of period	$	(13	)	$	(76	)

The changes in net unrealized investment gains (losses) were as follows:

	Nine Months   Ended   September 30, 2016
	(In millions)
Balance, beginning of period	$	11,773
Fixed maturity securities on which noncredit OTTI losses have been recognized	63
Unrealized investment gains (losses) during the period	19,845
Unrealized investment gains (losses) relating to:
Future policy benefits	(5,408		)
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(2		)
DAC, VOBA and DSI	(1,117		)
Policyholder dividend obligation	(1,569		)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	(20		)
Deferred income tax benefit (expense)	(3,927		)
Net unrealized investment gains (losses)	19,638
Net unrealized investment gains (losses) attributable to noncontrolling interests	19
Balance, end of period	$	19,657
Change in net unrealized investment gains (losses)	$	7,865
Change in net unrealized investment gains (losses) attributable to noncontrolling interests	19
Change in net unrealized investment gains (losses) attributable to MetLife, Inc.	$	7,884

Concentrations of Credit Risk

Investments in any counterparty that were greater than 10% of the Company’s equity, other than the U.S. government and its agencies, were in fixed income securities of the Japanese government and its agencies with an estimated fair value of $29.4 billion and $20.9 billion at September 30, 2016 and December 31, 2015, respectively. The Company’s investment in fixed maturity and equity securities to counterparties that primarily conduct business in Japan, including Japan government and agency fixed maturity securities, was $33.8 billion and $25.4 billion at September 30, 2016 and December 31, 2015, respectively.

Securities Lending

Elements of the securities lending program are presented below at:

	September 30, 2016		December 31, 2015
	(In millions)
Securities on loan: (1)
Amortized cost	$	26,855	$	27,223
Estimated fair value	$	31,326	$	29,646
Cash collateral on deposit from counterparties (2)	$	32,119	$	30,197
Security collateral on deposit from counterparties (3)	$	134	$	50
Reinvestment portfolio — estimated fair value	$	32,454	$	30,258

__________________

(1) Included within fixed maturity securities, cash equivalents and short-term investments. At September 30, 2016, both amortized cost and estimated fair value also included $114 million, at estimated fair value, of securities which are not reflected on the consolidated financial statements.

(2) Included within payables for collateral under securities loaned and other transactions.

(3) Security collateral on deposit from counterparties may not be sold or re-pledged, unless the counterparty is in default, and is not reflected on the consolidated financial statements.

The cash collateral liability by loaned security type and remaining tenor of the agreements were as follows at:

	September 30, 2016								December 31, 2015
	Remaining Tenor of Securities Lending Agreements								Remaining Tenor of Securities Lending Agreements
	Open (1)		1 Month or Less		1 to 6 Months		Total		Open (1)		1 Month or Less		1 to 6 Months		Total
	(In millions)
Cash collateral liability by loaned security type:
U.S. government and agency	$	8,362	$	10,162	$	11,090	$	29,614	$	10,116	$	11,157	$	5,986	$	27,259
Agency RMBS	—		—		1,196		1,196		—		951		600		1,551
Foreign government	—		836		50		886		2		510		486		998
U.S. corporate	1		391		—		392		9		380		—		389
Foreign corporate	—		31		—		31		—		—		—		—
Total	$	8,363	$	11,420	$	12,336	$	32,119	$	10,127	$	12,998	$	7,072	$	30,197

__________________

(1) The related loaned security could be returned to the Company on the next business day which would require the Company to immediately return the cash collateral.

If the Company is required to return significant amounts of cash collateral on short notice and is forced to sell securities to meet the return obligation, it may have difficulty selling such collateral that is invested in securities in a timely manner, be forced to sell securities in a volatile or illiquid market for less than what otherwise would have been realized under normal market conditions, or both. The estimated fair value of the securities on loan related to the cash collateral on open at September 30, 2016 was $8.1 billion, over 99% of which were U.S. government and agency securities which, if put back to the Company, could be immediately sold to satisfy the cash requirement.

The reinvestment portfolio acquired with the cash collateral consisted principally of fixed maturity securities (including U.S. government and agency, agency RMBS, short-term investments, ABS and U.S. corporate securities) with 65% invested in U.S. government and agency securities, agency RMBS, short-term investments, or held in cash and cash equivalents. If the securities on loan or the reinvestment portfolio become less liquid, the Company has the liquidity resources of most of its general account available to meet any potential cash demands when securities on loan are put back to the Company.

Repurchase Agreement Transactions

The Company participates in contemporaneous short-term repurchase agreements and reverse repurchase agreements with unaffiliated financial institutions. Under these agreements, the Company lends fixed maturity securities and contemporaneously borrows other fixed maturity securities (e.g., repurchase and reverse repurchase, respectively). The Company obtains cash collateral in an amount greater than or equal to 95% of the estimated fair value of the securities loaned, and pledges cash collateral in an amount generally equal to 98% of the estimated fair value of the borrowed securities at the inception of the transaction. The Company monitors the estimated fair value of the securities loaned and borrowed with additional collateral obtained as necessary throughout the duration of the transaction.

The Company accounted for these transactions as collateralized borrowing and lending. The amount of fixed maturity securities lent and borrowed, at estimated fair value, was $316 million and $306 million, respectively, at September 30, 2016. There were no such transactions outstanding as of December 31, 2015. Securities loaned under such transactions may be sold or re-pledged by the transferee. Securities borrowed under such transactions may be re-pledged and are not reflected on the consolidated financial statements. The amount of borrowed securities which were re-pledged was $114 million, at estimated fair value, at September 30, 2016.

The Company has elected to offset amounts recognized as receivables and payables resulting from these transactions. The gross amounts of the receivables and payables related to these transactions at September 30, 2016 were both $300 million. After the effect of offsetting of $300 million, the net amount presented on the consolidated balance sheet at September 30, 2016 was a liability of less than $1 million. Amounts owed to and due from counterparties may be settled in cash or offset, in accordance with the agreements. Cash inflows and outflows for cash settlements are reported on the consolidated statements of cash flows. At September 30, 2016, all $300 million of payables from repurchase agreements had a remaining tenor of one to six months and were primarily loans of U.S. corporate securities.

See Note 8 for information regarding the estimated fair value of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral.

The Company also participates in other short-term repurchase agreements with unaffiliated financial institutions. Under these agreements, the Company lends fixed maturity securities and receives cash as collateral in an amount generally equal to 85% to 100% of the estimated fair value of the securities loaned at the inception of the transaction. The associated liability is recorded at the amount of cash received. The Company monitors the estimated fair value of the collateral and the securities loaned throughout the duration of the transaction and additional collateral is obtained as necessary. Securities loaned under such transactions may be sold or re-pledged by the transferee.

Elements of the other short-term repurchase agreements are presented below at:

	September 30, 2016		December 31, 2015
	(In millions)
Securities on loan included within fixed maturity securities:
Amortized cost	$	91	$	51
Estimated fair value	$	109	$	56
Cash collateral received included within other liabilities	$	101	$	50
Reinvestment portfolio — estimated fair value	$	99	$	50

The cash collateral liability by loaned security type and remaining tenor of the agreements were as follows at:

	September 30, 2016						December 31, 2015
	Remaining Tenor of Other Repurchase Agreements						Remaining Tenor of Other Repurchase Agreements
	1 Month or Less		1 to 6  Months		Total		1 Month or Less		1 to 6 Months		Total
	(In millions)
Cash collateral liability by loaned security type:
Foreign corporate	$	14	$	13	$	27	$	—	$	25	$	25
All other corporate and government	37		37		$	74	—		25		$	25
Total	$	51	$	50	$	101	$	—	$	50	$	50

Invested Assets on Deposit, Held in Trust and Pledged as Collateral

Invested assets on deposit, held in trust and pledged as collateral are presented below at estimated fair value for all asset classes, except mortgage loans, which are presented at carrying value at:

	September 30, 2016		December 31, 2015
	(In millions)
Invested assets on deposit (regulatory deposits)	$	10,425	$	9,089
Invested assets held in trust (collateral financing arrangements and reinsurance agreements)	11,902		10,443
Invested assets pledged as collateral (1)	29,296		23,145
Total invested assets on deposit, held in trust and pledged as collateral	$	51,623	$	42,677

__________________

(1) The Company has pledged invested assets in connection with various agreements and transactions, including funding agreements (see Notes 4 and 12 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report), collateral financing arrangements (see Note 13 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report) and derivative transactions (see Note 8).

See “— Securities Lending” and “— Repurchase Agreement Transactions” for information regarding securities on loan and Note 6 for information regarding investments designated to the closed block.

Variable Interest Entities

The Company is involved with certain legal entities that are VIEs. In certain instances, the Company holds both the power to direct the most significant activities of the entity, as well as an economic interest in the entity and, as such, is deemed to be the primary beneficiary or consolidator of the entity. The determination of the VIE’s primary beneficiary requires an evaluation of the contractual and implied rights and obligations associated with each party’s relationship with or involvement in the entity.

Consolidated VIEs

Creditors or beneficial interest holders of VIEs where the Company is the primary beneficiary have no recourse to the general credit of the Company, as the Company’s obligation to the VIEs is limited to the amount of its committed investment.

The following table presents the total assets and total liabilities relating to VIEs for which the Company has concluded that it is the primary beneficiary and which are consolidated at:

	September 30, 2016				December 31, 2015
	Total Assets		Total Liabilities		Total Assets		Total Liabilities
	(In millions)
MRSC (collateral financing arrangement (primarily securities)) (1)	$	3,533	$	—	$	3,374	$	—
Operating joint venture (2)	—		—		2,465		2,079
CSEs (assets (primarily loans) and liabilities (primarily debt)) (3)	156		38		186		62
Other investments (4)	50		—		76		—
Total	$	3,739	$	38	$	6,101	$	2,141

__________________

(1) See Note 13 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report for a description of the MetLife Reinsurance Company of South Carolina (“MRSC”) collateral financing arrangement.

(2) Following a change in the foreign investment law in India, the Company no longer consolidated its India operating joint venture, effective January 1, 2016. Assets of the operating joint venture are primarily fixed maturity securities and separate account assets. Liabilities of the operating joint venture are primarily future policy benefits, other policy-related balances and separate account liabilities.

(3) The Company consolidates entities that are structured as CMBS and as collateralized debt obligations. The assets of these entities can only be used to settle their respective liabilities, and under no circumstances is the Company liable for any principal or interest shortfalls should any arise. The Company’s exposure was limited to that of its remaining investment in these entities of $98 million and $105 million at estimated fair value at September 30, 2016 and December 31, 2015, respectively.

(4) Other investments is primarily comprised of other invested assets and other limited partnership interests.

Unconsolidated VIEs

The carrying amount and maximum exposure to loss relating to VIEs in which the Company holds a significant variable interest but is not the primary beneficiary and which have not been consolidated were as follows at:

	September 30, 2016				December 31, 2015
	Carrying Amount		Maximum Exposure to Loss (1)		Carrying Amount		Maximum Exposure to Loss (1)
	(In millions)
Fixed maturity securities AFS:
Structured Securities (2)	$	73,334	$	73,334	$	65,824	$	65,824
U.S. and foreign corporate	3,374		3,374		3,261		3,261
Other limited partnership interests	5,978		10,572		5,186		7,074
Other invested assets	2,184		2,771		1,604		2,161
FVO and trading securities	576		576		586		586
Real estate joint ventures	107		137		65		82
Other (3)	120		120		71		71
Total	$	85,673	$	90,884	$	76,597	$	79,059

__________________

(1) The maximum exposure to loss relating to fixed maturity securities AFS, FVO and trading securities and equity securities AFS is equal to their carrying amounts or the carrying amounts of retained interests. The maximum exposure to loss relating to other limited partnership interests, mortgage loans and real estate joint ventures is equal to the carrying amounts plus any unfunded commitments. For certain of its investments in other invested assets, the Company’s return is in the form of income tax credits which are guaranteed by creditworthy third parties. For such investments, the maximum exposure to loss is equal to the carrying amounts plus any unfunded commitments, reduced by income tax credits guaranteed by third parties of $151 million and $179 million at September 30, 2016 and December 31, 2015, respectively. Such a maximum loss would be expected to occur only upon bankruptcy of the issuer or investee.

(2) For these variable interests, the Company’s involvement is limited to that of a passive investor in mortgage-backed or asset-backed securities issued by trusts that do not have substantial equity.

(3) Other is comprised of mortgage loans, non-redeemable preferred stock and a loan receivable.

As described in Note 15, the Company makes commitments to fund partnership investments in the normal course of business. Excluding these commitments, the Company did not provide financial or other support to investees designated as VIEs during both the nine months endedSeptember 30, 2016 and 2015.

Net Investment Income

The components of net investment income were as follows:

	Three Months   Ended   September 30,					Nine Months   Ended   September 30,
	2016		2015			2016		2015
	(In millions)
Investment income:
Fixed maturity securities	$	3,583	$	3,525		$	10,801	$	10,738
Equity securities	35		36			105		102
FVO and trading securities — Actively traded and FVO general account securities (1)	25		(35		)	41		4
Mortgage loans	806		786			2,464		2,317
Policy loans	148		147			444		450
Real estate and real estate joint ventures	210		233			516		767
Other limited partnership interests	263		216			429		681
Cash, cash equivalents and short-term investments	43		29			126		101
Operating joint ventures	5		(1		)	28		15
Other	95		28			187		180
Subtotal	5,213		4,964			15,141		15,355
Less: Investment expenses	281		308			862		923
Subtotal, net	4,932		4,656			14,279		14,432
FVO and trading securities — FVO contractholder-directed unit-linked investments (1)	529		(701		)	623		(79		)
FVO CSEs — interest income:
Commercial mortgage loans	3		4			8		13
Securities	—		—			—		1
Subtotal	532		(697		)	631		(65		)
Net investment income	$	5,464	$	3,959		$	14,910	$	14,367

__________________

(1) Changes in estimated fair value subsequent to purchase for securities still held as of the end of the respective periods included in net investment income were principally from FVO contractholder-directed unit-linked investments and, to a much lesser extent, Actively traded and FVO general account securities, and were $407 million and $283 million for the three months and nine months ended September 30, 2016, respectively, and ($872) million and ($645) million for the three months and nine months ended September 30, 2015, respectively.

See “— Variable Interest Entities” for discussion of CSEs.

FVO and trading securities are primarily comprised of securities for which the FVO has been elected (“FVO securities”). FVO securities include certain fixed maturity and equity securities held-for-investment by the general account to support asset and liability management strategies for certain insurance products and investments in certain separate accounts. FVO securities are primarily comprised of contractholder-directed investments supporting unit-linked variable annuity type liabilities which do not qualify for presentation as separate account summary total assets and liabilities. The investment returns on these investments inure to the contractholders and are offset by a corresponding change in policyholder account balances through interest credited to policyholder account balances. FVO securities also include securities held by CSEs. The Company previously maintained a trading securities portfolio, principally invested in fixed maturity securities, to support investment strategies that involved the active and frequent purchase and sale of actively traded securities and the execution of short sale agreements. In June 2016, the Company commenced a reinvestment of this portfolio into other asset classes and, at September 30, 2016, the Company no longer held any actively traded securities.

Net Investment Gains (Losses)

Components of Net Investment Gains (Losses)

The components of net investment gains (losses) were as follows:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Total gains (losses) on fixed maturity securities:
Total OTTI losses recognized — by sector and industry:
U.S. and foreign corporate securities — by industry:
Consumer	$	—		$	(17	)	$	—		$	(20	)
Industrial	—			(3		)	(79		)	(5		)
Communications	—			—			(3		)	—
Total U.S. and foreign corporate securities	—			(20		)	(82		)	(25		)
RMBS	(14		)	(1		)	(22		)	(16		)
ABS	—			—			(2		)	—
State and political subdivision	—			(6		)	—			(6		)
OTTI losses on fixed maturity securities recognized in earnings	(14		)	(27		)	(106		)	(47		)
Fixed maturity securities — net gains (losses) on sales and disposals	176			115			439			383
Total gains (losses) on fixed maturity securities	162			88			333			336
Total gains (losses) on equity securities:
Total OTTI losses recognized — by sector:
Non-redeemable preferred stock	—			(1		)	—			(1		)
Common stock	(5		)	(6		)	(72		)	(15		)
OTTI losses on equity securities recognized in earnings	(5		)	(7		)	(72		)	(16		)
Equity securities — net gains (losses) on sales and disposals	13			14			32			39
Total gains (losses) on equity securities	8			7			(40		)	23
Mortgage loans	(31		)	(26		)	(193		)	(78		)
Real estate and real estate joint ventures	(14		)	263			33			257
Other limited partnership interests	(9		)	(59		)	(50		)	(52		)
Other	(19		)	18			(94		)	14
Subtotal	97			291			(11		)	500
FVO CSEs:
Commercial mortgage loans	(3		)	(4		)	(3		)	(6		)
Securities	1			—			2			—
Long-term debt — related to commercial mortgage loans	1			1			1			3
Non-investment portfolio gains (losses) (1)	161			94			549			38
Subtotal	160			91			549			35
Total net investment gains (losses)	$	257		$	382		$	538		$	535

__________________

(1) Includes a gain from the U.S. Retail Advisor Force Divestiture of $103 million during both the three months and nine months ended September 30, 2016. See Note 3.

See “— Variable Interest Entities” for discussion of CSEs.

Gains (losses) from foreign currency transactions included within net investment gains (losses) were$69 millionand$437 millionfor thethree monthsandnine months endedSeptember 30, 2016, respectively, and$53 millionand($29) millionfor thethree monthsandnine months endedSeptember 30, 2015, respectively.

Sales or Disposals and Impairments of Fixed Maturity and Equity Securities

Investment gains and losses on sales of securities are determined on a specific identification basis. Proceeds from sales or disposals of fixed maturity and equity securities and the components of fixed maturity and equity securities net investment gains (losses) were as shown in the table below.

	Three Months   Ended   September 30,
	2016			2015			2016			2015
	Fixed Maturity Securities						Equity Securities
	(In millions)
Proceeds	$	25,091		$	27,264		$	64		$	55
Gross investment gains	$	310		$	371		$	15		$	20
Gross investment losses	(134		)	(256		)	(2		)	(6		)
OTTI losses	(14		)	(27		)	(5		)	(7		)
Net investment gains (losses)	$	162		$	88		$	8		$	7

	Nine Months   Ended   September 30,
	2016			2015			2016			2015
	Fixed Maturity Securities						Equity Securities
	(In millions)
Proceeds	$	83,352		$	86,590		$	151		$	211
Gross investment gains	$	1,025		$	1,047		$	40		$	54
Gross investment losses	(586		)	(664		)	(8		)	(15		)
OTTI losses	(106		)	(47		)	(72		)	(16		)
Net investment gains (losses)	$	333		$	336		$	(40	)	$	23

Credit Loss Rollforward

The table below presents a rollforward of the cumulative credit loss component of OTTI loss recognized in earnings on fixed maturity securities still held for which a portion of the OTTI loss was recognized in other comprehensive income (loss) (“OCI”):

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Balance, beginning of period	$	258		$	280		$	277		$	357
Additions:
Initial impairments — credit loss OTTI on securities not previously impaired	1			—			1			2
Additional impairments — credit loss OTTI on securities previously impaired	10			1			18			14
Reductions:
Sales (maturities, pay downs or prepayments) of securities previously impaired as credit loss OTTI	(17		)	(22		)	(43		)	(113		)
Securities impaired to net present value of expected future cash flows	—			—			(1		)	—
Increase in cash flows — accretion of previous credit loss OTTI	—			(1		)	—			(2		)
Balance, end of period	$	252		$	258		$	252		$	258

XML

Derivatives

9 Months Ended

Sep. 30, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives

8. Derivatives

Accounting for Derivatives

Freestanding Derivatives

Freestanding derivatives are carried on the Company’s balance sheet either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement.

Accruals on derivatives are generally recorded in accrued investment income or within other liabilities. However, accruals that are not scheduled to settle within one year are included with the derivatives carrying value in other invested assets or other liabilities.

If a derivative is not designated as an accounting hedge or its use in managing risk does not qualify for hedge accounting, changes in the estimated fair value of the derivative are reported in net derivative gains (losses) except as follows:

Statement of Operations Presentation:	Derivative:
Policyholder benefits and claims	•	Economic hedges of variable annuity guarantees included in future policy benefits
Net investment income	•	Economic hedges of equity method investments in joint ventures
	•	All derivatives held in relation to trading portfolios
	•	Derivatives held within contractholder-directed unit-linked investments

Hedge Accounting

To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. Hedge designation and financial statement presentation of changes in estimated fair value of the hedging derivatives are as follows:

• Fair value hedge (a hedge of the estimated fair value of a recognized asset or liability) - in net derivative gains (losses), consistent with the change in estimated fair value of the hedged item attributable to the designated risk being hedged.

• Cash flow hedge (a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability) - effectiveness in OCI (deferred gains or losses on the derivative are reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item); ineffectiveness in net derivative gains (losses).

• Net investment in a foreign operation hedge - effectiveness in OCI, consistent with the translation adjustment for the hedged net investment in the foreign operation; ineffectiveness in net derivative gains (losses).

The changes in estimated fair values of the hedging derivatives are exclusive of any accruals that are separately reported on the statement of operations within interest income or interest expense to match the location of the hedged item. Accruals on derivatives in net investment hedges are recognized in OCI.

In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness and the method that will be used to measure ineffectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship. Assessments of hedge effectiveness and measurements of ineffectiveness are also subject to interpretation and estimation and different interpretations or estimates may have a material effect on the amount reported in net income.

The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument.

When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item, the derivative continues to be carried on the balance sheet at its estimated fair value, with changes in estimated fair value recognized in net derivative gains (losses). The carrying value of the hedged recognized asset or liability under a fair value hedge is no longer adjusted for changes in its estimated fair value due to the hedged risk, and the cumulative adjustment to its carrying value is amortized into income over the remaining life of the hedged item. Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.

When hedge accounting is discontinued because it is no longer probable that the forecasted transactions will occur on the anticipated date or within two months of that date, the derivative continues to be carried on the balance sheet at its estimated fair value, with changes in estimated fair value recognized currently in net derivative gains (losses). Deferred gains and losses of a derivative recorded in OCI pursuant to the discontinued cash flow hedge of a forecasted transaction that is no longer probable are recognized immediately in net derivative gains (losses).

In all other situations in which hedge accounting is discontinued, the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses).

Embedded Derivatives

The Company sells variable annuities and issues certain insurance products and investment contracts and is a party to certain reinsurance agreements that have embedded derivatives. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated. The embedded derivative is bifurcated from the host contract and accounted for as a freestanding derivative if:

• the combined instrument is not accounted for in its entirety at estimated fair value with changes in estimated fair value recorded in earnings;

• the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract; and

• a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument.

Such embedded derivatives are carried on the balance sheet at estimated fair value with the host contract and changes in their estimated fair value are generally reported in net derivative gains (losses), except for those in policyholder benefits and claims related to ceded reinsurance of GMIB. If the Company is unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income. Additionally, the Company may elect to carry an entire contract on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income if that contract contains an embedded derivative that requires bifurcation. At inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent “excess” fees and are reported in universal life and investment-type product policy fees.

See Note 9 for information about the fair value hierarchy for derivatives.

Derivative Strategies

The Company is exposed to various risks relating to its ongoing business operations, including interest rate, foreign currency exchange rate, credit and equity market. The Company uses a variety of strategies to manage these risks, including the use of derivatives.

Derivatives are financial instruments with values derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (“OTC-cleared”), while others are bilateral contracts between two counterparties (“OTC-bilateral”). The types of derivatives the Company uses include swaps, forwards, futures and option contracts. To a lesser extent, the Company uses credit default swaps and structured interest rate swaps to synthetically replicate investment risks and returns which are not readily available in the cash market.

Interest Rate Derivatives

The Company uses a variety of interest rate derivatives to reduce its exposure to changes in interest rates, including interest rate swaps, interest rate total return swaps, caps, floors, swaptions, futures and forwards.

Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). In an interest rate swap, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest amounts as calculated by reference to an agreed notional amount. The Company utilizes interest rate swaps in fair value, cash flow and nonqualifying hedging relationships.

The Company uses structured interest rate swaps to synthetically create investments that are either more expensive to acquire or otherwise unavailable in the cash markets. These transactions are a combination of a derivative and a cash instrument such as a U.S. government and agency, or other fixed maturity security. Structured interest rate swaps are included in interest rate swaps and are not designated as hedging instruments.

Interest rate total return swaps are swaps whereby the Company agrees with another party to exchange, at specified intervals, the difference between the economic risk and reward of an asset or a market index and the London Interbank Offered Rate (“LIBOR”), calculated by reference to an agreed notional amount. No cash is exchanged at the outset of the contract. Cash is paid and received over the life of the contract based on the terms of the swap. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made by the counterparty at each due date. Interest rate total return swaps are used by the Company to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and liabilities (duration mismatches). The Company utilizes interest rate total return swaps in nonqualifying hedging relationships.

The Company purchases interest rate caps and floors primarily to protect its floating rate liabilities against rises in interest rates above a specified level, and against interest rate exposure arising from mismatches between assets and liabilities, as well as to protect its minimum rate guarantee liabilities against declines in interest rates below a specified level, respectively. In certain instances, the Company locks in the economic impact of existing purchased caps and floors by entering into offsetting written caps and floors. The Company utilizes interest rate caps and floors in nonqualifying hedging relationships.

In exchange-traded interest rate (Treasury and swap) futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of interest rate securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded interest rate (Treasury and swap) futures are used primarily to hedge mismatches between the duration of assets in a portfolio and the duration of liabilities supported by those assets, to hedge against changes in value of securities the Company owns or anticipates acquiring, to hedge against changes in interest rates on anticipated liability issuances by replicating Treasury or swap curve performance, and to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. The Company utilizes exchange-traded interest rate futures in nonqualifying hedging relationships.

Swaptions are used by the Company to hedge interest rate risk associated with the Company’s long-term liabilities and invested assets. A swaption is an option to enter into a swap with a forward starting effective date. In certain instances, the Company locks in the economic impact of existing purchased swaptions by entering into offsetting written swaptions. The Company pays a premium for purchased swaptions and receives a premium for written swaptions. The Company utilizes swaptions in nonqualifying hedging relationships. Swaptions are included in interest rate options.

The Company enters into interest rate forwards to buy and sell securities. The price is agreed upon at the time of the contract and payment for such a contract is made at a specified future date. The Company utilizes interest rate forwards in cash flow and nonqualifying hedging relationships.

Foreign Currency Exchange Rate Derivatives

The Company uses foreign currency exchange rate derivatives, including foreign currency swaps, foreign currency forwards, currency options and exchange-traded currency futures, to reduce the risk from fluctuations in foreign currency exchange rates associated with its assets and liabilities denominated in foreign currencies. The Company also uses foreign currency derivatives to hedge the foreign currency exchange rate risk associated with certain of its net investments in foreign operations.

In a foreign currency swap transaction, the Company agrees with another party to exchange, at specified intervals, the difference between one currency and another at a fixed exchange rate, generally set at inception, calculated by reference to an agreed upon notional amount. The notional amount of each currency is exchanged at the inception and termination of the currency swap by each party. The Company utilizes foreign currency swaps in fair value, cash flow and nonqualifying hedging relationships.

In a foreign currency forward transaction, the Company agrees with another party to deliver a specified amount of an identified currency at a specified future date. The price is agreed upon at the time of the contract and payment for such a contract is made at the specified future date. The Company utilizes foreign currency forwards in fair value, net investment in foreign operations and nonqualifying hedging relationships.

The Company enters into currency options that give it the right, but not the obligation, to sell the foreign currency amount in exchange for a functional currency amount within a limited time at a contracted price. The contracts may also be net settled in cash, based on differentials in the foreign currency exchange rate and the strike price. The Company uses currency options to hedge against the foreign currency exposure inherent in certain of its variable annuity products. The Company also uses currency options as an economic hedge of foreign currency exposure related to the Company’s international subsidiaries. The Company utilizes currency options in net investment in foreign operations and nonqualifying hedging relationships.

To a lesser extent, the Company uses exchange-traded currency futures to hedge currency mismatches between assets and liabilities, and to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. The Company utilizes exchange-traded currency futures in nonqualifying hedging relationships.

Credit Derivatives

The Company enters into purchased credit default swaps to hedge against credit-related changes in the value of its investments. In a credit default swap transaction, the Company agrees with another party to pay, at specified intervals, a premium to hedge credit risk. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the delivery of par quantities of the referenced investment equal to the specified swap notional amount in exchange for the payment of cash amounts by the counterparty equal to the par value of the investment surrendered. Credit events vary by type of issuer but typically include bankruptcy, failure to pay debt obligations, repudiation, moratorium, involuntary restructuring or governmental intervention. In each case, payout on a credit default swap is triggered only after the Credit Derivatives Determinations Committee of the International Swaps and Derivatives Association, Inc. (“ISDA”) deems that a credit event has occurred. The Company utilizes credit default swaps in nonqualifying hedging relationships.

The Company enters into written credit default swaps to synthetically create credit investments that are either more expensive to acquire or otherwise unavailable in the cash markets. These transactions are a combination of a derivative and one or more cash instruments, such as U.S. government and agency securities, or other fixed maturity securities. These credit default swaps are not designated as hedging instruments.

The Company also enters into certain purchased and written credit default swaps held in relation to trading portfolios for the purpose of generating profits on short-term differences in price. These credit default swaps are not designated as hedging instruments.

The Company enters into forwards to lock in the price to be paid for forward purchases of certain securities. The price is agreed upon at the time of the contract and payment for the contract is made at a specified future date. When the primary purpose of entering into these transactions is to hedge against the risk of changes in purchase price due to changes in credit spreads, the Company designates these transactions as credit forwards. The Company utilizes credit forwards in cash flow hedging relationships.

Equity Derivatives

The Company uses a variety of equity derivatives to reduce its exposure to equity market risk, including equity index options, equity variance swaps, exchange-traded equity futures and equity total return swaps.

Equity index options are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. To hedge against adverse changes in equity indices, the Company enters into contracts to sell the equity index within a limited time at a contracted price. The contracts will be net settled in cash based on differentials in the indices at the time of exercise and the strike price. Certain of these contracts may also contain settlement provisions linked to interest rates. In certain instances, the Company may enter into a combination of transactions to hedge adverse changes in equity indices within a pre-determined range through the purchase and sale of options. The Company utilizes equity index options in nonqualifying hedging relationships.

Equity variance swaps are used by the Company primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. In an equity variance swap, the Company agrees with another party to exchange amounts in the future, based on changes in equity volatility over a defined period. The Company utilizes equity variance swaps in nonqualifying hedging relationships.

In exchange-traded equity futures transactions, the Company agrees to purchase or sell a specified number of contracts, the value of which is determined by the different classes of equity securities, and to post variation margin on a daily basis in an amount equal to the difference in the daily market values of those contracts. The Company enters into exchange-traded futures with regulated futures commission merchants that are members of the exchange. Exchange-traded equity futures are used primarily to hedge minimum guarantees embedded in certain variable annuity products offered by the Company. The Company utilizes exchange-traded equity futures in nonqualifying hedging relationships.

In an equity total return swap, the Company agrees with another party to exchange, at specified intervals, the difference between the economic risk and reward of an asset or a market index and LIBOR, calculated by reference to an agreed notional amount. No cash is exchanged at the outset of the contract. Cash is paid and received over the life of the contract based on the terms of the swap. The Company uses equity total return swaps to hedge its equity market guarantees in certain of its insurance products. Equity total return swaps can be used as hedges or to synthetically create investments. The Company utilizes equity total return swaps in nonqualifying hedging relationships.

Primary Risks Managed by Derivatives

The following table presents the gross notional amount, estimated fair value and primary underlying risk exposure of the Company’s derivatives, excluding embedded derivatives, held at:

		September 30, 2016						December 31, 2015
	Primary Underlying Risk Exposure	Gross Notional Amount		Estimated Fair Value				Gross Notional Amount		Estimated Fair Value
				Assets		Liabilities				Assets		Liabilities
		(In millions)
Derivatives Designated as Hedging Instruments:
Fair value hedges:
Interest rate swaps	Interest rate	$	5,383	$	2,824	$	14	$	5,528	$	2,215	$	12
Foreign currency swaps	Foreign currency exchange rate	1,221		28		156		2,154		62		159
Foreign currency forwards	Foreign currency exchange rate	1,485		196		—		1,685		—		52
Subtotal		8,089		3,048		170		9,367		2,277		223
Cash flow hedges:
Interest rate swaps	Interest rate	2,251		672		—		2,190		487		—
Interest rate forwards	Interest rate	2,032		49		10		105		23		—
Foreign currency swaps	Foreign currency exchange rate	27,202		2,212		1,684		23,661		1,303		1,803
Subtotal		31,485		2,933		1,694		25,956		1,813		1,803
Foreign operations hedges:
Foreign currency forwards	Foreign currency exchange rate	1,087		6		53		3,916		63		12
Currency options	Foreign currency exchange rate	9,212		18		226		7,569		205		36
Subtotal		10,299		24		279		11,485		268		48
Total qualifying hedges		49,873		6,005		2,143		46,808		4,358		2,074
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate swaps	Interest rate	82,791		9,586		3,033		89,336		5,111		2,247
Interest rate floors	Interest rate	15,201		350		34		23,837		311		48
Interest rate caps	Interest rate	79,030		35		3		68,928		105		3
Interest rate futures	Interest rate	9,110		4		41		5,808		4		7
Interest rate options	Interest rate	21,383		1,790		1		30,234		1,177		30
Interest rate forwards	Interest rate	171		16		—		43		1		—
Interest rate total return swaps	Interest rate	5,925		106		36		—		—		—
Synthetic GICs	Interest rate	5,328		—		—		4,216		—		—
Foreign currency swaps	Foreign currency exchange rate	12,790		1,183		467		11,081		766		431
Foreign currency forwards	Foreign currency exchange rate	17,371		584		250		11,724		154		220
Currency futures	Foreign currency exchange rate	1,060		—		2		930		—		—
Currency options	Foreign currency exchange rate	4,780		204		11		9,590		466		189
Credit default swaps — purchased	Credit	2,038		10		44		1,870		28		34
Credit default swaps — written	Credit	11,664		150		10		10,311		78		13
Equity futures	Equity market	12,886		13		68		7,206		63		18
Equity index options	Equity market	53,911		1,519		1,362		55,682		1,542		1,041
Equity variance swaps	Equity market	23,658		228		745		23,437		195		636
Equity total return swaps	Equity market	5,070		5		102		3,803		47		58
Total non-designated or nonqualifying derivatives		364,167		15,783		6,209		358,036		10,048		4,975
Total		$	414,040	$	21,788	$	8,352	$	404,844	$	14,406	$	7,049

Based on gross notional amounts, a substantial portion of the Company’s derivatives was not designated or did not qualify as part of a hedging relationship at both September 30, 2016 and December 31, 2015. The Company’s use of derivatives includes (i) derivatives that serve as macro hedges of the Company’s exposure to various risks and that generally do not qualify for hedge accounting due to the criteria required under the portfolio hedging rules; (ii) derivatives that economically hedge insurance liabilities that contain mortality or morbidity risk and that generally do not qualify for hedge accounting because the lack of these risks in the derivatives cannot support an expectation of a highly effective hedging relationship; (iii) derivatives that economically hedge embedded derivatives that do not qualify for hedge accounting because the changes in estimated fair value of the embedded derivatives are already recorded in net income; and (iv) written credit default swaps that are used to synthetically create credit investments and that do not qualify for hedge accounting because they do not involve a hedging relationship. For these nonqualified derivatives, changes in market factors can lead to the recognition of fair value changes on the statement of operations without an offsetting gain or loss recognized in earnings for the item being hedged.

Net Derivative Gains (Losses)

The components of net derivative gains (losses) were as follows:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Freestanding derivatives and hedging gains (losses) (1)	$	(1,852	)	$	2,318		$	3,177		$	1,433
Embedded derivatives gains (losses)	801			(1,833		)	(4,992		)	(1,039		)
Total net derivative gains (losses)	$	(1,051	)	$	485		$	(1,815	)	$	394

__________________

(1) Includes foreign currency transaction gains (losses) on hedged items in cash flow and nonqualifying hedging relationships, which are not presented elsewhere in this note.

The following table presents earned income on derivatives:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Qualifying hedges:
Net investment income	$	76		$	55		$	206		$	158
Interest credited to policyholder account balances	—			6			7			21
Other expenses	(3		)	(2		)	(9		)	(4		)
Nonqualifying hedges:
Net investment income	—			(1		)	(1		)	(3		)
Net derivative gains (losses)	312			256			843			757
Policyholder benefits and claims	6			4			17			12
Total	$	391		$	318		$	1,063		$	941

Nonqualifying Derivatives and Derivatives for Purposes Other Than Hedging

The following table presents the amount and location of gains (losses) recognized in income for derivatives that were not designated or not qualifying as hedging instruments:

	Net Derivative Gains (Losses)			Net Investment Income (1)			Policyholder Benefits and Claims (2)
	(In millions)
Three Months Ended September 30, 2016
Interest rate derivatives	$	(1,082	)	$	—		$	19
Foreign currency exchange rate derivatives	146			—			(5		)
Credit derivatives — purchased	(21		)	—			—
Credit derivatives — written	60			—			—
Equity derivatives	(1,212		)	(5		)	(260		)
Total	$	(2,109	)	$	(5	)	$	(246	)
Three Months Ended September 30, 2015
Interest rate derivatives	$	1,157		$	—		$	17
Foreign currency exchange rate derivatives	364			—			—
Credit derivatives — purchased	16			3			—
Credit derivatives — written	(77		)	(1		)	—
Equity derivatives	747			(1		)	340
Total	$	2,207		$	1		$	357
Nine Months Ended September 30, 2016
Interest rate derivatives	$	2,547		$	—		$	116
Foreign currency exchange rate derivatives	1,865			—			(17		)
Credit derivatives — purchased	(48		)	—			—
Credit derivatives — written	57			—			—
Equity derivatives	(1,472		)	(19		)	(293		)
Total	$	2,949		$	(19	)	$	(194	)
Nine Months Ended September 30, 2015
Interest rate derivatives	$	250		$	—		$	10
Foreign currency exchange rate derivatives	443			—			—
Credit derivatives — purchased	9			3			—
Credit derivatives — written	(108		)	—			—
Equity derivatives	99			(8		)	214
Total	$	693		$	(5	)	$	224

__________________

(1) Changes in estimated fair value related to economic hedges of equity method investments in joint ventures, derivatives held in relation to trading portfolios and derivatives held within contractholder-directed unit-linked investments.

(2) Changes in estimated fair value related to economic hedges of variable annuity guarantees included in future policy benefits.

Fair Value Hedges

The Company designates and accounts for the following as fair value hedges when they have met the requirements of fair value hedging: (i) interest rate swaps to convert fixed rate assets and liabilities to floating rate assets and liabilities; (ii) foreign currency swaps to hedge the foreign currency fair value exposure of foreign currency denominated assets and liabilities; and (iii) foreign currency forwards to hedge the foreign currency fair value exposure of foreign currency denominated investments.

The Company recognizes gains and losses on derivatives and the related hedged items in fair value hedges within net derivative gains (losses). The following table presents the amount of such net derivative gains (losses):

Derivatives in Fair Value Hedging Relationships	Hedged Items in Fair Value Hedging Relationships	Net Derivative Gains (Losses) Recognized for Derivatives			Net Derivative Gains (Losses) Recognized for Hedged Items			Ineffectiveness Recognized in Net Derivative Gains (Losses)
		(In millions)
Three Months Ended September 30, 2016
Interest rate swaps:	Fixed maturity securities	$	6		$	(5	)	$	1
	Policyholder liabilities (1)	(45		)	41			(4		)
Foreign currency swaps:	Foreign-denominated fixed maturity securities	1			(1		)	—
	Foreign-denominated policyholder account balances (2)	(1		)	1			—
Foreign currency forwards:	Foreign-denominated fixed maturity securities	19			(18		)	1
Total		$	(20	)	$	18		$	(2	)
Three Months Ended September 30, 2015
Interest rate swaps:	Fixed maturity securities	$	(4	)	$	3		$	(1	)
	Policyholder liabilities (1)	289			(290		)	(1		)
Foreign currency swaps:	Foreign-denominated fixed maturity securities	6			(3		)	3
	Foreign-denominated policyholder account balances (2)	(47		)	46			(1		)
Foreign currency forwards:	Foreign-denominated fixed maturity securities	49			(45		)	4
Total		$	293		$	(289	)	$	4
Nine Months Ended September 30, 2016
Interest rate swaps:	Fixed maturity securities	$	(5	)	$	2		$	(3	)
	Policyholder liabilities (1)	498			(507		)	(9		)
Foreign currency swaps:	Foreign-denominated fixed maturity securities	7			(7		)	—
	Foreign-denominated policyholder account balances (2)	(27		)	24			(3		)
Foreign currency forwards:	Foreign-denominated fixed maturity securities	295			(272		)	23
Total		$	768		$	(760	)	$	8
Nine Months Ended September 30, 2015
Interest rate swaps:	Fixed maturity securities	$	(5	)	$	8		$	3
	Policyholder liabilities (1)	120			(126		)	(6		)
Foreign currency swaps:	Foreign-denominated fixed maturity securities	13			(6		)	7
	Foreign-denominated policyholder account balances (2)	(186		)	179			(7		)
Foreign currency forwards:	Foreign-denominated fixed maturity securities	(49		)	45			(4		)
Total		$	(107	)	$	100		$	(7	)

__________________

(1) Fixed rate liabilities reported in policyholder account balances or future policy benefits.

(2) Fixed rate or floating rate liabilities.

For the Company’s foreign currency forwards, the change in the estimated fair value of the derivative related to the changes in the difference between the spot price and the forward price is excluded from the assessment of hedge effectiveness. For all other derivatives, all components of each derivative’s gain or loss were included in the assessment of hedge effectiveness. For the three months and nine months endedSeptember 30, 2016, ($6) million and ($16) million, respectively, of the change in estimated fair value of derivatives was excluded from the assessment of hedge effectiveness. For the three months and nine months endedSeptember 30, 2015, ($4) million and ($9) million, respectively, of the change in estimated fair value of derivatives was excluded from the assessment of hedge effectiveness.

Cash Flow Hedges

The Company designates and accounts for the following as cash flow hedges when they have met the requirements of cash flow hedging: (i) interest rate swaps to convert floating rate assets and liabilities to fixed rate assets and liabilities; (ii) foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated assets and liabilities; (iii) interest rate forwards and credit forwards to lock in the price to be paid for forward purchases of investments; (iv) interest rate swaps and interest rate forwards to hedge the forecasted purchases of fixed-rate investments; and (v) interest rate swaps and interest rate forwards to hedge forecasted fixed-rate borrowings.

In certain instances, the Company discontinued cash flow hedge accounting because the forecasted transactions were no longer probable of occurring. Because certain of the forecasted transactions also were not probable of occurring within two months of the anticipated date, the Company reclassified amounts from AOCI into net derivative gains (losses). These amounts were $12 million and $7 million for the three months and nine months endedSeptember 30, 2016, respectively. These amounts were ($3) million for the three months ended September 30, 2015. For the nine months endedSeptember 30, 2015, the amounts reclassified from AOCI into net derivative gains (losses) were not significant.

At September 30, 2016 and December 31, 2015, the maximum length of time over which the Company was hedging its exposure to variability in future cash flows for forecasted transactions did not exceed six years and five years, respectively.

At September 30, 2016 and December 31, 2015, the balance in AOCI associated with cash flow hedges was $3.6 billion and $2.4 billion, respectively.

The following table presents the effects of derivatives in cash flow hedging relationships on the consolidated statements of operations and comprehensive income (loss) and the consolidated statements of equity:

Derivatives in Cash Flow Hedging Relationships	Amount of Gains (Losses) Deferred in AOCI on Derivatives			Amount and Location of Gains (Losses) Reclassified from AOCI into Income (Loss)								Amount and Location of Gains (Losses) Recognized in Income (Loss) on Derivatives
	(Effective Portion)			(Effective Portion)								(Ineffective Portion)
				Net Derivative Gains (Losses)			Net Investment Income			Other Expenses		Net Derivative Gains (Losses)
	(In millions)
Three Months Ended September 30, 2016
Interest rate swaps	$	23		$	28		$	4		$	—	$	—
Interest rate forwards	(5		)	1			1			—		—
Foreign currency swaps	(42		)	59			—			—		(3		)
Credit forwards	—			—			1			—		—
Total	$	(24	)	$	88		$	6		$	—	$	(3	)
Three Months Ended September 30, 2015
Interest rate swaps	$	211		$	40		$	3		$	—	$	1
Interest rate forwards	7			1			1			1		—
Foreign currency swaps	(116		)	(286		)	—			—		4
Credit forwards	—			1			—			—		—
Total	$	102		$	(244	)	$	4		$	1	$	5
Nine Months Ended September 30, 2016
Interest rate swaps	$	376		$	56		$	11		$	—	$	—
Interest rate forwards	42			2			4			1		—
Foreign currency swaps	1,054			96			(1		)	1		(1		)
Credit forwards	—			3			1			—		—
Total	$	1,472		$	157		$	15		$	2	$	(1	)
Nine Months Ended September 30, 2015
Interest rate swaps	$	116		$	52		$	9		$	—	$	3
Interest rate forwards	2			5			3			2		—
Foreign currency swaps	(224		)	(563		)	(1		)	1		6
Credit forwards	—			1			1			—		—
Total	$	(106	)	$	(505	)	$	12		$	3	$	9

All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness.

AtSeptember 30, 2016, the Company expects to reclassify ($64) millionof deferred net gains (losses) on derivatives in AOCI to earnings within the next 12 months.

Hedges of Net Investments in Foreign Operations

The Company uses foreign currency exchange rate derivatives, which may include foreign currency forwards and currency options, to hedge portions of its net investments in foreign operations against adverse movements in exchange rates. The Company measures ineffectiveness on these derivatives based upon the change in forward rates.

When net investments in foreign operations are sold or substantially liquidated, the amounts in AOCI are reclassified to the statement of operations.

The following table presents the effects of derivatives in net investment hedging relationships on the consolidated statements of operations and comprehensive income (loss) and the consolidated statements of equity:

Derivatives in Net Investment Hedging Relationships (1), (2)	Amount of Gains (Losses) Deferred in AOCI (Effective Portion)
	(In millions)
Three Months Ended September 30, 2016
Foreign currency forwards	$	(23	)
Currency options	(37		)
Total	$	(60	)
Three Months Ended September 30, 2015
Foreign currency forwards	$	88
Currency options	(18		)
Total	$	70
Nine Months Ended September 30, 2016
Foreign currency forwards	$	(358	)
Currency options	(351		)
Total	$	(709	)
Nine Months Ended September 30, 2015
Foreign currency forwards	$	244
Currency options	(61		)
Total	$	183

__________________

(1) During both thethree monthsandnine months endedSeptember 30, 2016and2015, there werenosales or substantial liquidations of net investments in foreign operations that would have required the reclassification of gains or losses from AOCI into earnings.

(2) There was no ineffectiveness recognized for the Company’s hedges of net investments in foreign operations. All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness.

At September 30, 2016 and December 31, 2015, the cumulative foreign currency translation gain (loss) recorded in AOCI related to hedges of net investments in foreign operations was $347 million and $1.1 billion, respectively.

Credit Derivatives

In connection with synthetically created credit investment transactions and credit default swaps held in relation to the trading portfolio, the Company writes credit default swaps for which it receives a premium to insure credit risk. Such credit derivatives are included within the nonqualifying derivatives and derivatives for purposes other than hedging table. If a credit event occurs, as defined by the contract, the contract may be cash settled or it may be settled gross by the Company paying the counterparty the specified swap notional amount in exchange for the delivery of par quantities of the referenced credit obligation. The Company’s maximum amount at risk, assuming the value of all referenced credit obligations is zero, was $11.7 billion and $10.3 billion at September 30, 2016 and December 31, 2015, respectively. The Company can terminate these contracts at any time through cash settlement with the counterparty at an amount equal to the then current estimated fair value of the credit default swaps. At September 30, 2016 and December 31, 2015, the Company would have received $140 million and $65 million, respectively, to terminate all of these contracts.

The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at:

	September 30, 2016						December 31, 2015
Rating Agency Designation of Referenced Credit Obligations (1)	Estimated Fair Value of Credit Default Swaps			Maximum Amount of Future Payments under Credit Default Swaps		Weighted Average Years to Maturity (2)	Estimated Fair Value of Credit Default Swaps			Maximum Amount of Future Payments under Credit Default Swaps		Weighted Average Years to Maturity (2)
	(Dollars in millions)
Aaa/Aa/A
Single name credit default swaps (corporate)	$	7		$	483	3.3	$	6		$	661	2.5
Credit default swaps referencing indices	21			1,937		3.5	6			1,635		3.4
Subtotal	28			2,420		3.5	12			2,296		3.2
Baa
Single name credit default swaps (corporate)	8			946		2.6	8			1,349		2.5
Credit default swaps referencing indices	97			7,917		5.1	37			5,863		4.8
Subtotal	105			8,863		4.8	45			7,212		4.4
Ba
Single name credit default swaps (corporate)	(5		)	155		4.3	(2		)	64		2.3
Credit default swaps referencing indices	—			—		—	(1		)	100		1.0
Subtotal	(5		)	155		4.3	(3		)	164		1.5
B
Single name credit default swaps (corporate)	1			70		2.1	—			—		—
Credit default swaps referencing indices	11			156		5.3	11			639		4.9
Subtotal	12			226		4.3	11			639		4.9
Total	$	140		$	11,664	4.5	$	65		$	10,311	4.1

__________________

(1) The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s Investors Service (“Moody’s”), Standard & Poor’s Ratings Services (“S&P”) and Fitch Ratings. If no rating is available from a rating agency, then an internally developed rating is used.

(2) The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts.

The Company has also entered into credit default swaps to purchase credit protection on certain of the referenced credit obligations in the table above. As a result, the maximum amounts of potential future recoveries available to offset the $11.7 billion and $10.3 billion from the table above were $30 million and $80 million at September 30, 2016 and December 31, 2015, respectively.

At September 30, 2016, there were no written credit default swaps held in relation to the trading portfolio. At December 31, 2015, written credit default swaps held in relation to the trading portfolio amounted to $20 million in gross notional amount and ($2) million in estimated fair value.

Credit Risk on Freestanding Derivatives

The Company may be exposed to credit-related losses in the event of nonperformance by its counterparties to derivatives. Generally, the current credit exposure of the Company’s derivatives is limited to the net positive estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements.

The Company manages its credit risk related to derivatives by entering into transactions with creditworthy counterparties and establishing and monitoring exposure limits. The Company’s OTC-bilateral derivative transactions are generally governed by ISDA Master Agreements which provide for legally enforceable set-off and close-out netting of exposures to specific counterparties in the event of early termination of a transaction, which includes, but is not limited to, events of default and bankruptcy. In the event of an early termination, the Company is permitted to set off receivables from the counterparty against payables to the same counterparty arising out of all included transactions. Substantially all of the Company’s ISDA Master Agreements also include Credit Support Annex provisions which require both the pledging and accepting of collateral in connection with its OTC-bilateral derivatives.

The Company’s OTC-cleared derivatives are effected through central clearing counterparties and its exchange-traded derivatives are effected through regulated exchanges. Such positions are marked to market and margined on a daily basis (both initial margin and variation margin), and the Company has minimal exposure to credit-related losses in the event of nonperformance by counterparties to such derivatives.

See Note 9for a description of the impact of credit risk on the valuation of derivatives.

The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:

	September 30, 2016						December 31, 2015
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement (1)	Assets			Liabilities			Assets			Liabilities
	(In millions)
Gross estimated fair value of derivatives:
OTC-bilateral (2)	$	18,154		$	6,603		$	13,017		$	5,848
OTC-cleared (2)	3,949			1,627			1,600			1,217
Exchange-traded	18			111			67			25
Total gross estimated fair value of derivatives (2)	22,121			8,341			14,684			7,090
Amounts offset on the consolidated balance sheets	—			—			—			—
Estimated fair value of derivatives presented on the consolidated balance sheets (2)	22,121			8,341			14,684			7,090
Gross amounts not offset on the consolidated balance sheets:
Gross estimated fair value of derivatives: (3)
OTC-bilateral	(4,984		)	(4,984		)	(4,368		)	(4,368		)
OTC-cleared	(1,609		)	(1,609		)	(1,200		)	(1,200		)
Exchange-traded	(5		)	(5		)	(1		)	(1		)
Cash collateral: (4), (5)
OTC-bilateral	(9,606		)	—			(6,140		)	(7		)
OTC-cleared	(2,101		)	—			(378		)	(10		)
Exchange-traded	—			(9		)	—			(20		)
Securities collateral: (6)
OTC-bilateral	(3,199		)	(1,577		)	(2,078		)	(1,395		)
OTC-cleared	—			—			—			—
Exchange-traded	—			(95		)	—			(3		)
Net amount after application of master netting agreements and collateral	$	617		$	62		$	519		$	86

__________________

(1) See Note 7 for information regarding the Company’s gross and net payables and receivables under repurchase agreement transactions.

(2) At September 30, 2016 and December 31, 2015, derivative assets included income or expense accruals reported in accrued investment income or in other liabilities of $333 million and $278 million, respectively, and derivative liabilities included income or expense accruals reported in accrued investment income or in other liabilities of ($11) million and $41 million, respectively.

(3) Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.

(4) Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives is included in cash and cash equivalents, short-term investments or in fixed maturity securities, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet.

(5) The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At September 30, 2016 and December 31, 2015, the Company received excess cash collateral of $554 million and $89 million, respectively, and provided excess cash collateral of $432 million and $204 million, respectively, which is not included in the table above due to the foregoing limitation.

(6) Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at September 30, 2016, none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At September 30, 2016 and December 31, 2015, the Company received excess securities collateral with an estimated fair value of $137 million and $100 million, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At September 30, 2016 and December 31, 2015, the Company provided excess securities collateral with an estimated fair value of $185 million and $150 million, respectively, for its OTC-bilateral derivatives, and $960 million and $315 million, respectively, for its OTC-cleared derivatives, and $462 million and $224 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.

The Company’s collateral arrangements for its OTC-bilateral derivatives generally require the party in a net liability position, after considering the effect of netting agreements, to pledge collateral when the estimated fair value of that party’s derivatives reaches a minimum transfer amount. A small number of these arrangements also include credit-contingent provisions that include a threshold above which collateral must be posted. Such agreements provide for a reduction of these thresholds (on a sliding scale that converges toward zero) in the event of downgrades in the credit ratings of MetLife, Inc. and/or the counterparty. In addition, substantially all of the Company’s netting agreements for derivatives contain provisions that require both the Company and the counterparty to maintain a specific investment grade credit rating from each of Moody’s and S&P. If a party’s credit or financial strength rating, as applicable, were to fall below that specific investment grade credit rating, that party would be in violation of these provisions, and the other party to the derivatives could terminate the transactions and demand immediate settlement and payment based on such party’s reasonable valuation of the derivatives.

The following table presents the estimated fair value of the Company’s OTC-bilateral derivatives that are in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged. The table also presents the incremental collateral that MetLife, Inc. would be required to provide if there was a one-notch downgrade in MetLife, Inc.’s senior unsecured debt rating at the reporting date or if the Company’s credit or financial strength rating, as applicable, sustained a downgrade to a level that triggered full overnight collateralization or termination of the derivative position at the reporting date. OTC-bilateral derivatives that are not subject to collateral agreements are excluded from this table.

	September 30, 2016						December 31, 2015
	Derivatives Subject to Credit- Contingent Provisions		Derivatives Not Subject to Credit- Contingent Provisions		Total		Derivatives Subject to Credit- Contingent Provisions		Derivatives Not Subject to Credit- Contingent Provisions		Total
	(In millions)
Estimated Fair Value of Derivatives in a Net Liability Position (1)	$	1,606	$	12	$	1,618	$	1,270	$	207	$	1,477
Estimated Fair Value of Collateral Provided:
Fixed maturity securities	$	1,737	$	20	$	1,757	$	1,365	$	174	$	1,539
Cash	$	—	$	—	$	—	$	4	$	4	$	8
Estimated Fair Value of Incremental Collateral Provided Upon:
One-notch downgrade in the Company’s credit or financial strength rating, as applicable	$	2	$	—	$	2	$	1	$	—	$	1
Downgrade in the Company’s credit or financial strength rating, as applicable, to a level that triggers full overnight collateralization or termination of the derivative position	$	2	$	—	$	2	$	1	$	—	$	1

__________________

(1) After taking into consideration the existence of netting agreements.

Embedded Derivatives

The Company issues certain products or purchases certain investments that contain embedded derivatives that are required to be separated from their host contracts and accounted for as freestanding derivatives. These host contracts principally include: variable annuities with guaranteed minimum benefits, including GMWBs, GMABs and certain GMIBs; ceded reinsurance of guaranteed minimum benefits related to certain GMIBs; assumed reinsurance of guaranteed minimum benefits related to GMWBs and GMABs; funding agreements with equity or bond indexed crediting rates; funds withheld on assumed and ceded reinsurance; fixed annuities with equity-indexed returns; and certain debt and equity securities.

The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:

	Balance Sheet Location	September 30, 2016			December 31, 2015
		(In millions)
Net embedded derivatives within asset host contracts:
Ceded guaranteed minimum benefits	Premiums, reinsurance and other receivables	$	514		$	356
Funds withheld on assumed reinsurance	Other invested assets	64			35
Options embedded in debt or equity securities	Investments	(240		)	(220		)
Net embedded derivatives within asset host contracts		$	338		$	171
Net embedded derivatives within liability host contracts:
Direct guaranteed minimum benefits	Policyholder account balances and Future policy benefits	$	5,000		$	(20	)
Assumed guaranteed minimum benefits	Policyholder account balances	1,706			965
Funds withheld on ceded reinsurance	Other liabilities	79			(14		)
Other	Policyholder account balances	98			4
Net embedded derivatives within liability host contracts		$	6,883		$	935

The following table presents changes in estimated fair value related to embedded derivatives:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Net derivative gains (losses) (1)	$	801		$	(1,833	)	$	(4,992	)	$	(1,039	)
Policyholder benefits and claims	$	(14	)	$	59		$	91		$	40

__________________

(1) The valuation of guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were($224) millionand$1.2 billionfor thethree monthsandnine months endedSeptember 30, 2016, respectively, and$253 millionand$222 millionfor thethree monthsandnine months endedSeptember 30, 2015, respectively.

XML

Fair Value

9 Months Ended

Sep. 30, 2016

Fair Value Disclosures [Abstract]

Fair Value

9. Fair Value

Considerable judgment is often required in interpreting market data to develop estimates of fair value, and the use of different assumptions or valuation methodologies may have a material effect on the estimated fair value amounts.

Recurring Fair Value Measurements

The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, including those items for which the Company has elected the FVO, are presented below at:

	September 30, 2016
	Fair Value Hierarchy
	Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	98,569	$	7,107	$	105,676
U.S. government and agency	40,780		28,688		317		69,785
Foreign corporate	—		53,667		6,752		60,419
Foreign government	—		63,443		322		63,765
RMBS	4,349		35,510		5,450		45,309
State and political subdivision	—		17,417		46		17,463
ABS	—		14,506		1,078		15,584
CMBS	—		11,909		532		12,441
Total fixed maturity securities	45,129		323,709		21,604		390,442
Equity securities	1,364		1,270		655		3,289
FVO and trading securities:
Actively traded securities	—		—		—		—
FVO general account securities	578		30		113		721
FVO contractholder-directed unit-linked investments	11,061		2,816		123		14,000
FVO securities held by CSEs	—		2		7		9
Total FVO and trading securities	11,639		2,848		243		14,730
Short-term investments (1)	5,561		4,310		673		10,544
Mortgage loans:
Residential mortgage loans — FVO	—		—		481		481
Commercial mortgage loans held by CSEs — FVO	—		143		—		143
Total mortgage loans	—		143		481		624
Other investments	92		63		—		155
Derivative assets: (2)
Interest rate	4		15,272		156		15,432
Foreign currency exchange rate	—		4,369		62		4,431
Credit	—		141		19		160
Equity market	14		1,417		334		1,765
Total derivative assets	18		21,199		571		21,788
Net embedded derivatives within asset host contracts (3)	—		—		578		578
Separate account assets (4)	87,035		227,343		1,270		315,648
Total assets	$	150,838	$	580,885	$	26,075	$	757,798
Liabilities
Derivative liabilities: (2)
Interest rate	$	41	$	3,084	$	47	$	3,172
Foreign currency exchange rate	2		2,795		52		2,849
Credit	—		54		—		54
Equity market	68		1,448		761		2,277
Total derivative liabilities	111		7,381		860		8,352
Net embedded derivatives within liability host contracts (3)	—		—		6,883		6,883
Long-term debt of CSEs — FVO	—		26		12		38
Trading liabilities (5)	—		—		—		—
Separate account liabilities (4)	1		75		6		82
Total liabilities	$	112	$	7,482	$	7,761	$	15,355

	December 31, 2015
	Fair Value Hierarchy
	Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	93,758	$	7,036	$	100,794
U.S. government and agency	37,660		23,986		—		61,646
Foreign corporate	—		51,438		5,760		57,198
Foreign government	—		49,643		856		50,499
RMBS	—		34,088		4,709		38,797
State and political subdivision	—		15,395		46		15,441
ABS	—		12,731		1,663		14,394
CMBS	—		11,889		744		12,633
Total fixed maturity securities	37,660		292,928		20,814		351,402
Equity securities	1,274		1,615		432		3,321
FVO and trading securities:
Actively traded securities	—		400		4		404
FVO general account securities	506		32		89		627
FVO contractholder-directed unit-linked investments	10,829		2,985		167		13,981
FVO securities held by CSEs	—		2		10		12
Total FVO and trading securities	11,335		3,419		270		15,024
Short-term investments (1)	2,543		5,985		291		8,819
Mortgage loans:
Residential mortgage loans — FVO	—		—		314		314
Commercial mortgage loans held by CSEs — FVO	—		172		—		172
Total mortgage loans	—		172		314		486
Other investments	109		53		—		162
Derivative assets: (2)
Interest rate	4		9,405		25		9,434
Foreign currency exchange rate	—		3,003		16		3,019
Credit	—		99		7		106
Equity market	63		1,435		349		1,847
Total derivative assets	67		13,942		397		14,406
Net embedded derivatives within asset host contracts (3)	—		—		391		391
Separate account assets (4)	77,080		222,814		1,704		301,598
Total assets	$	130,068	$	540,928	$	24,613	$	695,609
Liabilities
Derivative liabilities: (2)
Interest rate	$	7	$	2,340	$	—	$	2,347
Foreign currency exchange rate	—		2,754		148		2,902
Credit	—		45		2		47
Equity market	18		1,077		658		1,753
Total derivative liabilities	25		6,216		808		7,049
Net embedded derivatives within liability host contracts (3)	—		—		935		935
Long-term debt of CSEs — FVO	—		49		11		60
Trading liabilities (5)	103		50		—		153
Separate account liabilities (4)	—		—		—		—
Total liabilities	$	128	$	6,315	$	1,754	$	8,197

__________________

(1) Short-term investments as presented in the tables above differ from the amounts presented on the consolidated balance sheets because certain short-term investments are not measured at estimated fair value on a recurring basis.

(2) Derivative assets are presented within other invested assets on the consolidated balance sheets and derivative liabilities are presented within other liabilities on the consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the consolidated balance sheets, but are presented net for purposes of the rollforward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables.

(3) Net embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables and other invested assets on the consolidated balance sheets. Net embedded derivatives within liability host contracts are presented within policyholder account balances, future policy benefits and other liabilities on the consolidated balance sheets. At September 30, 2016 and December 31, 2015, debt and equity securities also included embedded derivatives of ($240) million and ($220) million, respectively.

(4) Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders whose liability is reflected within separate account liabilities. Separate account liabilities are set equal to the estimated fair value of separate account assets. Separate account liabilities presented in the tables above represent derivative liabilities.

(5) Trading liabilities are presented within other liabilities on the consolidated balance sheets.

The following describes the valuation methodologies used to measure assets and liabilities at fair value. The description includes the valuation techniques and key inputs for each category of assets or liabilities that are classified within Level 2 and Level 3 of the fair value hierarchy.

Investments

Valuation Controls and Procedures

On behalf of the Company’s Chief Investment Officer and Chief Financial Officer, a pricing and valuation committee that is independent of the trading and investing functions and comprised of senior management, provides oversight of control systems and valuation policies for securities, mortgage loans and derivatives. On a quarterly basis, this committee reviews and approves new transaction types and markets, ensures that observable market prices and market-based parameters are used for valuation, wherever possible, and determines that judgmental valuation adjustments, when applied, are based upon established policies and are applied consistently over time. This committee also provides oversight of the selection of independent third-party pricing providers and the controls and procedures to evaluate third-party pricing. Periodically, the Chief Accounting Officer reports to the Audit Committee of MetLife, Inc.’s Board of Directors regarding compliance with fair value accounting standards.

The Company reviews its valuation methodologies on an ongoing basis and revises those methodologies when necessary based on changing market conditions. Assurance is gained on the overall reasonableness and consistent application of input assumptions, valuation methodologies and compliance with fair value accounting standards through controls designed to ensure valuations represent an exit price. Several controls are utilized, including certain monthly controls, which include, but are not limited to, analysis of portfolio returns to corresponding benchmark returns, comparing a sample of executed prices of securities sold to the fair value estimates, comparing fair value estimates to management’s knowledge of the current market, reviewing the bid/ask spreads to assess activity, comparing prices from multiple independent pricing services and ongoing due diligence to confirm that independent pricing services use market-based parameters. The process includes a determination of the observability of inputs used in estimated fair values received from independent pricing services or brokers by assessing whether these inputs can be corroborated by observable market data. The Company ensures that prices received from independent brokers, also referred to herein as “consensus pricing,” represent a reasonable estimate of fair value by considering such pricing relative to the Company’s knowledge of the current market dynamics and current pricing for similar financial instruments. While independent non-binding broker quotations are utilized, they are not used for a significant portion of the portfolio. For example, fixed maturity securities priced using independent non-binding broker quotations represent less than 1% of the total estimated fair value of fixed maturity securities and 5% of the total estimated fair value of Level 3 fixed maturity securities at September 30, 2016.

The Company also applies a formal process to challenge any prices received from independent pricing services that are not considered representative of estimated fair value. If prices received from independent pricing services are not considered reflective of market activity or representative of estimated fair value, independent non-binding broker quotations are obtained, or an internally developed valuation is prepared. Internally developed valuations of current estimated fair value, which reflect internal estimates of liquidity and nonperformance risks, compared with pricing received from the independent pricing services, did not produce material differences in the estimated fair values for the majority of the portfolio; accordingly, overrides were not material. This is, in part, because internal estimates of liquidity and nonperformance risks are generally based on available market evidence and estimates used by other market participants. In the absence of such market-based evidence, management’s best estimate is used.

Securities, Short-term Investments, Other Investments, Long-term Debt of CSEs — FVO and Trading Liabilities

When available, the estimated fair value of these financial instruments is based on quoted prices in active markets that are readily and regularly obtainable. Generally, these are the most liquid of the Company’s securities holdings and valuation of these securities does not involve management’s judgment.

When quoted prices in active markets are not available, the determination of estimated fair value is based on market standard valuation methodologies, giving priority to observable inputs. The significant inputs to the market standard valuation methodologies for certain types of securities with reasonable levels of price transparency are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. When observable inputs are not available, the market standard valuation methodologies rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs can be based in large part on management’s judgment or estimation and cannot be supported by reference to market activity. Even though these inputs are unobservable, management believes they are consistent with what other market participants would use when pricing such securities and are considered appropriate given the circumstances.

The estimated fair value of investments in certain separate accounts included in FVO contractholder-directed unit-linked investments, FVO securities held by CSEs, other investments, long-term debt of CSEs — FVO and trading liabilities is determined on a basis consistent with the methodologies described herein for securities.

The valuation of most instruments listed below is determined using independent pricing sources, matrix pricing, discounted cash flow methodologies or other similar techniques that use either observable market inputs or unobservable inputs.

Instrument	Level 2 Observable Inputs			Level 3 Unobservable Inputs
Fixed Maturity Securities
U.S. corporate and Foreign corporate securities
	Valuation Techniques: Principally the market and income approaches.			Valuation Techniques: Principally the market approach.
	Key Inputs:			Key Inputs:
	•	quoted prices in markets that are not active		•	illiquidity premium
	•	benchmark yields; spreads off benchmark yields; new issuances; issuer rating		•	delta spread adjustments to reflect specific credit-related issues
	•	trades of identical or comparable securities; duration		•	credit spreads
	•	Privately-placed securities are valued using the additional key inputs:		•	quoted prices in markets that are not active for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2
		•	market yield curve; call provisions
		•	observable prices and spreads for similar public or private securities that incorporate the credit quality and industry sector of the issuer	•	independent non-binding broker quotations
		•	delta spread adjustments to reflect specific credit-related issues
U.S. government and agency, Foreign government and State and political subdivision securities
	Valuation Techniques: Principally the market approach.			Valuation Techniques: Principally the market approach.
	Key Inputs:			Key Inputs:
	•	quoted prices in markets that are not active		•	independent non-binding broker quotations
	•	benchmark U.S. Treasury yield or other yields		•	quoted prices in markets that are not active for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2
	•	the spread off the U.S. Treasury yield curve for the identical security
	•	issuer ratings and issuer spreads; broker-dealer quotes		•	credit spreads
	•	comparable securities that are actively traded
Structured Securities
	Valuation Techniques: Principally the market and income approaches.			Valuation Techniques: Principally the market and income approaches.
	Key Inputs:			Key Inputs:
	•	quoted prices in markets that are not active		•	credit spreads
	•	spreads for actively traded securities; spreads off benchmark yields		•	quoted prices in markets that are not active for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2
	•	expected prepayment speeds and volumes
	•	current and forecasted loss severity; ratings; geographic region		•	independent non-binding broker quotations
	•	weighted average coupon and weighted average maturity
	•	average delinquency rates; debt-service coverage ratios
	•	issuance-specific information, including, but not limited to:
		•	collateral type; structure of the security; vintage of the loans
		•	payment terms of the underlying assets
		•	payment priority within the tranche; deal performance

Instrument	Level 2 Observable Inputs		Level 3 Unobservable Inputs
Equity Securities
	Valuation Techniques: Principally the market approach.		Valuation Techniques: Principally the market and income approaches.
	Key Input:		Key Inputs:
	•	quoted prices in markets that are not considered active	•	credit ratings; issuance structures
			•	quoted prices in markets that are not active for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2
			•	independent non-binding broker quotations
FVO and trading securities, Short-term investments, and Other investments
	•	Contractholder-directed unit-linked investments include mutual fund interests without readily determinable fair values given prices are not published publicly. Valuation of these mutual funds is based upon quoted prices or reported net asset value (“NAV”) provided by the fund managers, which were based on observable inputs.	•	FVO and trading securities and short-term investments are of a similar nature and class to the fixed maturity and equity securities described above; accordingly, the valuation techniques and unobservable inputs used in their valuation are also similar to those described above.
	•	All other investments are of a similar nature and class to the fixed maturity and equity securities described above; accordingly, the valuation techniques and observable inputs used in their valuation are also similar to those described above.
Mortgage Loans — FVO
Commercial mortgage loans held by CSEs — FVO
	Valuation Techniques: Principally the market approach.		•	N/A
	Key Input:
	•	quoted securitization market price determined principally by independent pricing services using observable inputs
Residential mortgage loans — FVO
	•	N/A	Valuation Techniques: Principally the market approach, including matrix pricing or other similar techniques.
			Key Inputs:
			•	Inputs that are unobservable or cannot be derived principally from, or corroborated by, observable market data
Separate Account Assets and Separate Account Liabilities (1)
Mutual funds and hedge funds without readily determinable fair values as prices are not published publicly
	Key Input:		•	N/A
	•	quoted prices or reported NAV provided by the fund managers
Other limited partnership interests
	•	N/A	Valuation Techniques: Valued giving consideration to the underlying holdings of the partnerships and by applying a premium or discount, if appropriate.
			Key Inputs:
			•	liquidity; bid/ask spreads; performance record of the fund manager
			•	other relevant variables that may impact the exit value of the particular partnership interest

__________________

(1) Estimated fair value equals carrying value, based on the value of the underlying assets, including: mutual fund interests, fixed maturity securities, equity securities, derivatives, hedge funds, other limited partnership interests, short-term investments and cash and cash equivalents. Fixed maturity securities, equity securities, derivatives, short-term investments and cash and cash equivalents are similar in nature to the instruments described under “— Securities, Short-term Investments, Other Investments, Long-term Debt of CSEs — FVO and Trading Liabilities” and “— Derivatives — Freestanding Derivatives.”

Derivatives

The estimated fair value of derivatives is determined through the use of quoted market prices for exchange-traded derivatives, or through the use of pricing models for OTC-bilateral and OTC-cleared derivatives. The determination of estimated fair value, when quoted market values are not available, is based on market standard valuation methodologies and inputs that management believes are consistent with what other market participants would use when pricing such instruments. Derivative valuations can be affected by changes in interest rates, foreign currency exchange rates, financial indices, credit spreads, default risk, nonperformance risk, volatility, liquidity and changes in estimates and assumptions used in the pricing models. The valuation controls and procedures for derivatives are described in “— Investments.”

The significant inputs to the pricing models for most OTC-bilateral and OTC-cleared derivatives are inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Certain OTC-bilateral and OTC-cleared derivatives may rely on inputs that are significant to the estimated fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and management believes they are consistent with what other market participants would use when pricing such instruments.

Most inputs for OTC-bilateral and OTC-cleared derivatives are mid-market inputs but, in certain cases, liquidity adjustments are made when they are deemed more representative of exit value. Market liquidity, as well as the use of different methodologies, assumptions and inputs, may have a material effect on the estimated fair values of the Company’s derivatives and could materially affect net income.

The credit risk of both the counterparty and the Company are considered in determining the estimated fair value for all OTC-bilateral and OTC-cleared derivatives, and any potential credit adjustment is based on the net exposure by counterparty after taking into account the effects of netting agreements and collateral arrangements. The Company values its OTC-bilateral and OTC-cleared derivatives using standard swap curves which may include a spread to the risk-free rate, depending upon specific collateral arrangements. This credit spread is appropriate for those parties that execute trades at pricing levels consistent with similar collateral arrangements. As the Company and its significant derivative counterparties generally execute trades at such pricing levels and hold sufficient collateral, additional credit risk adjustments are not currently required in the valuation process. The Company’s ability to consistently execute at such pricing levels is in part due to the netting agreements and collateral arrangements that are in place with all of its significant derivative counterparties. An evaluation of the requirement to make additional credit risk adjustments is performed by the Company each reporting period.

Freestanding Derivatives

Level 2 Valuation Techniques and Key Inputs:

This level includes all types of derivatives utilized by the Company with the exception of exchange-traded derivatives included within Level 1 and those derivatives with unobservable inputs as described in Level 3.

Level 3 Valuation Techniques and Key Inputs:

These valuation methodologies generally use the same inputs as described in the corresponding sections for Level 2 measurements of derivatives. However, these derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data.

Freestanding derivatives are principally valued using the income approach. Valuations of non-option-based derivatives utilize present value techniques, whereas valuations of option-based derivatives utilize option pricing models. Key inputs are as follows:

Instrument		Interest Rate		Foreign Currency Exchange Rate		Credit		Equity Market
Inputs common to Level 2 and Level 3 by instrument type	•	swap yield curves	•	swap yield curves	•	swap yield curves	•	swap yield curves
	•	basis curves	•	basis curves	•	credit curves	•	spot equity index levels
	•	interest rate volatility (1)	•	currency spot rates	•	recovery rates	•	dividend yield curves
			•	cross currency basis curves			•	equity volatility (1)
			•	currency volatility (1)
Level 3	•	swap yield curves (2)	•	swap yield curves (2)	•	swap yield curves (2)	•	dividend yield curves (2)
	•	basis curves (2)	•	basis curves (2)	•	credit curves (2)	•	equity volatility (1), (2)
	•	interest rate volatility (1), (2)	•	cross currency basis curves (2)	•	credit spreads	•	correlation between model inputs (1)
	•	repurchase rates	•	currency correlation	•	repurchase rates
			•	currency volatility (1)	•	independent non-binding broker quotations

__________________

(1) Option-based only.

(2) Extrapolation beyond the observable limits of the curve(s).

Embedded Derivatives

Embedded derivatives principally include certain direct, assumed and ceded variable annuity guarantees, equity or bond indexed crediting rates within certain funding agreements and annuity contracts, and those related to funds withheld on ceded reinsurance agreements. Embedded derivatives are recorded at estimated fair value with changes in estimated fair value reported in net income.

The Company issues certain variable annuity products with guaranteed minimum benefits. GMWBs, GMABs and certain GMIBs contain embedded derivatives, which are measured at estimated fair value separately from the host variable annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances and future policy benefits on the consolidated balance sheets.

The Company’s actuarial department calculates the fair value of these embedded derivatives, which are estimated as the present value of projected future benefits minus the present value of projected future fees using actuarial and capital market assumptions including expectations concerning policyholder behavior. The calculation is based on in-force business, and is performed using standard actuarial valuation software which projects future cash flows from the embedded derivative over multiple risk neutral stochastic scenarios using observable risk-free rates.

Capital market assumptions, such as risk-free rates and implied volatilities, are based on market prices for publicly traded instruments to the extent that prices for such instruments are observable. Implied volatilities beyond the observable period are extrapolated based on observable implied volatilities and historical volatilities. Actuarial assumptions, including mortality, lapse, withdrawal and utilization, are unobservable and are reviewed at least annually based on actuarial studies of historical experience.

The valuation of these guarantee liabilities includes nonperformance risk adjustments and adjustments for a risk margin related to non-capital market inputs. The nonperformance adjustment is determined by taking into consideration publicly available information relating to spreads in the secondary market for MetLife, Inc.’s debt, including related credit default swaps. These observable spreads are then adjusted, as necessary, to reflect the priority of these liabilities and the claims paying ability of the issuing insurance subsidiaries compared to MetLife, Inc.

Risk margins are established to capture the non-capital market risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, premium persistency, partial withdrawal and surrenders. The establishment of risk margins requires the use of significant management judgment, including assumptions of the amount and cost of capital needed to cover the guarantees. These guarantees may be more costly than expected in volatile or declining equity markets. Market conditions including, but not limited to, changes in interest rates, equity indices, market volatility and foreign currency exchange rates; changes in nonperformance risk; and variations in actuarial assumptions regarding policyholder behavior, mortality and risk margins related to non-capital market inputs, may result in significant fluctuations in the estimated fair value of the guarantees that could materially affect net income.

The Company ceded the risk associated with certain of the GMIBs previously described. These reinsurance agreements contain embedded derivatives which are included within premiums, reinsurance and other receivables on the consolidated balance sheets with changes in estimated fair value reported in net derivative gains (losses) or policyholder benefits and claims depending on the statement of operations classification of the direct risk. The value of the embedded derivatives on the ceded risk is determined using a methodology consistent with that described previously for the guarantees directly written by the Company with the exception of the input for nonperformance risk that reflects the credit of the reinsurer.

The estimated fair value of the embedded derivatives within funds withheld related to certain ceded reinsurance is determined based on the change in estimated fair value of the underlying assets held by the Company in a reference portfolio backing the funds withheld liability. The estimated fair value of the underlying assets is determined as previously described in “— Investments — Securities, Short-term Investments, Other Investments, Long-term Debt of CSEs — FVO and Trading Liabilities.” The estimated fair value of these embedded derivatives is included, along with their funds withheld hosts, in other liabilities on the consolidated balance sheets with changes in estimated fair value recorded in net derivative gains (losses). Changes in the credit spreads on the underlying assets, interest rates and market volatility may result in significant fluctuations in the estimated fair value of these embedded derivatives that could materially affect net income.

The estimated fair value of the embedded equity and bond indexed derivatives contained in certain funding agreements is determined using market standard swap valuation models and observable market inputs, including a nonperformance risk adjustment. The estimated fair value of these embedded derivatives are included, along with their funding agreements host, within policyholder account balances with changes in estimated fair value recorded in net derivative gains (losses). Changes in equity and bond indices, interest rates and the Company’s credit standing may result in significant fluctuations in the estimated fair value of these embedded derivatives that could materially affect net income.

The Company issues certain annuity contracts which allow the policyholder to participate in returns from equity indices. These equity indexed features are embedded derivatives which are measured at estimated fair value separately from the host fixed annuity contract, with changes in estimated fair value reported in net derivative gains (losses). These embedded derivatives are classified within policyholder account balances on the consolidated balance sheets.

The estimated fair value of the embedded equity indexed derivatives, based on the present value of future equity returns to the policyholder using actuarial and present value assumptions including expectations concerning policyholder behavior, is calculated by the Company’s actuarial department. The calculation is based on in-force business and uses standard capital market techniques, such as Black-Scholes, to calculate the value of the portion of the embedded derivative for which the terms are set. The portion of the embedded derivative covering the period beyond where terms are set is calculated as the present value of amounts expected to be spent to provide equity indexed returns in those periods. The valuation of these embedded derivatives also includes the establishment of a risk margin, as well as changes in nonperformance risk.

Embedded Derivatives Within Asset and Liability Host Contracts

Level 3 Valuation Techniques and Key Inputs:

Direct and assumed guaranteed minimum benefits

These embedded derivatives are principally valued using the income approach. Valuations are based on option pricing techniques, which utilize significant inputs that may include swap yield curves, currency exchange rates and implied volatilities. These embedded derivatives result in Level 3 classification because one or more of the significant inputs are not observable in the market or cannot be derived principally from, or corroborated by, observable market data. Significant unobservable inputs generally include: the extrapolation beyond observable limits of the swap yield curves and implied volatilities, actuarial assumptions for policyholder behavior and mortality and the potential variability in policyholder behavior and mortality, nonperformance risk and cost of capital for purposes of calculating the risk margin.

Reinsurance ceded on certain guaranteed minimum benefits

These embedded derivatives are principally valued using the income approach. The valuation techniques and significant market standard unobservable inputs used in their valuation are similar to those described above in “— Direct and assumed guaranteed minimum benefits” and also include counterparty credit spreads.

Transfers between Levels

Overall, transfers between levels occur when there are changes in the observability of inputs and market activity. Transfers into or out of any level are assumed to occur at the beginning of the period.

Transfers between Levels 1 and 2:

For assets and liabilities measured at estimated fair value and still held at September 30, 2016, transfers between Levels 1 and 2 were not significant. For assets and liabilities measured at estimated fair value and still held at December 31, 2015, transfers between Levels 1 and 2 were $203 million.

Transfers into or out of Level 3:

Assets and liabilities are transferred into Level 3 when a significant input cannot be corroborated with market observable data. This occurs when market activity decreases significantly and underlying inputs cannot be observed, current prices are not available, and/or when there are significant variances in quoted prices, thereby affecting transparency. Assets and liabilities are transferred out of Level 3 when circumstances change such that a significant input can be corroborated with market observable data. This may be due to a significant increase in market activity, a specific event, or one or more significant input(s) becoming observable.

Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)

The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:

					September 30, 2016				December 31, 2015				Impact of Increase in Input on Estimated Fair Value (2)
	Valuation Techniques		Significant Unobservable Inputs		Range			Weighted Average (1)	Range			Weighted Average (1)
Fixed maturity securities (3)
U.S. corporate and foreign corporate	•	Matrix pricing	•	Delta spread adjustments (4)	(269)	-	603	(4)	(65)	-	240	39	Decrease
	•	Market pricing	•	Quoted prices (5)	6	-	788	123	—	-	780	156	Increase
	•	Consensus pricing	•	Offered quotes (5)	23	-	121	98	68	-	121	98	Increase
Foreign government	•	Market pricing	•	Quoted prices (5)	100	-	124	104	96	-	135	113	Increase
RMBS	•	Market pricing	•	Quoted prices (5)	7	-	131	90	19	-	292	92	Increase (6)
ABS	•	Market pricing	•	Quoted prices (5)	5	-	105	99	16	-	109	100	Increase (6)
	•	Consensus pricing	•	Offered quotes (5)	98	-	107	100	66	-	105	99	Increase (6)
Derivatives
Interest rate	•	Present value techniques	•	Swap yield (7)	200	-	300		307	-	317		Increase (8)
			•	Repurchase rates (9)	(6)	-	17						Decrease (8)
Foreign currency exchange rate	•	Present value techniques	•	Swap yield (7)	50	-	328		28	-	381		Increase (8)
Credit	•	Present value techniques	•	Credit spreads (10)	97	-	100		98	-	100		Decrease (8)
	•	Consensus pricing	•	Offered quotes (11)
Equity market	•	Present value techniques or option pricing models	•	Volatility (12)	13%	-	36%		15%	-	36%		Increase (8)
			•	Correlation (13)	40%	-	40%		70%	-	70%
Embedded derivatives
Direct, assumed and ceded guaranteed minimum benefits	•	Option pricing techniques	•	Mortality rates:
				Ages 0 - 40	0%	-	0.21%		0%	-	0.21%		Decrease (14)
				Ages 41 - 60	0.01%	-	0.78%		0.01%	-	0.78%		Decrease (14)
				Ages 61 - 115	0%	-	100%		0.04%	-	100%		Decrease (14)
			•	Lapse rates:
				Durations 1 - 10	0.25%	-	100%		0.25%	-	100%		Decrease (15)
				Durations 11 - 20	2%	-	100%		2%	-	100%		Decrease (15)
				Durations 21 - 116	1.25%	-	100%		1%	-	100%		Decrease (15)
			•	Utilization rates	0%	-	25%		0%	-	25%		Increase (16)
			•	Withdrawal rates	0%	-	20%		0%	-	20%		(17)
			•	Long-term equity volatilities	9.95%	-	33%		8.79%	-	33%		Increase (18)
			•	Nonperformance risk spread	0.05%	-	2.03%		(0.47)%	-	1.31%		Decrease (19)

__________________

(1) The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities.

(2) The impact of a decrease in input would have the opposite impact on estimated fair value. For embedded derivatives, changes to direct and assumed guaranteed minimum benefits are based on liability positions; changes to ceded guaranteed minimum benefits are based on asset positions.

(3) Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations.

(4) Range and weighted average are presented in basis points.

(5) Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par.

(6) Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates.

(7) Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curves are utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.

(8) Changes in estimated fair value are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions.

(9) Ranges represent different repurchase rates utilized as components within the valuation methodology and are presented in basis points.

(10) Represents the risk quoted in basis points of a credit default event on the underlying instrument. Credit derivatives with significant unobservable inputs are primarily comprised of written credit default swaps.

(11) At both September 30, 2016 and December 31, 2015, independent non-binding broker quotations were used in the determination of less than 1% of the total net derivative estimated fair value.

(12) Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.

(13) Ranges represent the different correlation factors utilized as components within the valuation methodology. Presenting a range of correlation factors is more representative of the unobservable input used in the valuation. Increases (decreases) in correlation in isolation will increase (decrease) the significance of the change in valuations.

(14) Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(15) Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(16) The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(17) The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.

(18) Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(19) Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.

The following is a summary of the valuation techniques and significant unobservable inputs used in the fair value measurement of assets and liabilities classified within Level 3 that are not included in the preceding table. Generally, all other classes of securities classified within Level 3, including those within separate account assets and embedded derivatives within funds withheld related to certain ceded and assumed reinsurance, use the same valuation techniques and significant unobservable inputs as previously described for Level 3 securities. This includes matrix pricing and discounted cash flow methodologies, inputs such as quoted prices for identical or similar securities that are less liquid and based on lower levels of trading activity than securities classified in Level 2, as well as independent non-binding broker quotations. The residential mortgage loans — FVO and long-term debt of CSEs — FVO are valued using independent non-binding broker quotations and internal models including matrix pricing and discounted cash flow methodologies using current interest rates. The sensitivity of the estimated fair value to changes in the significant unobservable inputs for these other assets and liabilities is similar in nature to that described in the preceding table. The valuation techniques and significant unobservable inputs used in the fair value measurement for the more significant assets measured at estimated fair value on a nonrecurring basis and determined using significant unobservable inputs (Level 3) are summarized in “— Nonrecurring Fair Value Measurements.”

The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities
	Corporate (1)			U.S. Government and Agency			Foreign Government			Structured Securities			State and Political Subdivision			Equity Securities			FVO and Trading Securities (2)
	(In millions)
Three Months Ended September 30, 2016
Balance, beginning of period	$	13,710		$	323		$	376		$	6,700		$	53		$	682		$	231
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	15			—			2			34			—			5			4
Total realized/unrealized gains (losses) included in AOCI	98			(1		)	1			39			3			(9		)	—
Purchases (5)	680			99			21			1,034			—			4			18
Sales (5)	(595		)	—			(7		)	(512		)	—			(20		)	(6		)
Issuances (5)	—			—			—			—			—			—			—
Settlements (5)	—			—			—			—			—			—			—
Transfers into Level 3 (6)	424			—			—			81			7			1			—
Transfers out of Level 3 (6)	(473		)	(104		)	(71		)	(316		)	(17		)	(8		)	(4		)
Balance, end of period	$	13,859		$	317		$	322		$	7,060		$	46		$	655		$	243
Three Months Ended September 30, 2015
Balance, beginning of period	$	13,520		$	55		$	1,336		$	7,018		$	55		$	489		$	475
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	25			—			4			29			—			6			(16		)
Total realized/unrealized gains (losses) included in AOCI	(296		)	—			(1		)	(46		)	1			(14		)	—
Purchases (5)	955			—			17			2,544			20			12			91
Sales (5)	(351		)	(1		)	(17		)	(418		)	—			(13		)	(41		)
Issuances (5)	—			—			—			—			—			—			—
Settlements (5)	—			—			—			—			—			—			—
Transfers into Level 3 (6)	699			18			11			361			—			—			80
Transfers out of Level 3 (6)	(1,850		)	(55		)	(659		)	(955		)	(30		)	(30		)	(191		)
Balance, end of period	$	12,702		$	17		$	691		$	8,533		$	46		$	450		$	398
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2016 (7)	$	1		$	—		$	2		$	33		$	—		$	(1	)	$	4
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2015 (7)	$	10		$	—		$	4		$	33		$	—		$	—		$	(16	)

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Short-term Investments			Residential Mortgage Loans — FVO			Net Derivatives (8)			Net Embedded Derivatives (9)			Separate Accounts (10)			Long-term Debt of CSEs — FVO			Trading Liabilities
	(In millions)
Three Months Ended September 30, 2016
Balance, beginning of period	$	175		$	449		$	(132	)	$	(6,804	)	$	1,627		$	(12	)	$	—
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	1			10			(116		)	765			(25		)	—			—
Total realized/unrealized gains (losses) included in AOCI	(1		)	—			(7		)	(27		)	—			—			—
Purchases (5)	664			42			—			—			4			—			—
Sales (5)	(55		)	(5		)	—			—			(155		)	—			—
Issuances (5)	—			—			(1		)	—			30			—			—
Settlements (5)	—			(15		)	(33		)	(239		)	(45		)	—			—
Transfers into Level 3 (6)	—			—			—			—			8			—			—
Transfers out of Level 3 (6)	(111		)	—			—			—			(180		)	—			—
Balance, end of period	$	673		$	481		$	(289	)	$	(6,305	)	$	1,264		$	(12	)	$	—
Three Months Ended September 30, 2015
Balance, beginning of period	$	1,809		$	345		$	(372	)	$	841		$	1,925		$	(12	)	$	(4	)
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	—			(2		)	(97		)	(1,753		)	24			—			—
Total realized/unrealized gains (losses) included in AOCI	—			—			7			(38		)	—			—			—
Purchases (5)	1,296			18			—			—			95			—			(2		)
Sales (5)	(11		)	(37		)	—			—			(93		)	—			—
Issuances (5)	—			—			(1		)	—			—			—			—
Settlements (5)	—			(9		)	24			(216		)	—			1			—
Transfers into Level 3 (6)	5			—			—			—			2			—			—
Transfers out of Level 3 (6)	(1,786		)	—			—			—			(271		)	—			4
Balance, end of period	$	1,313		$	315		$	(439	)	$	(1,166	)	$	1,682		$	(11	)	$	(2	)
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2016 (7)	$	1		$	10		$	(103	)	$	750		$	—		$	—		$	—
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2015 (7)	$	—		$	(2	)	$	(103	)	$	(1,743	)	$	—		$	—		$	—

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities
	Corporate (1)			U.S. Government and Agency			Foreign Government			Structured Securities			State and Political Subdivision			Equity Securities			FVO and Trading Securities (2)
	(In millions)
Nine Months Ended September 30, 2016
Balance, beginning of period	$	12,796		$	—		$	856		$	7,116		$	46		$	432		$	270
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	(4		)	—			9			101			1			(21		)	9
Total realized/unrealized gains (losses) included in AOCI	1,027			17			(2		)	28			2			43			—
Purchases (5)	1,893			111			58			2,291			—			20			43
Sales (5)	(1,034		)	—			(36		)	(1,357		)	—			(25		)	(29		)
Issuances (5)	—			—			—			—			—			—			—
Settlements (5)	—			—			—			—			—			—			—
Transfers into Level 3 (6)	711			200			41			43			7			455			18
Transfers out of Level 3 (6)	(1,530		)	(11		)	(604		)	(1,162		)	(10		)	(249		)	(68		)
Balance, end of period	$	13,859		$	317		$	322		$	7,060		$	46		$	655		$	243
Nine Months Ended September 30, 2015
Balance, beginning of period	$	13,432		$	—		$	1,311		$	7,392		$	—		$	345		$	567
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	62			—			10			88			—			7			(27		)
Total realized/unrealized gains (losses) included in AOCI	(759		)	(1		)	1			(68		)	—			(22		)	—
Purchases (5)	1,884			—			30			4,062			46			57			130
Sales (5)	(964		)	(1		)	(39		)	(1,304		)	—			(34		)	(130		)
Issuances (5)	—			—			—			—			—			—			—
Settlements (5)	—			—			—			—			—			—			—
Transfers into Level 3 (6)	844			19			7			355			—			107			82
Transfers out of Level 3 (6)	(1,797		)	—			(629		)	(1,992		)	—			(10		)	(224		)
Balance, end of period	$	12,702		$	17		$	691		$	8,533		$	46		$	450		$	398
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2016 (7)	$	2		$	—		$	9		$	96		$	1		$	(27	)	$	9
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2015 (7)	$	21		$	—		$	10		$	89		$	—		$	—		$	(25	)

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Short-term Investments			Residential Mortgage Loans — FVO			Net Derivatives (8)			Net Embedded Derivatives (9)			Separate Accounts (10)			Long-term Debt of CSEs — FVO			Trading Liabilities
	(In millions)
Nine Months Ended September 30, 2016
Balance, beginning of period	$	291		$	314		$	(411	)	$	(544	)	$	1,704		$	(11	)	$	—
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	1			22			110			(4,851		)	7			—			—
Total realized/unrealized gains (losses) included in AOCI	4			—			36			(237		)	—			—			—
Purchases (5)	673			187			12			—			108			—			—
Sales (5)	(294		)	(12		)	—			—			(233		)	—			—
Issuances (5)	—			—			(1		)	—			27			—			—
Settlements (5)	—			(30		)	(33		)	(673		)	(58		)	(1		)	—
Transfers into Level 3 (6)	1			—			—			—			9			—			—
Transfers out of Level 3 (6)	(3		)	—			(2		)	—			(300		)	—			—
Balance, end of period	$	673		$	481		$	(289	)	$	(6,305	)	$	1,264		$	(12	)	$	—
Nine Months Ended September 30, 2015
Balance, beginning of period	$	336		$	308		$	(300	)	$	430		$	1,922		$	(13	)	$	—
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	1			18			(163		)	(964		)	5			—			—
Total realized/unrealized gains (losses) included in AOCI	—			—			3			(19		)	—			—			—
Purchases (5)	1,313			114			4			—			297			—			(2		)
Sales (5)	(28		)	(100		)	—			—			(232		)	—			—
Issuances (5)	—			—			(1		)	—			—			—			—
Settlements (5)	—			(25		)	18			(613		)	(2		)	2			—
Transfers into Level 3 (6)	—			—			—			—			3			—			—
Transfers out of Level 3 (6)	(309		)	—			—			—			(311		)	—			—
Balance, end of period	$	1,313		$	315		$	(439	)	$	(1,166	)	$	1,682		$	(11	)	$	(2	)
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2016 (7)	$	1		$	22		$	90		$	(4,884	)	$	—		$	—		$	—
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2015 (7)	$	—		$	18		$	(141	)	$	(973	)	$	—		$	—		$	—

__________________

(1) Comprised of U.S. and foreign corporate securities.

(2) Comprised of actively traded securities, FVO general account securities, FVO contractholder-directed unit-linked investments and FVO securities held by CSEs.

(3) Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities are included in net investment gains (losses), while changes in estimated fair value of residential mortgage loans — FVO are included in net investment income. Lapses associated with net embedded derivatives are included in net derivative gains (losses). Substantially all realized/unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivatives gains (losses).

(4) Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward.

(5) Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.

(6) Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.

(7) Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods. Substantially all changes in unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivative gains (losses).

(8) Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.

(9) Embedded derivative assets and liabilities are presented net for purposes of the rollforward.

(10) Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income (loss). For the purpose of this disclosure, these changes are presented within net investment gains (losses). Separate account assets and liabilities are presented net for the purposes of the rollforward.

Fair Value Option

The following table presents information for certain assets and liabilities accounted for under the FVO. These assets and liabilities were initially measured at fair value.

	Residential Mortgage Loans — FVO						Certain Assets and Liabilities of CSEs — FVO (1)
	September 30, 2016			December 31, 2015			September 30, 2016			December 31, 2015
	(In millions)
Assets
Unpaid principal balance	$	641		$	436		$	95		$	121
Difference between estimated fair value and unpaid principal balance	(160		)	(122		)	48			51
Carrying value at estimated fair value	$	481		$	314		$	143		$	172
Loans in non-accrual status	$	186		$	122		$	—		$	—
Liabilities
Contractual principal balance							$	50		$	71
Difference between estimated fair value and contractual principal balance							(12		)	(11		)
Carrying value at estimated fair value							$	38		$	60

__________________

(1) These assets and liabilities are comprised of commercial mortgage loans and long-term debt. Changes in estimated fair value on these assets and liabilities and gains or losses on sales of these assets are recognized in net investment gains (losses). Interest income on commercial mortgage loans held by CSEs — FVO is recognized in net investment income. Interest expense from long-term debt of CSEs — FVO is recognized in other expenses.

Nonrecurring Fair Value Measurements

The following table presents information for assets measured at estimated fair value on a nonrecurring basis during the periods and still held at the reporting dates (for example, when there is evidence of impairment). The estimated fair values for these assets were determined using significant unobservable inputs (Level 3).

	At   September 30,				Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016		2015		2016			2015			2016			2015
	Carrying Value After Measurement				Gains (Losses)
	(In millions)
Mortgage loans (1)	$	12	$	44	$	—		$	—		$	—		$	(1	)
Other limited partnership interests (2)	$	78	$	53	$	(9	)	$	(8	)	$	(45	)	$	(27	)
Other assets (3)	$	—	$	—	$	—		$	—		$	(44	)	$	—
Goodwill (4)	$	—	$	—	$	(260	)	$	—		$	(260	)	$	—

__________________

(1) Estimated fair values for impaired mortgage loans are based on independent broker quotations or valuation models using unobservable inputs or, if the loans are in foreclosure or are otherwise determined to be collateral dependent, are based on the estimated fair value of the underlying collateral or the present value of the expected future cash flows.

(2) For these cost method investments, estimated fair value is determined from information provided on the financial statements of the underlying entities including NAV data. These investments include private equity and debt funds that typically invest primarily in various strategies including domestic and international leveraged buyout funds; power, energy, timber and infrastructure development funds; venture capital funds; and below investment grade debt and mezzanine debt funds. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next two to 10 years. Unfunded commitments for these investments at both September 30, 2016 and 2015 were not significant.

(3) During the nine months ended September 30, 2016, the Company recognized an impairment of computer software in connection with the U.S. Retail Advisor Force Divestiture. See Note 3.

(4) As discussed in Note 10, for both the three months and nine months ended September 30, 2016, the Company recorded an impairment of goodwill associated with the reporting units within the Brighthouse Financial segment.

Fair Value of Financial Instruments Carried at Other Than Fair Value

The following tables provide fair value information for financial instruments that are carried on the balance sheet at amounts other than fair value. These tables exclude the following financial instruments: cash and cash equivalents, accrued investment income, payables for collateral under securities loaned and other transactions, short-term debt and those short-term investments that are not securities, such as time deposits, and therefore are not included in the three level hierarchy table disclosed in the “— Recurring Fair Value Measurements” section. The estimated fair value of the excluded financial instruments, which are primarily classified in Level 2, approximates carrying value as they are short-term in nature such that the Company believes there is minimal risk of material changes in interest rates or credit quality. All remaining balance sheet amounts excluded from the tables below are not considered financial instruments subject to this disclosure.

The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:

	September 30, 2016
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Mortgage loans	$	70,532	$	—	$	—	$	73,585	$	73,585
Policy loans	$	11,177	$	—	$	1,107	$	12,594	$	13,701
Real estate joint ventures	$	25	$	—	$	—	$	87	$	87
Other limited partnership interests	$	414	$	—	$	—	$	461	$	461
Other invested assets	$	559	$	169	$	—	$	390	$	559
Premiums, reinsurance and other receivables	$	4,030	$	—	$	910	$	3,218	$	4,128
Other assets	$	243	$	—	$	205	$	76	$	281
Liabilities
Policyholder account balances	$	126,417	$	—	$	—	$	133,084	$	133,084
Long-term debt	$	16,505	$	—	$	18,526	$	—	$	18,526
Collateral financing arrangements	$	4,084	$	—	$	—	$	3,749	$	3,749
Junior subordinated debt securities	$	3,168	$	—	$	4,142	$	—	$	4,142
Other liabilities	$	6,919	$	—	$	6,429	$	492	$	6,921
Separate account liabilities	$	123,253	$	—	$	123,253	$	—	$	123,253

	December 31, 2015
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Mortgage loans	$	66,616	$	—	$	—	$	68,539	$	68,539
Policy loans	$	11,258	$	—	$	1,279	$	12,072	$	13,351
Real estate joint ventures	$	35	$	—	$	—	$	104	$	104
Other limited partnership interests	$	524	$	—	$	—	$	615	$	615
Other invested assets	$	537	$	155	$	2	$	380	$	537
Premiums, reinsurance and other receivables	$	2,822	$	—	$	484	$	2,421	$	2,905
Other assets	$	235	$	—	$	207	$	60	$	267
Liabilities
Policyholder account balances	$	125,040	$	—	$	—	$	130,125	$	130,125
Long-term debt	$	17,954	$	—	$	19,360	$	—	$	19,360
Collateral financing arrangements	$	4,139	$	—	$	—	$	3,899	$	3,899
Junior subordinated debt securities	$	3,194	$	—	$	4,029	$	—	$	4,029
Other liabilities	$	2,249	$	—	$	865	$	1,385	$	2,250
Separate account liabilities	$	112,119	$	—	$	112,119	$	—	$	112,119

The methods, assumptions and significant valuation techniques and inputs used to estimate the fair value of financial instruments are summarized as follows:

Mortgage Loans

The estimated fair value of mortgage loans is primarily determined by estimating expected future cash flows and discounting them using current interest rates for similar mortgage loans with similar credit risk, or is determined from pricing for similar loans.

Policy Loans

Policy loans with fixed interest rates are classified within Level 3. The estimated fair values for these loans are determined using a discounted cash flow model applied to groups of similar policy loans determined by the nature of the underlying insurance liabilities. Cash flow estimates are developed by applying a weighted-average interest rate to the outstanding principal balance of the respective group of policy loans and an estimated average maturity determined through experience studies of the past performance of policyholder repayment behavior for similar loans. These cash flows are discounted using current risk-free interest rates with no adjustment for borrower credit risk, as these loans are fully collateralized by the cash surrender value of the underlying insurance policy. Policy loans with variable interest rates are classified within Level 2 and the estimated fair value approximates carrying value due to the absence of borrower credit risk and the short time period between interest rate resets, which presents minimal risk of a material change in estimated fair value due to changes in market interest rates.

Real Estate Joint Ventures and Other Limited Partnership Interests

The estimated fair values of these cost method investments are generally based on the Company’s share of the NAV as provided on the financial statements of the investees. In certain circumstances, management may adjust the NAV by a premium or discount when it has sufficient evidence to support applying such adjustments.

Other Invested Assets

These other invested assets are principally comprised of various interest-bearing assets held in foreign subsidiaries and certain amounts due under contractual indemnifications. For the various interest-bearing assets held in foreign subsidiaries, the Company evaluates the specific facts and circumstances of each instrument to determine the appropriate estimated fair values. These estimated fair values were not materially different from the recognized carrying values.

Premiums, Reinsurance and Other Receivables

Premiums, reinsurance and other receivables are principally comprised of certain amounts recoverable under reinsurance agreements, amounts on deposit with financial institutions to facilitate daily settlements related to certain derivatives and amounts receivable for securities sold but not yet settled.

Amounts recoverable under ceded reinsurance agreements, which the Company has determined do not transfer significant risk such that they are accounted for using the deposit method of accounting, have been classified as Level 3. The valuation is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using interest rates determined to reflect the appropriate credit standing of the assuming counterparty.

The amounts on deposit for derivative settlements, classified within Level 2, essentially represent the equivalent of demand deposit balances and amounts due for securities sold are generally received over short periods such that the estimated fair value approximates carrying value.

Other Assets

These other assets are principally comprised of a receivable for cash paid to an unaffiliated financial institution under the MetLife Reinsurance Company of Charleston (“MRC”) collateral financing arrangement described in Note 13 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report. The estimated fair value of the receivable for the cash paid to the unaffiliated financial institution under the MRC collateral financing arrangement is determined by discounting the expected future cash flows using a discount rate that reflects the credit rating of the unaffiliated financial institution.

Policyholder Account Balances

These policyholder account balances include investment contracts which primarily include certain funding agreements, fixed deferred annuities, modified guaranteed annuities, fixed term payout annuities and total control accounts (“TCA”). The valuation of these investment contracts is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using current market risk-free interest rates adding a spread to reflect the nonperformance risk in the liability.

Long-term Debt, Collateral Financing Arrangements and Junior Subordinated Debt Securities

The estimated fair values of long-term debt, collateral financing arrangements and junior subordinated debt securities are principally determined using market standard valuation methodologies.

Valuations of instruments classified as Level 2 are based primarily on quoted prices in markets that are not active or using matrix pricing that use standard market observable inputs such as quoted prices in markets that are not active and observable yields and spreads in the market. Instruments valued using discounted cash flow methodologies use standard market observable inputs including market yield curve, duration, call provisions, observable prices and spreads for similar publicly traded or privately traded issues.

Valuations of instruments classified as Level 3 are based primarily on discounted cash flow methodologies that utilize unobservable discount rates that can vary significantly based upon the specific terms of each individual arrangement. The determination of estimated fair values of collateral financing arrangements incorporates valuations obtained from the counterparties to the arrangements, as part of the collateral management process.

Other Liabilities

Other liabilities consist primarily of interest payable, amounts due for securities purchased but not yet settled, and funds withheld amounts payable, which are contractually withheld by the Company in accordance with the terms of the reinsurance agreements. The Company evaluates the specific terms, facts and circumstances of each instrument to determine the appropriate estimated fair values, which are not materially different from the carrying values, with the exception of certain deposit type reinsurance payables. For such payables, the estimated fair value is determined as the present value of expected future cash flows, which are discounted using an interest rate determined to reflect the appropriate credit standing of the assuming counterparty.

Separate Account Liabilities

Separate account liabilities represent those balances due to policyholders under contracts that are classified as investment contracts.

Separate account liabilities classified as investment contracts primarily represent variable annuities with no significant mortality risk to the Company such that the death benefit is equal to the account balance, funding agreements related to group life contracts and certain contracts that provide for benefit funding.

Since separate account liabilities are fully funded by cash flows from the separate account assets which are recognized at estimated fair value as described in the section “— Recurring Fair Value Measurements,” the value of those assets approximates the estimated fair value of the related separate account liabilities. The valuation techniques and inputs for separate account liabilities are similar to those described for separate account assets.

XML

Equity

9 Months Ended

Sep. 30, 2016

Equity [Abstract]

Equity

11. Equity

Preferred Stock

Preferred stock authorized, issued and outstanding was as follows at both September 30, 2016 and December 31, 2015:

Series	Shares Authorized	Shares Issued	Shares Outstanding
Floating Rate Non-Cumulative Preferred Stock, Series A	27,600,000	24,000,000	24,000,000
5.25% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series C	1,500,000	1,500,000	1,500,000
Series A Junior Participating Preferred Stock	10,000,000	—	—
Not designated	160,900,000	—	—
Total	200,000,000	25,500,000	25,500,000

Common Stock

Duringthenine months endedSeptember 30, 2016and2015, MetLife, Inc. repurchased1,445,864 and22,475,816shares through open market purchases for$70 millionand$1.1 billion, respectively.

At September 30, 2016, MetLife, Inc. had no remaining common stock repurchase authorizations. Common stock repurchases are dependent upon several factors, including the Company’s capital position, liquidity, financial strength and credit ratings, general market conditions, the market price of MetLife, Inc.’s common stock compared to management’s assessment of the stock’s underlying value and applicable regulatory approvals, as well as other legal and accounting factors.

Stock-Based Compensation Plans

Performance Shares and Performance Units

Awards under the MetLife, Inc. 2005 Stock and Incentive Compensation Plan and the MetLife, Inc. 2015 Stock and Incentive Compensation Plan (the “2015 Stock Plan”) were outstanding at September 30, 2016. All awards granted in 2015 or later were granted under the 2015 Stock Plan. There were no outstanding awards to MetLife, Inc. directors, for their service as directors, as of September 30, 2016.

For Performance Share and Performance Unit awards outstanding as of September 30, 2016, any vested Performance Shares and Performance Units will be multiplied by a performance factor of 0% to 175%. Assuming that MetLife, Inc. has met threshold performance goals related to its adjusted income or total shareholder return, the MetLife, Inc. Compensation Committee will determine the performance factor in its discretion. In doing so, the Compensation Committee may consider MetLife, Inc.’s total shareholder return relative to the performance of its competitors and MetLife, Inc.’s operating return on equity relative to its business plan. The estimated fair value of Performance Shares and Performance Units will be remeasured each quarter until they become payable.

Payout of 2013 – 2015 Performance Shares and Performance Units

Final Performance Shares are paid in shares of MetLife, Inc. common stock. Final Performance Units are payable in cash equal to the closing price of MetLife, Inc. common stock on a date following the last day of the three-year performance period. The performance factor for the January 1, 2013 – December 31, 2015 performance period was 86.2%. This factor has been applied to the 1,592,650 Performance Shares and 234,787 Performance Units associated with that performance period that vested on December 31, 2015. As a result, in the first quarter of 2016, MetLife, Inc. issued 1,372,864 shares of its common stock (less withholding for taxes and other items, as applicable), excluding shares that payees choose to defer, and MetLife, Inc. or its affiliates paid the cash value of 202,386 units (less withholding for taxes and other items, as applicable).

Accumulated Other Comprehensive Income (Loss)

Information regarding changes in the balances of each component of AOCI attributable to MetLife, Inc., was as follows:

	Three Months   Ended   September 30, 2016
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Foreign Currency Translation Adjustments			Defined Benefit Plans Adjustment			Total
	(In millions)
Balance, beginning of period	$	18,204		$	2,431		$	(4,020	)	$	(1,983	)	$	14,632
OCI before reclassifications	(1,066		)	(24		)	49			(259		)	(1,300		)
Deferred income tax benefit (expense)	281			8			30			85			404
AOCI before reclassifications, net of income tax	17,419			2,415			(3,941		)	(2,157		)	13,736
Amounts reclassified from AOCI	(173		)	(94		)	—			46			(221		)
Deferred income tax benefit (expense)	60			30			—			(10		)	80
Amounts reclassified from AOCI, net of income tax	(113		)	(64		)	—			36			(141		)
Balance, end of period	$	17,306		$	2,351		$	(3,941	)	$	(2,121	)	$	13,595
	Three Months   Ended   September 30, 2015
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Foreign Currency Translation Adjustments			Defined Benefit Plans Adjustment			Total
	(In millions)
Balance, beginning of period	$	11,761		$	1,102		$	(4,214	)	$	(2,206	)	$	6,443
OCI before reclassifications	962			102			(336		)	—			728
Deferred income tax benefit (expense)	(340		)	(47		)	(24		)	—			(411		)
AOCI before reclassifications, net of income tax	12,383			1,157			(4,574		)	(2,206		)	6,760
Amounts reclassified from AOCI	(102		)	239			—			57			194
Deferred income tax benefit (expense)	34			(77		)	—			(20		)	(63		)
Amounts reclassified from AOCI, net of income tax	(68		)	162			—			37			131
Balance, end of period	$	12,315		$	1,319		$	(4,574	)	$	(2,169	)	$	6,891

	Nine Months   Ended   September 30, 2016
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Foreign Currency Translation Adjustments			Defined Benefit Plans Adjustment			Total
	(In millions)
Balance, beginning of period	$	10,315		$	1,458		$	(4,950	)	$	(2,052	)	$	4,771
OCI before reclassifications	10,872			1,472			809			(248		)	12,905
Deferred income tax benefit (expense)	(3,656		)	(460		)	200			81			(3,835		)
AOCI before reclassifications, net of income tax	17,531			2,470			(3,941		)	(2,219		)	13,841
Amounts reclassified from AOCI	(339		)	(174		)	—			145			(368		)
Deferred income tax benefit (expense)	114			55			—			(47		)	122
Amounts reclassified from AOCI, net of income tax	(225		)	(119		)	—			98			(246		)
Balance, end of period	$	17,306		$	2,351		$	(3,941	)	$	(2,121	)	$	13,595
	Nine Months   Ended   September 30, 2015
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Foreign Currency Translation Adjustments			Defined Benefit Plans Adjustment			Total
	(In millions)
Balance, beginning of period	$	15,159		$	1,076		$	(3,303	)	$	(2,283	)	$	10,649
OCI before reclassifications	(3,923		)	(106		)	(1,243		)	3			(5,269		)
Deferred income tax benefit (expense)	1,337			37			(28		)	(1		)	1,345
AOCI before reclassifications, net of income tax	12,573			1,007			(4,574		)	(2,281		)	6,725
Amounts reclassified from AOCI	(392		)	490			—			171			269
Deferred income tax benefit (expense)	134			(178		)	—			(59		)	(103		)
Amounts reclassified from AOCI, net of income tax	(258		)	312			—			112			166
Balance, end of period	$	12,315		$	1,319		$	(4,574	)	$	(2,169	)	$	6,891

__________________

(1) See Note 7 for information on offsets to investments related to future policy benefits, DAC, VOBA and DSI, and the policyholder dividend obligation.

Information regarding amounts reclassified out of each component of AOCI was as follows:

AOCI Components	Amounts Reclassified from AOCI												Consolidated Statement of Operations and Comprehensive Income (Loss) Locations
	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Net unrealized investment gains (losses):
Net unrealized investment gains (losses)	$	163		$	104		$	288		$	353		Net investment gains (losses)
Net unrealized investment gains (losses)	4			3			23			60			Net investment income
Net unrealized investment gains (losses)	6			(5		)	28			(21		)	Net derivative gains (losses)
Net unrealized investment gains (losses), before income tax	173			102			339			392
Income tax (expense) benefit	(60		)	(34		)	(114		)	(134		)
Net unrealized investment gains (losses), net of income tax	113			68			225			258
Unrealized gains (losses) on derivatives - cash flow hedges:
Interest rate swaps	28			40			56			52			Net derivative gains (losses)
Interest rate swaps	4			3			11			9			Net investment income
Interest rate forwards	1			1			2			5			Net derivative gains (losses)
Interest rate forwards	1			1			4			3			Net investment income
Interest rate forwards	—			1			1			2			Other expenses
Foreign currency swaps	59			(286		)	96			(563		)	Net derivative gains (losses)
Foreign currency swaps	—			—			(1		)	(1		)	Net investment income
Foreign currency swaps	—			—			1			1			Other expenses
Credit forwards	—			1			3			1			Net derivative gains (losses)
Credit forwards	1			—			1			1			Net investment income
Gains (losses) on cash flow hedges, before income tax	94			(239		)	174			(490		)
Income tax (expense) benefit	(30		)	77			(55		)	178
Gains (losses) on cash flow hedges, net of income tax	64			(162		)	119			(312		)
Defined benefit plans adjustment: (1)
Amortization of net actuarial gains (losses)	(47		)	(58		)	(150		)	(174		)
Amortization of prior service (costs) credit	1			1			5			3
Amortization of defined benefit plan items, before income tax	(46		)	(57		)	(145		)	(171		)
Income tax (expense) benefit	10			20			47			59
Amortization of defined benefit plan items, net of income tax	(36		)	(37		)	(98		)	(112		)
Total reclassifications, net of income tax	$	141		$	(131	)	$	246		$	(166	)

__________________

(1) These AOCI components are included in the computation of net periodic benefit costs. See Note 13.

XML

Goodwill

9 Months Ended

Sep. 30, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

10. Goodwill

The Company tests goodwill for impairment during the third quarter of each year at the reporting unit level based upon the best available data at June 30, of that year. A reporting unit is the operating segment or a business one level below the operating segment, if discrete financial information is prepared and regularly reviewed by management at that level. Step 1 of the goodwill impairment process requires a comparison of the fair value of a reporting unit to its carrying value. To determine the fair values of its reporting units, the Company generally applies a market multiple, discounted cash flow, and/or an actuarial based valuation approach. The market multiple valuation approach utilizes market multiples of companies with similar businesses and the projected operating earnings of the reporting unit. The discounted cash flow valuation approach requires judgments about revenues, operating earnings projections, capital market assumptions and discount rates. The actuarial based approaches such as embedded value or cash flow testing estimate the net worth of the reporting unit and the value of existing and new business. The actuarial based approaches require judgments and assumptions about level of economic capital required to support the mix of business, long-term growth rates, the account value of in-force business, projections of new and renewal business, as well as margins on such business, the level of interest rates, credit spreads, equity market levels, and the discount rate that the Company believes is appropriate for the respective reporting unit.

In anticipation of the Separation, in the third quarter of 2016, MetLife reorganized its businesses into six segments: U.S.; Asia; Latin America; EMEA; MetLife Holdings; and Brighthouse Financial. In connection with the reorganization, MetLife realigned certain businesses among its existing and new segments. As a result, the Company reallocated goodwill based on the relative fair values of the reporting units within such segments.

Based on a quantitative analysis performed for the Life and Run-off reporting units within the Brighthouse Financial segment, the Company concluded that the carrying values of these reporting units exceeded their estimated fair values, indicating a potential for goodwill impairment. Accordingly, the Company performed Step 2 of the goodwill impairment process for each of the reporting units, which compares the implied estimated fair value of the reporting unit’s goodwill with its carrying value. This analysis indicated that the goodwill associated with these reporting units was not recoverable. As a result, the Company recorded a non-cash charge in the aggregate of $260 million ($223 million, net of income tax) for the impairment of the entire goodwill balance, which is reported in goodwill impairment in the interim condensed consolidated statements of operations and comprehensive income for both the three months and nine months ended September 30, 2016.

In addition, the Company performed its annual goodwill impairment tests of all other reporting units during the third quarter of 2016 using a qualitative assessment and/or quantitative assessments under the market multiple, discounted cash flow and/or actuarial based valuation approaches based on best available data as of June 30, 2016 and concluded that the estimated fair values of all such reporting units were in excess of their carrying values and, therefore, goodwill was not impaired.

Management continues to evaluate current market conditions that may affect the estimated fair value of the reporting units to assess whether any goodwill impairment exists. Deteriorating or adverse market conditions for certain reporting units may have a significant impact on the estimated fair value of these reporting units and could result in future impairments of goodwill.

Information regarding goodwill by segment, as well as Corporate & Other, was as follows:

	U.S.		Asia		Latin America		EMEA		MetLife Holdings			Brighthouse Financial			Corporate & Other			Total
	(In millions)
Balance at January 1, 2016
Goodwill	$	1,451	$	4,508	$	1,186	$	1,143	$	2,579		$	260		$	218		$	11,345
Accumulated impairment (1)	—		—		—		—		(1,692		)	—			(176		)	(1,868		)
Total goodwill, net	1,451		4,508		1,186		1,143		887			260			42			9,477
Dispositions (2)	—		—		—		—		—			—			(42		)	(42		)
Impairment	—		—		—		—		—			(260		)	—			(260		)
Effect of foreign currency translation and other	—		352		64		1		—			—			—			417
Balance at September 30, 2016
Goodwill	1,451		4,860		1,250		1,144		2,579			260			176			11,720
Accumulated impairment	—		—		—		—		(1,692		)	(260		)	(176		)	(2,128		)
Total goodwill, net	$	1,451	$	4,860	$	1,250	$	1,144	$	887		$	—		$	—		$	9,592

__________________

(1) The $1.9 billion accumulated impairment relates to the retail annuities business, which was impaired in 2012 and includes the allocated goodwill from Corporate & Other. Although the entire balance is reflected in the MetLife Holdings segment, it also relates to the retail annuities business within the Brighthouse Financial segment.

(2) In conjunction with the U.S. Retail Advisor Force Divestiture, the Company reduced goodwill in Corporate & Other by $42 million during the nine months ended September 30, 2016. See Note 3.

XML

Other Expenses

9 Months Ended

Sep. 30, 2016

Other Income and Expenses [Abstract]

Other Expenses

12. Other Expenses

Information on other expenses was as follows:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Compensation	$	1,101		$	1,157		$	3,600		$	3,706
Pension, postretirement and postemployment benefit costs	80			100			323			297
Commissions	1,049			1,103			3,277			3,382
Volume-related costs	214			264			694			761
Capitalization of DAC	(863		)	(955		)	(2,759		)	(2,850		)
Amortization of DAC and VOBA	1,017			1,131			2,133			3,053
Amortization of negative VOBA	(55		)	(90		)	(221		)	(282		)
Interest expense on debt	292			302			910			908
Premium taxes, licenses and fees	187			199			591			568
Professional services	373			366			1,101			1,079
Rent and related expenses, net of sublease income	90			78			285			245
Other (1)	443			878			1,432			1,798
Total other expenses	$	3,928		$	4,533		$	11,366		$	12,665

__________________

(1) The Company recorded a non-cash charge to net income of $792 million, net of income tax, during the third quarter of 2015. The charge was related to an uncertain tax position and was comprised of a $557 million charge included in provision for income tax expense (benefit) and a $362 million ($235 million, net of income tax) charge included in other expenses.

XML

Employee Benefit Plans

9 Months Ended

Sep. 30, 2016

Compensation and Retirement Disclosure [Abstract]

Employee Benefit Plans

13. Employee Benefit Plans

Pension and Other Postretirement Benefit Plans

Certain subsidiaries of MetLife, Inc. sponsor and/or administer various defined benefit pension plans and other postretirement employee benefit plans covering employees and sales representatives who meet specified eligibility requirements. These subsidiaries also provide certain postemployment benefits and certain postretirement medical and life insurance benefits for retired employees.

The components of net periodic benefit costs were as follows:

	Three Months   Ended   September 30,
	2016						2015
	Pension Benefits			Other Postretirement Benefits			Pension Benefits			Other Postretirement Benefits
	(In millions)
Service costs	$	67		$	4		$	68		$	3
Interest costs	102			21			106			22
Curtailment costs (1)	(1		)	(1		)	—			—
Expected return on plan assets	(140		)	(19		)	(136		)	(19		)
Amortization of net actuarial (gains) losses	44			3			48			10
Amortization of prior service costs (credit)	—			(1		)	(1		)	—
Net periodic benefit costs (credit)	$	72		$	7		$	85		$	16
	Nine Months   Ended   September 30,
	2016						2015
	Pension Benefits			Other Postretirement Benefits			Pension Benefits			Other Postretirement Benefits
	(In millions)
Service costs	$	212		$	8		$	206		$	12
Interest costs	322			63			318			67
Curtailment costs (1)	(1		)	26			—			—
Expected return on plan assets	(394		)	(56		)	(408		)	(59		)
Amortization of net actuarial (gains) losses	143			7			143			31
Amortization of prior service costs (credit)	—			(5		)	(1		)	(2		)
Net periodic benefit costs (credit)	$	282		$	43		$	258		$	49

__________________

(1) The Company recognized curtailment charges on certain postretirement benefit plans in connection with the U.S Retail Advisor Force Divestiture. See Note 3.

XML

Earnings Per Common Share

9 Months Ended

Sep. 30, 2016

Earnings Per Share [Abstract]

Earnings Per Common Share

14. Earnings Per Common Share

The following table presents the weighted average shares used in calculating basic earnings per common share and those used in calculating diluted earnings per common share for each income category presented below:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016		2015
	(In millions, except share and per share data)
Weighted Average Shares:
Weighted average common stock outstanding for basic earnings per common share	1,100,504,563			1,118,856,041			1,100,558,083		1,120,130,708
Incremental common shares from assumed:
Exercise or issuance of stock-based awards	8,749,753			11,085,040			8,445,077		10,575,611
Weighted average common stock outstanding for diluted earnings per common share	1,109,254,316			1,129,941,081			1,109,003,160		1,130,706,319
Net Income (Loss):
Net income (loss)	$	573		$	1,198		$	2,890	$	4,480
Less: Net income (loss) attributable to noncontrolling interests	(4		)	(5		)	2		4
Less: Preferred stock dividends	6			6			58		67
Preferred stock repurchase premium	—			—			—		42
Net income (loss) available to MetLife, Inc.’s common shareholders	$	571		$	1,197		$	2,830	$	4,367
Basic	$	0.52		$	1.07		$	2.57	$	3.90
Diluted	$	0.51		$	1.06		$	2.55	$	3.86

XML

Contingencies, Commitments and Guarantees

9 Months Ended

Sep. 30, 2016

Commitments and Contingencies Disclosure [Abstract]

Contingencies, Commitments and Guarantees

15. Contingencies, Commitments and Guarantees

Contingencies

Litigation

The Company is a defendant in a large number of litigation matters. In some of the matters, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages or other relief. Jurisdictions may permit claimants not to specify the monetary damages sought or may permit claimants to state only that the amount sought is sufficient to invoke the jurisdiction of the trial court. In addition, jurisdictions may permit plaintiffs to allege monetary damages in amounts well exceeding reasonably possible verdicts in the jurisdiction for similar matters. This variability in pleadings, together with the actual experience of the Company in litigating or resolving through settlement numerous claims over an extended period of time, demonstrates to management that the monetary relief which may be specified in a lawsuit or claim bears little relevance to its merits or disposition value.

Due to the vagaries of litigation, the outcome of a litigation matter and the amount or range of potential loss at particular points in time may normally be difficult to ascertain. Uncertainties can include how fact finders will evaluate documentary evidence and the credibility and effectiveness of witness testimony, and how trial and appellate courts will apply the law in the context of the pleadings or evidence presented, whether by motion practice, or at trial or on appeal. Disposition valuations are also subject to the uncertainty of how opposing parties and their counsel will themselves view the relevant evidence and applicable law.

The Company establishes liabilities for litigation and regulatory loss contingencies when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Liabilities have been established for a number of the matters noted below. It is possible that some of the matters could require the Company to pay damages or make other expenditures or establish accruals in amounts that could not be reasonably estimated at September 30, 2016. While the potential future charges could be material in the particular quarterly or annual periods in which they are recorded, based on information currently known to management, management does not believe any such charges are likely to have a material effect on the Company’s financial position.

Matters as to Which an Estimate Can Be Made

For some of the matters disclosed below, the Company is able to estimate a reasonably possible range of loss. For such matters where a loss is believed to be reasonably possible, but not probable, no accrual has been made. As of September 30, 2016, the Company estimates the aggregate range of reasonably possible losses in excess of amounts accrued for these matters to be $0 to $400 million.

Matters as to Which an Estimate Cannot Be Made

For other matters disclosed below, the Company is not currently able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts, and the progress of settlement negotiations. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation contingencies and updates its accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews.

Asbestos-Related Claims

MLIC is and has been a defendant in a large number of asbestos-related suits filed primarily in state courts. These suits principally allege that the plaintiff or plaintiffs suffered personal injury resulting from exposure to asbestos and seek both actual and punitive damages. MLIC has never engaged in the business of manufacturing, producing, distributing or selling asbestos or asbestos-containing products nor has MLIC issued liability or workers’ compensation insurance to companies in the business of manufacturing, producing, distributing or selling asbestos or asbestos-containing products. The lawsuits principally have focused on allegations with respect to certain research, publication and other activities of one or more of MLIC’s employees during the period from the 1920’s through approximately the 1950’s and allege that MLIC learned or should have learned of certain health risks posed by asbestos and, among other things, improperly publicized or failed to disclose those health risks. MLIC believes that it should not have legal liability in these cases. The outcome of most asbestos litigation matters, however, is uncertain and can be impacted by numerous variables, including differences in legal rulings in various jurisdictions, the nature of the alleged injury and factors unrelated to the ultimate legal merit of the claims asserted against MLIC. MLIC employs a number of resolution strategies to manage its asbestos loss exposure, including seeking resolution of pending litigation by judicial rulings and settling individual or groups of claims or lawsuits under appropriate circumstances.

Claims asserted against MLIC have included negligence, intentional tort and conspiracy concerning the health risks associated with asbestos. MLIC’s defenses (beyond denial of certain factual allegations) include that: (i) MLIC owed no duty to the plaintiffs— it had no special relationship with the plaintiffs and did not manufacture, produce, distribute or sell the asbestos products that allegedly injured plaintiffs; (ii) plaintiffs did not rely on any actions of MLIC; (iii) MLIC’s conduct was not the cause of the plaintiffs’ injuries; (iv) plaintiffs’ exposure occurred after the dangers of asbestos were known; and (v) the applicable time with respect to filing suit has expired. During the course of the litigation, certain trial courts have granted motions dismissing claims against MLIC, while other trial courts have denied MLIC’s motions. There can be no assurance that MLIC will receive favorable decisions on motions in the future. While most cases brought to date have settled, MLIC intends to continue to defend aggressively against claims based on asbestos exposure, including defending claims at trials.

As reported in the 2015 Annual Report, MLIC received approximately 3,856 asbestos-related claims in 2015. During the nine months endedSeptember 30, 2016 and 2015, MLIC received approximately 3,267 and 2,971 new asbestos-related claims, respectively. See Note 21 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report for historical information concerning asbestos claims and MLIC’s increase in its recorded liability at December 31, 2014. The number of asbestos cases that may be brought, the aggregate amount of any liability that MLIC may incur, and the total amount paid in settlements in any given year are uncertain and may vary significantly from year to year.

The ability of MLIC to estimate its ultimate asbestos exposure is subject to considerable uncertainty, and the conditions impacting its liability can be dynamic and subject to change. The availability of reliable data is limited and it is difficult to predict the numerous variables that can affect liability estimates, including the number of future claims, the cost to resolve claims, the disease mix and severity of disease in pending and future claims, the impact of the number of new claims filed in a particular jurisdiction and variations in the law in the jurisdictions in which claims are filed, the possible impact of tort reform efforts, the willingness of courts to allow plaintiffs to pursue claims against MLIC when exposure to asbestos took place after the dangers of asbestos exposure were well known, and the impact of any possible future adverse verdicts and their amounts.

The ability to make estimates regarding ultimate asbestos exposure declines significantly as the estimates relate to years further in the future. In the Company’s judgment, there is a future point after which losses cease to be probable and reasonably estimable. It is reasonably possible that the Company’s total exposure to asbestos claims may be materially greater than the asbestos liability currently accrued and that future charges to income may be necessary. While the potential future charges could be material in the particular quarterly or annual periods in which they are recorded, based on information currently known by management, management does not believe any such charges are likely to have a material effect on the Company’s financial position.

The Company believes adequate provision has been made in its consolidated financial statements for all probable and reasonably estimable losses for asbestos-related claims. MLIC’s recorded asbestos liability is based on its estimation of the following elements, as informed by the facts presently known to it, its understanding of current law and its past experiences: (i) the probable and reasonably estimable liability for asbestos claims already asserted against MLIC, including claims settled but not yet paid; (ii) the probable and reasonably estimable liability for asbestos claims not yet asserted against MLIC, but which MLIC believes are reasonably probable of assertion; and (iii) the legal defense costs associated with the foregoing claims. Significant assumptions underlying MLIC’s analysis of the adequacy of its recorded liability with respect to asbestos litigation include: (i) the number of future claims; (ii) the cost to resolve claims; and (iii) the cost to defend claims.

MLIC reevaluates on a quarterly and annual basis its exposure from asbestos litigation, including studying its claims experience, reviewing external literature regarding asbestos claims experience in the United States, assessing relevant trends impacting asbestos liability and considering numerous variables that can affect its asbestos liability exposure on an overall or per claim basis. These variables include bankruptcies of other companies involved in asbestos litigation, legislative and judicial developments, the number of pending claims involving serious disease, the number of new claims filed against it and other defendants and the jurisdictions in which claims are pending. Based upon its regular reevaluation of its exposure from asbestos litigation, MLIC has updated its liability analysis for asbestos-related claims through September 30, 2016.

Regulatory Matters

The Company receives and responds to subpoenas or other inquiries seeking a broad range of information from state regulators, including state insurance commissioners; state attorneys general or other state governmental authorities; federal regulators, including the SEC; federal governmental authorities, including congressional committees; and the Financial Industry Regulatory Authority (“FINRA”), as well as from local and national regulators and government authorities in countries outside the United States where MetLife conducts business. The issues involved in information requests and regulatory matters vary widely. The Company cooperates in these inquiries.

Law Enforcement Inquiry Regarding Mortgage Servicing

MetLife, through its affiliate MetLife Bank, National Association (“MetLife Bank”), was engaged in the origination, sale and servicing of forward and reverse residential mortgage loans from 2008 to 2013. In May 2013, MetLife Bank received a subpoena from the U.S. Department of Justice requiring production of documents relating to MetLife Bank’s payment of certain foreclosure-related expenses to law firms and business entities affiliated with law firms and relating to MetLife Bank’s supervision of such payments, including expenses submitted to the Federal National Mortgage Association, the Federal Home Loan Mortgage Corp. and the U.S. Department of Housing and Urban Development for reimbursement. In August 2013, MetLife Bank merged with MetLife Home Loans LLC (“MLHL”) with MLHL as the surviving non-bank entity. Management believes that the Company’s consolidated financial statements as a whole will not be materially affected by this matter.

In the Matter of Chemform, Inc. Site, Pompano Beach, Broward County, Florida

In July 2010, the Environmental Protection Agency (“EPA”) advised MLIC that it believed payments were due under two settlement agreements, known as “Administrative Orders on Consent,” that New England Mutual Life Insurance Company signed in 1989 and 1992 with respect to the cleanup of a Superfund site in Florida (the “Chemform Site”). The EPA is requesting payment of an amount under $1 million from MLIC and a third party for past costs and an additional amount for future environmental testing costs at the Chemform Site. In September 2012, the EPA, MLIC and the third party executed an Administrative Order on Consent under which MLIC and the third party have agreed to be responsible for certain environmental testing at the Chemform Site. The Company estimates that its costs for the environmental testing will not exceed $100,000. The September 2012 Administrative Order on Consent does not resolve the EPA’s claim for past clean-up costs. The EPA may seek additional costs if the environmental testing identifies issues. The Company estimates that the aggregate cost to resolve this matter will not exceed $1 million.

Sales Practices Regulatory Matters

Regulatory authorities in a number of states and FINRA, and occasionally the SEC, have had investigations or inquiries relating to sales of individual life insurance policies or annuities or other products by MLIC, MetLife USA, NELICO, General American Life Insurance Company (“GALIC”), FMLI, and MSI. These investigations often focus on the conduct of particular financial services representatives and the sale of unregistered or unsuitable products or the misuse of client assets. Over the past several years, these and a number of investigations by other regulatory authorities were resolved for monetary payments and certain other relief, including restitution payments. The Company may continue to resolve investigations in a similar manner. The Company believes adequate provision has been made in its consolidated financial statements for all probable and reasonably estimable losses for these sales practices-related investigations or inquiries.

Sale and Replacement of Variable Annuities and FINRA Letter of Acceptance, Waiver and Consent

MSI has entered into a Letter of Acceptance, Waiver and Consent with FINRA (hereinafter, the “Letter”). In the Letter, FINRA stated that, from 2009 through 2014, MSI violated certain National Association of Securities Dealers and FINRA rules in connection with replacements of certain variable annuities and the sale of certain riders on such annuities. MSI was censured, paid a $20 million fine and an additional $5 million to impacted customers.

Unclaimed Property Litigation

West Virginia Lawsuits

On September 20, 2012, the West Virginia Treasurer filed an action against MLIC in West Virginia state court(West Virginia ex rel. John D. Perdue v. Metropolitan Life Insurance Company, Circuit Court of Putnam County, Civil Action No. 12-C-295)alleging that MLIC violated the West Virginia Uniform Unclaimed Property Act (the “Act”), seeking to compel compliance with the Act, and seeking payment of unclaimed property, interest, and penalties. On November 14, 2012, November 21, 2012, December 28, 2012, and January 9, 2013, the Treasurer filed substantially identical suits against MetLife Investors USA, NELICO, MetLife Insurance Company of Connecticut and GALIC, respectively. On August 17, 2016, these companies and the West Virginia Treasurer reached an agreement in principle to resolve these actions.

City of Westland Police and Fire Retirement System v. MetLife, Inc., et. al. (S.D.N.Y., filed January 12, 2012)

Seeking to represent a class of persons who purchased MetLife, Inc. common shares between February 2, 2010, and October 6, 2011, the plaintiff filed a third amended complaint alleging that MetLife, Inc. and several current and former directors and executive officers of MetLife, Inc. violated the Securities Act of 1933 (“Securities Act”), as well as the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by issuing, or causing MetLife, Inc. to issue, materially false and misleading statements concerning MetLife, Inc.’s potential liability for millions of dollars in insurance benefits that should have been paid to beneficiaries or escheated to the states. Plaintiff seeks unspecified compensatory damages and other relief. The defendants intend to defend this action vigorously.

City of Birmingham Retirement and Relief System v. MetLife, Inc., et al. (Circuit Court of Jefferson County, Alabama, filed July 5, 2012)

Seeking to represent a class of persons who purchased MetLife, Inc. common equity units in or traceable to a public offering in March 2011, the plaintiff filed an action alleging that MetLife, Inc., certain current and former directors and executive officers of MetLife, Inc., and various underwriters violated several provisions of the Securities Act related to the filing of the registration statement by issuing, or causing MetLife, Inc. to issue, materially false and misleading statements and/or omissions concerning MetLife, Inc.’s potential liability for millions of dollars in insurance benefits that should have been paid to beneficiaries or escheated to the states. Plaintiff seeks unspecified compensatory damages and other relief. On October 14, 2015, the court denied the defendants’ motion to dismiss the complaint. On October 28, 2016, the parties signed a stipulation of settlement agreeing to resolve this action. Plaintiff is seeking court approval of this settlement.

Total Control Accounts Litigation

Owens v. Metropolitan Life Insurance Company (N.D. Ga., filed April 17, 2014)

Plaintiff filed this putative class action lawsuit on behalf of all persons for whom MLIC established a retained asset account, known as a TCA, to pay death benefits under an Employee Retirement Income Security Act of 1974 (“ERISA”) plan. The action alleges that MLIC’s use of the TCA as the settlement option for life insurance benefits under some group life insurance policies violates MLIC’s fiduciary duties under ERISA. As damages, plaintiff seeks disgorgement of profits that MLIC realized on accounts owned by members of the putative class. On September 27, 2016, the court denied MLIC’s summary judgment motion in full and granted plaintiff’s partial summary judgment motion. The Company intends to defend this action vigorously.

Reinsurance Litigation

Robainas, et al. v. Metropolitan Life Insurance Company (S.D.N.Y., December 16, 2014)

Plaintiffs filed this putative class action lawsuit on behalf of themselves and all persons and entities who, directly or indirectly, purchased, renewed or paid premiums on life insurance policies issued by MLIC from 2009 through 2014 (the “Policies”). Two similar actions were subsequently filed,Yale v. Metropolitan Life Ins. Co. (S.D.N.Y., January 12, 2015) and International Association of Machinists and Aerospace Workers District Lodge 15 v. Metropolitan Life Ins. Co. (E.D.N.Y., February 2, 2015). Both of these actions were consolidated with the Robainas action. The consolidated complaint alleges that MLIC inadequately disclosed in its statutory annual statements that certain reinsurance transactions with affiliated reinsurance companies were collateralized using “contractual parental guarantees,” and thereby allegedly misrepresented its financial condition and the adequacy of its reserves. The lawsuit sought recovery under Section 4226 of the New York Insurance Law of a statutory penalty in the amount of the premiums paid for the Policies. On October 9, 2015, the court granted MLIC’s motion to dismiss the consolidated complaint, finding that plaintiffs lacked Article III standing because they did not allege any concrete injury as a result of the alleged conduct. Plaintiffs appealed this decision to the Second Circuit Court of Appeals.

Intoccia v. Metropolitan Life Insurance Company (S.D.N.Y., April 20, 2015)

Plaintiffs filed this putative class action on behalf of themselves and all persons and entities who, directly or indirectly, purchased, renewed or paid premiums for Guaranteed Benefits Insurance Riders attached to variable annuity contracts with MLIC from 2009 through 2015 (the “Annuities”). The court consolidatedWeilert v. Metropolitan Life Ins. Co. (S.D.N.Y., April 30, 2015) with theIntocciacase, and the consolidated, amended complaint alleges that MLIC inadequately disclosed in its statutory annual statements that certain reinsurance transactions with affiliated reinsurance companies were collateralized using “contractual parental guarantees,” and thereby allegedly misrepresented its financial condition and the adequacy of its reserves. The lawsuits seek recovery under Section 4226 of the New York Insurance Law of a statutory penalty in the amount of the premiums paid for Guaranteed Benefits Insurance Riders attached to the Annuities. The Court granted MLIC’s motion to dismiss, adopting the reasoning of theRobainas decision. Plaintiffs appealed this decision to the Second Circuit Court of Appeals.

Diversified Lending Group Litigations

Hartshorne v. MetLife Inc., et al. (Los Angeles County Superior Court, filed March 25, 2015)

Plaintiffs have named MetLife, Inc., MSI and NELICO in 12 related lawsuits in California state court alleging various causes of action including multiple negligence and statutory claims relating to a Ponzi scheme involving the Diversified Lending Group (“DLG”). In August 2016, a trial of claims by one of the plaintiffs, Christine Ramirez, resulted in a verdict against MetLife, Inc., MSI, and NELICO for approximately $200 thousand in compensatory damages and $15 million in punitive damages. The Company intends to appeal this verdict.

Other Litigation

McGuire v. Metropolitan Life Insurance Company (E.D. Mich., filed February 22, 2012)

The fiduciary for the Union Carbide Employees’ Pension Plan alleged that MLIC, which issued annuity contracts to fund some of the benefits the Plan provides, engaged in transactions that ERISA prohibits and violated duties under ERISA and federal common law by determining that no dividends were payable with respect to the contracts from and after 1999. The parties have resolved this matter, and the court has dismissed the action.

Sun Life Assurance Company of Canada Indemnity Claim

In 2006, Sun Life Assurance Company of Canada (“Sun Life”), as successor to the purchaser of MLIC’s Canadian operations, filed a lawsuit in Toronto, seeking a declaration that MLIC remains liable for “market conduct claims” related to certain individual life insurance policies sold by MLIC that were subsequently transferred to Sun Life. In January 2010, the court found that Sun Life had given timely notice of its claim for indemnification but, because it found that Sun Life had not yet incurred an indemnifiable loss, granted MLIC’s motion for summary judgment. Both parties agreed to consider the indemnity claim through arbitration. In September 2010, Sun Life notified MLIC that a purported class action lawsuit was filed against Sun Life in Toronto alleging sales practices claims regarding the policies sold by MLIC and transferred to Sun Life. On August 30, 2011, Sun Life notified MLIC that another purported class action lawsuit was filed against Sun Life in Vancouver, BC alleging sales practices claims regarding certain of the same policies sold by MLIC and transferred to Sun Life. Sun Life contends that MLIC is obligated to indemnify Sun Life for some or all of the claims in these lawsuits. These sales practices cases against Sun Life are ongoing, and the Company is unable to estimate the reasonably possible loss or range of loss arising from this litigation.

Fauley v. Metropolitan Life Insurance Company, et al. (Circuit Court of the 19th Judicial Circuit, Lake County, Ill., July 3, 2014)

Plaintiffs filed this lawsuit against defendants, including MLIC and a former MetLife financial services representative, alleging that the defendants sent unsolicited fax advertisements to plaintiff and others in violation of the Telephone Consumer Protection Act, as amended by the Junk Fax Prevention Act, 47 U.S.C. § 227. The court issued a final order certifying a nationwide settlement class and approving a settlement under which MLIC has agreed to pay up to $23 million to resolve claims as to fax advertisements sent between August 23, 2008 and August 7, 2014. On March 23, 2016, the intermediate appellate court affirmed the trial court’s order. On September 28, 2016, the Illinois Supreme Court denied an objector’s petition for leave to appeal.

MetLife, Inc. v. Financial Stability Oversight Council (D. D.C., January 13, 2015)

MetLife, Inc. filed this action in U.S. District Court for the District of Columbia (“D.C. District Court”) seeking to overturn the Financial Stability Oversight Council’s (“FSOC”) designation of MetLife, Inc. as a non-bank systemically important financial institution (“non-bank SIFI”). The suit is brought under the section of the Dodd-Frank Wall Street Reform and Consumer Protection Act providing that a company designated as a non-bank SIFI may petition the federal courts for review, and seeks an order requiring that the final determination be rescinded. The D.C. District Court issued a decision on March 30, 2016 granting, in part, MetLife, Inc.’s cross motion for summary judgment and rescinding the FSOC’s designation of MetLife, Inc. as a non-bank SIFI. On April 8, 2016, the FSOC appealed the D.C. District Court’s order to the United States Court of Appeals for the District of Columbia.

Voshall v. Metropolitan Life Insurance Company (Superior Court of the State of California, County of Los Angeles, April 8, 2015)

Plaintiff filed this putative class action lawsuit on behalf of himself and all persons covered under a long-term group disability income insurance policy issued by MLIC to public entities in California between April 8, 2011 and April 8, 2015. Plaintiff alleges that MLIC improperly reduced benefits by including cost of living adjustments and employee paid contributions in the employer retirement benefits and other income that reduces the benefit payable under such policies. Plaintiff asserts causes of action for declaratory relief, violation of the California Business & Professions Code, breach of contract and breach of the implied covenant of good faith and fair dealing. The Company intends to defend this action vigorously.

Martin v. Metropolitan Life Insurance Company, (Superior Court of the State of California, County of Contra Costa, filed December 17, 2015)

Plaintiffs filed this putative class action lawsuit on behalf of themselves and all California persons who have been charged compound interest by MLIC in life insurance policy and/or premium loan balances within the last four years. Plaintiffs allege that MLIC has engaged in a pattern and practice of charging compound interest on life insurance policy and premium loans without the borrower authorizing such compounding, and that this constitutes an unlawful business practice under California law. Plaintiff asserts causes of action for declaratory relief, violation of California’s Unfair Competition Law and Usury Law, and unjust enrichment. Plaintiff seeks declaratory and injunctive relief, restitution of interest, and damages in an unspecified amount. On April 12, 2016, the court granted MLIC’s motion to dismiss. Plaintiffs have filed a notice appealing this ruling.

Lau v. Metropolitan Life Insurance Company (S.D.N.Y. filed, December 3, 2015)

This putative class action lawsuit was filed by a single defined contribution plan participant on behalf of all ERISA plans whose assets were invested in MetLife’s “Group Annuity Contract Stable Value Funds” within the past six years. The suit alleges breaches of fiduciary duty under ERISA and challenges the “spread” with respect to the stable value fund group annuity products sold to retirement plans. The allegations focus on the methodology MetLife uses to establish and reset the crediting rate, the terms under which plan participants are permitted to transfer funds from a stable value option to another investment option, the procedures followed if an employer terminates a contract, and the level of disclosure provided. Plaintiff seeks declaratory and injunctive relief, as well as damages in an unspecified amount. The Company intends to defend this action vigorously.

Newman v. Metropolitan Life Insurance Company (N.D. Ill., filed March 23, 2016)

Plaintiff filed this putative class action alleging causes of action for breach of contract, fraud, and violations of the Illinois Consumer Fraud and Deceptive Business Practices Act, based on MLIC’s class-wide increase in premiums charged for long-term care insurance policies. Plaintiff alleges a class consisting of herself and all persons over age 65 who selected a Reduced Pay at Age 65 payment feature and whose premium rates were increased after age 65. Plaintiff asserts that premiums could not be increased for these class members and/or that marketing material was misleading as to MLIC’s right to increase premiums. Plaintiff seeks unspecified compensatory, statutory and punitive damages as well as recessionary and injunctive relief. The Company intends to defend this action vigorously.

Thrivent Financial for Lutherans v. MetLife Insurance Company USA, (E.D. Wis., filed September 12, 2016)

Plaintiff filed a complaint against MetLife USA contending that MetLife’s use of the Brighthouse Financial trademark and logo will infringe on its trademarks. Alleging violations of federal and state law, plaintiff seeks preliminary and permanent injunctions, compensatory damages, and other relief. MetLife USA intends to defend this action vigorously.

Sales Practices Claims

Over the past several years, the Company has faced numerous claims, including class action lawsuits, alleging improper marketing or sales of individual life insurance policies, annuities, mutual funds, other products or the misuse of client assets. Some of the current cases seek substantial damages, including punitive and treble damages and attorneys’ fees. The Company continues to defend vigorously against the claims in these matters. The Company believes adequate provision has been made in its consolidated financial statements for all probable and reasonably estimable losses for sales practices matters.

Summary

Putative or certified class action litigation and other litigation and claims and assessments against the Company, in addition to those discussed previously and those otherwise provided for in the Company’s consolidated financial statements, have arisen in the course of the Company’s business, including, but not limited to, in connection with its activities as an insurer, mortgage lending bank, employer, investor, investment advisor and taxpayer. Further, state insurance regulatory authorities and other federal and state authorities regularly make inquiries and conduct investigations concerning the Company’s compliance with applicable insurance and other laws and regulations.

It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings. In some of the matters referred to previously, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Although in light of these considerations it is possible that an adverse outcome in certain cases could have a material effect upon the Company’s financial position, based on information currently known by the Company’s management, in its opinion, the outcomes of such pending investigations and legal proceedings are not likely to have such an effect. However, given the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company’s consolidated net income or cash flows in particular quarterly or annual periods.

Commitments

Mortgage Loan Commitments

The Company commits to lend funds under mortgage loan commitments. The amounts of these mortgage loan commitments were $4.0 billion and $4.4 billion at September 30, 2016 and December 31, 2015, respectively.

Commitments to Fund Partnership Investments, Bank Credit Facilities, Bridge Loans and Private Corporate Bond Investments

The Company commits to fund partnership investments and to lend funds under bank credit facilities, bridge loans and private corporate bond investments. The amounts of these unfunded commitments were $8.6 billion and $7.1 billion at September 30, 2016 and December 31, 2015, respectively.

Guarantees

In the normal course of its business, the Company has provided certain indemnities, guarantees and commitments to third parties such that it may be required to make payments now or in the future. In the context of acquisition, disposition, investment and other transactions, the Company has provided indemnities and guarantees, including those related to tax, environmental and other specific liabilities and other indemnities and guarantees that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. In addition, in the normal course of business, the Company provides indemnifications to counterparties in contracts with triggers similar to the foregoing, as well as for certain other liabilities, such as third-party lawsuits. These obligations are often subject to time limitations that vary in duration, including contractual limitations and those that arise by operation of law, such as applicable statutes of limitation. In some cases, the maximum potential obligation under the indemnities and guarantees is subject to a contractual limitation ranging from less than $1 million to $329 million, with a cumulative maximum of $1.2 billion, while in other cases such limitations are not specified or applicable. Since certain of these obligations are not subject to limitations, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future. Management believes that it is unlikely the Company will have to make any material payments under these indemnities, guarantees, or commitments.

In addition, the Company indemnifies its directors and officers as provided in its charters and by-laws. Also, the Company indemnifies its agents for liabilities incurred as a result of their representation of the Company’s interests. Since these indemnities are generally not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these indemnities in the future.

The Company has also minimum fund yield requirements on certain international pension funds in accordance with local laws. Since these guarantees are not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount that could become due under these guarantees in the future.

The Company’s recorded liabilities were $9 million and $8 million at September 30, 2016 and December 31, 2015, respectively, for indemnities, guarantees and commitments.

XML

Subsequent Event

9 Months Ended

Sep. 30, 2016

Subsequent Events [Abstract]

Subsequent Event

16. Subsequent Event

Common Stock Dividend

On October 25, 2016, the MetLife, Inc. Board of Directors declared a fourth quarter 2016 common stock dividend of$0.40 per share payable on December 13, 2016 to shareholders of record as of November 7, 2016. The Company estimates that the aggregate dividend payment will be$441 million.

XML

Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the interim condensed consolidated financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from estimates.

Consolidation of Subsidiaries

The accompanying interim condensed consolidated financial statements include the accounts of MetLife, Inc. and its subsidiaries, as well as partnerships and joint ventures in which the Company has control, and variable interest entities (“VIEs”) for which the Company is the primary beneficiary. Intercompany accounts and transactions have been eliminated.

Prior to January 1, 2016, certain international subsidiaries had a fiscal year cutoff of November 30th. Accordingly, the Company’s interim condensed consolidated financial statements reflect the assets and liabilities of such subsidiaries as of November 30, 2015 and the operating results of such subsidiaries for the three months and nine months ended August 31, 2015. Effective January 1, 2016, the Company converted its Japan operations to calendar year-end reporting. The elimination of a one-month reporting lag of a subsidiary is considered a change in accounting principle and requires retrospective application. While the Company believes that eliminating the lag in the reporting of its Japan operations was preferable in order to consistently reflect events, economic conditions and global trends in the financial statements, the Company determined that it was impracticable to apply the effects of the lag elimination to financial reporting periods prior to January 1, 2015. The effect of not retroactively applying this change in accounting, however, was not material to the 2015 or 2016 consolidated financial statements. Therefore, the Company reported the cumulative effect of the change in accounting principle in net income for the three months ended March 31, 2016 and the nine months ended September 30, 2016 and did not retrospectively apply the effects of this change to prior periods. See Note 2.

The Company uses the equity method of accounting for equity securities when it has significant influence or at least 20% interest and for real estate joint ventures and other limited partnership interests (“investees”) when it has more than a minor ownership interest or more than a minor influence over the investee’s operations, but does not have a controlling financial interest. The Company generally recognizes its share of the investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period. The Company uses the cost method of accounting for investments in which it has virtually no influence over the investee’s operations.

The accompanying interim condensed consolidated financial statements are unaudited and reflect all adjustments (including normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in conformity with GAAP. Interim results are not necessarily indicative of full year performance. The December 31, 2015 consolidated balance sheet data was derived from audited consolidated financial statements included in MetLife, Inc.’s Annual Report on Form 10‑K for the year ended December 31, 2015 (the “2015 Annual Report”), which include all disclosures required by GAAP. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company included in the 2015 Annual Report.

Closed block assets, liabilities, revenues and expenses are combined on a line-by-line basis with the assets, liabilities, revenues and expenses outside the closed block based on the nature of the particular item.

Fiscal Period

Prior to January 1, 2016, certain international subsidiaries had a fiscal year cutoff of November 30th. Accordingly, the Company’s interim condensed consolidated financial statements reflect the assets and liabilities of such subsidiaries as of November 30, 2015 and the operating results of such subsidiaries for the three months and nine months ended August 31, 2015.

Investments

Maturities of Fixed Maturity Securities

Actual maturities may differ from contractual maturities due to the exercise of call or prepayment options. Fixed maturity securities not due at a single maturity date have been presented in the year of final contractual maturity. Structured Securities are shown separately, as they are not due at a single maturity.

Past Due and Interest Accrual Status of Mortgage Loans

The Company defines delinquency consistent with industry practice, when mortgage loans are past due as follows: commercial and residential mortgage loans — 60 days and agricultural mortgage loans — 90 days.

Variable Interest Entities

The Company is involved with certain legal entities that are VIEs. In certain instances, the Company holds both the power to direct the most significant activities of the entity, as well as an economic interest in the entity and, as such, is deemed to be the primary beneficiary or consolidator of the entity. The determination of the VIE’s primary beneficiary requires an evaluation of the contractual and implied rights and obligations associated with each party’s relationship with or involvement in the entity.

Derivatives

Freestanding Derivatives

Freestanding derivatives are carried on the Company’s balance sheet either as assets within other invested assets or as liabilities within other liabilities at estimated fair value. The Company does not offset the estimated fair value amounts recognized for derivatives executed with the same counterparty under the same master netting agreement.

Accruals on derivatives are generally recorded in accrued investment income or within other liabilities. However, accruals that are not scheduled to settle within one year are included with the derivatives carrying value in other invested assets or other liabilities.

If a derivative is not designated as an accounting hedge or its use in managing risk does not qualify for hedge accounting, changes in the estimated fair value of the derivative are reported in net derivative gains (losses) except as follows:

Statement of Operations Presentation:	Derivative:
Policyholder benefits and claims	•	Economic hedges of variable annuity guarantees included in future policy benefits
Net investment income	•	Economic hedges of equity method investments in joint ventures
	•	All derivatives held in relation to trading portfolios
	•	Derivatives held within contractholder-directed unit-linked investments

Hedge Accounting

To qualify for hedge accounting, at the inception of the hedging relationship, the Company formally documents its risk management objective and strategy for undertaking the hedging transaction, as well as its designation of the hedge. Hedge designation and financial statement presentation of changes in estimated fair value of the hedging derivatives are as follows:

• Fair value hedge (a hedge of the estimated fair value of a recognized asset or liability) - in net derivative gains (losses), consistent with the change in estimated fair value of the hedged item attributable to the designated risk being hedged.

• Cash flow hedge (a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability) - effectiveness in OCI (deferred gains or losses on the derivative are reclassified into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item); ineffectiveness in net derivative gains (losses).

• Net investment in a foreign operation hedge - effectiveness in OCI, consistent with the translation adjustment for the hedged net investment in the foreign operation; ineffectiveness in net derivative gains (losses).

The changes in estimated fair values of the hedging derivatives are exclusive of any accruals that are separately reported on the statement of operations within interest income or interest expense to match the location of the hedged item. Accruals on derivatives in net investment hedges are recognized in OCI.

In its hedge documentation, the Company sets forth how the hedging instrument is expected to hedge the designated risks related to the hedged item and sets forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness and the method that will be used to measure ineffectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship. Assessments of hedge effectiveness and measurements of ineffectiveness are also subject to interpretation and estimation and different interpretations or estimates may have a material effect on the amount reported in net income.

The Company discontinues hedge accounting prospectively when: (i) it is determined that the derivative is no longer highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item; (ii) the derivative expires, is sold, terminated, or exercised; (iii) it is no longer probable that the hedged forecasted transaction will occur; or (iv) the derivative is de-designated as a hedging instrument.

When hedge accounting is discontinued because it is determined that the derivative is not highly effective in offsetting changes in the estimated fair value or cash flows of a hedged item, the derivative continues to be carried on the balance sheet at its estimated fair value, with changes in estimated fair value recognized in net derivative gains (losses). The carrying value of the hedged recognized asset or liability under a fair value hedge is no longer adjusted for changes in its estimated fair value due to the hedged risk, and the cumulative adjustment to its carrying value is amortized into income over the remaining life of the hedged item. Provided the hedged forecasted transaction is still probable of occurrence, the changes in estimated fair value of derivatives recorded in OCI related to discontinued cash flow hedges are released into the statement of operations when the Company’s earnings are affected by the variability in cash flows of the hedged item.

When hedge accounting is discontinued because it is no longer probable that the forecasted transactions will occur on the anticipated date or within two months of that date, the derivative continues to be carried on the balance sheet at its estimated fair value, with changes in estimated fair value recognized currently in net derivative gains (losses). Deferred gains and losses of a derivative recorded in OCI pursuant to the discontinued cash flow hedge of a forecasted transaction that is no longer probable are recognized immediately in net derivative gains (losses).

In all other situations in which hedge accounting is discontinued, the derivative is carried at its estimated fair value on the balance sheet, with changes in its estimated fair value recognized in the current period as net derivative gains (losses).

Embedded Derivatives

The Company sells variable annuities and issues certain insurance products and investment contracts and is a party to certain reinsurance agreements that have embedded derivatives. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated. The embedded derivative is bifurcated from the host contract and accounted for as a freestanding derivative if:

• the combined instrument is not accounted for in its entirety at estimated fair value with changes in estimated fair value recorded in earnings;

• the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract; and

• a separate instrument with the same terms as the embedded derivative would qualify as a derivative instrument.

Such embedded derivatives are carried on the balance sheet at estimated fair value with the host contract and changes in their estimated fair value are generally reported in net derivative gains (losses), except for those in policyholder benefits and claims related to ceded reinsurance of GMIB. If the Company is unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income. Additionally, the Company may elect to carry an entire contract on the balance sheet at estimated fair value, with changes in estimated fair value recognized in the current period in net investment gains (losses) or net investment income if that contract contains an embedded derivative that requires bifurcation. At inception, the Company attributes to the embedded derivative a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits. Any additional fees represent “excess” fees and are reported in universal life and investment-type product policy fees.

Derivatives are financial instruments with values derived from interest rates, foreign currency exchange rates, credit spreads and/or other financial indices. Derivatives may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (“OTC-cleared”), while others are bilateral contracts between two counterparties (“OTC-bilateral”). The types of derivatives the Company uses include swaps, forwards, futures and option contracts. To a lesser extent, the Company uses credit default swaps and structured interest rate swaps to synthetically replicate investment risks and returns which are not readily available in the cash market.

The Company designates and accounts for the following as fair value hedges when they have met the requirements of fair value hedging: (i) interest rate swaps to convert fixed rate assets and liabilities to floating rate assets and liabilities; (ii) foreign currency swaps to hedge the foreign currency fair value exposure of foreign currency denominated assets and liabilities; and (iii) foreign currency forwards to hedge the foreign currency fair value exposure of foreign currency denominated investments.

The Company designates and accounts for the following as cash flow hedges when they have met the requirements of cash flow hedging: (i) interest rate swaps to convert floating rate assets and liabilities to fixed rate assets and liabilities; (ii) foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated assets and liabilities; (iii) interest rate forwards and credit forwards to lock in the price to be paid for forward purchases of investments; (iv) interest rate swaps and interest rate forwards to hedge the forecasted purchases of fixed-rate investments; and (v) interest rate swaps and interest rate forwards to hedge forecasted fixed-rate borrowings.

The Company uses foreign currency exchange rate derivatives, which may include foreign currency forwards and currency options, to hedge portions of its net investments in foreign operations against adverse movements in exchange rates. The Company measures ineffectiveness on these derivatives based upon the change in forward rates.

When net investments in foreign operations are sold or substantially liquidated, the amounts in AOCI are reclassified to the statement of operations.

The Company may be exposed to credit-related losses in the event of nonperformance by its counterparties to derivatives. Generally, the current credit exposure of the Company’s derivatives is limited to the net positive estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements.

Employee Benefit Plans

Certain subsidiaries of MetLife, Inc. sponsor and/or administer various defined benefit pension plans and other postretirement employee benefit plans covering employees and sales representatives who meet specified eligibility requirements. These subsidiaries also provide certain postemployment benefits and certain postretirement medical and life insurance benefits for retired employees.

Closed Block

On April 7, 2000 (the “Demutualization Date”), Metropolitan Life Insurance Company (“MLIC”) converted from a mutual life insurance company to a stock life insurance company and became a wholly-owned subsidiary of MetLife, Inc. The conversion was pursuant to an order by the New York Superintendent of Insurance approving MLIC’s plan of reorganization, as amended (the “Plan of Reorganization”). On the Demutualization Date, MLIC established a closed block for the benefit of holders of certain individual life insurance policies of MLIC.

Experience within the closed block, in particular mortality and investment yields, as well as realized and unrealized gains and losses, directly impact the policyholder dividend obligation. Amortization of the closed block DAC, which resides outside of the closed block, is based upon cumulative actual and expected earnings within the closed block. Accordingly, the Company’s net income continues to be sensitive to the actual performance of the closed block.

XML

Segment Information (Tables)

9 Months Ended

Sep. 30, 2016

Segment Reporting [Abstract]

Segment Reporting Information, by Segment

	Operating Results
Three Months Ended September 30, 2016	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate & Other			Total			Adjustments			Total Consolidated
	(In millions)
Revenues
Premiums	$	5,936		$	1,822		$	653		$	500		$	1,093		$	347		$	40		$	10,391		$	—		$	10,391
Universal life and investment-type product policy fees	245			394			227			104			357			903			(31		)	2,199			97			2,296
Net investment income	1,590			707			311			81			1,537			941			(7		)	5,160			304			5,464
Other revenues	192			12			11			17			105			50			(28		)	359			7			366
Net investment gains (losses)	—			—			—			—			—			—			—			—			257			257
Net derivative gains (losses)	—			—			—			—			—			—			—			—			(1,051		)	(1,051		)
Total revenues	7,963			2,935			1,202			702			3,092			2,241			(26		)	18,109			(386		)	17,723
Expenses
Policyholder benefits and claims and policyholder dividends	5,894			1,363			681			257			1,853			814			10			10,872			295			11,167
Interest credited to policyholder account balances	322			331			85			28			261			288			—			1,315			505			1,820
Goodwill impairment	—			—			—			—			—			—			—			—			260			260
Capitalization of DAC	(124		)	(440		)	(83		)	(103		)	(44		)	(70		)	1			(863		)	—			(863		)
Amortization of DAC and VOBA	117			331			(2		)	106			219			509			2			1,282			(265		)	1,017
Amortization of negative VOBA	—			(46		)	(1		)	(3		)	—			—			—			(50		)	(5		)	(55		)
Interest expense on debt	2			—			1			—			15			32			241			291			1			292
Other expenses	912			930			335			332			401			560			(3		)	3,467			70			3,537
Total expenses	7,123			2,469			1,016			617			2,705			2,133			251			16,314			861			17,175
Provision for income tax expense (benefit)	288			142			53			11			121			40			(287		)	368			(393		)	(25		)
Operating earnings	$	552		$	324		$	133		$	74		$	266		$	68		$	10		1,427
Adjustments to:
Total revenues																						(386		)
Total expenses																						(861		)
Provision for income tax (expense) benefit																						393
Net income (loss)																						$	573					$	573

	Operating Results
Three Months Ended September 30, 2015	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate & Other			Total			Adjustments			Total Consolidated
	(In millions)
Revenues
Premiums	$	6,023		$	1,736		$	586		$	501		$	1,115		$	468		$	(53	)	$	10,376		$	(1	)	$	10,375
Universal life and investment-type product policy fees	233			382			261			106			370			921			(26		)	2,247			99			2,346
Net investment income	1,522			670			277			82			1,521			862			(85		)	4,849			(890		)	3,959
Other revenues	184			26			10			11			223			99			(58		)	495			(11		)	484
Net investment gains (losses)	—			—			—			—			—			—			—			—			382			382
Net derivative gains (losses)	—			—			—			—			—			—			—			—			485			485
Total revenues	7,962			2,814			1,134			700			3,229			2,350			(222		)	17,967			64			18,031
Expenses
Policyholder benefits and claims and policyholder dividends	5,976			1,331			581			233			1,885			846			(72		)	10,780			(92		)	10,688
Interest credited to policyholder account balances	304			327			88			27			266			313			6			1,331			(684		)	647
Goodwill impairment	—			—			—			—			—			—			—			—			—			—
Capitalization of DAC	(128		)	(435		)	(81		)	(107		)	(101		)	(102		)	(1		)	(955		)	—			(955		)
Amortization of DAC and VOBA	118			309			48			127			173			197			(1		)	971			160			1,131
Amortization of negative VOBA	—			(77		)	—			(5		)	—			—			—			(82		)	(8		)	(90		)
Interest expense on debt	1			—			—			—			13			32			248			294			8			302
Other expenses	908			896			348			352			647			614			361			4,126			19			4,145
Total expenses	7,179			2,351			984			627			2,883			1,900			541			16,465			(597		)	15,868
Provision for income tax expense (benefit)	272			125			(33		)	7			103			103			214			791			174			965
Operating earnings	$	511		$	338		$	183		$	66		$	243		$	347		$	(977	)	711
Adjustments to:
Total revenues																						64
Total expenses																						597
Provision for income tax (expense) benefit																						(174		)
Net income (loss)																						$	1,198					$	1,198

	Operating Results
Nine Months Ended September 30, 2016	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate & Other			Total			Adjustments			Total Consolidated
	(In millions)
Revenues
Premiums	$	16,127		$	5,161		$	1,885		$	1,519		$	3,312		$	1,020		$	51		$	29,075		$	426		$	29,501
Universal life and investment-type product policy fees	743			1,114			764			294			1,073			2,622			(87		)	6,523			403			6,926
Net investment income	4,615			2,003			809			244			4,489			2,624			(37		)	14,747			163			14,910
Other revenues	589			45			26			56			512			482			(380		)	1,330			10			1,340
Net investment gains (losses)	—			—			—			—			—			—			—			—			538			538
Net derivative gains (losses)	—			—			—			—			—			—			—			—			(1,815		)	(1,815		)
Total revenues	22,074			8,323			3,484			2,113			9,386			6,748			(453		)	51,675			(275		)	51,400
Expenses
Policyholder benefits and claims and policyholder dividends	16,210			3,923			1,814			801			5,603			2,525			(26		)	30,850			908			31,758
Interest credited to policyholder account balances	967			974			249			87			780			868			5			3,930			716			4,646
Goodwill impairment	—			—			—			—			—			—			—			—			260			260
Capitalization of DAC	(356		)	(1,251		)	(236		)	(310		)	(240		)	(255		)	(6		)	(2,654		)	(105		)	(2,759		)
Amortization of DAC and VOBA	353			921			127			311			636			823			7			3,178			(1,045		)	2,133
Amortization of negative VOBA	—			(167		)	(1		)	(10		)	—			—			—			(178		)	(43		)	(221		)
Interest expense on debt	7			—			1			—			43			96			759			906			4			910
Other expenses	2,772			2,658			968			1,001			1,861			1,739			(163		)	10,836			467			11,303
Total expenses	19,953			7,058			2,922			1,880			8,683			5,796			576			46,868			1,162			48,030
Provision for income tax expense (benefit)	720			377			141			32			203			260			(658		)	1,075			(595		)	480
Operating earnings	$	1,401		$	888		$	421		$	201		$	500		$	692		$	(371	)	3,732
Adjustments to:
Total revenues																						(275		)
Total expenses																						(1,162		)
Provision for income tax (expense) benefit																						595
Net income (loss)																						$	2,890					$	2,890

	Operating Results
Nine Months Ended September 30, 2015	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Brighthouse Financial			Corporate & Other			Total			Adjustments			Total Consolidated
	(In millions)
Revenues
Premiums	$	15,712		$	5,297		$	1,925		$	1,534		$	3,345		$	1,159		$	(30	)	$	28,942		$	(2	)	$	28,940
Universal life and investment-type product policy fees	700			1,179			856			322			1,117			2,789			(87		)	6,876			298			7,174
Net investment income	4,723			2,033			774			249			4,690			2,536			11			15,016			(649		)	14,367
Other revenues	567			82			27			40			711			310			(212		)	1,525			(28		)	1,497
Net investment gains (losses)	—			—			—			—			—			—			—			—			535			535
Net derivative gains (losses)	—			—			—			—			—			—			—			—			394			394
Total revenues	21,702			8,591			3,582			2,145			9,863			6,794			(318		)	52,359			548			52,907
Expenses
Policyholder benefits and claims and policyholder dividends	15,675			4,046			1,793			737			5,479			2,103			(103		)	29,730			237			29,967
Interest credited to policyholder account balances	905			992			263			91			793			940			20			4,004			(64		)	3,940
Goodwill impairment	—			—			—			—			—			—			—			—			—			—
Capitalization of DAC	(365		)	(1,268		)	(246		)	(372		)	(292		)	(305		)	(2		)	(2,850		)	—			(2,850		)
Amortization of DAC and VOBA	352			971			195			388			423			595			1			2,925			128			3,053
Amortization of negative VOBA	—			(241		)	(1		)	(13		)	—			—			—			(255		)	(27		)	(282		)
Interest expense on debt	4			—			—			—			41			96			757			898			10			908
Other expenses	2,740			2,669			1,070			1,103			1,988			1,830			408			11,808			28			11,836
Total expenses	19,311			7,169			3,074			1,934			8,432			5,259			1,081			46,260			312			46,572
Provision for income tax expense (benefit)	819			332			40			25			454			410			(156		)	1,924			(69		)	1,855
Operating earnings	$	1,572		$	1,090		$	468		$	186		$	977		$	1,125		$	(1,243	)	4,175
Adjustments to:
Total revenues																						548
Total expenses																						(312		)
Provision for income tax (expense) benefit																						69
Net income (loss)																						$	4,480					$	4,480

The following table presents total assets with respect to the Company’s segments, as well as Corporate & Other, at:

	September 30, 2016		December 31, 2015
	(In millions)
U.S.	$	257,943	$	237,858
Asia	133,881		113,895
Latin America	70,421		64,808
EMEA	27,764		26,767
MetLife Holdings	195,267		187,677
Brighthouse Financial	240,696		226,792
Corporate & Other	26,932		20,136
Total	$	952,904	$	877,933

XML

Insurance (Tables)

9 Months Ended

Sep. 30, 2016

Insurance [Abstract]

Insurance Liabilities

Information regarding insurance liabilities by segment, as well as Corporate & Other, was as follows at:

	September 30, 2016			December 31, 2015
	(In millions)
U.S.	$	129,448		$	123,060
Asia	96,648			83,510
Latin America	15,228			14,022
EMEA	19,206			19,009
MetLife Holdings	105,995			102,853
Brighthouse Financial	79,241			71,853
Corporate & Other	(6,156		)	(5,451		)
Total	$	439,610		$	408,856

Guarantees related to Annuity, Universal and Variable Life Contracts

Information regarding the Company’s guarantee exposure, which includes direct and assumed business, but excludes offsets from hedging or ceded reinsurance, if any, was as follows at:

	September 30, 2016								December 31, 2015
	In the Event of Death				At Annuitization				In the Event of Death				At Annuitization
	(Dollars in millions)
Annuity Contracts (1):
Variable Annuity Guarantees:
Total account value (2), (3)	$	183,010			$	92,187			$	181,413			$	91,240
Separate account value	$	153,486			$	88,546			$	151,901			$	87,841
Net amount at risk (2)	$	8,157	(4	)	$	4,663	(5	)	$	10,339	(4	)	$	2,762	(5	)
Average attained age of contractholders	66 years				66 years				66 years				66 years
Other Annuity Guarantees:
Total account value (3)	N/A				$	1,600			N/A				$	1,560
Net amount at risk	N/A				$	576	(6	)	N/A				$	422	(6	)
Average attained age of contractholders	N/A				50 years				N/A				51 years

	September 30, 2016				December 31, 2015
	Secondary Guarantees		Paid-Up Guarantees		Secondary Guarantees		Paid-Up Guarantees
	(Dollars in millions)
Universal and Variable Life Contracts (1):
Total account value (3)	$	17,640	$	3,365	$	17,211	$	3,461
Net amount at risk (7)	$	176,066	$	18,068	$	175,958	$	19,047
Average attained age of policyholders	57 years		62 years		57 years		62 years

__________________

(1) The Company’s annuity and life contracts with guarantees may offer more than one type of guarantee in each contract. Therefore, the amounts listed above may not be mutually exclusive.

(2) Includes amounts, which are not reported on the consolidated balance sheets, from assumed reinsurance of certain variable annuity products from the Company’s former operating joint venture in Japan.

(3) Includes the contractholder’s investments in the general account and separate account, if applicable.

(4) Defined as the death benefit less the total account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date and includes any additional contractual claims associated with riders purchased to assist with covering income taxes payable upon death.

(5) Defined as the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. This amount represents the Company’s potential economic exposure to such guarantees in the event all contractholders were to annuitize on the balance sheet date, even though the contracts contain terms that allow annuitization of the guaranteed amount only after the 10th anniversary of the contract, which not all contractholders have achieved.

(6) Defined as either the excess of the upper tier, adjusted for a profit margin, less the lower tier, as of the balance sheet date or the amount (if any) that would be required to be added to the total account value to purchase a lifetime income stream, based on current annuity rates, equal to the minimum amount provided under the guaranteed benefit. These amounts represent the Company’s potential economic exposure to such guarantees in the event all contractholders were to annuitize on the balance sheet date.

(7) Defined as the guarantee amount less the account value, as of the balance sheet date. It represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date.

XML

Deferred Policy Acquisition Costs and Value of Business Acquired (DAC and VOBA by Segment) (Tables)

9 Months Ended

Sep. 30, 2016

Deferred Policy Acquisition Costs and Value of Business Acquired [Abstract]

Information regarding Deferred Policy Acquisition Costs and Value of Business Acquired by Segment

Information regarding total DAC and VOBA by segment, as well as Corporate & Other, was as follows at:

	September 30, 2016		December 31, 2015
	(In millions)
U.S.	$	618	$	615
Asia	9,148		8,374
Latin America	1,846		1,753
EMEA	1,554		1,532
MetLife Holdings	4,962		5,436
Brighthouse Financial	6,589		6,390
Corporate & Other	31		30
Total	$	24,748	$	24,130

XML

Closed Block (Tables)

9 Months Ended

Sep. 30, 2016

Closed Block Disclosure [Abstract]

Closed block liabilities and assets

Information regarding the closed block liabilities and assets designated to the closed block was as follows at:

	September 30, 2016			December 31, 2015
	(In millions)
Closed Block Liabilities
Future policy benefits	$	40,840		$	41,278
Other policy-related balances	256			249
Policyholder dividends payable	506			468
Policyholder dividend obligation	3,352			1,783
Current income tax payable	8			—
Other liabilities	601			380
Total closed block liabilities	45,563			44,158
Assets Designated to the Closed Block
Investments:
Fixed maturity securities available-for-sale, at estimated fair value	29,194			27,556
Equity securities available-for-sale, at estimated fair value	107			111
Mortgage loans	5,739			6,022
Policy loans	4,553			4,642
Real estate and real estate joint ventures	672			462
Other invested assets	1,233			1,066
Total investments	41,498			39,859
Cash and cash equivalents	72			236
Accrued investment income	482			474
Premiums, reinsurance and other receivables	65			56
Current income tax recoverable	—			11
Deferred income tax assets	195			234
Total assets designated to the closed block	42,312			40,870
Excess of closed block liabilities over assets designated to the closed block	3,251			3,288
Amounts included in accumulated other comprehensive income (loss) (“AOCI”)
Unrealized investment gains (losses), net of income tax	2,452			1,382
Unrealized gains (losses) on derivatives, net of income tax	88			76
Allocated to policyholder dividend obligation, net of income tax	(2,179		)	(1,159		)
Total amounts included in AOCI	361			299
Maximum future earnings to be recognized from closed block assets and liabilities	$	3,612		$	3,587

Closed block policyholder dividend obligation

Information regarding the closed block policyholder dividend obligation was as follows:

	Nine Months   Ended   September 30, 2016		Year   Ended   December 31, 2015
	(In millions)
Balance, beginning of period	$	1,783	$	3,155
Change in unrealized investment and derivative gains (losses)	1,569		(1,372		)
Balance, end of period	$	3,352	$	1,783

Closed block revenues and expenses

Information regarding the closed block revenues and expenses was as follows:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Revenues
Premiums	$	436		$	447		$	1,297		$	1,334
Net investment income	486			487			1,435			1,500
Net investment gains (losses)	(3		)	(9		)	(19		)	(8		)
Net derivative gains (losses)	4			13			(3		)	25
Total revenues	923			938			2,710			2,851
Expenses
Policyholder benefits and claims	619			635			1,861			1,886
Policyholder dividends	232			273			723			757
Other expenses	33			36			100			109
Total expenses	884			944			2,684			2,752
Revenues, net of expenses before provision for income tax expense (benefit)	39			(6		)	26			99
Provision for income tax expense (benefit)	13			(1		)	8			36
Revenues, net of expenses and provision for income tax expense (benefit)	$	26		$	(5	)	$	18		$	63

XML

Investments (Tables)

9 Months Ended

Sep. 30, 2016

Investments, Debt and Equity Securities [Abstract]

Fixed Maturity and Equity Securities Available-for-Sale

The following table presents the fixed maturity and equity securities available-for-sale (“AFS”) by sector. Redeemable preferred stock is reported within U.S. corporate and foreign corporate fixed maturity securities and non-redeemable preferred stock is reported within equity securities. Included within fixed maturity securities are structured securities including residential mortgage-backed securities (“RMBS”), asset-backed securities (“ABS”) and commercial mortgage-backed securities (“CMBS”) (collectively, “Structured Securities”).

	September 30, 2016											December 31, 2015
	Cost or Amortized Cost		Gross Unrealized							Estimated Fair Value		Cost or Amortized Cost		Gross Unrealized							Estimated Fair Value
			Gains		Temporary Losses		OTTI Losses							Gains		Temporary Losses		OTTI Losses
	(In millions)
Fixed maturity securities:
U.S. corporate	$	95,808	$	10,589	$	721	$	—		$	105,676	$	96,466	$	6,583	$	2,255	$	—		$	100,794
U.S. government and agency	60,340		9,491		46		—			69,785		56,499		5,373		226		—			61,646
Foreign corporate	57,423		4,264		1,268		—			60,419		56,003		3,019		1,822		2			57,198
Foreign government	54,425		9,479		139		—			63,765		45,451		5,269		221		—			50,499
RMBS	43,838		1,788		310		7			45,309		37,914		1,366		424		59			38,797
State and political subdivision	14,539		2,939		11		4			17,463		13,723		1,795		67		10			15,441
ABS	15,685		122		220		3			15,584		14,498		131		229		6			14,394
CMBS (1)	11,855		662		77		(1		)	12,441		12,410		347		125		(1		)	12,633
Total fixed maturity securities	$	353,913	$	39,334	$	2,792	$	13		$	390,442	$	332,964	$	23,883	$	5,369	$	76		$	351,402
Equity securities:
Common stock	$	2,000	$	449	$	14	$	—		$	2,435	$	1,962	$	397	$	107	$	—		$	2,252
Non-redeemable preferred stock	838		63		47		—			854		1,035		85		51		—			1,069
Total equity securities	$	2,838	$	512	$	61	$	—		$	3,289	$	2,997	$	482	$	158	$	—		$	3,321

__________________

(1) The noncredit loss component of other-than-temporary impairment (“OTTI”) losses for CMBS was in an unrealized gain position of $1 million at both September 30, 2016 and December 31, 2015 due to increases in estimated fair value subsequent to initial recognition of noncredit losses on such securities. See also “— Net Unrealized Investment Gains (Losses).”

Available-for-sale fixed maturity securities by contractual maturity date

The amortized cost and estimated fair value of fixed maturity securities, by contractual maturity date, were as follows at September 30, 2016:

	Due in One Year or Less		Due After One Year Through Five Years		Due After Five Years Through Ten Years		Due After Ten Years		Structured Securities		Total Fixed Maturity Securities
	(In millions)
Amortized cost	$	15,378	$	77,046	$	72,056	$	118,055	$	71,378	$	353,913
Estimated fair value	$	15,464	$	81,187	$	76,987	$	143,470	$	73,334	$	390,442

Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale

The following table presents the estimated fair value and gross unrealized losses of fixed maturity and equity securities AFS in an unrealized loss position, aggregated by sector and by length of time that the securities have been in a continuous unrealized loss position at:

	September 30, 2016								December 31, 2015
	Less than 12 Months				Equal to or Greater than 12 Months				Less than 12 Months				Equal to or Greater than 12 Months
	Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses		Estimated Fair Value		Gross Unrealized Losses
	(Dollars in millions)
Fixed maturity securities:
U.S. corporate	$	5,559	$	274	$	4,612	$	447	$	27,526	$	1,629	$	3,762	$	626
U.S. government and agency	6,305		24		164		22		19,628		222		298		4
Foreign corporate	6,781		404		6,112		864		14,447		911		5,251		913
Foreign government	2,136		75		851		64		3,530		166		429		55
RMBS	5,692		127		3,259		190		13,467		287		2,431		196
State and political subdivision	321		5		79		10		1,618		55		168		22
ABS	2,084		105		3,476		118		7,329		124		2,823		111
CMBS	701		34		791		42		4,876		81		637		43
Total fixed maturity securities	$	29,579	$	1,048	$	19,344	$	1,757	$	92,421	$	3,475	$	15,799	$	1,970
Equity securities:
Common stock	$	102	$	14	$	5	$	—	$	203	$	105	$	20	$	2
Non-redeemable preferred stock	49		3		163		44		79		2		200		49
Total equity securities	$	151	$	17	$	168	$	44	$	282	$	107	$	220	$	51
Total number of securities in an unrealized loss position	2,579				1,871				6,366				1,489

Disclosure of Mortgage Loans Net of Valuation Allowance

Mortgage loans are summarized as follows at:

	September 30, 2016					December 31, 2015
	Carrying Value			% of Total		Carrying Value			% of Total
	(Dollars in millions)
Mortgage loans:
Commercial	$	45,801		64.4	%	$	44,012		65.6	%
Agricultural	14,141			19.9		13,188			19.6
Residential	10,920			15.3		9,734			14.5
Subtotal (1)	70,862			99.6		66,934			99.7
Valuation allowances	(330		)	(0.5	)	(318		)	(0.5	)
Subtotal mortgage loans, net	70,532			99.1		66,616			99.2
Residential — FVO	481			0.7		314			0.5
Commercial mortgage loans held by CSEs — FVO	143			0.2		172			0.3
Total mortgage loans, net	$	71,156		100.0	%	$	67,102		100.0	%

__________________

(1) Purchases of mortgage loans were$856 millionand$2.3 billionfor thethree monthsandnine months endedSeptember 30, 2016, respectively, and$1.0 billionand$3.2 billionfor thethree monthsandnine months endedSeptember 30, 2015, respectively.

Disclosure of mortgage loans held-for-investment and valuation allowances by method of evaluation for credit loss

Mortgage loans by portfolio segment, by method of evaluation of credit loss, impaired mortgage loans including those modified in a troubled debt restructuring, and the related valuation allowances, were as follows at:

	Evaluated Individually for Credit Losses										Evaluated Collectively for Credit Losses				Impaired Loans
	Impaired Loans with a Valuation Allowance						Impaired Loans without a Valuation Allowance
	Unpaid Principal Balance		Recorded Investment		Valuation Allowances		Unpaid Principal Balance		Recorded Investment		Recorded Investment		Valuation Allowances		Carrying Value
	(In millions)
September 30, 2016
Commercial	$	—	$	—	$	—	$	12	$	12	$	45,789	$	227	$	12
Agricultural	16		13		1		39		38		14,090		42		50
Residential	—		—		—		236		215		10,705		60		215
Total	$	16	$	13	$	1	$	287	$	265	$	70,584	$	329	$	277
December 31, 2015
Commercial	$	—	$	—	$	—	$	57	$	57	$	43,955	$	217	$	57
Agricultural	49		47		3		22		21		13,120		39		65
Residential	—		—		—		141		131		9,603		59		131
Total	$	49	$	47	$	3	$	220	$	209	$	66,678	$	315	$	253

Allowance for Loan and Lease Losses, Provision for Loss, Net

The changes in the valuation allowance, by portfolio segment, were as follows:

	Nine Months   Ended   September 30,
	2016												2015
	Commercial			Agricultural			Residential			Total			Commercial			Agricultural		Residential			Total
	(In millions)
Balance, beginning of period	$	217		$	42		$	59		$	318		$	224		$	39	$	42		$	305
Provision (release) (1)	153			3			13			169			3			2		27			32
Charge-offs, net of recoveries (1)	(143		)	(2		)	(12		)	(157		)	(12		)	—		(14		)	(26		)
Balance, end of period	$	227		$	43		$	60		$	330		$	215		$	41	$	55		$	311

__________________

(1) In connection with an acquisition in 2010, certain impaired commercial mortgage loans were acquired and accordingly, were not originated by the Company. Such commercial mortgage loans have been accounted for as purchased credit impaired (“PCI”) commercial mortgage loans. As explained in Note 8 of the Notes to Consolidated Financial Statements included in the 2015 Annual Report, decreases in cash flows expected to be collected on PCI commercial mortgage loans can result in provisions for losses on mortgage loan. For the nine months endedSeptember 30, 2016, in connection with the maturity of an acquired PCI commercial mortgage loan, an increase to the commercial mortgage loan valuation allowance of$143 millionwas recorded and charged-off upon maturity. The Company will recover a substantial portion of the loss on the loan incurred through an indemnification agreement entered into in connection with the acquisition in 2010.

Schedule of Financing Receivables, Non Accrual Status

The past due and accrual status of mortgage loans at recorded investment, prior to valuation allowances, by portfolio segment, were as follows at:

	Past Due				Nonaccrual Status
	September 30, 2016		December 31, 2015		September 30, 2016		December 31, 2015
	(In millions)
Commercial	$	—	$	2	$	—	$	—
Agricultural	144		103		39		46
Residential	333		326		322		318
Total	$	477	$	431	$	361	$	364

Components of net unrealized investment gains (losses) included in accumulated other comprehensive income (loss)

The components of net unrealized investment gains (losses), included in AOCI, were as follows:

	September 30, 2016			December 31, 2015
	(In millions)
Fixed maturity securities	$	36,444		$	18,164
Fixed maturity securities with noncredit OTTI losses included in AOCI	(13		)	(76		)
Total fixed maturity securities	36,431			18,088
Equity securities	579			422
Derivatives	3,648			2,350
Other	397			287
Subtotal	41,055			21,147
Amounts allocated from:
Future policy benefits	(5,571		)	(163		)
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(2		)	—
DAC, VOBA and DSI	(2,390		)	(1,273		)
Policyholder dividend obligation	(3,352		)	(1,783		)
Subtotal	(11,315		)	(3,219		)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	7			27
Deferred income tax benefit (expense)	(10,078		)	(6,151		)
Net unrealized investment gains (losses)	19,669			11,804
Net unrealized investment gains (losses) attributable to noncontrolling interests	(12		)	(31		)
Net unrealized investment gains (losses) attributable to MetLife, Inc.	$	19,657		$	11,773

The changes in net unrealized investment gains (losses) were as follows:

	Nine Months   Ended   September 30, 2016
	(In millions)
Balance, beginning of period	$	11,773
Fixed maturity securities on which noncredit OTTI losses have been recognized	63
Unrealized investment gains (losses) during the period	19,845
Unrealized investment gains (losses) relating to:
Future policy benefits	(5,408		)
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(2		)
DAC, VOBA and DSI	(1,117		)
Policyholder dividend obligation	(1,569		)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	(20		)
Deferred income tax benefit (expense)	(3,927		)
Net unrealized investment gains (losses)	19,638
Net unrealized investment gains (losses) attributable to noncontrolling interests	19
Balance, end of period	$	19,657
Change in net unrealized investment gains (losses)	$	7,865
Change in net unrealized investment gains (losses) attributable to noncontrolling interests	19
Change in net unrealized investment gains (losses) attributable to MetLife, Inc.	$	7,884

Other than Temporary Impairment, Credit Losses Recognized in Earnings [Table Text Block]

The changes in fixed maturity securities with noncredit OTTI losses included in AOCI were as follows:

	Nine Months   Ended   September 30, 2016			Year   Ended   December 31, 2015
	(In millions)
Balance, beginning of period	$	(76	)	$	(112	)
Noncredit OTTI losses and subsequent changes recognized	12			6
Securities sold with previous noncredit OTTI loss	34			125
Subsequent changes in estimated fair value	17			(95		)
Balance, end of period	$	(13	)	$	(76	)

Securities Lending

Elements of the securities lending program are presented below at:

	September 30, 2016		December 31, 2015
	(In millions)
Securities on loan: (1)
Amortized cost	$	26,855	$	27,223
Estimated fair value	$	31,326	$	29,646
Cash collateral on deposit from counterparties (2)	$	32,119	$	30,197
Security collateral on deposit from counterparties (3)	$	134	$	50
Reinvestment portfolio — estimated fair value	$	32,454	$	30,258

__________________

(1) Included within fixed maturity securities, cash equivalents and short-term investments. At September 30, 2016, both amortized cost and estimated fair value also included $114 million, at estimated fair value, of securities which are not reflected on the consolidated financial statements.

(2) Included within payables for collateral under securities loaned and other transactions.

(3) Security collateral on deposit from counterparties may not be sold or re-pledged, unless the counterparty is in default, and is not reflected on the consolidated financial statements.

The cash collateral liability by loaned security type and remaining tenor of the agreements were as follows at:

	September 30, 2016								December 31, 2015
	Remaining Tenor of Securities Lending Agreements								Remaining Tenor of Securities Lending Agreements
	Open (1)		1 Month or Less		1 to 6 Months		Total		Open (1)		1 Month or Less		1 to 6 Months		Total
	(In millions)
Cash collateral liability by loaned security type:
U.S. government and agency	$	8,362	$	10,162	$	11,090	$	29,614	$	10,116	$	11,157	$	5,986	$	27,259
Agency RMBS	—		—		1,196		1,196		—		951		600		1,551
Foreign government	—		836		50		886		2		510		486		998
U.S. corporate	1		391		—		392		9		380		—		389
Foreign corporate	—		31		—		31		—		—		—		—
Total	$	8,363	$	11,420	$	12,336	$	32,119	$	10,127	$	12,998	$	7,072	$	30,197

__________________

(1) The related loaned security could be returned to the Company on the next business day which would require the Company to immediately return the cash collateral.

Repurchase Agreements

Elements of the other short-term repurchase agreements are presented below at:

	September 30, 2016		December 31, 2015
	(In millions)
Securities on loan included within fixed maturity securities:
Amortized cost	$	91	$	51
Estimated fair value	$	109	$	56
Cash collateral received included within other liabilities	$	101	$	50
Reinvestment portfolio — estimated fair value	$	99	$	50

The cash collateral liability by loaned security type and remaining tenor of the agreements were as follows at:

	September 30, 2016						December 31, 2015
	Remaining Tenor of Other Repurchase Agreements						Remaining Tenor of Other Repurchase Agreements
	1 Month or Less		1 to 6  Months		Total		1 Month or Less		1 to 6 Months		Total
	(In millions)
Cash collateral liability by loaned security type:
Foreign corporate	$	14	$	13	$	27	$	—	$	25	$	25
All other corporate and government	37		37		$	74	—		25		$	25
Total	$	51	$	50	$	101	$	—	$	50	$	50

Invested Assets on Deposit, Held in Trust and Pledged as Collateral

Invested assets on deposit, held in trust and pledged as collateral are presented below at estimated fair value for all asset classes, except mortgage loans, which are presented at carrying value at:

	September 30, 2016		December 31, 2015
	(In millions)
Invested assets on deposit (regulatory deposits)	$	10,425	$	9,089
Invested assets held in trust (collateral financing arrangements and reinsurance agreements)	11,902		10,443
Invested assets pledged as collateral (1)	29,296		23,145
Total invested assets on deposit, held in trust and pledged as collateral	$	51,623	$	42,677

__________________

(1) The Company has pledged invested assets in connection with various agreements and transactions, including funding agreements (see Notes 4 and 12 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report), collateral financing arrangements (see Note 13 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report) and derivative transactions (see Note 8).

The Components of Net Investment Income

The components of net investment income were as follows:

	Three Months   Ended   September 30,					Nine Months   Ended   September 30,
	2016		2015			2016		2015
	(In millions)
Investment income:
Fixed maturity securities	$	3,583	$	3,525		$	10,801	$	10,738
Equity securities	35		36			105		102
FVO and trading securities — Actively traded and FVO general account securities (1)	25		(35		)	41		4
Mortgage loans	806		786			2,464		2,317
Policy loans	148		147			444		450
Real estate and real estate joint ventures	210		233			516		767
Other limited partnership interests	263		216			429		681
Cash, cash equivalents and short-term investments	43		29			126		101
Operating joint ventures	5		(1		)	28		15
Other	95		28			187		180
Subtotal	5,213		4,964			15,141		15,355
Less: Investment expenses	281		308			862		923
Subtotal, net	4,932		4,656			14,279		14,432
FVO and trading securities — FVO contractholder-directed unit-linked investments (1)	529		(701		)	623		(79		)
FVO CSEs — interest income:
Commercial mortgage loans	3		4			8		13
Securities	—		—			—		1
Subtotal	532		(697		)	631		(65		)
Net investment income	$	5,464	$	3,959		$	14,910	$	14,367

__________________

(1) Changes in estimated fair value subsequent to purchase for securities still held as of the end of the respective periods included in net investment income were principally from FVO contractholder-directed unit-linked investments and, to a much lesser extent, Actively traded and FVO general account securities, and were $407 million and $283 million for the three months and nine months ended September 30, 2016, respectively, and ($872) million and ($645) million for the three months and nine months ended September 30, 2015, respectively.

The components of net investment gains (losses)

The components of net investment gains (losses) were as follows:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Total gains (losses) on fixed maturity securities:
Total OTTI losses recognized — by sector and industry:
U.S. and foreign corporate securities — by industry:
Consumer	$	—		$	(17	)	$	—		$	(20	)
Industrial	—			(3		)	(79		)	(5		)
Communications	—			—			(3		)	—
Total U.S. and foreign corporate securities	—			(20		)	(82		)	(25		)
RMBS	(14		)	(1		)	(22		)	(16		)
ABS	—			—			(2		)	—
State and political subdivision	—			(6		)	—			(6		)
OTTI losses on fixed maturity securities recognized in earnings	(14		)	(27		)	(106		)	(47		)
Fixed maturity securities — net gains (losses) on sales and disposals	176			115			439			383
Total gains (losses) on fixed maturity securities	162			88			333			336
Total gains (losses) on equity securities:
Total OTTI losses recognized — by sector:
Non-redeemable preferred stock	—			(1		)	—			(1		)
Common stock	(5		)	(6		)	(72		)	(15		)
OTTI losses on equity securities recognized in earnings	(5		)	(7		)	(72		)	(16		)
Equity securities — net gains (losses) on sales and disposals	13			14			32			39
Total gains (losses) on equity securities	8			7			(40		)	23
Mortgage loans	(31		)	(26		)	(193		)	(78		)
Real estate and real estate joint ventures	(14		)	263			33			257
Other limited partnership interests	(9		)	(59		)	(50		)	(52		)
Other	(19		)	18			(94		)	14
Subtotal	97			291			(11		)	500
FVO CSEs:
Commercial mortgage loans	(3		)	(4		)	(3		)	(6		)
Securities	1			—			2			—
Long-term debt — related to commercial mortgage loans	1			1			1			3
Non-investment portfolio gains (losses) (1)	161			94			549			38
Subtotal	160			91			549			35
Total net investment gains (losses)	$	257		$	382		$	538		$	535

__________________

(1) Includes a gain from the U.S. Retail Advisor Force Divestiture of $103 million during both the three months and nine months ended September 30, 2016. See Note 3.

Proceeds from sales or disposals of fixed maturity and equity securities and the components of fixed maturity and equity securities net investment gains and losses

Proceeds from sales or disposals of fixed maturity and equity securities and the components of fixed maturity and equity securities net investment gains (losses) were as shown in the table below.

	Three Months   Ended   September 30,
	2016			2015			2016			2015
	Fixed Maturity Securities						Equity Securities
	(In millions)
Proceeds	$	25,091		$	27,264		$	64		$	55
Gross investment gains	$	310		$	371		$	15		$	20
Gross investment losses	(134		)	(256		)	(2		)	(6		)
OTTI losses	(14		)	(27		)	(5		)	(7		)
Net investment gains (losses)	$	162		$	88		$	8		$	7

	Nine Months   Ended   September 30,
	2016			2015			2016			2015
	Fixed Maturity Securities						Equity Securities
	(In millions)
Proceeds	$	83,352		$	86,590		$	151		$	211
Gross investment gains	$	1,025		$	1,047		$	40		$	54
Gross investment losses	(586		)	(664		)	(8		)	(15		)
OTTI losses	(106		)	(47		)	(72		)	(16		)
Net investment gains (losses)	$	333		$	336		$	(40	)	$	23

Rollforward of the Cumulative Credit Loss Component of OTTI income (loss)

The table below presents a rollforward of the cumulative credit loss component of OTTI loss recognized in earnings on fixed maturity securities still held for which a portion of the OTTI loss was recognized in other comprehensive income (loss) (“OCI”):

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Balance, beginning of period	$	258		$	280		$	277		$	357
Additions:
Initial impairments — credit loss OTTI on securities not previously impaired	1			—			1			2
Additional impairments — credit loss OTTI on securities previously impaired	10			1			18			14
Reductions:
Sales (maturities, pay downs or prepayments) of securities previously impaired as credit loss OTTI	(17		)	(22		)	(43		)	(113		)
Securities impaired to net present value of expected future cash flows	—			—			(1		)	—
Increase in cash flows — accretion of previous credit loss OTTI	—			(1		)	—			(2		)
Balance, end of period	$	252		$	258		$	252		$	258

Variable Interest Entity, Primary Beneficiary [Member]

Variable Interest Entity [Line Items]

Schedule of Variable Interest Entities [Table Text Block]

Creditors or beneficial interest holders of VIEs where the Company is the primary beneficiary have no recourse to the general credit of the Company, as the Company’s obligation to the VIEs is limited to the amount of its committed investment.

The following table presents the total assets and total liabilities relating to VIEs for which the Company has concluded that it is the primary beneficiary and which are consolidated at:

	September 30, 2016				December 31, 2015
	Total Assets		Total Liabilities		Total Assets		Total Liabilities
	(In millions)
MRSC (collateral financing arrangement (primarily securities)) (1)	$	3,533	$	—	$	3,374	$	—
Operating joint venture (2)	—		—		2,465		2,079
CSEs (assets (primarily loans) and liabilities (primarily debt)) (3)	156		38		186		62
Other investments (4)	50		—		76		—
Total	$	3,739	$	38	$	6,101	$	2,141

__________________

(1) See Note 13 of the Notes to the Consolidated Financial Statements included in the 2015 Annual Report for a description of the MetLife Reinsurance Company of South Carolina (“MRSC”) collateral financing arrangement.

(2) Following a change in the foreign investment law in India, the Company no longer consolidated its India operating joint venture, effective January 1, 2016. Assets of the operating joint venture are primarily fixed maturity securities and separate account assets. Liabilities of the operating joint venture are primarily future policy benefits, other policy-related balances and separate account liabilities.

(3) The Company consolidates entities that are structured as CMBS and as collateralized debt obligations. The assets of these entities can only be used to settle their respective liabilities, and under no circumstances is the Company liable for any principal or interest shortfalls should any arise. The Company’s exposure was limited to that of its remaining investment in these entities of $98 million and $105 million at estimated fair value at September 30, 2016 and December 31, 2015, respectively.

(4) Other investments is primarily comprised of other invested assets and other limited partnership interests.

Variable Interest Entity, Not Primary Beneficiary [Member]

Variable Interest Entity [Line Items]

Schedule of Variable Interest Entities [Table Text Block]

The carrying amount and maximum exposure to loss relating to VIEs in which the Company holds a significant variable interest but is not the primary beneficiary and which have not been consolidated were as follows at:

	September 30, 2016				December 31, 2015
	Carrying Amount		Maximum Exposure to Loss (1)		Carrying Amount		Maximum Exposure to Loss (1)
	(In millions)
Fixed maturity securities AFS:
Structured Securities (2)	$	73,334	$	73,334	$	65,824	$	65,824
U.S. and foreign corporate	3,374		3,374		3,261		3,261
Other limited partnership interests	5,978		10,572		5,186		7,074
Other invested assets	2,184		2,771		1,604		2,161
FVO and trading securities	576		576		586		586
Real estate joint ventures	107		137		65		82
Other (3)	120		120		71		71
Total	$	85,673	$	90,884	$	76,597	$	79,059

__________________

(1) The maximum exposure to loss relating to fixed maturity securities AFS, FVO and trading securities and equity securities AFS is equal to their carrying amounts or the carrying amounts of retained interests. The maximum exposure to loss relating to other limited partnership interests, mortgage loans and real estate joint ventures is equal to the carrying amounts plus any unfunded commitments. For certain of its investments in other invested assets, the Company’s return is in the form of income tax credits which are guaranteed by creditworthy third parties. For such investments, the maximum exposure to loss is equal to the carrying amounts plus any unfunded commitments, reduced by income tax credits guaranteed by third parties of $151 million and $179 million at September 30, 2016 and December 31, 2015, respectively. Such a maximum loss would be expected to occur only upon bankruptcy of the issuer or investee.

(2) For these variable interests, the Company’s involvement is limited to that of a passive investor in mortgage-backed or asset-backed securities issued by trusts that do not have substantial equity.

(3) Other is comprised of mortgage loans, non-redeemable preferred stock and a loan receivable.

Commercial

Mortgage Loans on Real Estate [Line Items]

Disclosure of the mortgage loans portfolio segment by the recorded investment, prior to valuation allowances, by credit quality indicator categories

The credit quality of commercial mortgage loans was as follows at:

	Recorded Investment										Estimated Fair Value		% of Total
	Debt Service Coverage Ratios								% of Total
	> 1.20x		1.00x - 1.20x		< 1.00x		Total
	(Dollars in millions)
September 30, 2016
Loan-to-value ratios:
Less than 65%	$	41,391	$	879	$	675	$	42,945	93.8	%	$	44,770	93.9	%
65% to 75%	2,194		39		298		2,531		5.5		2,563		5.4
76% to 80%	42		—		—		42		0.1		40		0.1
Greater than 80%	143		53		87		283		0.6		299		0.6
Total	$	43,770	$	971	$	1,060	$	45,801	100	%	$	47,672	100	%
December 31, 2015
Loan-to-value ratios:
Less than 65%	$	38,163	$	1,063	$	544	$	39,770	90.4	%	$	40,921	90.7	%
65% to 75%	3,270		138		76		3,484		7.9		3,451		7.7
76% to 80%	—		—		—		—		—		—		—
Greater than 80%	381		140		237		758		1.7		732		1.6
Total	$	41,814	$	1,341	$	857	$	44,012	100.0	%	$	45,104	100.0	%

Agricultural

Mortgage Loans on Real Estate [Line Items]

Disclosure of the mortgage loans portfolio segment by the recorded investment, prior to valuation allowances, by credit quality indicator categories

The credit quality of agricultural mortgage loans was as follows at:

	September 30, 2016				December 31, 2015
	Recorded Investment		% of Total		Recorded Investment		% of Total
	(Dollars in millions)
Loan-to-value ratios:
Less than 65%	$	13,543	95.8	%	$	12,399	94.0	%
65% to 75%	532		3.8		710		5.4
76% to 80%	20		0.1		21		0.2
Greater than 80%	46		0.3		58		0.4
Total	$	14,141	100.0	%	$	13,188	100.0	%

Residential

Mortgage Loans on Real Estate [Line Items]

Disclosure of the mortgage loans portfolio segment by the recorded investment, prior to valuation allowances, by credit quality indicator categories

The credit quality of residential mortgage loans was as follows at:

	September 30, 2016				December 31, 2015
	Recorded Investment		% of Total		Recorded Investment		% of Total
	(Dollars in millions)
Performance indicators:
Performing	$	10,587	97.0	%	$	9,408	96.7	%
Nonperforming	333		3.0		326		3.3
Total	$	10,920	100.0	%	$	9,734	100.0	%

XML

Derivatives (Tables)

9 Months Ended

Sep. 30, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location

The following table presents the gross notional amount, estimated fair value and primary underlying risk exposure of the Company’s derivatives, excluding embedded derivatives, held at:

		September 30, 2016						December 31, 2015
	Primary Underlying Risk Exposure	Gross Notional Amount		Estimated Fair Value				Gross Notional Amount		Estimated Fair Value
				Assets		Liabilities				Assets		Liabilities
		(In millions)
Derivatives Designated as Hedging Instruments:
Fair value hedges:
Interest rate swaps	Interest rate	$	5,383	$	2,824	$	14	$	5,528	$	2,215	$	12
Foreign currency swaps	Foreign currency exchange rate	1,221		28		156		2,154		62		159
Foreign currency forwards	Foreign currency exchange rate	1,485		196		—		1,685		—		52
Subtotal		8,089		3,048		170		9,367		2,277		223
Cash flow hedges:
Interest rate swaps	Interest rate	2,251		672		—		2,190		487		—
Interest rate forwards	Interest rate	2,032		49		10		105		23		—
Foreign currency swaps	Foreign currency exchange rate	27,202		2,212		1,684		23,661		1,303		1,803
Subtotal		31,485		2,933		1,694		25,956		1,813		1,803
Foreign operations hedges:
Foreign currency forwards	Foreign currency exchange rate	1,087		6		53		3,916		63		12
Currency options	Foreign currency exchange rate	9,212		18		226		7,569		205		36
Subtotal		10,299		24		279		11,485		268		48
Total qualifying hedges		49,873		6,005		2,143		46,808		4,358		2,074
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate swaps	Interest rate	82,791		9,586		3,033		89,336		5,111		2,247
Interest rate floors	Interest rate	15,201		350		34		23,837		311		48
Interest rate caps	Interest rate	79,030		35		3		68,928		105		3
Interest rate futures	Interest rate	9,110		4		41		5,808		4		7
Interest rate options	Interest rate	21,383		1,790		1		30,234		1,177		30
Interest rate forwards	Interest rate	171		16		—		43		1		—
Interest rate total return swaps	Interest rate	5,925		106		36		—		—		—
Synthetic GICs	Interest rate	5,328		—		—		4,216		—		—
Foreign currency swaps	Foreign currency exchange rate	12,790		1,183		467		11,081		766		431
Foreign currency forwards	Foreign currency exchange rate	17,371		584		250		11,724		154		220
Currency futures	Foreign currency exchange rate	1,060		—		2		930		—		—
Currency options	Foreign currency exchange rate	4,780		204		11		9,590		466		189
Credit default swaps — purchased	Credit	2,038		10		44		1,870		28		34
Credit default swaps — written	Credit	11,664		150		10		10,311		78		13
Equity futures	Equity market	12,886		13		68		7,206		63		18
Equity index options	Equity market	53,911		1,519		1,362		55,682		1,542		1,041
Equity variance swaps	Equity market	23,658		228		745		23,437		195		636
Equity total return swaps	Equity market	5,070		5		102		3,803		47		58
Total non-designated or nonqualifying derivatives		364,167		15,783		6,209		358,036		10,048		4,975
Total		$	414,040	$	21,788	$	8,352	$	404,844	$	14,406	$	7,049

The following table presents earned income on derivatives:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Qualifying hedges:
Net investment income	$	76		$	55		$	206		$	158
Interest credited to policyholder account balances	—			6			7			21
Other expenses	(3		)	(2		)	(9		)	(4		)
Nonqualifying hedges:
Net investment income	—			(1		)	(1		)	(3		)
Net derivative gains (losses)	312			256			843			757
Policyholder benefits and claims	6			4			17			12
Total	$	391		$	318		$	1,063		$	941

Components of Net Derivatives Gains (Losses)

The components of net derivative gains (losses) were as follows:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Freestanding derivatives and hedging gains (losses) (1)	$	(1,852	)	$	2,318		$	3,177		$	1,433
Embedded derivatives gains (losses)	801			(1,833		)	(4,992		)	(1,039		)
Total net derivative gains (losses)	$	(1,051	)	$	485		$	(1,815	)	$	394

__________________

(1) Includes foreign currency transaction gains (losses) on hedged items in cash flow and nonqualifying hedging relationships, which are not presented elsewhere in this note.

Amount and location of gains (losses) recognized in income for derivatives that are not designated or qualifying as hedging instruments

The following table presents the amount and location of gains (losses) recognized in income for derivatives that were not designated or not qualifying as hedging instruments:

	Net Derivative Gains (Losses)			Net Investment Income (1)			Policyholder Benefits and Claims (2)
	(In millions)
Three Months Ended September 30, 2016
Interest rate derivatives	$	(1,082	)	$	—		$	19
Foreign currency exchange rate derivatives	146			—			(5		)
Credit derivatives — purchased	(21		)	—			—
Credit derivatives — written	60			—			—
Equity derivatives	(1,212		)	(5		)	(260		)
Total	$	(2,109	)	$	(5	)	$	(246	)
Three Months Ended September 30, 2015
Interest rate derivatives	$	1,157		$	—		$	17
Foreign currency exchange rate derivatives	364			—			—
Credit derivatives — purchased	16			3			—
Credit derivatives — written	(77		)	(1		)	—
Equity derivatives	747			(1		)	340
Total	$	2,207		$	1		$	357
Nine Months Ended September 30, 2016
Interest rate derivatives	$	2,547		$	—		$	116
Foreign currency exchange rate derivatives	1,865			—			(17		)
Credit derivatives — purchased	(48		)	—			—
Credit derivatives — written	57			—			—
Equity derivatives	(1,472		)	(19		)	(293		)
Total	$	2,949		$	(19	)	$	(194	)
Nine Months Ended September 30, 2015
Interest rate derivatives	$	250		$	—		$	10
Foreign currency exchange rate derivatives	443			—			—
Credit derivatives — purchased	9			3			—
Credit derivatives — written	(108		)	—			—
Equity derivatives	99			(8		)	214
Total	$	693		$	(5	)	$	224

__________________

(1) Changes in estimated fair value related to economic hedges of equity method investments in joint ventures, derivatives held in relation to trading portfolios and derivatives held within contractholder-directed unit-linked investments.

(2) Changes in estimated fair value related to economic hedges of variable annuity guarantees included in future policy benefits.

Net derivatives gains (losses) recognized on fair value derivatives and the related hedged items

The Company recognizes gains and losses on derivatives and the related hedged items in fair value hedges within net derivative gains (losses). The following table presents the amount of such net derivative gains (losses):

Derivatives in Fair Value Hedging Relationships	Hedged Items in Fair Value Hedging Relationships	Net Derivative Gains (Losses) Recognized for Derivatives			Net Derivative Gains (Losses) Recognized for Hedged Items			Ineffectiveness Recognized in Net Derivative Gains (Losses)
		(In millions)
Three Months Ended September 30, 2016
Interest rate swaps:	Fixed maturity securities	$	6		$	(5	)	$	1
	Policyholder liabilities (1)	(45		)	41			(4		)
Foreign currency swaps:	Foreign-denominated fixed maturity securities	1			(1		)	—
	Foreign-denominated policyholder account balances (2)	(1		)	1			—
Foreign currency forwards:	Foreign-denominated fixed maturity securities	19			(18		)	1
Total		$	(20	)	$	18		$	(2	)
Three Months Ended September 30, 2015
Interest rate swaps:	Fixed maturity securities	$	(4	)	$	3		$	(1	)
	Policyholder liabilities (1)	289			(290		)	(1		)
Foreign currency swaps:	Foreign-denominated fixed maturity securities	6			(3		)	3
	Foreign-denominated policyholder account balances (2)	(47		)	46			(1		)
Foreign currency forwards:	Foreign-denominated fixed maturity securities	49			(45		)	4
Total		$	293		$	(289	)	$	4
Nine Months Ended September 30, 2016
Interest rate swaps:	Fixed maturity securities	$	(5	)	$	2		$	(3	)
	Policyholder liabilities (1)	498			(507		)	(9		)
Foreign currency swaps:	Foreign-denominated fixed maturity securities	7			(7		)	—
	Foreign-denominated policyholder account balances (2)	(27		)	24			(3		)
Foreign currency forwards:	Foreign-denominated fixed maturity securities	295			(272		)	23
Total		$	768		$	(760	)	$	8
Nine Months Ended September 30, 2015
Interest rate swaps:	Fixed maturity securities	$	(5	)	$	8		$	3
	Policyholder liabilities (1)	120			(126		)	(6		)
Foreign currency swaps:	Foreign-denominated fixed maturity securities	13			(6		)	7
	Foreign-denominated policyholder account balances (2)	(186		)	179			(7		)
Foreign currency forwards:	Foreign-denominated fixed maturity securities	(49		)	45			(4		)
Total		$	(107	)	$	100		$	(7	)

__________________

(1) Fixed rate liabilities reported in policyholder account balances or future policy benefits.

(2) Fixed rate or floating rate liabilities.

Derivatives and Non-Derivative Hedging Instruments in Net Investment Hedging Relationships

The following table presents the effects of derivatives in net investment hedging relationships on the consolidated statements of operations and comprehensive income (loss) and the consolidated statements of equity:

Derivatives in Net Investment Hedging Relationships (1), (2)	Amount of Gains (Losses) Deferred in AOCI (Effective Portion)
	(In millions)
Three Months Ended September 30, 2016
Foreign currency forwards	$	(23	)
Currency options	(37		)
Total	$	(60	)
Three Months Ended September 30, 2015
Foreign currency forwards	$	88
Currency options	(18		)
Total	$	70
Nine Months Ended September 30, 2016
Foreign currency forwards	$	(358	)
Currency options	(351		)
Total	$	(709	)
Nine Months Ended September 30, 2015
Foreign currency forwards	$	244
Currency options	(61		)
Total	$	183

__________________

(1) During both thethree monthsandnine months endedSeptember 30, 2016and2015, there werenosales or substantial liquidations of net investments in foreign operations that would have required the reclassification of gains or losses from AOCI into earnings.

(2) There was no ineffectiveness recognized for the Company’s hedges of net investments in foreign operations. All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness.

Schedule of estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps

The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at:

	September 30, 2016						December 31, 2015
Rating Agency Designation of Referenced Credit Obligations (1)	Estimated Fair Value of Credit Default Swaps			Maximum Amount of Future Payments under Credit Default Swaps		Weighted Average Years to Maturity (2)	Estimated Fair Value of Credit Default Swaps			Maximum Amount of Future Payments under Credit Default Swaps		Weighted Average Years to Maturity (2)
	(Dollars in millions)
Aaa/Aa/A
Single name credit default swaps (corporate)	$	7		$	483	3.3	$	6		$	661	2.5
Credit default swaps referencing indices	21			1,937		3.5	6			1,635		3.4
Subtotal	28			2,420		3.5	12			2,296		3.2
Baa
Single name credit default swaps (corporate)	8			946		2.6	8			1,349		2.5
Credit default swaps referencing indices	97			7,917		5.1	37			5,863		4.8
Subtotal	105			8,863		4.8	45			7,212		4.4
Ba
Single name credit default swaps (corporate)	(5		)	155		4.3	(2		)	64		2.3
Credit default swaps referencing indices	—			—		—	(1		)	100		1.0
Subtotal	(5		)	155		4.3	(3		)	164		1.5
B
Single name credit default swaps (corporate)	1			70		2.1	—			—		—
Credit default swaps referencing indices	11			156		5.3	11			639		4.9
Subtotal	12			226		4.3	11			639		4.9
Total	$	140		$	11,664	4.5	$	65		$	10,311	4.1

__________________

(1) The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s Investors Service (“Moody’s”), Standard & Poor’s Ratings Services (“S&P”) and Fitch Ratings. If no rating is available from a rating agency, then an internally developed rating is used.

(2) The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts.

Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral

The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:

	September 30, 2016						December 31, 2015
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement (1)	Assets			Liabilities			Assets			Liabilities
	(In millions)
Gross estimated fair value of derivatives:
OTC-bilateral (2)	$	18,154		$	6,603		$	13,017		$	5,848
OTC-cleared (2)	3,949			1,627			1,600			1,217
Exchange-traded	18			111			67			25
Total gross estimated fair value of derivatives (2)	22,121			8,341			14,684			7,090
Amounts offset on the consolidated balance sheets	—			—			—			—
Estimated fair value of derivatives presented on the consolidated balance sheets (2)	22,121			8,341			14,684			7,090
Gross amounts not offset on the consolidated balance sheets:
Gross estimated fair value of derivatives: (3)
OTC-bilateral	(4,984		)	(4,984		)	(4,368		)	(4,368		)
OTC-cleared	(1,609		)	(1,609		)	(1,200		)	(1,200		)
Exchange-traded	(5		)	(5		)	(1		)	(1		)
Cash collateral: (4), (5)
OTC-bilateral	(9,606		)	—			(6,140		)	(7		)
OTC-cleared	(2,101		)	—			(378		)	(10		)
Exchange-traded	—			(9		)	—			(20		)
Securities collateral: (6)
OTC-bilateral	(3,199		)	(1,577		)	(2,078		)	(1,395		)
OTC-cleared	—			—			—			—
Exchange-traded	—			(95		)	—			(3		)
Net amount after application of master netting agreements and collateral	$	617		$	62		$	519		$	86

__________________

(1) See Note 7 for information regarding the Company’s gross and net payables and receivables under repurchase agreement transactions.

(2) At September 30, 2016 and December 31, 2015, derivative assets included income or expense accruals reported in accrued investment income or in other liabilities of $333 million and $278 million, respectively, and derivative liabilities included income or expense accruals reported in accrued investment income or in other liabilities of ($11) million and $41 million, respectively.

(3) Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.

(4) Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives is included in cash and cash equivalents, short-term investments or in fixed maturity securities, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet.

(5) The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At September 30, 2016 and December 31, 2015, the Company received excess cash collateral of $554 million and $89 million, respectively, and provided excess cash collateral of $432 million and $204 million, respectively, which is not included in the table above due to the foregoing limitation.

(6) Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at September 30, 2016, none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At September 30, 2016 and December 31, 2015, the Company received excess securities collateral with an estimated fair value of $137 million and $100 million, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At September 30, 2016 and December 31, 2015, the Company provided excess securities collateral with an estimated fair value of $185 million and $150 million, respectively, for its OTC-bilateral derivatives, and $960 million and $315 million, respectively, for its OTC-cleared derivatives, and $462 million and $224 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.

Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral

The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:

	September 30, 2016						December 31, 2015
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement (1)	Assets			Liabilities			Assets			Liabilities
	(In millions)
Gross estimated fair value of derivatives:
OTC-bilateral (2)	$	18,154		$	6,603		$	13,017		$	5,848
OTC-cleared (2)	3,949			1,627			1,600			1,217
Exchange-traded	18			111			67			25
Total gross estimated fair value of derivatives (2)	22,121			8,341			14,684			7,090
Amounts offset on the consolidated balance sheets	—			—			—			—
Estimated fair value of derivatives presented on the consolidated balance sheets (2)	22,121			8,341			14,684			7,090
Gross amounts not offset on the consolidated balance sheets:
Gross estimated fair value of derivatives: (3)
OTC-bilateral	(4,984		)	(4,984		)	(4,368		)	(4,368		)
OTC-cleared	(1,609		)	(1,609		)	(1,200		)	(1,200		)
Exchange-traded	(5		)	(5		)	(1		)	(1		)
Cash collateral: (4), (5)
OTC-bilateral	(9,606		)	—			(6,140		)	(7		)
OTC-cleared	(2,101		)	—			(378		)	(10		)
Exchange-traded	—			(9		)	—			(20		)
Securities collateral: (6)
OTC-bilateral	(3,199		)	(1,577		)	(2,078		)	(1,395		)
OTC-cleared	—			—			—			—
Exchange-traded	—			(95		)	—			(3		)
Net amount after application of master netting agreements and collateral	$	617		$	62		$	519		$	86

__________________

(1) See Note 7 for information regarding the Company’s gross and net payables and receivables under repurchase agreement transactions.

(2) At September 30, 2016 and December 31, 2015, derivative assets included income or expense accruals reported in accrued investment income or in other liabilities of $333 million and $278 million, respectively, and derivative liabilities included income or expense accruals reported in accrued investment income or in other liabilities of ($11) million and $41 million, respectively.

(3) Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.

(4) Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives is included in cash and cash equivalents, short-term investments or in fixed maturity securities, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet.

(5) The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At September 30, 2016 and December 31, 2015, the Company received excess cash collateral of $554 million and $89 million, respectively, and provided excess cash collateral of $432 million and $204 million, respectively, which is not included in the table above due to the foregoing limitation.

(6) Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at September 30, 2016, none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At September 30, 2016 and December 31, 2015, the Company received excess securities collateral with an estimated fair value of $137 million and $100 million, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At September 30, 2016 and December 31, 2015, the Company provided excess securities collateral with an estimated fair value of $185 million and $150 million, respectively, for its OTC-bilateral derivatives, and $960 million and $315 million, respectively, for its OTC-cleared derivatives, and $462 million and $224 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.

Derivative Instruments, Gain (Loss) [Line Items]

Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location

The following table presents the effects of derivatives in cash flow hedging relationships on the consolidated statements of operations and comprehensive income (loss) and the consolidated statements of equity:

Derivatives in Cash Flow Hedging Relationships	Amount of Gains (Losses) Deferred in AOCI on Derivatives			Amount and Location of Gains (Losses) Reclassified from AOCI into Income (Loss)								Amount and Location of Gains (Losses) Recognized in Income (Loss) on Derivatives
	(Effective Portion)			(Effective Portion)								(Ineffective Portion)
				Net Derivative Gains (Losses)			Net Investment Income			Other Expenses		Net Derivative Gains (Losses)
	(In millions)
Three Months Ended September 30, 2016
Interest rate swaps	$	23		$	28		$	4		$	—	$	—
Interest rate forwards	(5		)	1			1			—		—
Foreign currency swaps	(42		)	59			—			—		(3		)
Credit forwards	—			—			1			—		—
Total	$	(24	)	$	88		$	6		$	—	$	(3	)
Three Months Ended September 30, 2015
Interest rate swaps	$	211		$	40		$	3		$	—	$	1
Interest rate forwards	7			1			1			1		—
Foreign currency swaps	(116		)	(286		)	—			—		4
Credit forwards	—			1			—			—		—
Total	$	102		$	(244	)	$	4		$	1	$	5
Nine Months Ended September 30, 2016
Interest rate swaps	$	376		$	56		$	11		$	—	$	—
Interest rate forwards	42			2			4			1		—
Foreign currency swaps	1,054			96			(1		)	1		(1		)
Credit forwards	—			3			1			—		—
Total	$	1,472		$	157		$	15		$	2	$	(1	)
Nine Months Ended September 30, 2015
Interest rate swaps	$	116		$	52		$	9		$	—	$	3
Interest rate forwards	2			5			3			2		—
Foreign currency swaps	(224		)	(563		)	(1		)	1		6
Credit forwards	—			1			1			—		—
Total	$	(106	)	$	(505	)	$	12		$	3	$	9

Schedule of Derivative Instruments

The following table presents the estimated fair value of the Company’s OTC-bilateral derivatives that are in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged. The table also presents the incremental collateral that MetLife, Inc. would be required to provide if there was a one-notch downgrade in MetLife, Inc.’s senior unsecured debt rating at the reporting date or if the Company’s credit or financial strength rating, as applicable, sustained a downgrade to a level that triggered full overnight collateralization or termination of the derivative position at the reporting date. OTC-bilateral derivatives that are not subject to collateral agreements are excluded from this table.

	September 30, 2016						December 31, 2015
	Derivatives Subject to Credit- Contingent Provisions		Derivatives Not Subject to Credit- Contingent Provisions		Total		Derivatives Subject to Credit- Contingent Provisions		Derivatives Not Subject to Credit- Contingent Provisions		Total
	(In millions)
Estimated Fair Value of Derivatives in a Net Liability Position (1)	$	1,606	$	12	$	1,618	$	1,270	$	207	$	1,477
Estimated Fair Value of Collateral Provided:
Fixed maturity securities	$	1,737	$	20	$	1,757	$	1,365	$	174	$	1,539
Cash	$	—	$	—	$	—	$	4	$	4	$	8
Estimated Fair Value of Incremental Collateral Provided Upon:
One-notch downgrade in the Company’s credit or financial strength rating, as applicable	$	2	$	—	$	2	$	1	$	—	$	1
Downgrade in the Company’s credit or financial strength rating, as applicable, to a level that triggers full overnight collateralization or termination of the derivative position	$	2	$	—	$	2	$	1	$	—	$	1

__________________

(1) After taking into consideration the existence of netting agreements.

Embedded Derivative Financial Instruments [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location

The following table presents changes in estimated fair value related to embedded derivatives:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Net derivative gains (losses) (1)	$	801		$	(1,833	)	$	(4,992	)	$	(1,039	)
Policyholder benefits and claims	$	(14	)	$	59		$	91		$	40

__________________

(1) The valuation of guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were($224) millionand$1.2 billionfor thethree monthsandnine months endedSeptember 30, 2016, respectively, and$253 millionand$222 millionfor thethree monthsandnine months endedSeptember 30, 2015, respectively.

Schedule of Derivative Instruments

The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:

	Balance Sheet Location	September 30, 2016			December 31, 2015
		(In millions)
Net embedded derivatives within asset host contracts:
Ceded guaranteed minimum benefits	Premiums, reinsurance and other receivables	$	514		$	356
Funds withheld on assumed reinsurance	Other invested assets	64			35
Options embedded in debt or equity securities	Investments	(240		)	(220		)
Net embedded derivatives within asset host contracts		$	338		$	171
Net embedded derivatives within liability host contracts:
Direct guaranteed minimum benefits	Policyholder account balances and Future policy benefits	$	5,000		$	(20	)
Assumed guaranteed minimum benefits	Policyholder account balances	1,706			965
Funds withheld on ceded reinsurance	Other liabilities	79			(14		)
Other	Policyholder account balances	98			4
Net embedded derivatives within liability host contracts		$	6,883		$	935

XML

Fair Value (Tables)

9 Months Ended

Sep. 30, 2016

Fair Value Disclosures [Abstract]

Recurring Fair Value Measurements

The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy, including those items for which the Company has elected the FVO, are presented below at:

	September 30, 2016
	Fair Value Hierarchy
	Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	98,569	$	7,107	$	105,676
U.S. government and agency	40,780		28,688		317		69,785
Foreign corporate	—		53,667		6,752		60,419
Foreign government	—		63,443		322		63,765
RMBS	4,349		35,510		5,450		45,309
State and political subdivision	—		17,417		46		17,463
ABS	—		14,506		1,078		15,584
CMBS	—		11,909		532		12,441
Total fixed maturity securities	45,129		323,709		21,604		390,442
Equity securities	1,364		1,270		655		3,289
FVO and trading securities:
Actively traded securities	—		—		—		—
FVO general account securities	578		30		113		721
FVO contractholder-directed unit-linked investments	11,061		2,816		123		14,000
FVO securities held by CSEs	—		2		7		9
Total FVO and trading securities	11,639		2,848		243		14,730
Short-term investments (1)	5,561		4,310		673		10,544
Mortgage loans:
Residential mortgage loans — FVO	—		—		481		481
Commercial mortgage loans held by CSEs — FVO	—		143		—		143
Total mortgage loans	—		143		481		624
Other investments	92		63		—		155
Derivative assets: (2)
Interest rate	4		15,272		156		15,432
Foreign currency exchange rate	—		4,369		62		4,431
Credit	—		141		19		160
Equity market	14		1,417		334		1,765
Total derivative assets	18		21,199		571		21,788
Net embedded derivatives within asset host contracts (3)	—		—		578		578
Separate account assets (4)	87,035		227,343		1,270		315,648
Total assets	$	150,838	$	580,885	$	26,075	$	757,798
Liabilities
Derivative liabilities: (2)
Interest rate	$	41	$	3,084	$	47	$	3,172
Foreign currency exchange rate	2		2,795		52		2,849
Credit	—		54		—		54
Equity market	68		1,448		761		2,277
Total derivative liabilities	111		7,381		860		8,352
Net embedded derivatives within liability host contracts (3)	—		—		6,883		6,883
Long-term debt of CSEs — FVO	—		26		12		38
Trading liabilities (5)	—		—		—		—
Separate account liabilities (4)	1		75		6		82
Total liabilities	$	112	$	7,482	$	7,761	$	15,355

	December 31, 2015
	Fair Value Hierarchy
	Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Fixed maturity securities:
U.S. corporate	$	—	$	93,758	$	7,036	$	100,794
U.S. government and agency	37,660		23,986		—		61,646
Foreign corporate	—		51,438		5,760		57,198
Foreign government	—		49,643		856		50,499
RMBS	—		34,088		4,709		38,797
State and political subdivision	—		15,395		46		15,441
ABS	—		12,731		1,663		14,394
CMBS	—		11,889		744		12,633
Total fixed maturity securities	37,660		292,928		20,814		351,402
Equity securities	1,274		1,615		432		3,321
FVO and trading securities:
Actively traded securities	—		400		4		404
FVO general account securities	506		32		89		627
FVO contractholder-directed unit-linked investments	10,829		2,985		167		13,981
FVO securities held by CSEs	—		2		10		12
Total FVO and trading securities	11,335		3,419		270		15,024
Short-term investments (1)	2,543		5,985		291		8,819
Mortgage loans:
Residential mortgage loans — FVO	—		—		314		314
Commercial mortgage loans held by CSEs — FVO	—		172		—		172
Total mortgage loans	—		172		314		486
Other investments	109		53		—		162
Derivative assets: (2)
Interest rate	4		9,405		25		9,434
Foreign currency exchange rate	—		3,003		16		3,019
Credit	—		99		7		106
Equity market	63		1,435		349		1,847
Total derivative assets	67		13,942		397		14,406
Net embedded derivatives within asset host contracts (3)	—		—		391		391
Separate account assets (4)	77,080		222,814		1,704		301,598
Total assets	$	130,068	$	540,928	$	24,613	$	695,609
Liabilities
Derivative liabilities: (2)
Interest rate	$	7	$	2,340	$	—	$	2,347
Foreign currency exchange rate	—		2,754		148		2,902
Credit	—		45		2		47
Equity market	18		1,077		658		1,753
Total derivative liabilities	25		6,216		808		7,049
Net embedded derivatives within liability host contracts (3)	—		—		935		935
Long-term debt of CSEs — FVO	—		49		11		60
Trading liabilities (5)	103		50		—		153
Separate account liabilities (4)	—		—		—		—
Total liabilities	$	128	$	6,315	$	1,754	$	8,197

__________________

(1) Short-term investments as presented in the tables above differ from the amounts presented on the consolidated balance sheets because certain short-term investments are not measured at estimated fair value on a recurring basis.

(2) Derivative assets are presented within other invested assets on the consolidated balance sheets and derivative liabilities are presented within other liabilities on the consolidated balance sheets. The amounts are presented gross in the tables above to reflect the presentation on the consolidated balance sheets, but are presented net for purposes of the rollforward in the Fair Value Measurements Using Significant Unobservable Inputs (Level 3) tables.

(3) Net embedded derivatives within asset host contracts are presented within premiums, reinsurance and other receivables and other invested assets on the consolidated balance sheets. Net embedded derivatives within liability host contracts are presented within policyholder account balances, future policy benefits and other liabilities on the consolidated balance sheets. At September 30, 2016 and December 31, 2015, debt and equity securities also included embedded derivatives of ($240) million and ($220) million, respectively.

(4) Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders whose liability is reflected within separate account liabilities. Separate account liabilities are set equal to the estimated fair value of separate account assets. Separate account liabilities presented in the tables above represent derivative liabilities.

(5) Trading liabilities are presented within other liabilities on the consolidated balance sheets.

Fair Value Inputs, Quantitative Information

The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:

					September 30, 2016				December 31, 2015				Impact of Increase in Input on Estimated Fair Value (2)
	Valuation Techniques		Significant Unobservable Inputs		Range			Weighted Average (1)	Range			Weighted Average (1)
Fixed maturity securities (3)
U.S. corporate and foreign corporate	•	Matrix pricing	•	Delta spread adjustments (4)	(269)	-	603	(4)	(65)	-	240	39	Decrease
	•	Market pricing	•	Quoted prices (5)	6	-	788	123	—	-	780	156	Increase
	•	Consensus pricing	•	Offered quotes (5)	23	-	121	98	68	-	121	98	Increase
Foreign government	•	Market pricing	•	Quoted prices (5)	100	-	124	104	96	-	135	113	Increase
RMBS	•	Market pricing	•	Quoted prices (5)	7	-	131	90	19	-	292	92	Increase (6)
ABS	•	Market pricing	•	Quoted prices (5)	5	-	105	99	16	-	109	100	Increase (6)
	•	Consensus pricing	•	Offered quotes (5)	98	-	107	100	66	-	105	99	Increase (6)
Derivatives
Interest rate	•	Present value techniques	•	Swap yield (7)	200	-	300		307	-	317		Increase (8)
			•	Repurchase rates (9)	(6)	-	17						Decrease (8)
Foreign currency exchange rate	•	Present value techniques	•	Swap yield (7)	50	-	328		28	-	381		Increase (8)
Credit	•	Present value techniques	•	Credit spreads (10)	97	-	100		98	-	100		Decrease (8)
	•	Consensus pricing	•	Offered quotes (11)
Equity market	•	Present value techniques or option pricing models	•	Volatility (12)	13%	-	36%		15%	-	36%		Increase (8)
			•	Correlation (13)	40%	-	40%		70%	-	70%
Embedded derivatives
Direct, assumed and ceded guaranteed minimum benefits	•	Option pricing techniques	•	Mortality rates:
				Ages 0 - 40	0%	-	0.21%		0%	-	0.21%		Decrease (14)
				Ages 41 - 60	0.01%	-	0.78%		0.01%	-	0.78%		Decrease (14)
				Ages 61 - 115	0%	-	100%		0.04%	-	100%		Decrease (14)
			•	Lapse rates:
				Durations 1 - 10	0.25%	-	100%		0.25%	-	100%		Decrease (15)
				Durations 11 - 20	2%	-	100%		2%	-	100%		Decrease (15)
				Durations 21 - 116	1.25%	-	100%		1%	-	100%		Decrease (15)
			•	Utilization rates	0%	-	25%		0%	-	25%		Increase (16)
			•	Withdrawal rates	0%	-	20%		0%	-	20%		(17)
			•	Long-term equity volatilities	9.95%	-	33%		8.79%	-	33%		Increase (18)
			•	Nonperformance risk spread	0.05%	-	2.03%		(0.47)%	-	1.31%		Decrease (19)

__________________

(1) The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities.

(2) The impact of a decrease in input would have the opposite impact on estimated fair value. For embedded derivatives, changes to direct and assumed guaranteed minimum benefits are based on liability positions; changes to ceded guaranteed minimum benefits are based on asset positions.

(3) Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations.

(4) Range and weighted average are presented in basis points.

(5) Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par.

(6) Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates.

(7) Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curves are utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.

(8) Changes in estimated fair value are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions.

(9) Ranges represent different repurchase rates utilized as components within the valuation methodology and are presented in basis points.

(10) Represents the risk quoted in basis points of a credit default event on the underlying instrument. Credit derivatives with significant unobservable inputs are primarily comprised of written credit default swaps.

(11) At both September 30, 2016 and December 31, 2015, independent non-binding broker quotations were used in the determination of less than 1% of the total net derivative estimated fair value.

(12) Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.

(13) Ranges represent the different correlation factors utilized as components within the valuation methodology. Presenting a range of correlation factors is more representative of the unobservable input used in the valuation. Increases (decreases) in correlation in isolation will increase (decrease) the significance of the change in valuations.

(14) Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(15) Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(16) The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(17) The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.

(18) Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(19) Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.

Fair Value Inputs, Quantitative Information

The following table presents certain quantitative information about the significant unobservable inputs used in the fair value measurement, and the sensitivity of the estimated fair value to changes in those inputs, for the more significant asset and liability classes measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at:

					September 30, 2016				December 31, 2015				Impact of Increase in Input on Estimated Fair Value (2)
	Valuation Techniques		Significant Unobservable Inputs		Range			Weighted Average (1)	Range			Weighted Average (1)
Fixed maturity securities (3)
U.S. corporate and foreign corporate	•	Matrix pricing	•	Delta spread adjustments (4)	(269)	-	603	(4)	(65)	-	240	39	Decrease
	•	Market pricing	•	Quoted prices (5)	6	-	788	123	—	-	780	156	Increase
	•	Consensus pricing	•	Offered quotes (5)	23	-	121	98	68	-	121	98	Increase
Foreign government	•	Market pricing	•	Quoted prices (5)	100	-	124	104	96	-	135	113	Increase
RMBS	•	Market pricing	•	Quoted prices (5)	7	-	131	90	19	-	292	92	Increase (6)
ABS	•	Market pricing	•	Quoted prices (5)	5	-	105	99	16	-	109	100	Increase (6)
	•	Consensus pricing	•	Offered quotes (5)	98	-	107	100	66	-	105	99	Increase (6)
Derivatives
Interest rate	•	Present value techniques	•	Swap yield (7)	200	-	300		307	-	317		Increase (8)
			•	Repurchase rates (9)	(6)	-	17						Decrease (8)
Foreign currency exchange rate	•	Present value techniques	•	Swap yield (7)	50	-	328		28	-	381		Increase (8)
Credit	•	Present value techniques	•	Credit spreads (10)	97	-	100		98	-	100		Decrease (8)
	•	Consensus pricing	•	Offered quotes (11)
Equity market	•	Present value techniques or option pricing models	•	Volatility (12)	13%	-	36%		15%	-	36%		Increase (8)
			•	Correlation (13)	40%	-	40%		70%	-	70%
Embedded derivatives
Direct, assumed and ceded guaranteed minimum benefits	•	Option pricing techniques	•	Mortality rates:
				Ages 0 - 40	0%	-	0.21%		0%	-	0.21%		Decrease (14)
				Ages 41 - 60	0.01%	-	0.78%		0.01%	-	0.78%		Decrease (14)
				Ages 61 - 115	0%	-	100%		0.04%	-	100%		Decrease (14)
			•	Lapse rates:
				Durations 1 - 10	0.25%	-	100%		0.25%	-	100%		Decrease (15)
				Durations 11 - 20	2%	-	100%		2%	-	100%		Decrease (15)
				Durations 21 - 116	1.25%	-	100%		1%	-	100%		Decrease (15)
			•	Utilization rates	0%	-	25%		0%	-	25%		Increase (16)
			•	Withdrawal rates	0%	-	20%		0%	-	20%		(17)
			•	Long-term equity volatilities	9.95%	-	33%		8.79%	-	33%		Increase (18)
			•	Nonperformance risk spread	0.05%	-	2.03%		(0.47)%	-	1.31%		Decrease (19)

__________________

(1) The weighted average for fixed maturity securities is determined based on the estimated fair value of the securities.

(2) The impact of a decrease in input would have the opposite impact on estimated fair value. For embedded derivatives, changes to direct and assumed guaranteed minimum benefits are based on liability positions; changes to ceded guaranteed minimum benefits are based on asset positions.

(3) Significant increases (decreases) in expected default rates in isolation would result in substantially lower (higher) valuations.

(4) Range and weighted average are presented in basis points.

(5) Range and weighted average are presented in accordance with the market convention for fixed maturity securities of dollars per hundred dollars of par.

(6) Changes in the assumptions used for the probability of default is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumptions used for prepayment rates.

(7) Ranges represent the rates across different yield curves and are presented in basis points. The swap yield curves are utilized among different types of derivatives to project cash flows, as well as to discount future cash flows to present value. Since this valuation methodology uses a range of inputs across a yield curve to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.

(8) Changes in estimated fair value are based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions.

(9) Ranges represent different repurchase rates utilized as components within the valuation methodology and are presented in basis points.

(10) Represents the risk quoted in basis points of a credit default event on the underlying instrument. Credit derivatives with significant unobservable inputs are primarily comprised of written credit default swaps.

(11) At both September 30, 2016 and December 31, 2015, independent non-binding broker quotations were used in the determination of less than 1% of the total net derivative estimated fair value.

(12) Ranges represent the underlying equity volatility quoted in percentage points. Since this valuation methodology uses a range of inputs across multiple volatility surfaces to value the derivative, presenting a range is more representative of the unobservable input used in the valuation.

(13) Ranges represent the different correlation factors utilized as components within the valuation methodology. Presenting a range of correlation factors is more representative of the unobservable input used in the valuation. Increases (decreases) in correlation in isolation will increase (decrease) the significance of the change in valuations.

(14) Mortality rates vary by age and by demographic characteristics such as gender. Mortality rate assumptions are based on company experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(15) Base lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, as well as other factors, such as the applicability of any surrender charges. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. Lapse rates are also generally assumed to be lower in periods when a surrender charge applies. For any given contract, lapse rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(16) The utilization rate assumption estimates the percentage of contract holders with a GMIB or lifetime withdrawal benefit who will elect to utilize the benefit upon becoming eligible. The rates may vary by the type of guarantee, the amount by which the guaranteed amount is greater than the account value, the contract’s withdrawal history and by the age of the policyholder. For any given contract, utilization rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(17) The withdrawal rate represents the percentage of account balance that any given policyholder will elect to withdraw from the contract each year. The withdrawal rate assumption varies by age and duration of the contract, and also by other factors such as benefit type. For any given contract, withdrawal rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative. For GMWBs, any increase (decrease) in withdrawal rates results in an increase (decrease) in the estimated fair value of the guarantees. For GMABs and GMIBs, any increase (decrease) in withdrawal rates results in a decrease (increase) in the estimated fair value.

(18) Long-term equity volatilities represent equity volatility beyond the period for which observable equity volatilities are available. For any given contract, long-term equity volatility rates vary throughout the period over which cash flows are projected for purposes of valuing the embedded derivative.

(19) Nonperformance risk spread varies by duration and by currency. For any given contract, multiple nonperformance risk spreads will apply, depending on the duration of the cash flow being discounted for purposes of valuing the embedded derivative.

Fair Value, Measured on Recurring Basis, Unobservable Input Reconciliation

The following tables summarize the change of all assets and (liabilities) measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities
	Corporate (1)			U.S. Government and Agency			Foreign Government			Structured Securities			State and Political Subdivision			Equity Securities			FVO and Trading Securities (2)
	(In millions)
Three Months Ended September 30, 2016
Balance, beginning of period	$	13,710		$	323		$	376		$	6,700		$	53		$	682		$	231
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	15			—			2			34			—			5			4
Total realized/unrealized gains (losses) included in AOCI	98			(1		)	1			39			3			(9		)	—
Purchases (5)	680			99			21			1,034			—			4			18
Sales (5)	(595		)	—			(7		)	(512		)	—			(20		)	(6		)
Issuances (5)	—			—			—			—			—			—			—
Settlements (5)	—			—			—			—			—			—			—
Transfers into Level 3 (6)	424			—			—			81			7			1			—
Transfers out of Level 3 (6)	(473		)	(104		)	(71		)	(316		)	(17		)	(8		)	(4		)
Balance, end of period	$	13,859		$	317		$	322		$	7,060		$	46		$	655		$	243
Three Months Ended September 30, 2015
Balance, beginning of period	$	13,520		$	55		$	1,336		$	7,018		$	55		$	489		$	475
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	25			—			4			29			—			6			(16		)
Total realized/unrealized gains (losses) included in AOCI	(296		)	—			(1		)	(46		)	1			(14		)	—
Purchases (5)	955			—			17			2,544			20			12			91
Sales (5)	(351		)	(1		)	(17		)	(418		)	—			(13		)	(41		)
Issuances (5)	—			—			—			—			—			—			—
Settlements (5)	—			—			—			—			—			—			—
Transfers into Level 3 (6)	699			18			11			361			—			—			80
Transfers out of Level 3 (6)	(1,850		)	(55		)	(659		)	(955		)	(30		)	(30		)	(191		)
Balance, end of period	$	12,702		$	17		$	691		$	8,533		$	46		$	450		$	398
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2016 (7)	$	1		$	—		$	2		$	33		$	—		$	(1	)	$	4
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2015 (7)	$	10		$	—		$	4		$	33		$	—		$	—		$	(16	)

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Short-term Investments			Residential Mortgage Loans — FVO			Net Derivatives (8)			Net Embedded Derivatives (9)			Separate Accounts (10)			Long-term Debt of CSEs — FVO			Trading Liabilities
	(In millions)
Three Months Ended September 30, 2016
Balance, beginning of period	$	175		$	449		$	(132	)	$	(6,804	)	$	1,627		$	(12	)	$	—
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	1			10			(116		)	765			(25		)	—			—
Total realized/unrealized gains (losses) included in AOCI	(1		)	—			(7		)	(27		)	—			—			—
Purchases (5)	664			42			—			—			4			—			—
Sales (5)	(55		)	(5		)	—			—			(155		)	—			—
Issuances (5)	—			—			(1		)	—			30			—			—
Settlements (5)	—			(15		)	(33		)	(239		)	(45		)	—			—
Transfers into Level 3 (6)	—			—			—			—			8			—			—
Transfers out of Level 3 (6)	(111		)	—			—			—			(180		)	—			—
Balance, end of period	$	673		$	481		$	(289	)	$	(6,305	)	$	1,264		$	(12	)	$	—
Three Months Ended September 30, 2015
Balance, beginning of period	$	1,809		$	345		$	(372	)	$	841		$	1,925		$	(12	)	$	(4	)
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	—			(2		)	(97		)	(1,753		)	24			—			—
Total realized/unrealized gains (losses) included in AOCI	—			—			7			(38		)	—			—			—
Purchases (5)	1,296			18			—			—			95			—			(2		)
Sales (5)	(11		)	(37		)	—			—			(93		)	—			—
Issuances (5)	—			—			(1		)	—			—			—			—
Settlements (5)	—			(9		)	24			(216		)	—			1			—
Transfers into Level 3 (6)	5			—			—			—			2			—			—
Transfers out of Level 3 (6)	(1,786		)	—			—			—			(271		)	—			4
Balance, end of period	$	1,313		$	315		$	(439	)	$	(1,166	)	$	1,682		$	(11	)	$	(2	)
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2016 (7)	$	1		$	10		$	(103	)	$	750		$	—		$	—		$	—
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2015 (7)	$	—		$	(2	)	$	(103	)	$	(1,743	)	$	—		$	—		$	—

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Fixed Maturity Securities
	Corporate (1)			U.S. Government and Agency			Foreign Government			Structured Securities			State and Political Subdivision			Equity Securities			FVO and Trading Securities (2)
	(In millions)
Nine Months Ended September 30, 2016
Balance, beginning of period	$	12,796		$	—		$	856		$	7,116		$	46		$	432		$	270
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	(4		)	—			9			101			1			(21		)	9
Total realized/unrealized gains (losses) included in AOCI	1,027			17			(2		)	28			2			43			—
Purchases (5)	1,893			111			58			2,291			—			20			43
Sales (5)	(1,034		)	—			(36		)	(1,357		)	—			(25		)	(29		)
Issuances (5)	—			—			—			—			—			—			—
Settlements (5)	—			—			—			—			—			—			—
Transfers into Level 3 (6)	711			200			41			43			7			455			18
Transfers out of Level 3 (6)	(1,530		)	(11		)	(604		)	(1,162		)	(10		)	(249		)	(68		)
Balance, end of period	$	13,859		$	317		$	322		$	7,060		$	46		$	655		$	243
Nine Months Ended September 30, 2015
Balance, beginning of period	$	13,432		$	—		$	1,311		$	7,392		$	—		$	345		$	567
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	62			—			10			88			—			7			(27		)
Total realized/unrealized gains (losses) included in AOCI	(759		)	(1		)	1			(68		)	—			(22		)	—
Purchases (5)	1,884			—			30			4,062			46			57			130
Sales (5)	(964		)	(1		)	(39		)	(1,304		)	—			(34		)	(130		)
Issuances (5)	—			—			—			—			—			—			—
Settlements (5)	—			—			—			—			—			—			—
Transfers into Level 3 (6)	844			19			7			355			—			107			82
Transfers out of Level 3 (6)	(1,797		)	—			(629		)	(1,992		)	—			(10		)	(224		)
Balance, end of period	$	12,702		$	17		$	691		$	8,533		$	46		$	450		$	398
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2016 (7)	$	2		$	—		$	9		$	96		$	1		$	(27	)	$	9
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2015 (7)	$	21		$	—		$	10		$	89		$	—		$	—		$	(25	)

	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
	Short-term Investments			Residential Mortgage Loans — FVO			Net Derivatives (8)			Net Embedded Derivatives (9)			Separate Accounts (10)			Long-term Debt of CSEs — FVO			Trading Liabilities
	(In millions)
Nine Months Ended September 30, 2016
Balance, beginning of period	$	291		$	314		$	(411	)	$	(544	)	$	1,704		$	(11	)	$	—
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	1			22			110			(4,851		)	7			—			—
Total realized/unrealized gains (losses) included in AOCI	4			—			36			(237		)	—			—			—
Purchases (5)	673			187			12			—			108			—			—
Sales (5)	(294		)	(12		)	—			—			(233		)	—			—
Issuances (5)	—			—			(1		)	—			27			—			—
Settlements (5)	—			(30		)	(33		)	(673		)	(58		)	(1		)	—
Transfers into Level 3 (6)	1			—			—			—			9			—			—
Transfers out of Level 3 (6)	(3		)	—			(2		)	—			(300		)	—			—
Balance, end of period	$	673		$	481		$	(289	)	$	(6,305	)	$	1,264		$	(12	)	$	—
Nine Months Ended September 30, 2015
Balance, beginning of period	$	336		$	308		$	(300	)	$	430		$	1,922		$	(13	)	$	—
Total realized/unrealized gains (losses) included in net income (loss) (3) (4)	1			18			(163		)	(964		)	5			—			—
Total realized/unrealized gains (losses) included in AOCI	—			—			3			(19		)	—			—			—
Purchases (5)	1,313			114			4			—			297			—			(2		)
Sales (5)	(28		)	(100		)	—			—			(232		)	—			—
Issuances (5)	—			—			(1		)	—			—			—			—
Settlements (5)	—			(25		)	18			(613		)	(2		)	2			—
Transfers into Level 3 (6)	—			—			—			—			3			—			—
Transfers out of Level 3 (6)	(309		)	—			—			—			(311		)	—			—
Balance, end of period	$	1,313		$	315		$	(439	)	$	(1,166	)	$	1,682		$	(11	)	$	(2	)
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2016 (7)	$	1		$	22		$	90		$	(4,884	)	$	—		$	—		$	—
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at September 30, 2015 (7)	$	—		$	18		$	(141	)	$	(973	)	$	—		$	—		$	—

__________________

(1) Comprised of U.S. and foreign corporate securities.

(2) Comprised of actively traded securities, FVO general account securities, FVO contractholder-directed unit-linked investments and FVO securities held by CSEs.

(3) Amortization of premium/accretion of discount is included within net investment income. Impairments charged to net income (loss) on securities are included in net investment gains (losses), while changes in estimated fair value of residential mortgage loans — FVO are included in net investment income. Lapses associated with net embedded derivatives are included in net derivative gains (losses). Substantially all realized/unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivatives gains (losses).

(4) Interest and dividend accruals, as well as cash interest coupons and dividends received, are excluded from the rollforward.

(5) Items purchased/issued and then sold/settled in the same period are excluded from the rollforward. Fees attributed to embedded derivatives are included in settlements.

(6) Gains and losses, in net income (loss) and OCI, are calculated assuming transfers into and/or out of Level 3 occurred at the beginning of the period. Items transferred into and then out of Level 3 in the same period are excluded from the rollforward.

(7) Changes in unrealized gains (losses) included in net income (loss) relate to assets and liabilities still held at the end of the respective periods. Substantially all changes in unrealized gains (losses) included in net income (loss) for net derivatives and net embedded derivatives are reported in net derivative gains (losses).

(8) Freestanding derivative assets and liabilities are presented net for purposes of the rollforward.

(9) Embedded derivative assets and liabilities are presented net for purposes of the rollforward.

(10) Investment performance related to separate account assets is fully offset by corresponding amounts credited to contractholders within separate account liabilities. Therefore, such changes in estimated fair value are not recorded in net income (loss). For the purpose of this disclosure, these changes are presented within net investment gains (losses). Separate account assets and liabilities are presented net for the purposes of the rollforward.

Fair Value Option

The following table presents information for certain assets and liabilities accounted for under the FVO. These assets and liabilities were initially measured at fair value.

	Residential Mortgage Loans — FVO						Certain Assets and Liabilities of CSEs — FVO (1)
	September 30, 2016			December 31, 2015			September 30, 2016			December 31, 2015
	(In millions)
Assets
Unpaid principal balance	$	641		$	436		$	95		$	121
Difference between estimated fair value and unpaid principal balance	(160		)	(122		)	48			51
Carrying value at estimated fair value	$	481		$	314		$	143		$	172
Loans in non-accrual status	$	186		$	122		$	—		$	—
Liabilities
Contractual principal balance							$	50		$	71
Difference between estimated fair value and contractual principal balance							(12		)	(11		)
Carrying value at estimated fair value							$	38		$	60

__________________

(1) These assets and liabilities are comprised of commercial mortgage loans and long-term debt. Changes in estimated fair value on these assets and liabilities and gains or losses on sales of these assets are recognized in net investment gains (losses). Interest income on commercial mortgage loans held by CSEs — FVO is recognized in net investment income. Interest expense from long-term debt of CSEs — FVO is recognized in other expenses.

Nonrecurring Fair Value Measurements

The following table presents information for assets measured at estimated fair value on a nonrecurring basis during the periods and still held at the reporting dates (for example, when there is evidence of impairment). The estimated fair values for these assets were determined using significant unobservable inputs (Level 3).

	At   September 30,				Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016		2015		2016			2015			2016			2015
	Carrying Value After Measurement				Gains (Losses)
	(In millions)
Mortgage loans (1)	$	12	$	44	$	—		$	—		$	—		$	(1	)
Other limited partnership interests (2)	$	78	$	53	$	(9	)	$	(8	)	$	(45	)	$	(27	)
Other assets (3)	$	—	$	—	$	—		$	—		$	(44	)	$	—
Goodwill (4)	$	—	$	—	$	(260	)	$	—		$	(260	)	$	—

__________________

(1) Estimated fair values for impaired mortgage loans are based on independent broker quotations or valuation models using unobservable inputs or, if the loans are in foreclosure or are otherwise determined to be collateral dependent, are based on the estimated fair value of the underlying collateral or the present value of the expected future cash flows.

(2) For these cost method investments, estimated fair value is determined from information provided on the financial statements of the underlying entities including NAV data. These investments include private equity and debt funds that typically invest primarily in various strategies including domestic and international leveraged buyout funds; power, energy, timber and infrastructure development funds; venture capital funds; and below investment grade debt and mezzanine debt funds. Distributions will be generated from investment gains, from operating income from the underlying investments of the funds and from liquidation of the underlying assets of the funds. It is estimated that the underlying assets of the funds will be liquidated over the next two to 10 years. Unfunded commitments for these investments at both September 30, 2016 and 2015 were not significant.

(3) During the nine months ended September 30, 2016, the Company recognized an impairment of computer software in connection with the U.S. Retail Advisor Force Divestiture. See Note 3.

(4) As discussed in Note 10, for both the three months and nine months ended September 30, 2016, the Company recorded an impairment of goodwill associated with the reporting units within the Brighthouse Financial segment.

Fair Value of Financial Instruments Carried at Other Than Fair Value

The carrying values and estimated fair values for such financial instruments, and their corresponding placement in the fair value hierarchy, are summarized as follows at:

	September 30, 2016
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Mortgage loans	$	70,532	$	—	$	—	$	73,585	$	73,585
Policy loans	$	11,177	$	—	$	1,107	$	12,594	$	13,701
Real estate joint ventures	$	25	$	—	$	—	$	87	$	87
Other limited partnership interests	$	414	$	—	$	—	$	461	$	461
Other invested assets	$	559	$	169	$	—	$	390	$	559
Premiums, reinsurance and other receivables	$	4,030	$	—	$	910	$	3,218	$	4,128
Other assets	$	243	$	—	$	205	$	76	$	281
Liabilities
Policyholder account balances	$	126,417	$	—	$	—	$	133,084	$	133,084
Long-term debt	$	16,505	$	—	$	18,526	$	—	$	18,526
Collateral financing arrangements	$	4,084	$	—	$	—	$	3,749	$	3,749
Junior subordinated debt securities	$	3,168	$	—	$	4,142	$	—	$	4,142
Other liabilities	$	6,919	$	—	$	6,429	$	492	$	6,921
Separate account liabilities	$	123,253	$	—	$	123,253	$	—	$	123,253

	December 31, 2015
			Fair Value Hierarchy
	Carrying Value		Level 1		Level 2		Level 3		Total Estimated Fair Value
	(In millions)
Assets
Mortgage loans	$	66,616	$	—	$	—	$	68,539	$	68,539
Policy loans	$	11,258	$	—	$	1,279	$	12,072	$	13,351
Real estate joint ventures	$	35	$	—	$	—	$	104	$	104
Other limited partnership interests	$	524	$	—	$	—	$	615	$	615
Other invested assets	$	537	$	155	$	2	$	380	$	537
Premiums, reinsurance and other receivables	$	2,822	$	—	$	484	$	2,421	$	2,905
Other assets	$	235	$	—	$	207	$	60	$	267
Liabilities
Policyholder account balances	$	125,040	$	—	$	—	$	130,125	$	130,125
Long-term debt	$	17,954	$	—	$	19,360	$	—	$	19,360
Collateral financing arrangements	$	4,139	$	—	$	—	$	3,899	$	3,899
Junior subordinated debt securities	$	3,194	$	—	$	4,029	$	—	$	4,029
Other liabilities	$	2,249	$	—	$	865	$	1,385	$	2,250
Separate account liabilities	$	112,119	$	—	$	112,119	$	—	$	112,119

XML

Equity (Tables)

9 Months Ended

Sep. 30, 2016

Equity [Abstract]

Schedule of Stock by Class

Preferred stock authorized, issued and outstanding was as follows at both September 30, 2016 and December 31, 2015:

Series	Shares Authorized	Shares Issued	Shares Outstanding
Floating Rate Non-Cumulative Preferred Stock, Series A	27,600,000	24,000,000	24,000,000
5.25% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series C	1,500,000	1,500,000	1,500,000
Series A Junior Participating Preferred Stock	10,000,000	—	—
Not designated	160,900,000	—	—
Total	200,000,000	25,500,000	25,500,000

Components of Accumulated Other Comprehensive Income (Loss)

Information regarding changes in the balances of each component of AOCI attributable to MetLife, Inc., was as follows:

	Three Months   Ended   September 30, 2016
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Foreign Currency Translation Adjustments			Defined Benefit Plans Adjustment			Total
	(In millions)
Balance, beginning of period	$	18,204		$	2,431		$	(4,020	)	$	(1,983	)	$	14,632
OCI before reclassifications	(1,066		)	(24		)	49			(259		)	(1,300		)
Deferred income tax benefit (expense)	281			8			30			85			404
AOCI before reclassifications, net of income tax	17,419			2,415			(3,941		)	(2,157		)	13,736
Amounts reclassified from AOCI	(173		)	(94		)	—			46			(221		)
Deferred income tax benefit (expense)	60			30			—			(10		)	80
Amounts reclassified from AOCI, net of income tax	(113		)	(64		)	—			36			(141		)
Balance, end of period	$	17,306		$	2,351		$	(3,941	)	$	(2,121	)	$	13,595
	Three Months   Ended   September 30, 2015
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Foreign Currency Translation Adjustments			Defined Benefit Plans Adjustment			Total
	(In millions)
Balance, beginning of period	$	11,761		$	1,102		$	(4,214	)	$	(2,206	)	$	6,443
OCI before reclassifications	962			102			(336		)	—			728
Deferred income tax benefit (expense)	(340		)	(47		)	(24		)	—			(411		)
AOCI before reclassifications, net of income tax	12,383			1,157			(4,574		)	(2,206		)	6,760
Amounts reclassified from AOCI	(102		)	239			—			57			194
Deferred income tax benefit (expense)	34			(77		)	—			(20		)	(63		)
Amounts reclassified from AOCI, net of income tax	(68		)	162			—			37			131
Balance, end of period	$	12,315		$	1,319		$	(4,574	)	$	(2,169	)	$	6,891

	Nine Months   Ended   September 30, 2016
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Foreign Currency Translation Adjustments			Defined Benefit Plans Adjustment			Total
	(In millions)
Balance, beginning of period	$	10,315		$	1,458		$	(4,950	)	$	(2,052	)	$	4,771
OCI before reclassifications	10,872			1,472			809			(248		)	12,905
Deferred income tax benefit (expense)	(3,656		)	(460		)	200			81			(3,835		)
AOCI before reclassifications, net of income tax	17,531			2,470			(3,941		)	(2,219		)	13,841
Amounts reclassified from AOCI	(339		)	(174		)	—			145			(368		)
Deferred income tax benefit (expense)	114			55			—			(47		)	122
Amounts reclassified from AOCI, net of income tax	(225		)	(119		)	—			98			(246		)
Balance, end of period	$	17,306		$	2,351		$	(3,941	)	$	(2,121	)	$	13,595
	Nine Months   Ended   September 30, 2015
	Unrealized Investment Gains (Losses), Net of Related Offsets (1)			Unrealized Gains (Losses) on Derivatives			Foreign Currency Translation Adjustments			Defined Benefit Plans Adjustment			Total
	(In millions)
Balance, beginning of period	$	15,159		$	1,076		$	(3,303	)	$	(2,283	)	$	10,649
OCI before reclassifications	(3,923		)	(106		)	(1,243		)	3			(5,269		)
Deferred income tax benefit (expense)	1,337			37			(28		)	(1		)	1,345
AOCI before reclassifications, net of income tax	12,573			1,007			(4,574		)	(2,281		)	6,725
Amounts reclassified from AOCI	(392		)	490			—			171			269
Deferred income tax benefit (expense)	134			(178		)	—			(59		)	(103		)
Amounts reclassified from AOCI, net of income tax	(258		)	312			—			112			166
Balance, end of period	$	12,315		$	1,319		$	(4,574	)	$	(2,169	)	$	6,891

__________________

(1) See Note 7 for information on offsets to investments related to future policy benefits, DAC, VOBA and DSI, and the policyholder dividend obligation.

Reclassification out of Accumulated Other Comprehensive Income (Loss)

Information regarding amounts reclassified out of each component of AOCI was as follows:

AOCI Components	Amounts Reclassified from AOCI												Consolidated Statement of Operations and Comprehensive Income (Loss) Locations
	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Net unrealized investment gains (losses):
Net unrealized investment gains (losses)	$	163		$	104		$	288		$	353		Net investment gains (losses)
Net unrealized investment gains (losses)	4			3			23			60			Net investment income
Net unrealized investment gains (losses)	6			(5		)	28			(21		)	Net derivative gains (losses)
Net unrealized investment gains (losses), before income tax	173			102			339			392
Income tax (expense) benefit	(60		)	(34		)	(114		)	(134		)
Net unrealized investment gains (losses), net of income tax	113			68			225			258
Unrealized gains (losses) on derivatives - cash flow hedges:
Interest rate swaps	28			40			56			52			Net derivative gains (losses)
Interest rate swaps	4			3			11			9			Net investment income
Interest rate forwards	1			1			2			5			Net derivative gains (losses)
Interest rate forwards	1			1			4			3			Net investment income
Interest rate forwards	—			1			1			2			Other expenses
Foreign currency swaps	59			(286		)	96			(563		)	Net derivative gains (losses)
Foreign currency swaps	—			—			(1		)	(1		)	Net investment income
Foreign currency swaps	—			—			1			1			Other expenses
Credit forwards	—			1			3			1			Net derivative gains (losses)
Credit forwards	1			—			1			1			Net investment income
Gains (losses) on cash flow hedges, before income tax	94			(239		)	174			(490		)
Income tax (expense) benefit	(30		)	77			(55		)	178
Gains (losses) on cash flow hedges, net of income tax	64			(162		)	119			(312		)
Defined benefit plans adjustment: (1)
Amortization of net actuarial gains (losses)	(47		)	(58		)	(150		)	(174		)
Amortization of prior service (costs) credit	1			1			5			3
Amortization of defined benefit plan items, before income tax	(46		)	(57		)	(145		)	(171		)
Income tax (expense) benefit	10			20			47			59
Amortization of defined benefit plan items, net of income tax	(36		)	(37		)	(98		)	(112		)
Total reclassifications, net of income tax	$	141		$	(131	)	$	246		$	(166	)

__________________

(1) These AOCI components are included in the computation of net periodic benefit costs. See Note 13.

XML

Goodwill (Tables)

9 Months Ended

Sep. 30, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill Rollforward and by Segment

Information regarding goodwill by segment, as well as Corporate & Other, was as follows:

	U.S.		Asia		Latin America		EMEA		MetLife Holdings			Brighthouse Financial			Corporate & Other			Total
	(In millions)
Balance at January 1, 2016
Goodwill	$	1,451	$	4,508	$	1,186	$	1,143	$	2,579		$	260		$	218		$	11,345
Accumulated impairment (1)	—		—		—		—		(1,692		)	—			(176		)	(1,868		)
Total goodwill, net	1,451		4,508		1,186		1,143		887			260			42			9,477
Dispositions (2)	—		—		—		—		—			—			(42		)	(42		)
Impairment	—		—		—		—		—			(260		)	—			(260		)
Effect of foreign currency translation and other	—		352		64		1		—			—			—			417
Balance at September 30, 2016
Goodwill	1,451		4,860		1,250		1,144		2,579			260			176			11,720
Accumulated impairment	—		—		—		—		(1,692		)	(260		)	(176		)	(2,128		)
Total goodwill, net	$	1,451	$	4,860	$	1,250	$	1,144	$	887		$	—		$	—		$	9,592

__________________

(1) The $1.9 billion accumulated impairment relates to the retail annuities business, which was impaired in 2012 and includes the allocated goodwill from Corporate & Other. Although the entire balance is reflected in the MetLife Holdings segment, it also relates to the retail annuities business within the Brighthouse Financial segment.

(2) In conjunction with the U.S. Retail Advisor Force Divestiture, the Company reduced goodwill in Corporate & Other by $42 million during the nine months ended September 30, 2016. See Note 3.

XML

Other Expenses (Tables)

9 Months Ended

Sep. 30, 2016

Other Income and Expenses [Abstract]

Other Expenses

Information on other expenses was as follows:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016			2015
	(In millions)
Compensation	$	1,101		$	1,157		$	3,600		$	3,706
Pension, postretirement and postemployment benefit costs	80			100			323			297
Commissions	1,049			1,103			3,277			3,382
Volume-related costs	214			264			694			761
Capitalization of DAC	(863		)	(955		)	(2,759		)	(2,850		)
Amortization of DAC and VOBA	1,017			1,131			2,133			3,053
Amortization of negative VOBA	(55		)	(90		)	(221		)	(282		)
Interest expense on debt	292			302			910			908
Premium taxes, licenses and fees	187			199			591			568
Professional services	373			366			1,101			1,079
Rent and related expenses, net of sublease income	90			78			285			245
Other (1)	443			878			1,432			1,798
Total other expenses	$	3,928		$	4,533		$	11,366		$	12,665

__________________

(1) The Company recorded a non-cash charge to net income of $792 million, net of income tax, during the third quarter of 2015. The charge was related to an uncertain tax position and was comprised of a $557 million charge included in provision for income tax expense (benefit) and a $362 million ($235 million, net of income tax) charge included in other expenses.

XML

Employee Benefit Plans (Tables)

9 Months Ended

Sep. 30, 2016

Compensation and Retirement Disclosure [Abstract]

Net periodic benefit costs

The components of net periodic benefit costs were as follows:

	Three Months   Ended   September 30,
	2016						2015
	Pension Benefits			Other Postretirement Benefits			Pension Benefits			Other Postretirement Benefits
	(In millions)
Service costs	$	67		$	4		$	68		$	3
Interest costs	102			21			106			22
Curtailment costs (1)	(1		)	(1		)	—			—
Expected return on plan assets	(140		)	(19		)	(136		)	(19		)
Amortization of net actuarial (gains) losses	44			3			48			10
Amortization of prior service costs (credit)	—			(1		)	(1		)	—
Net periodic benefit costs (credit)	$	72		$	7		$	85		$	16
	Nine Months   Ended   September 30,
	2016						2015
	Pension Benefits			Other Postretirement Benefits			Pension Benefits			Other Postretirement Benefits
	(In millions)
Service costs	$	212		$	8		$	206		$	12
Interest costs	322			63			318			67
Curtailment costs (1)	(1		)	26			—			—
Expected return on plan assets	(394		)	(56		)	(408		)	(59		)
Amortization of net actuarial (gains) losses	143			7			143			31
Amortization of prior service costs (credit)	—			(5		)	(1		)	(2		)
Net periodic benefit costs (credit)	$	282		$	43		$	258		$	49

__________________

(1) The Company recognized curtailment charges on certain postretirement benefit plans in connection with the U.S Retail Advisor Force Divestiture. See Note 3.

XML

Earnings Per Common Share (Tables)

9 Months Ended

Sep. 30, 2016

Earnings Per Share [Abstract]

Earnings Per Common Share

The following table presents the weighted average shares used in calculating basic earnings per common share and those used in calculating diluted earnings per common share for each income category presented below:

	Three Months   Ended   September 30,						Nine Months   Ended   September 30,
	2016			2015			2016		2015
	(In millions, except share and per share data)
Weighted Average Shares:
Weighted average common stock outstanding for basic earnings per common share	1,100,504,563			1,118,856,041			1,100,558,083		1,120,130,708
Incremental common shares from assumed:
Exercise or issuance of stock-based awards	8,749,753			11,085,040			8,445,077		10,575,611
Weighted average common stock outstanding for diluted earnings per common share	1,109,254,316			1,129,941,081			1,109,003,160		1,130,706,319
Net Income (Loss):
Net income (loss)	$	573		$	1,198		$	2,890	$	4,480
Less: Net income (loss) attributable to noncontrolling interests	(4		)	(5		)	2		4
Less: Preferred stock dividends	6			6			58		67
Preferred stock repurchase premium	—			—			—		42
Net income (loss) available to MetLife, Inc.’s common shareholders	$	571		$	1,197		$	2,830	$	4,367
Basic	$	0.52		$	1.07		$	2.57	$	3.90
Diluted	$	0.51		$	1.06		$	2.55	$	3.86

XML

Business, Basis of Presentation and Summary of Significant Accounting Policies (Narrative) (Details)	9 Months Ended
	Sep. 30, 2016 Segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of segments	6

XML

Segment Information (Earnings) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Revenues
Premiums	$ 10,391	$ 10,375	$ 29,501	$ 28,940
Universal life and investment-type product policy fees	2,296	2,346	6,926	7,174
Net investment income	5,464	3,959	14,910	14,367
Other revenues	366	484	1,340	1,497
Net investment gains (losses)	257	382	538	535
Net derivative gains (losses)	(1,051)	485	(1,815)	394
Total revenues	17,723	18,031	51,400	52,907
Expenses
Policyholder benefits and claims and policyholder dividends	11,167	10,688	31,758	29,967
Interest credited to policyholder account balances	1,820	647	4,646	3,940
Goodwill impairment	260	0	260	0
Capitalization of DAC	(863)	(955)	(2,759)	(2,850)
Amortization of DAC and VOBA	1,017	1,131	2,133	3,053
Amortization of negative VOBA	(55)	(90)	(221)	(282)
Interest expense on debt	292	302	910	908
Other expenses	3,537	4,145	11,303	11,836
Total expenses	17,175	15,868	48,030	46,572
Provision for income tax expense (benefit)	(25)	965	480	1,855
Net income (loss)	573	1,198	2,890	4,480
U.S.
Expenses
Goodwill impairment			0
Asia
Expenses
Goodwill impairment			0
Latin America
Expenses
Goodwill impairment			0
EMEA
Expenses
Goodwill impairment			0
MetLife Holdings
Expenses
Goodwill impairment			0
Brighthouse Financial
Expenses
Goodwill impairment	260		260
Corporate & Other
Expenses
Goodwill impairment			0
Operating Segments
Revenues
Premiums	10,391	10,376	29,075	28,942
Universal life and investment-type product policy fees	2,199	2,247	6,523	6,876
Net investment income	5,160	4,849	14,747	15,016
Other revenues	359	495	1,330	1,525
Net investment gains (losses)	0	0	0	0
Net derivative gains (losses)	0	0	0	0
Total revenues	18,109	17,967	51,675	52,359
Expenses
Policyholder benefits and claims and policyholder dividends	10,872	10,780	30,850	29,730
Interest credited to policyholder account balances	1,315	1,331	3,930	4,004
Goodwill impairment	0	0	0	0
Capitalization of DAC	(863)	(955)	(2,654)	(2,850)
Amortization of DAC and VOBA	1,282	971	3,178	2,925
Amortization of negative VOBA	(50)	(82)	(178)	(255)
Interest expense on debt	291	294	906	898
Other expenses	3,467	4,126	10,836	11,808
Total expenses	16,314	16,465	46,868	46,260
Provision for income tax expense (benefit)	368	791	1,075	1,924
Operating earnings	1,427	711	3,732	4,175
Operating Segments | U.S.
Revenues
Premiums	5,936	6,023	16,127	15,712
Universal life and investment-type product policy fees	245	233	743	700
Net investment income	1,590	1,522	4,615	4,723
Other revenues	192	184	589	567
Net investment gains (losses)	0	0	0	0
Net derivative gains (losses)	0	0	0	0
Total revenues	7,963	7,962	22,074	21,702
Expenses
Policyholder benefits and claims and policyholder dividends	5,894	5,976	16,210	15,675
Interest credited to policyholder account balances	322	304	967	905
Goodwill impairment	0	0	0	0
Capitalization of DAC	(124)	(128)	(356)	(365)
Amortization of DAC and VOBA	117	118	353	352
Amortization of negative VOBA	0	0	0	0
Interest expense on debt	2	1	7	4
Other expenses	912	908	2,772	2,740
Total expenses	7,123	7,179	19,953	19,311
Provision for income tax expense (benefit)	288	272	720	819
Operating earnings	552	511	1,401	1,572
Operating Segments | Asia
Revenues
Premiums	1,822	1,736	5,161	5,297
Universal life and investment-type product policy fees	394	382	1,114	1,179
Net investment income	707	670	2,003	2,033
Other revenues	12	26	45	82
Net investment gains (losses)	0	0	0	0
Net derivative gains (losses)	0	0	0	0
Total revenues	2,935	2,814	8,323	8,591
Expenses
Policyholder benefits and claims and policyholder dividends	1,363	1,331	3,923	4,046
Interest credited to policyholder account balances	331	327	974	992
Goodwill impairment	0	0	0	0
Capitalization of DAC	(440)	(435)	(1,251)	(1,268)
Amortization of DAC and VOBA	331	309	921	971
Amortization of negative VOBA	(46)	(77)	(167)	(241)
Interest expense on debt	0	0	0	0
Other expenses	930	896	2,658	2,669
Total expenses	2,469	2,351	7,058	7,169
Provision for income tax expense (benefit)	142	125	377	332
Operating earnings	324	338	888	1,090
Operating Segments | Latin America
Revenues
Premiums	653	586	1,885	1,925
Universal life and investment-type product policy fees	227	261	764	856
Net investment income	311	277	809	774
Other revenues	11	10	26	27
Net investment gains (losses)	0	0	0	0
Net derivative gains (losses)	0	0	0	0
Total revenues	1,202	1,134	3,484	3,582
Expenses
Policyholder benefits and claims and policyholder dividends	681	581	1,814	1,793
Interest credited to policyholder account balances	85	88	249	263
Goodwill impairment	0	0	0	0
Capitalization of DAC	(83)	(81)	(236)	(246)
Amortization of DAC and VOBA	(2)	48	127	195
Amortization of negative VOBA	(1)	0	(1)	(1)
Interest expense on debt	1	0	1	0
Other expenses	335	348	968	1,070
Total expenses	1,016	984	2,922	3,074
Provision for income tax expense (benefit)	53	(33)	141	40
Operating earnings	133	183	421	468
Operating Segments | EMEA
Revenues
Premiums	500	501	1,519	1,534
Universal life and investment-type product policy fees	104	106	294	322
Net investment income	81	82	244	249
Other revenues	17	11	56	40
Net investment gains (losses)	0	0	0	0
Net derivative gains (losses)	0	0	0	0
Total revenues	702	700	2,113	2,145
Expenses
Policyholder benefits and claims and policyholder dividends	257	233	801	737
Interest credited to policyholder account balances	28	27	87	91
Goodwill impairment	0	0	0	0
Capitalization of DAC	(103)	(107)	(310)	(372)
Amortization of DAC and VOBA	106	127	311	388
Amortization of negative VOBA	(3)	(5)	(10)	(13)
Interest expense on debt	0	0	0	0
Other expenses	332	352	1,001	1,103
Total expenses	617	627	1,880	1,934
Provision for income tax expense (benefit)	11	7	32	25
Operating earnings	74	66	201	186
Operating Segments | MetLife Holdings
Revenues
Premiums	1,093	1,115	3,312	3,345
Universal life and investment-type product policy fees	357	370	1,073	1,117
Net investment income	1,537	1,521	4,489	4,690
Other revenues	105	223	512	711
Net investment gains (losses)	0	0	0	0
Net derivative gains (losses)	0	0	0	0
Total revenues	3,092	3,229	9,386	9,863
Expenses
Policyholder benefits and claims and policyholder dividends	1,853	1,885	5,603	5,479
Interest credited to policyholder account balances	261	266	780	793
Goodwill impairment	0	0	0	0
Capitalization of DAC	(44)	(101)	(240)	(292)
Amortization of DAC and VOBA	219	173	636	423
Amortization of negative VOBA	0	0	0	0
Interest expense on debt	15	13	43	41
Other expenses	401	647	1,861	1,988
Total expenses	2,705	2,883	8,683	8,432
Provision for income tax expense (benefit)	121	103	203	454
Operating earnings	266	243	500	977
Operating Segments | Brighthouse Financial
Revenues
Premiums	347	468	1,020	1,159
Universal life and investment-type product policy fees	903	921	2,622	2,789
Net investment income	941	862	2,624	2,536
Other revenues	50	99	482	310
Net investment gains (losses)	0	0	0	0
Net derivative gains (losses)	0	0	0	0
Total revenues	2,241	2,350	6,748	6,794
Expenses
Policyholder benefits and claims and policyholder dividends	814	846	2,525	2,103
Interest credited to policyholder account balances	288	313	868	940
Goodwill impairment	0	0	0	0
Capitalization of DAC	(70)	(102)	(255)	(305)
Amortization of DAC and VOBA	509	197	823	595
Amortization of negative VOBA	0	0	0	0
Interest expense on debt	32	32	96	96
Other expenses	560	614	1,739	1,830
Total expenses	2,133	1,900	5,796	5,259
Provision for income tax expense (benefit)	40	103	260	410
Operating earnings	68	347	692	1,125
Operating Segments | Corporate & Other
Revenues
Premiums	40	(53)	51	(30)
Universal life and investment-type product policy fees	(31)	(26)	(87)	(87)
Net investment income	(7)	(85)	(37)	11
Other revenues	(28)	(58)	(380)	(212)
Net investment gains (losses)	0	0	0	0
Net derivative gains (losses)	0	0	0	0
Total revenues	(26)	(222)	(453)	(318)
Expenses
Policyholder benefits and claims and policyholder dividends	10	(72)	(26)	(103)
Interest credited to policyholder account balances	0	6	5	20
Goodwill impairment	0	0	0	0
Capitalization of DAC	1	(1)	(6)	(2)
Amortization of DAC and VOBA	2	(1)	7	1
Amortization of negative VOBA	0	0	0	0
Interest expense on debt	241	248	759	757
Other expenses	(3)	361	(163)	408
Total expenses	251	541	576	1,081
Provision for income tax expense (benefit)	(287)	214	(658)	(156)
Operating earnings	10	(977)	(371)	(1,243)
Significant Reconciling Items
Revenues
Premiums	0	(1)	426	(2)
Universal life and investment-type product policy fees	97	99	403	298
Net investment income	304	(890)	163	(649)
Other revenues	7	(11)	10	(28)
Net investment gains (losses)	257	382	538	535
Net derivative gains (losses)	(1,051)	485	(1,815)	394
Total revenues	(386)	64	(275)	548
Expenses
Policyholder benefits and claims and policyholder dividends	295	(92)	908	237
Interest credited to policyholder account balances	505	(684)	716	(64)
Goodwill impairment	260	0	260	0
Capitalization of DAC	0	0	(105)	0
Amortization of DAC and VOBA	(265)	160	(1,045)	128
Amortization of negative VOBA	(5)	(8)	(43)	(27)
Interest expense on debt	1	8	4	10
Other expenses	70	19	467	28
Total expenses	861	(597)	1,162	312
Provision for income tax expense (benefit)	$ (393)	$ 174	$ (595)	$ (69)

XML

Segment Information (Total Assets) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Segment Reporting Information [Line Items]
Total assets	$ 952,904	$ 877,933
U.S.
Segment Reporting Information [Line Items]
Total assets	257,943	237,858
Asia
Segment Reporting Information [Line Items]
Total assets	133,881	113,895
Latin America
Segment Reporting Information [Line Items]
Total assets	70,421	64,808
EMEA
Segment Reporting Information [Line Items]
Total assets	27,764	26,767
MetLife Holdings
Segment Reporting Information [Line Items]
Total assets	195,267	187,677
Brighthouse Financial
Segment Reporting Information [Line Items]
Total assets	240,696	226,792
Corporate & Other
Segment Reporting Information [Line Items]
Total assets	$ 26,932	$ 20,136

XML

Segment Information (Narrative) (Details) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2016 USD ($)	Sep. 30, 2016 Segment
Segment Reporting Information [Line Items]
Number of segments | Segment		6
Brighthouse Financial | Universal Life
Segment Reporting Information [Line Items]
Net amount of other expense charge	$ 296
Write-off of deferred policy acquisition costs	254
Increase in insurance-related liabilities	$ 42

XML

Disposition (Disposition - Narrative) (Details) - MetLife U.S. Retail Advisor Force - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2016	Jul. 31, 2016
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net Consideration			$ 291
Gain on Disposition of Business	$ 103	$ 103
Gain on Disposition of Business, Net of Tax	$ 58	$ 58

XML

Insurance (Insurance Liabilities) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Insurance Liabilities [Line Items]
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	$ 439,610	$ 408,856
U.S.
Insurance Liabilities [Line Items]
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	129,448	123,060
Asia
Insurance Liabilities [Line Items]
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	96,648	83,510
Latin America
Insurance Liabilities [Line Items]
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	15,228	14,022
EMEA
Insurance Liabilities [Line Items]
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	19,206	19,009
MetLife Holdings
Insurance Liabilities [Line Items]
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	105,995	102,853
Brighthouse Financial
Insurance Liabilities [Line Items]
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	79,241	71,853
Corporate & Other
Insurance Liabilities [Line Items]
Insurance liabilities comprised of future policy benefits, policyholder account balances and other policy-related balances	$ (6,156)	$ (5,451)

XML

Insurance (Guarantees Related to Annuity Contracts) (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Variable Annuity Guarantees: | Guaranteed Death Benefits
Net Amount at Risk by Product and Guarantee [Line Items]
Total account value	$ 183,010	$ 181,413
Separate account value	153,486	151,901
Net amount at risk	$ 8,157	$ 10,339
Average attained age of contractholders	66 years	66 years
Variable Annuity Guarantees: | Guaranteed Annuitization Benefits
Net Amount at Risk by Product and Guarantee [Line Items]
Total account value	$ 92,187	$ 91,240
Separate account value	88,546	87,841
Net amount at risk	$ 4,663	$ 2,762
Average attained age of contractholders	66 years	66 years
Other Annuity Guarantees: | Guaranteed Annuitization Benefits
Net Amount at Risk by Product and Guarantee [Line Items]
Total account value	$ 1,600	$ 1,560
Net amount at risk	$ 576	$ 422
Average attained age of contractholders	50 years	51 years

XML

Insurance (Guarantees Related to Universal and Variable Life Contracts) (Details) - Universal and Variable Life Contracts - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Secondary Guarantees
Net Amount at Risk by Product and Guarantee [Line Items]
Total account value (3)	$ 17,640	$ 17,211
Net amount at risk (7)	$ 176,066	$ 175,958
Average attained age of policyholders	57 years	57 years
Paid-Up Guarantees
Net Amount at Risk by Product and Guarantee [Line Items]
Total account value (3)	$ 3,365	$ 3,461
Net amount at risk (7)	$ 18,068	$ 19,047
Average attained age of policyholders	62 years	62 years

XML

Deferred Policy Acquisition Costs and Value of Business Acquired (DAC and VOBA by Segment) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Segment Reporting Information [Line Items]
DAC and VOBA	$ 24,748	$ 24,130
U.S.
Segment Reporting Information [Line Items]
DAC and VOBA	618	615
Asia
Segment Reporting Information [Line Items]
DAC and VOBA	9,148	8,374
Latin America
Segment Reporting Information [Line Items]
DAC and VOBA	1,846	1,753
EMEA
Segment Reporting Information [Line Items]
DAC and VOBA	1,554	1,532
MetLife Holdings
Segment Reporting Information [Line Items]
DAC and VOBA	4,962	5,436
Brighthouse Financial
Segment Reporting Information [Line Items]
DAC and VOBA	6,589	6,390
Corporate & Other
Segment Reporting Information [Line Items]
DAC and VOBA	$ 31	$ 30

XML

Closed Block (Liabilities and Assets) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015	Dec. 31, 2014
Closed Block Liabilities
Future policy benefits	$ 40,840	$ 41,278
Other policy-related balances	256	249
Policyholder dividends payable	506	468
Policyholder dividend obligation	3,352	1,783	$ 3,155
Current income tax payable	8	0
Other liabilities	601	380
Total closed block liabilities	45,563	44,158
Assets Designated to the Closed Block
Fixed maturity securities available-for-sale, at estimated fair value	29,194	27,556
Equity securities available-for-sale, at estimated fair value	107	111
Mortgage loans	5,739	6,022
Policy loans	4,553	4,642
Real estate and real estate joint ventures	672	462
Other invested assets	1,233	1,066
Total investments	41,498	39,859
Cash and cash equivalents	72	236
Accrued investment income	482	474
Premiums, reinsurance and other receivables	65	56
Current income tax recoverable	0	11
Deferred income tax assets	195	234
Total assets designated to the closed block	42,312	40,870
Excess of closed block liabilities over assets designated to the closed block	3,251	3,288
Amounts included in accumulated other comprehensive income (loss) (“AOCI”)
Unrealized investment gains (losses), net of income tax	2,452	1,382
Unrealized gains (losses) on derivatives, net of income tax	88	76
Allocated to policyholder dividend obligation, net of income tax	(2,179)	(1,159)
Total amounts included in AOCI	361	299
Maximum future earnings to be recognized from closed block assets and liabilities	$ 3,612	$ 3,587

XML

Closed Block (Policyholder Dividend Obligation) (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Closed block policyholder dividend obligation
Balance, beginning of period	$ 1,783	$ 3,155
Change in unrealized investment and derivative gains (losses)	1,569	(1,372)
Balance, end of period	$ 3,352	$ 1,783

XML

Closed Block (Revenues and Expenses) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Revenues
Premiums	$ 436	$ 447	$ 1,297	$ 1,334
Net investment income	486	487	1,435	1,500
Net investment gains (losses)	(3)	(9)	(19)	(8)
Net derivative gains (losses)	4	13	(3)	25
Total revenues	923	938	2,710	2,851
Expenses
Policyholder benefits and claims	619	635	1,861	1,886
Policyholder dividends	232	273	723	757
Other expenses	33	36	100	109
Total expenses	884	944	2,684	2,752
Revenues, net of expenses before provision for income tax expense (benefit)	39	(6)	26	99
Provision for income tax expense (benefit)	13	(1)	8	36
Revenues, net of expenses and provision for income tax expense (benefit)	$ 26	$ (5)	$ 18	$ 63

XML

Investments (Fixed Maturity and Equity Securities Available-For-Sale by Sector) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015	Dec. 31, 2014
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	$ 353,913	$ 332,964
Cost or Amortized Cost	2,838	2,997
Gross Unrealized OTTI Loss	(13)	(76)	$ (112)
Available-for-sale Securities, Debt Securities	390,442	351,402
Equity securities	3,289	3,321
Fixed Maturity Securities
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	353,913	332,964
Gross Unrealized Gain	39,334	23,883
Gross Unrealized Temporary Loss	2,792	5,369
Gross Unrealized OTTI Loss	13	76
Available-for-sale Securities, Debt Securities	390,442	351,402
U.S. corporate
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	95,808	96,466
Gross Unrealized Gain	10,589	6,583
Gross Unrealized Temporary Loss	721	2,255
Gross Unrealized OTTI Loss	0	0
Available-for-sale Securities, Debt Securities	105,676	100,794
U.S. government and agency
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	60,340	56,499
Gross Unrealized Gain	9,491	5,373
Gross Unrealized Temporary Loss	46	226
Gross Unrealized OTTI Loss	0	0
Available-for-sale Securities, Debt Securities	69,785	61,646
Foreign corporate
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	57,423	56,003
Gross Unrealized Gain	4,264	3,019
Gross Unrealized Temporary Loss	1,268	1,822
Gross Unrealized OTTI Loss	0	2
Available-for-sale Securities, Debt Securities	60,419	57,198
Foreign government
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	54,425	45,451
Gross Unrealized Gain	9,479	5,269
Gross Unrealized Temporary Loss	139	221
Gross Unrealized OTTI Loss	0	0
Available-for-sale Securities, Debt Securities	63,765	50,499
RMBS
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	43,838	37,914
Gross Unrealized Gain	1,788	1,366
Gross Unrealized Temporary Loss	310	424
Gross Unrealized OTTI Loss	7	59
Available-for-sale Securities, Debt Securities	45,309	38,797
State and political subdivision
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	14,539	13,723
Gross Unrealized Gain	2,939	1,795
Gross Unrealized Temporary Loss	11	67
Gross Unrealized OTTI Loss	4	10
Available-for-sale Securities, Debt Securities	17,463	15,441
ABS
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	15,685	14,498
Gross Unrealized Gain	122	131
Gross Unrealized Temporary Loss	220	229
Gross Unrealized OTTI Loss	3	6
Available-for-sale Securities, Debt Securities	15,584	14,394
CMBS (1)
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	11,855	12,410
Gross Unrealized Gain	662	347
Gross Unrealized Temporary Loss	77	125
Gross Unrealized OTTI Loss	(1)	(1)
Available-for-sale Securities, Debt Securities	12,441	12,633
Equity securities
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	2,838	2,997
Gross Unrealized Gain	512	482
Gross Unrealized Temporary Loss	61	158
Gross Unrealized OTTI Loss	0	0
Equity securities	3,289	3,321
Common Stock
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	2,000	1,962
Gross Unrealized Gain	449	397
Gross Unrealized Temporary Loss	14	107
Gross Unrealized OTTI Loss	0	0
Equity securities	2,435	2,252
Non-redeemable preferred stock
Available-for-sale Securities [Abstract]
Cost or Amortized Cost	838	1,035
Gross Unrealized Gain	63	85
Gross Unrealized Temporary Loss	47	51
Gross Unrealized OTTI Loss	0	0
Equity securities	$ 854	$ 1,069

XML

Investments (Maturities of Fixed Maturity Securities) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Available-for-sale Securities, Debt Maturities [Abstract]
Amortized Cost, Due in one year or less	$ 15,378
Amortized Cost, Due after one year through five years	77,046
Amortized Cost, Due after five years through ten years	72,056
Amortized Cost, Due after ten years	118,055
Amortized Cost, Structured Securities	71,378
Amortized Cost, Subtotal	353,913	$ 332,964
Estimated Fair Value, Due in one year or less	15,464
Estimated Fair Value, Due after one year through five years	81,187
Estimated Fair Value, Due after five years through ten years	76,987
Estimated Fair Value, Due after ten years	143,470
Estimated Fair Value, Structured Securities	73,334
Available-for-sale Securities, Debt Securities	$ 390,442	$ 351,402

XML

Investments (Continuous Gross Unrealized Losses for Fixed Maturity and Equity Securities Available-For-Sale) (Details) $ in Millions	Sep. 30, 2016 USD ($)	Dec. 31, 2015 USD ($)
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Total number of securities in an unrealized loss position less than 12 months	2,579	6,366
Total number of securities in an unrealized loss position equal to or greater than 12 months	1,871	1,489
Fixed Maturity Securities
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	$ 29,579	$ 92,421
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	1,048	3,475
Equal to or Greater than 12 Months Estimated Fair Value	19,344	15,799
Equal to or Greater than 12 Months Gross Unrealized Loss	1,757	1,970
U.S. corporate
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	5,559	27,526
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	274	1,629
Equal to or Greater than 12 Months Estimated Fair Value	4,612	3,762
Equal to or Greater than 12 Months Gross Unrealized Loss	447	626
U.S. government and agency
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	6,305	19,628
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	24	222
Equal to or Greater than 12 Months Estimated Fair Value	164	298
Equal to or Greater than 12 Months Gross Unrealized Loss	22	4
Foreign corporate
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	6,781	14,447
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	404	911
Equal to or Greater than 12 Months Estimated Fair Value	6,112	5,251
Equal to or Greater than 12 Months Gross Unrealized Loss	864	913
Foreign government
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	2,136	3,530
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	75	166
Equal to or Greater than 12 Months Estimated Fair Value	851	429
Equal to or Greater than 12 Months Gross Unrealized Loss	64	55
RMBS
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	5,692	13,467
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	127	287
Equal to or Greater than 12 Months Estimated Fair Value	3,259	2,431
Equal to or Greater than 12 Months Gross Unrealized Loss	190	196
State and political subdivision
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	321	1,618
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	5	55
Equal to or Greater than 12 Months Estimated Fair Value	79	168
Equal to or Greater than 12 Months Gross Unrealized Loss	10	22
ABS
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	2,084	7,329
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	105	124
Equal to or Greater than 12 Months Estimated Fair Value	3,476	2,823
Equal to or Greater than 12 Months Gross Unrealized Loss	118	111
CMBS
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	701	4,876
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	34	81
Equal to or Greater than 12 Months Estimated Fair Value	791	637
Equal to or Greater than 12 Months Gross Unrealized Loss	42	43
Equity securities
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	151	282
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	17	107
Equal to or Greater than 12 Months Estimated Fair Value	168	220
Equal to or Greater than 12 Months Gross Unrealized Loss	44	51
Common Stock
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	102	203
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	14	105
Equal to or Greater than 12 Months Estimated Fair Value	5	20
Equal to or Greater than 12 Months Gross Unrealized Loss	0	2
Non-redeemable preferred stock
Continuous Gross Unrealized Loss and OTTI Loss for Fixed Maturity and Equity Securities Available-for-Sale
Less than 12 months Estimated Fair Value	49	79
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	3	2
Equal to or Greater than 12 Months Estimated Fair Value	163	200
Equal to or Greater than 12 Months Gross Unrealized Loss	$ 44	$ 49

XML

Investments (Mortgage Loans by Portfolio Segment) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2014
Company-held mortgage loans held-for-investment, net
Commercial mortgage loans	$ 45,801	$ 44,012
Percentage of loans receivable on commercial mortgage loans	64.40%	65.60%
Agricultural mortgage loans	$ 14,141	$ 13,188
Percentage of loans receivable on agricultural mortgage loans	19.90%	19.60%
Residential mortgage loans	$ 10,920	$ 9,734
Percentage of loans receivable on residential mortgage loans	15.30%	14.50%
Subtotal	$ 70,862	$ 66,934
Percentage of loans receivable on subtotal	99.60%	99.70%
Valuation allowances	$ (330)	$ (318)	$ (311)	$ (305)
Percentage of loans receivable on valuation allowances	(0.50%)	(0.50%)
Subtotal mortgage loans, net	$ 70,532	$ 66,616
Percentage of loans receivable on subtotal mortgage loans held-for-investment, net	99.10%	99.20%
Percentage of residential mortgage loans - FVO	0.70%	0.50%
Percentage of loans receivable on commercial mortgage loans held by consolidated securitization entities - fair value option	0.20%	0.30%
Total mortgage loans, net	$ 71,156	$ 67,102
Percentage of loans held for sale on total mortgage loans, net	100.00%	100.00%
Residential — FVO
Company-held mortgage loans held-for-investment, net
Total mortgage loans, net	$ 481	$ 314
Consolidated Securitization Entities
Company-held mortgage loans held-for-investment, net
Total mortgage loans, net	$ 143	$ 172

XML

Investments (Mortgage Loans and Valuation Allowance by Portfolio Segment) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Mortgage Loans on Real Estate [Line Items]
Unpaid Principal Balance	$ 16	$ 49
Recorded Investment	13	47
Valuation Allowances	1	3
Unpaid Principal Balance	287	220
Recorded Investment	265	209
Recorded Investment	70,584	66,678
Valuation Allowances	329	315
Carrying Value	277	253
Commercial
Mortgage Loans on Real Estate [Line Items]
Unpaid Principal Balance	0	0
Recorded Investment	0	0
Valuation Allowances	0	0
Unpaid Principal Balance	12	57
Recorded Investment	12	57
Recorded Investment	45,789	43,955
Valuation Allowances	227	217
Carrying Value	12	57
Agricultural
Mortgage Loans on Real Estate [Line Items]
Unpaid Principal Balance	16	49
Recorded Investment	13	47
Valuation Allowances	1	3
Unpaid Principal Balance	39	22
Recorded Investment	38	21
Recorded Investment	14,090	13,120
Valuation Allowances	42	39
Carrying Value	50	65
Residential
Mortgage Loans on Real Estate [Line Items]
Unpaid Principal Balance	0	0
Recorded Investment	0	0
Valuation Allowances	0	0
Unpaid Principal Balance	236	141
Recorded Investment	215	131
Recorded Investment	10,705	9,603
Valuation Allowances	60	59
Carrying Value	$ 215	$ 131

XML

Investments (Valuation Allowance Rollforward by Portfolio Segment) (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Mortgage Loans on Real Estate [Line Items]
Balance, beginning of period	$ 318	$ 305
Provision (release) (1)	169	32
Charge-offs, net of recoveries (1)	(157)	(26)
Balance, end of period	330	311
Commercial
Mortgage Loans on Real Estate [Line Items]
Balance, beginning of period	217	224
Provision (release) (1)	153	3
Charge-offs, net of recoveries (1)	(143)	(12)
Balance, end of period	227	215
Agricultural
Mortgage Loans on Real Estate [Line Items]
Balance, beginning of period	42	39
Provision (release) (1)	3	2
Charge-offs, net of recoveries (1)	(2)	0
Balance, end of period	43	41
Residential
Mortgage Loans on Real Estate [Line Items]
Balance, beginning of period	59	42
Provision (release) (1)	13	27
Charge-offs, net of recoveries (1)	(12)	(14)
Balance, end of period	$ 60	$ 55

XML

Investments (Credit Quality of Commercial Mortgage Loans) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	$ 45,801	$ 44,012
% of Total	100.00%	100.00%
Estimated Fair Value	$ 47,672	$ 45,104
% of Total	100.00%	100.00%
Less than 65%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	$ 42,945	$ 39,770
% of Total	93.80%	90.40%
Estimated Fair Value	$ 44,770	$ 40,921
% of Total	93.90%	90.70%
65% to 75%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	$ 2,531	$ 3,484
% of Total	5.50%	7.90%
Estimated Fair Value	$ 2,563	$ 3,451
% of Total	5.40%	7.70%
76% to 80%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	$ 42	$ 0
% of Total	0.10%	0.00%
Estimated Fair Value	$ 40	$ 0
% of Total	0.10%	0.00%
Greater than 80%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	$ 283	$ 758
% of Total	0.60%	1.70%
Estimated Fair Value	$ 299	$ 732
% of Total	0.60%	1.60%
Greater than 1.20x
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	$ 43,770	$ 41,814
Greater than 1.20x | Less than 65%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	41,391	38,163
Greater than 1.20x | 65% to 75%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	2,194	3,270
Greater than 1.20x | 76% to 80%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	42	0
Greater than 1.20x | Greater than 80%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	143	381
1.00x - 1.20x
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	971	1,341
1.00x - 1.20x | Less than 65%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	879	1,063
1.00x - 1.20x | 65% to 75%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	39	138
1.00x - 1.20x | 76% to 80%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	0	0
1.00x - 1.20x | Greater than 80%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	53	140
Less than 1.00x
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	1,060	857
Less than 1.00x | Less than 65%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	675	544
Less than 1.00x | 65% to 75%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	298	76
Less than 1.00x | 76% to 80%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	0	0
Less than 1.00x | Greater than 80%
Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans	$ 87	$ 237

XML

Investments (Credit Quality of Agricultural and Residential Mortgage Loans) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Agricultural Mortgage Loans - by Credit Quality Indicator:
Recorded Investment	$ 14,141	$ 13,188
% of Total	100.00%	100.00%
Residential Mortgage Loans - by Credit Quality Indicator:
Recorded Investment	$ 10,920	$ 9,734
% of Total	100.00%	100.00%
Less than 65%
Agricultural Mortgage Loans - by Credit Quality Indicator:
Recorded Investment	$ 13,543	$ 12,399
% of Total	95.80%	94.00%
65% to 75%
Agricultural Mortgage Loans - by Credit Quality Indicator:
Recorded Investment	$ 532	$ 710
% of Total	3.80%	5.40%
76% to 80%
Agricultural Mortgage Loans - by Credit Quality Indicator:
Recorded Investment	$ 20	$ 21
% of Total	0.10%	0.20%
Greater than 80%
Agricultural Mortgage Loans - by Credit Quality Indicator:
Recorded Investment	$ 46	$ 58
% of Total	0.30%	0.40%
Performing
Residential Mortgage Loans - by Credit Quality Indicator:
Recorded Investment	$ 10,587	$ 9,408
% of Total	97.00%	96.70%
Nonperforming
Residential Mortgage Loans - by Credit Quality Indicator:
Recorded Investment	$ 333	$ 326
% of Total	3.00%	3.30%

XML

Investments (Past Due and Interest Accrual Status of Mortgage Loans) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	$ 477	$ 431
Nonaccrual Status	361	364
Commercial
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	0	2
Nonaccrual Status	0	0
Agricultural
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	144	103
Nonaccrual Status	39	46
Residential
Financing Receivable, Recorded Investment, Aging [Abstract]
Past Due	333	326
Nonaccrual Status	$ 322	$ 318

XML

Investments (Net Unrealized Investment Gains Losses) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015	Dec. 31, 2014
Components of net unrealized investment gains (losses) included in accumulated other comprehensive loss
Fixed maturity securities	$ 36,444	$ 18,164
Fixed maturity securities with noncredit OTTI losses included in AOCI	(13)	(76)	$ (112)
Total fixed maturity securities	36,431	18,088
Equity securities	579	422
Derivatives	3,648	2,350
Other	397	287
Subtotal	41,055	21,147
Future policy benefits	(5,571)	(163)
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(2)	0
DAC, VOBA and DSI	(2,390)	(1,273)
Policyholder dividend obligation	(3,352)	(1,783)
Subtotal	(11,315)	(3,219)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	7	27
Deferred income tax benefit (expense)	(10,078)	(6,151)
Net unrealized investment gains (losses)	19,669	11,804
Net unrealized investment gains (losses) attributable to noncontrolling interests	(12)	(31)
Net unrealized investment gains (losses) attributable to MetLife, Inc.	$ 19,657	$ 11,773

XML

Investments (Changes in Fixed Maturity Securities with Noncredit OTTI Losses) (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Changes in fixed maturity securities with noncredit OTTI losses in accumulated other comprehensive income (loss)
Balance, beginning of period	$ (76)	$ (112)
Noncredit OTTI losses and subsequent changes recognized	12	6
Securities sold with previous noncredit OTTI loss	34	125
Subsequent changes in estimated fair value	17	(95)
Balance, end of period	$ (13)	$ (76)

XML

Investments (Changes in Net Unrealized Investment Gains Losses) (Details) $ in Millions	9 Months Ended
	Sep. 30, 2016 USD ($)
Changes In Net Unrealized Investment Gains Losses Included In Accumulated Other Comprehensive Loss [Abstract]
Balance, beginning of period	$ 11,773
Fixed maturity securities on which noncredit OTTI losses have been recognized	63
Unrealized investment gains (losses) during the period	19,845
Unrealized investment gains (losses) relating to:
Future policy benefits	(5,408)
DAC and VOBA related to noncredit OTTI losses recognized in AOCI	(2)
DAC, VOBA and DSI	(1,117)
Policyholder dividend obligation	(1,569)
Deferred income tax benefit (expense) related to noncredit OTTI losses recognized in AOCI	(20)
Deferred income tax benefit (expense)	(3,927)
Net unrealized investment gains (losses)	19,638
Net unrealized investment gains (losses) attributable to noncontrolling interests	19
Balance, end of period	19,657
Change in net unrealized investment gains (losses)	7,865
Change in net unrealized investment gains (losses) attributable to noncontrolling interests	19
Change in net unrealized investment gains (losses) attributable to MetLife, Inc.	$ 7,884

XML

Investments (Securities Lending) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Securities Financing Transaction [Line Items]
Cash collateral on deposit from counterparties	$ 32,119	$ 30,197
Security collateral on deposit from counterparties	134	50
Reinvestment portfolio — estimated fair value	32,454	30,258
Amortized cost
Securities Financing Transaction [Line Items]
Securities loaned	26,855	27,223
Estimated fair value
Securities Financing Transaction [Line Items]
Securities loaned	$ 31,326	$ 29,646

XML

Investments (Securities Lending Remaining Tenor) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Securities Financing Transaction [Line Items]
Total	$ 32,119	$ 30,197
U.S. government and agency
Securities Financing Transaction [Line Items]
Total	29,614	27,259
Agency RMBS
Securities Financing Transaction [Line Items]
Total	1,196	1,551
Foreign government
Securities Financing Transaction [Line Items]
Total	886	998
U.S. corporate
Securities Financing Transaction [Line Items]
Total	392	389
Foreign corporate
Securities Financing Transaction [Line Items]
Total	31	0
Maturity Overnight
Securities Financing Transaction [Line Items]
Total	8,363	10,127
Maturity Overnight | U.S. government and agency
Securities Financing Transaction [Line Items]
Total	8,362	10,116
Maturity Overnight | Agency RMBS
Securities Financing Transaction [Line Items]
Total	0	0
Maturity Overnight | Foreign government
Securities Financing Transaction [Line Items]
Total	0	2
Maturity Overnight | U.S. corporate
Securities Financing Transaction [Line Items]
Total	1	9
Maturity Overnight | Foreign corporate
Securities Financing Transaction [Line Items]
Total	0	0
Maturity Less than 30 Days
Securities Financing Transaction [Line Items]
Total	11,420	12,998
Maturity Less than 30 Days | U.S. government and agency
Securities Financing Transaction [Line Items]
Total	10,162	11,157
Maturity Less than 30 Days | Agency RMBS
Securities Financing Transaction [Line Items]
Total	0	951
Maturity Less than 30 Days | Foreign government
Securities Financing Transaction [Line Items]
Total	836	510
Maturity Less than 30 Days | U.S. corporate
Securities Financing Transaction [Line Items]
Total	391	380
Maturity Less than 30 Days | Foreign corporate
Securities Financing Transaction [Line Items]
Total	31	0
Maturity 30 to 180 Days
Securities Financing Transaction [Line Items]
Total	12,336	7,072
Maturity 30 to 180 Days | U.S. government and agency
Securities Financing Transaction [Line Items]
Total	11,090	5,986
Maturity 30 to 180 Days | Agency RMBS
Securities Financing Transaction [Line Items]
Total	1,196	600
Maturity 30 to 180 Days | Foreign government
Securities Financing Transaction [Line Items]
Total	50	486
Maturity 30 to 180 Days | U.S. corporate
Securities Financing Transaction [Line Items]
Total	0	0
Maturity 30 to 180 Days | Foreign corporate
Securities Financing Transaction [Line Items]
Total	$ 0	$ 0

XML

Investments (Repurchase Agreements - Securities Lending) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Securities Financing Transaction [Line Items]
Cash collateral on deposit from counterparties	$ 32,119	$ 30,197
Reinvestment portfolio — estimated fair value	32,454	30,258
Repurchase Agreements [Member]
Securities Financing Transaction [Line Items]
Cash collateral on deposit from counterparties	101	50
Reinvestment portfolio — estimated fair value	99	50
Repurchase Agreements [Member] | Amortized cost
Securities Financing Transaction [Line Items]
Securities Sold under Agreements to Repurchase	91	51
Repurchase Agreements [Member] | Estimated fair value
Securities Financing Transaction [Line Items]
Securities Sold under Agreements to Repurchase	$ 109	$ 56

XML

Investments (Repurchase Agreements - Securities Lending Remaining Tenor) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Securities Financing Transaction [Line Items]
Total	$ 32,119	$ 30,197
Repurchase Agreements [Member]
Securities Financing Transaction [Line Items]
Total	101	50
Other Debt Obligations [Member] | Repurchase Agreements [Member]
Securities Financing Transaction [Line Items]
Total	74	25
Foreign corporate
Securities Financing Transaction [Line Items]
Total	31	0
Foreign corporate | Repurchase Agreements [Member]
Securities Financing Transaction [Line Items]
Total	27	25
Maturity Less than 30 Days
Securities Financing Transaction [Line Items]
Total	11,420	12,998
Maturity Less than 30 Days | Repurchase Agreements [Member]
Securities Financing Transaction [Line Items]
Total	51	0
Maturity Less than 30 Days | Other Debt Obligations [Member] | Repurchase Agreements [Member]
Securities Financing Transaction [Line Items]
Total	37	0
Maturity Less than 30 Days | Foreign corporate
Securities Financing Transaction [Line Items]
Total	31	0
Maturity Less than 30 Days | Foreign corporate | Repurchase Agreements [Member]
Securities Financing Transaction [Line Items]
Total	14	0
Maturity 30 to 90 Days | Repurchase Agreements [Member]
Securities Financing Transaction [Line Items]
Total	50	50
Maturity 30 to 90 Days | Other Debt Obligations [Member] | Repurchase Agreements [Member]
Securities Financing Transaction [Line Items]
Total	37	25
Maturity 30 to 90 Days | Foreign corporate | Repurchase Agreements [Member]
Securities Financing Transaction [Line Items]
Total	$ 13	$ 25

XML

Investments (Invested Assets on Deposit, Held In Trust and Pledged as Collateral) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Investments, Debt and Equity Securities [Abstract]
Invested assets on deposit (regulatory deposits)	$ 10,425	$ 9,089
Invested assets held in trust (collateral financing arrangements and reinsurance agreements)	11,902	10,443
Invested assets pledged as collateral	29,296	23,145
Total invested assets on deposit, held in trust and pledged as collateral	$ 51,623	$ 42,677

XML

Investments (Consolidated Variable Interest Entities) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Variable Interest Entity [Line Items]
Total Assets	$ 3,739	$ 6,101
Total Liabilities	38	2,141
MRSC collateral financing arrangement
Variable Interest Entity [Line Items]
Total Assets	3,533	3,374
Total Liabilities	0	0
Operating joint venture
Variable Interest Entity [Line Items]
Total Assets	0	2,465
Total Liabilities	0	2,079
CSEs (assets (primarily loans) and liabilities (primarily debt))
Variable Interest Entity [Line Items]
Total Assets	156	186
Total Liabilities	38	62
Other
Variable Interest Entity [Line Items]
Total Assets	50	76
Total Liabilities	$ 0	$ 0

XML

Investments (Unconsolidated Variable Interest Entities) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Variable Interest Entity [Line Items]
Carrying Amount Asset	$ 85,673	$ 76,597
Carrying Amount Liability	90,884	79,059
Other limited partnership interests
Variable Interest Entity [Line Items]
Carrying Amount Asset	5,978	5,186
Carrying Amount Liability	10,572	7,074
Other invested assets
Variable Interest Entity [Line Items]
Carrying Amount Asset	2,184	1,604
Carrying Amount Liability	2,771	2,161
FVO and trading securities
Variable Interest Entity [Line Items]
Carrying Amount Asset	576	586
Carrying Amount Liability	576	586
Real estate joint ventures
Variable Interest Entity [Line Items]
Carrying Amount Asset	107	65
Carrying Amount Liability	137	82
Other
Variable Interest Entity [Line Items]
Carrying Amount Asset	120	71
Carrying Amount Liability	120	71
Structured securities (RMBS, CMBS, and ABS)
Variable Interest Entity [Line Items]
Carrying Amount Asset	73,334	65,824
Carrying Amount Liability	73,334	65,824
U.S. corporate and foreign corporate securities
Variable Interest Entity [Line Items]
Carrying Amount Asset	3,374	3,261
Carrying Amount Liability	$ 3,374	$ 3,261

XML

Investments (Net Investment Income) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Net Investment Income [Line Items]
Less: Investment expenses	$ 281	$ 308	$ 862	$ 923
Subtotal	5,464	3,959	14,910	14,367
Securities Investment
Net Investment Income [Line Items]
Subtotal	5,213	4,964	15,141	15,355
Subtotal	4,932	4,656	14,279	14,432
Fixed maturity securities
Net Investment Income [Line Items]
Subtotal	3,583	3,525	10,801	10,738
Equity securities
Net Investment Income [Line Items]
Subtotal	35	36	105	102
Actively traded securities and FVO general account securities
Net Investment Income [Line Items]
Subtotal	25	(35)	41	4
Mortgage loans
Net Investment Income [Line Items]
Subtotal	806	786	2,464	2,317
Policy loans
Net Investment Income [Line Items]
Subtotal	148	147	444	450
Real estate and real estate joint ventures
Net Investment Income [Line Items]
Subtotal	210	233	516	767
Other limited partnership interests
Net Investment Income [Line Items]
Subtotal	263	216	429	681
Cash, cash equivalents and short-term investments
Net Investment Income [Line Items]
Subtotal	43	29	126	101
Operating joint ventures
Net Investment Income [Line Items]
Subtotal	5	(1)	28	15
Other
Net Investment Income [Line Items]
Subtotal	95	28	187	180
Consolidated Securitization Entities And Fair Value Option Contractholder-Directed Unit-Linked
Net Investment Income [Line Items]
Subtotal	532	(697)	631	(65)
FVO contractholder-directed unit-linked investments
Net Investment Income [Line Items]
Subtotal	529	(701)	623	(79)
Commercial mortgage loans | Consolidated Securitization Entities
Net Investment Income [Line Items]
Subtotal	3	4	8	13
Securities | Consolidated Securitization Entities
Net Investment Income [Line Items]
Subtotal	$ 0	$ 0	$ 0	$ 1

XML

Investments (Components of Net Investment Gains Losses) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Marketable Securities, Gain (Loss) [Abstract]
Fixed maturity securities — net gains (losses) on sales and disposals	$ 176	$ 115	$ 439	$ 383
Equity securities — net gains (losses) on sales and disposals	13	14	32	39
Other net investment gains (losses):
Mortgage loans	(31)	(26)	(193)	(78)
Real estate and real estate joint ventures	(14)	263	33	257
Other limited partnership interests	(9)	(59)	(50)	(52)
Other	(19)	18	(94)	14
Subtotal	97	291	(11)	500
FVO CSEs - changes in estimated fair value subsequent to consolidation:
Commercial mortgage loans	(3)	(4)	(3)	(6)
Securities	1	0	2	0
Long-term debt — related to commercial mortgage loans	1	1	1	3
Non-investment portfolio gains (losses) (1)	161	94	549	38
Subtotal	160	91	549	35
Total net investment gains (losses)	257	382	538	535
Fixed Maturity Securities
Marketable Securities, Gain (Loss) [Abstract]
Total OTTI losses recognized in earnings	(14)	(27)	(106)	(47)
Net investment gains (losses)	162	88	333	336
Consumer
Marketable Securities, Gain (Loss) [Abstract]
Total OTTI losses recognized in earnings	0	(17)	0	(20)
Industrial
Marketable Securities, Gain (Loss) [Abstract]
Total OTTI losses recognized in earnings	0	(3)	(79)	(5)
Communications
Marketable Securities, Gain (Loss) [Abstract]
Total OTTI losses recognized in earnings	0	0	(3)	0
U.S. corporate and foreign corporate securities
Marketable Securities, Gain (Loss) [Abstract]
Total OTTI losses recognized in earnings	0	(20)	(82)	(25)
RMBS
Marketable Securities, Gain (Loss) [Abstract]
Total OTTI losses recognized in earnings	(14)	(1)	(22)	(16)
ABS
Marketable Securities, Gain (Loss) [Abstract]
Total OTTI losses recognized in earnings	0	0	(2)	0
State and political subdivision
Marketable Securities, Gain (Loss) [Abstract]
Total OTTI losses recognized in earnings	0	(6)	0	(6)
Equity securities
Marketable Securities, Gain (Loss) [Abstract]
Total OTTI losses recognized in earnings	(5)	(7)	(72)	(16)
Net investment gains (losses)	8	7	(40)	23
Nonredeemable Preferred Stock [Member]
Marketable Securities, Gain (Loss) [Abstract]
Total OTTI losses recognized in earnings	0	(1)	0	(1)
Common Stock
Marketable Securities, Gain (Loss) [Abstract]
Total OTTI losses recognized in earnings	$ (5)	$ (6)	$ (72)	$ (15)

XML

Investments (Sales or Disposals and Impairments of Fixed Maturity and Equity Securities) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Fixed Maturity Securities
Components of Sales or Disposals of Fixed Maturity and Equity Securities
Proceeds	$ 25,091	$ 27,264	$ 83,352	$ 86,590
Gross investment gains	310	371	1,025	1,047
Gross investment losses	(134)	(256)	(586)	(664)
Total OTTI losses recognized in earnings:
Total OTTI losses recognized in earnings	(14)	(27)	(106)	(47)
Net investment gains (losses)	162	88	333	336
Equity securities
Components of Sales or Disposals of Fixed Maturity and Equity Securities
Proceeds	64	55	151	211
Gross investment gains	15	20	40	54
Gross investment losses	(2)	(6)	(8)	(15)
Total OTTI losses recognized in earnings:
Total OTTI losses recognized in earnings	(5)	(7)	(72)	(16)
Net investment gains (losses)	$ 8	$ 7	$ (40)	$ 23

XML

Investments (Credit Loss Rollforward) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Roll Forward]
Balance, beginning of period	$ 258	$ 280	$ 277	$ 357
Additions:
Initial impairments — credit loss OTTI on securities not previously impaired	1	0	1	2
Additional impairments — credit loss OTTI on securities previously impaired	10	1	18	14
Reductions:
Sales (maturities, pay downs or prepayments) of securities previously impaired as credit loss OTTI	(17)	(22)	(43)	(113)
Securities impaired to net present value of expected future cash flows	0	0	(1)	0
Increase in cash flows — accretion of previous credit loss OTTI	0	(1)	0	(2)
Balance, end of period	$ 252	$ 258	$ 252	$ 258

XML

Investments (Fixed Maturity and Equity Securities Available-For-Sale - Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015	Dec. 31, 2014
Summary of Certain Fixed Maturity Securities
Gross Unrealized OTTI Loss	$ 13	$ 76	$ 112
Available-for-sale Securities, Debt Securities	390,442	351,402
CMBS
Summary of Certain Fixed Maturity Securities
Gross Unrealized OTTI Loss	1	1
Available-for-sale Securities, Debt Securities	12,441	12,633
Non-income producing fixed maturity securities
Summary of Certain Fixed Maturity Securities
Available-for-sale Securities, Debt Securities	44	54
Gross Unrealized Gain	$ (5)	$ 12

XML

Investments (Evaluation of Available-For-Sale Securities for OTTI and Evaluating Temporarily Impaired AFS Securities - Narrative) (Details) $ in Millions	9 Months Ended
	Sep. 30, 2016 USD ($) Contracts	Dec. 31, 2015 USD ($)
Schedule of Available-for-sale Securities [Line Items]
Equity securities available-for-sale with gross unrealized loss of equal to or greater than stated percentage	20.00%
Fixed Maturity Securities
Schedule of Available-for-sale Securities [Line Items]
Change in Gross Unrealized Temporary Loss	$ (2,600)
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	2,800
Gross Unrealized Temporary Loss	1,757	$ 1,970
Equity securities
Schedule of Available-for-sale Securities [Line Items]
Change in Gross Unrealized Temporary Loss	(97)
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	61
Gross Unrealized Temporary Loss	44	51
Non-redeemable preferred stock
Schedule of Available-for-sale Securities [Line Items]
Gross Unrealized Temporary Loss	44	$ 49
20% or more | Six months or greater | Fixed Maturity Securities
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	$ 321
Number of Securities | Contracts	74
20% or more | Six months or greater | Fixed Maturity Securities | Investment Grade
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	$ 199
Number of Securities | Contracts	35
Percentage of gross unrealized loss	62.00%
20% or more | Six months or greater | Fixed Maturity Securities | Below Investment Grade
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	$ 122
Number of Securities | Contracts	39
Percentage of gross unrealized loss	38.00%
20% or more | Twelve months or greater | Equity securities
Schedule of Available-for-sale Securities [Line Items]
Number of Securities | Contracts	6
Gross Unrealized Temporary Loss	$ 38
20% or more | Twelve months or greater | Non-redeemable preferred stock | Aaa/Aa/A | Financial Services Industry
Schedule of Available-for-sale Securities [Line Items]
Percentage of gross unrealized loss	61.00%

XML

Investments (Mortgage Loans - Narrative) (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016 USD ($)	Sep. 30, 2015 USD ($)	Sep. 30, 2016 USD ($)	Sep. 30, 2015 USD ($)	Dec. 31, 2015 USD ($)
Mortgage Loans on Real Estate [Line Items]
Financing Receivable, Significant Purchases	$ 856	$ 1,000	$ 2,300	$ 3,200
Percentage of Mortgage Loans Classified as Performing	99.00%		99.00%		99.00%
Financing Receivable, Modifications, Subsequent Default, Number of Contracts	0	0	0	0
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Provision for Loan Losses			$ 143
Commercial
Mortgage Loans on Real Estate [Line Items]
Impaired Financing Receivable, Average Recorded Investment	$ 90	$ 118	109	$ 144
Agricultural
Mortgage Loans on Real Estate [Line Items]
Impaired Financing Receivable, Average Recorded Investment	52	62	56	62
Estimated fair value of mortgage loans held-for-investment	14,600		14,600		$ 13,500
Residential
Mortgage Loans on Real Estate [Line Items]
Impaired Financing Receivable, Average Recorded Investment	202	$ 96	174	$ 72
Estimated fair value of mortgage loans held-for-investment	$ 11,400		$ 11,400		$ 9,900

XML

Investments (Cash Equivalents - Narrative) (Details) - USD ($) $ in Billions	Sep. 30, 2016	Dec. 31, 2015
Investments, Debt and Equity Securities [Abstract]
Cash equivalents	$ 7.3	$ 7.5

XML

Investments (Concentrations of Credit Risk - Narrative) (Details) - USD ($) $ in Billions	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Securities holdings exposure in single issuer greater than stated percentage of Company's equity	10.00%	10.00%
Foreign government | Japan
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Government and agency fixed maturity securities	$ 29.4	$ 20.9
Fixed maturity and equity securities | Japan
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Government and agency fixed maturity securities	$ 33.8	$ 25.4

XML

Investments (Securities Lending - Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Amortized cost
Securities Financing Transaction [Line Items]
Securities Loaned	$ 26,855	$ 27,223
Estimated fair value
Securities Financing Transaction [Line Items]
Securities Loaned	31,326	$ 29,646
Reserve for Off-balance Sheet Activities | Amortized cost
Securities Financing Transaction [Line Items]
Securities Loaned	114
Reserve for Off-balance Sheet Activities | Estimated fair value
Securities Financing Transaction [Line Items]
Securities Loaned	$ 114

XML

Investments (Securities Lending Remaining Tenor - Narrative) (Details) - Estimated fair value $ in Billions	Sep. 30, 2016 USD ($)
Securities Financing Transaction [Line Items]
Cash collateral on deposit from counterparties	$ 8.1
Securities Investment
Securities Financing Transaction [Line Items]
Percentage of Reinvestment Portfolio in Fixed Maturity Securities	65.00%
Minimum | U.S. government and agency
Securities Financing Transaction [Line Items]
Percentage Of US Treasury And Agency Securities At Estimated Fair Value Of Securities On Loan Relating To Cash Collateral On Open	99.00%

XML

Investments (Repurchase Agreement - Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Offsetting Assets [Line Items]
Fair Value of Securities Received as Collateral that Have Been Resold or Repledged	$ 114
Receivable Under Reverse Repurchase Agreements	300
Payable Under Repurchase Agreements	300
Amount Offset in Balance Sheet	300
Maximum
Offsetting Assets [Line Items]
Net Amount Assets (Liabilities) From Repurchase, Reverse Repurchase Agreements	1
Corporate fixed maturity securities
Offsetting Assets [Line Items]
Payable Under Repurchase Agreements	$ 300
Fixed Maturity Securities
Offsetting Assets [Line Items]
Percentage of Estimated Fair Value of Borrowed Securities at Inception Based on Pledged Cash Collateral	98.00%
Securities Loaned, Not Subject to Master Netting Arrangement	$ 316	$ 0
Securities Borrowed, Not Subject to Master Netting Arrangement	$ 306	$ 0
Fixed Maturity Securities | Minimum
Offsetting Assets [Line Items]
Percentage of Estimated Fair Value of Securities Loaned at Inception Based on Collateral Obtained	95.00%
Percentage of Estimated Fair Value of Securities Loaned at Inception Based on Cash Collateral Received	85.00%
Fixed Maturity Securities | Maximum
Offsetting Assets [Line Items]
Percentage of Estimated Fair Value of Securities Loaned at Inception Based on Cash Collateral Received	100.00%

XML

Investments (Variable Interest Entities - Narrative) (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Variable Interest Entity [Line Items]
Tax credits guaranteed by third parties that reduce maximum exposure to loss related to other invested assets	$ 151		$ 179
Variable Interest Entity, Financial or Other Support, Amount	0	$ 0
Consolidated Entities
Variable Interest Entity [Line Items]
Variable interest, maximum exposure to loss in consolidated securitization entities	$ 98		$ 105

XML

Investments (Net Investment Income - Narrative) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Net Investment Income [Line Items]
Fair Value Option And Trading Securities	$ 14,730,000,000		$ 14,730,000,000		$ 15,024,000,000
FVO contractholder-directed unit-linked investments
Net Investment Income [Line Items]
Changes in estimated fair value included in net investment income	407,000,000	$ (872,000,000)	283,000,000	$ (645,000,000)
Actively Traded Securities At Estimated Fair Value And Fvo General Account Securities [Member]
Net Investment Income [Line Items]
Fair Value Option And Trading Securities	$ 0		$ 0

XML

Investments (Net Investment Gains Losses - Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gains (losses) from foreign currency transactions	$ 69	$ 53	$ 437	$ (29)
Investments Sold [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Investment portfolio gains (losses)	$ 103		$ 103

XML

Derivatives (Primary Risks) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Derivatives, Fair Value [Line Items]
Gross Notional Amount	$ 414,040	$ 404,844
Estimated Fair Value Assets	21,788	14,406
Estimated Fair Value Liabilities	8,352	7,049
Derivatives Designated as Hedging Instruments:
Derivatives, Fair Value [Line Items]
Gross Notional Amount	49,873	46,808
Estimated Fair Value Assets	6,005	4,358
Estimated Fair Value Liabilities	2,143	2,074
Derivatives Designated as Hedging Instruments: | Fair Value Hedges [Member]
Derivatives, Fair Value [Line Items]
Gross Notional Amount	8,089	9,367
Estimated Fair Value Assets	3,048	2,277
Estimated Fair Value Liabilities	170	223
Derivatives Designated as Hedging Instruments: | Fair Value Hedges [Member] | Interest rate swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	5,383	5,528
Estimated Fair Value Assets	2,824	2,215
Estimated Fair Value Liabilities	14	12
Derivatives Designated as Hedging Instruments: | Fair Value Hedges [Member] | Foreign currency swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	1,221	2,154
Estimated Fair Value Assets	28	62
Estimated Fair Value Liabilities	156	159
Derivatives Designated as Hedging Instruments: | Fair Value Hedges [Member] | Foreign currency forwards
Derivatives, Fair Value [Line Items]
Gross Notional Amount	1,485	1,685
Estimated Fair Value Assets	196	0
Estimated Fair Value Liabilities	0	52
Derivatives Designated as Hedging Instruments: | Cash Flow Hedges [Member]
Derivatives, Fair Value [Line Items]
Gross Notional Amount	31,485	25,956
Estimated Fair Value Assets	2,933	1,813
Estimated Fair Value Liabilities	1,694	1,803
Derivatives Designated as Hedging Instruments: | Cash Flow Hedges [Member] | Interest rate swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	2,251	2,190
Estimated Fair Value Assets	672	487
Estimated Fair Value Liabilities	0	0
Derivatives Designated as Hedging Instruments: | Cash Flow Hedges [Member] | Interest rate forwards
Derivatives, Fair Value [Line Items]
Gross Notional Amount	2,032	105
Estimated Fair Value Assets	49	23
Estimated Fair Value Liabilities	10	0
Derivatives Designated as Hedging Instruments: | Cash Flow Hedges [Member] | Foreign currency swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	27,202	23,661
Estimated Fair Value Assets	2,212	1,303
Estimated Fair Value Liabilities	1,684	1,803
Derivatives Designated as Hedging Instruments: | Foreign Operations Hedges [Member]
Derivatives, Fair Value [Line Items]
Gross Notional Amount	10,299	11,485
Estimated Fair Value Assets	24	268
Estimated Fair Value Liabilities	279	48
Derivatives Designated as Hedging Instruments: | Foreign Operations Hedges [Member] | Foreign currency forwards
Derivatives, Fair Value [Line Items]
Gross Notional Amount	1,087	3,916
Estimated Fair Value Assets	6	63
Estimated Fair Value Liabilities	53	12
Derivatives Designated as Hedging Instruments: | Foreign Operations Hedges [Member] | Currency options
Derivatives, Fair Value [Line Items]
Gross Notional Amount	9,212	7,569
Estimated Fair Value Assets	18	205
Estimated Fair Value Liabilities	226	36
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Derivatives, Fair Value [Line Items]
Gross Notional Amount	364,167	358,036
Estimated Fair Value Assets	15,783	10,048
Estimated Fair Value Liabilities	6,209	4,975
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Interest rate swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	82,791	89,336
Estimated Fair Value Assets	9,586	5,111
Estimated Fair Value Liabilities	3,033	2,247
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Interest rate forwards
Derivatives, Fair Value [Line Items]
Gross Notional Amount	171	43
Estimated Fair Value Assets	16	1
Estimated Fair Value Liabilities	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Interest rate floors
Derivatives, Fair Value [Line Items]
Gross Notional Amount	15,201	23,837
Estimated Fair Value Assets	350	311
Estimated Fair Value Liabilities	34	48
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Interest rate caps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	79,030	68,928
Estimated Fair Value Assets	35	105
Estimated Fair Value Liabilities	3	3
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Interest rate futures
Derivatives, Fair Value [Line Items]
Gross Notional Amount	9,110	5,808
Estimated Fair Value Assets	4	4
Estimated Fair Value Liabilities	41	7
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Interest rate options
Derivatives, Fair Value [Line Items]
Gross Notional Amount	21,383	30,234
Estimated Fair Value Assets	1,790	1,177
Estimated Fair Value Liabilities	1	30
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Equity total return swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	5,925	0
Estimated Fair Value Assets	106	0
Estimated Fair Value Liabilities	36	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Synthetic GICs
Derivatives, Fair Value [Line Items]
Gross Notional Amount	5,328	4,216
Estimated Fair Value Assets	0	0
Estimated Fair Value Liabilities	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Foreign currency swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	12,790	11,081
Estimated Fair Value Assets	1,183	766
Estimated Fair Value Liabilities	467	431
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Foreign currency forwards
Derivatives, Fair Value [Line Items]
Gross Notional Amount	17,371	11,724
Estimated Fair Value Assets	584	154
Estimated Fair Value Liabilities	250	220
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Currency futures
Derivatives, Fair Value [Line Items]
Gross Notional Amount	1,060	930
Estimated Fair Value Assets	0	0
Estimated Fair Value Liabilities	2	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Currency options
Derivatives, Fair Value [Line Items]
Gross Notional Amount	4,780	9,590
Estimated Fair Value Assets	204	466
Estimated Fair Value Liabilities	11	189
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Credit default swaps — purchased
Derivatives, Fair Value [Line Items]
Gross Notional Amount	2,038	1,870
Estimated Fair Value Assets	10	28
Estimated Fair Value Liabilities	44	34
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Credit default swaps — written
Derivatives, Fair Value [Line Items]
Gross Notional Amount	11,664	10,311
Estimated Fair Value Assets	150	78
Estimated Fair Value Liabilities	10	13
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Equity futures
Derivatives, Fair Value [Line Items]
Gross Notional Amount	12,886	7,206
Estimated Fair Value Assets	13	63
Estimated Fair Value Liabilities	68	18
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Equity index options
Derivatives, Fair Value [Line Items]
Gross Notional Amount	53,911	55,682
Estimated Fair Value Assets	1,519	1,542
Estimated Fair Value Liabilities	1,362	1,041
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Equity variance swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	23,658	23,437
Estimated Fair Value Assets	228	195
Estimated Fair Value Liabilities	745	636
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Equity total return swaps
Derivatives, Fair Value [Line Items]
Gross Notional Amount	5,070	3,803
Estimated Fair Value Assets	5	47
Estimated Fair Value Liabilities	$ 102	$ 58

XML

Derivatives (Net Derivative Gains Losses) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Components of Net Derivatives Gains (Losses)
Derivatives and hedging gains (losses)	$ (1,852)	$ 2,318	$ 3,177	$ 1,433
Embedded derivatives gains (losses)	801	(1,833)	(4,992)	(1,039)
Total net derivative gains (losses)	$ (1,051)	$ 485	$ (1,815)	$ 394

XML

Derivatives (Earned Income On Derivatives) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Derivative Instruments, Gain (Loss) [Line Items]
Interest Income (Expense), Nonoperating, Net	$ 391	$ 318	$ 1,063	$ 941
Derivatives Designated as Hedging Instruments: | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Interest Income (Expense), Nonoperating, Net	76	55	206	158
Derivatives Designated as Hedging Instruments: | Interest credited to policyholder account balances
Derivative Instruments, Gain (Loss) [Line Items]
Interest Income (Expense), Nonoperating, Net	0	6	7	21
Derivatives Designated as Hedging Instruments: | Other expenses
Derivative Instruments, Gain (Loss) [Line Items]
Interest Income (Expense), Nonoperating, Net	(3)	(2)	(9)	(4)
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Interest Income (Expense), Nonoperating, Net	0	(1)	(1)	(3)
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Net derivative gains (losses)
Derivative Instruments, Gain (Loss) [Line Items]
Interest Income (Expense), Nonoperating, Net	312	256	843	757
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Policyholder benefits and claims
Derivative Instruments, Gain (Loss) [Line Items]
Interest Income (Expense), Nonoperating, Net	$ 6	$ 4	$ 17	$ 12

XML

Derivatives (Gains Losses Recognized in Income Not Designated or Qualifying) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	$ (20)	$ 293	$ 768	$ (107)
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Net derivative gains (losses)
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	(2,109)	2,207	2,949	693
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Net derivative gains (losses) | Interest rate derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	(1,082)	1,157	2,547	250
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Net derivative gains (losses) | Foreign currency exchange rate derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	146	364	1,865	443
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Net derivative gains (losses) | Credit derivatives — purchased
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	(21)	16	(48)	9
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Net derivative gains (losses) | Credit derivatives — written
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	60	(77)	57	(108)
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Net derivative gains (losses) | Equity derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	(1,212)	747	(1,472)	99
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	(5)	1	(19)	(5)
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Net investment income | Interest rate derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	0	0	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Net investment income | Foreign currency exchange rate derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	0	0	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Net investment income | Credit derivatives — purchased
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	0	3	0	3
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Net investment income | Credit derivatives — written
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	0	(1)	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Net investment income | Equity derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	(5)	(1)	(19)	(8)
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Policyholder benefits and claims
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	(246)	357	(194)	224
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Policyholder benefits and claims | Interest rate derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	19	17	116	10
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Policyholder benefits and claims | Foreign currency exchange rate derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	(5)	0	(17)	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Policyholder benefits and claims | Credit derivatives — purchased
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	0	0	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Policyholder benefits and claims | Credit derivatives — written
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	0	0	0	0
Derivatives Not Designated or Not Qualifying as Hedging Instruments: | Policyholder benefits and claims | Equity derivatives
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	$ (260)	$ 340	$ (293)	$ 214

XML

Derivatives (Fair Value Hedges) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivative Gains (Losses) Recognized for Derivatives	$ (20)	$ 293	$ 768	$ (107)
Net Derivative Gains (Losses) Recognized for Hedged Items	18	(289)	(760)	100
Ineffectiveness Recognized in Net Derivative Gains (Losses)	(2)	4	8	(7)
Interest rate swaps | Fixed Maturity Securities
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivative Gains (Losses) Recognized for Derivatives	6	(4)	(5)	(5)
Net Derivative Gains (Losses) Recognized for Hedged Items	(5)	3	2	8
Ineffectiveness Recognized in Net Derivative Gains (Losses)	1	(1)	(3)	3
Interest rate swaps | Policyholder account balances [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivative Gains (Losses) Recognized for Derivatives	(45)	289	498	120
Net Derivative Gains (Losses) Recognized for Hedged Items	41	(290)	(507)	(126)
Ineffectiveness Recognized in Net Derivative Gains (Losses)	(4)	(1)	(9)	(6)
Foreign currency swaps | Foreign-denominated fixed maturity securities
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivative Gains (Losses) Recognized for Derivatives	1	6	7	13
Net Derivative Gains (Losses) Recognized for Hedged Items	(1)	(3)	(7)	(6)
Ineffectiveness Recognized in Net Derivative Gains (Losses)	0	3	0	7
Foreign currency swaps | Foreign-denominated policyholder account balances [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivative Gains (Losses) Recognized for Derivatives	(1)	(47)	(27)	(186)
Net Derivative Gains (Losses) Recognized for Hedged Items	1	46	24	179
Ineffectiveness Recognized in Net Derivative Gains (Losses)	0	(1)	(3)	(7)
Foreign currency forwards | Foreign-denominated fixed maturity securities
Derivative Instruments, Gain (Loss) [Line Items]
Net Derivative Gains (Losses) Recognized for Derivatives	19	49	295	(49)
Net Derivative Gains (Losses) Recognized for Hedged Items	(18)	(45)	(272)	45
Ineffectiveness Recognized in Net Derivative Gains (Losses)	$ 1	$ 4	$ 23	$ (4)

XML

Derivatives (Cash Flow Hedges) (Details) - Cash Flow Hedges [Member] - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Derivatives in cash flow hedging relationships
Amount of Gains (Losses) Deferred in AOCI (Effective Portion)	$ (24)	$ 102	$ 1,472	$ (106)
Interest rate swaps
Derivatives in cash flow hedging relationships
Amount of Gains (Losses) Deferred in AOCI (Effective Portion)	23	211	376	116
Foreign currency swaps
Derivatives in cash flow hedging relationships
Amount of Gains (Losses) Deferred in AOCI (Effective Portion)	(42)	(116)	1,054	(224)
Credit forwards [Member]
Derivatives in cash flow hedging relationships
Amount of Gains (Losses) Deferred in AOCI (Effective Portion)	0	0	0	0
Interest rate forwards
Derivatives in cash flow hedging relationships
Amount of Gains (Losses) Deferred in AOCI (Effective Portion)	(5)	7	42	2
Net derivative gains (losses)
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	88	(244)	157	(505)
Amount and Location of Gains (Losses) Recognized In Income (Loss) on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)	(3)	5	(1)	9
Net derivative gains (losses) | Interest rate swaps
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	28	40	56	52
Amount and Location of Gains (Losses) Recognized In Income (Loss) on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	1	0	3
Net derivative gains (losses) | Foreign currency swaps
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	59	(286)	96	(563)
Amount and Location of Gains (Losses) Recognized In Income (Loss) on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)	(3)	4	(1)	6
Net derivative gains (losses) | Credit forwards [Member]
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	0	1	3	1
Amount and Location of Gains (Losses) Recognized In Income (Loss) on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	0	0	0
Net derivative gains (losses) | Interest rate forwards
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	1	1	2	5
Amount and Location of Gains (Losses) Recognized In Income (Loss) on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	0	0	0
Net Investment Income
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	6	4	15	12
Net Investment Income | Interest rate swaps
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	4	3	11	9
Net Investment Income | Foreign currency swaps
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	0	0	(1)	(1)
Net Investment Income | Credit forwards [Member]
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	1	0	1	1
Net Investment Income | Interest rate forwards
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	1	1	4	3
Other expenses
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	0	1	2	3
Other expenses | Interest rate swaps
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	0	0	0	0
Other expenses | Foreign currency swaps
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	0	0	1	1
Other expenses | Credit forwards [Member]
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	0	0	0	0
Other expenses | Interest rate forwards
Derivatives in cash flow hedging relationships
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	$ 0	$ 1	$ 1	$ 2

XML

Derivatives (Hedges of Net Investments in Foreign Operations) (Details) - Foreign Operations Hedges [Member] - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gains (Losses) Deferred in AOCI (Effective Portion)	$ (60)	$ 70	$ (709)	$ 183
Foreign currency forwards
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gains (Losses) Deferred in AOCI (Effective Portion)	(23)	88	(358)	244
Currency options
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gains (Losses) Deferred in AOCI (Effective Portion)	$ (37)	$ (18)	$ (351)	$ (61)

XML

Derivatives (Credit Derivatives) (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 140	$ 65
Maximum Amount of Future Payments under Credit Default Swaps	$ 11,664	$ 10,311
Weighted Average Years to Maturity	4 years 6 months	4 years 1 month
Aaa/Aa/A
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 28	$ 12
Maximum Amount of Future Payments under Credit Default Swaps	$ 2,420	$ 2,296
Weighted Average Years to Maturity	3 years 6 months	3 years 2 months
Aaa/Aa/A | Single name credit default swaps (corporate)
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 7	$ 6
Maximum Amount of Future Payments under Credit Default Swaps	$ 483	$ 661
Weighted Average Years to Maturity	3 years 4 months	2 years 6 months
Aaa/Aa/A | Credit default swaps referencing indices
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 21	$ 6
Maximum Amount of Future Payments under Credit Default Swaps	$ 1,937	$ 1,635
Weighted Average Years to Maturity	3 years 6 months	3 years 5 months
Baa
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 105	$ 45
Maximum Amount of Future Payments under Credit Default Swaps	$ 8,863	$ 7,212
Weighted Average Years to Maturity	4 years 10 months	4 years 5 months
Baa | Single name credit default swaps (corporate)
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 8	$ 8
Maximum Amount of Future Payments under Credit Default Swaps	$ 946	$ 1,349
Weighted Average Years to Maturity	2 years 7 months	2 years 6 months
Baa | Credit default swaps referencing indices
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 97	$ 37
Maximum Amount of Future Payments under Credit Default Swaps	$ 7,917	$ 5,863
Weighted Average Years to Maturity	5 years 1 month	4 years 10 months
Ba
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ (5)	$ (3)
Maximum Amount of Future Payments under Credit Default Swaps	$ 155	$ 164
Weighted Average Years to Maturity	4 years 4 months	1 year 6 months
Ba | Single name credit default swaps (corporate)
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ (5)	$ (2)
Maximum Amount of Future Payments under Credit Default Swaps	$ 155	$ 64
Weighted Average Years to Maturity	4 years 4 months	2 years 4 months
Ba | Credit default swaps referencing indices
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 0	$ (1)
Maximum Amount of Future Payments under Credit Default Swaps	$ 0	$ 100
Weighted Average Years to Maturity	0 years	1 year
B
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 12	$ 11
Maximum Amount of Future Payments under Credit Default Swaps	$ 226	$ 639
Weighted Average Years to Maturity	4 years 4 months	4 years 11 months
B | Single name credit default swaps (corporate)
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 1	$ 0
Maximum Amount of Future Payments under Credit Default Swaps	$ 70	$ 0
Weighted Average Years to Maturity	2 years 1 month	0 years
B | Credit default swaps referencing indices
Credit Derivatives [Line Items]
Estimated Fair Value of Credit Default Swaps	$ 11	$ 11
Maximum Amount of Future Payments under Credit Default Swaps	$ 156	$ 639
Weighted Average Years to Maturity	5 years 4 months	4 years 11 months

XML

Derivatives (Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Offsetting Assets [Line Items]
Gross estimated fair value of derivative assets	$ 22,121	$ 14,684
Gross estimated fair value of derivative liabilities	8,341	7,090
Amounts offset in the consolidated balance sheet, Assets	0	0
Amounts offset in the consolidated balance sheet, Liabilities	0	0
Estimated fair value of derivative assets presented in the consolidated balance sheets	22,121	14,684
Estimated fair value of derivative liabilities presented in the consolidated balance sheets	8,341	7,090
Net amount of derivative assets after application of master netting agreements and cash collateral	617	519
Net amount of derivative liabilities after application of master netting agreements and cash collateral	62	86
Over the Counter [Member]
Offsetting Assets [Line Items]
Gross estimated fair value of derivative assets	18,154	13,017
Gross estimated fair value of derivative liabilities	6,603	5,848
Gross estimated fair value of derivative assets	(4,984)	(4,368)
Gross estimated fair value of derivative liabilities	(4,984)	(4,368)
Cash collateral on derivative assets	(9,606)	(6,140)
Cash collateral on derivative liabilities	0	(7)
Securities collateral on derivative assets	(3,199)	(2,078)
Securities collateral on derivative liabilities	(1,577)	(1,395)
Cleared [Member]
Offsetting Assets [Line Items]
Gross estimated fair value of derivative assets	3,949	1,600
Gross estimated fair value of derivative liabilities	1,627	1,217
Gross estimated fair value of derivative assets	(1,609)	(1,200)
Gross estimated fair value of derivative liabilities	(1,609)	(1,200)
Cash collateral on derivative assets	(2,101)	(378)
Cash collateral on derivative liabilities	0	(10)
Securities collateral on derivative assets	0	0
Securities collateral on derivative liabilities	0	0
Exchange-traded
Offsetting Assets [Line Items]
Gross estimated fair value of derivative assets	18	67
Gross estimated fair value of derivative liabilities	111	25
Gross estimated fair value of derivative assets	(5)	(1)
Gross estimated fair value of derivative liabilities	(5)	(1)
Cash collateral on derivative assets	0	0
Cash collateral on derivative liabilities	(9)	(20)
Securities collateral on derivative assets	0	0
Securities collateral on derivative liabilities	$ (95)	$ (3)

XML

Derivatives (Credit Risk on Freestanding Derivatives) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Credit Derivatives [Line Items]
Estimated Fair Value of Derivatives in a Net Liability Position (1)	$ 1,618	$ 1,477
Estimated Fair Value Of Incremental Collateral Provided Upon A One Notch Downgrade In The Company's Credit Rating	2	1
Estimated Fair Value Of Incremental Collateral Provided Upon A Downgrade In The Company's Credit Rating to a Level that Triggers Full Overnight Collateralization or Termination of the Derivative Position	2	1
Fixed maturity securities
Credit Derivatives [Line Items]
Estimated Fair Value of Collateral Provided:	1,757	1,539
Cash
Credit Derivatives [Line Items]
Estimated Fair Value of Collateral Provided:	0	8
Derivatives Subject to Credit- Contingent Provisions
Credit Derivatives [Line Items]
Estimated Fair Value of Derivatives in a Net Liability Position (1)	1,606	1,270
Estimated Fair Value Of Incremental Collateral Provided Upon A One Notch Downgrade In The Company's Credit Rating	2	1
Estimated Fair Value Of Incremental Collateral Provided Upon A Downgrade In The Company's Credit Rating to a Level that Triggers Full Overnight Collateralization or Termination of the Derivative Position	2	1
Derivatives Subject to Credit- Contingent Provisions | Fixed maturity securities
Credit Derivatives [Line Items]
Estimated Fair Value of Collateral Provided:	1,737	1,365
Derivatives Subject to Credit- Contingent Provisions | Cash
Credit Derivatives [Line Items]
Estimated Fair Value of Collateral Provided:	0	4
Derivatives Not Subject to Credit- Contingent Provisions
Credit Derivatives [Line Items]
Estimated Fair Value of Derivatives in a Net Liability Position (1)	12	207
Estimated Fair Value Of Incremental Collateral Provided Upon A One Notch Downgrade In The Company's Credit Rating	0	0
Estimated Fair Value Of Incremental Collateral Provided Upon A Downgrade In The Company's Credit Rating to a Level that Triggers Full Overnight Collateralization or Termination of the Derivative Position	0	0
Derivatives Not Subject to Credit- Contingent Provisions | Fixed maturity securities
Credit Derivatives [Line Items]
Estimated Fair Value of Collateral Provided:	20	174
Derivatives Not Subject to Credit- Contingent Provisions | Cash
Credit Derivatives [Line Items]
Estimated Fair Value of Collateral Provided:	$ 0	$ 4

XML

Derivatives (Embedded Derivatives) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Net embedded derivatives within asset host contracts	$ 338	$ 171
Net embedded derivatives within liability host contracts	6,883	935
Ceded guaranteed minimum benefits | Premiums, reinsurance and other receivables
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Net embedded derivatives within asset host contracts	514	356
Direct guaranteed minimum benefits | Policyholder account balances [Member]
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Net embedded derivatives within liability host contracts	5,000	(20)
Funds withheld on assumed reinsurance | Other invested assets
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Net embedded derivatives within asset host contracts	64	35
Assumed guaranteed minimum benefits | Policyholder account balances [Member]
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Net embedded derivatives within liability host contracts	1,706	965
Funds withheld on ceded reinsurance | Other liabilities
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Net embedded derivatives within liability host contracts	79	(14)
Other | Policyholder account balances [Member]
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Net embedded derivatives within liability host contracts	98	4
Options embedded in debt or equity securities [Member] | Investments
Embedded Derivative, Fair Value of Embedded Derivative, Net [Abstract]
Net embedded derivatives within asset host contracts	$ (240)	$ (220)

XML

Derivatives (Changes in Estimated Fair Value Related to Embedded Derivatives) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Derivative Instruments, Gain (Loss) [Line Items]
Net derivatives gains (losses)	$ 801	$ (1,833)	$ (4,992)	$ (1,039)
Net derivative gains (losses)
Derivative Instruments, Gain (Loss) [Line Items]
Net derivatives gains (losses)	801	(1,833)	(4,992)	(1,039)
Policyholder benefits and claims
Derivative Instruments, Gain (Loss) [Line Items]
Net derivatives gains (losses)	$ (14)	$ 59	$ 91	$ 40

XML

Derivatives (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Derivatives, Fair Value [Line Items]
Estimated Fair Value Assets	$ 21,788		$ 21,788		$ 14,406
Estimated Fair Value Liabilities	8,352		8,352		7,049
Maximum Amount of Future Payments under Credit Default Swaps	11,664		11,664		10,311
Estimated Fair Value of Credit Default Swaps	140		140		65
Excess securities collateral received on derivatives	554		554		$ 89
Derivative Instruments, Gain (Loss) [Line Items]
Net derivatives gains (losses)	801	$ (1,833)	$ (4,992)	$ (1,039)
Derivative, Average Remaining Maturity			4 years 6 months		4 years 1 month
Derivative Instrument Detail [Abstract]
Net amounts reclassified into net derivatives gains (losses) on discontinued cash flow hedges	12	(3)	$ 7	0
Hedging exposure to variability in future cash flows for specific length of time			6 years		5 years
Accumulated Other Comprehensive Income Loss	3,600		$ 3,600		$ 2,400
Deferred net gains (losses) expected to be reclassified to earnings			(64)
Amount and Location of Gains (Losses) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income (Loss) (Effective Portion)	$ 0	$ 0	$ 0	$ 0
Immateriality of cash flow effectiveness	0	0	0	0
Cumulative foreign currency translation gain (loss) recorded in accumulated other comprehensive income (loss) for net investment in foreign operations hedges	$ 347		$ 347		1,100
Potential future recoveries available to offset maximum amount of future payments under credit default swaps	30		30		80
Excess securities collateral provided on derivatives	432		432		204
Change in fair value of derivatives excluded from the assessment of hedge effectiveness	(6)	$ (4)	(16)	$ (9)
Securities collateral received which the company is permitted to sell or repledge, amount that has been sold or repledged	0		0
Over the Counter [Member]
Derivatives, Fair Value [Line Items]
Cash collateral on derivative assets	(9,606)		(9,606)		(6,140)
Excess securities collateral received on derivatives	(137)		(137)		(100)
Excess securities collateral provided on derivatives	(185)		(185)		(150)
Exchange-traded
Derivatives, Fair Value [Line Items]
Cash collateral on derivative assets	0		0		0
Excess securities collateral received on derivatives	(960)		(960)		(315)
Excess securities collateral provided on derivatives	(462)		(462)		(224)
Hedge Funds [Member]
Derivatives, Fair Value [Line Items]
Maximum Amount of Future Payments under Credit Default Swaps					20
Estimated Fair Value of Credit Default Swaps					(2)
Ba [Member]
Derivatives, Fair Value [Line Items]
Maximum Amount of Future Payments under Credit Default Swaps	155		$ 155		$ 164
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Average Remaining Maturity			4 years 4 months		1 year 6 months
Nonperformance Risk [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Net derivatives gains (losses)	(224)	$ 253	$ 1,200	$ 222
B
Derivatives, Fair Value [Line Items]
Maximum Amount of Future Payments under Credit Default Swaps	226		$ 226		$ 639
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Average Remaining Maturity			4 years 4 months		4 years 11 months
Accrued Liabilities [Member]
Derivatives, Fair Value [Line Items]
Estimated Fair Value Assets	333		$ 333		$ 278
Estimated Fair Value Liabilities	(11)		(11)		41
Credit Index Product [Member] | Ba [Member]
Derivatives, Fair Value [Line Items]
Maximum Amount of Future Payments under Credit Default Swaps	0		$ 0		$ 100
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Average Remaining Maturity			0 years		1 year
Credit Index Product [Member] | B
Derivatives, Fair Value [Line Items]
Maximum Amount of Future Payments under Credit Default Swaps	156		$ 156		$ 639
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Average Remaining Maturity			5 years 4 months		4 years 11 months
Credit Default Swap [Member] | Ba [Member]
Derivatives, Fair Value [Line Items]
Maximum Amount of Future Payments under Credit Default Swaps	155		$ 155		$ 64
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Average Remaining Maturity			4 years 4 months		2 years 4 months
Credit Default Swap [Member] | B
Derivatives, Fair Value [Line Items]
Maximum Amount of Future Payments under Credit Default Swaps	$ 70		$ 70		$ 0
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Average Remaining Maturity			2 years 1 month		0 years

XML

Fair Value (Recurring Fair Value Measurements) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Assets [Abstract]
Available-for-sale Securities, Debt Securities	$ 390,442	$ 351,402
Available-for-sale Securities, Equity Securities	3,289	3,321
Actively traded securities	0	404
Fair Value Option And Trading Securities	14,730	15,024
Short-term investments	11,655	9,299
Mortgage loans at estimated fair value	71,156	67,102
Derivative assets	21,788	14,406
Net embedded derivatives within asset host contracts	338	171
Separate account assets	315,648	301,598
Liabilities [Abstract]
Derivative liabilities	8,352	7,049
Net embedded derivatives within liability host contracts	6,883	935
Long-term debt, at estimated fair value, relating to variable interest entities	16,553	18,023
Separate account liabilities	315,648	301,598
Residential mortgage loans — FVO
Assets [Abstract]
Mortgage loans at estimated fair value	481	314
Consolidated Securitization Entities
Assets [Abstract]
Mortgage loans at estimated fair value	143	172
Liabilities [Abstract]
Long-term debt, at estimated fair value, relating to variable interest entities	38	60
Recurring
Assets [Abstract]
Available-for-sale Securities, Debt Securities	390,442	351,402
Available-for-sale Securities, Equity Securities	3,289	3,321
Actively traded securities	0	404
Fair Value Option And Trading Securities	14,730	15,024
Short-term investments	10,544	8,819
Mortgage loans at estimated fair value	624	486
Other investments	155	162
Derivative assets	21,788	14,406
Net embedded derivatives within asset host contracts	578	391
Separate account assets	315,648	301,598
Total assets	757,798	695,609
Liabilities [Abstract]
Derivative liabilities	8,352	7,049
Net embedded derivatives within liability host contracts	6,883	935
Trading liabilities	0	153
Total liabilities	15,355	8,197
Recurring | Interest rate contracts
Assets [Abstract]
Derivative assets	15,432	9,434
Liabilities [Abstract]
Derivative liabilities	3,172	2,347
Recurring | Foreign currency exchange rate contracts
Assets [Abstract]
Derivative assets	4,431	3,019
Liabilities [Abstract]
Derivative liabilities	2,849	2,902
Recurring | Credit contracts
Assets [Abstract]
Derivative assets	160	106
Liabilities [Abstract]
Derivative liabilities	54	47
Recurring | Equity market contracts
Assets [Abstract]
Derivative assets	1,765	1,847
Liabilities [Abstract]
Derivative liabilities	2,277	1,753
Recurring | Derivative Liabilities Within Separate Accounts
Liabilities [Abstract]
Separate account liabilities	82	0
Recurring | FVO general account securities
Assets [Abstract]
Fair Value Option And Trading Securities	721	627
Recurring | FVO contractholder-directed unit-linked investments
Assets [Abstract]
Fair Value Option And Trading Securities	14,000	13,981
Recurring | Residential mortgage loans — FVO
Assets [Abstract]
Mortgage loans at estimated fair value	481	314
Recurring | Consolidated Securitization Entities
Assets [Abstract]
Fair Value Option And Trading Securities	9	12
Mortgage loans at estimated fair value	143	172
Liabilities [Abstract]
Long-term debt, at estimated fair value, relating to variable interest entities	38	60
Recurring | U.S. corporate
Assets [Abstract]
Available-for-sale Securities, Debt Securities	105,676	100,794
Recurring | U.S. government and agency
Assets [Abstract]
Available-for-sale Securities, Debt Securities	69,785	61,646
Recurring | Foreign corporate
Assets [Abstract]
Available-for-sale Securities, Debt Securities	60,419	57,198
Recurring | Foreign government
Assets [Abstract]
Available-for-sale Securities, Debt Securities	63,765	50,499
Recurring | RMBS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	45,309	38,797
Recurring | State and political subdivision
Assets [Abstract]
Available-for-sale Securities, Debt Securities	17,463	15,441
Recurring | ABS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	15,584	14,394
Recurring | CMBS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	12,441	12,633
Recurring | Level 1
Assets [Abstract]
Available-for-sale Securities, Debt Securities	45,129	37,660
Available-for-sale Securities, Equity Securities	1,364	1,274
Actively traded securities	0	0
Fair Value Option And Trading Securities	11,639	11,335
Short-term investments	5,561	2,543
Mortgage loans at estimated fair value	0	0
Other investments	92	109
Derivative assets	18	67
Net embedded derivatives within asset host contracts	0	0
Separate account assets	87,035	77,080
Total assets	150,838	130,068
Liabilities [Abstract]
Derivative liabilities	111	25
Net embedded derivatives within liability host contracts	0	0
Trading liabilities	0	103
Total liabilities	112	128
Recurring | Level 1 | Interest rate contracts
Assets [Abstract]
Derivative assets	4	4
Liabilities [Abstract]
Derivative liabilities	41	7
Recurring | Level 1 | Foreign currency exchange rate contracts
Assets [Abstract]
Derivative assets	0	0
Liabilities [Abstract]
Derivative liabilities	2	0
Recurring | Level 1 | Credit contracts
Assets [Abstract]
Derivative assets	0	0
Liabilities [Abstract]
Derivative liabilities	0	0
Recurring | Level 1 | Equity market contracts
Assets [Abstract]
Derivative assets	14	63
Liabilities [Abstract]
Derivative liabilities	68	18
Recurring | Level 1 | Derivative Liabilities Within Separate Accounts
Liabilities [Abstract]
Separate account liabilities	1	0
Recurring | Level 1 | FVO general account securities
Assets [Abstract]
Fair Value Option And Trading Securities	578	506
Recurring | Level 1 | FVO contractholder-directed unit-linked investments
Assets [Abstract]
Fair Value Option And Trading Securities	11,061	10,829
Recurring | Level 1 | Residential mortgage loans — FVO
Assets [Abstract]
Mortgage loans at estimated fair value	0	0
Recurring | Level 1 | Consolidated Securitization Entities
Assets [Abstract]
Fair Value Option And Trading Securities	0	0
Mortgage loans at estimated fair value	0	0
Liabilities [Abstract]
Long-term debt, at estimated fair value, relating to variable interest entities	0	0
Recurring | Level 1 | U.S. corporate
Assets [Abstract]
Available-for-sale Securities, Debt Securities	0	0
Recurring | Level 1 | U.S. government and agency
Assets [Abstract]
Available-for-sale Securities, Debt Securities	40,780	37,660
Recurring | Level 1 | Foreign corporate
Assets [Abstract]
Available-for-sale Securities, Debt Securities	0	0
Recurring | Level 1 | Foreign government
Assets [Abstract]
Available-for-sale Securities, Debt Securities	0	0
Recurring | Level 1 | RMBS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	4,349	0
Recurring | Level 1 | State and political subdivision
Assets [Abstract]
Available-for-sale Securities, Debt Securities	0	0
Recurring | Level 1 | ABS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	0	0
Recurring | Level 1 | CMBS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	0	0
Recurring | Level 2
Assets [Abstract]
Available-for-sale Securities, Debt Securities	323,709	292,928
Available-for-sale Securities, Equity Securities	1,270	1,615
Actively traded securities	0	400
Fair Value Option And Trading Securities	2,848	3,419
Short-term investments	4,310	5,985
Mortgage loans at estimated fair value	143	172
Other investments	63	53
Derivative assets	21,199	13,942
Net embedded derivatives within asset host contracts	0	0
Separate account assets	227,343	222,814
Total assets	580,885	540,928
Liabilities [Abstract]
Derivative liabilities	7,381	6,216
Net embedded derivatives within liability host contracts	0	0
Trading liabilities	0	50
Total liabilities	7,482	6,315
Recurring | Level 2 | Interest rate contracts
Assets [Abstract]
Derivative assets	15,272	9,405
Liabilities [Abstract]
Derivative liabilities	3,084	2,340
Recurring | Level 2 | Foreign currency exchange rate contracts
Assets [Abstract]
Derivative assets	4,369	3,003
Liabilities [Abstract]
Derivative liabilities	2,795	2,754
Recurring | Level 2 | Credit contracts
Assets [Abstract]
Derivative assets	141	99
Liabilities [Abstract]
Derivative liabilities	54	45
Recurring | Level 2 | Equity market contracts
Assets [Abstract]
Derivative assets	1,417	1,435
Liabilities [Abstract]
Derivative liabilities	1,448	1,077
Recurring | Level 2 | Derivative Liabilities Within Separate Accounts
Liabilities [Abstract]
Separate account liabilities	75	0
Recurring | Level 2 | FVO general account securities
Assets [Abstract]
Fair Value Option And Trading Securities	30	32
Recurring | Level 2 | FVO contractholder-directed unit-linked investments
Assets [Abstract]
Fair Value Option And Trading Securities	2,816	2,985
Recurring | Level 2 | Residential mortgage loans — FVO
Assets [Abstract]
Mortgage loans at estimated fair value	0	0
Recurring | Level 2 | Consolidated Securitization Entities
Assets [Abstract]
Fair Value Option And Trading Securities	2	2
Mortgage loans at estimated fair value	143	172
Liabilities [Abstract]
Long-term debt, at estimated fair value, relating to variable interest entities	26	49
Recurring | Level 2 | U.S. corporate
Assets [Abstract]
Available-for-sale Securities, Debt Securities	98,569	93,758
Recurring | Level 2 | U.S. government and agency
Assets [Abstract]
Available-for-sale Securities, Debt Securities	28,688	23,986
Recurring | Level 2 | Foreign corporate
Assets [Abstract]
Available-for-sale Securities, Debt Securities	53,667	51,438
Recurring | Level 2 | Foreign government
Assets [Abstract]
Available-for-sale Securities, Debt Securities	63,443	49,643
Recurring | Level 2 | RMBS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	35,510	34,088
Recurring | Level 2 | State and political subdivision
Assets [Abstract]
Available-for-sale Securities, Debt Securities	17,417	15,395
Recurring | Level 2 | ABS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	14,506	12,731
Recurring | Level 2 | CMBS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	11,909	11,889
Recurring | Level 3
Assets [Abstract]
Available-for-sale Securities, Debt Securities	21,604	20,814
Available-for-sale Securities, Equity Securities	655	432
Actively traded securities	0	4
Fair Value Option And Trading Securities	243	270
Short-term investments	673	291
Mortgage loans at estimated fair value	481	314
Other investments	0	0
Derivative assets	571	397
Net embedded derivatives within asset host contracts	578	391
Separate account assets	1,270	1,704
Total assets	26,075	24,613
Liabilities [Abstract]
Derivative liabilities	860	808
Net embedded derivatives within liability host contracts	6,883	935
Trading liabilities	0	0
Total liabilities	7,761	1,754
Recurring | Level 3 | Interest rate contracts
Assets [Abstract]
Derivative assets	156	25
Liabilities [Abstract]
Derivative liabilities	47	0
Recurring | Level 3 | Foreign currency exchange rate contracts
Assets [Abstract]
Derivative assets	62	16
Liabilities [Abstract]
Derivative liabilities	52	148
Recurring | Level 3 | Credit contracts
Assets [Abstract]
Derivative assets	19	7
Liabilities [Abstract]
Derivative liabilities	0	2
Recurring | Level 3 | Equity market contracts
Assets [Abstract]
Derivative assets	334	349
Liabilities [Abstract]
Derivative liabilities	761	658
Recurring | Level 3 | Derivative Liabilities Within Separate Accounts
Liabilities [Abstract]
Separate account liabilities	6	0
Recurring | Level 3 | FVO general account securities
Assets [Abstract]
Fair Value Option And Trading Securities	113	89
Recurring | Level 3 | FVO contractholder-directed unit-linked investments
Assets [Abstract]
Fair Value Option And Trading Securities	123	167
Recurring | Level 3 | Residential mortgage loans — FVO
Assets [Abstract]
Mortgage loans at estimated fair value	481	314
Recurring | Level 3 | Consolidated Securitization Entities
Assets [Abstract]
Fair Value Option And Trading Securities	7	10
Mortgage loans at estimated fair value	0	0
Liabilities [Abstract]
Long-term debt, at estimated fair value, relating to variable interest entities	12	11
Recurring | Level 3 | U.S. corporate
Assets [Abstract]
Available-for-sale Securities, Debt Securities	7,107	7,036
Recurring | Level 3 | U.S. government and agency
Assets [Abstract]
Available-for-sale Securities, Debt Securities	317	0
Recurring | Level 3 | Foreign corporate
Assets [Abstract]
Available-for-sale Securities, Debt Securities	6,752	5,760
Recurring | Level 3 | Foreign government
Assets [Abstract]
Available-for-sale Securities, Debt Securities	322	856
Recurring | Level 3 | RMBS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	5,450	4,709
Recurring | Level 3 | State and political subdivision
Assets [Abstract]
Available-for-sale Securities, Debt Securities	46	46
Recurring | Level 3 | ABS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	1,078	1,663
Recurring | Level 3 | CMBS
Assets [Abstract]
Available-for-sale Securities, Debt Securities	$ 532	$ 744

XML

Fair Value (Quantitative Information) (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Interest rate contracts | Minimum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Swap yield	2.00%	3.07%
Repurchase Rate	(0.06%)
Interest rate contracts | Maximum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Swap yield	3.00%	3.17%
Repurchase Rate	0.17%
Foreign currency exchange rate contracts | Minimum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Swap yield	0.50%	0.28%
Foreign currency exchange rate contracts | Maximum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Swap yield	3.28%	3.81%
Credit contracts | Minimum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Credit spreads	0.97%	0.98%
Credit contracts | Maximum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Credit spreads	1.00%	1.00%
Equity market contracts | Minimum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Correlation	40.00%	70.00%
Volatility	13.00%	15.00%
Equity market contracts | Maximum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Correlation	40.00%	70.00%
Volatility	36.00%	36.00%
Embedded derivatives direct and assumed guaranteed minimum benefits | Minimum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Utilization rates	0.00%	0.00%
Withdrawal rates	0.00%	0.00%
Long-term equity volatilities	9.95%	8.79%
Nonperformance risk spread	0.05%	(0.47%)
Embedded derivatives direct and assumed guaranteed minimum benefits | Minimum | Income Approach Valuation Technique | Durations 1 - 10
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Lapse Rate	0.25%	0.25%
Embedded derivatives direct and assumed guaranteed minimum benefits | Minimum | Income Approach Valuation Technique | Durations 11 - 20
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Lapse Rate	2.00%	2.00%
Embedded derivatives direct and assumed guaranteed minimum benefits | Minimum | Income Approach Valuation Technique | Durations 21 - 116
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Lapse Rate	1.25%	1.00%
Embedded derivatives direct and assumed guaranteed minimum benefits | Minimum | Income Approach Valuation Technique | Ages 0 - 40
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Mortality Rate	0.00%	0.00%
Embedded derivatives direct and assumed guaranteed minimum benefits | Minimum | Income Approach Valuation Technique | Ages 41 - 60
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Mortality Rate	0.01%	0.01%
Embedded derivatives direct and assumed guaranteed minimum benefits | Minimum | Income Approach Valuation Technique | Ages 61 - 115
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Mortality Rate	0.00%	0.04%
Embedded derivatives direct and assumed guaranteed minimum benefits | Maximum | Income Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Utilization rates	25.00%	25.00%
Withdrawal rates	20.00%	20.00%
Long-term equity volatilities	33.00%	33.00%
Nonperformance risk spread	2.03%	1.31%
Embedded derivatives direct and assumed guaranteed minimum benefits | Maximum | Income Approach Valuation Technique | Durations 1 - 10
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Lapse Rate	100.00%	100.00%
Embedded derivatives direct and assumed guaranteed minimum benefits | Maximum | Income Approach Valuation Technique | Durations 11 - 20
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Lapse Rate	100.00%	100.00%
Embedded derivatives direct and assumed guaranteed minimum benefits | Maximum | Income Approach Valuation Technique | Durations 21 - 116
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Lapse Rate	100.00%	100.00%
Embedded derivatives direct and assumed guaranteed minimum benefits | Maximum | Income Approach Valuation Technique | Ages 0 - 40
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Mortality Rate	0.21%	0.21%
Embedded derivatives direct and assumed guaranteed minimum benefits | Maximum | Income Approach Valuation Technique | Ages 41 - 60
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Mortality Rate	0.78%	0.78%
Embedded derivatives direct and assumed guaranteed minimum benefits | Maximum | Income Approach Valuation Technique | Ages 61 - 115
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Mortality Rate	100.00%	100.00%
U.S. corporate and foreign corporate securities | Minimum | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Delta spread adjustments	(2.69%)	(0.65%)
Offered quotes	$ 23	$ 68
Quoted prices	$ 6	$ 0
U.S. corporate and foreign corporate securities | Maximum | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Delta spread adjustments	6.03%	2.40%
Offered quotes	$ 121	$ 121
Quoted prices	$ 788	$ 780
U.S. corporate and foreign corporate securities | Weighted Average | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Delta spread adjustments	(0.04%)	0.39%
Offered quotes	$ 98	$ 98
Quoted prices	123	156
Foreign government | Minimum | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Quoted prices	100	96
Foreign government | Maximum | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Quoted prices	124	135
Foreign government | Weighted Average | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Quoted prices	104	113
RMBS | Minimum | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Quoted prices	7	19
RMBS | Maximum | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Quoted prices	131	292
RMBS | Weighted Average | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Quoted prices	90	92
ABS | Minimum | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Offered quotes	98	66
Quoted prices	5	16
ABS | Maximum | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Offered quotes	107	105
Quoted prices	105	109
ABS | Weighted Average | Market Approach Valuation Technique
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Offered quotes	100	99
Quoted prices	$ 99	$ 100

XML

Fair Value (Unobservable Input Reconciliation) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Consolidated Securitization Entities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	$ (12)	$ (12)	$ (11)	$ (13)
Total realized/unrealized gains (losses) included in net income (loss)	0	0	0	0
Total realized/unrealized gains (losses) included in AOCI	0	0	0	0
Purchases	0	0	0	0
Sales	0	0	0	0
Issuances	0	0	0	0
Settlements	0	1	(1)	2
Transfers into Level 3	0	0	0	0
Transfers out of Level 3	0	0	0	0
Balance, end of period	(12)	(11)	(12)	(11)
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	0	0	0	0
Net Derivatives
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	(103)	(103)	90	(141)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance, beginning of period	(132)	(372)	(411)	(300)
Total realized/unrealized gains (losses) included in net income (loss)	(116)	(97)	110	(163)
Total realized/unrealized gains (losses) included in AOCI	(7)	7	36	3
Purchases	0	0	12	4
Sales	0	0	0	0
Issuances	(1)	(1)	(1)	(1)
Settlements	(33)	24	(33)	18
Transfers into Level 3	0	0	0	0
Transfers out of Level 3	0	0	(2)	0
Balance, end of period	(289)	(439)	(289)	(439)
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	(103)	(103)	90	(141)
Net Embedded Derivatives
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	750	(1,743)	(4,884)	(973)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance, beginning of period	(6,804)	841	(544)	430
Total realized/unrealized gains (losses) included in net income (loss)	765	(1,753)	(4,851)	(964)
Total realized/unrealized gains (losses) included in AOCI	(27)	(38)	(237)	(19)
Purchases	0	0	0	0
Sales	0	0	0	0
Issuances	0	0	0	0
Settlements	(239)	(216)	(673)	(613)
Transfers into Level 3	0	0	0	0
Transfers out of Level 3	0	0	0	0
Balance, end of period	(6,305)	(1,166)	(6,305)	(1,166)
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	750	(1,743)	(4,884)	(973)
Residential mortgage loans — FVO
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	449	345	314	308
Total realized/unrealized gains (losses) included in net income (loss)	10	(2)	22	18
Total realized/unrealized gains (losses) included in AOCI	0	0	0	0
Purchases	42	18	187	114
Sales	(5)	(37)	(12)	(100)
Issuances	0	0	0	0
Settlements	(15)	(9)	(30)	(25)
Transfers into Level 3	0	0	0	0
Transfers out of Level 3	0	0	0	0
Balance, end of period	481	315	481	315
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	10	(2)	22	18
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	10	(2)	22	18
Trading Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	0	(4)	0	0
Total realized/unrealized gains (losses) included in net income (loss)	0	0	0	0
Total realized/unrealized gains (losses) included in AOCI	0	0	0	0
Purchases	0	(2)	0	(2)
Sales	0	0	0	0
Issuances	0	0	0	0
Settlements	0	0	0	0
Transfers into Level 3	0	0	0	0
Transfers out of Level 3	0	4	0	0
Balance, end of period	0	(2)	0	(2)
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	0	0	0	0
Corporate fixed maturity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	13,710	13,520	12,796	13,432
Total realized/unrealized gains (losses) included in net income (loss)	15	25	(4)	62
Total realized/unrealized gains (losses) included in AOCI	98	(296)	1,027	(759)
Purchases	680	955	1,893	1,884
Sales	(595)	(351)	(1,034)	(964)
Issuances	0	0	0	0
Settlements	0	0	0	0
Transfers into Level 3	424	699	711	844
Transfers out of Level 3	(473)	(1,850)	(1,530)	(1,797)
Balance, end of period	13,859	12,702	13,859	12,702
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	1	10	2	21
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	1	10	2	21
U.S. government and agency
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	323	55	0	0
Total realized/unrealized gains (losses) included in net income (loss)	0	0	0	0
Total realized/unrealized gains (losses) included in AOCI	(1)	0	17	(1)
Purchases	99	0	111	0
Sales	0	(1)	0	(1)
Issuances	0	0	0	0
Settlements	0	0	0	0
Transfers into Level 3	0	18	200	19
Transfers out of Level 3	(104)	(55)	(11)	0
Balance, end of period	317	17	317	17
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	0	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	0	0	0	0
Foreign government
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	376	1,336	856	1,311
Total realized/unrealized gains (losses) included in net income (loss)	2	4	9	10
Total realized/unrealized gains (losses) included in AOCI	1	(1)	(2)	1
Purchases	21	17	58	30
Sales	(7)	(17)	(36)	(39)
Issuances	0	0	0	0
Settlements	0	0	0	0
Transfers into Level 3	0	11	41	7
Transfers out of Level 3	(71)	(659)	(604)	(629)
Balance, end of period	322	691	322	691
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	2	4	9	10
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	2	4	9	10
Structured Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	6,700	7,018	7,116	7,392
Total realized/unrealized gains (losses) included in net income (loss)	34	29	101	88
Total realized/unrealized gains (losses) included in AOCI	39	(46)	28	(68)
Purchases	1,034	2,544	2,291	4,062
Sales	(512)	(418)	(1,357)	(1,304)
Issuances	0	0	0	0
Settlements	0	0	0	0
Transfers into Level 3	81	361	43	355
Transfers out of Level 3	(316)	(955)	(1,162)	(1,992)
Balance, end of period	7,060	8,533	7,060	8,533
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	33	33	96	89
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	33	33	96	89
State and political subdivision
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	53	55	46	0
Total realized/unrealized gains (losses) included in net income (loss)	0	0	1	0
Total realized/unrealized gains (losses) included in AOCI	3	1	2	0
Purchases	0	20	0	46
Sales	0	0	0	0
Issuances	0	0	0	0
Settlements	0	0	0	0
Transfers into Level 3	7	0	7	0
Transfers out of Level 3	(17)	(30)	(10)	0
Balance, end of period	46	46	46	46
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	0	0	1	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	0	0	1	0
Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	682	489	432	345
Total realized/unrealized gains (losses) included in net income (loss)	5	6	(21)	7
Total realized/unrealized gains (losses) included in AOCI	(9)	(14)	43	(22)
Purchases	4	12	20	57
Sales	(20)	(13)	(25)	(34)
Issuances	0	0	0	0
Settlements	0	0	0	0
Transfers into Level 3	1	0	455	107
Transfers out of Level 3	(8)	(30)	(249)	(10)
Balance, end of period	655	450	655	450
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	(1)	0	(27)	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	(1)	0	(27)	0
FVO And Trading Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	231	475	270	567
Total realized/unrealized gains (losses) included in net income (loss)	4	(16)	9	(27)
Total realized/unrealized gains (losses) included in AOCI	0	0	0	0
Purchases	18	91	43	130
Sales	(6)	(41)	(29)	(130)
Issuances	0	0	0	0
Settlements	0	0	0	0
Transfers into Level 3	0	80	18	82
Transfers out of Level 3	(4)	(191)	(68)	(224)
Balance, end of period	243	398	243	398
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	4	(16)	9	(25)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	4	(16)	9	(25)
Short-term Investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	175	1,809	291	336
Total realized/unrealized gains (losses) included in net income (loss)	1	0	1	1
Total realized/unrealized gains (losses) included in AOCI	(1)	0	4	0
Purchases	664	1,296	673	1,313
Sales	(55)	(11)	(294)	(28)
Issuances	0	0	0	0
Settlements	0	0	0	0
Transfers into Level 3	0	5	1	0
Transfers out of Level 3	(111)	(1,786)	(3)	(309)
Balance, end of period	673	1,313	673	1,313
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	1	0	1	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	1	0	1	0
Separate Accounts
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	1,627	1,925	1,704	1,922
Total realized/unrealized gains (losses) included in net income (loss)	(25)	24	7	5
Total realized/unrealized gains (losses) included in AOCI	0	0	0	0
Purchases	4	95	108	297
Sales	(155)	(93)	(233)	(232)
Issuances	30	0	27	0
Settlements	(45)	0	(58)	(2)
Transfers into Level 3	8	2	9	3
Transfers out of Level 3	(180)	(271)	(300)	(311)
Balance, end of period	1,264	1,682	1,264	1,682
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	0	0	0	0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Changes in unrealized gains (losses) included in net income (loss) for the instruments still held at end of period	$ 0	$ 0	$ 0	$ 0

XML

Fair Value (Fair Value Option for Certain Assets and Liabilities) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Fair Value, Option, Quantitative Disclosures [Line Items]
Carrying value at estimated fair value	$ 71,156	$ 67,102
Carrying value at estimated fair value	16,553	18,023
Consolidated Securitization Entities
Fair Value, Option, Quantitative Disclosures [Line Items]
Unpaid principal balance	95	121
Difference between estimated fair value and unpaid principal balance	48	51
Carrying value at estimated fair value	143	172
Loans in non-accrual status	0	0
Contractual principal balance	50	71
Difference between estimated fair value and contractual principal balance	(12)	(11)
Carrying value at estimated fair value	38	60
Residential mortgage loans — FVO
Fair Value, Option, Quantitative Disclosures [Line Items]
Unpaid principal balance	641	436
Difference between estimated fair value and unpaid principal balance	(160)	(122)
Carrying value at estimated fair value	481	314
Loans in non-accrual status	$ 186	$ 122

XML

Fair Value (Nonrecurring Fair Value Measurements) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Level 3 | Mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Value After Measurement	$ 12	$ 44	$ 12	$ 44
Level 3 | Other limited partnership interests
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Value After Measurement	78	53	78	53
Level 3 | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Value After Measurement	0	0	0	0
Level 3 | Goodwill
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Value After Measurement	0	0	0	0
Nonrecurring | Mortgage loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gains (Losses)	0	0	0	(1)
Nonrecurring | Other limited partnership interests
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gains (Losses)	(9)	(8)	(45)	(27)
Nonrecurring | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gains (Losses)	0	0	(44)	0
Nonrecurring | Goodwill
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gains (Losses)	$ (260)	$ 0	$ (260)	$ 0

XML

Fair Value (Financial Instruments Carried at Other Than Fair Value) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Assets
Policy loans	$ 11,177	$ 11,258
Liabilities
Collateral financing arrangements	4,084	4,139
Junior subordinated debt securities	3,168	3,194
Separate account liabilities	315,648	301,598
Carrying Value
Assets
Mortgage loans	70,532	66,616
Policy loans	11,177	11,258
Real estate joint ventures	25	35
Other limited partnership interests	414	524
Other invested assets	559	537
Premiums, reinsurance and other receivables	4,030	2,822
Other assets	243	235
Liabilities
Policyholder account balances	126,417	125,040
Long-term debt	16,505	17,954
Collateral financing arrangements	4,084	4,139
Junior subordinated debt securities	3,168	3,194
Other liabilities	6,919	2,249
Separate account liabilities	123,253	112,119
Estimated Fair Value
Assets
Mortgage loans	73,585	68,539
Policy loans	13,701	13,351
Real estate joint ventures	87	104
Other limited partnership interests	461	615
Other invested assets	559	537
Premiums, reinsurance and other receivables	4,128	2,905
Other assets	281	267
Liabilities
Policyholder account balances	133,084	130,125
Long-term debt	18,526	19,360
Collateral financing arrangements	3,749	3,899
Junior subordinated debt securities	4,142	4,029
Other liabilities	6,921	2,250
Separate account liabilities	123,253	112,119
Estimated Fair Value | Level 1
Assets
Mortgage loans	0	0
Policy loans	0	0
Real estate joint ventures	0	0
Other limited partnership interests	0	0
Other invested assets	169	155
Premiums, reinsurance and other receivables	0	0
Other assets	0	0
Liabilities
Policyholder account balances	0	0
Long-term debt	0	0
Collateral financing arrangements	0	0
Junior subordinated debt securities	0	0
Other liabilities	0	0
Separate account liabilities	0	0
Estimated Fair Value | Level 2
Assets
Mortgage loans	0	0
Policy loans	1,107	1,279
Real estate joint ventures	0	0
Other limited partnership interests	0	0
Other invested assets	0	2
Premiums, reinsurance and other receivables	910	484
Other assets	205	207
Liabilities
Policyholder account balances	0	0
Long-term debt	18,526	19,360
Collateral financing arrangements	0	0
Junior subordinated debt securities	4,142	4,029
Other liabilities	6,429	865
Separate account liabilities	123,253	112,119
Estimated Fair Value | Level 3
Assets
Mortgage loans	73,585	68,539
Policy loans	12,594	12,072
Real estate joint ventures	87	104
Other limited partnership interests	461	615
Other invested assets	390	380
Premiums, reinsurance and other receivables	3,218	2,421
Other assets	76	60
Liabilities
Policyholder account balances	133,084	130,125
Long-term debt	0	0
Collateral financing arrangements	3,749	3,899
Junior subordinated debt securities	0	0
Other liabilities	492	1,385
Separate account liabilities	$ 0	$ 0

XML

Fair Value (Recurring Fair Value Measurements) (Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Net Embedded Derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	$ (240)	$ (220)

XML

Fair Value (Transfers Between Levels) (Narrative) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2015 USD ($)
Fair Value Disclosures [Abstract]
Fair Value Assets And Liabilities Transferred Between Levels 1 And Levels 2	$ 203

XML

Fair Value (Nonrecurring Fair Value Measurements) (Narrative) (Details) - Private Equity And Debt Funds	9 Months Ended
	Sep. 30, 2016
Minimum
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Liquidation period	2 years
Maximum
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Liquidation period	10 years

XML

Equity (Preferred Stock) (Details) - shares	Sep. 30, 2016	Dec. 31, 2015
Class of Stock [Line Items]
Preferred Stock, Shares Issued	25,500,000	25,500,000
Preferred Stock, Shares Outstanding	25,500,000	25,500,000
Preferred Stock, Shares Authorized	200,000,000	200,000,000
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Issued	24,000,000	24,000,000
Preferred Stock, Shares Outstanding	24,000,000	24,000,000
Preferred Stock, Shares Authorized	27,600,000	27,600,000
Series C Preferred Stock
Class of Stock [Line Items]
Preferred Stock, Shares Issued	1,500,000	1,500,000
Preferred Stock, Shares Outstanding	1,500,000	1,500,000
Preferred Stock, Shares Authorized	1,500,000	1,500,000
Series A Junior Preferred Stock
Class of Stock [Line Items]
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Not Designated Preferred Stock
Class of Stock [Line Items]
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Preferred Stock, Shares Authorized	160,900,000	160,900,000

XML

Goodwill (Goodwill) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Goodwill Rollforward and by Segment
Goodwill			$ 11,345
Accumulated impairment			(1,868)
Total goodwill, net			9,477
Dispositions			(42)
Impairment	$ (260)	$ 0	(260)	$ 0
Effect of foreign currency translation and other			417
Goodwill	11,720		11,720
Accumulated impairment	(2,128)		(2,128)
Total goodwill, net	9,592		9,592
U.S.
Goodwill Rollforward and by Segment
Goodwill			1,451
Accumulated impairment			0
Total goodwill, net			1,451
Dispositions			0
Impairment			0
Effect of foreign currency translation and other			0
Goodwill	1,451		1,451
Accumulated impairment	0		0
Total goodwill, net	1,451		1,451
Asia
Goodwill Rollforward and by Segment
Goodwill			4,508
Accumulated impairment			0
Total goodwill, net			4,508
Dispositions			0
Impairment			0
Effect of foreign currency translation and other			352
Goodwill	4,860		4,860
Accumulated impairment	0		0
Total goodwill, net	4,860		4,860
Latin America
Goodwill Rollforward and by Segment
Goodwill			1,186
Accumulated impairment			0
Total goodwill, net			1,186
Dispositions			0
Impairment			0
Effect of foreign currency translation and other			64
Goodwill	1,250		1,250
Accumulated impairment	0		0
Total goodwill, net	1,250		1,250
EMEA
Goodwill Rollforward and by Segment
Goodwill			1,143
Accumulated impairment			0
Total goodwill, net			1,143
Dispositions			0
Impairment			0
Effect of foreign currency translation and other			1
Goodwill	1,144		1,144
Accumulated impairment	0		0
Total goodwill, net	1,144		1,144
MetLife Holdings
Goodwill Rollforward and by Segment
Goodwill			2,579
Accumulated impairment			(1,692)
Total goodwill, net			887
Dispositions			0
Impairment			0
Effect of foreign currency translation and other			0
Goodwill	2,579		2,579
Accumulated impairment	(1,692)		(1,692)
Total goodwill, net	887		887
Brighthouse Financial
Goodwill Rollforward and by Segment
Goodwill			260
Accumulated impairment			0
Total goodwill, net			260
Dispositions			0
Impairment	(260)		(260)
Effect of foreign currency translation and other			0
Goodwill	260		260
Accumulated impairment	(260)		(260)
Total goodwill, net	0		0
Goodwill, impairment loss, net of tax	223		223
Corporate & Other
Goodwill Rollforward and by Segment
Goodwill			218
Accumulated impairment			(176)
Total goodwill, net			42
Impairment			0
Effect of foreign currency translation and other			0
Goodwill	176		176
Accumulated impairment	(176)		(176)
Total goodwill, net	$ 0		0
Corporate & Other | MetLife U.S. Retail Advisor Force
Goodwill Rollforward and by Segment
Dispositions			$ (42)

XML

Equity (Components of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance, beginning of period	$ 14,632	$ 6,443	$ 4,771	$ 10,649
OCI before reclassifications	(1,300)	728	12,905	(5,269)
Deferred income tax benefit (expense)	404	(411)	(3,835)	1,345
AOCI before reclassifications, net of income tax	13,736	6,760	13,841	6,725
Amounts reclassified from AOCI	(221)	194	(368)	269
Deferred income tax benefit (expense)	80	(63)	122	(103)
Amounts reclassified from AOCI, net of income tax	(141)	131	(246)	166
Balance, end of period	13,595	6,891	13,595	6,891
Unrealized Investment Gains (Losses), Net of Related Offsets
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance, beginning of period	18,204	11,761	10,315	15,159
OCI before reclassifications	(1,066)	962	10,872	(3,923)
Deferred income tax benefit (expense)	281	(340)	(3,656)	1,337
AOCI before reclassifications, net of income tax	17,419	12,383	17,531	12,573
Amounts reclassified from AOCI	(173)	(102)	(339)	(392)
Deferred income tax benefit (expense)	60	34	114	134
Amounts reclassified from AOCI, net of income tax	(113)	(68)	(225)	(258)
Balance, end of period	17,306	12,315	17,306	12,315
Unrealized Gains (Losses) on Derivatives
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance, beginning of period	2,431	1,102	1,458	1,076
OCI before reclassifications	(24)	102	1,472	(106)
Deferred income tax benefit (expense)	8	(47)	(460)	37
AOCI before reclassifications, net of income tax	2,415	1,157	2,470	1,007
Amounts reclassified from AOCI	(94)	239	(174)	490
Deferred income tax benefit (expense)	30	(77)	55	(178)
Amounts reclassified from AOCI, net of income tax	(64)	162	(119)	312
Balance, end of period	2,351	1,319	2,351	1,319
Foreign Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance, beginning of period	(4,020)	(4,214)	(4,950)	(3,303)
OCI before reclassifications	49	(336)	809	(1,243)
Deferred income tax benefit (expense)	30	(24)	200	(28)
AOCI before reclassifications, net of income tax	(3,941)	(4,574)	(3,941)	(4,574)
Amounts reclassified from AOCI	0	0	0	0
Deferred income tax benefit (expense)	0	0	0	0
Amounts reclassified from AOCI, net of income tax	0	0	0	0
Balance, end of period	(3,941)	(4,574)	(3,941)	(4,574)
Defined Benefit Plans Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance, beginning of period	(1,983)	(2,206)	(2,052)	(2,283)
OCI before reclassifications	(259)	0	(248)	3
Deferred income tax benefit (expense)	85	0	81	(1)
AOCI before reclassifications, net of income tax	(2,157)	(2,206)	(2,219)	(2,281)
Amounts reclassified from AOCI	46	57	145	171
Deferred income tax benefit (expense)	(10)	(20)	(47)	(59)
Amounts reclassified from AOCI, net of income tax	36	37	98	112
Balance, end of period	$ (2,121)	$ (2,169)	$ (2,121)	$ (2,169)

XML

Equity (Reclassifications Out of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net investment gains (losses)	$ 257	$ 382	$ 538	$ 535
Net derivative gains (losses)	(1,051)	485	(1,815)	394
Net investment income	5,464	3,959	14,910	14,367
Other expenses	(3,928)	(4,533)	(11,366)	(12,665)
Income (loss) from continuing operations before provision for income tax	548	2,163	3,370	6,335
Provision for income tax expense (benefit)	25	(965)	(480)	(1,855)
Net income (loss)	573	1,198	2,890	4,480
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net income (loss)	141	(131)	246	(166)
Reclassification out of Accumulated Other Comprehensive Income | Unrealized Investment Gains (Losses), Net of Related Offsets
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net investment gains (losses)	163	104	288	353
Net derivative gains (losses)	6	(5)	28	(21)
Net investment income	4	3	23	60
Income (loss) from continuing operations before provision for income tax	173	102	339	392
Provision for income tax expense (benefit)	(60)	(34)	(114)	(134)
Net income (loss)	113	68	225	258
Reclassification out of Accumulated Other Comprehensive Income | Unrealized Gains (Losses) on Derivatives
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income (loss) from continuing operations before provision for income tax	94	(239)	174	(490)
Provision for income tax expense (benefit)	(30)	77	(55)	178
Net income (loss)	64	(162)	119	(312)
Reclassification out of Accumulated Other Comprehensive Income | Unrealized Gains (Losses) on Derivatives | Interest rate swaps
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net derivative gains (losses)	28	40	56	52
Net investment income	4	3	11	9
Reclassification out of Accumulated Other Comprehensive Income | Unrealized Gains (Losses) on Derivatives | Interest rate forwards
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net derivative gains (losses)	1	1	2	5
Net investment income	1	1	4	3
Other expenses	0	1	1	2
Reclassification out of Accumulated Other Comprehensive Income | Unrealized Gains (Losses) on Derivatives | Foreign currency swaps
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net derivative gains (losses)	59	(286)	96	(563)
Net investment income	0	0	(1)	(1)
Other expenses	0	0	1	1
Reclassification out of Accumulated Other Comprehensive Income | Unrealized Gains (Losses) on Derivatives | Credit forwards
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net derivative gains (losses)	0	1	3	1
Net investment income	1	0	1	1
Reclassification out of Accumulated Other Comprehensive Income | Defined Benefit Plans Adjustment
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amortization of net actuarial gains (losses)	(47)	(58)	(150)	(174)
Amortization of prior service (costs) credit	1	1	5	3
Income (loss) from continuing operations before provision for income tax	(46)	(57)	(145)	(171)
Provision for income tax expense (benefit)	10	20	47	59
Net income (loss)	$ (36)	$ (37)	$ (98)	$ (112)

XML

Equity (Common Stock - Narrative) (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Equity [Abstract]
Treasury Stock, Shares, Acquired	1,445,864	22,475,816
Treasury Stock, Value, Acquired, Cost Method	$ 70	$ 1,107

XML

Equity (Stock-Based Compensation Plans - Narrative) (Details) - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2016
Minimum
Equity - Stock-based Compensation Plans [Line Items]
Future Performance Factor			0.00%
Maximum
Equity - Stock-based Compensation Plans [Line Items]
Future Performance Factor			175.00%
Performance Shares
Equity - Stock-based Compensation Plans [Line Items]
Performance Factor		86.20%
Vested in period		1,592,650
Issued in period	1,372,864
Performance Units
Equity - Stock-based Compensation Plans [Line Items]
Vested in period		234,787
Paid in period	202,386

XML

Other Expenses (Other Expenses) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Unrecognized tax benefits, decrease resulting from prior period tax positions		$ 792
Provision for income tax expense (benefit)	$ (25)	965	$ 480	$ 1,855
Other expenses	3,928	4,533	11,366	12,665
Compensation	1,101	1,157	3,600	3,706
Pension, postretirement and postemployment benefit costs	80	100	323	297
Commissions	1,049	1,103	3,277	3,382
Volume-related costs	214	264	694	761
Capitalization of DAC	(863)	(955)	(2,759)	(2,850)
Amortization of DAC and VOBA	1,017	1,131	2,133	3,053
Amortization of negative VOBA	(55)	(90)	(221)	(282)
Interest expense on debt	292	302	910	908
Premium taxes, licenses and fees	187	199	591	568
Professional services	373	366	1,101	1,079
Rent and related expenses, net of sublease income	90	78	285	245
Other (1)	443	878	1,432	1,798
Total other expenses	$ 3,928	4,533	$ 11,366	$ 12,665
Possible Change in Tax Assessment
Provision for income tax expense (benefit)		557
Other expenses		362
Net amount of other expense charge		235
Total other expenses		$ 362

XML

Employee Benefit Plans (Net Periodic Benefit Costs) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Pension Benefits
Net periodic benefit costs [Abstract]
Service costs	$ 67	$ 68	$ 212	$ 206
Interest costs	102	106	322	318
Curtailment costs	(1)	0	(1)	0
Expected return on plan assets	(140)	(136)	(394)	(408)
Amortization of net actuarial (gains) losses	44	48	143	143
Amortization of prior service costs (credit)	0	(1)	0	(1)
Net periodic benefit costs	72	85	282	258
Other Postretirement Benefits
Net periodic benefit costs [Abstract]
Service costs	4	3	8	12
Interest costs	21	22	63	67
Curtailment costs	(1)	0	26	0
Expected return on plan assets	(19)	(19)	(56)	(59)
Amortization of net actuarial (gains) losses	3	10	7	31
Amortization of prior service costs (credit)	(1)	0	(5)	(2)
Net periodic benefit costs	$ 7	$ 16	$ 43	$ 49

XML

Earnings Per Common Share (Earnings Per Common Share) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Weighted Average Shares:
Weighted average common stock outstanding for basic earnings per common share	1,100,504,563	1,118,856,041	1,100,558,083	1,120,130,708
Incremental common shares from assumed:
Exercise or issuance of stock-based awards	8,749,753	11,085,040	8,445,077	10,575,611
Weighted average common stock outstanding for diluted earnings per common share	1,109,254,316	1,129,941,081	1,109,003,160	1,130,706,319
Net Income (Loss):
Net income (loss)	$ 573	$ 1,198	$ 2,890	$ 4,480
Less: Net income (loss) attributable to noncontrolling interests	(4)	(5)	2	4
Less: Preferred stock dividends	6	6	58	67
Preferred stock repurchase premium	0	0	0	42
Net income (loss) available to MetLife, Inc.’s common shareholders	$ 571	$ 1,197	$ 2,830	$ 4,367
Basic	$ 0.52	$ 1.07	$ 2.57	$ 3.90
Diluted	$ 0.51	$ 1.06	$ 2.55	$ 3.86

XML

Contingencies, Commitments and Guarantees (Contingencies - Narrative) (Details)	9 Months Ended		12 Months Ended
	Sep. 30, 2016 USD ($) Claims	Sep. 30, 2015 Claims	Dec. 31, 2015 Claims
Minimum
Loss Contingencies
Loss Contingency, Range of Possible Loss, Portion Not Accrued	$ 0
Maximum
Loss Contingencies
Loss Contingency, Range of Possible Loss, Portion Not Accrued	$ 400,000,000
Superfund Site Settlement Agreements
Loss Contingencies
Number of regulatory matters and other claims | Claims	2
Maximum estimate of costs for environmental testing	$ 100,000
Superfund Site Settlement Agreements | Minimum
Loss Contingencies
Damages Sought	1,000,000
Superfund Site Settlement Agreements | Maximum
Loss Contingencies
Maximum estimate of aggregate costs to resolve matter	1,000,000
Fauley V. Metropolitan Life Insurance Company, et al. | Maximum
Loss Contingencies
Loss Contingency, Estimate of Possible Loss	23,000,000
FINRA
Loss Contingencies
Litigation Settlement, Amount	20,000,000
FINRA Customer Reimbursement
Loss Contingencies
Litigation Settlement, Amount	$ 5,000,000
Asbestos Related Claims
Loss Contingencies
Asbestos-Related Claims | Claims	3,267	2,971	3,856
Compensatory Damages | Hartshorne V. MetLife Inc., et al.
Loss Contingencies
Damages Sought	$ 200,000
Punitive Damages | Hartshorne V. MetLife Inc., et al.
Loss Contingencies
Damages Sought	$ 15,000,000

XML

Contingencies, Commitments and Guarantees (Commitments and Guarantees - Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Liabilities for indemnities, guarantees and commitments	$ 9	$ 8
Cumulative maximum indemnities and guarantees contractual limitation	1,200
Minimum
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Indemnities and guarantees contractual limitation range	1
Maximum
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Indemnities and guarantees contractual limitation range	329
Commitments to Fund Partnership Investments, Bank Credit Facilities, Bridge Loans and Private Corporate Bond Investments
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Fair Value Disclosure, Off-balance Sheet Risks, Face Amount, Liability	8,600	7,100
Mortgage Loan Commitments
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Fair Value Disclosure, Off-balance Sheet Risks, Face Amount, Liability	$ 4,000	$ 4,400

XML

Subsequent Event (Details) - Subsequent Event [Member] $ / shares in Units, $ in Millions	3 Months Ended
	Dec. 31, 2016 USD ($) $ / shares
Subsequent Event [Line Items]
Approved dividend, amount per share | $ / shares	$ 0.40
Estimated aggregate dividend payment | $	$ 441